Citrus Sinensis ID: 015898

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------40
Protein Sequence
MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccEEEcccccccccEEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEEcccEEEccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHcHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEEEEEEEEEccEEEEEEEEcccccEEEEEHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHcccccEcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mgntcrgsftgklyqgysqpedhsnnskrntnsdctnsdystpslnsqqlVSQEfskenpkkdnsaprispskkdnimrrgidnqtyyvlghktdNIRDLYTLGRklgqgqfgttyLCTEIATGIEFACKSIskrklisredvEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHslgvmhrdlkpenfllvnkdddfslkaidfglsvffkpgqiftdvvgspyyvapevllkhygpeadvwTAGVILYILLsgvppfwaetQQGIFDAVLKghidfesdpwplisDSAKDLIRKMLcsqpserltahevlchpwicengvapdrsldpAVLSRLKQFSAMNKLKKMALRVSASA
Flexible Loop (DISEMBL)
mgntcrgsftgklyqgysqpedhsnnskrNTNSDCTNSDYSTPSLNSQQLVSQEfskenpkkdnsaprispskkdnimrrGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEfacksiskrklisredvEDVRREIQIMhhlaghkniVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA
Low Complexity Region (SEG)
MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA
Disordered region (IsUnstruct)
*******************************************************************************RGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR*L***VL***********************
Disordered Region (DISOPRED)
*****************************************************************************************LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA
Disordered Region (DISEMBL)
MGNTCRGSFTGKLYQGY****************************************************SPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK*********
Disordered Region (DISPRO)
****************************************************************************************VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	398	2.2.26 [Sep-21-2011]
A5A7I7	557	Calcium-dependent protein	N/A	no	0.977	0.698	0.812	0.0
Q38871	556	Calcium-dependent protein	yes	no	0.984	0.705	0.815	0.0
Q38872	544	Calcium-dependent protein	no	no	0.959	0.702	0.801	0.0
A5A7I8	535	Calcium-dependent protein	N/A	no	0.927	0.689	0.798	0.0
Q9SZM3	484	Calcium-dependent protein	no	no	0.806	0.663	0.881	1e-170
P53684	542	Calcium-dependent protein	no	no	0.844	0.619	0.769	1e-150
Q38870	646	Calcium-dependent protein	no	no	0.964	0.594	0.643	1e-147
Q06850	610	Calcium-dependent protein	no	no	0.788	0.514	0.764	1e-147
P53682	534	Calcium-dependent protein	no	no	0.907	0.676	0.657	1e-143
Q9ZV15	583	Calcium-dependent protein	no	no	0.997	0.680	0.581	1e-143

>sp|A5A7I7|CDPK4_SOLTU Calcium-dependent protein kinase 4 OS=Solanum tuberosum GN=CPK4 PE=2 SV=1

 Score =  669 bits (1725), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/400 (81%), Positives = 353/400 (88%), Gaps = 11/400 (2%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRN--TNSDCTNSDYSTPSLNSQQLVSQEFSKE 58
           MGNTCRGS  GK +QGY+QPED S ++  N  + +  ++SD  +P+ N+QQ         
Sbjct: 1   MGNTCRGSIGGKTFQGYTQPEDSSCSTNHNPSSGNSYSSSDNFSPTSNAQQ-------NS 53

Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
           N KK++S   +SP K    M R   NQ YYV+GH T NIRDLYTLGRKLGQGQFGTTYLC
Sbjct: 54  NHKKEHSLSLVSPRKAS--MNRSGSNQAYYVMGHMTPNIRDLYTLGRKLGQGQFGTTYLC 111

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
           TE +TG E+ACKSISKRKLIS+EDVEDVRREIQIMHHL+GH+NIVTIKGAYED L VHIV
Sbjct: 112 TENSTGAEYACKSISKRKLISKEDVEDVRREIQIMHHLSGHRNIVTIKGAYEDPLYVHIV 171

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           ME+C+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKD+
Sbjct: 172 MEICSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDN 231

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV
Sbjct: 232 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 291

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           PPFWAETQQGIFDAVLKGHIDF+SDPWPLIS+SAKDLIRKMLC QPSERLTAHEVLCHPW
Sbjct: 292 PPFWAETQQGIFDAVLKGHIDFDSDPWPLISESAKDLIRKMLCMQPSERLTAHEVLCHPW 351

Query: 359 ICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 352 ICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 391

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.
Solanum tuberosum (taxid: 4113)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q38871|CDPK5_ARATH Calcium-dependent protein kinase 5 OS=Arabidopsis thaliana GN=CPK5 PE=1 SV=1

 Score =  657 bits (1695), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/400 (81%), Positives = 358/400 (89%), Gaps = 8/400 (2%)

Query: 1   MGNTCRGSFTGKLYQG-YSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
           MGN+CRGSF  KL +G  ++PED+S  S  N +S   NSD+S    N+  +++QEFSK+N
Sbjct: 1   MGNSCRGSFKDKLDEGDNNKPEDYSKTSTTNLSS---NSDHSP---NAADIIAQEFSKDN 54

Query: 60  PKKDNSA-PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
              +NS  P +    ++ IMRR  DNQ YYVLGHKT NIRD+YTL RKLGQGQFGTTYLC
Sbjct: 55  NSNNNSKDPALVIPLREPIMRRNPDNQAYYVLGHKTPNIRDIYTLSRKLGQGQFGTTYLC 114

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
           TEIA+G+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGH +IVTIKGAYEDSL VHIV
Sbjct: 115 TEIASGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHGSIVTIKGAYEDSLYVHIV 174

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           MELCAGGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDD
Sbjct: 175 MELCAGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 234

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK YGPEADVWTAGVILYILLSGV
Sbjct: 235 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKRYGPEADVWTAGVILYILLSGV 294

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           PPFWAETQQGIFDAVLKG+IDFESDPWP+ISDSAKDLIR+ML S+P+ERLTAHEVL HPW
Sbjct: 295 PPFWAETQQGIFDAVLKGYIDFESDPWPVISDSAKDLIRRMLSSKPAERLTAHEVLRHPW 354

Query: 359 ICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMAL+V A +
Sbjct: 355 ICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALKVIAES 394

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38872|CDPK6_ARATH Calcium-dependent protein kinase 6 OS=Arabidopsis thaliana GN=CPK6 PE=1 SV=1

 Score =  655 bits (1690), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/398 (80%), Positives = 350/398 (87%), Gaps = 16/398 (4%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGN+CRGSF  K+Y+G     +HS   + + ++  T S   +P+ +      Q+FSK+N 
Sbjct: 1   MGNSCRGSFKDKIYEG-----NHSRPEENSKSTTTTVSSVHSPTTD------QDFSKQN- 48

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
               + P +    K+ IMRR +DNQ+YYVLGHKT NIRDLYTL RKLGQGQFGTTYLCT+
Sbjct: 49  ----TNPALVIPVKEPIMRRNVDNQSYYVLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTD 104

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           IATG+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct: 105 IATGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 164

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LCAGGELFDRII RGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 165 LCAGGELFDRIIHRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 224

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQIF DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP
Sbjct: 225 SLKAIDFGLSVFFKPGQIFKDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 284

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           FWAETQQGIFDAVLKG+IDF++DPWP+ISDSAKDLIRKMLCS PSERLTAHEVL HPWIC
Sbjct: 285 FWAETQQGIFDAVLKGYIDFDTDPWPVISDSAKDLIRKMLCSSPSERLTAHEVLRHPWIC 344

Query: 361 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ENGVAPDR+LDPAVLSRLKQFSAMNKLKKMAL+V A +
Sbjct: 345 ENGVAPDRALDPAVLSRLKQFSAMNKLKKMALKVIAES 382

May play a role in signal transduction pathways that involve calcium as a second messenger. Functions in abscisic acid (ABA) regulation of guard cell S-type anion-and Ca(2+)-permeable channels and stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5A7I8|CDPK5_SOLTU Calcium-dependent protein kinase 5 OS=Solanum tuberosum GN=CPK5 PE=2 SV=1

 Score =  655 bits (1689), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/398 (79%), Positives = 341/398 (85%), Gaps = 29/398 (7%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGN CRGSF GK +QGY QP+DHS +   N+N    NSD   P    Q LV+        
Sbjct: 1   MGNACRGSFGGKTFQGYPQPQDHSES---NSNPK-HNSDSPKPKKEQQPLVT-------- 48

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
                            M R   NQ+YYVLGHKT NIRDLYTLGRKLGQGQFGTTYLCTE
Sbjct: 49  -----------------MNRTSTNQSYYVLGHKTPNIRDLYTLGRKLGQGQFGTTYLCTE 91

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           +++GI++ACKSI+KRKLIS+EDVEDVRREIQIMHHLAGHKNIV+IKGAYED L VHIVME
Sbjct: 92  LSSGIDYACKSIAKRKLISKEDVEDVRREIQIMHHLAGHKNIVSIKGAYEDPLYVHIVME 151

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LC GGELFDRIIQRGHY+ERKAA+LT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 152 LCGGGELFDRIIQRGHYTERKAADLTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 211

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP
Sbjct: 212 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 271

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           FWAETQQGIFDAVLKGHIDF+SDPWPL+S+SAKDLIRKMLC +PSERLTAHEVLCHPWIC
Sbjct: 272 FWAETQQGIFDAVLKGHIDFDSDPWPLLSESAKDLIRKMLCMRPSERLTAHEVLCHPWIC 331

Query: 361 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ENGVAPDR+LDPAVLSRLK FSAMNKLKKMALRV A +
Sbjct: 332 ENGVAPDRALDPAVLSRLKHFSAMNKLKKMALRVIAES 369

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.

Solanum tuberosum (taxid: 4113)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZM3|CDPKQ_ARATH Calcium-dependent protein kinase 26 OS=Arabidopsis thaliana GN=CPK26 PE=2 SV=1

 Score =  598 bits (1541), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 283/321 (88%), Positives = 302/321 (94%)

Query: 78  MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           M+    NQ  YVLG KT +IRDLY+LG KLGQGQFGTTY+C EI+TG E+ACKSI+KRKL
Sbjct: 1   MKHSGGNQACYVLGQKTPSIRDLYSLGHKLGQGQFGTTYMCKEISTGREYACKSITKRKL 60

Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
           IS+EDVEDVRREIQIMHHLAG+KNIVTIKGAYED L VHIVMELC+GGELFDRIIQRGHY
Sbjct: 61  ISKEDVEDVRREIQIMHHLAGYKNIVTIKGAYEDPLYVHIVMELCSGGELFDRIIQRGHY 120

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           SERKAAEL +IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ
Sbjct: 121 SERKAAELIKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 180

Query: 258 IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
           IF DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYIL+SGVPPFWAETQQGIFDAVLKGH
Sbjct: 181 IFEDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILVSGVPPFWAETQQGIFDAVLKGH 240

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSR 377
           IDF+SDPWPLISDSAK+LIR MLCS+PSERLTAH+VL HPWICENGVAPDR+LDPAVLSR
Sbjct: 241 IDFDSDPWPLISDSAKNLIRGMLCSRPSERLTAHQVLRHPWICENGVAPDRALDPAVLSR 300

Query: 378 LKQFSAMNKLKKMALRVSASA 398
           LKQFSAMNKLK+MALRV A +
Sbjct: 301 LKQFSAMNKLKQMALRVIAES 321

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53684|CDPKB_ORYSJ Calcium-dependent protein kinase isoform 11 OS=Oryza sativa subsp. japonica GN=CPK11 PE=2 SV=2

 Score =  532 bits (1371), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 260/338 (76%), Positives = 296/338 (87%), Gaps = 2/338 (0%)

Query: 61  KKDNSAPRISPSK--KDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
           K D++ P ++  K    +I+RRG+D  +  VLG KT ++R+ Y +GRKLGQGQFGTTYLC
Sbjct: 37  KFDDTWPEVNNFKPTAASILRRGLDPTSINVLGRKTADLREHYIIGRKLGQGQFGTTYLC 96

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
           TEI TG E+ACK+I KRKLI++EDVEDVRREIQIMHHL+GHKN+V IK  YED   VHIV
Sbjct: 97  TEINTGCEYACKTIPKRKLITKEDVEDVRREIQIMHHLSGHKNVVAIKDVYEDGQAVHIV 156

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           MELCAGGELFDRI ++GHYSERKAAEL RIIV +V  CHSLGVMHRDLKPENFLL++KDD
Sbjct: 157 MELCAGGELFDRIQEKGHYSERKAAELIRIIVSIVAMCHSLGVMHRDLKPENFLLLDKDD 216

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           D S+KAIDFGLSVFFKPGQ+FT++VGSPYYVAPEVL K YGPE+DVW+AGVILY+LLSGV
Sbjct: 217 DLSIKAIDFGLSVFFKPGQVFTELVGSPYYVAPEVLHKRYGPESDVWSAGVILYVLLSGV 276

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           PPFWAETQQGIFDAVLKGHIDF+SDPWP ISDSAKDLIRKML   PSERL AHEVL HPW
Sbjct: 277 PPFWAETQQGIFDAVLKGHIDFQSDPWPKISDSAKDLIRKMLSHCPSERLKAHEVLRHPW 336

Query: 359 ICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSA 396
           ICENGVA D++LDP+V+SRLKQFSAMNKLKK+ALRV A
Sbjct: 337 ICENGVATDQALDPSVISRLKQFSAMNKLKKLALRVIA 374

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1

 Score =  521 bits (1343), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 249/387 (64%), Positives = 299/387 (77%), Gaps = 3/387 (0%)

Query: 12  KLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISP 71
           K+    S+ E     SKR       ++   T S +  +    E + E   +  + P+  P
Sbjct: 100 KVVPEESKQEVPPEESKREVVVQPESAKPETKSESKPETTKPETTSETKPETKAEPQ-KP 158

Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
                +   G+  +T  VL  KT+N ++ Y+LGRKLGQGQFGTT+LC E  TG E+ACKS
Sbjct: 159 KHMRRVSSAGL--RTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKS 216

Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
           ISKRKL++ EDVEDVRREIQIMHHLAGH N+++IKGAYED + VH+VMELC+GGELFDRI
Sbjct: 217 ISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRI 276

Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQRGHY+ERKAAEL R IVGV+EACHSLGVMHRDLKPENFL V++++D  LK IDFGLS+
Sbjct: 277 IQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSM 336

Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
           FFKP ++FTDVVGSPYYVAPEVL K YGPE+DVW+AGVI+YILLSGVPPFWAET+QGIF+
Sbjct: 337 FFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFE 396

Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD 371
            VL G +DF SDPWP IS+SAKDL+RKML   P  RLTAH+VLCHPW+  +GVAPD+ LD
Sbjct: 397 QVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLD 456

Query: 372 PAVLSRLKQFSAMNKLKKMALRVSASA 398
            AVLSR+KQFSAMNK KKMALRV A +
Sbjct: 457 SAVLSRMKQFSAMNKFKKMALRVIAES 483

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06850|CDPK1_ARATH Calcium-dependent protein kinase 1 OS=Arabidopsis thaliana GN=CPK1 PE=1 SV=1

 Score =  521 bits (1342), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 240/314 (76%), Positives = 273/314 (86%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +T  VL  KT+N ++ Y+LGRKLGQGQFGTT+LC E  TG EFACKSI+KRKL++ EDVE
Sbjct: 134 RTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVE 193

Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           DVRREIQIMHHLAGH N+++IKGAYED + VH+VME CAGGELFDRIIQRGHY+ERKAAE
Sbjct: 194 DVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAE 253

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           LTR IVGVVEACHSLGVMHRDLKPENFL V+K +D  LK IDFGLS+FFKP  +FTDVVG
Sbjct: 254 LTRTIVGVVEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVG 313

Query: 265 SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           SPYYVAPEVL K YGPEADVW+AGVI+YILLSGVPPFWAET+QGIF+ VL G +DF SDP
Sbjct: 314 SPYYVAPEVLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDP 373

Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAM 384
           WP IS+SAKDL+RKML   P +RLTAH+VLCHPW+  +GVAPD+ LD AVLSR+KQFSAM
Sbjct: 374 WPSISESAKDLVRKMLVRDPKKRLTAHQVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAM 433

Query: 385 NKLKKMALRVSASA 398
           NK KKMALRV A +
Sbjct: 434 NKFKKMALRVIAES 447

May play a role in signal transduction pathways that involve calcium as a second messenger. Phosphorylates the Ca(2+)-ATPase ACA2 resulting in the inhibition of its calcium activation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53682|CDPK1_ORYSJ Calcium-dependent protein kinase isoform 1 OS=Oryza sativa subsp. japonica GN=SPK PE=2 SV=2

 Score =  509 bits (1312), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 240/365 (65%), Positives = 293/365 (80%), Gaps = 4/365 (1%)

Query: 35  CTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNI---MRRGIDNQTYYVLG 91
           C N  Y     NS +  +  F+      +++    S S + ++   +R+G+ N    VLG
Sbjct: 5   CQNGTYGNNYQNSNRFQNDRFASRYVDGNDTEDCYSGSSRASLAGALRQGL-NLKSPVLG 63

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +KT N+R+LYTLGR+LGQGQFG TYLCTEI+TG ++ACK+I K  L    D+EDVRREIQ
Sbjct: 64  YKTPNVRELYTLGRELGQGQFGKTYLCTEISTGCQYACKTILKSNLRCVSDIEDVRREIQ 123

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           IMHHL+G KNIVTIK  YED   VHIVMELCAGGELF +I +RGHYSERKAAEL +IIVG
Sbjct: 124 IMHHLSGQKNIVTIKDTYEDEQAVHIVMELCAGGELFSKIQKRGHYSERKAAELIKIIVG 183

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           ++E CHS GVMHRDLKPENFLL++ DD+FS+KAIDFGLSVFF+PGQ+F +VVGSPYY+AP
Sbjct: 184 IIETCHSHGVMHRDLKPENFLLLDADDEFSVKAIDFGLSVFFRPGQVFREVVGSPYYIAP 243

Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL K YGPEAD+WTAGVILY+LL+GVPPFWA+TQ GI++ VL G IDF+S+ WP ISDS
Sbjct: 244 EVLEKRYGPEADIWTAGVILYVLLTGVPPFWADTQSGIYEKVLDGRIDFKSNRWPRISDS 303

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMA 391
           AKDLI+KMLC  PSERL AHEVL HPWIC+NGVA +R+LDP+VL RLKQFSAMN+LKK++
Sbjct: 304 AKDLIKKMLCPYPSERLKAHEVLKHPWICDNGVATNRALDPSVLPRLKQFSAMNRLKKLS 363

Query: 392 LRVSA 396
           L++ A
Sbjct: 364 LQIIA 368

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZV15|CDPKK_ARATH Calcium-dependent protein kinase 20 OS=Arabidopsis thaliana GN=CPK20 PE=2 SV=1

 Score =  507 bits (1306), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 251/432 (58%), Positives = 314/432 (72%), Gaps = 35/432 (8%)

Query: 1   MGNTCRG----------SFTGKLYQGYSQPEDHSNNSK----RNTNSDCTNSDYSTPSLN 46
           MGNTC G          S +  +++   +P+D   +SK    R  N    N D S   ++
Sbjct: 1   MGNTCVGPNLNPNGFLQSVSAAVWRN-QKPDDSIKSSKDESSRKKNDKSVNGDDSNGHVS 59

Query: 47  SQ------------------QLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDN--QT 86
           S                   ++ ++E   +   ++   P   P KK+  M+R      Q 
Sbjct: 60  STVDPAPSTLPTPSTPPPPVKMANEEPPPKPITENKEDPNSKPQKKEAHMKRMASAGLQI 119

Query: 87  YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
             VLG KT+N++D+Y++GRKLGQGQFGTT+LC +  TG EFACK+I+KRKL + EDVEDV
Sbjct: 120 DSVLGRKTENLKDIYSVGRKLGQGQFGTTFLCVDKKTGKEFACKTIAKRKLTTPEDVEDV 179

Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           RREIQIMHHL+GH N++ I GAYED++ VH+VME+CAGGELFDRIIQRGHY+E+KAAEL 
Sbjct: 180 RREIQIMHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHYTEKKAAELA 239

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           RIIVGV+EACHSLGVMHRDLKPENFL V+ D++ +LK IDFGLSVFFKPG+ FTDVVGSP
Sbjct: 240 RIIVGVIEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGETFTDVVGSP 299

Query: 267 YYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           YYVAPEVL KHY  E DVW+AGVI+YILLSGVPPFW ET+QGIF+ VLKG +DF S+PWP
Sbjct: 300 YYVAPEVLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGDLDFISEPWP 359

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNK 386
            +S+SAKDL+R+ML   P +R+T HEVLCHPW   +GVA D+ LD AVLSRL+QFSAMNK
Sbjct: 360 SVSESAKDLVRRMLIRDPKKRMTTHEVLCHPWARVDGVALDKPLDSAVLSRLQQFSAMNK 419

Query: 387 LKKMALRVSASA 398
           LKK+A++V A +
Sbjct: 420 LKKIAIKVIAES 431

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	398
225428322	561	PREDICTED: calcium-dependent protein kin	0.992	0.704	0.884	0.0
147864481	561	hypothetical protein VITISV_017368 [Viti	0.992	0.704	0.879	0.0
224131906	560	calcium dependent protein kinase 6 [Popu	0.979	0.696	0.858	0.0
449454305	566	PREDICTED: calcium-dependent protein kin	0.992	0.697	0.858	0.0
224104811	565	calcium dependent protein kinase 5 [Popu	0.979	0.690	0.853	0.0
255559179	561	calcium-dependent protein kinase, putati	0.987	0.700	0.86	0.0
20453015	558	calmodulin-like-domain protein kinase CP	0.982	0.700	0.847	0.0
20453013	571	phloem calmodulin-like-domain protein ki	1.0	0.697	0.834	0.0
402810032	449	calcium dependent protein kinase 6, part	0.992	0.879	0.816	0.0
356551652	558	PREDICTED: calcium-dependent protein kin	0.974	0.695	0.825	0.0

>gi|225428322|ref|XP_002282994.1| PREDICTED: calcium-dependent protein kinase 4 [Vitis vinifera]

 Score =  739 bits (1908), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 352/398 (88%), Positives = 372/398 (93%), Gaps = 3/398 (0%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGNTCRGSF GK +QGY QPE+ S  SKRN  SD +NSDYS  SLNSQQLVSQEF+KENP
Sbjct: 1   MGNTCRGSFRGKYFQGYGQPEEQST-SKRN--SDRSNSDYSPSSLNSQQLVSQEFAKENP 57

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
           KK+     +SP+ KD  MRRG+DNQ+YYVLGHKT NIRDLY+LGRKLGQGQFGTTYLCT+
Sbjct: 58  KKETRVSILSPTNKDGTMRRGVDNQSYYVLGHKTANIRDLYSLGRKLGQGQFGTTYLCTD 117

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           +ATGIE+ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct: 118 MATGIEYACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 177

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LCAGGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 178 LCAGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 237

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVL KHYGPEADVWTAGVILYILLSGVPP
Sbjct: 238 SLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLCKHYGPEADVWTAGVILYILLSGVPP 297

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           FWAETQQGIFDAVLKG IDFES+PWPLISDSAKDLIRKMLCS+P++RLTAHEVLCHPWIC
Sbjct: 298 FWAETQQGIFDAVLKGFIDFESEPWPLISDSAKDLIRKMLCSRPADRLTAHEVLCHPWIC 357

Query: 361 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 358 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVIAES 395

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864481|emb|CAN78387.1| hypothetical protein VITISV_017368 [Vitis vinifera]

 Score =  735 bits (1897), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/398 (87%), Positives = 371/398 (93%), Gaps = 3/398 (0%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGNTCRGSF GK +QGY QPE+ S  SKRN  SD +NSDYS  SLNSQQLVSQEF+KENP
Sbjct: 1   MGNTCRGSFRGKYFQGYGQPEEQST-SKRN--SDRSNSDYSPSSLNSQQLVSQEFAKENP 57

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
           KK+     +SP+ KD  MRRG+DNQ+YYVLGHKT NIRDLY+LGRKLGQGQFGTT LCT+
Sbjct: 58  KKETRVSILSPTNKDGTMRRGVDNQSYYVLGHKTANIRDLYSLGRKLGQGQFGTTXLCTD 117

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           +ATGIE+ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct: 118 MATGIEYACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 177

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LCAGGELFDRIIQRGHYSER+AAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 178 LCAGGELFDRIIQRGHYSERRAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 237

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVL KHYGPEADVWTAGVILYILLSGVPP
Sbjct: 238 SLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLCKHYGPEADVWTAGVILYILLSGVPP 297

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           FWAETQQGIFDAVLKG IDFES+PWPLISDSAKDLIRKMLCS+P++RLTAHEVLCHPWIC
Sbjct: 298 FWAETQQGIFDAVLKGFIDFESEPWPLISDSAKDLIRKMLCSRPADRLTAHEVLCHPWIC 357

Query: 361 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 358 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVIAES 395

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224131906|ref|XP_002328137.1| calcium dependent protein kinase 6 [Populus trichocarpa] gi|222837652|gb|EEE76017.1| calcium dependent protein kinase 6 [Populus trichocarpa]

 Score =  726 bits (1875), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/402 (85%), Positives = 371/402 (92%), Gaps = 12/402 (2%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS----NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFS 56
           MGNTCRGSF GKLYQGY+QP++ S    +NSKRN +SD +NS+YS  SL  Q+L      
Sbjct: 1   MGNTCRGSFKGKLYQGYNQPDEQSTTTASNSKRNASSDHSNSEYSISSLTPQEL------ 54

Query: 57  KENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTY 116
             NPKKD++ P ISP+KKD IMRRG+DNQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTY
Sbjct: 55  --NPKKDSNLPLISPTKKDTIMRRGVDNQAYYVLGHKTANIRDLYTLGRKLGQGQFGTTY 112

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           LCT+I+TGIE+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VH
Sbjct: 113 LCTDISTGIEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDQLYVH 172

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IVMELC+GGELFDRIIQRGHY+ERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNK
Sbjct: 173 IVMELCSGGELFDRIIQRGHYTERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNK 232

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           DDDFSLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVLLK YGPEADVWTAGVILYILLS
Sbjct: 233 DDDFSLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLLKQYGPEADVWTAGVILYILLS 292

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
           GVPPFWAETQQGIFDAVLKG+IDF+SDPWP+ISDSAKDLIRKMLCSQPSERLTAHEVLCH
Sbjct: 293 GVPPFWAETQQGIFDAVLKGYIDFDSDPWPVISDSAKDLIRKMLCSQPSERLTAHEVLCH 352

Query: 357 PWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           PWI +NGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 353 PWINDNGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 394

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454305|ref|XP_004144896.1| PREDICTED: calcium-dependent protein kinase 4-like [Cucumis sativus] gi|449471982|ref|XP_004153460.1| PREDICTED: calcium-dependent protein kinase 4-like [Cucumis sativus] gi|449530458|ref|XP_004172212.1| PREDICTED: calcium-dependent protein kinase 4-like [Cucumis sativus]

 Score =  718 bits (1854), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/403 (85%), Positives = 370/403 (91%), Gaps = 8/403 (1%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSN-NSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
           MGNTCRGSF G ++QGYSQPED S  NSKRNTN   T++D+S  S+++  L+SQEF+KEN
Sbjct: 1   MGNTCRGSFKGNIFQGYSQPEDSSTPNSKRNTN---TSADHSPSSISTNNLISQEFAKEN 57

Query: 60  P--KKDN--SAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
               KDN  +   +SP+KKD  MR+  +NQ YYVLGHKT NIRDLYTLGRKLGQGQFGTT
Sbjct: 58  KIKSKDNDCNPTFLSPTKKDYTMRKSAENQAYYVLGHKTANIRDLYTLGRKLGQGQFGTT 117

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
           YLCTEI TGIE+ACKSISKRKLI++EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL V
Sbjct: 118 YLCTEITTGIEYACKSISKRKLIAKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLYV 177

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           HIVMELC+GGELFDRIIQRGHYSERKAAELTRIIVGVVE CHSLGVMHRDLKPENFLLVN
Sbjct: 178 HIVMELCSGGELFDRIIQRGHYSERKAAELTRIIVGVVETCHSLGVMHRDLKPENFLLVN 237

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILL 295
           KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP ADVWTAGVILYILL
Sbjct: 238 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPAADVWTAGVILYILL 297

Query: 296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           SGVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDSAKDLIRKMLCS+PS+RLTAHEVLC
Sbjct: 298 SGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSAKDLIRKMLCSRPSDRLTAHEVLC 357

Query: 356 HPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           HPWICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 358 HPWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 400

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104811|ref|XP_002313574.1| calcium dependent protein kinase 5 [Populus trichocarpa] gi|222849982|gb|EEE87529.1| calcium dependent protein kinase 5 [Populus trichocarpa]

 Score =  716 bits (1849), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/402 (85%), Positives = 368/402 (91%), Gaps = 12/402 (2%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS----NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFS 56
           MGNTCRGSF G L+QGY+QP++ S    +NSKR+ +SD +NS++S  SL SQ+L      
Sbjct: 1   MGNTCRGSFKGILHQGYNQPDEQSTVTASNSKRHASSDHSNSEHSFSSLTSQELT----- 55

Query: 57  KENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTY 116
              PKKD++ P ISP+KKD IMRR +DNQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTY
Sbjct: 56  ---PKKDSNLPLISPTKKDTIMRRSVDNQAYYVLGHKTPNIRDLYTLGRKLGQGQFGTTY 112

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           LCTEI TG+++ACKSI KRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VH
Sbjct: 113 LCTEILTGMDYACKSICKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVH 172

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IVMELC+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNK
Sbjct: 173 IVMELCSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNK 232

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS
Sbjct: 233 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 292

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
           GVPPFWAETQQGIFDAVLKG+IDF+SDPWPLISDSAKDLIRKMLCS PSERLTAHEVLCH
Sbjct: 293 GVPPFWAETQQGIFDAVLKGYIDFDSDPWPLISDSAKDLIRKMLCSSPSERLTAHEVLCH 352

Query: 357 PWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           PWICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 353 PWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 394

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255559179|ref|XP_002520611.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223540210|gb|EEF41784.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  712 bits (1839), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/400 (86%), Positives = 371/400 (92%), Gaps = 7/400 (1%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS--NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKE 58
           MGNTCRGSF GKLYQGYSQPED S  +++ RN +S+ +N+++S  S+      +QEF+K+
Sbjct: 1   MGNTCRGSFKGKLYQGYSQPEDQSTASHTNRNPSSNNSNTEHSPTSV-----TAQEFAKD 55

Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
           NPKKDN+ P ISP++KD IMRRG DNQ+YYVLGHKT NIRDLYTLGRKLGQGQFGTTYLC
Sbjct: 56  NPKKDNNFPLISPNRKDLIMRRGADNQSYYVLGHKTANIRDLYTLGRKLGQGQFGTTYLC 115

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
            E +TG E+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIV
Sbjct: 116 VENSTGTEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDQLYVHIV 175

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           MELC+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDD
Sbjct: 176 MELCSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 235

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV
Sbjct: 236 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 295

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           PPFWAETQQGIFDAVLKG+IDFESDPWPLISDSAKDLI KMLC +PS+RLTAHEVLCHPW
Sbjct: 296 PPFWAETQQGIFDAVLKGYIDFESDPWPLISDSAKDLIHKMLCGRPSDRLTAHEVLCHPW 355

Query: 359 ICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           ICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 356 ICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 395

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|20453015|gb|AAL68972.1| calmodulin-like-domain protein kinase CPK2 [Cucurbita maxima]

 Score =  704 bits (1816), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/399 (84%), Positives = 361/399 (90%), Gaps = 8/399 (2%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSN-NSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
           MGNTCRGSF G ++QGYSQPE+ S  N KRN N    +SD+S  S+N+  L+SQ F++EN
Sbjct: 1   MGNTCRGSFKGNIFQGYSQPEESSTPNFKRNING---SSDHSPSSINTNNLISQAFAEEN 57

Query: 60  PKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCT 119
             K     + +  KKD  MR+  +NQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTYLCT
Sbjct: 58  KTK----SKDNDCKKDYTMRKSAENQAYYVLGHKTANIRDLYTLGRKLGQGQFGTTYLCT 113

Query: 120 EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM 179
           EI TGIE+ACKSISKRKLI++EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL VHIVM
Sbjct: 114 EIMTGIEYACKSISKRKLIAKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLYVHIVM 173

Query: 180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD 239
           ELC+GGELFDRIIQRGHYSERKAAELTRIIVGVVE CHSLGVMHRDLKPENFLLVNKDDD
Sbjct: 174 ELCSGGELFDRIIQRGHYSERKAAELTRIIVGVVETCHSLGVMHRDLKPENFLLVNKDDD 233

Query: 240 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
           FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP ADVWTAGVILYILLSGVP
Sbjct: 234 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPAADVWTAGVILYILLSGVP 293

Query: 300 PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           PFWAETQQGIFDAVLKGHIDF+SDPWPLISDSAKDLIRKMLCS+PS+RLTAHEVLCHPWI
Sbjct: 294 PFWAETQQGIFDAVLKGHIDFDSDPWPLISDSAKDLIRKMLCSRPSDRLTAHEVLCHPWI 353

Query: 360 CENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           CENGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 354 CENGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 392

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|20453013|gb|AAL68971.1| phloem calmodulin-like-domain protein kinase PCPK1 [Cucurbita maxima]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/405 (83%), Positives = 364/405 (89%), Gaps = 7/405 (1%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS---NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSK 57
           MGNTCRGSF G ++QGYSQPED S   +    +++S  +NSD S  S+N+  L++QEFSK
Sbjct: 1   MGNTCRGSFKGNIFQGYSQPEDSSTLYSKRNNSSSSARSNSDISPTSINTHNLIAQEFSK 60

Query: 58  ENPKK----DNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFG 113
           EN  K    D +   +SP+KKD  MR+  +NQ YYVLGHKT NIRDLYTLGRKLGQGQFG
Sbjct: 61  ENKTKSKDNDYNQAFLSPTKKDFTMRKSAENQAYYVLGHKTANIRDLYTLGRKLGQGQFG 120

Query: 114 TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL 173
           TTYLCTEI TGIE+ACKSISKRKLI++EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL
Sbjct: 121 TTYLCTEITTGIEYACKSISKRKLIAKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL 180

Query: 174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL 233
            VHIVMELC+GGELFDRII RGHYSERKAAELTRIIVGVVE CHSLGVMHRDLKPENFLL
Sbjct: 181 YVHIVMELCSGGELFDRIIHRGHYSERKAAELTRIIVGVVETCHSLGVMHRDLKPENFLL 240

Query: 234 VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYI 293
           VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG PYYVAPEVLLKHYGP ADVWTAGVILYI
Sbjct: 241 VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGRPYYVAPEVLLKHYGPAADVWTAGVILYI 300

Query: 294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           LLSGVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDSAKD+IRKMLCS+PS+RLTAHEV
Sbjct: 301 LLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSAKDIIRKMLCSRPSDRLTAHEV 360

Query: 354 LCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           LCHPWICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 361 LCHPWICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALRVIAES 405

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|402810032|gb|AFR11236.1| calcium dependent protein kinase 6, partial [Chenopodium album]

 Score =  691 bits (1782), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/414 (81%), Positives = 365/414 (88%), Gaps = 19/414 (4%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS---------------NNSKRNTNSDCTNSDYSTPSL 45
           MGNTCRGSF  K +QG +QPEDHS               N +KRN   D   SDYS  SL
Sbjct: 1   MGNTCRGSFGVKFHQGETQPEDHSVGNSNSNTNSNTTSSNTTKRN---DSDYSDYSPNSL 57

Query: 46  NSQQLVSQEFSKENPKKDNSAPRISPSKKDN-IMRRGIDNQTYYVLGHKTDNIRDLYTLG 104
            +QQLV+QEF+++NPKKD+++  + P  KDN  +R+  DNQ YYVLGHKT NIRDLYTLG
Sbjct: 58  RNQQLVNQEFAQDNPKKDHNSVVVVPMAKDNNTVRKQSDNQAYYVLGHKTANIRDLYTLG 117

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           RKLGQGQFGTTYLCTEI+TGIE+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVT
Sbjct: 118 RKLGQGQFGTTYLCTEISTGIEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVT 177

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           IKGAYED L VHIVMELC+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHR
Sbjct: 178 IKGAYEDPLYVHIVMELCSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHR 237

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADV 284
           DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVLLK+YG EADV
Sbjct: 238 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLLKNYGFEADV 297

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDS KDLIRKMLCS P
Sbjct: 298 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSGKDLIRKMLCSNP 357

Query: 345 SERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
            ERLTAH+VLCHPWICE+GVAPDR+LDPAV+SRLK FSAMNKLKKMALRV A +
Sbjct: 358 KERLTAHQVLCHPWICESGVAPDRALDPAVISRLKHFSAMNKLKKMALRVIAES 411

Source: Chenopodium album

Species: Chenopodium album

Genus: Chenopodium

Family: Amaranthaceae

Order: Caryophyllales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551652|ref|XP_003544188.1| PREDICTED: calcium-dependent protein kinase 4-like [Glycine max]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/402 (82%), Positives = 354/402 (88%), Gaps = 14/402 (3%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGNTCRGS  GK  QG+SQPEDHS   KR+T        +S PS   QQ  +   +  N 
Sbjct: 1   MGNTCRGSLKGKYIQGFSQPEDHS---KRSTT-------HSDPSSTKQQDDNDNNNNNNN 50

Query: 61  KKDNSAPRISP----SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTY 116
             +N+    +     +K++ IMRRG+DNQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTY
Sbjct: 51  NNNNNNNNNNNLPFNAKREAIMRRGLDNQAYYVLGHKTPNIRDLYTLGRKLGQGQFGTTY 110

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           LCTE +T IE+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VH
Sbjct: 111 LCTENSTSIEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVH 170

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IVMELC+GGELFDRIIQRGHY+ERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNK
Sbjct: 171 IVMELCSGGELFDRIIQRGHYTERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNK 230

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           DDDFSLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS
Sbjct: 231 DDDFSLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 290

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
           GVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDS KDLIRKMLCSQPSERLTAH+VLCH
Sbjct: 291 GVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSGKDLIRKMLCSQPSERLTAHQVLCH 350

Query: 357 PWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
           PWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRV A +
Sbjct: 351 PWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVIAES 392

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	398
TAIR|locus:2122063	556	CPK5 "calmodulin-domain protei	0.984	0.705	0.817	1.8e-172
TAIR|locus:2827528	544	CPK6 "calcium dependent protei	0.959	0.702	0.809	2.8e-169
TAIR|locus:2175503	610	CPK1 "calcium dependent protei	0.891	0.581	0.702	1.5e-136
TAIR|locus:2075885	646	CPK2 "calmodulin-domain protei	0.949	0.585	0.650	4.4e-132
TAIR|locus:2065021	583	CPK20 "calcium-dependent prote	0.944	0.644	0.643	6.1e-131
TAIR|locus:2014691	495	CDPK2 "AT1G35670" [Arabidopsis	0.773	0.622	0.714	2.3e-119
TAIR|locus:2136917	501	CPK4 "calcium-dependent protei	0.773	0.614	0.714	1.6e-118
TAIR|locus:2039215	520	CPK25 "calcium-dependent prote	0.879	0.673	0.641	4.2e-118
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.773	0.588	0.672	1.3e-116
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.773	0.583	0.675	1.6e-116

TAIR|locus:2122063 CPK5 "calmodulin-domain protein kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1676 (595.0 bits), Expect = 1.8e-172, P = 1.8e-172
 Identities = 327/400 (81%), Positives = 359/400 (89%)

Query:     1 MGNTCRGSFTGKLYQG-YSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
             MGN+CRGSF  KL +G  ++PED+S  S  N +S   NSD+S P  N+  +++QEFSK+N
Sbjct:     1 MGNSCRGSFKDKLDEGDNNKPEDYSKTSTTNLSS---NSDHS-P--NAADIIAQEFSKDN 54

Query:    60 PKKDNSA-PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
                +NS  P +    ++ IMRR  DNQ YYVLGHKT NIRD+YTL RKLGQGQFGTTYLC
Sbjct:    55 NSNNNSKDPALVIPLREPIMRRNPDNQAYYVLGHKTPNIRDIYTLSRKLGQGQFGTTYLC 114

Query:   119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
             TEIA+G+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGH +IVTIKGAYEDSL VHIV
Sbjct:   115 TEIASGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHGSIVTIKGAYEDSLYVHIV 174

Query:   179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
             MELCAGGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDD
Sbjct:   175 MELCAGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 234

Query:   239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
             DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK YGPEADVWTAGVILYILLSGV
Sbjct:   235 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKRYGPEADVWTAGVILYILLSGV 294

Query:   299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             PPFWAETQQGIFDAVLKG+IDFESDPWP+ISDSAKDLIR+ML S+P+ERLTAHEVL HPW
Sbjct:   295 PPFWAETQQGIFDAVLKGYIDFESDPWPVISDSAKDLIRRMLSSKPAERLTAHEVLRHPW 354

Query:   359 ICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
             ICENGVAPDR+LDPAVLSRLKQFSAMNKLKKMAL+V A +
Sbjct:   355 ICENGVAPDRALDPAVLSRLKQFSAMNKLKKMALKVIAES 394

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
 Identities = 322/398 (80%), Positives = 349/398 (87%)

Query:     1 MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
             MGN+CRGSF  K+Y+G        N+S+   NS  T +  S  S++S     Q+FSK+N 
Sbjct:     1 MGNSCRGSFKDKIYEG--------NHSRPEENSKSTTTTVS--SVHSPT-TDQDFSKQNT 49

Query:    61 KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
                   P +    K+ IMRR +DNQ+YYVLGHKT NIRDLYTL RKLGQGQFGTTYLCT+
Sbjct:    50 N-----PALVIPVKEPIMRRNVDNQSYYVLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTD 104

Query:   121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
             IATG+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct:   105 IATGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 164

Query:   181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
             LCAGGELFDRII RGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct:   165 LCAGGELFDRIIHRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 224

Query:   241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
             SLKAIDFGLSVFFKPGQIF DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP
Sbjct:   225 SLKAIDFGLSVFFKPGQIFKDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 284

Query:   301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
             FWAETQQGIFDAVLKG+IDF++DPWP+ISDSAKDLIRKMLCS PSERLTAHEVL HPWIC
Sbjct:   285 FWAETQQGIFDAVLKGYIDFDTDPWPVISDSAKDLIRKMLCSSPSERLTAHEVLRHPWIC 344

Query:   361 ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
             ENGVAPDR+LDPAVLSRLKQFSAMNKLKKMAL+V A +
Sbjct:   345 ENGVAPDRALDPAVLSRLKQFSAMNKLKKMALKVIAES 382

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006820 "anion transport" evidence=RCA

GO:0006862 "nucleotide transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0015696 "ammonium transport" evidence=RCA

GO:0015802 "basic amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0043269 "regulation of ion transport" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1311 (466.6 bits), Expect = 1.5e-136, Sum P(2) = 1.5e-136
 Identities = 250/356 (70%), Positives = 287/356 (80%)

Query:    44 SLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMR-RGIDNQTYYVLGHKTDNIRDLYT 102
             SL S+    QE   E   +    P   P K  ++ R      +T  VL  KT+N ++ Y+
Sbjct:    92 SLESKPETKQETKSETKPESKPDPPAKPKKPKHMKRVSSAGLRTESVLQRKTENFKEFYS 151

Query:   103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
             LGRKLGQGQFGTT+LC E  TG EFACKSI+KRKL++ EDVEDVRREIQIMHHLAGH N+
Sbjct:   152 LGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNV 211

Query:   163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
             ++IKGAYED + VH+VME CAGGELFDRIIQRGHY+ERKAAELTR IVGVVEACHSLGVM
Sbjct:   212 ISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVM 271

Query:   223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA 282
             HRDLKPENFL V+K +D  LK IDFGLS+FFKP  +FTDVVGSPYYVAPEVL K YGPEA
Sbjct:   272 HRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEA 331

Query:   283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
             DVW+AGVI+YILLSGVPPFWAET+QGIF+ VL G +DF SDPWP IS+SAKDL+RKML  
Sbjct:   332 DVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVR 391

Query:   343 QPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
              P +RLTAH+VLCHPW+  +GVAPD+ LD AVLSR+KQFSAMNK KKMALRV A +
Sbjct:   392 DPKKRLTAHQVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIAES 447

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016020 "membrane" evidence=NAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1295 (460.9 bits), Expect = 4.4e-132, P = 4.4e-132
 Identities = 248/381 (65%), Positives = 297/381 (77%)

Query:    18 SQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNI 77
             S+ E     SKR       ++   T S +  +    E + E   +  + P+  P     +
Sbjct:   106 SKQEVPPEESKREVVVQPESAKPETKSESKPETTKPETTSETKPETKAEPQ-KPKHMRRV 164

Query:    78 MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
                G+  +T  VL  KT+N ++ Y+LGRKLGQGQFGTT+LC E  TG E+ACKSISKRKL
Sbjct:   165 SSAGL--RTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKL 222

Query:   138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
             ++ EDVEDVRREIQIMHHLAGH N+++IKGAYED + VH+VMELC+GGELFDRIIQRGHY
Sbjct:   223 LTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHY 282

Query:   198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +ERKAAEL R IVGV+EACHSLGVMHRDLKPENFL V++++D  LK IDFGLS+FFKP +
Sbjct:   283 TERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDE 342

Query:   258 IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
             +FTDVVGSPYYVAPEVL K YGPE+DVW+AGVI+YILLSGVPPFWAET+QGIF+ VL G 
Sbjct:   343 VFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGD 402

Query:   318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSR 377
             +DF SDPWP IS+SAKDL+RKML   P  RLTAH+VLCHPW+  +GVAPD+ LD AVLSR
Sbjct:   403 LDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSR 462

Query:   378 LKQFSAMNKLKKMALRVSASA 398
             +KQFSAMNK KKMALRV A +
Sbjct:   463 MKQFSAMNKFKKMALRVIAES 483

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;NAS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

TAIR|locus:2065021 CPK20 "calcium-dependent protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 1268 (451.4 bits), Expect = 6.1e-131, Sum P(2) = 6.1e-131
 Identities = 245/381 (64%), Positives = 297/381 (77%)

Query:    22 DHSNNSKRNTNSDCTNSDYSTPSLNSQQL-VSQEFSKENPKKDNSA-PRISPSKKDNIMR 79
             D SN    +T  D   S   TPS     + ++ E     P  +N   P   P KK+  M+
Sbjct:    52 DDSNGHVSST-VDPAPSTLPTPSTPPPPVKMANEEPPPKPITENKEDPNSKPQKKEAHMK 110

Query:    80 R--GIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
             R      Q   VLG KT+N++D+Y++GRKLGQGQFGTT+LC +  TG EFACK+I+KRKL
Sbjct:   111 RMASAGLQIDSVLGRKTENLKDIYSVGRKLGQGQFGTTFLCVDKKTGKEFACKTIAKRKL 170

Query:   138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
              + EDVEDVRREIQIMHHL+GH N++ I GAYED++ VH+VME+CAGGELFDRIIQRGHY
Sbjct:   171 TTPEDVEDVRREIQIMHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHY 230

Query:   198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +E+KAAEL RIIVGV+EACHSLGVMHRDLKPENFL V+ D++ +LK IDFGLSVFFKPG+
Sbjct:   231 TEKKAAELARIIVGVIEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGE 290

Query:   258 IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
              FTDVVGSPYYVAPEVL KHY  E DVW+AGVI+YILLSGVPPFW ET+QGIF+ VLKG 
Sbjct:   291 TFTDVVGSPYYVAPEVLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGD 350

Query:   318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSR 377
             +DF S+PWP +S+SAKDL+R+ML   P +R+T HEVLCHPW   +GVA D+ LD AVLSR
Sbjct:   351 LDFISEPWPSVSESAKDLVRRMLIRDPKKRMTTHEVLCHPWARVDGVALDKPLDSAVLSR 410

Query:   378 LKQFSAMNKLKKMALRVSASA 398
             L+QFSAMNKLKK+A++V A +
Sbjct:   411 LQQFSAMNKLKKIAIKVIAES 431

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2014691 CDPK2 "AT1G35670" [Arabidopsis thaliana (taxid:3702)]

 Score = 1175 (418.7 bits), Expect = 2.3e-119, P = 2.3e-119
 Identities = 220/308 (71%), Positives = 254/308 (82%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VL ++T  +RD Y LG+KLGQGQFGTTYLCTE +T   +ACKSI KRKL+ RED EDV R
Sbjct:    14 VLPYQTPRLRDHYLLGKKLGQGQFGTTYLCTEKSTSANYACKSIPKRKLVCREDYEDVWR 73

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             EIQIMHHL+ H N+V IKG YEDS+ VHIVME+C GGELFDRI+ +GH+SER+A +L + 
Sbjct:    74 EIQIMHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGHFSEREAVKLIKT 133

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             I+GVVEACHSLGVMHRDLKPENFL  +  DD  LKA DFGLSVF+KPGQ   DVVGSPYY
Sbjct:   134 ILGVVEACHSLGVMHRDLKPENFLFDSPKDDAKLKATDFGLSVFYKPGQYLYDVVGSPYY 193

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             VAPEVL K YGPE DVW+AGVILYILLSGVPPFWAET+ GIF  +L+G +DF+SDPWP I
Sbjct:   194 VAPEVLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKLDFKSDPWPTI 253

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
             S++AKDLI KML   P +R++AHE LCHPWI +   APD+ LDPAVLSRLKQFS MNK+K
Sbjct:   254 SEAAKDLIYKMLERSPKKRISAHEALCHPWIVDEQAAPDKPLDPAVLSRLKQFSQMNKIK 313

Query:   389 KMALRVSA 396
             KMALRV A
Sbjct:   314 KMALRVIA 321

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=ISS;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:1901979 "regulation of inward rectifier potassium channel activity" evidence=IDA

TAIR|locus:2136917 CPK4 "calcium-dependent protein kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
 Identities = 220/308 (71%), Positives = 253/308 (82%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VL ++T  +RD Y LG+KLGQGQFGTTYLCTE ++   +ACKSI KRKL+ RED EDV R
Sbjct:    13 VLPYETPRLRDHYLLGKKLGQGQFGTTYLCTEKSSSANYACKSIPKRKLVCREDYEDVWR 72

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             EIQIMHHL+ H N+V IKG YEDS+ VHIVME+C GGELFDRI+ +G +SER+AA+L + 
Sbjct:    73 EIQIMHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGCFSEREAAKLIKT 132

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             I+GVVEACHSLGVMHRDLKPENFL  +  DD  LKA DFGLSVF+KPGQ   DVVGSPYY
Sbjct:   133 ILGVVEACHSLGVMHRDLKPENFLFDSPSDDAKLKATDFGLSVFYKPGQYLYDVVGSPYY 192

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             VAPEVL K YGPE DVW+AGVILYILLSGVPPFWAET+ GIF  +L+G IDF+SDPWP I
Sbjct:   193 VAPEVLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKIDFKSDPWPTI 252

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
             S+ AKDLI KML   P +R++AHE LCHPWI +   APD+ LDPAVLSRLKQFS MNK+K
Sbjct:   253 SEGAKDLIYKMLDRSPKKRISAHEALCHPWIVDEHAAPDKPLDPAVLSRLKQFSQMNKIK 312

Query:   389 KMALRVSA 396
             KMALRV A
Sbjct:   313 KMALRVIA 320

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2039215 CPK25 "calcium-dependent protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1163 (414.5 bits), Expect = 4.2e-118, P = 4.2e-118
 Identities = 225/351 (64%), Positives = 270/351 (76%)

Query:    47 SQQLVSQEFSKENPKKDNSAPRISPSKKDNIMR-RGIDNQTYYVLGHKTDNIRDLYTLGR 105
             SQ    ++ S E  KK   A   S  K  N+ R      Q   VL  KT ++++ Y LG 
Sbjct:    77 SQGQGGRKCSDEEYKKRAIACANSKRKAHNVRRLMSAGLQAESVLKTKTGHLKEYYNLGS 136

Query:   106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
             KLG GQFGTT++C E  TG E+ACKSI KRKL + EDVEDVRREI+IM HL G  N+++I
Sbjct:   137 KLGHGQFGTTFVCVEKGTGEEYACKSIPKRKLENEEDVEDVRREIEIMKHLLGQPNVISI 196

Query:   166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             KGAYEDS+ VH+VMELC GGELFDRI++RGHYSERKAA L ++I+GVV+ CHSLGVMHRD
Sbjct:   197 KGAYEDSVAVHMVMELCRGGELFDRIVERGHYSERKAAHLAKVILGVVQTCHSLGVMHRD 256

Query:   226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVW 285
             LKPENFL VN D+D  LKAIDFGLS+F KPG+ FTDVVGSPYY+APEVL K+YGPEAD+W
Sbjct:   257 LKPENFLFVNDDEDSPLKAIDFGLSMFLKPGENFTDVVGSPYYIAPEVLNKNYGPEADIW 316

Query:   286 TAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS 345
             +AGV++Y+LLSG  PFW ET++ IF+ VL+G +D  SDPWP +S+SAKDLIRKML   P 
Sbjct:   317 SAGVMIYVLLSGSAPFWGETEEEIFNEVLEGELDLTSDPWPQVSESAKDLIRKMLERNPI 376

Query:   346 ERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSA 396
             +RLTA +VLCHPWI + G APD  LD  VLSRLK+FSA +KLKKMALRV A
Sbjct:   377 QRLTAQQVLCHPWIRDEGNAPDTPLDTTVLSRLKKFSATDKLKKMALRVIA 427

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
 Identities = 207/308 (67%), Positives = 257/308 (83%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VLG   ++++  YTLG++LG+GQFG T+LCT+ ATG++FACK+I+KRKL+++ED+EDVRR
Sbjct:    56 VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             E+QIMHHL G  NIV +KGAYED   VH+VMELCAGGELFDRII +GHYSER AA L R 
Sbjct:   116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             IV ++  CHS+GV+HRDLKPENFLL++KD++  LKA DFGLSVF+KPG++F D+VGS YY
Sbjct:   176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             +APEVL + YGPEAD+W+ GV+LYILL GVPPFWAE++ GIF+A+L G +DF SDPWP+I
Sbjct:   236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
             S  AKDL+RKML S P +RLTA +VL HPWI E+G APD  LD AV+SRLKQF AMN  K
Sbjct:   296 SPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 355

Query:   389 KMALRVSA 396
             K+ALRV A
Sbjct:   356 KVALRVIA 363

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
 Identities = 208/308 (67%), Positives = 257/308 (83%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VLG   ++++  Y+LG++LG+GQFG T+LCT+ ATG +FACK+I+KRKL+++ED+EDVRR
Sbjct:    61 VLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRR 120

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             E+QIMHHL G  NIV +KGAYED   VH+VMELCAGGELFDRII +GHYSER AA L R 
Sbjct:   121 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 180

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             IV +V  CHS+GV+HRDLKPENFLL+NKD++  LKA DFGLSVF+KPG++F D+VGS YY
Sbjct:   181 IVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 240

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             +APEVL + YGPEAD+W+ GV+LYILL GVPPFWAE++ GIF+A+L+GH+DF SDPWP I
Sbjct:   241 IAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSI 300

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
             S  AKDL++KML S P +RLTA +VL HPWI E+G APD  LD AV+SRLKQF AMN  K
Sbjct:   301 SPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 360

Query:   389 KMALRVSA 396
             K+ALRV A
Sbjct:   361 KVALRVIA 368

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
A5A7I8	CDPK5_SOLTU	2, ., 7, ., 1, 1, ., 1	0.7989	0.9271	0.6897	N/A	no
A5A7I7	CDPK4_SOLTU	2, ., 7, ., 1, 1, ., 1	0.8125	0.9773	0.6983	N/A	no
Q38871	CDPK5_ARATH	2, ., 7, ., 1, 1, ., 1	0.815	0.9849	0.7050	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00036285001	SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (561 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00027665001	SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (769 aa)						•			0.800
	GSVIVG00022728001	SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (873 aa)						•			0.800
	GSVIVG00006233001	SubName- Full=Chromosome chr1 scaffold_166, whole genome shotgun sequence; (805 aa)						•			0.800
	GSVIVG00002525001	SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (943 aa)						•			0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	398
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-102
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-95
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-65
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-58
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-58
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-54
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-52
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-51
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-49
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-48
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-46
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-46
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-45
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-41
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-40
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-40
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-39
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-39
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-38
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-38
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-37
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-36
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-36
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-35
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-35
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-35
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-35
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-35
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-33
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-33
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-33
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-33
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-32
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-32
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-32
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-32
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-32
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-32
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-32
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-31
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-31
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-31
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-30
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-30
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-30
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-29
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-29
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-29
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-29
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-29
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-29
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-28
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-28
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-27
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-27
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-27
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-27
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-27
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-27
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-26
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-25
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-25
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-25
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-25
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-25
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-25
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-25
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-24
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-24
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-24
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-24
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-24
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-23
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-23
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-23
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-23
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-22
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-22
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-22
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-21
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-20
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-19
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-17
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-17
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	7e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
pfam06293	206	pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  304 bits (780), Expect = e-102
 Identities = 119/261 (45%), Positives = 157/261 (60%), Gaps = 9/261 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +  KLG+G FG  YL  +  TG   A K I K+K+  ++D E + REI+I+  L  H 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +   +ED   +++VME C GG+LFD + +RG  SE +A    R I+  +E  HS G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           ++HRDLKPEN LL   D+D  +K  DFGL+    PG+  T  VG+P Y+APEVLL K YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
              D+W+ GVILY LL+G PPF  + Q   +F  + K    F    W  IS  AKDLIRK
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRK 233

Query: 339 MLCSQPSERLTAHEVLCHPWI 359
           +L   P +RLTA E L HP+ 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  284 bits (729), Expect = 7e-95
 Identities = 117/265 (44%), Positives = 154/265 (58%), Gaps = 11/265 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L RKLG G FGT Y      TG   A K + KR   S++D    RREI+I+  L  H 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +  A+ED   +++VME C GG+LFD + + G  SE +A ++   I+  +E  HS G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLLKH-- 277
           ++HRDLKPEN LL        +K  DFGL+    K     T  VG+P+Y+APEVLL    
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           YGP+ DVW+ GVILY LL+G PPF  E    Q  +   +L   ++F+   W   S+ AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 335 LIRKMLCSQPSERLTAHEVLCHPWI 359
           LI+K L   PS+R TA E+L HPW 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 2e-65
 Identities = 99/261 (37%), Positives = 146/261 (55%), Gaps = 21/261 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  +  TG  +A K + K+K+I R++VE    E  I+  +  H  IV + 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRIIVGVVEACHSLGVM 222
            A++    +++V+E   GGELF  + + G +SE      AAE    IV  +E  HSLG++
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE----IVLALEYLHSLGII 115

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-KHYGP 280
           +RDLKPEN LL   D D  +K  DFGL+         T+   G+P Y+APEVLL K YG 
Sbjct: 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
             D W+ GV+LY +L+G PPF+AE ++ I++ +LK  + F       +S  A+DLI  +L
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF----LSPEARDLISGLL 228

Query: 341 CSQPSERLTAHEVLC---HPW 358
              P++RL +        HP+
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  201 bits (514), Expect = 3e-62
 Identities = 93/288 (32%), Positives = 136/288 (47%), Gaps = 41/288 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ +G+G F T  L  E  T  E+A K + KR+LI  + V+ V+ E +++  L GH 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK----AAELTRIIVGVVEAC 216
            I+ +   ++D   ++ V+E    GEL   I + G   E+     AAE+   +    E  
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL----EYL 118

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI------------------ 258
           HS G++HRDLKPEN LL   D D  +K  DFG +    P                     
Sbjct: 119 HSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 259 ---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
              F   VG+  YV+PE+L  K  G  +D+W  G I+Y +L+G PPF    +   F  +L
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235

Query: 315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH----EVLCHPW 358
           K    F     P     AKDLI K+L   P +RL  +    E+  HP+
Sbjct: 236 KLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  188 bits (481), Expect = 2e-58
 Identities = 94/255 (36%), Positives = 129/255 (50%), Gaps = 44/255 (17%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FGT YL  +  TG + A K I K    S   +E++ REI+I+  L  H NIV + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLN-HPNIVKLY 57

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
           G +ED   +++VME C GG L D + +  G  SE +   +   I+  +E  HS G++HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--KHYGPEA 282
           LKPEN LL    D+  +K  DFGLS        +   +VG+P Y+APEVLL   +Y  ++
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D+W+ GVILY L                                      KDLIRKML  
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 343 QPSERLTAHEVLCHP 357
            P +R +A E+L H 
Sbjct: 201 DPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  189 bits (482), Expect = 8e-58
 Identities = 93/270 (34%), Positives = 135/270 (50%), Gaps = 27/270 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           + +G +G  +L  + +TG  +A K I K  +I +  V+ V  E  I+      ++   +K
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA---QSPYVVK 57

Query: 167 GAY----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
             Y    + +L   +VME   GG+L   +   G   E  A      IV  +E  HS G++
Sbjct: 58  LYYSFQGKKNLY--LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQIF--------TDVVGSPYYVAPEV 273
           HRDLKP+N L+   D +  LK  DFGLS       QI           +VG+P Y+APEV
Sbjct: 116 HRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +L + +    D W+ G ILY  L G+PPF  ET + IF  +L G I++  D    +SD A
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230

Query: 333 KDLIRKMLCSQPSERLTAH---EVLCHPWI 359
            DLI K+L   P +RL A    E+  HP+ 
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  180 bits (458), Expect = 3e-54
 Identities = 90/266 (33%), Positives = 138/266 (51%), Gaps = 14/266 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +T G  LG+G FG+ YL  +  TG   A KS+ +    S E++E + REI+I+  L  H 
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQ-HP 59

Query: 161 NIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV   G+   E+   ++I +E  +GG L   + + G   E    + TR I+  +   HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIFTDVVGSPYYVAPEVLL 275
            G++HRD+K  N L+   D D  +K  DFG +        G+    V G+PY++APEV+ 
Sbjct: 120 NGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAK 333
            + YG  AD+W+ G  +  + +G PP+          A+ K     E    P  +S+ AK
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSGEPPEIPEHLSEEAK 234

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWI 359
           D +RK L   P +R TA E+L HP++
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  175 bits (445), Expect = 5e-52
 Identities = 94/270 (34%), Positives = 148/270 (54%), Gaps = 28/270 (10%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG G FG   L     +G  +A K +SK K++  + VE V  E +I+  +  H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK----AAELTRIIVGVVEAC 216
            +V + G+++D   +++VME   GGELF  + + G + E      AA+    +V  +E  
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----VVLALEYL 117

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSPYYVAPEVL 274
           HSL +++RDLKPEN LL   D D  +K  DFG   F K   G+ +T + G+P Y+APE++
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFG---FAKRVKGRTYT-LCGTPEYLAPEII 170

Query: 275 L-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
           L K YG   D W  G+++Y +L+G PPF+ +    I++ +L+G + F S      S  AK
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAK 226

Query: 334 DLIRKMLCSQPSERL-----TAHEVLCHPW 358
           DLIR +L    ++RL       +++  HPW
Sbjct: 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  173 bits (440), Expect = 1e-51
 Identities = 91/262 (34%), Positives = 135/262 (51%), Gaps = 18/262 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG G FG   L    +    FA K + KR ++     E +  E +I+     H  IV + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++D   ++++ME C GGEL+  +  RG + E  A      +V   E  H+ G+++RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVW 285
           KPEN LL   D +  +K +DFG +   K GQ      G+P YVAPE++L K Y    D W
Sbjct: 120 KPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 286 TAGVILYILLSGVPPFWA--ETQQGIFDAVLKG--HIDFESDPWPLISDSAKDLIRKMLC 341
           + G++LY LL+G PPF    E    I++ +LKG   ++F   P   I  +AKDLI+++L 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF---P-NYIDKAAKDLIKQLLR 232

Query: 342 SQPSERL-----TAHEVLCHPW 358
             P ERL        ++  H W
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  172 bits (438), Expect = 3e-51
 Identities = 77/266 (28%), Positives = 133/266 (50%), Gaps = 16/266 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + +++G+G FG  YL    + G  +  K I    + S ++ ED   E++I+  L  H 
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEAC 216
           NI+    ++E+   + IVME   GG+L  +I ++      + E +  +    +   ++  
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL 275
           HS  ++HRD+KP+N  L     +  +K  DFG+S V      +   VVG+PYY++PE+  
Sbjct: 120 HSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI-SDSAK 333
            K Y  ++D+W+ G +LY L +   PF  E    +   +LKG       P P   S   +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYSSELR 232

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWI 359
           +L+  +L   P ER +  ++L  P+I
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  166 bits (422), Expect = 5e-49
 Identities = 91/264 (34%), Positives = 130/264 (49%), Gaps = 16/264 (6%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+ +  K+G+G FG  Y      TG E A K I   KL S+E  E +  EIQI+     H
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-H 56

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHS 218
            NIV   G+Y     + IVME C+GG L D +       +E + A + + ++  +E  HS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
            G++HRD+K  N LL     D  +K IDFGLS      +    +VG+PY++APEV+  K 
Sbjct: 117 NGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDFESDPWP-LISDSAKD 334
           Y  +AD+W+ G+    L  G PP+            L             P   SD  KD
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELP----PMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 335 LIRKMLCSQPSERLTAHEVLCHPW 358
            ++K L   P +R TA ++L HP+
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  168 bits (425), Expect = 2e-48
 Identities = 96/283 (33%), Positives = 139/283 (49%), Gaps = 30/283 (10%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + RKLG+G FG  YL  +       A K ++K+     ++VE   REIQI+  L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACH 217
           NIV +   ++D   +++VME   GG L D + + G     SE +A  +   I+  +E  H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-------FTDVVGSPYYVA 270
           S G++HRD+KPEN LL    D   +K IDFGL+                +  VG+P Y+A
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 271 PEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW- 325
           PEVLL     +    +D+W+ G+ LY LL+G+PPF  E         LK  I     P  
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-IILELPTPSL 235

Query: 326 ---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                     LIS +A DL++K+L   P  RL++   L H  +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  160 bits (408), Expect = 1e-46
 Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 39/290 (13%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y +  ++G+G  G  +   +  TG   A K ++ R+L     + +   REI+ +     H
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQAC-QH 58

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHS 218
             +V +   +       +VME      L + +        E +     R+++  V   H+
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG--QIFTDVVGSPYYVAPEVLL- 275
            G+MHRDLKP N L+     D  LK  DFGL+  F     ++++  V + +Y APE+L  
Sbjct: 118 NGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLK---------------- 315
            + Y P  D+W  G I   LL+G P F  E    Q  I    L                 
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 316 GHIDF-ESDPWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             I F ES P PL       S  A DL++ +L   PS+RL+A E L HP+
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 6e-46
 Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 10/258 (3%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + + +G FG+ YL  + +TG  FA K + K  +I++  V +V+ E  IM        +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +  +++    +++VME   GG+    I   G   E  A +    +V  VE  H  G++HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA-D 283
           D+KPEN L+   D    LK  DFGLS   + G      VG+P Y+APE +L     +  D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W+ G +++  L G PPF AET   +FD +L   I++  +     S  A DLI ++LC  
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 344 PSERLTAH---EVLCHPW 358
           P++RL A+   E+  HP+
Sbjct: 236 PAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 7e-45
 Identities = 89/284 (31%), Positives = 139/284 (48%), Gaps = 37/284 (13%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG  +L  +  TG  +A K + K  +I R  +  VR E  I+   A    IV + 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSPWIVKLY 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++D   +++VME   GG+L + +I++  + E  A      +V  +++ H LG +HRD+
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLS-------------------VFFKPGQIFTD------ 261
           KP+N L+   D D  +K  DFGL                    +F     +         
Sbjct: 128 KPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184

Query: 262 -----VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
                 VG+P Y+APEVL    YG E D W+ GVILY +L G PPF+++T Q  ++ ++ 
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244

Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT-AHEVLCHPW 358
                   P P +S  A DLI ++LC  P +RL    E+  HP+
Sbjct: 245 WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 9e-43
 Identities = 84/294 (28%), Positives = 132/294 (44%), Gaps = 47/294 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLA 157
           Y    KLG+G +G  Y   +  TG   A K I   +L + E+      +R EI ++  L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALR-EISLLKELK 56

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RII--QRGHYSERKAAELTRIIVGVV 213
            H NIV +         +++V E C      D  + +  + G  S      +   ++  +
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPE 272
             CHS  ++HRDLKP+N +L+N+D    LK  DFGL+  F  P + +T  V + +Y APE
Sbjct: 112 AYCHSHRILHRDLKPQN-ILINRDG--VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168

Query: 273 VLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IFD-------------AV 313
           +LL  KHY    D+W+ G I   +++G P F  +++      IF                
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228

Query: 314 LKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           L  +      F         P +     DL+ KML   P++R++A E L HP+ 
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  147 bits (374), Expect = 5e-42
 Identities = 83/262 (31%), Positives = 128/262 (48%), Gaps = 12/262 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  +G+G FG  Y    + TG   A K IS  K I  E ++ + +EI ++ +L  H 
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLK-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV   G+ E S  ++I++E    G L   I + G + E   A     ++  +   H  G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVL-LKHY 278
           V+HRD+K  N +L  KD    +K  DFG++       +    VVG+PY++APEV+ +   
Sbjct: 120 VIHRDIKAAN-ILTTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
              +D+W+ G  +  LL+G PP++       +F  V   H          IS   KD + 
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG----ISPELKDFLM 232

Query: 338 KMLCSQPSERLTAHEVLCHPWI 359
           +     P+ R TA ++L HPWI
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  145 bits (368), Expect = 9e-41
 Identities = 87/269 (32%), Positives = 135/269 (50%), Gaps = 20/269 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+LY    K+G+G  G  Y  T+ ATG E A K +     + +++ E +  EI IM    
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCK 73

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H NIV    +Y     + +VME   GG L D I Q  ++      ++  +   V++   
Sbjct: 74  -HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ--NFVRMNEPQIAYVCREVLQGLE 130

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGSPYYVAPEV 273
             HS  V+HRD+K +N LL +KD   S+K  DFG +      +     VVG+PY++APEV
Sbjct: 131 YLHSQNVIHRDIKSDNILL-SKDG--SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDF-ESDPWPLISD 330
           + +  YGP+ D+W+ G++   +  G PP+  E   + +F    KG       + W   S 
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW---SP 244

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             KD + K L   P +R +A E+L HP++
Sbjct: 245 EFKDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 5e-40
 Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 44/293 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG 158
           Y    K+G+G +G  Y   +  TG   A K I  R      +       REI+++  L  
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELN- 56

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           H NI+ +   +     +++V E       +L     ++    E         ++  +  C
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFC 114

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL 275
           HS G++HRDLKPEN LL+N +    LK  DFGL+  F  P + +T  V + +Y APE+LL
Sbjct: 115 HSHGILHRDLKPEN-LLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171

Query: 276 --KHYGPEADVWTAGVILYILLSGVPPF-----------------------WAETQQGIF 310
             K Y    D+W+ G I   LLS  P F                       W +      
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231

Query: 311 DAVLKGHIDFESDPWPLI----SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +            P P +    S  A DL+ +ML   P +R+TA + L HP+ 
Sbjct: 232 NYKFS-FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  143 bits (362), Expect = 9e-40
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 49/295 (16%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHH 155
           Y  G+KLG+G +   Y   +  TG   A K I   KL  R++ +D       REI+++  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQE 58

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAG---GELFDRII--QRGHYSERKAAELTRIIV 210
           L  H NI+ +   +     +++V E         + D+ I          K+     + +
Sbjct: 59  LK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI---KS--YMLMTL 112

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYV 269
             +E  HS  ++HRDLKP N L+     D  LK  DFGL+  F  P +  T  V + +Y 
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV---------- 313
           APE+L   +HYG   D+W+ G I   LL  VP    ++   Q G IF+A+          
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 314 ---LKGHIDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
              L  +++F+  P       +P  SD A DL++++L   P++R+TA + L HP+
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  141 bits (357), Expect = 2e-39
 Identities = 77/268 (28%), Positives = 128/268 (47%), Gaps = 20/268 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G FG   +  +  T   FA K ++K+K + +  V +V  E +I+  L  H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEAC 216
            +V +  +++D   +++V++L  GG+L   + Q+  +SE    E  +     IV  +E  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE----EQVKFWICEIVLALEYL 116

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL- 275
           HS G++HRD+KP+N LL   D+   +   DF ++    P  + T   G+P Y+APEVL  
Sbjct: 117 HSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--WPLISDSAK 333
           + Y    D W+ GV  Y  L G  P+   ++               +D       S  A 
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQETADVLYPATWSTEAI 230

Query: 334 DLIRKMLCSQPSERL--TAHEVLCHPWI 359
           D I K+L   P +RL     ++  HP+ 
Sbjct: 231 DAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 2e-39
 Identities = 84/282 (29%), Positives = 142/282 (50%), Gaps = 22/282 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G FG  +L  +  +   +A K ++  ++I  +  + V  E +++  ++ H  I+ + 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLF 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
               D   ++++ME   GGELF  +   G +S          IV  +E  HS  +++RDL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVLL-KHYGPEADV 284
           KPEN LL   D +  +K  DFG   F K  +  T  + G+P Y+APEV+  K +    D 
Sbjct: 128 KPENILL---DKEGHIKLTDFG---FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDW 181

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G+++Y +L G PPF+ +   GI++ +L G ++F       +   AKDLI+K+L    
Sbjct: 182 WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH----LDLYAKDLIKKLLVVDR 237

Query: 345 SERL-----TAHEVLCHPW---ICENGVAPDRSLDPAVLSRL 378
           + RL      A +V  H W   +  + V P R L P ++ ++
Sbjct: 238 TRRLGNMKNGADDVKNHRWFKSVDWDDV-PQRKLKPPIVPKV 278

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  140 bits (354), Expect = 2e-38
 Identities = 85/249 (34%), Positives = 136/249 (54%), Gaps = 15/249 (6%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
           +G  LG G FG   +     TG  +A K + KR+++  + V+ V +E  I+  L+ H  I
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFI 80

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           V +  +++D   V+ ++E   GGELF  + + G +    A      +V   E  HS  ++
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +RDLKPEN LL   D+   +K  DFG   F K  P + FT + G+P Y+APEV+  K +G
Sbjct: 141 YRDLKPENLLL---DNKGHVKVTDFG---FAKKVPDRTFT-LCGTPEYLAPEVIQSKGHG 193

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D WT GV+LY  ++G PPF+ +T   I++ +L G + F +  W      A+DL++ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGL 249

Query: 340 LCSQPSERL 348
           L +  ++RL
Sbjct: 250 LQTDHTKRL 258

Length = 329

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  136 bits (346), Expect = 8e-38
 Identities = 77/266 (28%), Positives = 116/266 (43%), Gaps = 26/266 (9%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSI------SKRKLISREDVEDVRREIQIMHHLAGH 159
            LGQG  G  Y      TG  +A K I        RK +         RE++ +      
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL--------LRELKTLRS-CES 58

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS- 218
             +V   GA+     + IV+E   GG L D + + G   E   A + R I+  ++  H+ 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLL-K 276
             ++HRD+KP N LL+N   +  +K  DFG+S   +      +  VG+  Y++PE +  +
Sbjct: 119 RHIIHRDIKPSN-LLINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-DFESDPWP--LISDSAK 333
            Y   AD+W+ G+ L     G  PF    Q   F+  L   I D      P    S   +
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE--LMQAICDGPPPSLPAEEFSPEFR 233

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWI 359
           D I   L   P +R +A E+L HP+I
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 7e-37
 Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 45/292 (15%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG+G  G  +L     TG  FA K + K+++I R  V+ V  E +I+  L  H  + T
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERK-----AAELTRIIVGVVEACHS 218
           +  +++    + +VM+ C GGELF     Q G     +     AAE    ++  +E  H 
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE----VLLALEYLHL 121

Query: 219 LGVMHRDLKPENFLL------VNKDDDFSLKAIDFGLSVFF---------KPGQIFTDV- 262
           LG+++RDLKPEN LL      +  D D S ++      V               I ++  
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 263 -----------VGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
                      VG+  Y+APEV+    +G   D WT G++LY +L G  PF    +   F
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL----TAHEVLCHPW 358
             +LK  + F     P +S SA+DLIRK+L   PS+RL     A E+  HP+
Sbjct: 242 SNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 1e-36
 Identities = 88/278 (31%), Positives = 126/278 (45%), Gaps = 11/278 (3%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++GQG +G  +L  +  TG   A K + K  L    +V  V  E  I+      + +V +
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             A++D   +++ ME   GG+    +   G  SE  A      +   V+A H LG +HRD
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADV 284
           LKPENFL+   D    +K  DFGLS           VVGSP Y+APEVL  K Y    D 
Sbjct: 127 LKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWPLISDSAKDLIRKML 340
           W+ G +LY  L G PPF   T    ++ +       +     DP   +SD A DLI K++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 341 CSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRL 378
                   +  ++  HP+  E      R L P  +  L
Sbjct: 242 NDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPEL 279

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  134 bits (340), Expect = 5e-36
 Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 22/265 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    ++   +A K +SK ++I R D      E  IM H A  + IV + 
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIVQLH 109

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHY--SERKAAELTRIIVGVVEACHSLGVMHR 224
            A++D   +++VME   GG+L + +    +Y   E+ A   T  +V  ++A HS+G +HR
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTD-VVGSPYYVAPEVLLK-----H 277
           D+KP+N LL   D    LK  DFG  +     G +  D  VG+P Y++PEVL       +
Sbjct: 167 DVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDSAKDL 335
           YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + F  D    IS  AKDL
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISKQAKDL 281

Query: 336 IRKMLCSQPSE--RLTAHEVLCHPW 358
           I   L  +     R    E+  HP+
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  131 bits (330), Expect = 3e-35
 Identities = 80/274 (29%), Positives = 134/274 (48%), Gaps = 23/274 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHL 156
           + L R LG G +G  +L  ++     G  +A K + K  ++ + +  E  R E Q++  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR H++E +       IV  ++  
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT--DVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F   +        G+  Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 275 LKH---YGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV+ + LL+G  PF  +    +Q  I   +LK    F       
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT---- 234

Query: 328 ISDSAKDLIRKMLCSQPSERL---TAHEVLCHPW 358
           +S  A+D I+K+L   P +RL    A E+  HP+
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  129 bits (326), Expect = 6e-35
 Identities = 84/275 (30%), Positives = 128/275 (46%), Gaps = 32/275 (11%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAG 158
            G K+G G FG  Y    + TG   A K I    +  K I     +++  E++++  L  
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-----KEIADEMKVLELLK- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H N+V   G       V+I ME C+GG L + +       E      T  ++  +   HS
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPYYVAPEV 273
            G++HRD+KP N  L   D +  +K  DFG +V  K      G+    + G+P Y+APEV
Sbjct: 118 HGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 274 L----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFDAVLKGHIDFESDPWP- 326
           +     K +G  AD+W+ G ++  + +G  P W+E      I   V  GH      P P 
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGH----KPPIPD 229

Query: 327 --LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              +S   KD + + L S P +R TA E+L HP++
Sbjct: 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 7e-35
 Identities = 88/292 (30%), Positives = 133/292 (45%), Gaps = 44/292 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + ++LG G FG+ YL     TG   A K + K+K  S E+  ++R E++ +  L  H 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLR-EVKSLRKLNEHP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHS 218
           NIV +K  + ++  ++ V E    G L+  +  R    +SE     +   I+  +   H 
Sbjct: 59  NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G  HRDLKPEN L+   +    +K  DFGL+   +    +TD V + +Y APE+LL+  
Sbjct: 118 HGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 278 -YGPEADVWTAGVILYILLSGVPPF--WAETQQGIFD--AVLKGHIDFESDPWP------ 326
            Y    D+W  G I+  L +  P F   +E  Q ++   +VL G        WP      
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVL-GT--PTKQDWPEGYKLA 230

Query: 327 -----------------LI---SDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                            LI   S  A DLI+ ML   P +R TA + L HP+
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  128 bits (325), Expect = 8e-35
 Identities = 85/274 (31%), Positives = 129/274 (47%), Gaps = 35/274 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
            +G+G FGT       + G     K I    +  +E  + V  E+ I+  L  H NIV  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELK-HPNIVR- 63

Query: 166 KGAYED------SLCVHIVMELCAGGELFDRIIQRGHYSERKAAE---LTRIIVGVVEA- 215
              Y D      +  ++IVME C GG+L  ++IQ+    ERK  E   + RI+  ++ A 
Sbjct: 64  ---YYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKC-KKERKYIEEEFIWRILTQLLLAL 118

Query: 216 --CHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPY 267
             CH+       V+HRDLKP N  L   D + ++K  DFGL+        F    VG+PY
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175

Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           Y++PE L    Y  ++D+W+ G ++Y L +  PPF A  Q  +   + +G         P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIP 231

Query: 327 LI-SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              S    ++I+ ML   P +R +  E+L  P I
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 8e-35
 Identities = 85/302 (28%), Positives = 141/302 (46%), Gaps = 62/302 (20%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L  +  TG  +A K + K +++ +E V  VR E  I+   A +  +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VVEACHSLGVM 222
            +++D   ++++ME   GG++   ++++  ++E    E TR  +      +++ H LG +
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE----EETRFYIAETILAIDSIHKLGYI 123

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--------------PGQIFTD------- 261
           HRD+KP+N LL   D    +K  DFGL    K                  F D       
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 262 ------------------VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFW 302
                              VG+P Y+APEV L+  Y  E D W+ GVI+Y +L G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 303 AETQQGIFDAVL--KGHIDFESD-PWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCH 356
           ++  Q  +  ++  K  + F  + P   +S  AKDLI+++ C     RL     +E+  H
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCCE-AERRLGNNGVNEIKSH 296

Query: 357 PW 358
           P+
Sbjct: 297 PF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  128 bits (324), Expect = 4e-34
 Identities = 85/261 (32%), Positives = 131/261 (50%), Gaps = 19/261 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            +++  D LC   VME   GGELF  + +   +SE +A      IV  +   HS  V++R
Sbjct: 62  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           DLK EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232

Query: 343 QPSERL-----TAHEVLCHPW 358
            P +RL      A E++ H +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 1e-33
 Identities = 84/268 (31%), Positives = 132/268 (49%), Gaps = 21/268 (7%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHK 160
            G+ LGQG FG  YLC ++ TG E A K +         +++V  +  EIQ++ +L  H+
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HE 64

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            IV   G   D   + I ME   GG + D++   G  +E    + TR I+  VE  HS  
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFG----LSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           ++HRD+K  N L   +D   ++K  DFG    L      G     V G+PY+++PEV+  
Sbjct: 125 IVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWA--ETQQGIFDAVLKGHIDFESDPW--PLISDS 331
             YG +ADVW+ G  +  +L+  PP WA  E    IF    +      ++P     +S  
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPQLPSHVSPD 235

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           A++ +R+       +R +A E+L H ++
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  125 bits (316), Expect = 2e-33
 Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 20/274 (7%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L   +G G     Y    +    + A K I   K   +  V+++R+E+Q M     
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--CQTSVDELRKEVQAMSQCN- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFD---RIIQRGHYSERKAAELTRIIVGVVEA 215
           H N+V    ++     + +VM   +GG L D       RG   E   A + + ++  +E 
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQIF----TDVVGSPYYVA 270
            HS G +HRD+K  N LL    +D S+K  DFG+S      G          VG+P ++A
Sbjct: 118 LHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 271 PEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH---IDFESDPW 325
           PEV+ +   Y  +AD+W+ G+    L +G  P+       +    L+     ++  +D  
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              S S + +I   L   PS+R TA E+L H + 
Sbjct: 235 KY-SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  125 bits (316), Expect = 3e-33
 Identities = 87/277 (31%), Positives = 131/277 (47%), Gaps = 41/277 (14%)

Query: 110 GQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY 169
           G +G  YL     T   FA K I+K+ LI R  ++ V  E  I+   A +  +V++  ++
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSF 70

Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLGVMHRD 225
           E    + +VME   GG+    +   G        ++ R+     V  +E  H+ G++HRD
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLLKNIGALP----VDMARMYFAETVLALEYLHNYGIVHRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFF--------------KPGQIFTD--VVGSPYYV 269
           LKP+N L+ +      +K  DFGLS                 K  + F D  V G+P Y+
Sbjct: 127 LKPDNLLITSMG---HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183

Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-- 326
           APEV+L+  YG   D W  G+ILY  L G  PF+ +T + +F  V+   I+     WP  
Sbjct: 184 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPEG 238

Query: 327 --LISDSAKDLIRKMLCSQPSERL---TAHEVLCHPW 358
              +   A+DLI ++L   P ERL    A EV  H +
Sbjct: 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  124 bits (312), Expect = 5e-33
 Identities = 87/261 (33%), Positives = 129/261 (49%), Gaps = 12/261 (4%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           G  LG G FG+ Y    +  G  FA K  S++      +E V+ + +EI ++  L  H N
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           IV   G   +   ++I +EL  GG L   + + G + E      TR I+  +E  H    
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYG 279
           +HRD+K  N L+   D +  +K  DFG++             GSPY++APEV+ +   YG
Sbjct: 124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRK 338
             AD+W+ G  +  + +G PP W++ +     AV K     E  P P  +SD AKD I K
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 339 MLCSQPSERLTAHEVLCHPWI 359
            L   PS R TA E+L HP++
Sbjct: 238 CLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 6e-33
 Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 74/306 (24%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAG 158
            ++G+G +G  Y      TG   A K I       R + E         REI+++  L  
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI-------RMENEKEGFPITAIREIKLLQKL-R 56

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELF--------D--RIIQRG--HYSERKAAELT 206
           H NIV +K           ++     G ++        D   ++      ++E +     
Sbjct: 57  HPNIVRLKE----------IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM 106

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVG 264
           + ++  ++  HS G++HRD+K  N L+   ++D  LK  DFGL+  +       +T+ V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDF 320
           + +Y  PE+LL    YGPE D+W+ G IL  L  G P F   T+    + + +  G    
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 321 ESDPWP---------------------------LISDSAKDLIRKMLCSQPSERLTAHEV 353
           E+  WP                           LI  SA DL+ K+L   P +R++A + 
Sbjct: 224 EN--WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281

Query: 354 LCHPWI 359
           L H + 
Sbjct: 282 LQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  123 bits (310), Expect = 1e-32
 Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 18/264 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +KLG+G +G+ Y    ++    +A K +    + S+++ ED   EI+I+  +  H 
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RIIVGVVE---A 215
           NI++ K A+ D   + IVME    G+L  + I +     +   E    RI + ++    A
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
            H   ++HRDLK  N LLV  D    +K  D G+S   K     T  +G+P+Y+APEV  
Sbjct: 119 LHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKKNMAKT-QIGTPHYMAPEVWK 174

Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI-SDSAK 333
              Y  ++D+W+ G +LY + +  PPF A + Q +   V +G    +  P P I S   +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQ 230

Query: 334 DLIRKMLCSQPSERLTAHEVLCHP 357
           + IR ML  +P  R    ++L  P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  125 bits (315), Expect = 2e-32
 Identities = 89/310 (28%), Positives = 142/310 (45%), Gaps = 69/310 (22%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + +G G FG   L  ++ T   +A K++ K  ++ R     V+ E  I+   A ++ +V 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  +++D   ++ VM+   GG++   +I+ G + E  A    AELT  I    E+ H +G
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAI----ESVHKMG 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL---------SVFFKPGQ-------------- 257
            +HRD+KP+N L+   D D  +K  DFGL         S +++ G               
Sbjct: 122 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 258 ---------------------IFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
                                +   +VG+P Y+APEVLL+  Y    D W+ GVILY +L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 296 SGVPPFWA----ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH 351
            G PPF A    ETQ  + +     HI  ++     +S  A DLI + LC    +RL  +
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAK----LSREASDLILR-LCCGAEDRLGKN 293

Query: 352 ---EVLCHPW 358
              E+  HP+
Sbjct: 294 GADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  123 bits (311), Expect = 3e-32
 Identities = 85/272 (31%), Positives = 133/272 (48%), Gaps = 29/272 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +  E ATG  +A K + K  L+++E V     E  I+  ++    I  ++
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWIPQLQ 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKA----AELTRIIVGVVEACHSLG 220
            A++D   +++VME   GG+L   ++ R    + E  A    AEL   I  V    H +G
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSV----HQMG 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAPEVLLK-- 276
            +HRD+KPEN L+   D    +K  DFG +        + + + VG+P Y+APEVL    
Sbjct: 123 YVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 277 -----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLIS 329
                 YG E D W+ GVI Y ++ G  PF   T    ++ ++  +  + F  D  P +S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--PKVS 237

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
               DLI+ +LC    ERL    + CHP+  +
Sbjct: 238 SDFLDLIQSLLCG-QKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  123 bits (311), Expect = 3e-32
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 16/271 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISRED-VEDVRREIQIMHHL 156
           + L + LG G +G  +L  ++    TG  +A K + K  L+ +   VE  R E  ++ H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++  +GGE+F  + QR ++SE +    +  I+  +E  
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--KPGQIFTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F  +  +      G+  Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
                +G   D W+ G++++ LL+G  PF  E ++     V +  +  +      I   A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 333 KDLIRKMLCSQPSERL-----TAHEVLCHPW 358
           +DL+ K+L   P +RL      A E+  HP+
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  122 bits (308), Expect = 4e-32
 Identities = 89/279 (31%), Positives = 143/279 (51%), Gaps = 15/279 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A K ++ ++   +E + +   EI +M     H 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENK-HP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 250

Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLS 376
           + L     +R +A E+L HP++      P  SL P + +
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFL--KIAKPLSSLTPLIAA 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  123 bits (309), Expect = 5e-32
 Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 19/259 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 62  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232

Query: 343 QPSERL-----TAHEVLCH 356
            P +RL      A EV+ H
Sbjct: 233 DPKQRLGGGPSDAKEVMEH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  121 bits (306), Expect = 7e-32
 Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 41/290 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +  K+G+G F          TG  +A K + K+   S E V ++R EIQ +  L+ H 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHP 58

Query: 161 NIVTIKGAYEDSL--CVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVEACH 217
           NI+ +     D     + +V EL     L++ I  R     E++       ++  ++  H
Sbjct: 59  NILRLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFG--LSVFFKPGQIFTDVVGSPYYVAPEVLL 275
             G+ HRD+KPEN L+     D  LK  DFG    ++ KP   +T+ + + +Y APE LL
Sbjct: 118 RNGIFHRDIKPENILI----KDDILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLL 171

Query: 276 K--HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFD-------AVLK-----GH 317
              +YGP+ D+W  G + + +LS  P F    +      I D        VLK      H
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 318 IDFESDP---------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           +++              P  S    DL++K+L   P ER+TA + L HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  121 bits (306), Expect = 7e-32
 Identities = 82/273 (30%), Positives = 136/273 (49%), Gaps = 37/273 (13%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T+ +TG + A K +  RK   RE + +   E+ IM     H NIV +
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HPNIVEM 81

Query: 166 KGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
             +Y   D L V  VME   GG L D I+     +E + A +   ++  +   H+ GV+H
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLKH 277
           RD+K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APEV+ + 
Sbjct: 139 RDIKSDSILLTS---DGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRL 190

Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK--- 333
            YG E D+W+ G+++  ++ G PP++ E         L+       +  P + +  K   
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPKLKNLHKVSP 243

Query: 334 ---DLIRKMLCSQPSERLTAHEVLCHPWICENG 363
                + +ML   P++R TA E+L HP++ + G
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  119 bits (301), Expect = 3e-31
 Identities = 85/265 (32%), Positives = 128/265 (48%), Gaps = 24/265 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C   ATG  +ACK + K++L  R+  +    E +I+      + IV++ 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVM 222
            A+E  D LC  +VM L  GG+L   I   G   + E +A      I+  +E  H   ++
Sbjct: 60  YAFETKDDLC--LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           +RDLKPEN LL   DD  +++  D GL+V  K G+      G+P Y+APEVL    Y   
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 282 ADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            D +  G  LY +++G  PF        ++ +    L+  +++        S  AKDL  
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK----FSPEAKDLCE 230

Query: 338 KMLCSQPSERL-----TAHEVLCHP 357
            +L   P +RL     +A EV  HP
Sbjct: 231 ALLQKDPEKRLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 3e-31
 Identities = 89/295 (30%), Positives = 129/295 (43%), Gaps = 50/295 (16%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLA 157
            LG  +G+G +G    C   ATG   A K     K    ED EDV+    RE++++  L 
Sbjct: 5   VLGV-VGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQLR 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            H+NIV +K A+     +++V E       EL +     G             ++  +  
Sbjct: 59  -HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAY 115

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--KPGQIFTDVVGSPYYVAPEV 273
           CHS  ++HRD+KPEN +LV++     LK  DFG +     +P    TD V + +Y APE+
Sbjct: 116 CHSHNIIHRDIKPEN-ILVSESG--VLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Query: 274 LLK--HYGPEADVWTAGVILYILLSGVPPF------------------WAETQQGIF--D 311
           L+   +YG   DVW  G I+  LL G P F                     + Q +F  +
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232

Query: 312 AVLKGHIDFE-SDPWPL-------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
               G    E S P  L       +S  A D ++  L   P ERLT  E+L HP+
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  121 bits (304), Expect = 3e-31
 Identities = 84/261 (32%), Positives = 132/261 (50%), Gaps = 17/261 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIE-FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           R LG G FG   L T         A K   K K+I ++ V+ V  E +I++++  H   V
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCV 94

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
            + G+++D   +++V+E   GGE F  + +   +           IV + E   SL +++
Sbjct: 95  NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEA 282
           RDLKPEN LL   D D  +K  DFG +      + +T + G+P Y+APE+LL   +G  A
Sbjct: 155 RDLKPENLLL---DKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPEILLNVGHGKAA 209

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D WT G+ +Y +L G PPF+A     I+  +L+G I F       + ++ K L++K+L  
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSH 265

Query: 343 QPSERL-----TAHEVLCHPW 358
             ++R       A  V  HPW
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 4e-31
 Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 57/286 (19%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           +L+TL   +G+G FG  Y   +  T    A K I   +  + +++ED+++EIQ +     
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRS 58

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              I    G++     + I+ME C GG   D +++ G   E   A + R ++  +E  H 
Sbjct: 59  -PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FT-----DVVGSPYYVAPE 272
            G +HRD+K  N LL  + D   +K  DFG+S     GQ+  T       VG+P+++APE
Sbjct: 117 EGKIHRDIKAANILLSEEGD---VKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168

Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---- 327
           V+ +  Y  +AD+W+ G+    L  G PP                     SD  P+    
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPL--------------------SDLHPMRVLF 208

Query: 328 --------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                          S   KD +   L   P ER +A E+L H +I
Sbjct: 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  118 bits (298), Expect = 5e-31
 Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 33/274 (12%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           +++ +  KLG+G +G+ Y      TG   A K +        ED++++ +EI I+     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CD 56

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEAC 216
              IV   G+Y  +  + IVME C  G + D  +I  +    E  AA L + + G+    
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE-YL 115

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT------DVVGSPYYVA 270
           HS   +HRD+K  N LL   +++   K  DFG+S     GQ+         V+G+P+++A
Sbjct: 116 HSNKKIHRDIKAGNILL---NEEGQAKLADFGVS-----GQLTDTMAKRNTVIGTPFWMA 167

Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDP--W 325
           PEV+ +  Y  +AD+W+ G+    +  G PP+ ++    + IF    K      SDP  W
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPY-SDIHPMRAIFMIPNKPPPTL-SDPEKW 225

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              S    D ++K L   P ER +A ++L HP+I
Sbjct: 226 ---SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  119 bits (300), Expect = 1e-30
 Identities = 85/267 (31%), Positives = 140/267 (52%), Gaps = 23/267 (8%)

Query: 105 RKLGQGQFGTTYLC---TEIATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHK 160
           + LG+G +G  +     T   TG  FA K + K  ++ +++D    + E  I+  +  H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            IV +  A++    +++++E  +GGELF  + + G + E  A      I   +E  H  G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPGQIFTDVVGSPYYVAPEVLLKH 277
           +++RDLKPEN LL   D    +K  DFGL   S+    G +     G+  Y+APE+L++ 
Sbjct: 121 IIYRDLKPENILL---DAQGHVKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175

Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +G   D W+ G ++Y +L+G PPF AE ++   D +LKG ++      P ++  A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231

Query: 337 RKMLCSQPSERL-----TAHEVLCHPW 358
           +K+L   PS RL      A EV  HP+
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 1e-30
 Identities = 87/312 (27%), Positives = 145/312 (46%), Gaps = 73/312 (23%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVT 164
           +G+G FG   L  +  TG  +A K++ K ++  ++ +  V+ E  +   LA   +  +V+
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV---LAESDSPWVVS 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLG 220
           +  +++D+  ++++ME   GG+L   +I+   +SE    ++TR      V  +EA H LG
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE----DVTRFYMAECVLAIEAVHKLG 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------------------KPG------ 256
            +HRD+KP+N L+   D    +K  DFGLS  F                  K        
Sbjct: 122 FIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 257 --------------QIFT----------DVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL 291
                         QI T            VG+P Y+APE+ L+  YG E D W+ G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 292 YILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL- 348
           +  L G PPF +E     +  ++  +  + F  D    +S  A+DLIR+++ +    RL 
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLITN-AENRLG 295

Query: 349 --TAHEVLCHPW 358
              AHE+  HP+
Sbjct: 296 RGGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 2e-30
 Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 21/264 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVT 164
           +G+G FG  Y   +  T   +A K +SK++++++++V     E  I+      ++  IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +K +++    +++V +  +GGELF  + + G +SE +A      +V  +E  H   +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL--KHY 278
           DLKPEN LL   D    +   DFGLS   K             G+  Y+APEVLL  K Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
               D W+ GV+++ +  G  PF+AE  Q ++  +  G + F   P  ++SD  +  ++ 
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKG 231

Query: 339 MLCSQPSERLTAH----EVLCHPW 358
           +L   P  RL AH    E+  HP+
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  117 bits (294), Expect = 3e-30
 Identities = 78/276 (28%), Positives = 140/276 (50%), Gaps = 25/276 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHL 156
           + L + LG G +G  +L  +++   +G  +A K + K  ++ + +  E  R E Q++ H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR  + E++    +  IV  +E  
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F   ++       G+  Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 275 L---KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV++Y LL+G  PF  +    +Q  I   +LK    +  +   L
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 328 ISDSAKDLIRKMLCSQPSERL-----TAHEVLCHPW 358
               AKD+I+++L   P +RL      A E+  HP+
Sbjct: 239 ----AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 5e-30
 Identities = 80/269 (29%), Positives = 140/269 (52%), Gaps = 26/269 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +     TG  +A K ++K +++ R +    R E  ++ +    + I  + 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITNLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLGVM 222
            A++D   +++VM+   GG+L   +     + +R   ++ R     +V  +++ H LG +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVL------ 274
           HRD+KP+N LL   D +  ++  DFG  +     G + ++V VG+P Y++PE+L      
Sbjct: 125 HRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDSA 332
              YGPE D W+ GV +Y +L G  PF+AE+    +  ++  K H  F  D    +S+ A
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSEEA 240

Query: 333 KDLIRKMLCSQPSERL---TAHEVLCHPW 358
           KDLIR+++CS P  RL      +   HP+
Sbjct: 241 KDLIRRLICS-PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 1e-29
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)

Query: 102 TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           TLG+KLG+G FG  Y            +E A K++ +    S + +E+  RE +IM  L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL- 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H N+V + G   +   ++IVME   GG+L   +  R +  +   ++L    + +     
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGME 116

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG-SPY-YVAPE 272
              S   +HRDL   N L+    ++  +K  DFGLS        +    G  P  ++APE
Sbjct: 117 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Query: 273 VLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
            L +  +  ++DVW+ GV+L+ + + G  P+   + + + + +  G+        P   +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------LPQPPN 227

Query: 331 SAKDLIRKML-C--SQPSERLTAHEVL 354
              +L   ML C    P +R T  E++
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  116 bits (292), Expect = 1e-29
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG+G FG   L     T   +A K + K  ++  +DVE    E +++     H  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 165 IKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +   +  +D L    VME   GG+L   I + G + E +A      IV  ++  H  G++
Sbjct: 61  LHSCFQTKDRLF--FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK----PGQIFTDVVGSPYYVAPEVLLKH- 277
           +RDLK +N LL   D +  +K  DFG+    K     G   +   G+P Y+APE+L    
Sbjct: 119 YRDLKLDNVLL---DSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQP 172

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YGP  D W  GV+LY +L+G  PF  + +  +F ++L+  + +    W  +S  AK +++
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILK 228

Query: 338 KMLCSQPSERLTAH-----EVLCHP 357
             L   P +RL        ++  HP
Sbjct: 229 SFLTKNPEKRLGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  116 bits (292), Expect = 1e-29
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 15/265 (5%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG   L     +G  +A K + K  ++  +DVE    E +I+     H  +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  VME   GG+L   I +   + E +A      I   +   H  G+++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           DLK +N LL   D +   K  DFG+       G+  +   G+P Y+APE+L +  YGP  
Sbjct: 121 DLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV+LY +L G  PF AE +  +F+A+L   + + +  W  +S  A D+++  +  
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTK 233

Query: 343 QPSERLTA------HEVLCHPWICE 361
            P+ RL +        +L HP+  E
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  115 bits (289), Expect = 1e-29
 Identities = 85/263 (32%), Positives = 129/263 (49%), Gaps = 16/263 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVS 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G   + E +A      I   +E  H   
Sbjct: 65  LAYAYETKDALC--LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 123 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G +LY +++G  PF    ++   + V +   + + +     S  A+ L + +
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239

Query: 340 LCSQPSERL-----TAHEVLCHP 357
           LC  P ERL      A EV  HP
Sbjct: 240 LCKDPKERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 89/279 (31%), Positives = 131/279 (46%), Gaps = 38/279 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           ++ Y L +++G G +G  Y   +IATG   A K I   KL   +D E +++EI ++    
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKE-C 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEA 215
            H NIV   G+Y     + IVME C GG L D I Q  RG  SE + A + R  +  +  
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAY 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYV 269
            H  G +HRD+K  N LL    +D  +K  DFG+S      Q+   +      +G+PY++
Sbjct: 117 LHETGKIHRDIKGANILLT---EDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWM 168

Query: 270 APEVLLKH----YGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDFESDP 324
           APEV        Y  + D+W  G+    L    PP +     + +F       I   + P
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSNFP 222

Query: 325 WPLISDSAK------DLIRKMLCSQPSERLTAHEVLCHP 357
            P + D  K      D I+K L   P +R TA ++L HP
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 2e-29
 Identities = 86/283 (30%), Positives = 136/283 (48%), Gaps = 23/283 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG      +  T   +A K+I K  ++SR +V     E  ++  +     IV +K
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++    +++V+    GGELF  + + G +   +A   T  ++  +E  H   V++RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL          T+   G+P Y+APE+LL H Y    D 
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           WT GV+LY +L+G+PPF+ E    ++  +L+  + F           AKDL+  +L   P
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDP 232

Query: 345 SERL---TAHEVLCHPW--------ICENGVAPDRSLDPAVLS 376
           + RL    A E+  HP+        +   G+ P     PAV S
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQP--PFKPAVSS 273

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  115 bits (288), Expect = 2e-29
 Identities = 88/279 (31%), Positives = 144/279 (51%), Gaps = 15/279 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT +   ++ATG E A K I+ +K   +E + +   EI +M  L  + 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVMKELK-NP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    ++     + +VME  AGG L D ++      E + A + R  +  +E  H+  
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL       S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 136 VIHRDIKSDNVLLGMDG---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SPIFRDFLN 250

Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLS 376
           + L     +R +A E+L HP++      P  SL P +L+
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFL--KLAKPLSSLTPLILA 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  116 bits (292), Expect = 2e-29
 Identities = 91/305 (29%), Positives = 135/305 (44%), Gaps = 62/305 (20%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR---REIQIMHHLA 157
           Y L + +G G +G      +  TG + A K IS       +D+ D +   REI+++ HL 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHLR 57

Query: 158 GHKNIVTIK-----GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE------LT 206
            H+NI+ +       + ED   V+IV EL    +L  ++I     S +   +      L 
Sbjct: 58  -HENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVI----KSPQPLTDDHIQYFLY 110

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDV 262
           +I+ G+ +  HS  V+HRDLKP N +LVN + D  LK  DFGL+             T+ 
Sbjct: 111 QILRGL-KYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEY 166

Query: 263 VGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET---Q-QGIFDAVLKG 316
           V + +Y APE+LL    Y    D+W+ G I   LL+  P F       Q   I + +   
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226

Query: 317 H---IDFESD----------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
               + F +                 P     P  S  A DL+ KML   P +R+TA E 
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286

Query: 354 LCHPW 358
           L HP+
Sbjct: 287 LAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 3e-29
 Identities = 78/271 (28%), Positives = 137/271 (50%), Gaps = 25/271 (9%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHL-- 156
           LY     +G+G +G  Y    + TG   A K I+   L + +D V D++RE+ ++  L  
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQ 58

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEA 215
           +   NI    G+Y     + I+ME   GG +  R + + G  +E+  + + R ++  ++ 
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVL 274
            H +GV+HRD+K  N L+ N  +   +K  DFG++          +  VG+PY++APEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-LKGHID---FESDPWPLI 328
              K+Y  +AD+W+ G+ +Y + +G PP+   +    F A+ L         E + +   
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY--- 227

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           S   ++ +   L  +P ERL+A E+L   WI
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  116 bits (292), Expect = 3e-29
 Identities = 96/325 (29%), Positives = 145/325 (44%), Gaps = 65/325 (20%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L  ++ T   +A K++ K+ +++R  V  V+ E  I+   A ++ +V 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  +++D   ++ VM+   GG++   +I+   + E  A    AELT  I    E+ H +G
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ESVHKMG 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--------------------PGQIFT 260
            +HRD+KP+N L+   D D  +K  DFGL   F+                    P  ++ 
Sbjct: 122 FIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 261 DV----------------------------VGSPYYVAPEVLL-KHYGPEADVWTAGVIL 291
           DV                            VG+P Y+APEVLL K Y    D W+ GVIL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 292 YILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL--- 348
           + +L G PPF A T       V+         P   +S  A DLI K+ CS   ERL   
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA-EERLGRN 297

Query: 349 TAHEVLCHPWICENGVAPDRSLDPA 373
            A ++  HP+  E   + D    PA
Sbjct: 298 GADDIKAHPFFSEVDFSSDIRTQPA 322

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (284), Expect = 6e-29
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 27/267 (10%)

Query: 102 TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           TLG+KLG+G FG  Y  T         +E A K++ +    S + +E+  RE +IM  L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL- 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G   +   + IVME   GG+L D + +     E   ++L    + +     
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGME 117

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG-SPY-YVAPE 272
              S   +HRDL   N L+    ++  +K  DFGLS        +    G  P  ++APE
Sbjct: 118 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 273 VLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
            L +  +  ++DVW+ GV+L+ + + G  P+   +   + + + KG+        P   +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL------PKPPN 228

Query: 331 SAKDLIRKML-C--SQPSERLTAHEVL 354
              +L + ML C    P +R T  E++
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  115 bits (288), Expect = 8e-29
 Identities = 99/306 (32%), Positives = 146/306 (47%), Gaps = 36/306 (11%)

Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 33  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 93  ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 150

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207

Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 267

Query: 320 FESDPWPLISDSAKDLIRKMLCSQPSE--RLTAHEVLCHP------WICEN------GVA 365
           F  D    IS  AK+LI   L  +     R    E+  H       W  E        V 
Sbjct: 268 FPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVV 325

Query: 366 PDRSLD 371
           PD S D
Sbjct: 326 PDLSSD 331

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  113 bits (284), Expect = 1e-28
 Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 20/260 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 62  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L 
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLSGLLK 232

Query: 342 SQPSERL-----TAHEVLCH 356
             P +RL      A E++ H
Sbjct: 233 KDPKQRLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  113 bits (284), Expect = 2e-28
 Identities = 87/266 (32%), Positives = 138/266 (51%), Gaps = 29/266 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E A+G  +A K + K  +I++++V     E +++ +   H  + ++K
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            +++  D LC   VME   GGELF  + +   +SE +       IV  ++  HS  +++R
Sbjct: 62  YSFQTKDRLC--FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLLKH- 277
           DLK EN +L   D D  +K  DFGL    K G   TD        G+P Y+APEVL  + 
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLC---KEG--ITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YG   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F   P  L +D AK L+ 
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF---PRTLSAD-AKSLLS 227

Query: 338 KMLCSQPSERL-----TAHEVLCHPW 358
            +L   P++RL      A E++ H +
Sbjct: 228 GLLIKDPNKRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 3e-28
 Identities = 81/294 (27%), Positives = 126/294 (42%), Gaps = 44/294 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMHHL--A 157
           Y    ++G+G +GT Y   ++ TG   A K +  R  +S E +     REI ++  L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESF 58

Query: 158 GHKNIVTI-----KGAYEDSLCVHIVMELC----AGGELFDRIIQRGHYSERKAAELTRI 208
            H NIV +         +  L + +V E      A      +  + G        +L R 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT--YLSKCPKPG-LPPETIKDLMRQ 115

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           ++  V+  HS  ++HRDLKP+N +LV  D    +K  DFGL+  +      T VV + +Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQN-ILVTSDG--QVKIADFGLARIYSFEMALTSVVVTLWY 172

Query: 269 VAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFD------------ 311
            APEVLL+  Y    D+W+ G I   L    P F   ++      IFD            
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 312 --AVLKGHIDF-----ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             ++ +               P I +   DL++KML   P +R++A E L HP+
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  113 bits (285), Expect = 3e-28
 Identities = 89/306 (29%), Positives = 136/306 (44%), Gaps = 57/306 (18%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L  ++ T   +A K++ K+ ++ R  V  V+ E  I+   A ++ +V 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +  +++D   ++ VM+   GG++   +I+ G + E  A      +   VE+ H +G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQIFTD---------- 261
           D+KP+N L+   D D  +K  DFGL   F+               Q   D          
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 262 -------------------------VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
                                    +VG+P Y+APEVLL+  Y    D W+ GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHE 352
            G PPF A+T       V+         P   +S  A DLI K LC  P +RL    A E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301

Query: 353 VLCHPW 358
           +  HP+
Sbjct: 302 IKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  110 bits (277), Expect = 7e-28
 Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 16/265 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ +  GG+L   I   G+  + E +A      I+  +E  H   
Sbjct: 65  LAYAYETKDALC--LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
            ++RDLKPEN LL   DD   ++  D GL+V    G+     VG+  Y+APEVL  + Y 
Sbjct: 123 TVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G ++Y ++ G  PF    ++   + V +  ++ E       S+ AK + + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239

Query: 340 LCSQPSERL-----TAHEVLCHPWI 359
           L   P +RL      A EV  HP+ 
Sbjct: 240 LTKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  110 bits (276), Expect = 7e-28
 Identities = 84/272 (30%), Positives = 138/272 (50%), Gaps = 24/272 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSI--SKRKLISREDVEDVRREIQIMHHLAG 158
           + LG+ LGQG FG  YLC +  TG E A K +        + ++V  +  EIQ++ +L  
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL- 62

Query: 159 HKNIVTIKGAYEDSL--CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           H+ IV   G   D +   + I ME   GG + D++   G  +E    + TR I+  V   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK----PGQIFTDVVGSPYYVAPE 272
           HS  ++HRD+K  N L   +D   ++K  DFG S   +     G     V G+PY+++PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPW--PL 327
           V+  + YG +AD+W+ G  +  +L+  PP WAE +    IF    +      ++P   P 
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPPH 233

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +SD  +D ++++   +   R +A E+L H ++
Sbjct: 234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  110 bits (275), Expect = 8e-28
 Identities = 84/265 (31%), Positives = 132/265 (49%), Gaps = 18/265 (6%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSIS--KRKLISREDVEDVRREIQIMHHLAGHKN 161
           G+ LGQG FG  YLC ++ TG E A K +        + ++V  +  EIQ++ +L  H+ 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65

Query: 162 IVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           IV   G   D     + I ME   GG + D++   G  +E    + TR I+  +   HS 
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFG----LSVFFKPGQIFTDVVGSPYYVAPEVLL 275
            ++HRD+K  N L   +D   ++K  DFG    L      G     V G+PY+++PEV+ 
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAK 333
            + YG +ADVW+ G  +  +L+  PP WAE +     A+ K      +   P  IS+ A+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHISEHAR 239

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPW 358
           D +  +   +   R +A E+L HP+
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  110 bits (277), Expect = 8e-28
 Identities = 84/290 (28%), Positives = 145/290 (50%), Gaps = 35/290 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   +  E  +G + A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQ-HQNVVEM 83

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + ++ME   GG L D I+ +   +E + A +   ++  +   HS GV+HRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLKH-Y 278
           +K ++ LL     D  +K  DFG        QI  DV      VG+PY++APEV+ +  Y
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRTPY 194

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK----- 333
           G E D+W+ G+++  ++ G PP+++++        ++        P P + ++ K     
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVL 247

Query: 334 -DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
            D + +ML  +P ER TA E+L HP++ + G+     L P +    K+ S
Sbjct: 248 RDFLERMLTREPQERATAQELLDHPFLLQTGLP--ECLVPLIQQYRKRTS 295

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  110 bits (276), Expect = 1e-27
 Identities = 88/279 (31%), Positives = 143/279 (51%), Gaps = 15/279 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   +IATG E A K ++ ++   +E + +   EI +M     + 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRE-NKNP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  ++  HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPERL-SAVFRDFLN 250

Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLS 376
           + L      R +A E+L HP++      P  SL P +++
Sbjct: 251 RCLEMDVDRRGSAKELLQHPFL--KLAKPLSSLTPLIIA 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  110 bits (277), Expect = 2e-27
 Identities = 80/265 (30%), Positives = 129/265 (48%), Gaps = 25/265 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH--HLAGHKNIVT 164
           LG+G FG   L     TG  +A K++ K  +I+R++VE +  E +I    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    V  VME  AGG+L    I    +SE +A      +V  ++  H   +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL-KHYG 279
           DLK +N LL   D +  +K  DFGL    K G  F D      G+P ++APEVL    Y 
Sbjct: 126 DLKLDNLLL---DTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDLIRK 338
              D W  GV++Y +L G  PF  + ++ +FD+++      +   +P  +S  A  ++R+
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234

Query: 339 MLCSQPSERL-----TAHEVLCHPW 358
           +L   P  RL      A +V   P+
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  108 bits (271), Expect = 3e-27
 Identities = 83/260 (31%), Positives = 130/260 (50%), Gaps = 17/260 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + R +G+G FG   L   + +  ++A K I  R   S   VED R+E  ++  +  H 
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGH-YSERKAAE-LTRIIVGVVEACH 217
           NIV  K ++E    ++IVME C GG+L  +I +QRG  + E    +   ++ +G V+  H
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG-VQHIH 117

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLK 276
              V+HRD+K +N  L     +  +K  DFG + +   PG      VG+PYYV PE+   
Sbjct: 118 EKRVLHRDIKSKNIFLTQ---NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKD 334
             Y  ++D+W+ G ILY L +   PF A + + +   V +G       P P   S   + 
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY----KPLPSHYSYELRS 230

Query: 335 LIRKMLCSQPSERLTAHEVL 354
           LI++M    P  R +A  +L
Sbjct: 231 LIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  110 bits (277), Expect = 3e-27
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 18/269 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + + +G+G FG   L    ++   +A K +SK ++I R D      E  IM   A   
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +  A++D   +++VME   GG+L + ++      E+ A   T  +V  ++A HS+G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDV-VGSPYYVAPEVLLK-- 276
           ++HRD+KP+N LL   D    LK  DFG  +   + G +  D  VG+P Y++PEVL    
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 277 ---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDS 331
              +YG E D W+ GV L+ +L G  PF+A++  G +  ++  K  ++F  D    IS  
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE--ISKH 277

Query: 332 AKDLIRKMLCSQPSE--RLTAHEVLCHPW 358
           AK+LI   L  +     R    E+  HP+
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  110 bits (276), Expect = 3e-27
 Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 41/272 (15%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L  +  TG  +A K + K  ++ +E V  +R E  I+   A    +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++D L ++++ME   GG++   ++++   +E +        V  +++ H LG +HRD+
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPG------------------------------ 256
           KP+N LL   D    +K  DFGL    K                                
Sbjct: 128 KPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 257 ------QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
                 Q+    VG+P Y+APEV ++  Y    D W+ GVI+Y +L G PPF +ET Q  
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
           +  V+         P   IS+ AKDLI +  C
Sbjct: 245 YKKVMNWKETLIFPPEVPISEKAKDLILRFCC 276

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  109 bits (275), Expect = 3e-27
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 16/264 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  ++  +DV+    E +I+   A H  +  + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    +  VME   GG+L  +I +   + E ++      +   +   H  GV++RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADV 284
           K +N LL   D +   K  DFG+       G   T   G+P Y+APE+L +  YGP  D 
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV++Y +++G PPF A+ +  +F+++L  H D     W  +S  A  +++  +   P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVW--LSKEAVSILKAFMTKNP 235

Query: 345 SERL-------TAHEVLCHPWICE 361
           ++RL           +  HP+  E
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  110 bits (276), Expect = 4e-27
 Identities = 82/292 (28%), Positives = 130/292 (44%), Gaps = 45/292 (15%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L  +  TG  +A K + K  ++ +E V  +R E  I+    G   +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMF 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++D   ++++ME   GG++   ++++   SE          V  ++A H LG +HRD+
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPG------------------------------ 256
           KP+N LL   D    +K  DFGL    K                                
Sbjct: 128 KPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 257 ------QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
                 Q+    VG+P Y+APEV ++  Y    D W+ GVI+Y +L G PPF +ET Q  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCHPW 358
           +  V+         P   IS+ AKDLI +  C+    R+      E+  HP+
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  108 bits (271), Expect = 5e-27
 Identities = 77/269 (28%), Positives = 139/269 (51%), Gaps = 13/269 (4%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 82

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEAD 283
           +K ++ LL +   D  +K  DFG      K       +VG+PY++APE++ +  YGPE D
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
           +W+ G+++  ++ G PP++ E        +++ ++  +      +S S K  + ++L   
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 344 PSERLTAHEVLCHPWICENGVAPDRSLDP 372
           P++R TA E+L HP++ + G  P   + P
Sbjct: 258 PAQRATAAELLKHPFLAKAG--PPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (269), Expect = 8e-27
 Identities = 81/282 (28%), Positives = 129/282 (45%), Gaps = 44/282 (15%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHH 155
           DL  LG +LG G  G         TG   A K+I       +  +     + RE+ I+H 
Sbjct: 2   DLEYLG-ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-----ILRELDILHK 55

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVV 213
                 IV   GA+ ++  + I ME   GG L D+I++   G   ER    L +I V V+
Sbjct: 56  -CNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERI---LGKIAVAVL 110

Query: 214 EAC----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGS 265
           +          ++HRD+KP N L+ ++     +K  DFG+S     GQ+   +    VG+
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGT 162

Query: 266 PYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFDAVLKGHIDFE- 321
             Y+APE +    Y  ++D+W+ G+ L  L +G  P+  E     GIF+ +L+  ++   
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEPP 221

Query: 322 ----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               S  +   S   +D +   L   P ER +  E+L HP+I
Sbjct: 222 PRLPSGKF---SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  107 bits (269), Expect = 9e-27
 Identities = 88/277 (31%), Positives = 138/277 (49%), Gaps = 15/277 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A   I +  L  +   E +  EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 251

Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           + L     +R +A E+L H ++      P  SL P +
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFL--KIAKPLSSLTPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  108 bits (272), Expect = 1e-26
 Identities = 70/248 (28%), Positives = 125/248 (50%), Gaps = 9/248 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A G  +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HSL +++RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +  +  +   G+P Y+APEVL K  Y    D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +  + +    IS SA+ L+  +L    
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISVSARHLLEGLLQKDR 235

Query: 345 SERLTAHE 352
           ++RL A +
Sbjct: 236 TKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  106 bits (266), Expect = 2e-26
 Identities = 68/264 (25%), Positives = 136/264 (51%), Gaps = 14/264 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   +K+G+G FG   L      G ++  K I+  K+  +E  E+ R+E+ ++ ++  H 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMK-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRG-HYSERKAAELTRIIVGVVEACHS 218
           NIV  + ++E++  ++IVM+ C GG+L+ +I  QRG  + E +  +    I   ++  H 
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-K 276
             ++HRD+K +N  L     D ++K  DFG++ V     ++    +G+PYY++PE+   +
Sbjct: 120 RKILHRDIKSQNIFLTK---DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDL 335
            Y  ++D+W  G +LY + +    F A   + +   +++G       P     S   ++L
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY----PPVSSHYSYDLRNL 232

Query: 336 IRKMLCSQPSERLTAHEVLCHPWI 359
           + ++    P +R + + +L   +I
Sbjct: 233 VSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  106 bits (265), Expect = 7e-26
 Identities = 69/246 (28%), Positives = 123/246 (50%), Gaps = 9/246 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A    +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HSL +++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +     +   G+P Y+APEVL K  Y    D 
Sbjct: 123 KPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +  +    P I++SA+ L+  +L    
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235

Query: 345 SERLTA 350
           ++RL A
Sbjct: 236 TKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  104 bits (261), Expect = 9e-26
 Identities = 76/261 (29%), Positives = 115/261 (44%), Gaps = 12/261 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   R LG+G FG   L            K ++  +L  +E   D   EI I+  L  H 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQ-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHS 218
           NI+     + D   + I ME   GG L+D+I+++    + E         IV  V   H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-K 276
            G++HRD+K  N  L  K     +K  DFG+S          + VVG+PYY++PE+    
Sbjct: 120 AGILHRDIKTLNIFL-TKAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y  ++D+W  G +LY LL+    F A     +   +++G+       +   S     L+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLV 233

Query: 337 RKMLCSQPSERLTAHEVLCHP 357
             +L   P +R TA EVL  P
Sbjct: 234 HSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  104 bits (261), Expect = 1e-25
 Identities = 82/267 (30%), Positives = 136/267 (50%), Gaps = 33/267 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + TE  TG + A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYH-HENVVDM 84

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APEV+ +  Y
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFC-----AQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK--DLI 336
           G E D+W+ G+++  ++ G PP++ E         L+       +  P + DS K   ++
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPP-------LQAMRRIRDNLPPRVKDSHKVSSVL 248

Query: 337 RK----MLCSQPSERLTAHEVLCHPWI 359
           R     ML  +PS+R TA E+L HP++
Sbjct: 249 RGFLDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  103 bits (259), Expect = 2e-25
 Identities = 78/263 (29%), Positives = 128/263 (48%), Gaps = 16/263 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E +I+  +   + +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ +  GG+L   I   G+  + E++A      +   +E      
Sbjct: 65  LAYAYETKDALC--LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    G+     VG+  Y+APEV+  + Y 
Sbjct: 123 IVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G ++Y ++ G  PF    ++   + V +   + + +     S+ AK + R +
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239

Query: 340 LCSQPSERL-----TAHEVLCHP 357
           L   P ERL      A  V  HP
Sbjct: 240 LTKNPKERLGCRGNGAAGVKQHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  105 bits (262), Expect = 2e-25
 Identities = 71/253 (28%), Positives = 133/253 (52%), Gaps = 26/253 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +         FA K ++K +++ R +    R E  ++ +   ++ I T+ 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITTLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLGVM 222
            A++D   +++VM+   GG+L   +     + +R   ++ R     +V  +++ H L  +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAPEVLLK---- 276
           HRD+KP+N L+   D +  ++  DFG  +   + G + + V VG+P Y++PE+L      
Sbjct: 125 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 277 --HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL----ISD 330
              YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +P     +S+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVTDVSE 238

Query: 331 SAKDLIRKMLCSQ 343
            AKDLIR+++CS+
Sbjct: 239 DAKDLIRRLICSR 251

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-25
 Identities = 81/263 (30%), Positives = 130/263 (49%), Gaps = 16/263 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G+  + E +A      I   +E  H   
Sbjct: 65  LAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    G+     VG+  Y+APEV+  + Y 
Sbjct: 123 IVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G ++Y ++ G  PF    ++   + V +   + + +     S++A+ + R++
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239

Query: 340 LCSQPSERL-----TAHEVLCHP 357
           L   P  RL      A EV  HP
Sbjct: 240 LTKDPGFRLGCRGEGAEEVKAHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-25
 Identities = 88/283 (31%), Positives = 133/283 (46%), Gaps = 30/283 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D++ +  +LG G FG  Y      TG+  A K I   ++ S E++ED   EI I+  
Sbjct: 2   NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSE 58

Query: 156 LAGHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
              H NIV +  AY  E+ L   I++E C GG L   +++     +E +   + R ++  
Sbjct: 59  CK-HPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGSPYYVAP 271
           +   HS  V+HRDLK  N LL    D   +K  DFG+S   K   Q     +G+PY++AP
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           EV+         Y  +AD+W+ G+ L  L    PP        +   +LK      S+P 
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK------SEPP 226

Query: 326 PLI-----SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
            L      S S  D ++  L   P +R TA E+L HP++ +  
Sbjct: 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  103 bits (259), Expect = 5e-25
 Identities = 71/247 (28%), Positives = 123/247 (49%), Gaps = 15/247 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLGVMHRD 225
             ++    ++ VME   GG+L   I Q G + E  A      I +G+    HS G+++RD
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF-FLHSKGIIYRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGL---SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPE 281
           LK +N +L   D +  +K  DFG+   ++F   G+      G+P Y+APE++  + YG  
Sbjct: 127 LKLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV+LY +L+G PPF  E +  +F ++++ ++ +       +S  A  + + +L 
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLLT 237

Query: 342 SQPSERL 348
             P++RL
Sbjct: 238 KHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  103 bits (257), Expect = 5e-25
 Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 17/263 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C   ATG  +ACK ++K++L  R+  E    E +I+  +   + IV++ 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLA 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACHSLGVM 222
            A++    + +VM +  GG+L   I     +   + E +A   T  I+  +E  H   ++
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-KHYGP 280
           +RDLKPEN LL   D+D +++  D GL+V  K GQ  T    G+P ++APE+L  + Y  
Sbjct: 120 YRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDLIRKM 339
             D +  GV LY +++   PF A  ++ + +  LK  I  +S  +P   S ++K     +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 340 LCSQPSERL-----TAHEVLCHP 357
           L   P +RL         +  HP
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  103 bits (258), Expect = 6e-25
 Identities = 77/252 (30%), Positives = 114/252 (45%), Gaps = 51/252 (20%)

Query: 148 REIQIMHHLAGHKNIVTIK----GAYEDSLCVHIVMELCAGGE-----LFDRIIQRGHYS 198
           REI I+  L  H NIVT+K    G+  D   +++VME     E     L + + Q    S
Sbjct: 53  REINILLKL-QHPNIVTVKEVVVGSNLDK--IYMVMEYV---EHDLKSLMETMKQPFLQS 106

Query: 199 ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQ 257
           E K   L   ++  V   H   ++HRDLK  N LL N+     LK  DFGL+  +  P +
Sbjct: 107 EVKC--LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLK 161

Query: 258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF--WAETQQ--GIFD 311
            +T +V + +Y APE+LL  K Y    D+W+ G I   LL+  P F   +E  Q   IF 
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221

Query: 312 AV---------------LKGHIDFESDP-WPL--------ISDSAKDLIRKMLCSQPSER 347
            +                     F   P   L        +SD+  DL+ ++L   P++R
Sbjct: 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281

Query: 348 LTAHEVLCHPWI 359
           ++A + L HP+ 
Sbjct: 282 ISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 29/274 (10%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSI---------SKRKLISREDVEDVRREIQIMH 154
           G  +G G FG+ YL    ++G   A K +           RK   R  ++ + REI ++ 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRK---RSMLDALAREIALLK 61

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+NIV   G+  D+  ++I +E   GG +   +   G + E       R I+  + 
Sbjct: 62  ELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-------DVVGSPY 267
             H+ G++HRD+K  N L+ NK     +K  DFG+S   +   + T        + GS +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKG---GIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 268 YVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPW 325
           ++APEV+ +  Y  +AD+W+ G ++  +L+G  PF   TQ Q IF        +  S+  
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN-- 235

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             IS  A D + K      ++R TA E+L HP++
Sbjct: 236 --ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 25/274 (9%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-------VEDVRREIQIMHHL 156
           G  +G+G +G  YL   + TG   A K +     I+          V+ +R EI+ +  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NIV   G       + I +E   GG +   +   G + E+     T  ++  +   
Sbjct: 66  D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV-----GSPYYVAP 271
           HS G++HRDLK +N L+   D D   K  DFG+S   K   I+ +       GS +++AP
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAP 179

Query: 272 EVL-LKH--YGPEADVWTAGVILYILLSGVPPFWA--ETQQGIFD-AVLKGHIDFESDPW 325
           EV+      Y  + D+W+ G ++  + +G  P W+  E    +F     +       D  
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             +S  A D +       P  R TA E+L HP+I
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  102 bits (255), Expect = 2e-24
 Identities = 73/271 (26%), Positives = 140/271 (51%), Gaps = 27/271 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D + + + +G+G FG   +     T   +A K ++K +++ R +    R E  ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VVE 214
            + I T+  A++D   +++VM+   GG+L   +     + +R   ++ R  +      + 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIH 116

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAPE 272
           + H L  +HRD+KP+N LL   D +  ++  DFG  +   + G + + V VG+P Y++PE
Sbjct: 117 SIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 273 VL------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           +L      +  YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP 230

Query: 327 L----ISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S+ AKDLI++++CS+   RL  + +
Sbjct: 231 SHITDVSEEAKDLIQRLICSR-ERRLGQNGI 260

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  100 bits (251), Expect = 2e-24
 Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 19/267 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   R +G+G +G   L      G ++  K ++ R    RE  +   +E Q++  L  H 
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLK-HP 59

Query: 161 NIVTIKGAYEDSLC-VHIVMELCAGGELFDRII-QRGHY-SERKAAELTRIIVGVVEACH 217
           NIV  + ++E     ++IVM  C GG+L+ ++  Q+G    E +  E    I   ++  H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              ++HRDLK +N  L   +    +K  D G++ V      + + ++G+PYY++PE+   
Sbjct: 120 EKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK-- 333
           K Y  ++DVW  G  +Y + +    F A+    +   +++G +       P+  D +   
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP------PMPKDYSPEL 230

Query: 334 -DLIRKMLCSQPSERLTAHEVLCHPWI 359
            +LI  ML  +P +R +   +L  P+I
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  101 bits (253), Expect = 3e-24
 Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 19/267 (7%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+T  R++G G FG  Y   ++ T    A K +S     S E  +D+ +E++ +  L  H
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-H 74

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            N +  KG Y       +VME C G   ++ +  + +    E + A +    +  +   H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           S   +HRD+K  N LL    +  ++K  DFG +    P   F   VG+PY++APEV+L  
Sbjct: 133 SHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAM 186

Query: 277 ---HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
               Y  + DVW+ G+    L    PP F       ++           S+ W   SD  
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYF 243

Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           ++ +   L   P +R ++ E+L H ++
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (249), Expect = 4e-24
 Identities = 84/270 (31%), Positives = 132/270 (48%), Gaps = 20/270 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHHLA 157
           + LG+ LG+G FG  YLC +  TG E A K +      +  S+E V  +  EIQ++ +L 
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLR 62

Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            H  IV   G   D     + I +E   GG + D++   G  +E      TR I+  V  
Sbjct: 63  -HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSPYYVAP 271
            HS  ++HRD+K  N L   +D   ++K  DFG S         G     V G+PY+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-IS 329
           EV+  + YG +ADVW+    +  +L+  PP WAE +     A+ K          P  +S
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTKPMLPDGVS 235

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           D+ +D ++++   +   R TA  +L HP++
Sbjct: 236 DACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.5 bits (249), Expect = 5e-24
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 45/241 (18%)

Query: 105 RKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           +KLG+G FG  Y      +     E A K++ +    S E+ +D  +E ++M  L GH N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK------AAELTRIIVGVVEA 215
           +V + G   +   +++V+E   GG+L D + +                +L    + +  A
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI--A 115

Query: 216 C-----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
                  S   +HRDL   N L+    +D  +K  DFGLS          DV    YY  
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSR---------DVYDDDYYRK 163

Query: 270 -----------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
                      APE L    +  ++DVW+ GV+L+ + + G  P+   + + + + + KG
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223

Query: 317 H 317
           +
Sbjct: 224 Y 224

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  100 bits (251), Expect = 6e-24
 Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 15/251 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L      G  +A K + K+ +++R++ + +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HS+ +++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH-YGPE 281
           KPEN LL   D    +   DFGL    K G   +D      G+P Y+APEV+ K  Y   
Sbjct: 123 KPENILL---DSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  G +LY +L G+PPF+      ++D +L   +       P  S +A  ++ ++L 
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232

Query: 342 SQPSERLTAHE 352
                RL A E
Sbjct: 233 KDRQRRLGAKE 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 7e-24
 Identities = 90/312 (28%), Positives = 134/312 (42%), Gaps = 66/312 (21%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS--------KRKLISREDVEDVR 147
           ++   Y     +G+G +G     T   TG++ A K IS        +R L          
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL---------- 51

Query: 148 REIQIMHHLAGHKNIVTIK-----GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
           REI+I+     H+NI+ I       ++E    V+IV EL    +L+ ++I+  H S    
Sbjct: 52  REIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHI 108

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP----GQI 258
                 I+  ++  HS  V+HRDLKP N LL+N + D  LK  DFGL+    P       
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSN-LLLNTNCD--LKICDFGLARIADPEHDHTGF 165

Query: 259 FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF--------------- 301
            T+ V + +Y APE++L  K Y    D+W+ G IL  +LS  P F               
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225

Query: 302 ----WAETQQGIFDAVLKGHIDFESDPW----------PLISDSAKDLIRKMLCSQPSER 347
                 E    I     + +I  +S P+          P     A DL+ KML   P +R
Sbjct: 226 LGTPSQEDLNCIISLRARNYI--KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283

Query: 348 LTAHEVLCHPWI 359
           +T  E L HP++
Sbjct: 284 ITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  100 bits (251), Expect = 7e-24
 Identities = 88/314 (28%), Positives = 135/314 (42%), Gaps = 75/314 (23%)

Query: 101 YTLGRKLGQGQFGTTYLC----TEIATGIEFACKSISK---RKLISREDVEDVRREIQIM 153
           Y L ++LGQG +G   +C     E +     A K I+    +K++++  +    RE++++
Sbjct: 2   YELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLL 55

Query: 154 HHLAGHKNIVTI-------KGAYEDSLCVHIVME------LCAGGELFDRIIQRGHYSER 200
            H  GHKNI  +        G + +      +ME      + +G  L D   Q   Y   
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY--- 112

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-- 258
                 +I+ G+ +  HS  V+HRDLKP N LLVN D +  LK  DFGL+  F       
Sbjct: 113 ------QILCGL-KYIHSANVLHRDLKPGN-LLVNADCE--LKICDFGLARGFSENPGEN 162

Query: 259 ---FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAE--------- 304
               T+ V + +Y APE++L  + Y    DVW+ G IL  LL   P F  +         
Sbjct: 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222

Query: 305 -------------------TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS 345
                               Q  I          FES  +P  +  A DL+ K+L   P+
Sbjct: 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPT 281

Query: 346 ERLTAHEVLCHPWI 359
           +R++  E L HP++
Sbjct: 282 KRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 99.3 bits (247), Expect = 2e-23
 Identities = 82/283 (28%), Positives = 136/283 (48%), Gaps = 18/283 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE--RKAAELTRIIVGVVEACHSLGVM 222
           +   ++    +  VME   GG+L   I Q  H  +  R       II G+ +  HS G++
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGL-QFLHSKGIV 118

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLL-KHYGP 280
           +RDLK +N LL   D D  +K  DFG+      G   T    G+P Y+APE+LL + Y  
Sbjct: 119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRKM 339
             D W+ GV+LY +L G  PF    ++ +F +     I  ++  +P  ++  AKD++ K+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-----IRMDNPCYPRWLTREAKDILVKL 230

Query: 340 LCSQPSERLTAH-EVLCHPWICEN--GVAPDRSLDPAVLSRLK 379
              +P  RL    ++  HP+  E       +R ++P    ++K
Sbjct: 231 FVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVK 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 25/264 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEF-ACKSIS-------KRKLISREDVEDVRREIQI 152
           Y +   LG G FG  Y   +   G    A K I+       K K    + + D+  E+ I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG---GELFDRIIQRG-HYSERKAAELTRI 208
           +     H NIV     + ++  ++IVM+L  G   GE F+ + ++   ++E +   +  I
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER---IWNI 118

Query: 209 IVGVVEACHSLG----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
            V +V A   L     ++HRDL P N +L   D    +   DFGL+   +P    T VVG
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITDFGLAKQKQPESKLTSVVG 175

Query: 265 SPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
           +  Y  PE++    YG +ADVW  G ILY + +  PPF++     +   +++    +E  
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPL 233

Query: 324 PWPLISDSAKDLIRKMLCSQPSER 347
           P  + S+   D+I   L      R
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 81/288 (28%), Positives = 123/288 (42%), Gaps = 46/288 (15%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           KLG+G + T Y      TG   A K I    L + E       REI +M  L  H+NIV 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELK-HENIVR 62

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI------IVGVVEACHS 218
           +         + +V E     +L   +   G    R A +   +      ++  +  CH 
Sbjct: 63  LHDVIHTENKLMLVFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-- 275
             V+HRDLKP+N LL+NK  +  LK  DFGL+  F  P   F++ V + +Y AP+VLL  
Sbjct: 119 NRVLHRDLKPQN-LLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK-- 333
           + Y    D+W+ G I+  +++G P F     +     + +         WP IS   +  
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 334 -----------------------DLIRKMLCSQPSERLTAHEVLCHPW 358
                                  DL+ ++L   P  R++AH+ L HPW
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 14/262 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +  K+G+G FG  +     A    +A K I   K+ +R + E+   E +++  L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKL-DSS 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGH-YSERKAAEL-TRIIVGVVEACH 217
            I+    ++ D   ++IVME    G+L   + +QRG    E +      +I++G+    H
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL-AHLH 118

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL- 275
           S  ++HRD+K  N  L   D   ++K  D G++        F + +VG+PYY++PE+   
Sbjct: 119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           K Y  ++DVW  GV+LY   +G  PF A  Q  +   +++G     S  +   S     L
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQL 232

Query: 336 IRKMLCSQPSERLTAHEVLCHP 357
           I + L     +R    ++L +P
Sbjct: 233 IDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 98.1 bits (244), Expect = 2e-23
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 29/277 (10%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHHL 156
            +T G  LG+G +GT Y C     G   A K +   +   L + ++ E ++ E+ ++  L
Sbjct: 1   EWTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NIV   G   D   + I ME   GG +   + + G   E    + T+ I+  V   
Sbjct: 60  K-HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG-------LSVFFKPGQIFTDVVGSPYYV 269
           H+  V+HRD+K  N +L+       +K IDFG       + +      +   + G+PY++
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFDAVLKGHIDFESDPWP 326
           APEV+ +  YG ++D+W+ G  ++ + +G PP  A   +   +F      +I       P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMF------YIGAHRGLMP 228

Query: 327 LISDS----AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            + DS    A D +   L     ER +A ++L H ++
Sbjct: 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 99.3 bits (247), Expect = 2e-23
 Identities = 67/246 (27%), Positives = 119/246 (48%), Gaps = 9/246 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    + G  +A K + K+ ++ +++   +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      +   +   HSL +++RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +P +  +   G+P Y+APEVL K  Y    D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +          + +A DL+  +L    
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235

Query: 345 SERLTA 350
             RL A
Sbjct: 236 RRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 11/259 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G FG  +LC   A       K I   ++ ++++    + E Q++  L+ H NI+ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIE 63

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVM 222
               + +   + IVME   GG L + I +R +    E         I+  +   H+  ++
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPE 281
           HRDLK +N LL +K     +K  DFG+S           VVG+P Y++PE+   K Y  +
Sbjct: 124 HRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
           +D+W  G +LY L S    F A     +   ++ G     SD +   S   + LI  ML 
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY---SPDLRQLILSMLN 238

Query: 342 SQPSERLTAHEVLCHPWIC 360
             PS+R    +++  P IC
Sbjct: 239 LDPSKRPQLSQIMAQP-IC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 97.2 bits (243), Expect = 3e-23
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 38/237 (16%)

Query: 102 TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            LG+KLG+G FG  Y  T       T  + A K++  ++  S E+ E+   E  IM  L 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL- 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G       ++IV E   GG+L D + + G   +    +L ++ + + +   
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGME 116

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N L+    ++  +K  DFGLS          D+    YY      
Sbjct: 117 YLESKNFVHRDLAARNCLV---TENLVVKISDFGLS---------RDIYEDDYYRKRGGG 164

Query: 270 -------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                  APE L    +  ++DVW+ GV+L+ + + G  P+   + + + + +  G+
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221

Length = 258

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 98.1 bits (244), Expect = 5e-23
 Identities = 70/245 (28%), Positives = 119/245 (48%), Gaps = 11/245 (4%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLGVMHRD 225
             ++    ++ VME   GG+L   I Q G + E +A      I VG+    H  G+++RD
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF-FLHRRGIIYRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEAD 283
           LK +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   D
Sbjct: 127 LKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVD 183

Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV+LY +L+G PPF  E +  +F ++++ ++ +       +S  A  + + ++   
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKH 239

Query: 344 PSERL 348
           PS+RL
Sbjct: 240 PSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 41/286 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            ++ L   +G+G +G  Y      TG   A K +   +    ++ E+++ E  I+   + 
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSN 61

Query: 159 HKNIVTIKGAY--EDSLCVH----IVMELCAGG---ELFDRIIQRGH-YSERKAAELTRI 208
           H NI T  GA+  ++         +VMELC GG   +L   + ++G    E   A + R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPY 267
            +  +   H   V+HRD+K +N LL     +  +K +DFG+S          +  +G+PY
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 268 YVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHID 319
           ++APEV+     P+A      DVW+ G+    L  G PP   +    + +F         
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALFKIP------ 231

Query: 320 FESDPWPLISDSAK------DLIRKMLCSQPSERLTAHEVLCHPWI 359
              +P P +           D I + L     +R    E+L HP+I
Sbjct: 232 --RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 97.6 bits (243), Expect = 8e-23
 Identities = 84/295 (28%), Positives = 134/295 (45%), Gaps = 51/295 (17%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK---RKLISREDVEDVRREIQIMHHLA 157
           Y   + +G G FG      +  TG   A K I K     ++++       RE++++ HL 
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR----TYRELKLLKHLR 67

Query: 158 GHKNIVTIKGAY----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
            H+NI+++   +    ED   ++ V EL   G    R++      ++        I+  +
Sbjct: 68  -HENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGL 121

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           +  HS GV+HRDLKP N +L+N++ D  LK  DFGL+    P    T  V + YY APE+
Sbjct: 122 KYVHSAGVVHRDLKPSN-ILINENCD--LKICDFGLARIQDPQ--MTGYVSTRYYRAPEI 176

Query: 274 LL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL----------------K 315
           +L  + Y  E D+W+AG I   +L G P F  +     F  +                 +
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236

Query: 316 GHIDF-----ESDPWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             + F     + +P P          SA DL+ KML   P +R++A E L HP++
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.5 bits (240), Expect = 9e-23
 Identities = 70/267 (26%), Positives = 126/267 (47%), Gaps = 13/267 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLA 157
           +  G++LG G F + Y   ++ TG   A K ++  +  S E    VE +R+EI++M  L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL- 60

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H +I+ + GA  +    ++ +E  AGG +   + + G + E      T  ++  +   H
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-----FFKPGQIFTDVVGSPYYVAPE 272
              ++HRD+K  N L+ +      L+  DFG +          G+    ++G+  ++APE
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISD 330
           VL  + YG   DVW+ G ++  + +  PP+ AE        + K      +   P  +S 
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHP 357
             +D+  + L  QP +R  + E+L HP
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 96.6 bits (240), Expect = 9e-23
 Identities = 75/254 (29%), Positives = 125/254 (49%), Gaps = 16/254 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG         TG  +ACK + K++L  +   +    E +I+  +     IV + 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
            A+E    + +VM L  GG+L   I    +RG   ER      +I  G++   HS+ +++
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH-LHSMDIVY 118

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           RD+KPEN LL   DD  + +  D GL+V  K G+  T   G+  Y+APE+L  + Y    
Sbjct: 119 RDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 283 DVWTAGVILYILLSGVPPF--WAE--TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           D +  G  +Y +++G  PF    E   ++ +    L+  + FE   +   ++ +KD+ R 
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF---TEESKDICRL 232

Query: 339 MLCSQPSERLTAHE 352
            L  +P +RL + E
Sbjct: 233 FLAKKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 81/279 (29%), Positives = 129/279 (46%), Gaps = 40/279 (14%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHK 160
            +LG+G  G+   C    TG+ FA       K I+ +   D++    RE++I        
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFA------LKTITTDPNPDLQKQILRELEINKSCK-SP 59

Query: 161 NIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVV 213
            IV   GA+  E S  + I ME C GG L D I ++     G   E+   ++   ++  +
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYV 269
              HS  ++HRD+KP N LL  K     +K  DFG+S     G++   +     G+ +Y+
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKG---QVKLCDFGVS-----GELVNSLAGTFTGTSFYM 170

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------DFES 322
           APE +  K Y   +DVW+ G+ L  +     PF  E +  +    L  +I      + + 
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230

Query: 323 DPWPLI--SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +P   I  S+  KD I++ L   P+ R T  ++L HPWI
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 15/270 (5%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           ++   L+T  R++G G FG  Y   ++ T    A K +S     S E  +D+ +E++ + 
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            +  H N +  KG Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 81  RIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL        +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASIASPANSF---VGTPYWMAPEVI 193

Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S+ W   S
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---S 250

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           D  ++ +   L   P +R T+ E+L H ++
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 68/264 (25%), Positives = 129/264 (48%), Gaps = 14/264 (5%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
             + + +K+G+GQF   Y    +  G   A K +   +++  +  +D  +EI ++  L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RIIVGV---V 213
           H N++    ++ ++  ++IV+EL   G+L  R+I+     +R   E T  +  V +   +
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPE 272
           E  HS  +MHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK-GHIDFESDPWPLISD 330
            + ++ Y  ++D+W+ G +LY + +   PF+ + +  ++    K    D+   P    S+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEKCDYPPLPADHYSE 235

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             +DL+ + +   P +R     VL
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 13/246 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT-I 165
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++  L+G    +T +
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLGVMHR 224
              ++    ++ VME   GG+L  +I Q G + E  A      I +G+    HS G+++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF-FLHSKGIIYR 125

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEA 282
           DLK +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   
Sbjct: 126 DLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV+LY +L+G  PF  E +  +F ++++ ++ +       +S  A  + + ++  
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTK 238

Query: 343 QPSERL 348
            P +RL
Sbjct: 239 HPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 89/302 (29%), Positives = 130/302 (43%), Gaps = 51/302 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           D Y    K+G+G +G  Y   +  TG     K ++ +K     D E +     REI ++ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQ 55

Query: 155 HLAGHKNIV---TIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--- 206
            L+    IV    ++   E +    +++V E     +L   +   G    R     T   
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114

Query: 207 ---RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV 262
              +++ GV   CH  GVMHRDLKP+N LLV+K     LK  D GL   F  P + +T  
Sbjct: 115 FMYQLLKGVAH-CHKHGVMHRDLKPQN-LLVDKQKGL-LKIADLGLGRAFSIPVKSYTHE 171

Query: 263 VGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFW--AETQQ--GIFD----- 311
           + + +Y APEVLL   HY    D+W+ G I   +    P F   +E QQ   IF      
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231

Query: 312 ------AVLKGHIDFESDPW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
                  V K     E   W         P +S    DL++KML   P++R++A   L H
Sbjct: 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291

Query: 357 PW 358
           P+
Sbjct: 292 PY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 75/253 (29%), Positives = 127/253 (50%), Gaps = 22/253 (8%)

Query: 107 LGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           LGQG FG  +L  +I     G  +A K + K  L  R+ V   + E  I+  +  H  IV
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEV-NHPFIV 61

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSL 219
            +  A++    ++++++   GG+LF R+ +   ++E       AEL       ++  HSL
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL----ALDHLHSL 117

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVL-LKH 277
           G+++RDLKPEN LL   D++  +K  DFGLS      +       G+  Y+APEV+  + 
Sbjct: 118 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ L+R
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 230

Query: 338 KMLCSQPSERLTA 350
            +    P+ RL A
Sbjct: 231 ALFKRNPANRLGA 243

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 94.7 bits (235), Expect = 5e-22
 Identities = 88/310 (28%), Positives = 141/310 (45%), Gaps = 46/310 (14%)

Query: 78  MRRGID-NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK 136
           +RR +D N+ + ++G              +LG G FG  Y      TG   A K I  + 
Sbjct: 4   VRRDLDPNEVWEIIG--------------ELGDGAFGKVYKAKNKETGALAAAKVIETK- 48

Query: 137 LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI---IQ 193
             S E++ED   EI+I+     H  IV + GA+     + I++E C GG + D I   + 
Sbjct: 49  --SEEELEDYMVEIEILAT-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELD 104

Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-F 252
           RG  +E +   + R ++  ++  HS+ ++HRDLK  N LL    D   +K  DFG+S   
Sbjct: 105 RG-LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKN 160

Query: 253 FKPGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            K  Q     +G+PY++APEV++        Y  +AD+W+ G+ L  +    PP      
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   + K      S+P  L   S      +D ++  L   P  R +A ++L HP++  
Sbjct: 221 MRVLLKIAK------SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274

Query: 362 -NGVAPDRSL 370
                P R L
Sbjct: 275 VTSNRPLREL 284

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 94.0 bits (233), Expect = 7e-22
 Identities = 87/280 (31%), Positives = 126/280 (45%), Gaps = 35/280 (12%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N ++ + L +++G G +G  Y    + TG   A K I   KL   ED   V++EI IM  
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-IMMK 61

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
              H NIV   G+Y     + I ME C GG L D     G  SE + A ++R  +  +  
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYV 269
            HS G MHRD+K  N LL    D+  +K  DFG+S      QI   +      +G+PY++
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWM 173

Query: 270 APEVLLKH----YGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDP 324
           APEV        Y    D+W  G+    L    PP F     + +F   L    +F+   
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQP-- 228

Query: 325 WPLISDSAK------DLIRKMLCSQPSERLTAHEVLCHPW 358
            P + D  K        ++  L   P +R TA ++L HP+
Sbjct: 229 -PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 85/301 (28%), Positives = 137/301 (45%), Gaps = 46/301 (15%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y     +G G +G      +  TG + A K +S R   S    +   RE++++ H+
Sbjct: 13  VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHM 71

Query: 157 AGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             H+N++ +   +      ED   V++V  L  G +L + I++    S+     L   I+
Sbjct: 72  D-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQFLVYQIL 128

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS G++HRDLKP N + VN+D +  LK +DFGL+         T  V + +Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSN-IAVNEDCE--LKILDFGLAR--HTDDEMTGYVATRWYRA 183

Query: 271 PEVLLK--HYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQGI 309
           PE++L   HY    D+W+ G I+  LL+G   F                     E  Q I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243

Query: 310 FDAVLKGHI---------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
                + +I         DF  + +   +  A DL+ KML   P +R+TA E L HP++ 
Sbjct: 244 SSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302

Query: 361 E 361
           E
Sbjct: 303 E 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 15/247 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L      G  FA K++ K  ++  +DVE    E +++     +  +  + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    +  VME   GG+L   I  +G +   +A      IV  ++  HS G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL---SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           K +N +L   D D  +K  DFG+   +VF       +   G+P Y+APE+L    Y    
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFSV 177

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-WPLISDSAKDLIRKMLC 341
           D W+ GV+LY +L G  PF  + +  +F+++    +D    P W  I+  +KD++ K+  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKESKDILEKLFE 232

Query: 342 SQPSERL 348
             P+ RL
Sbjct: 233 RDPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 79/250 (31%), Positives = 120/250 (48%), Gaps = 21/250 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   FA K++ K  ++  +DVE    E +++     H  +  + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVM 222
             ++    +  VME   GG+L   I   G + E +A    AE   II G+ +  H  G++
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE---IICGL-QFLHKKGII 118

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLL-KHYGP 280
           +RDLK +N LL   D D  +K  DFG+      G+       G+P Y+APE+L  + Y  
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW--PLISDSAKDLIRK 338
             D W+ GV+LY +L G  PF  E +  +FD++L         P     IS  AKD + K
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWISKEAKDCLSK 229

Query: 339 MLCSQPSERL 348
           +    P++RL
Sbjct: 230 LFERDPTKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 92.7 bits (230), Expect = 1e-21
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 13/264 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + +K+G+G FG  YL    +       K I   K+  +E  E  ++E+ ++  +  H 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMK-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRG-HYSERKA-AELTRIIVGVVEACH 217
           NIVT   +++++  + IVME C GG+L  RI  QRG  +SE +  +   +I +G ++  H
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG-LKHIH 118

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              ++HRD+K +N  L    +    K  DFG++       ++    VG+PYY++PE+   
Sbjct: 119 DRKILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           + Y  + D+W+ G +LY L +   PF       +   + +G+    S   P  S   + L
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLRSL 233

Query: 336 IRKMLCSQPSERLTAHEVLCHPWI 359
           I ++    P +R +   +L  P++
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 96.7 bits (240), Expect = 2e-21
 Identities = 77/232 (33%), Positives = 115/232 (49%), Gaps = 34/232 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + +K+G G+FG  +L     T   F  K+IS R L  RE  + V  E+ +M  L  HK
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK-HK 72

Query: 161 NIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVV 213
           NIV     +  + +  ++I+ME C  G+L  R IQ+     G   E    ++TR ++  +
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 214 EACHSLG-------VMHRDLKPENFLL----------VNKDDDFSLKAI----DFGLSVF 252
             CH+L        V+HRDLKP+N  L            + ++ + + I    DFGLS  
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 253 FKPGQIFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPF 301
                +    VG+PYY +PE+LL   K Y  ++D+W  G I+Y L SG  PF
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 88/304 (28%), Positives = 134/304 (44%), Gaps = 73/304 (24%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G +G         T  + A K I+     +R D +   REI+++ HL  H+N++ IK
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD-HENVIAIK 70

Query: 167 G--------AYEDSLCVHIVMELCAGGELFD----RIIQRGHYSERKAAELT-------- 206
                    A+ D   V+IV EL       D    +II       R +  L+        
Sbjct: 71  DIMPPPHREAFND---VYIVYEL------MDTDLHQII-------RSSQTLSDDHCQYFL 114

Query: 207 -RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVG 264
            +++ G+ +  HS  V+HRDLKP N LL+N + D  LK  DFGL+    + G   T+ V 
Sbjct: 115 YQLLRGL-KYIHSANVLHRDLKPSN-LLLNANCD--LKICDFGLARTTSEKGDFMTEYVV 170

Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVL----K 315
           + +Y APE+LL    Y    DVW+ G I   LL   P F  +    Q  +   +L    +
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230

Query: 316 GHIDFESDP--------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             + F  +                     +P  +  A DL+ KML   PS+R+T  E L 
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290

Query: 356 HPWI 359
           HP++
Sbjct: 291 HPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 15/271 (5%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL        +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 183

Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S  W   S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 240

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           +  ++ +   L   P +R T+  +L H ++ 
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 15/270 (5%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+  +++    ++G G FG  Y  T   T    A K +S     + E  +D+ +E++ + 
Sbjct: 17  DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  KG Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 77  QLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL        +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASKSSPANSF---VGTPYWMAPEVI 189

Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S+ W   +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---T 246

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           DS +  +   L   P ER  + E+L H ++
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFV 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 82/288 (28%), Positives = 126/288 (43%), Gaps = 45/288 (15%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           K+G+G +G  + C    TG   A K     K +  ED   ++    REI+++  L  H N
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPN 61

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLG 220
           +V +   +     +H+V E C    + + + +      E    ++    +  V  CH   
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--KH 277
            +HRD+KPEN +L+ K     +K  DFG +     PG  +TD V + +Y APE+L+    
Sbjct: 121 CIHRDVKPEN-ILITKQG--QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 278 YGPEADVWTAGVILYILLSGVP--PFWAETQQ----------------GIF--DAVLKG- 316
           YGP  DVW  G +   LL+G P  P  ++  Q                 IF  +   KG 
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237

Query: 317 HIDFESDPWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
            I       PL      IS  A   ++  L   P+ERL+  E+L HP+
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 80/300 (26%), Positives = 125/300 (41%), Gaps = 52/300 (17%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG G  G  +   +       A K I      S   V+   REI+I+  L  H NIV 
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIRRLD-HDNIVK 66

Query: 165 I-----KGAYEDSLCVHIVMEL---CAGGELFD----RIIQRGHYSERKAAELTRIIVGV 212
           +         + +  V  + EL       E  +     ++++G  SE  A      ++  
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPY 267
           ++  HS  V+HRDLKP N + +N  +D  LK  DFGL+    P     G +   +V + +
Sbjct: 127 LKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKW 183

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAV-------- 313
           Y +P +LL   +Y    D+W AG I   +L+G P F      E  Q I ++V        
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 314 ----------LKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                     ++        P     P ++  A D + ++L   P +RLTA E L HP++
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 91.7 bits (227), Expect = 5e-21
 Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 26/274 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMH 154
           +L+T   K+G+G FG      E+  GI+   + +   K+I    + +++ED+++EI ++ 
Sbjct: 4   ELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  ++
Sbjct: 58  Q-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 115

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    S
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------NNPPTLEGNYS 226

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
              K+ +   L  +PS R TA E+L H +I    
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 91.7 bits (227), Expect = 5e-21
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 26/273 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED----VEDVRREIQIMH 154
           +L+T   ++G+G FG      E+  GI+   + +   K+I  E+    +ED+++EI ++ 
Sbjct: 4   ELFTKLERIGKGSFG------EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G + E + A + + I+  ++
Sbjct: 58  Q-CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLD 115

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL  + D   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD-- 330
           + +  Y  +AD+W+ G+    L  G PP        +    +   I  +++P  L  +  
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP-----NSDMHPMRVLFLIP-KNNPPTLTGEFS 226

Query: 331 -SAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
              K+ I   L   PS R TA E+L H +I +N
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.9 bits (233), Expect = 6e-21
 Identities = 64/187 (34%), Positives = 96/187 (51%), Gaps = 16/187 (8%)

Query: 177 IVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFL 232
           ++ME  +GG+L  +I QR      + E +   L   IV  ++  HS  +MHRDLK  N  
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201

Query: 233 LVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVL-LKHYGPEADVWTAG 288
           L+       +K  DFG S  +       + +   G+PYY+APE+   K Y  +AD+W+ G
Sbjct: 202 LMPTG---IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258

Query: 289 VILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDLIRKMLCSQPSER 347
           VILY LL+   PF   +Q+ I   VL G    + DP+P  +S   K L+  +L   P+ R
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYG----KYDPFPCPVSSGMKALLDPLLSKNPALR 314

Query: 348 LTAHEVL 354
            T  ++L
Sbjct: 315 PTTQQLL 321

Length = 478

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 85/295 (28%), Positives = 134/295 (45%), Gaps = 37/295 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G +G+ Y      TG+  A K I  R  +       +  E+ I+H  A    IV  
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHK-AVSPYIVDF 64

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR-----IIVGVVEACHSLG 220
            GA+     V++ ME    G L D++   G  +E    ++ R     ++ G+        
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLK 276
           ++HRD+KP N +LVN +    +K  DFG+S     G +   +    +G   Y+APE  +K
Sbjct: 124 IIHRDVKPTN-VLVNGNG--QVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE-RIK 174

Query: 277 HYGP--------EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL- 327
             GP        ++DVW+ G+ +  +  G  P+  ET   IF A L   +D   DP  L 
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVD--GDPPTLP 231

Query: 328 --ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ 380
              SD A+D + K L   P+ R T  ++L HPW+ +     D  +   V   LK+
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK-NADVDMAEWVTGALKR 285

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 82/298 (27%), Positives = 131/298 (43%), Gaps = 66/298 (22%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGH 159
           K+G+G +G  Y   +  TG   A K I       R + ED        REI ++  L  H
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELN-H 57

Query: 160 KNIVTIKGAYEDSLCVHIV-----------MELCAGGELFDRIIQRGHYSERKAAELTRI 208
            NIV +         +++V           M+      L   +I+   Y         ++
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY---------QL 108

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY 267
           + G+   CHS  V+HRDLKP+N LL++++   +LK  DFGL+  F  P + +T  V + +
Sbjct: 109 LQGIA-YCHSHRVLHRDLKPQN-LLIDREG--ALKLADFGLARAFGVPVRTYTHEVVTLW 164

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFW--AETQQ--GIF-------DAVL 314
           Y APE+LL  + Y    D+W+ G I   +++  P F   +E  Q   IF       + V 
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 315 KGHI---DFES-----------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
            G     D++               P + +   DL+ KML   P++R++A   L HP+
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 24/287 (8%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  + + +  +LG G FG  Y      TG+  A K I  +   S E++ED   EI I+  
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILAS 58

Query: 156 LAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGV 212
              H NIV +  A  YE++L   I++E CAGG +   +++     +E +   + +  +  
Sbjct: 59  -CDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +   H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++AP
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172

Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP- 324
           EV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P 
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232

Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
            W   S   KD ++K L      R T  ++L HP++  N   P R L
Sbjct: 233 RW---SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIREL 276

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 88/314 (28%), Positives = 138/314 (43%), Gaps = 67/314 (21%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           D Y    K+G+G +G  Y   +  T    A K I     + +ED E V     REI ++ 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR----LEQED-EGVPSTAIREISLLK 56

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIV-----------MELCAGGELFDRIIQRGHYSERKAA 203
            +  H NIV ++        +++V           M+         R+I+          
Sbjct: 57  EMQ-HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK---------T 106

Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDV 262
            L +I+ G+   CHS  V+HRDLKP+N L+  + +  +LK  DFGL+  F  P + FT  
Sbjct: 107 YLYQILRGIA-YCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHE 163

Query: 263 VGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK----- 315
           V + +Y APE+LL  +HY    D+W+ G I   +++  P F  +++    D + K     
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRIL 220

Query: 316 GHIDFESDP--------------W---------PLISDSAKDLIRKMLCSQPSERLTAHE 352
           G  + E+ P              W         P +  +  DL+ KML   PS+R+TA  
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280

Query: 353 VLCHPWICENGVAP 366
            L H +  + G AP
Sbjct: 281 ALEHEYFKDLGDAP 294

Length = 294

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 79/272 (29%), Positives = 128/272 (47%), Gaps = 26/272 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVEDVRREIQIMHHLA 157
           Y L ++LG+G FGT YL  +     E      K I   +L   E V+   +E Q++  L 
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKLD 60

Query: 158 GHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAE-LTRIIV 210
            H  IV    ++   D+ C  I+ E C G +L  ++ +  H     SE +  E   ++++
Sbjct: 61  -HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGSPYYV 269
           G V   H   ++HRDLK +N  L N      LK  DFG+S        + T   G+PYY+
Sbjct: 118 G-VHYMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172

Query: 270 APEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           +PE  LKH  Y  ++D+W+ G ILY +      F  +    +   +++G      + +  
Sbjct: 173 SPEA-LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYS- 230

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  +++ ML   PS R +A E+L +P+I
Sbjct: 231 --RQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 26/270 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED----VEDVRREIQIMH 154
           +L+T   ++G+G FG      E+  GI+   K +   K+I  E+    +ED+++EI ++ 
Sbjct: 4   ELFTKLERIGKGSFG------EVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  I    G+Y     + I+ME   GG   D +++ G   E   A + R I+  ++
Sbjct: 58  Q-CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLD 115

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL  + D   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      + P  L    S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK------NSPPTLEGQYS 226

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              K+ +   L   P  R TA E+L H +I
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 12/254 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y  T +      A K +   +++  +  +D  +EI ++  L  H 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEAC 216
           N++    ++ +   ++IV+EL   G+L   I     Q+    ER   +    +   VE  
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVLL 275
           HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK-GHIDFESDPWPLISDSAK 333
           ++ Y  ++D+W+ G +LY + +   PF+ + +  +F    K    D+   P    S+  +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238

Query: 334 DLIRKMLCSQPSER 347
           +L+   +   P +R
Sbjct: 239 ELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.5 bits (219), Expect = 5e-20
 Identities = 68/253 (26%), Positives = 124/253 (49%), Gaps = 18/253 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y  T +  G+  A K +    L+  +   D  +EI ++  L  H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRII-----QRGHYSERKAAELTRIIVGVVEA 215
           N++    ++ +   ++IV+EL   G+L  R+I     Q+    E+   +    +   +E 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVL 274
            HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            ++ Y  ++D+W+ G +LY + +   PF+ + +  ++    K     + D  PL SD   
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIE---QCDYPPLPSDHYS 234

Query: 334 DLIRKM--LCSQP 344
           + +R++  +C  P
Sbjct: 235 EELRQLVNMCINP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 88.7 bits (220), Expect = 9e-20
 Identities = 86/319 (26%), Positives = 126/319 (39%), Gaps = 81/319 (25%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           D + +  ++G+G +G  Y   +  TG   A K +       R D E         REI+I
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIREIKI 59

Query: 153 MHHLAGHKNIVTI----------------KGA------YEDSLCVHIVMELCAGGELFDR 190
           +  L  H+NIV +                KGA      Y D    H +M L   G +   
Sbjct: 60  LRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLV--- 111

Query: 191 IIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
                H+SE       + ++  +  CH    +HRD+K  N LL NK     +K  DFGL+
Sbjct: 112 -----HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLA 163

Query: 251 VFFKPG--QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
             +     + +T+ V + +Y  PE+LL  + YGP  DVW+ G IL  L +  P F A  +
Sbjct: 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223

Query: 307 QGIFDAVLKGHIDFESDPWP--------------------------LISDSAKDLIRKML 340
               + + +         WP                           I   A DL+  ML
Sbjct: 224 LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283

Query: 341 CSQPSERLTAHEVLCHPWI 359
              PS+R TA E L  PW+
Sbjct: 284 TLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 87/319 (27%), Positives = 137/319 (42%), Gaps = 62/319 (19%)

Query: 95  DNIRDLYT-LGRKLGQGQFGTTYLCTEIATGIEFACK-----SISKRKLISREDVEDV-- 146
            +I + Y   G  LG+G +G      +  TG   A K      IS      R+ V     
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 147 ----RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSER 200
                RE++IM+ +  H+NI+ +   Y +   +++VM++ A    ++ DR I R   S+ 
Sbjct: 64  HFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI-RLTESQV 121

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------- 253
           K   L +I+ G+    H    MHRDL P N  + +K      K  DFGL+  +       
Sbjct: 122 KCI-LLQILNGL-NVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSD 176

Query: 254 --------KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA 303
                   +  +  T  V + +Y APE+L+  + Y    D+W+ G I   LL+G P F  
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236

Query: 304 ET---QQG-IFDAV-------------LKGHIDFE-------SDPWPLISDSAKDLIRKM 339
           E    Q G IF+ +             L  + +F           +P  SD A DL++ +
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296

Query: 340 LCSQPSERLTAHEVLCHPW 358
           L   P ER++A E L H +
Sbjct: 297 LKLNPLERISAKEALKHEY 315

Length = 335

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 79/270 (29%), Positives = 129/270 (47%), Gaps = 34/270 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G +G  Y   +++T +  A K I +R       V+ +  EI +  +L  H+NIV   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYL 71

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-----LTRIIVGVVEACHSLGV 221
           G+  ++    I ME   GG L    + R  +   K  E      T+ I+  ++  H   +
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSA--LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 222 MHRDLKPENFLLVNKDDDFS--LKAIDFGLS---VFFKP-GQIFTDVVGSPYYVAPEVL- 274
           +HRD+K +N +LVN    +S  +K  DFG S       P  + FT   G+  Y+APEV+ 
Sbjct: 130 VHRDIKGDN-VLVNT---YSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVID 182

Query: 275 --LKHYGPEADVWTAGVILYILLSGVPPFW--AETQQGIFD-AVLKGHIDFESDPWPLIS 329
              + YG  AD+W+ G  +  + +G PPF    E Q  +F   + K H +        +S
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES----LS 238

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             AK+ I +     P +R +AH++L  P++
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 56/293 (19%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 63

Query: 165 IKGAYEDSLCVHIV-----------MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           +         +++V           M+      +   +I+         + L +++ G+ 
Sbjct: 64  LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK---------SYLFQLLQGLA 114

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPE 272
             CHS  V+HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE
Sbjct: 115 -FCHSHRVLHRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170

Query: 273 VLL--KHYGPEADVWTAGVILYILLS--GVPPFWAETQQ--GIF-------DAVLKGHI- 318
           +LL  K+Y    D+W+ G I   +++   + P  +E  Q   IF       + V  G   
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230

Query: 319 --DFESD--PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             D++     W         P + +  +DL+ +ML   P++R++A   L HP+
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           ++ L   +G G +G  Y    + TG   A K +     ++ ++ E++++EI ++   + H
Sbjct: 7   IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHH 62

Query: 160 KNIVTIKGAY--------EDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAAELTRII 209
           +NI T  GA+        +D L   +VME C  G + D I   +     E   A + R I
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVGSPY 267
           +  +   H   V+HRD+K +N LL    ++  +K +DFG+S       G+  T  +G+PY
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPY 176

Query: 268 YVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDF 320
           ++APEV+     P+A      D+W+ G+    +  G PP       + +F          
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236

Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +S  W   S   +  I   L    S+R T  +++ HP+I
Sbjct: 237 KSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 88/323 (27%), Positives = 139/323 (43%), Gaps = 54/323 (16%)

Query: 83  DNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           D+Q Y V +   T  +   Y   + +G G  G      +   GI  A K +S R   ++ 
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQT 62

Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRG 195
             +   RE+ ++     HKNI+++   +      E+   V++VMEL        ++I   
Sbjct: 63  HAKRAYREL-VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHME 119

Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+     
Sbjct: 120 LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACT 175

Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS------------------ 296
             + T  V + YY APEV+L   Y    D+W+ G I+  L+                   
Sbjct: 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235

Query: 297 ---GVPP--FWAETQQGIFDAVLKG----HIDFES--DPWPLISDS---------AKDLI 336
              G P   F    Q  + + V        I FE     W   S+S         A+DL+
Sbjct: 236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295

Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
            KML   P +R++  E L HP+I
Sbjct: 296 SKMLVIDPDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 86.3 bits (213), Expect = 8e-19
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 18/255 (7%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G+++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + YG   
Sbjct: 121 DLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 283 DVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
           D W  GV+++ +++G  PF            T+  +F  +L+  I         +S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAA 233

Query: 334 DLIRKMLCSQPSERL 348
            +++  L   P ERL
Sbjct: 234 SVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 81/273 (29%), Positives = 119/273 (43%), Gaps = 35/273 (12%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L +++G G +G  Y    + TG   A K I   KL   +D   +++EI  M     H 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEI-FMVKECKHC 66

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV   G+Y     + I ME C GG L D     G  SE + A + R  +  +   HS G
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVL 274
            MHRD+K  N LL +  D   +K  DFG++      +I   +      +G+PY++APEV 
Sbjct: 127 KMHRDIKGANILLTDNGD---VKLADFGVA-----AKITATIAKRKSFIGTPYWMAPEVA 178

Query: 275 LKH----YGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
                  Y    D+W  G+    L    PP F     + +F   L    +F+    P + 
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQP---PKLK 232

Query: 330 DSAK------DLIRKMLCSQPSERLTAHEVLCH 356
           D  K      + ++  L   P +R TA  +L H
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 79/295 (26%), Positives = 126/295 (42%), Gaps = 40/295 (13%)

Query: 82  IDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           ID Q Y       D + DL  LG ++G G  G  Y      TG   A K +  R+  ++E
Sbjct: 5   IDGQKY-----PAD-LNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKE 55

Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSE 199
           + + +  ++ ++        IV   G +     V I MEL +     D++++R  G   E
Sbjct: 56  ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPE 113

Query: 200 RKAAELTRIIVGVVEACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
               ++T   V +V+A H L    GV+HRD+KP N LL   D   ++K  DFG+S     
Sbjct: 114 DILGKMT---VAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD 167

Query: 256 GQIFTDVVGSPYYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
            +  T   G   Y+APE +        Y   ADVW+ G+ L  L +G  P+  +  +  F
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY--KNCKTEF 225

Query: 311 DAVLKGHIDFESDPWPLISDSA------KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + + K       +  P +  +          +   L     +R    E+L HP+I
Sbjct: 226 EVLTK----ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 84/313 (26%), Positives = 128/313 (40%), Gaps = 76/313 (24%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           D   LG +LG G  G         +G+      I  RKLI  E    +R    RE++++H
Sbjct: 2   DFEKLG-ELGAGNGGVVTKVLHRPSGL------IMARKLIHLEIKPAIRNQIIRELKVLH 54

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  IV   GA+     + I ME   GG L D+++       +KA  +   I+G + 
Sbjct: 55  E-CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL-------KKAGRIPENILGKIS 105

Query: 215 ACHSLG---------VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--- 262
                G         +MHRD+KP N +LVN   +  +K  DFG+S     GQ+   +   
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSN-ILVNSRGE--IKLCDFGVS-----GQLIDSMANS 157

Query: 263 -VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQG---IFDAVLK-- 315
            VG+  Y++PE L   HY  ++D+W+ G+ L  +  G  P      +    +F   +   
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217

Query: 316 ----------GHID--------FE------SDPWPLI-----SDSAKDLIRKMLCSQPSE 346
                     GH          FE      ++P P +     SD  +D + K L   P E
Sbjct: 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKE 277

Query: 347 RLTAHEVLCHPWI 359
           R    E+  HP+I
Sbjct: 278 RADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 86/292 (29%), Positives = 124/292 (42%), Gaps = 58/292 (19%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHH 155
           DL T+   LG G  G+      I TG   A K +   +K  +  +     + RE+QIMH 
Sbjct: 6   DLETI-SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-----RIIV 210
                 IV+  GA+ +   + + ME    G L DRI        +K   +      +I V
Sbjct: 60  -CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY-------KKGGPIPVEILGKIAV 110

Query: 211 GVVEACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV---- 262
            VVE    L     +MHRD+KP N +LVN      +K  DFG+S     G++   +    
Sbjct: 111 AVVEGLTYLYNVHRIMHRDIKPSN-ILVNSRGQ--IKLCDFGVS-----GELINSIADTF 162

Query: 263 VGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ--------GIFDAV 313
           VG+  Y++PE +    Y  ++DVW+ G+ +  L  G  PF              GI D  
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-- 220

Query: 314 LKGHIDFESDPWPLISDS----AKDLIRKMLCSQPSERLTAHEVLC--HPWI 359
           L   I  E  P  L S       +D +   L   P+ER T  + LC   P+I
Sbjct: 221 LLQQIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQ-LCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 47/294 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIMHHLAG 158
           YT   K+G+G +G  Y      TG   A K I   +L S E+       REI ++  L  
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQ- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVME-LCAGGELFDRIIQRGHYSERKAAE--LTRIIVGVVEA 215
           H NIV ++        ++++ E L    + +   + +G Y + +  +  L +I+ G++  
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL-F 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CHS  V+HRDLKP+N L+   D+   +K  DFGL+  F  P +++T  V + +Y APEVL
Sbjct: 117 CHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFW--AETQQ--GIF-------DAVLKGHIDFE 321
           L    Y    D+W+ G I   + +  P F   +E  Q   IF       + V  G     
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG---VT 230

Query: 322 SDP--------W---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           S P        W           + +   DL+ KML   P++R++A + L HP+
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 78/288 (27%), Positives = 121/288 (42%), Gaps = 46/288 (15%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           K+G+G +GT +      T    A K +        +D E V     REI ++  L  HKN
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK-HKN 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           IV +         + +V E C     + FD     G             ++  +  CHS 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--K 276
            V+HRDLKP+N LL+NK+ +  LK  DFGL+  F  P + ++  V + +Y  P+VL   K
Sbjct: 119 NVLHRDLKPQN-LLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 277 HYGPEADVWTAGVILYILL-SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD----- 330
            Y    D+W+AG I   L  +G P F           + +       + WP +S      
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 331 --------------------SAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                               + +DL++ +L   P +R++A E L HP+
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 80/292 (27%), Positives = 131/292 (44%), Gaps = 46/292 (15%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLA 157
            LG  +G+G +G    C    TG   A K     K +  ED + V+    REI+++  L 
Sbjct: 5   NLG-LVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEAC 216
            H+N+V +   +     +++V E      L D      G    R    L +I+ G+ E C
Sbjct: 59  -HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI-EFC 116

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL 275
           HS  ++HRD+KPEN +LV++     +K  DFG +     PG+++TD V + +Y APE+L+
Sbjct: 117 HSHNIIHRDIKPEN-ILVSQSG--VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 276 K--HYGPEADVWTAGVILYILLSGVPPF------------------WAETQQGIFD--AV 313
               YG   D+W  G ++  +L+G P F                       Q IF    +
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 314 LKG-------HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             G        I+     +P +S    DL ++ L   P +R ++ ++L H +
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 55/298 (18%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  +++G G +G+     +  TG + A K +S R   S    +   RE+ ++ H+  H+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQ-HE 74

Query: 161 NIV------TIKGAYEDSLCVHIVMELCAGGELFDRI----IQRGHYSERKAAELTRIIV 210
           N++      T   + ++    ++VM        + +     I     SE K   L   ++
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMP-------YMQTDLQKIMGHPLSEDKVQYLVYQML 127

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS G++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y A
Sbjct: 128 CGLKYIHSAGIIHRDLKPGN-LAVNEDCE--LKILDFGLAR--HADAEMTGYVVTRWYRA 182

Query: 271 PEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAE------TQ-------------QGI 309
           PEV+L   HY    D+W+ G I+  +L+G   F  +      TQ             Q +
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242

Query: 310 FDAVLKGHI---------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
            D   K +I         DF S  +P  S  A DL+ KML     +RLTA E L HP+
Sbjct: 243 EDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 31/226 (13%)

Query: 97  IRD---LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +RD   ++ L   +G G +G  Y    + TG   A K +     ++ ++ E+++ EI ++
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINML 66

Query: 154 HHLAGHKNIVTIKGAY--------EDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAA 203
              + H+NI T  GA+        +D L   +VME C  G + D +   +     E   A
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKEDWIA 124

Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTD 261
            + R I+  +   H+  V+HRD+K +N LL    ++  +K +DFG+S       G+  T 
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT- 180

Query: 262 VVGSPYYVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPF 301
            +G+PY++APEV+     P+A      D+W+ G+    +  G PP 
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 22/206 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN---IV 163
           +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    +   IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 164 TIKGAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERK----AAELTRIIVGVVEACH 217
            +  A+   D L    +++L  GG+L   + Q G +SE +    AAE   II+G+ E  H
Sbjct: 61  CMSYAFHTPDKLS--FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE---IILGL-EHMH 114

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 170

Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 47/296 (15%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN 161
           L R +G+G +G  Y   +  +G   A K +       R+ +     REI ++ +L  H N
Sbjct: 12  LNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLR-HPN 67

Query: 162 IVTIK----GAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           IV +K    G + DS  + +VME C      L D +     +SE +   L   ++  ++ 
Sbjct: 68  IVELKEVVVGKHLDS--IFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQY 123

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
            H   ++HRDLK  N LL +K     LK  DFGL+  +  P +  T  V + +Y APE+L
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKG---CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Query: 275 L--KHYGPEADVWTAGVILYILLSGVP--PFWAETQQ-----------------GIFDAV 313
           L    Y    D+W  G IL  LL+  P  P  +E +Q                 G  D  
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240

Query: 314 LKGHIDFESDPW-------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
           L G       P+       P +S++   L+  +L   P +R TA E L   +  E 
Sbjct: 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 63/263 (23%)

Query: 148 REIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVME-----LCAGGELFDRIIQRGH 196
           RE+ +M  L  HKNI+      T + + E+   V++VME     LC       ++IQ   
Sbjct: 64  RELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQMDL 115

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++V    D +LK +DFGL+      
Sbjct: 116 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSN-IVVK--SDCTLKILDFGLARTAGTS 171

Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL---------------------YIL 294
            + T  V + YY APEV+L   Y    D+W+ G I+                      I 
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231

Query: 295 LSGVPP--FWAETQQGIFDAVL-----KGH-ID--FESDPWPLISDS--------AKDLI 336
             G P   F +  Q  + + V       G+  +  F    +P  S+S        A+DL+
Sbjct: 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291

Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
            KML   P +R++  + L HP+I
Sbjct: 292 SKMLVIDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 83/331 (25%), Positives = 131/331 (39%), Gaps = 88/331 (26%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKL----ISREDVEDVRREIQIM 153
            Y +   +G+G +G  Y         G E+A K     K     IS+       REI ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALL 56

Query: 154 HHLAGHKNIVTIKGAYEDS--LCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRII 209
             L  H+N+V++   + +     V+++ +        D  +II+   + + K   +   +
Sbjct: 57  RELK-HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIK--FHRQAKRVSIPPSM 109

Query: 210 V---------GVVEACHSLGVMHRDLKPENFLLV-NKDDDFSLKAIDFGLS-VFFKPGQI 258
           V         GV    HS  V+HRDLKP N L++    +   +K  D GL+ +F  P + 
Sbjct: 110 VKSLLWQILNGV-HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 259 FTD---VVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVP-------------P 300
             D   VV + +Y APE+LL  +HY    D+W  G I   LL+  P             P
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLI-------------------------------- 328
           F  +  + IF+  + G        WP I                                
Sbjct: 229 FQRDQLERIFE--VLGTPT--EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284

Query: 329 -SDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                 DL+RK+L   P++R+TA E L HP+
Sbjct: 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 81.7 bits (201), Expect = 4e-17
 Identities = 87/322 (27%), Positives = 140/322 (43%), Gaps = 54/322 (16%)

Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 59

Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 60  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMEL 116

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 117 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 172

Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Query: 298 -----VPPFWAETQQGIFDAVLK----GHIDF-----------ESDPWPLISDSAKDLIR 337
                 P F  + Q  + + V        + F           +S+   L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292

Query: 338 KMLCSQPSERLTAHEVLCHPWI 359
           KML   P++R++  E L HP+I
Sbjct: 293 KMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 16/253 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G +    L         +A K + K  +   ED++ V+ E  +    + +  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++ +  + +V+E   GG+L   + ++    E  A      I   +   H  G+++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D D  +K  D+G+      PG   +   G+P Y+APE+L  + YG   
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 283 DVWTAGVILYILLSGVPPF-------WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           D W  GV+++ +++G  PF          T+  +F  +L+  I         +S  A  +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233

Query: 336 IRKMLCSQPSERL 348
           ++  L   P ERL
Sbjct: 234 LKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 16/203 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN---IV 163
           +G+G FG  Y C +  TG  +A K + K+++  ++  E +    +IM  L    +   IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60

Query: 164 TIKGAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLG 220
            +  A+   D LC   +++L  GG+L   + Q G +SE++     T II+G+ E  H+  
Sbjct: 61  CMTYAFHTPDKLC--FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL-EHMHNRF 117

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K   Y
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAY 173

Query: 279 GPEADVWTAGVILYILLSGVPPF 301
              AD ++ G +L+ LL G  PF
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 68/264 (25%), Positives = 119/264 (45%), Gaps = 23/264 (8%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G +    L     T   +A K I K  +   ED++ V+ E  +    + H  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  V+E  +GG+L   + ++    E  A   +  I   +   H  G+++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + YG   
Sbjct: 121 DLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 283 DVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
           D W  GV+++ +++G  PF            T+  +F  +L+  I         +S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAS 233

Query: 334 DLIRKMLCSQPSERLTAHEVLCHP 357
            +++  L   P ERL      CHP
Sbjct: 234 SVLKGFLNKDPKERLG-----CHP 252

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 56/178 (31%), Positives = 79/178 (44%), Gaps = 38/178 (21%)

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVVGSPYYVA 270
           HS  V+HRDLKP N LL   + D  +K  DFGL+             + TD V + +Y A
Sbjct: 124 HSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPF----------------WAETQQGI--- 309
           PE+LL    Y    D+W+ G IL  +L G P F                   + + I   
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 310 --------FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                    D++         +  P  SD A DL++K+L   P++RLTA E L HP++
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 64/309 (20%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHL 156
           Y    K+GQG FG  +      T    A K +    L+  E  E       REI+I+  L
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKV----LMENEK-EGFPITALREIKILQLL 68

Query: 157 AGHKNIV-------TIKGAYE-DSLCVHIVMELCA---GGELFDRIIQRGHYSERKAAEL 205
             H+N+V       T    Y       ++V E C     G L ++ ++   ++  +  ++
Sbjct: 69  K-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKV 124

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIF 259
            ++++  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      KP   +
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKP-NRY 180

Query: 260 TDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV--LK 315
           T+ V + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     +  L 
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 316 GHIDFESDP-------------------------WPLISD-SAKDLIRKMLCSQPSERLT 349
           G I  E  P                          P + D  A DLI K+L   P++R+ 
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300

Query: 350 AHEVLCHPW 358
           A   L H +
Sbjct: 301 ADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG   LC        TG + A KS+        +   D  REI+I+  L  H+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLD-HE 66

Query: 161 NIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI---IVGVV 213
           NIV  KG  E     SL   ++ME    G L  R   + H  +     L      I   +
Sbjct: 67  NIVKYKGVCEKPGGRSLR--LIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YY 268
           +   S   +HRDL   N L+   + +  +K  DFGL+      + +   V  P     ++
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESPIFW 178

Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLS 296
            APE L    +   +DVW+ GV LY L +
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 79/322 (24%), Positives = 127/322 (39%), Gaps = 76/322 (23%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREI 150
            +RD Y +  KLG+G FG  Y   +I TG   A K I    L+  E  +D       REI
Sbjct: 6   KLRD-YEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNE--KDGFPITALREI 58

Query: 151 QIMHHLAGHKNIVTI--------KGAYEDSLCVHIVM-----ELCAGGELFDRIIQRGHY 197
           +I+  L  H N+V +          +      V++V      +L   G L +        
Sbjct: 59  KILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLEN---PSVKL 112

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPG 256
           +E +       ++  +   H   ++HRD+K  N L+ N+     LK  DFGL+  +  P 
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG---ILKIADFGLARPYDGPP 169

Query: 257 QI-----------FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA 303
                        +T++V + +Y  PE+LL  + Y    D+W  G +   + +  P    
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229

Query: 304 ETQ--QG--IFDAV----------------LKGHIDFESDP-------WPLISDSAKDLI 336
           ++   Q   IF                    +G   F + P         L  +   DL+
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL-DLL 288

Query: 337 RKMLCSQPSERLTAHEVLCHPW 358
            K+L   P +RLTA + L HP+
Sbjct: 289 SKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 90/339 (26%), Positives = 143/339 (42%), Gaps = 66/339 (19%)

Query: 69  ISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFA 128
           +S SK+DN       N     +G  T  +   Y   + +G G  G      +       A
Sbjct: 1   MSRSKRDN-------NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA 53

Query: 129 CKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELC 182
            K +S R   ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL 
Sbjct: 54  IKKLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL 242
                  ++IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +L
Sbjct: 112 DAN--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTL 165

Query: 243 KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG---- 297
           K +DFGL+       + T  V + YY APEV+L   Y    D+W+ G I+  ++ G    
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Query: 298 -------------------VPPFWAETQ------------------QGIFDAVLKGHIDF 320
                               P F  + Q                  + +F  VL      
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPA 282

Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +S+   L +  A+DL+ KML    S+R++  E L HP+I
Sbjct: 283 DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 44/300 (14%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y   +++G G +GT     +  TG + A K +  R   S    +   RE++++ H+
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHM 71

Query: 157 AGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             H+N++ +   +   L +      ++VM     G    ++++    SE +   L   ++
Sbjct: 72  K-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  H+ G++HRDLKP N L VN  +D  LK +DFGL+   +     T  V + +Y A
Sbjct: 129 KGLKYIHAAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--QTDSEMTGYVVTRWYRA 183

Query: 271 PEVLLK--HYGPEADVWTAGVILYILL---------------------SGVPP--FWAET 305
           PEV+L   HY    D+W+ G I+  +L                     +G P   F  + 
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243

Query: 306 QQGIFDAVLKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           Q       +K    F    +    P  +  A +++ KML      R+TA E L HP+  E
Sbjct: 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 50/293 (17%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV--- 163
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 82

Query: 164 ---TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
              T   + E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 83  DVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 141 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 195

Query: 279 GPEADVWTAGVILYILLS---------------------GVPPFWAETQQGIFDAVLKGH 317
               D+W+ G I+  LL+                     G P   AE  + I     + +
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG--AELLKKISSESARNY 253

Query: 318 I---------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           I         +F  + +   +  A DL+ KML     +R+TA + L H +  +
Sbjct: 254 IQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 78/279 (27%), Positives = 120/279 (43%), Gaps = 44/279 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-------EIATGIEFACKSISKRKLISREDVEDVRREI 150
           R+  TLGR +G+GQFG  Y          +IA  ++  CK+ +     S    E   +E 
Sbjct: 5   REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCT-----SPSVREKFLQEA 58

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RI 208
            IM     H +IV + G   ++  V IVMEL   GEL         Y +     L    +
Sbjct: 59  YIMRQF-DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLASL 109

Query: 209 IVGVVEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I+   +         S   +HRD+   N L+ + D    +K  DFGLS + +    +   
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKAS 166

Query: 263 VGS-PY-YVAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHI 318
            G  P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGVKNNDVIGRI 221

Query: 319 DF-ESDPWP-LISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           +  E  P P     +   L+ K     PS+R    E+  
Sbjct: 222 ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 48/288 (16%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKNI 162
           +G+G +G    C    T      + ++ +K    E+ E+V+    RE++++  L   +NI
Sbjct: 9   VGEGAYGVVLKCRHKETK-----EIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENI 62

Query: 163 VTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           V +K A+     +++V E       EL + +   G   E+  + + ++I   +  CH   
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLI-KAIHWCHKND 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLL-KH 277
           ++HRD+KPEN LL++ +D   LK  DFG +     G    +T+ V + +Y +PE+LL   
Sbjct: 121 IVHRDIKPEN-LLISHND--VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAET------------------QQGIFDAVLKGH-I 318
           YG   D+W+ G IL  L  G P F  E+                  Q  +F +  + H +
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237

Query: 319 DFESDPWP---------LISDSAKDLIRKMLCSQPSERLTAHEVLCHP 357
            F +   P         ++S    DL++ +L   P++R    + L HP
Sbjct: 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 78.4 bits (193), Expect = 9e-16
 Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 27/278 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH----- 155
           Y + R LG G  GT      ++ G  FA K +    + S  D    + E+  + +     
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFS 92

Query: 156 -LAGHKNIVTIKGAYEDS-LCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRII 209
            +  H++         ++ L + +V++    G+L   I  R      + E +A  L   +
Sbjct: 93  IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGS 265
           +  V   HS  ++HRD+K  N LL +      +K  DFG S  +    +  DV     G+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNG---LVKLGDFGFSKMYA-ATVSDDVGRTFCGT 208

Query: 266 PYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           PYYVAPE+   K Y  +AD+++ GV+LY LL+   PF  E  + +    L G      DP
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----DP 264

Query: 325 WP-LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
            P  IS   ++++  +L S P  R ++ ++L  P IC+
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP-ICK 301

Length = 496

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 87/317 (27%), Positives = 130/317 (41%), Gaps = 84/317 (26%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KRKLISREDVEDVRREIQ 151
           Y     +G G +G      +  +G + A K I          KR L          RE++
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----------RELK 56

Query: 152 IMHHLAGHKNIVTIKGAY----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
           I+ H   H NI+ I+        D   V++VM+L    +L   II   H  +    E  R
Sbjct: 57  ILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDL-HHII---HSDQPLTEEHIR 110

Query: 208 -----IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG----LSVFFKPGQI 258
                ++ G+ +  HS  V+HRDLKP N LLVN+  D  L+  DFG    LS      + 
Sbjct: 111 YFLYQLLRGL-KYIHSANVIHRDLKPSN-LLVNE--DCELRIGDFGMARGLSSSPTEHKY 166

Query: 259 F-TDVVGSPYYVAPEVLLK--HYGPEADVWTAGVI-------------------LYILLS 296
           F T+ V + +Y APE+LL    Y    D+W+ G I                   L ++LS
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226

Query: 297 --GVPPFWAETQQGIFDAVLKGHI-----DFESD---PW----PLISDSAKDLIRKMLCS 342
             G P       + + + +    +     +       PW    P  S  A DL+ +ML  
Sbjct: 227 VLGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280

Query: 343 QPSERLTAHEVLCHPWI 359
            P ER+T  + L HP++
Sbjct: 281 DPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 23/216 (10%)

Query: 147 RREIQIMHHLAGHKNIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           RRE  +   L  H NIV +   G     L +  V E   G  L + +   G      A E
Sbjct: 26  RRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALP---AGE 80

Query: 205 LTRIIVGVVEA---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG----- 256
             R+++ V++A    H+ G++HRDLKP+N ++         K +DFG+     PG     
Sbjct: 81  TGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDAD 139

Query: 257 ----QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
                  T+V+G+P Y APE L  +   P +D++  G+I    L+G       +   I  
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILY 199

Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER 347
             L   +D    PW +       ++RK L   P +R
Sbjct: 200 QQL-SPVDVSLPPW-IAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 75/262 (28%), Positives = 113/262 (43%), Gaps = 23/262 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG G  GT Y    + T    A K I     I+ E  + +  E++I++       I+   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDS-PYIIGFY 65

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH---SLGVMH 223
           GA+     + I  E   GG L         Y +     L RI V VV+      SL ++H
Sbjct: 66  GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           RD+KP N +LVN      +K  DFG+S       I    VG+  Y+APE +  + YG  +
Sbjct: 119 RDVKPSN-MLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 283 DVWTAGVILYILLSGVPPF-WAETQQGIFDAV--LKGHIDFESDPWP--LISDSAKDLIR 337
           DVW+ G+    L  G  P+   +  QG    +  L+  +D +    P    S+     I 
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234

Query: 338 KMLCSQPSERLTAHEVLCHPWI 359
           + +  QP ER     ++ HP+I
Sbjct: 235 QCMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 46/221 (20%)

Query: 105 RKLGQGQFGTT---YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           ++LG G FG+        +    +E A K++ +  + + +   +  RE  +M  L  H  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQL-DHPC 57

Query: 162 IVTIKG-AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL-TRIIVGV--VEACH 217
           IV + G    + L   +VMEL   G L   + +R         EL  ++ +G+  +E+ H
Sbjct: 58  IVRLIGVCKGEPLM--LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA------P 271
               +HRDL   N LLVN+      K  DFG+S             GS YY A      P
Sbjct: 116 ---FVHRDLAARNVLLVNRH---QAKISDFGMSRALGA--------GSDYYRATTAGRWP 161

Query: 272 EVLLKHYGPE----------ADVWTAGVILYILLS-GVPPF 301
              LK Y PE          +DVW+ GV L+   S G  P+
Sbjct: 162 ---LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 44/292 (15%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV- 163
             +G G +G+     +     + A K +S R   S        RE++++ H+  H+N++ 
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMK-HENVIG 78

Query: 164 -----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
                T   + E+   V++V  L  G +L + I++    S+     L   ++  ++  HS
Sbjct: 79  LLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N + VN  +D  L+ +DFGL+   +     T  V + +Y APE++L   
Sbjct: 137 AGIIHRDLKPSN-VAVN--EDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWM 191

Query: 277 HYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFDAVLKGHIDF------------ 320
           HY    D+W+ G I+  LL G   F    + +  + I + V     +             
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251

Query: 321 -ESDPWPLISDSAK----------DLIRKMLCSQPSERLTAHEVLCHPWICE 361
            +S P     D  K          DL+ KML     +R++A E L HP+  +
Sbjct: 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 29/279 (10%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGH 159
             ++G G  GT Y      TG  +A K I      + ED   VR    REI+I+     H
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYG----NHED--TVRRQICREIEILRD-VNH 131

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            N+V     ++ +  + +++E   GG L    I      E+  A++ R I+  +   H  
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLADVARQILSGIAYLHRR 187

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL---L 275
            ++HRD+KP N L+   +   ++K  DFG+S +  +        VG+  Y++PE +   L
Sbjct: 188 HIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 276 KH--Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
            H  Y G   D+W+ GV +     G  PF    +QG + A L   I     P    + S 
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDW-ASLMCAICMSQPPEAPATASR 302

Query: 333 --KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS 369
             +  I   L  +P++R +A ++L HP+I        + 
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQG 341

Length = 353

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 31/230 (13%)

Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG  TD    + T+G+    G +G  Y  T    G   A K +     IS  D E++  E
Sbjct: 17  LGDPTDTWEIIETIGK----GTYGKVYKVTNKKDGSLAAVKILDP---ISDVD-EEIEAE 68

Query: 150 IQIMHHLAGHKNIVTIKGA-YEDSLCVH----IVMELCAGG---ELFDRIIQRGHYSERK 201
             I+  L  H N+V   G  Y+    V     +V+ELC GG   EL   ++  G   +  
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE- 127

Query: 202 AAELTRIIVGVV---EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI 258
            A ++ I+ G +   +  H+  ++HRD+K  N LL  +     +K +DFG+S      ++
Sbjct: 128 -AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG---GVKLVDFGVSAQLTSTRL 183

Query: 259 FTDV-VGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPF 301
             +  VG+P+++APEV+         Y    DVW+ G+    L  G PP 
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.7 bits (189), Expect = 5e-15
 Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 56/291 (19%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-------REIQIM 153
           Y + R +G+G  G  YL  +       A K I       RED+ +         RE +I 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-------REDLSENPLLKKRFLREAKIA 56

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--------RIIQRGHYSERKAAEL 205
             L  H  IV +     D   V+  M    G  L            + +    +      
Sbjct: 57  ADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 206 TRI---IVGVVEACHSLGVMHRDLKPENFLL------------------VNKDDDFSLKA 244
             I   I   +E  HS GV+HRDLKP+N LL                  + ++D   +  
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 245 IDFGL--SVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA-DVWTAGVILYILLSGVPPF 301
            +  +  S    PG+I    VG+P Y+APE LL     E+ D++  GVILY +L+   P+
Sbjct: 176 DERNICYSSMTIPGKI----VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Query: 302 WAETQQGIFDAVLKGHIDF--ESDPWPLISDSAKDLIRKMLCSQPSERLTA 350
             +  + I     +  I    E  P+  I      +  K L   P+ER ++
Sbjct: 232 RRKKGRKI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279

Length = 932

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 66/301 (21%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG--HKN 161
           ++G G +GT Y   +  +G   A KS+   ++ + ED   +   RE+ ++  L    H N
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGE---------LFDRIIQ--RGHYSE--------RKA 202
           IV +             M++CA            +F+ + Q  R +  +           
Sbjct: 64  IVRL-------------MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI 110

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
            +L R  +  ++  H+  ++HRDLKPEN L+ +      +K  DFGL+  +      T V
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLARIYSCQMALTPV 167

Query: 263 VGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKG 316
           V + +Y APEVLL+  Y    D+W+ G I   +    P F   ++      IFD + L  
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227

Query: 317 HIDFESD------------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             D+  D            P P+      I +S   L+ +ML   P +R++A   L HP+
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Query: 359 I 359
            
Sbjct: 288 F 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 83/308 (26%), Positives = 128/308 (41%), Gaps = 67/308 (21%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VRREIQIMHHLA 157
           Y +   +G+G +G      +  TG + A K I+       E V D   + REI+++  L 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND----VFEHVSDATRILREIKLLRLLR 57

Query: 158 GHKNIVTIKG--------AYEDSLCVHIVMELCAGGELFDRI-----IQRGHYSERKAAE 204
            H +IV IK          ++D   +++V EL    +L   I     +   H+       
Sbjct: 58  -HPDIVEIKHIMLPPSRREFKD---IYVVFEL-MESDLHQVIKANDDLTPEHHQ----FF 108

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFK--PGQIF-T 260
           L +++  + +  H+  V HRDLKP+N L    + D  LK  DFGL+ V F   P  IF T
Sbjct: 109 LYQLLRAL-KYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 261 DVVGSPYYVAPEV---LLKHYGPEADVWTAGVILYILLSGVPPF---------------- 301
           D V + +Y APE+       Y P  D+W+ G I   +L+G P F                
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224

Query: 302 ---WAETQQGI--------FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTA 350
                ET   +          ++ K      S  +P     A  L+ ++L   P +R TA
Sbjct: 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA 284

Query: 351 HEVLCHPW 358
            E L  P+
Sbjct: 285 EEALADPY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 39/101 (38%), Positives = 58/101 (57%), Gaps = 10/101 (9%)

Query: 262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF 320
           ++G+P Y+APE+LL K +GP  D W  GV L+  L+G+PPF  ET Q +F  +L   I  
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597

Query: 321 ESDPWP----LISDSAKDLIRKMLCSQPSERLTAHEVLCHP 357
              PWP     +S +A++ I  +L   P++R    E+  HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 38/284 (13%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D + +   +G+G +G  +       G + A K +     I     E++  E  I+  L+ 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73

Query: 159 HKNIVTIKGAYEDSLCVH-----IVMELCAGGELFDRI---IQRGHYSERK--AAELTRI 208
           H N+V   G Y      +     +V+ELC GG + D +   ++RG   E    A  L   
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPY 267
           ++G+ +  H    +HRD+K  N LL  +     +K +DFG+S      ++  +  VG+P+
Sbjct: 134 LMGL-QHLHVNKTIHRDVKGNNILLTTEG---GVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 268 YVAPEV------LLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           ++APEV      L   Y    DVW+ G+    L  G PP  A+         ++      
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKIP 242

Query: 322 SDPWP------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +P P      L S+   D IRK L     +R T  ++L H +I
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 68/243 (27%), Positives = 97/243 (39%), Gaps = 34/243 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           RD  TL R LG G FG  Y           +E      +  +  S +D  D   E  IM 
Sbjct: 5   RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQ--RGHYSERKAAELTRIIV 210
               H+NIV + G   + L   I++EL AGG+L  F R  +      S     +L     
Sbjct: 65  KFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 211 GVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            V + C  L     +HRD+   N LL  K      K  DFG++          D+  + Y
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASY 174

Query: 268 Y------------VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           Y            + PE  L   +  + DVW+ GV+L+ + S G  P+   T Q + + V
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Query: 314 LKG 316
             G
Sbjct: 235 TGG 237

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 51/183 (27%), Positives = 77/183 (42%), Gaps = 51/183 (27%)

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL----SVFFKPGQIFTDVVGSPYYVAP 271
           CH   V+HRDLKP+N L+  + +   LK  DFGL    SV   P + +++ V + +Y  P
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRPP 172

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------D 323
           +VLL    Y    D+W  G I Y + +G P F      G  D   + H  F        +
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF-----PGSTDVEDQLHKIFRVLGTPTEE 227

Query: 324 PWPLIS----------------------------DSAKDLIRKMLCSQPSERLTAHEVLC 355
            WP +S                               ++L  K L  +P +R++A E + 
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287

Query: 356 HPW 358
           HP+
Sbjct: 288 HPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 65/282 (23%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM-HHL-AGHKNIV 163
           KL  G+FG   +     T   F  K I  +              I+ M H L   + N +
Sbjct: 23  KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----------NAIEPMVHQLMKDNPNFI 72

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---G 220
            +  +        ++M+    G+LFD + + G  SE   AE+ +II  +VEA + L    
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE---AEVKKIIRQLVEALNDLHKHN 129

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-------YVAPEV 273
           ++H D+K EN L     D   L   D+GL            ++G+P        Y +PE 
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYL--CDYGLCK----------IIGTPSCYDGTLDYFSPEK 177

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-------- 324
           +  H Y    D W  GV+ Y LL+G  PF             K   D E D         
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPF-------------KEDEDEELDLESLLKRQQ 224

Query: 325 WPL-----ISDSAKDLIRKMLCSQPSERLTAH-EVLCHPWIC 360
             L     +S +A D ++ ML    + RLT + E++ HP++ 
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 78/276 (28%), Positives = 112/276 (40%), Gaps = 48/276 (17%)

Query: 107 LGQGQFGTTY---LCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           LG G FG  Y       +  G   I  A K++  RK  + ++ ++  +E  +M +   H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNF-NHP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER------KAAELTRIIVGVVE 214
           NIV + G    +   +I+MEL  GG+L   +  R    ER         EL  I + V +
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAK 117

Query: 215 ACHSLGVM---HRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPGQIFTDVVGSPYY- 268
            C  L  M   HRDL   N L+  K  D    +K  DFGL+          D+  S YY 
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSDYYR 168

Query: 269 -----------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLK 315
                      +APE LL   +  ++DVW+ GV+++ IL  G  P+ A   Q +   V  
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228

Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH 351
           G             D    L+       PSER T  
Sbjct: 229 GG---RLQKPENCPDKIYQLMTNCWAQDPSERPTFD 261

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 64/268 (23%), Positives = 113/268 (42%), Gaps = 42/268 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR--KLISREDV---EDVRREIQI 152
           R+ +TL RKLG G FG  +         E   K+  +   K++  +D+   +D ++E+Q 
Sbjct: 5   REEFTLERKLGSGYFGEVW---------EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQA 55

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY---SERKA---AELT 206
           +  L  HK+++++         V+I+ EL   G L         +    E +    A L 
Sbjct: 56  LKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLI 107

Query: 207 RIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
            +   V E    L     +HRDL   N L+    +D   K  DFGL+   K     +   
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDK 164

Query: 264 GSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF 320
             PY + APE      +  ++DVW+ G++LY + + G  P+       ++D +  G+   
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--- 221

Query: 321 ESDPWPL-ISDSAKDLIRKMLCSQPSER 347
              P P         ++ +   ++P +R
Sbjct: 222 -RMPCPAKCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 77/294 (26%), Positives = 119/294 (40%), Gaps = 54/294 (18%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHK 160
            KLG+G + T Y       GI      +   K+IS +  E V     RE  ++  L  H 
Sbjct: 11  EKLGEGSYATVY------KGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HA 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHS 218
           NIV +         +  V E     +L   +IQ   G +       + +++ G+    H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGL-AYIHG 121

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL-- 275
             ++HRDLKP+N L+    +   LK  DFGL+     P Q ++  V + +Y  P+VLL  
Sbjct: 122 QHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF---ESDPWPLISD-- 330
             Y    D+W AG I   +L G P F   +   +F+ + K          D WP +S   
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKLP 236

Query: 331 --------------------------SAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                                      A+DL  +ML   P +R++A + L HP+
Sbjct: 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 41/233 (17%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
            K+G+G FG  Y    +    E A K+   R  +  +      +E +I+     H NIV 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RIIVGVVEAC------ 216
           + G       ++IVMEL  GG L         +  +K   LT  +++   ++A       
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVKKLLQMSLDAAAGMEYL 109

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS---------VFFKPGQIFTDVVGSPY 267
            S   +HRDL   N L+    ++  LK  DFG+S         V     QI       P 
Sbjct: 110 ESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQI-------PI 159

Query: 268 -YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            + APE L    Y  E+DVW+ G++L+   S G  P+   + Q   + +  G+
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 37/178 (20%)

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF--FKPGQIFTDVVGSPYYVAPEVL 274
           HS G++HRD+KP N LLVN   +  LK  DFGL+        +  T  V + YY APE+L
Sbjct: 120 HSAGILHRDIKPGN-LLVN--SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAET--QQ--GIFDAV--------------L 314
           +  +HY    D+W+ G I   LL     F A++  QQ   I D +               
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236

Query: 315 KGHIDFESDPWP-------LISD----SAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           + HI       P        +S      A  L+ +ML   P +R++A + L HP++ E
Sbjct: 237 RAHI-LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 41/223 (18%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  +G G FG  Y    I T  + A K +        +D +   RE+ IM +L  H 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNL-NHI 119

Query: 161 NIVTIKGAY--------EDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRI 208
           NI+ +K  Y        E ++ +++VME          I Q  H    +  R    L   
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEF---------IPQTVHKYMKHYARNNHALPLF 170

Query: 209 IVGVV--EAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           +V +   + C      HS  + HRDLKP+N L+    +  +LK  DFG +     GQ   
Sbjct: 171 LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLLAGQRSV 228

Query: 261 DVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
             + S +Y APE++L   +Y    D+W+ G I+  ++ G P F
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271

Length = 440

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 47/268 (17%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAG 158
           T  ++LG GQFG  +L  +    I+ A K I       RE     +D   E ++M  L+ 
Sbjct: 7   TFLKELGSGQFGVVHL-GKWRGKIDVAIKMI-------REGAMSEDDFIEEAKVMMKLS- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H N+V + G       + IV E  A G L + + +R    +     L  +   V EA   
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEY 115

Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---APE 272
           L   G +HRDL   N  LV   +D  +K  DFGL+ +    Q +T   G+ + V    PE
Sbjct: 116 LESNGFIHRDLAARN-CLVG--EDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPE 171

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           V     +  ++DVW+ GV+++ + S G  P+   +   + ++V  G+             
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------ 219

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPW 358
               L R  L          + ++   W
Sbjct: 220 ----LYRPKLAPTE-----VYTIMYSCW 238

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 47/291 (16%)

Query: 106 KLGQGQFGTTYLCTEIATGIEF-ACKSISKRKLISREDVE-DVRREIQIMHHLAG--HKN 161
           ++G+G +G  +   ++  G  F A K +  R     E +     RE+ ++ HL    H N
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 162 IVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +V +       +   E  L +   H+  +L       D++ + G  +E     + +++ G
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           + +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + +Y AP
Sbjct: 123 L-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 272 EVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHID------ 319
           EVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D      
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 320 -----FESDPW-------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                F S            I +  KDL+ K L   P++R++A+  L HP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 21/228 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M  L+
Sbjct: 4   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H+ +V + G       ++IV E  + G L + + + G   +   ++L  +   V E   
Sbjct: 58  -HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ--PSQLLEMCKDVCEGMA 114

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---AP 271
              S   +HRDL   N L+   DD   +K  DFGLS +    + +T  VGS + V    P
Sbjct: 115 YLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170

Query: 272 EVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           EVLL   +  ++DVW  GV+++ + S G  P+         + V +G 
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+      I  RKLI  E    +R    RE+Q++H       
Sbjct: 12  ELGAGNGGVVFKVSHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 64

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 125 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 176

Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 25/230 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQI 152
           N ++L  LG  +G+G+FG   L      G + A K +       ++D    +    E  +
Sbjct: 4   NSKEL-KLGATIGKGEFGDVMLGD--YRGQKVAVKCL-------KDDSTAAQAFLAEASV 53

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL--TRIIV 210
           M  L  H N+V + G       ++IV E  A G L D +  RG      A +L     + 
Sbjct: 54  MTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YV 269
             +E       +HRDL   N L+    +D   K  DFGL+   K      D    P  + 
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLA---KEASQGQDSGKLPVKWT 166

Query: 270 APEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           APE L  K +  ++DVW+ G++L+ + S G  P+     + +   V KG+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY 216

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 33/209 (15%)

Query: 107 LGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
           LG+G FG+  LC     +  TG   A K   K +  + E + D  REI+I+  L  H NI
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HDNI 67

Query: 163 VTIKG-AYE-DSLCVHIVMELCAGGELFDRIIQRGHYSE-RKAAELTRIIVGVVEACHSL 219
           V  KG  Y      + +VME    G L D + +     + RK       I   +E   S 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-YY 268
             +HRDL   N L+ +   +  +K  DFGL+             +PG+       SP ++
Sbjct: 128 RYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKVREPGE-------SPIFW 177

Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLS 296
            APE L +  +   +DVW+ GV+LY L +
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 36/222 (16%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G         +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 64

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-LTRIIVGVVEACHSL- 219
           IV   GA+     + I ME   GG L D++++    ++R   E L ++ + V+     L 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE---AKRIPEEILGKVSIAVLRGLAYLR 120

Query: 220 ---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPE 272
               +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172

Query: 273 VLL-KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIF 310
            L   HY  ++D+W+ G+ L  L  G   +PP  A+  + IF
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   LC        TG + A KS+          + D+++EI+I+ +L  H+
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 66

Query: 161 NIVTIKGAYEDSL--CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG   +     + ++ME    G L + + +  +    K  +  +  V + +    
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDY 124

Query: 219 LG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF---TDVVGSP-YYVAP 271
           LG    +HRDL   N L+ ++     +K  DFGL+   +  + +    D + SP ++ AP
Sbjct: 125 LGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 272 EVLL--KHYGPEADVWTAGVILYILLS 296
           E L+  K Y   +DVW+ GV LY LL+
Sbjct: 182 ECLIQSKFY-IASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 21/233 (9%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T +      T    A K I   +L   E       RE+ ++ +L  H NIVT
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLK-HANIVT 67

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE--LTRIIVGVVEACHSLGVM 222
           +        C+ +V E     +L   +   G+       +  + +++ G+   CH   ++
Sbjct: 68  LHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGL-SYCHKRKIL 125

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGL----SVFFKPGQIFTDVVGSPYYVAPEVLL--K 276
           HRDLKP+N L+  K +   LK  DFGL    SV   P + +++ V + +Y  P+VLL   
Sbjct: 126 HRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNEVVTLWYRPPDVLLGST 179

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
            Y    D+W  G ILY + +G P F   T +     + +       + WP I+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 59/255 (23%), Positives = 111/255 (43%), Gaps = 47/255 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLI----SREDVEDVRREIQI 152
           RD  TLG+ LG+G FG   +   +    +   ++++   K++    + +D+ D+  E+++
Sbjct: 14  RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI---- 208
           M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+    
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 209 ------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
                       +   +E   S   +HRDL   N L+   +    +K  DFGL+      
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLA------ 184

Query: 257 QIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFW 302
               DV    YY            +APE L    Y  ++DVW+ GV+++ I   G  P+ 
Sbjct: 185 ---RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241

Query: 303 AETQQGIFDAVLKGH 317
               + +F  + +GH
Sbjct: 242 GIPVEELFKLLKEGH 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 53/296 (17%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T Y      T    A K I   +L   E       RE+ ++  L  H NIVT
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 68

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAEL--TRIIVGVVEACH 217
           +         +H    L    E  D+ +++     G+       +L   +++ G+   CH
Sbjct: 69  LHD------IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGL-NYCH 121

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL- 275
              V+HRDLKP+N L+  + +   LK  DFGL+     P + +++ V + +Y  P++LL 
Sbjct: 122 RRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------------GHIDF 320
              Y  + D+W  G I Y + +G P F   T +     + +               + +F
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238

Query: 321 ESDPWP-------------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
           +S  +P             L SD A +L+ K+L  +  +R++A E + HP+    G
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGA-ELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 25/235 (10%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T +      T    A K I   +L   E       RE+ ++  L  H NIVT
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 68

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAE--LTRIIVGVVEACH 217
           +         VH    L    E  D+ +++     G+       +  L +I+ G+   CH
Sbjct: 69  LHD------IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA-YCH 121

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              V+HRDLKP+N L+  + +   LK  DFGL+     P + +++ V + +Y  P+VLL 
Sbjct: 122 RRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
              Y  + D+W  G I + + SG P F   T +     + +       + WP IS
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 21/218 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---REDVEDVRREIQIMH 154
           R+  + G+ LG G FG     T        A   ++ + L       + E +  E++IM 
Sbjct: 34  RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGV 212
           HL  H+NIV + GA      + ++ E C  G+L + + ++     +       +  +   
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-------SVFFKPGQIFTDVVGS 265
           +    S   +HRDL   N LL +      +K  DFGL       S +   G     V   
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNARLPV--- 207

Query: 266 PYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
             ++APE +    Y  E+DVW+ G++L+ + S G  P+
Sbjct: 208 -KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 70/223 (31%), Positives = 112/223 (50%), Gaps = 24/223 (10%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           TLG  +G+G+FG   L  E  TG + A K+I K  + ++  +E    E  +M  L  HKN
Sbjct: 9   TLGEIIGEGEFGAV-LQGEY-TGQKVAVKNI-KCDVTAQAFLE----ETAVMTKLH-HKN 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G    +  ++IVMEL + G L + +  RG        +L +  + V E    L  
Sbjct: 61  LVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLES 118

Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVAPEVLLKH 277
             ++HRDL   N L+    +D   K  DFGL+   + G +  D    P  + APE  LKH
Sbjct: 119 KKLVHRDLAARNILV---SEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEA-LKH 171

Query: 278 --YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             +  ++DVW+ GV+L+ + S G  P+   + + + + V KG+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY 214

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 67/263 (25%), Positives = 118/263 (44%), Gaps = 37/263 (14%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           TL +++G GQFG  +L   +    + A K+I +   +S ED  +   E Q+M  L+ H  
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKR-KVAIKTI-REGAMSEEDFIE---EAQVMMKLS-HPK 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG +S+     +   +   +    S  
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---APEVL-LK 276
           V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ + V   +PEV    
Sbjct: 121 VIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176

Query: 277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
            Y  ++DVW+ GV+++ + S G  P+   +   + + +  G                  L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----------------RL 220

Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
            +  L SQ     + +E++ H W
Sbjct: 221 YKPRLASQ-----SVYELMQHCW 238

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 30/209 (14%)

Query: 105 RKLGQGQFGTTYL-CTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   L C + A   TG   A K++ +     +++    ++EI I+  L  H+
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HE 66

Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-- 216
           NIV  KG   +     + ++ME    G L D       Y  +    L ++++   + C  
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119

Query: 217 ----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV---GSP-YY 268
               HS   +HRDL   N LL   D+D  +K  DFGL+     G  +  V     SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLS 296
            A E L ++ +   +DVW+ GV LY LL+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 44/285 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            DL  +  +LG+G +G       + TG   A K I  R  ++ ++ + +  ++ I     
Sbjct: 1   DDLEVI-EELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSV 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
                VT  GA      V I ME+      + + ++  +G         L +I V +V+A
Sbjct: 58  DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDI--LGKIAVSIVKA 115

Query: 216 CH----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV-----GSP 266
                  L V+HRD+KP N +L+N++     K  DFG+S     G +   V      G  
Sbjct: 116 LEYLHSKLSVIHRDVKPSN-VLINRNGQV--KLCDFGIS-----GYLVDSVAKTIDAGCK 167

Query: 267 YYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPF--WAETQQGIFDAVLKGHID 319
            Y+APE +      K Y  ++DVW+ G+ +  L +G  P+  W    Q +   V      
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV------ 221

Query: 320 FESDPWPLI-----SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              +P P +     S   +D + K L     ER    E+L HP+ 
Sbjct: 222 --EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 16/222 (7%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  ++LG GQFG  +L  +    I+ A K+I++  +      ED   E ++M  L+ H  
Sbjct: 7   TFMKELGSGQFGVVHL-GKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLS-HPK 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G       ++IV E    G L + + QR G  S+     + + +   +E      
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---APEVLL-K 276
            +HRDL   N L+        +K  DFG++ +    + +T   G+ + V    PEV    
Sbjct: 121 FIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFS 176

Query: 277 HYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            Y  ++DVW+ GV+++ +   G  PF  ++   + + + +G 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G FG  +     A     A KS   R+ +  +      +E +I+   + H NIV +
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYS-HPNIVRL 58

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII---VGVVEACHSLGVM 222
            G       ++IVMEL  GG+    +   G     K  EL +++      +E   S   +
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS------VFFKPGQIFTDVVGSPYYVAPEVL-L 275
           HRDL   N L+  K+    LK  DFG+S      V+   G +    V    + APE L  
Sbjct: 117 HRDLAARNCLVTEKN---VLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEALNY 170

Query: 276 KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
             Y  E+DVW+ G++L+   S G  P+   + Q   +A+ +G
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 67/264 (25%), Positives = 113/264 (42%), Gaps = 29/264 (10%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAG 158
           T+  KLG GQ+G  Y        +  A K++       +ED   VE+  +E  +M  +  
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEEFLKEAAVMKEIK- 60

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL----TRIIVGVVE 214
           H N+V + G        +I+ E    G L D  ++  +  E  A  L    T+I    +E
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSA-ME 118

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
                  +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + AP
Sbjct: 119 YLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 174

Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E L    +  ++DVW  GV+L+ I   G+ P+       +++ + KG   +  +      
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCP 231

Query: 330 DSAKDLIRKMLCSQPSERLTAHEV 353
               +L+R      PS+R +  E+
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 72/252 (28%), Positives = 111/252 (44%), Gaps = 36/252 (14%)

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           L  +  T   F  K + K    SRE +  +   +  M  L  HK IV+     EDS  V 
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCL--HKYIVS-----EDS--VF 61

Query: 177 IVMELCAGGELFDRIIQRGHYSE----RKAAELTRIIVGVVEACHSLGVMHRDLKPENFL 232
           +V++   GG+L+  I +  +  E    R AAE+    V  ++A H  G++ RDL P N L
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEM----VVALDALHREGIVCRDLNPNNIL 117

Query: 233 LVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA-DVWTAGVIL 291
           L   DD   ++   F      +      + V    Y APEV       EA D W+ G IL
Sbjct: 118 L---DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAIL 172

Query: 292 YILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTA- 350
           + LL+G      +T      + +  H       W  +S+ A+ L++++L   P+ERL A 
Sbjct: 173 FELLTG------KTLVECHPSGINTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAG 224

Query: 351 ----HEVLCHPW 358
                ++  HP+
Sbjct: 225 VAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 54/245 (22%), Positives = 101/245 (41%), Gaps = 46/245 (18%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAGHKNIV 163
           LG+G FG  Y           +  S++ + L    +    ++ R+E ++M  L  H NIV
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIV 71

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-------------ELTRIIV 210
            + G         ++ E  A G+L + +++   +S+  A              +   I +
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 211 GVVEACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            +      L     +HRDL   N  LV   +  ++K  DFGLS          D+  + Y
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARN-CLVG--EGLTVKISDFGLS---------RDIYSADY 179

Query: 268 Y------------VAPE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           Y            + PE +L   +  E+D+W+ GV+L+ + S G+ P++  + Q + + +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Query: 314 LKGHI 318
               +
Sbjct: 240 RSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 32/234 (13%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL----------ISREDVEDVRREIQ 151
            + + +G G+FG      E+ +G     K   KR++           + +   D   E  
Sbjct: 7   KIEKVIGAGEFG------EVCSG---RLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRII 209
           IM     H NI+ ++G    S  V IV E    G L D  +++  G ++  +   + R I
Sbjct: 58  IMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGI 115

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGS-P 266
              ++    +G +HRDL   N +LVN   +   K  DFGLS   +  P   +T   G  P
Sbjct: 116 ASGMKYLSDMGYVHRDLAARN-ILVNS--NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 267 Y-YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             + APE +  + +   +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 47/287 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL  LG ++G+G FGT        +G   A K I  R  +  ++ + +  ++ ++   + 
Sbjct: 5   DLKDLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 159 HKNIVTIKGA-YEDSLCVHIVMELCAGG-ELFDRII---QRGHYSERKAAELTRIIVGVV 213
              IV   GA + +  C  I MEL     + F + +    +    E     L +I V  V
Sbjct: 62  CPYIVKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEI---LGKIAVATV 117

Query: 214 EACH----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-----VG 264
           +A +     L ++HRD+KP N LL   D + ++K  DFG+S     GQ+   +      G
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGIS-----GQLVDSIAKTRDAG 169

Query: 265 SPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPF--WAETQQGIFD---AVLK 315
              Y+APE +       Y   +DVW+ G+ LY + +G  P+  W      +FD    V+K
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK 225

Query: 316 GHID---FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           G  D     +      S S  + I   L    S+R    E+L HP+I
Sbjct: 226 G--DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 19/227 (8%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           T+ + +G G+FG          G   I+ A K++  +   S +   D   E  IM     
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFD- 63

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V I+ E    G L D+ + R +  +    +L  ++ G+      
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFL-RENDGKFTVGQLVGMLRGIASGMKY 121

Query: 219 LGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG--SPY-YVAPE 272
           L  M   HRDL   N +LVN +     K  DFGLS   +  +      G   P  + APE
Sbjct: 122 LSEMNYVHRDLAARN-ILVNSN--LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 273 VL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            +  + +   +DVW+ G++++ ++S G  P+W  + Q +  AV  G+
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 47/255 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLI----SREDVEDVRREIQI 152
           R   TLG+ LG+G FG   +   I    +   K ++   K++    + +D+ D+  E+++
Sbjct: 11  RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEM 70

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI---- 208
           M  +  HKNI+ + GA      +++++E  + G L + +  R       + +  ++    
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 209 ------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
                       +   +E   S   +HRDL   N L+    +D  +K  DFGL+      
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLA------ 181

Query: 257 QIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFW 302
               DV    YY            +APE L    Y  ++DVW+ GV+L+ I   G  P+ 
Sbjct: 182 ---RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Query: 303 AETQQGIFDAVLKGH 317
               + +F  + +GH
Sbjct: 239 GIPVEELFKLLKEGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 32/263 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G++        ++  S  D  D   E++++  L  H NI+ + 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 167 GAYEDSLCVHIVMELCAGGELFD-----RII--------QRGHYSERKAAELTRIIVGVV 213
           GA E+   ++I +E    G L D     R++        + G  S   + +L +    V 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    ++ + K  DFGLS    V+ K       V    
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPV---- 182

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y  ++DVW+ GV+L+ ++S G  P+   T   +++ + +G   +  + 
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEK 239

Query: 325 WPLISDSAKDLIRKMLCSQPSER 347
                D   +L+R+    +P ER
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 21/229 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHL 156
           R    L RKLG GQFG      E+  G+      ++ + L     D +D   E QIM  L
Sbjct: 5   RTSIQLLRKLGAGQFG------EVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL 58

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  ++ +         ++IV EL   G L +  +Q G     K  +L  +   V    
Sbjct: 59  R-HPKLIQLYAVCTLEEPIYIVTELMKYGSLLE-YLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 217 HSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVA 270
             L      HRDL   N +LV   ++   K  DFGL+   K   I+    G+ +   + A
Sbjct: 117 AYLEAQNYIHRDLAARN-VLVG--ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTA 172

Query: 271 PE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           PE  L   +  ++DVW+ G++L  I+  G  P+   T   +   V +G+
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY 221

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 47/255 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLIS---REDVEDVRREIQI 152
           RD   LG+ LG+G FG   +   I    E   +   ++ + L S    +D+ D+  E+++
Sbjct: 17  RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 76

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----------------GH 196
           M  +  HKNI+ + GA      +++++E  + G L + +  R                  
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
            S +        +   +E   S   +HRDL   N L+    +D  +K  DFGL+      
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA------ 187

Query: 257 QIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFW 302
               D+    YY            +APE L    Y  ++DVW+ GV+L+ I   G  P+ 
Sbjct: 188 ---RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 303 AETQQGIFDAVLKGH 317
               + +F  + +GH
Sbjct: 245 GVPVEELFKLLKEGH 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L RKLG GQFG  ++ T   T  + A K++    +      E   +E QIM  L 
Sbjct: 5   RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQEAQIMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E  + G L D  ++ G   + +  +L  +   + E   
Sbjct: 60  -HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
              S   +HRDL   N L+    ++   K  DFGL+   +    +T   G+ +   + AP
Sbjct: 118 YLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAP 173

Query: 272 EVLLKHYGP---EADVWTAGVILY 292
           E     YG    ++DVW+ G++L 
Sbjct: 174 EAAN--YGRFTIKSDVWSFGILLT 195

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + + + +G FG  YL  +      +A K + K  +I++  V  V+ E      LA  K
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE---RDALALSK 62

Query: 161 N--IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           +  IV +  + + +  V++VME   GG++   +   G++ E  A +    +   ++  H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
            G++HRDLKP+N L+ N+     +K  DFGLS
Sbjct: 123 HGIIHRDLKPDNMLISNEG---HIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMH 154
           RD   L R+LG+G FG  +L  C  +    +    ++   K  +  D  +D  RE +++ 
Sbjct: 4   RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL----------FDRIIQR----GHYSER 200
           +   H+NIV   G   +     +V E    G+L             +       G  +  
Sbjct: 64  NF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           +  ++   I   +    S   +HRDL   N L+     D  +K  DFG+S          
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMS---------R 170

Query: 261 DVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY 292
           DV  + YY            + PE ++ + +  E+DVW+ GV+L+
Sbjct: 171 DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 55/290 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y        +       A K++++   +   +  +   E  +
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASV 62

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE------LT 206
           M     H ++V + G         +VMEL A G+L   +  R    E +         L 
Sbjct: 63  MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQ 119

Query: 207 RIIVGVVEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           + I    E         +   +HRDL   N  +V   +D ++K  DFG++          
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARN-CMVA--EDLTVKIGDFGMT---------R 167

Query: 261 DVVGSPYY------------VAPEVLLK-HYGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            +APE L    +  ++DVW+ GV+L+ +      P+   + 
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227

Query: 307 QGIFDAVLKG-HIDF-ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V+ G H+D  E+ P  L+     +L+R      P  R T  E++
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLL-----ELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 42/231 (18%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI-------MHHLAGH 159
           LG+G FG  +  T +      A K+            ED+ +E++I       +     H
Sbjct: 3   LGKGNFGEVFKGT-LKDKTPVAVKTCK----------EDLPQELKIKFLSEARILKQYDH 51

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA---C 216
            NIV + G       ++IVMEL  GG+    +  R    E K  +L +  +         
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYL 109

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------VFFKPG--QIFTDVVGSPYY 268
            S   +HRDL   N L+    ++  LK  DFG+S      ++   G  QI         +
Sbjct: 110 ESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------W 160

Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            APE L    Y  E+DVW+ G++L+   S GV P+   T Q   + V KG+
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 25/261 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T  + A K++    ++     E   +E QIM  L 
Sbjct: 5   RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMP----EAFLQEAQIMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E    G L D  ++ G     K  +L  +   + +   
Sbjct: 60  -HDKLVPLYAVVSEE-PIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
               +  +HRDL+  N L+    D+   K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 117 YIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL-I 328
           E  L   +  ++DVW+ G++L  L++ G  P+     + + + V +G+      P P   
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY----RMPCPQGC 228

Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +S  +L++      P ER T
Sbjct: 229 PESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 29/224 (12%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L  +G+                 T    A K I+     S+ED++ +++EI     L  H
Sbjct: 3   LTLIGKCFEDLMIVHLAKHK--PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-H 58

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR-IIVGVVEA--- 215
            NI+    ++     +++V  L A G   D +  + H+ E         I+  V+ A   
Sbjct: 59  PNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDY 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSP------ 266
            HS G +HR +K  + LL         K +  GL       K G+    V   P      
Sbjct: 117 IHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 267 -YYVAPEVL---LKHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
             +++PEVL   L+ Y  ++D+++ G+    L +G  PF  +  
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMP 214

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 59/215 (27%), Positives = 86/215 (40%), Gaps = 34/215 (15%)

Query: 106 KLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
           KLG G FG         +G   I  A K +   KL   + ++D  +E  IMH L  H+N+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD-HENL 58

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLG 220
           + + G       + +V EL   G L DR+ +   GH+      +    I   +    S  
Sbjct: 59  IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----------- 269
            +HRDL   N LL + D    +K  DFGL                 +YV           
Sbjct: 118 FIHRDLAARNILLASDD---KVKIGDFGLMRALP--------QNEDHYVMEEHLKVPFAW 166

Query: 270 -APEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            APE L    +   +DVW  GV L+ + + G  P+
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 48/285 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD  TLG+ LG+G FG       +         +++ + L    + +D+ D+  E+++M 
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG--- 211
            +  HKNI+ + G       +++V+E  A G L D +  R    E  + +  R       
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 212 ---VVEACH----------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI 258
              +V   +          S   +HRDL   N L+    +D  +K  DFGL+        
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA-------- 179

Query: 259 FTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAE 304
             D+    YY            +APE L    Y  ++DVW+ GV+L+ I   G  P+   
Sbjct: 180 -RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238

Query: 305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT 349
             + +F  + +G+     +     +     L+R      PS+R T
Sbjct: 239 PVEELFKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPT 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 32/232 (13%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----REDVEDVRR-----EIQ 151
            + R LG G+FG      E+  G     K  SKR+L       R    D +R     E  
Sbjct: 8   KIERILGTGRFG------ELCRG---CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
            +     H NIV ++G       + IV E  + G L D  +++ H  +  A +L  ++ G
Sbjct: 59  TLGQF-DHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRK-HEGQLVAGQLMGMLPG 115

Query: 212 VVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG-SP- 266
           +      L   G +H+ L     +LVN D     K   F      K   I+T + G SP 
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHK-VLVNSD--LVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
            + APE +   H+   +DVW+ G++++ ++S G  P+W  + Q +  AV  G
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 77/303 (25%), Positives = 117/303 (38%), Gaps = 54/303 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D Y    KLG+G + T Y       G   A K I   +L   E       RE  ++  L 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLK 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVME-----LCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
            H NIV +         + +V E     LC   +  D+    G + E     L +++ G+
Sbjct: 62  -HANIVLLHDIIHTKETLTLVFEYVHTDLC---QYMDKH-PGGLHPENVKLFLFQLLRGL 116

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAP 271
               H   ++HRDLKP+N L+    D   LK  DFGL+     P   +++ V + +Y  P
Sbjct: 117 -SYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF---ESDPWP 326
           +VLL    Y    D+W  G I   ++ GV  F     + I D + +  +       D WP
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQDQLERIFLVLGTPNEDTWP 230

Query: 327 LIS----------------------------DSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
            +                             + A+DL  K+L   P  RL+A   L H +
Sbjct: 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Query: 359 ICE 361
             +
Sbjct: 291 FSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 40/231 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI---------EFACKSISKRKLISREDV----- 143
           R    L  KLG+GQFG  +LC   A G+         EF  + +     + R DV     
Sbjct: 4   RQQLRLKEKLGEGQFGEVHLCE--AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61

Query: 144 EDVRREIQIMHHLAGHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK 201
            D  +EI+IM  L  + NI+ + G    +D LC  ++ E    G+L   + QR   S   
Sbjct: 62  NDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLC--MITEYMENGDLNQFLSQREIESTFT 118

Query: 202 AAE------------LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            A             +   I   ++   SL  +HRDL   N L+    + +++K  DFG+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGM 175

Query: 250 SVFFKPGQIF----TDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           S     G  +      V+   +     +LL  +   +DVW  GV L+ + +
Sbjct: 176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L      G + A K I K    ++  +     E  +M  
Sbjct: 4   NMKEL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATAQAFLA----EASVMTQ 55

Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 56  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 113

Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 114 AMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 167

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS 296
           PE L  K +  ++DVW+ G++L+ + S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 41/269 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++ K   +S E   +   E QIM  L 
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTL-KPGTMSPESFLE---EAQIMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E  + G L D  ++ G     K   L  +   V     
Sbjct: 60  -HDKLVQLYAVVSEE-PIYIVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
               +  +HRDL+  N L+    D    K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 117 YIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E  L   +  ++DVW+ G++L  L++ G  P+     + + + V +G+            
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------ 220

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                   +M C Q    ++ HE++   W
Sbjct: 221 --------RMPCPQDCP-ISLHELMLQCW 240

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 63/271 (23%), Positives = 115/271 (42%), Gaps = 45/271 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 5   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVV 213
            H+ +V +     +   ++IV E  + G L D +  +G   +     +  ++   I   +
Sbjct: 60  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVA 270
                +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + A
Sbjct: 116 AYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTA 171

Query: 271 PE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           PE  L   +  ++DVW+ G++L  L + G  P+     + + D V +G+           
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------- 220

Query: 329 SDSAKDLIRKMLCSQPSE-RLTAHEVLCHPW 358
                    +M C  P E   + H+++C  W
Sbjct: 221 ---------RMPC--PPECPESLHDLMCQCW 240

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 62/263 (23%), Positives = 108/263 (41%), Gaps = 32/263 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 167 GAYEDSLCVHIVMELCAGGELFD-----RII--------QRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D     R++             S   + +L      V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 175

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G   +  + 
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEK 232

Query: 325 WPLISDSAKDLIRKMLCSQPSER 347
                D   DL+R+    +P ER
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 187

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 244

Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            PL   D   DL+R+    +P ER +  ++L
Sbjct: 245 -PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)

Query: 104 GRKLGQGQFGTTYLC--TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           G K+G+G +G  Y     +     E+A K I    +          REI ++  L  H N
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPN 59

Query: 162 IVTIKGAY--EDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVG-----VV 213
           ++ ++  +       V ++ +  A  +L+  I   R   + +K  +L R +V      ++
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF----KPGQIFTDVVGS 265
           +  H L    V+HRDLKP N L++ +  +   +K  D G +  F    KP      VV +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 266 PYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
            +Y APE+LL  +HY    D+W  G I   LL+  P F
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 18/171 (10%)

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAEL 205
           REI ++  L  H N+++++  +       + +           II+  R   + +K  +L
Sbjct: 47  REIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 105

Query: 206 TR-----IIVGVVEACHSLG---VMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF--- 253
            R     ++  +++  H L    V+HRDLKP N L++ +  +   +K  D G +  F   
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 254 -KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
            KP      VV + +Y APE+LL  +HY    D+W  G I   LL+  P F
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 55/259 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIE---------FACKSISKRKLISREDVEDVRR 148
           RD   LG+ LG+G FG        A GI+          A K +      + +D+ D+  
Sbjct: 11  RDRLVLGKPLGEGCFGQVVRAE--AYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLIS 66

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+++M  +  HKNI+ + G       +++++E  A G L + +  R         ++T++
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 209 ----------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
                           +   +E   S   +HRDL   N +LV +D+   +K  DFGL+  
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN-VLVTEDN--VMKIADFGLA-- 181

Query: 253 FKPGQIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGV 298
                    V    YY            +APE L    Y  ++DVW+ G++++ I   G 
Sbjct: 182 -------RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234

Query: 299 PPFWAETQQGIFDAVLKGH 317
            P+     + +F  + +GH
Sbjct: 235 SPYPGIPVEELFKLLREGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 89/407 (21%), Positives = 160/407 (39%), Gaps = 76/407 (18%)

Query: 20  PEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMR 79
               +N+++R+ +     +  ST S  ++       +K+      +   ++P  K   + 
Sbjct: 44  TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVT 103

Query: 80  RGIDNQT------YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS 133
             + NQ+      Y VLG   D     + +   LG+G FG      +       A K + 
Sbjct: 104 YALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR 163

Query: 134 KRKLISREDVEDVRREIQIMHHL-----AGHKNIVTIKGAYE-DSLCVHIVMELCAGGEL 187
                +R    D + EIQ M  +     A    ++ I+  ++ ++  + IVM    G  L
Sbjct: 164 NVPKYTR----DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK-YGPCL 218

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD--------- 237
            D I++ G +S R  A++       ++  H+ L +MH DLKPEN L+   D         
Sbjct: 219 LDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278

Query: 238 ----DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILY 292
               D   ++  D G     +  +  T +V + +Y +PEV+L   +    D+W+ G I+Y
Sbjct: 279 ALPPDPCRVRICDLGGCCDERHSR--TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336

Query: 293 ILLSG----------------------VPPFWA-----ETQQGIFDAVLKGHIDFESDPW 325
            L +G                      +P  WA     E  + ++++   G +   +DP 
Sbjct: 337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSA--GQLRPCTDPK 394

Query: 326 PL------------ISDSAK-DLIRKMLCSQPSERLTAHEVLCHPWI 359
            L            I D    DLI  +L     +RL A ++  HP++
Sbjct: 395 HLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 54/257 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIE---FACKSISKRKLISREDVEDVRREIQI 152
           RD+  L R+LG+G FG  +L  C  ++   +    A K++    L +R+D +   RE ++
Sbjct: 5   RDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ---REAEL 60

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELF--------DRIIQRGHYSERKAAE 204
           + +L  H++IV   G   D   + +V E    G+L         D +I       +   E
Sbjct: 61  LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 205 L---------TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
           L         ++I  G+V    S   +HRDL   N L+     +  +K  DFG+S     
Sbjct: 120 LGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGA---NLLVKIGDFGMS----- 170

Query: 256 GQIFTDVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPF 301
                DV  + YY            + PE ++ + +  E+DVW+ GVIL+ I   G  P+
Sbjct: 171 ----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 302 WAETQQGIFDAVLKGHI 318
           +  +   + + + +G +
Sbjct: 227 FQLSNTEVIECITQGRV 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 26/81 (32%), Positives = 45/81 (55%), Gaps = 4/81 (4%)

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRD+K EN  +   +D   +   D G + F      F  + G+    APEVL +
Sbjct: 174 HAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR 230

Query: 277 -HYGPEADVWTAGVILYILLS 296
             Y  +AD+W+AG++L+ +L+
Sbjct: 231 DKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 60/253 (23%), Positives = 106/253 (41%), Gaps = 51/253 (20%)

Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           RD+  L  +LG+G FG  +L  C  +    +    ++   K  S    +D +RE +++  
Sbjct: 5   RDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV 63

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE----------- 204
           L  H++IV   G   +   + +V E    G+L +R + R H  + K              
Sbjct: 64  LQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHGPDAKILAGGEDVAPGQLT 120

Query: 205 -------LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
                   ++I  G+V    SL  +HRDL   N L+        +K  DFG+S       
Sbjct: 121 LGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLV---GQGLVVKIGDFGMS------- 169

Query: 258 IFTDVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWA 303
              D+  + YY            + PE +L + +  E+D+W+ GV+L+ I   G  P++ 
Sbjct: 170 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227

Query: 304 ETQQGIFDAVLKG 316
            +     + + +G
Sbjct: 228 LSNTEAIECITQG 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIF 259
             + R ++  ++  H  G++HRD+K EN +LVN  +D  L   DFG + F +        
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319

Query: 260 TDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY 292
             + G+    APEVL    Y P  D+W+AG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 21/229 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++        + A K++    +     V+    E  +M  L 
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEA 215
            H  +V +         ++I+ E  A G L D  +  + G     K  + +  I   +  
Sbjct: 60  -HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    +    K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 119 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 174

Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            +  ++G    ++DVW+ G++LY I+  G  P+   +   +  A+ +G+
Sbjct: 175 AI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 63/292 (21%)

Query: 105 RKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVE-DVRREIQIMHHLAGH 159
           R +GQG FG  +     A G+     F   ++   K  +  D++ D +RE  +M     H
Sbjct: 11  RDIGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DH 67

Query: 160 KNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG------ 211
            NIV + G  A    +C  ++ E  A G+L + +  R   ++   +  T           
Sbjct: 68  PNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 212 ----VVEACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
                 + C +  V            +HRDL   N L+    ++  +K  DFGLS     
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS----- 177

Query: 256 GQIFTDVVGSPYYVAPE-------------VLLKHYGPEADVWTAGVILYILLS-GVPPF 301
                ++  + YY A E             +    Y  E+DVW  GV+L+ + S G+ P+
Sbjct: 178 ----RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Query: 302 WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           +    + +   V  G++    D  PL      +L+R      PS+R +   +
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPDNCPL---ELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 25/237 (10%)

Query: 101 YTLGRKLGQGQFGT---TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +TLGR LG+G+FG+     L +E  +  + A K + K  + S  D+E+  RE   M    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58

Query: 158 GHKNI-----VTIKGAYEDSLCVHIV-MELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
            H N+     V+++   +  L + +V +     G+L   ++      E     L  ++  
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 212 VVEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           +++         S   +HRDL   N +L   +++ ++   DFGLS     G  +     S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 266 PY---YVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
                ++A E L  + Y   +DVW  GV ++ I+  G  P+       I++ ++KG+
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTY--LCTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 5   REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 62

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 63  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I    E    +  +      HRDL   N ++     DF++K  DFG++          D+
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RDI 169

Query: 263 VGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY 292
             + YY            +APE L    +   +D+W+ GV+L+
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 44/246 (17%)

Query: 103 LGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           L R+LG+G FG  +L  C  +    +    ++   K  S    +D  RE +++ +L  H+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HE 67

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA-----AELTR-------- 207
           +IV   G   +   + +V E    G+L   +   G  +   A     AELT+        
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 208 -IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
            I  G+V    S   +HRDL   N L+    ++  +K  DFG+S          DV  + 
Sbjct: 128 QIAAGMVYLA-SQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYSTD 174

Query: 267 YY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDA 312
           YY            + PE ++ + +  E+DVW+ GV+L+ I   G  P++  +   + + 
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234

Query: 313 VLKGHI 318
           + +G +
Sbjct: 235 ITQGRV 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 36/218 (16%)

Query: 105 RKLGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           R +G+G FG  Y  T I + G +  C   S  ++   E+VE   +E  IM   + H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVL 59

Query: 164 TIKG-AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG-- 220
           ++ G          +V+     G+L + I    H    K  +L    + V +    L   
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASK 117

Query: 221 -VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY----------- 268
             +HRDL   N +L   D+ F++K  DFGL+          D+    YY           
Sbjct: 118 KFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLP 165

Query: 269 ---VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
              +A E L    +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 3/95 (3%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           RD    G+ LG G FG     T    G E     ++ + L +    ++ E +  E++I+ 
Sbjct: 37  RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS 96

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD 189
           HL  HKNIV + GA      V ++ E C  G+L +
Sbjct: 97  HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 43/233 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI------EFACKSISKRKLIS-----REDVE-- 144
           R   T   KLG+GQFG  +LC   A G+      +F+      + ++      RED    
Sbjct: 4   RKRLTFKEKLGEGQFGEVHLCE--AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 145 ---DVRREIQIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
              D  +EI+IM  L    NI+ +       D LC  ++ E    G+L ++ + R    E
Sbjct: 62  ARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLC--MITEYMENGDL-NQFLSRHEPQE 117

Query: 200 RKAAELTRI------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
                                I   ++   SL  +HRDL   N  LV K  ++++K  DF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN-CLVGK--NYTIKIADF 174

Query: 248 GLSVFFKPGQIF----TDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           G+S     G  +      V+   +     +LL  +   +DVW  GV L+ +L+
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 31/239 (12%)

Query: 102 TLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            LG+ LG+G+FG+     L  +  + ++ A K++ K  + +  ++E+   E   M     
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59

Query: 159 HKNI-----VTIKGAYEDSLCVHIV-MELCAGGELFDRII--QRGHYSERKAAE-LTRII 209
           H N+     V  + +    +   +V +     G+L   ++  + G   E+   + L + +
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 210 VGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV------FFKPGQIFT 260
           V +   +E   +   +HRDL   N +L    +D ++   DFGLS       +++ G+I  
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 261 DVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
             V    ++A E L    Y  ++DVW  GV ++ I   G  P+       I+D +  G+
Sbjct: 177 MPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 51/288 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    IA G+         A K++++   + RE +E +  E 
Sbjct: 5   REKITMSRELGQGSFGMVY--EGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 60

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE----LT 206
            +M     H ++V + G         ++MEL   G+L   +       E    +    L 
Sbjct: 61  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 167

Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 228 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 30/178 (16%)

Query: 140 REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
           +   +++ RE +IMH L  +  IV + G  E +  + +VME+ +GG L         +  
Sbjct: 36  KSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMASGGPL-------NKFLS 86

Query: 200 RKAAELTRIIVGVVEACH--SLGV--------MHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            K  E+T  +  VVE  H  S+G+        +HRDL   N LLVN+      K  DFGL
Sbjct: 87  GKKDEIT--VSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGL 141

Query: 250 S-VFFKPGQIFTDVVGSPY---YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           S         +       +   + APE +    +   +DVW+ G+ ++   S G  P+
Sbjct: 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 98  RDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           RD   LGR LG G FG     T +  +   + ++ A K +  +      + + +  E++I
Sbjct: 36  RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKML--KSTARSSEKQALMSELKI 93

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH 196
           M HL  H NIV + GA      ++I+ E C  G+L D + +  H
Sbjct: 94  MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 18/102 (17%)

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + R ++  ++  H   ++HRD+K EN + +N   D  L   DFG + F  P     D+  
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLG--DFGAACF--P----VDINA 237

Query: 265 SPYY--------VAPEVLLKH-YGPEADVWTAGVILYILLSG 297
           + YY         APE+L +  YGP  D+W+AG++L+ + + 
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 64/249 (25%), Positives = 100/249 (40%), Gaps = 75/249 (30%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-EFACKS--ISKRKLIS--------REDV--- 143
           R       KLG+GQFG  +LC   A G+ +F+ K+   +              R D    
Sbjct: 4   RQPLNFVEKLGEGQFGEVHLCE--ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 144 --EDVRREIQIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
             ED  +E++I+  L+   NI  + G    +  LC  ++ME    G+L         + +
Sbjct: 62  AREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLC--MIMEYMENGDL-------NQFLQ 111

Query: 200 RKAAEL-------------------TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           +  AE                    T+I  G+     SL  +HRDL   N  LV K  ++
Sbjct: 112 KHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLNFVHRDLATRN-CLVGK--NY 167

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYY------VAP-------EVLLKHYGPEADVWTA 287
           ++K  DFG+S          ++  S YY        P        VLL  +  ++DVW  
Sbjct: 168 TIKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 288 GVILYILLS 296
           GV L+ +L+
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)

Query: 104 GRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            + LG G FGT +    I  G    I  A K+I  R    R+  +++   +  M  L  H
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DH 68

Query: 160 KNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
             IV + G     +C    + +V +L   G L D +  R H        L    V + + 
Sbjct: 69  AYIVRLLG-----ICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKG 121

Query: 216 CHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYV 269
            + L    ++HR+L   N LL     D  ++  DFG++    P      +++      ++
Sbjct: 122 MYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 270 APE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           A E +L   Y  ++DVW+ GV ++ ++S G  P+       + D + KG
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 13/115 (11%)

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + +++ G+    H +G++HRD+KPEN L+     D  +K IDFG +V    G  F  + G
Sbjct: 315 MRQVLTGL-RKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYG 370

Query: 265 --SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPF-WAETQQGIFDAVLKG 316
              P Y  PE L+    P++        +  LLS   PF W   +  +FD+   G
Sbjct: 371 MLDPRYSPPEELVM---PQSCPRAPAPAMAALLS---PFAWLYGRPDLFDSYTAG 419

Length = 507

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 55/243 (22%), Positives = 100/243 (41%), Gaps = 46/243 (18%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFA-CKSISKRKLISR-EDVEDVRREIQIMHHLAGHKNIV 163
           +LG+  FG  Y       G++ A   +I   K I+  +   + ++E  +M  L  H NIV
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIV 70

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-----------------ELT 206
            + G       V ++ E    G+L + +I R  +S+   +                  + 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             I   +E   S   +H+DL   N L+    +   +K  D GLS          ++  + 
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS---------REIYSAD 178

Query: 267 YY-VAPEVLLK------------HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           YY V P+ LL              +  ++D+W+ GV+L+ + S G+ P++  + Q + + 
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238

Query: 313 VLK 315
           V K
Sbjct: 239 VRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMH 154
           +R  Y +   L  G  G  ++CT+             ++K+I +     +   REI I+ 
Sbjct: 90  VRMQYNILSSLTPGSEGEVFVCTKHG--------DEQRKKVIVKAVTGGKTPGREIDILK 141

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMEL--CAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
            ++ H+ I+ +  AY     V +VM    C   +LF  + + G     +A  + R ++  
Sbjct: 142 TIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQRRLLEA 197

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-----FFKP---GQIFTDVVG 264
           +   H  G++HRD+K EN  L ++ ++  L   DFG +         P   G   T    
Sbjct: 198 LAYLHGRGIIHRDVKTENIFL-DEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETN 254

Query: 265 SPYYVAPEVLLKHYGPEADVWTAGVILY 292
           SP  +A    L  Y  + D+W+AG++L+
Sbjct: 255 SPELLA----LDPYCAKTDIWSAGLVLF 278

Length = 392

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 57/244 (23%), Positives = 109/244 (44%), Gaps = 42/244 (17%)

Query: 102 TLGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            LG+ LG+G+FG+       +  + ++ A K++ K  + +R ++ED   E   M     H
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEF-DH 59

Query: 160 KNIVTIKGAYEDSLCVH-----------IVMELCAGGEL-----FDRIIQRGHY--SERK 201
            N++ + G     +C+            +++     G+L     + R+     Y  ++  
Sbjct: 60  PNVMRLIG-----VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML 114

Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV------FFKP 255
              +T I  G+ E   S   +HRDL   N +L   +++ ++   DFGLS       +++ 
Sbjct: 115 VKFMTDIASGM-EYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQ 170

Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAV 313
           G+I    V    ++A E L    Y  ++DVW+ GV ++ I   G  P+       I+D +
Sbjct: 171 GRIAKMPVK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Query: 314 LKGH 317
            +G+
Sbjct: 228 RQGN 231

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 47/231 (20%)

Query: 106 KLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKL-----ISREDV-----EDVRREI 150
           KLG+GQFG  +LC E+        ++F       R L     I R D       D  +E+
Sbjct: 12  KLGEGQFGEVHLC-EVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 151 QIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGEL--------FDRIIQRGHYSER 200
           +I+  L    NI+ + G    ED LC  ++ E    G+L         D   + G+ +  
Sbjct: 71  KILSRLK-DPNIIRLLGVCVDEDPLC--MITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 201 KAAELTRI-----------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            A  L  I           I   ++   SL  +HRDL   N L+    ++ ++K  DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGM 184

Query: 250 SVFFKPG---QIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILYILLS 296
           S     G   +I    V    ++A E +L+  +   +DVW  GV L+ +L 
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 7/97 (7%)

Query: 98  RDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           RD   LGR LG G FG     T Y  +     ++ A K +      S +  + +  E++I
Sbjct: 36  RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK--QALMSELKI 93

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD 189
           M HL  H NIV + GA   S  ++I+ E C  G+L +
Sbjct: 94  MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVN 130

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 35/107 (32%), Positives = 46/107 (42%), Gaps = 11/107 (10%)

Query: 147 RREIQIMHHLAGHKNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
           RRE +IM      K  V +   Y  D     IVME   G  L D +I      E + +  
Sbjct: 47  RREARIMSRA--RKAGVNVPAVYFVDPENFIIVMEYIEGEPLKD-LINSNGMEELELSRE 103

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
              +VG +   HS G++H DL   N +L        L  IDFGL+ F
Sbjct: 104 IGRLVGKL---HSAGIIHGDLTTSNMIL--SGGKIYL--IDFGLAEF 143

Length = 211

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 27/262 (10%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 5   RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 60  -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 117 FIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172

Query: 272 EVLLKHYGP---EADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           E +  ++G    ++DVW+ G++L  +++ G  P+   +   +  A+ +G+     +  P 
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP- 229

Query: 328 ISDSAKDLIRKMLCSQPSERLT 349
             +   +++ +   ++P ER T
Sbjct: 230 --EELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 31/116 (26%), Positives = 46/116 (39%), Gaps = 14/116 (12%)

Query: 139 SREDVEDVRREIQIMHHLAGHKNIV-TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
           SRE   D  RE+ I+  LA     V  +  + E     +++ME   G  L +   +    
Sbjct: 31  SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED 90

Query: 198 SERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              + AEL   +       H L    + H DL P N L+   DD   L  ID+  +
Sbjct: 91  IAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKR---KLISRED-----VEDVRREIQIMHHLA 157
           +LG G FGT      +  G+ +  K   K    K++  ++      +++ RE  +M  L 
Sbjct: 2   ELGSGNFGT------VKKGM-YKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL- 53

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            +  IV + G  E    + +VMEL   G L   + +  H +E+   EL   +   ++   
Sbjct: 54  DNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS---PY-YVAPEV 273
               +HRDL   N LLV +      K  DFGLS      + +         P  + APE 
Sbjct: 113 ETNFVHRDLAARNVLLVTQH---YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 274 LLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 40.7 bits (95), Expect = 9e-04
 Identities = 56/258 (21%), Positives = 104/258 (40%), Gaps = 58/258 (22%)

Query: 103 LGRKLGQGQFGTTY--LCTEIA--TGIE-FACKSISKRKLISREDVEDVRREIQIMHHLA 157
           LG+ LG+G+FG         +    G    A K + +    S  ++ D+  E  ++  + 
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQR------GHYSERKAAELTR-- 207
            H +++ + GA      + +++E    G L  F R  ++      G    R ++ L    
Sbjct: 62  -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 208 ---IIVGVV-----EACH------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
              + +G +     +          + ++HRDL   N L+    +   +K  DFGLS   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLS--- 174

Query: 254 KPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
                  DV     YV            A E L  H Y  ++DVW+ GV+L+ +++ G  
Sbjct: 175 ------RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228

Query: 300 PFWAETQQGIFDAVLKGH 317
           P+     + +F+ +  G+
Sbjct: 229 PYPGIAPERLFNLLKTGY 246

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 10/89 (11%)

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           ++   +L  +HR  K  N LL     D  LK    G   F  P Q   D    PY++APE
Sbjct: 24  LQCLGALRELHRQAKSGNILL---TWDGLLKL--DGSVAFKTPEQSRPD----PYFMAPE 74

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPP 300
           V+  + Y  +AD+++ G+ LY  L    P
Sbjct: 75  VIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 8/85 (9%)

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY-YVAPEVLL-KH 277
           +HRDL   N LL   +    +K  DFGL+  ++  P  +       P  ++APE +  K 
Sbjct: 196 IHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 18/72 (25%), Positives = 29/72 (40%), Gaps = 1/72 (1%)

Query: 177 IVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           ++ E   G +     + +    +E     L R +  ++   H  GV H DL   N LL  
Sbjct: 94  LLTERLEGAQDLVTWLAQWADPAEELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDT 153

Query: 236 KDDDFSLKAIDF 247
            +  F +  IDF
Sbjct: 154 GEGGFKVWLIDF 165

These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 26/94 (27%)

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV------------ 269
           +HRDL   N LL   +    +K  DFGL+          D+   P YV            
Sbjct: 195 IHRDLAARNILLSENN---VVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           APE +  K Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 7/80 (8%)

Query: 198 SERKAAELTRIIVGVVEA---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            ER+   +  I+  ++ A    HS G++HRD+KP+N +       F  K ID G +   +
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLGAAADLR 307

Query: 255 PG--QIFTDVVGSPYYVAPE 272
            G   I  + +  P Y APE
Sbjct: 308 VGINYIPKEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 6/87 (6%)

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--VGSPYYVA 270
           VE  H   ++HRD+K EN  L N D    L   DFG ++ F+  +   D   VG+    +
Sbjct: 280 VEYIHDKKLIHRDIKLENIFL-NCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNS 336

Query: 271 PEVLLKH-YGPEADVWTAGVILYILLS 296
           PE+L    Y    D+W+ G+IL  +LS
Sbjct: 337 PEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 8/85 (9%)

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY-YVAPEVLL-KH 277
           +HRDL   N LL   +    +K  DFGL+  ++  P  +       P  ++APE +  + 
Sbjct: 201 IHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 54/164 (32%)

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
           T+K   E +  VHIV ++ AG E                               S  V+H
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLS----------------------------SHHVVH 147

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY------------VAP 271
           +DL   N L+ +K    ++K  D GL         F +V  + YY            ++P
Sbjct: 148 KDLATRNVLVFDK---LNVKISDLGL---------FREVYAADYYKLMGNSLLPIRWMSP 195

Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           E ++   +  ++D+W+ GV+L+ + S G+ P+   + Q + + +
Sbjct: 196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	398
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.86
smart00090	237	RIO RIO-like kinase.	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
KOG1243	690	consensus Protein kinase [General function predict	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.43
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.02
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.9
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.74
PRK09902	216	hypothetical protein; Provisional	98.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.67
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.66
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
PF01636	239	APH: Phosphotransferase enzyme family This family	98.6
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.55
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.38
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.32
PLN02876	822	acyl-CoA dehydrogenase	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.11
PRK10593	297	hypothetical protein; Provisional	98.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.0
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.95
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.95
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.91
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.9
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.83
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.63
PRK05231	319	homoserine kinase; Provisional	97.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.36
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.34
KOG2270	520	consensus Serine/threonine protein kinase involved	97.29
PLN02236	344	choline kinase	97.23
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.23
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.2
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.05
PLN02756	418	S-methyl-5-thioribose kinase	97.02
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.79
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.41
PRK12396	409	5-methylribose kinase; Reviewed	96.36
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.33
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.09
PRK11768	325	serine/threonine protein kinase; Provisional	96.03
PTZ00384	383	choline kinase; Provisional	95.82
PRK06148	1013	hypothetical protein; Provisional	95.45
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.39
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.34
PTZ00296	442	choline kinase; Provisional	94.33
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.49

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-64  Score=465.92  Aligned_cols=271  Identities=38%  Similarity=0.642  Sum_probs=249.8

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC----HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ..+.+.|.+.+.||+|+||.|-+|.++.+|+.||||++.++....    ......+.+|+++|++|+ |||||+++++|+
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence            347788999999999999999999999999999999998876543    122345679999999998 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      ..+..||||||++||+|++.+..++.+.+...+.+++|++.||.|||++||+||||||+|||+..+.++..+||+|||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999987777899999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHHcCCCcCCCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPW  325 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  325 (398)
                      +.........+.||||.|.|||++.+    .+..++|+||+||+||-+++|.+||.+..... +.+++.++.+.+....|
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            99988888999999999999999973    25568999999999999999999998877665 89999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      ..+++++.+||.+||..||++|||++|+|+||||+......
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence            99999999999999999999999999999999999876554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-60  Score=456.64  Aligned_cols=257  Identities=38%  Similarity=0.580  Sum_probs=244.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      .+|+.++.||+|||+.||.+++..+|+.||+|++.+..+......+++.+||+|.+.|. |||||+++++|++.+.+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            46999999999999999999999999999999999988888889999999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      .|+|..++|..++++++.++|.+++.+++||+.||.|||+++|||||||..|+++   +++.+|||+|||+|..+..+ +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999999999999999999999999999999999999999999999   89999999999999988754 7


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ...+.||||.|+|||++.+ .++..+||||+||+||.||.|++||...+..+.+..|......++.    .++.+++|||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            7788999999999999985 5999999999999999999999999999999999999999988887    4899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .+||.+||.+|||+++||.|+||+...
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            999999999999999999999995433

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-61  Score=419.60  Aligned_cols=296  Identities=40%  Similarity=0.728  Sum_probs=279.3

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.+.|.+-+.||+|.|+.||++.+..+|+.+|+|++...++ +....+.+.+|+.|-+.|+ ||||+++.+.+.+....
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence            466779999999999999999999999999999999977665 4447899999999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |||+|++.|++|..-+.++..+++..+...++||++||.|+|.+||||||+||+|+|+...+....+||+|||+|.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999999999998888888899999999999999999999999999999999999998878888999999999999888


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      +......+|||.|||||++.+ .|+..+|||+-||+||-|+.|.+||++++...+++.|.++...++...|+.+++++++
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            788889999999999999985 5999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhh
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALR  393 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (398)
                      ||++||..||.+|+|+.|+|+|||+++..-.....--+....+|+.|++++|+|-.+|-
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLt  304 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILT  304 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHH
Confidence            99999999999999999999999999998888888888999999999999999987764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-59  Score=429.75  Aligned_cols=273  Identities=33%  Similarity=0.593  Sum_probs=248.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.++||+|+||+||.++.+.+++.+|+|++++..+......+....|..||..+. ||.||+++..|++...+|+|
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence            45999999999999999999999999999999999999888888999999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec-CCCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~-~~~~  257 (398)
                      +||+.||.|+.+|.+.+.|++..++.++..|+.||.|||++|||||||||+|||+   |.+|+++|+|||+++.. ..+.
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC
Confidence            9999999999999999999999999999999999999999999999999999999   99999999999999854 4445


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ...++|||+.|||||++.+ .|+.++|.||||+++|||++|.+||.+.+...+.+++.++.......   .++.++++||
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardll  257 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDLL  257 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHHH
Confidence            5667899999999999986 59999999999999999999999999999999999999988444332   4789999999


Q ss_pred             HHhcccCCCCCC----CHHHHhcCCCccCCCCCCC--CCCCHHHHHHH
Q 015898          337 RKMLCSQPSERL----TAHEVLCHPWICENGVAPD--RSLDPAVLSRL  378 (398)
Q Consensus       337 ~~~L~~dP~~Rp----s~~eiL~hp~~~~~~~~~~--~~~~~~~~~~~  378 (398)
                      +++|..||++|.    ++.+|-+||||++-.|...  ..+.|+|.|.+
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~  305 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV  305 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence            999999999995    7899999999999665433  34455666554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-57  Score=432.76  Aligned_cols=268  Identities=36%  Similarity=0.608  Sum_probs=247.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      .+|.+++.||+|+|++|++|.++.+++.||||++.++.+..+...+-+.+|-.+|.+|.+||.|++|+..|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            34999999999999999999999999999999999988877777888999999999998899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      +||+++|+|.++|.+.+.|++..++.++.+|+.||+|||++|||||||||+|||+   |+++++||.|||.|+.+.+...
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence            9999999999999999999999999999999999999999999999999999999   9999999999999987643211


Q ss_pred             --------------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC
Q 015898          259 --------------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       259 --------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (398)
                                    ..+++||..|.+||+|.. ..++.+|||+||||+|+|+.|.+||.+.++.-++++|+.-.+.|+..
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~  309 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG  309 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence                          145899999999999985 57899999999999999999999999999999999999999888875


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHH
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA  373 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~  373 (398)
                          +++.+.|||+++|..||.+|+|+++|.+||||.+..|......+||
T Consensus       310 ----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP  355 (604)
T KOG0592|consen  310 ----FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPP  355 (604)
T ss_pred             ----CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCC
Confidence                7899999999999999999999999999999999887765554443

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-56  Score=431.66  Aligned_cols=303  Identities=59%  Similarity=0.979  Sum_probs=283.3

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ....+.+.|++.+.||.|.||.||+|.++.+|+.+|+|++.+.........+.+.+|+.+|++|.+||||+.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            34556778999999999999999999999999999999999887766667789999999999998899999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeecCCce
Q 015898          173 LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSV  251 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DFG~a~  251 (398)
                      ..+++|||+|.||.|++.+.+. .+++..+..+++|++.|+.|||+.||+||||||+|+|+...++ ++.+|++|||+|.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999887 4999999999999999999999999999999999999966543 4689999999999


Q ss_pred             ecCCCCcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ....+......+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||++.+.......+..+.+.|....|+.++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            988877888999999999999999 5799999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSA  396 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (398)
                      .+.++|.+||..||.+|+|+.++|+|||+.+....+.....+....+++++..++++++.++|+.+
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLA  333 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999999988888888888889999999999999999887654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1e-57  Score=434.01  Aligned_cols=277  Identities=32%  Similarity=0.546  Sum_probs=253.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|+++++||+|+||.||+|+.+.+|..+|+|++++.......+++.++.|-.+|.... +|.||+++..|++..++|||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEEE
Confidence            56999999999999999999999999999999999999889999999999999999954 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC---
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP---  255 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~---  255 (398)
                      |||++||++..+|...+.|++..++.++.+++.|++.||+.|+|||||||+|+||   |..|++||+|||++.....   
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999   9999999999999753210   


Q ss_pred             -------------------CC--------------------------cccccccCCcccCcccccc-cCCCcccHHHHHH
Q 015898          256 -------------------GQ--------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGV  289 (398)
Q Consensus       256 -------------------~~--------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~  289 (398)
                                         .+                          .....+|||.|+|||++.+ .|+..+|+|||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                               00                          0113589999999999996 5999999999999


Q ss_pred             HHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCCCCC
Q 015898          290 ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCHPWICENGVAP  366 (398)
Q Consensus       290 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eiL~hp~~~~~~~~~  366 (398)
                      ||||||.|.+||...++.+.+.++......+....-..+++++.|||.+||+ ||++|.   .++||.+||||++..|..
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~  455 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH  455 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence            9999999999999999999999999877444444445678999999999999 999998   589999999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 015898          367 DRSLDPAVLSRLKQ  380 (398)
Q Consensus       367 ~~~~~~~~~~~~~~  380 (398)
                      .+..+++|.|+++.
T Consensus       456 l~~~~apfvP~v~~  469 (550)
T KOG0605|consen  456 LREMPAPFVPQVNS  469 (550)
T ss_pred             hhcCCCCCCCCCCC
Confidence            99999999998764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-57  Score=413.05  Aligned_cols=260  Identities=26%  Similarity=0.361  Sum_probs=232.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-eEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-~~~l  177 (398)
                      .+.+..+.||+|+.|+||+|.++.+++.+|+|++...  .+++..+++.+|+++++... ||+||.+||.|...+ .++|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEe
Confidence            3466788999999999999999999999999999433  36777889999999999996 999999999999988 5999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||.+|+|.+++..-+.+++.....++.+++.||.|||+ .+||||||||+|||+   +..|.+||||||.+....+.
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence            99999999999999988999999999999999999999995 999999999999999   88999999999999887665


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-----ChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                       ...+++||..|||||.+.+ .|+.++||||||++++|+.+|+.||...     ...+++..|..+..+-...  ..+++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence             6688999999999999986 6999999999999999999999999764     5667777777754332222  14899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ++++||.+||++||.+|||++|+|+|||+++......
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v  346 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV  346 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence            9999999999999999999999999999998775554

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-56  Score=394.61  Aligned_cols=257  Identities=33%  Similarity=0.596  Sum_probs=242.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||+|.+++++.+|..+|+|++.+..+....+++...+|..+|+.+. ||.++++++.|.+.+.+||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEEE
Confidence            4889999999999999999999999999999999998888889999999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||++||.|+.++.+.++|++..++.++.+|+.||+|||+++|++|||||+|||+   |.+|++||.|||+|+.....  .
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--E
Confidence            999999999999999999999999999999999999999999999999999999   99999999999999987654  4


Q ss_pred             cccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      -+.||||.|+|||++. +.|+.++|.|||||++|||+.|.+||...+..+++++|..+.+.++.-    ++.+++|||.+
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~----fs~~~kdLl~~  274 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY----FSSDAKDLLKK  274 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc----cCHHHHHHHHH
Confidence            5789999999999998 469999999999999999999999999999999999999999998874    88999999999


Q ss_pred             hcccCCCCCC-----CHHHHhcCCCccCCCCCC
Q 015898          339 MLCSQPSERL-----TAHEVLCHPWICENGVAP  366 (398)
Q Consensus       339 ~L~~dP~~Rp-----s~~eiL~hp~~~~~~~~~  366 (398)
                      +|+.|-.+|.     -..+|..||||++..|..
T Consensus       275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             HHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            9999999994     567999999999866544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.5e-57  Score=403.66  Aligned_cols=260  Identities=26%  Similarity=0.476  Sum_probs=226.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|+...++|+|+||+||+|+++.+|+.||||.+.... .++.-.+-.++||++|++|. |+|+|.++++|.....+++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            35888899999999999999999999999999996433 24555566889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~  256 (398)
                      +|||+. ++.+.|.+. ..++...+..+++|++.|+.|+|++++|||||||+|||+   ..++.+||||||+|+... ++
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence            999966 555666554 448999999999999999999999999999999999999   788899999999999887 77


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC--------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF--------------  320 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------  320 (398)
                      +.++.++.|++|+|||.+.+  +|+..+||||+||++.||++|.+.|.+....+.+..|.+.--.+              
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            88999999999999999986  59999999999999999999999999998888777665521111              


Q ss_pred             -----C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          321 -----E--------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       321 -----~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                           +        ...++.++.-+.||+++||+.||++|++..|+|.||||.++..
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence                 1        1123456788999999999999999999999999999976553

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=407.16  Aligned_cols=264  Identities=35%  Similarity=0.614  Sum_probs=240.6

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|.+.+.||.|+||+||+|+++.++..||||.+.+... .....+.+..||.+|+.|. |||||.++++++.++.+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEE
Confidence            34569999999999999999999999999999999987765 6777888999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC---ccEEEeecCCceec
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD---FSLKAIDFGLSVFF  253 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~---~~~kL~DFG~a~~~  253 (398)
                      +|||||.||+|.+++...+.+++..++.++.||+.||++||+++||||||||.|||+......   -.+||+|||+|+..
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999999999999999999999999999999999999999999999664222   68999999999999


Q ss_pred             CCCCcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .++....+.+|++.|||||++. .+|+.|+|+||+|+++|++++|+.||...+..+.+..+.++....+.. ...++...
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-~~~~s~~~  244 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-PAELSNPL  244 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-hhhccCch
Confidence            9998889999999999999996 679999999999999999999999999999999999887766443332 22456778


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .+|+...|..+|..|.+..+-+.|+++....
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8999999999999999999999999997765

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-56  Score=393.54  Aligned_cols=295  Identities=35%  Similarity=0.624  Sum_probs=263.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccC-----CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..|.-.+.||.|..++|-++.++.+|..+|+|++......     ..+..+.-.+|+.||+++.+||+|+.+.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            3466778999999999999999999999999998643221     12334567789999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+++|+|+|+.|.|+|+|...-.++++..+.|++|+++|++|||.++||||||||+|||+   +++..+||+|||+|+.+
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeecc
Confidence            999999999999999999998889999999999999999999999999999999999999   89999999999999999


Q ss_pred             CCCCcccccccCCcccCccccc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      ..++.....||||+|+|||.+.       ..|+...|+||.|||||.|+.|.+|||...+--++..|..+.+.|..+.|.
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa  253 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA  253 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence            9999999999999999999984       248899999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCH----HHHHHHHHHHHHHHHHHHHhhhcc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP----AVLSRLKQFSAMNKLKKMALRVSA  396 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  396 (398)
                      +++...+|||.+||+.||.+|+|++|+|+||||........+.+.|    +.+..-..+.++.+||-.++-|+|
T Consensus       254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP~~~~~~~k~qt~~~aRkrFk~ail~vra  327 (411)
T KOG0599|consen  254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSPVVEVELVKDQTSERARKRFKVAILTVRA  327 (411)
T ss_pred             hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCCCcchhhhhhhhhHHhhhheeeeeehHHH
Confidence            9999999999999999999999999999999998766666666665    333333456677777777776665

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-55  Score=426.23  Aligned_cols=263  Identities=37%  Similarity=0.639  Sum_probs=246.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+-|++++.||+|+-|.|-+|++..+|+.+|||++.+....+......+.+||-||+.|. |||++.+|++|++..++|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEE
Confidence            345999999999999999999999999999999998876556667788999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |.||++||.|++++...+++++.+++++++||+.|+.|||..+|+||||||+|+|+   |..+.+||+|||+|..-.++.
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCc
Confidence            99999999999999999999999999999999999999999999999999999999   888889999999999988888


Q ss_pred             cccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ...+.||+|+|.|||++.+.  -+.++||||.|||||.||+|.+||.+.+...++.++.+|.+..+.    .++.++++|
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdL  242 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDL  242 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHH
Confidence            88999999999999999974  468999999999999999999999999999999999999988774    589999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENGVAPDR  368 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~  368 (398)
                      |.+||..||++|+|++||++|||+.+..-.++.
T Consensus       243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            999999999999999999999999997655544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-56  Score=416.71  Aligned_cols=266  Identities=31%  Similarity=0.456  Sum_probs=230.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-eE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CV  175 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-~~  175 (398)
                      +-++|.+.++||.|.||.||+|+.+.+|..||||.++++. .+.++. .-.||++.|++|..||||+++.+++.+.+ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            5578999999999999999999999999999999997543 343333 34579999999988999999999998888 99


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |+|||||+ .+|+++++.+ +.|++..++.|++||+.||+|+|++|++|||+||+|||+   .....+||+|||+|+.+.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccc
Confidence            99999995 5999999765 459999999999999999999999999999999999999   556689999999999999


Q ss_pred             CCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC----------
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES----------  322 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------  322 (398)
                      ....++.++.|++|+|||+++.  .|+.+.||||+|||++|+.+-++.|.|.+..+.+.+|..-......          
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            8889999999999999999984  5999999999999999999999999999888877777541111111          


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 015898          323 ----------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR  368 (398)
Q Consensus       323 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~  368 (398)
                                      ...+.++.++.++|.+||.|||++||||.++|+||||+........
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~  303 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSS  303 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccccc
Confidence                            1123478899999999999999999999999999999886654433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-54  Score=415.25  Aligned_cols=258  Identities=42%  Similarity=0.704  Sum_probs=236.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH--hhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.|.+++.||+|+||+|+.|.+..++..||+|++.++.....  ...+.+.+|+.+++.+..||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34569999999999999999999999999999998776533211  3456777999999999889999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC-ccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~-~~~kL~DFG~a~~~  253 (398)
                      +|+||||+.||+|++++...+++.+..++.+++|++.|++|||++||+||||||+|||+   +.+ +.+||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999   777 99999999999988


Q ss_pred             -CCCCcccccccCCcccCcccccc-c-C-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC-
Q 015898          254 -KPGQIFTDVVGSPYYVAPEVLLK-H-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI-  328 (398)
Q Consensus       254 -~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  328 (398)
                       ..+......+||+.|+|||++.+ . | +.++||||+||+||.|++|..||.+.+...++..+.++.+.++..    + 
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~  247 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LL  247 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cC
Confidence             46677889999999999999985 3 5 478999999999999999999999999999999999998887764    4 


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      ++++++|+.+||..||.+|+|+.+|+.||||+.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999999997

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-54  Score=393.61  Aligned_cols=269  Identities=30%  Similarity=0.481  Sum_probs=232.9

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec---
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~---  171 (398)
                      ..+...|...+.||.|+||.|+.|.++.+|+.||||.+. ..+.+....++..+|+++|++++ |+||+.+++++..   
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-NPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR   95 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhh-hhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence            345556777899999999999999999999999999985 34557778899999999999998 9999999999865   


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                        -+.+|+|+|+| +.+|...++.+..+++..+..+++||++||+|+|+.+|+||||||.|+|+   +.+..+||||||+
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGL  171 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccc
Confidence              45699999999 56888888877779999999999999999999999999999999999999   8888899999999


Q ss_pred             ceecCC---CCcccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-----
Q 015898          250 SVFFKP---GQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----  319 (398)
Q Consensus       250 a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----  319 (398)
                      |+....   ....+.++.|++|+|||++.  ..|+.+.||||.||||+||++|++.|.+.+..+.+..+..-...     
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            998753   45568899999999999987  36999999999999999999999999888877666655441111     


Q ss_pred             ------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          320 ------------------FE----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       320 ------------------~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                                        .+    ...++..++.++||+++||.+||.+|+|++|+|+||||..+..+.++.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                              11    112457889999999999999999999999999999999988776666

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-54  Score=419.33  Aligned_cols=275  Identities=29%  Similarity=0.495  Sum_probs=251.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.++||+|+||+|+++..+.+++.+|||++++..+...++++..+.|..|+....+||.+++++..|+...++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            45999999999999999999999999999999999999999999999999999999988899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||+.||++. ++.+.+.|++..++.++..|+.||.|||++||||||||.+|||+   |.+|++||+|||+++... .+.
T Consensus       448 mey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCCC
Confidence            9999999953 45555779999999999999999999999999999999999999   999999999999998754 456


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ...++||||.|||||++.+ .|+.++|.|||||+|||||.|..||.+.+..++++.|......++.    .++.++++++
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il  599 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIM  599 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHH
Confidence            7788999999999999986 5999999999999999999999999999999999999998877775    4899999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCCccCCCC--CCCCCCCHHHHHHHHHH
Q 015898          337 RKMLCSQPSERLT-----AHEVLCHPWICENGV--APDRSLDPAVLSRLKQF  381 (398)
Q Consensus       337 ~~~L~~dP~~Rps-----~~eiL~hp~~~~~~~--~~~~~~~~~~~~~~~~~  381 (398)
                      +++|..||++|.-     +++|..||||+.-.|  -......|++.|.++..
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~  651 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP  651 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence            9999999999984     589999999998554  44566778888877654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-53  Score=397.84  Aligned_cols=258  Identities=29%  Similarity=0.460  Sum_probs=226.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~  175 (398)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|.+..... .........+||.||++|. ||||++|.+...+.  +.+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceE
Confidence            4669999999999999999999999999999999976543 4455677889999999997 99999999988765  789


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||+|||+. +|..++... -.|++.++..+++||+.||+|||++||+|||||.+||||   |.+|.+||+|||+|+++.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence            999999965 787777553 369999999999999999999999999999999999999   999999999999999776


Q ss_pred             CCC--cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC-----
Q 015898          255 PGQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW-----  325 (398)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  325 (398)
                      ...  .++..+.|.+|+|||.+++  .|+.++|+||.||||.||++|++.|.+.+..+.+..|.+-.-....+.|     
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            543  5788899999999999996  5999999999999999999999999999999988888763332222222     


Q ss_pred             --------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          326 --------------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       326 --------------------~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                                          ..++..+.+|+..||+.||++|.||.++|+|+||..
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                                236788999999999999999999999999999943

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-52  Score=385.12  Aligned_cols=277  Identities=32%  Similarity=0.490  Sum_probs=251.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||.|.-|+||+|....++..+|+|++.+..........++..|.+||..+. ||.++.||..|+.+...|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence            45899999999999999999999999999999999988878888889999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-
Q 015898          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-  255 (398)
                      ||||+||+|..++++.  +.|++..++.++..++.||+|||-.|||+|||||+||||   .++|++.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence            9999999998877654  459999999999999999999999999999999999999   8999999999998542210 


Q ss_pred             ----------------------------------C----------------------CcccccccCCcccCcccccc-cC
Q 015898          256 ----------------------------------G----------------------QIFTDVVGSPYYVAPEVLLK-HY  278 (398)
Q Consensus       256 ----------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~-~~  278 (398)
                                                        .                      .....++||-.|+|||++.+ ..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                              0                      01124689999999999996 48


Q ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHh
Q 015898          279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT----AHEVL  354 (398)
Q Consensus       279 ~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eiL  354 (398)
                      +.++|+|+|||++|||+.|..||.+.+..+.+..+......|+..+  .++..++|||+++|.+||.+|..    +.||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999999888775  68899999999999999999998    99999


Q ss_pred             cCCCccCCCCCCCCCCCHHHHHHHHHH
Q 015898          355 CHPWICENGVAPDRSLDPAVLSRLKQF  381 (398)
Q Consensus       355 ~hp~~~~~~~~~~~~~~~~~~~~~~~~  381 (398)
                      +||||++..|...+...||.+|.....
T Consensus       391 ~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  391 RHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             cCccccCCChhheeccCCCcCCCcccc
Confidence            999999999999999999998876554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-52  Score=366.83  Aligned_cols=259  Identities=31%  Similarity=0.491  Sum_probs=225.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|...++||+|.||.||+|.+..+|+.||||.+......+ .......+||+.|+.+. |+||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            46888999999999999999999999999999997664322 22346789999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      +||++ .+|+..++.. ..++..++..++.+++.||+|||++.|+||||||.|+|+   +++|.+||+|||+|+.+... 
T Consensus        80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            99995 4898888654 458999999999999999999999999999999999999   88999999999999987654 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC--------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP--------  326 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  326 (398)
                      ...+..+.|++|+|||.+.+  .|+...||||.|||++||+.|.+.|.+.+.-+.+..+...--....+.|+        
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            34445588999999999985  59999999999999999999999999999988888887644333333332        


Q ss_pred             ----------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          327 ----------------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       327 ----------------~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                      .++.++.||+.+||..||.+|+|+.|+|+|+||....
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                            3567889999999999999999999999999998743

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.3e-53  Score=401.04  Aligned_cols=255  Identities=31%  Similarity=0.546  Sum_probs=236.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... ....++.+.+|++|++.|+ ||||+.++++|+...++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            358899999999999999999999999999999987654 5556788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      .||+.| +|+.++...+.++++.+..++.+++.||.|||+++|+|||+||.|||+   +..+.+|+||||+|+....+. 
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999976 999999999999999999999999999999999999999999999999   899999999999999876654 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ..+...|||.|||||.+.+ .|+..+|+||+||++||+++|++||+.....+..+.|......++.    ..+..++.||
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence            4567889999999999986 5999999999999999999999999999999999999888776665    5889999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.+|.+||.+|+|-.+++.|||.++..
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhh
Confidence            999999999999999999999999854

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-51  Score=382.15  Aligned_cols=263  Identities=34%  Similarity=0.600  Sum_probs=230.1

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC-----------HhhHHHHHHHHHHHHHhcCCCCeeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----------REDVEDVRREIQIMHHLAGHKNIVTI  165 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~~h~niv~l  165 (398)
                      .-+.|++++.||+|.||.|-+|++..+++.||||++.+.....           ...++++.+||.||++|. |||||+|
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence            3456999999999999999999999999999999997754421           122568999999999998 9999999


Q ss_pred             eEEEec--CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          166 KGAYED--SLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       166 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                      +++..+  .+.+|||+|||..|.+. +....+. +++.+++.++++++.||+|||.+|||||||||+|+|+   +++|++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~V  249 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTV  249 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcE
Confidence            999864  56799999999998884 3444455 9999999999999999999999999999999999999   888999


Q ss_pred             EEeecCCceecC------CCCcccccccCCcccCcccccc---c--CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHH
Q 015898          243 KAIDFGLSVFFK------PGQIFTDVVGSPYYVAPEVLLK---H--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFD  311 (398)
Q Consensus       243 kL~DFG~a~~~~------~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~  311 (398)
                      ||+|||.+....      ........+|||.|+|||...+   .  -+.+.||||+||+||.|+.|..||.+....+.++
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            999999998662      2234455799999999998864   2  4578999999999999999999999999999999


Q ss_pred             HHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      +|.+..+.|+..+  .+.+.++|||.+||++||++|++..+|..|||.......+
T Consensus       330 KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  330 KIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             HHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            9999998888764  5789999999999999999999999999999998876555

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-51  Score=372.01  Aligned_cols=260  Identities=27%  Similarity=0.373  Sum_probs=222.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~  175 (398)
                      .+.|+....|++|+||.||+|+++.+++.||+|.++...... -.--.-.+||.+|.+++ |||||.+-.+...  -+.+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence            355999999999999999999999999999999998765211 11224678999999998 9999999998764  4579


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||||||+. +|...+..-+ +|...++..++.|++.||+|||++.|+||||||+|+|+   ...|.+||+|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhc
Confidence            999999976 8888887654 79999999999999999999999999999999999999   888999999999999876


Q ss_pred             CC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC-----
Q 015898          255 PG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-----  326 (398)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  326 (398)
                      .. ..++..+.|.+|+|||.+.+  .|+.+.|+||+||||.||+++++.|.+....+.++.|.+-.-......|+     
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            55 45788899999999999985  59999999999999999999999999999988888886622221111111     


Q ss_pred             -----------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          327 -----------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       327 -----------------------~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                             .+++...+|+..+|..||.+|+||.|+|+|+||.+..
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                                   1458899999999999999999999999999999843

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=383.35  Aligned_cols=256  Identities=34%  Similarity=0.510  Sum_probs=217.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC--eEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--CVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~--~~~l  177 (398)
                      .|...+.||+|+||.||++.+..+|...|||.+...   +....+.+.+|+.+|.+|+ |||||+++|......  .+++
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEe
Confidence            377889999999999999999999999999998654   2222778999999999998 999999999754443  6999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DFG~a~~~~~  255 (398)
                      .|||+++|+|.+++...+ .+++..++.+++||+.||+|||++|||||||||+|||+   +. ++.+||+|||++.....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccccc
Confidence            999999999999999877 79999999999999999999999999999999999999   66 68999999999987653


Q ss_pred             ----CCcccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          256 ----GQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       256 ----~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                          ........||+.|||||++...  ...++|||||||++.||+||..||.. ......+-.+...... + .....+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~-P-~ip~~l  248 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL-P-EIPDSL  248 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC-C-CCCccc
Confidence                1224468999999999999843  23499999999999999999999987 3444444444433311 1 333458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      +.++++||.+|+..||++||||.++|.|||......
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            999999999999999999999999999999988665

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-53  Score=373.18  Aligned_cols=244  Identities=28%  Similarity=0.496  Sum_probs=217.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeE-EEecCCe-EEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKG-AYEDSLC-VHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~-~~~~~~~-~~l  177 (398)
                      .|++.++||.|+||+||++.+..+|..||.|.+.-. ..+....+.+..|+.+|++|. |||||++++ .|.+++. ++|
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhHH
Confidence            499999999999999999999999999999999743 346677788999999999998 999999998 5555555 999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHS--LG--VMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~--~~--iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      |||||.+|+|...++.    .+.+++..+++++.|++.||..||+  ..  |+||||||.||++   +.+|.+||+|||+
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGL  174 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchh
Confidence            9999999999988854    3569999999999999999999999  45  9999999999999   8899999999999


Q ss_pred             ceecCCCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          250 SVFFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       250 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ++.+.... ...+.+|||.||+||.+.+ .|+.++||||+||++|||+.-..||.+.+..++-.+|.++..+..+  ...
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~~  252 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DEH  252 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HHH
Confidence            99987664 3457899999999999985 6999999999999999999999999999999999999998654322  124


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTA  350 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~  350 (398)
                      .|.++..||.-|+..||+.||+.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            78999999999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.1e-51  Score=390.11  Aligned_cols=255  Identities=32%  Similarity=0.584  Sum_probs=228.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+..|+|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence            45999999999999999999999999999999997654444455678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc-
Confidence            9999999999999988889999999999999999999999999999999999999   888999999999998764432 


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                       ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..+...++.    .++..+.+||.
T Consensus       173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  247 (329)
T PTZ00263        173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVK  247 (329)
T ss_pred             -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHH
Confidence             34679999999999875 5899999999999999999999999988888888888777655443    37889999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      +||+.||.+||+     +++++.||||.+..
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            999999999997     79999999998743

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-52  Score=359.98  Aligned_cols=255  Identities=35%  Similarity=0.609  Sum_probs=236.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++++.||+|-||.||+|..+.++-.||+|++-+..+.......++.+|++|-..|+ ||||+++|++|.+....|++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence            45999999999999999999999999999999998877666666778999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||..+|+|+..|.  ...++++.....+++|++.||.|+|..++|||||||+|+|+   +..+.+||+|||.+.... .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-C
Confidence            99999999999998  56779999999999999999999999999999999999999   778899999999998765 4


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ......|||..|.+||...+ .++..+|+|++|++.||++.|.+||......+.++.+.+-.+.++.    .++.++.||
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhHHHH
Confidence            44577999999999999986 5999999999999999999999999999999999999998888774    589999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      |.+||..+|.+|.+..|++.|||+...
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-51  Score=383.75  Aligned_cols=255  Identities=29%  Similarity=0.508  Sum_probs=227.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence            5899999999999999999999999999999997544334445667889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--c
Confidence            999999999999888889999999999999999999999999999999999999   78889999999999865432  2


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..+...++.    .++..+++||++
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~  231 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKK  231 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHH
Confidence            34678999999999875 5899999999999999999999999998888888888877665543    368899999999


Q ss_pred             hcccCCCCCCC-----HHHHhcCCCccCCCC
Q 015898          339 MLCSQPSERLT-----AHEVLCHPWICENGV  364 (398)
Q Consensus       339 ~L~~dP~~Rps-----~~eiL~hp~~~~~~~  364 (398)
                      ||+.||.+||+     +.|+++||||....+
T Consensus       232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            99999999995     999999999986543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.8e-51  Score=388.54  Aligned_cols=250  Identities=33%  Similarity=0.546  Sum_probs=223.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997655445556677889999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~~  263 (398)
                      ++|.+++...+.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   888899999999987532 223344578


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++.    .+++++.+||.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence            9999999999975 5899999999999999999999999988888888887776655443    4789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCCccCC
Q 015898          343 QPSERL-----TAHEVLCHPWICEN  362 (398)
Q Consensus       343 dP~~Rp-----s~~eiL~hp~~~~~  362 (398)
                      ||++||     ++.++++||||.+.
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     89999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-51  Score=397.75  Aligned_cols=261  Identities=29%  Similarity=0.546  Sum_probs=226.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence            5899999999999999999999999999999997654444555677889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccccc
Confidence            999999999999888889999999999999999999999999999999999999   888999999999987543211  


Q ss_pred             -------------------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCC
Q 015898          258 -------------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP  299 (398)
Q Consensus       258 -------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~  299 (398)
                                                           .....+||+.|+|||++.+ .++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0113469999999999875 58999999999999999999999


Q ss_pred             CCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCCC
Q 015898          300 PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT---AHEVLCHPWICENGVA  365 (398)
Q Consensus       300 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eiL~hp~~~~~~~~  365 (398)
                      ||...........+......+.......+++++.+||.+||. +|.+|++   +.|+|.||||++..+.
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            999888887777776644333333333578999999999997 9999998   9999999999886543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=393.45  Aligned_cols=259  Identities=31%  Similarity=0.494  Sum_probs=226.5

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +....|...++||+|+.|.||.|....+++.||||.+.....   ...+-+.+|+.+|+.++ |+|||++++.|-.++.+
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhcc-chHHHHHHHHhccccee
Confidence            345679999999999999999999999999999999976543   33456889999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |+||||++||+|.|.+... .+++.++..|++.++.||+|||.+||||||||.+|||+   +.+|.+||+|||++..+..
T Consensus       346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecccc
Confidence            9999999999998877654 48999999999999999999999999999999999999   7788899999999987765


Q ss_pred             CC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. .....+|||+|||||++.. .|+++.||||||++++||+-|++||..+++...+..|..... ........+|++++
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk~~~klS~~~k  500 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLKNPEKLSPELK  500 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcCCccccCHHHH
Confidence            54 4567899999999999984 699999999999999999999999987776666655544322 23333457999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |||.+||+.|+++|+++.|+|+||||+.+.
T Consensus       501 dFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  501 DFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            999999999999999999999999995544

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.3e-50  Score=391.00  Aligned_cols=261  Identities=30%  Similarity=0.506  Sum_probs=224.2

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.++..+. |+||+++++.+.+...+|+||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEEE
Confidence            5899999999999999999999999999999997654444555678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   788999999999987543210  


Q ss_pred             ----------------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCC
Q 015898          258 ----------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW  302 (398)
Q Consensus       258 ----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~  302 (398)
                                                        .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              0124579999999999875 58999999999999999999999999


Q ss_pred             CcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCCCccCCCCC
Q 015898          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS---ERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~Rps~~eiL~hp~~~~~~~~  365 (398)
                      +....+.+..+..............+++++++||.+|++ +|.   .||+++||++||||++..+.
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            988888888877643332222223478999999999876 444   46899999999999886543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.7e-50  Score=377.69  Aligned_cols=259  Identities=29%  Similarity=0.445  Sum_probs=218.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++++. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            778899999999999999999999999999987654433444456789999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.||+||||||+|||+   ++++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998877543  358999999999999999999999999999999999999   7888999999999987655555


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..............++.++.+||.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            556789999999999975 6999999999999999999999999876543322222221111122223357899999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      +||+.||++||+     ++++++||||.+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999999997     89999999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-51  Score=376.37  Aligned_cols=259  Identities=38%  Similarity=0.636  Sum_probs=244.2

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..+.+-+|++.+.||+|.||+|-+|.+...|+.||||.+.+.++.+..+.-.+.+||+||..|. ||||+.++++|+..+
T Consensus        48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkd  126 (668)
T KOG0611|consen   48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKD  126 (668)
T ss_pred             ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCc
Confidence            3456678999999999999999999999999999999999999999999999999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+.|||||..+|.|+|++.+++.+++.+++.+++||..|+.|||+++++|||||.+|||+   |.++++||+|||++..+
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLY  203 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999   99999999999999999


Q ss_pred             CCCCcccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ..+....++||+|-|.+||++++.  -++.+|.|||||+||.|..|..||.+.+...+..+|..+.+..+.     -+..
T Consensus       204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSd  278 (668)
T KOG0611|consen  204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSD  278 (668)
T ss_pred             ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCch
Confidence            999999999999999999999974  468999999999999999999999999999999999998776554     3567


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      +.-||+.||..||++|.|+.||-.|=|+.=
T Consensus       279 A~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  279 ASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            899999999999999999999999988743

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-50  Score=388.95  Aligned_cols=259  Identities=31%  Similarity=0.461  Sum_probs=227.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..+. ||||+++++++...+..|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence            5999999999999999999999999999999997654434445677889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.....  ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--cc
Confidence            999999999999888889999999999999999999999999999999999999   8888999999999976543  33


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC----CCCCHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW----PLISDSAKD  334 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  334 (398)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..||...+..+.+..+............    ..++.++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            45689999999999875 5899999999999999999999999988887777766553322211111    246899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ||.+||..+|++||++.++++||||.+..+
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            999999999999999999999999998543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=374.00  Aligned_cols=260  Identities=31%  Similarity=0.451  Sum_probs=228.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++..+||.|.-++||+|+...+++.||||++.-+++.+  ..+.+.+|+..|+.+. ||||++++..|..+..+|+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEE
Confidence            345999999999999999999999999999999998776533  3889999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||.||.+|++++++...  ..+.+..+..|+++++.||.|||.+|.||||||+.||||   +++|.|||+|||.+..+-.
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence            99999999999999763  349999999999999999999999999999999999999   9999999999998655432


Q ss_pred             -CC----cccccccCCcccCccccc---ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC------C
Q 015898          256 -GQ----IFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF------E  321 (398)
Q Consensus       256 -~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------~  321 (398)
                       +.    .+..++||+.|||||+++   ..|+.|+||||||++..||.+|..||....+-+++-..+++....      .
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence             21    125679999999999976   359999999999999999999999999888888777777766542      2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .+.....+..++.+|..||+.||.+|||+.++|+|+||+...
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            233345678899999999999999999999999999998754

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-50  Score=395.53  Aligned_cols=272  Identities=28%  Similarity=0.502  Sum_probs=226.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEEE
Confidence            5899999999999999999999999999999987654444556678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||+++|+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   788899999999986321100  


Q ss_pred             ----------------------------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHH
Q 015898          258 ----------------------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVI  290 (398)
Q Consensus       258 ----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~i  290 (398)
                                                                    .....+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012469999999999875 58999999999999


Q ss_pred             HHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCCCCCCC
Q 015898          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER---LTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       291 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---ps~~eiL~hp~~~~~~~~~~  367 (398)
                      +|||++|..||......+.+..+..............++.++.+||.+||. +|.+|   +++.|++.||||.+..+...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~  316 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTI  316 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            999999999999888777777776533222222223578999999999998 66665   59999999999987654333


Q ss_pred             CCCCHHHHH
Q 015898          368 RSLDPAVLS  376 (398)
Q Consensus       368 ~~~~~~~~~  376 (398)
                      ....+++.+
T Consensus       317 ~~~~~~~~~  325 (377)
T cd05629         317 RQIRAPFIP  325 (377)
T ss_pred             ccCCCCccc
Confidence            333333333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.8e-50  Score=385.68  Aligned_cols=255  Identities=33%  Similarity=0.572  Sum_probs=227.4

Q ss_pred             ccceecceecccCceEEEEEEEccCC-cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      +.|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEE
Confidence            45999999999999999999876655 689999997655444556678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++|+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC-
Confidence            99999999999999888889999999999999999999999999999999999999   88899999999999875432 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                       .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+.......+..+...++.    .+++++.++|
T Consensus       185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  259 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLM  259 (340)
T ss_pred             -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHH
Confidence             245689999999999875 5899999999999999999999999998888888888877665543    4789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ++||+.||++|+     +++++++||||.+..
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            999999999995     899999999998754

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6e-50  Score=390.40  Aligned_cols=263  Identities=29%  Similarity=0.439  Sum_probs=222.0

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-----CCeeEEeE
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-----KNIVTIKG  167 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-----~niv~l~~  167 (398)
                      ..+.+..+|.+.+.||+|+||.|.+|.+..+++.||||+++..    .....+...|+.+|..|+.|     -|+|++++
T Consensus       180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            3445556899999999999999999999999999999999764    45567788899999999843     48999999


Q ss_pred             EEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          168 AYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       168 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      +|...+++|||+|++ ..+|+++++.++  .|+...++.++.||+.||.+||+.||||+||||+||||..... ..+||+
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVI  333 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVI  333 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEE
Confidence            999999999999999 569999998865  4889999999999999999999999999999999999965443 489999


Q ss_pred             ecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC-------
Q 015898          246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-------  317 (398)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-------  317 (398)
                      |||+|+..... .+ .++.++.|+|||++++ .|+.+.||||||||++||++|.+.|.+.+..+.+..|..-.       
T Consensus       334 DFGSSc~~~q~-vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  334 DFGSSCFESQR-VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             ecccccccCCc-ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99999875543 23 7889999999999997 69999999999999999999999999988888777765400       


Q ss_pred             --------CcCCC-----------C---------------------CCC------------CCCHHHHHHHHHhcccCCC
Q 015898          318 --------IDFES-----------D---------------------PWP------------LISDSAKDLIRKMLCSQPS  345 (398)
Q Consensus       318 --------~~~~~-----------~---------------------~~~------------~~~~~~~~li~~~L~~dP~  345 (398)
                              ..+..           .                     ..+            .-...+.|||++||.+||.
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence                    00000           0                     000            1124679999999999999


Q ss_pred             CCCCHHHHhcCCCccCCC
Q 015898          346 ERLTAHEVLCHPWICENG  363 (398)
Q Consensus       346 ~Rps~~eiL~hp~~~~~~  363 (398)
                      +|+|+.++|+||||.+..
T Consensus       492 ~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  492 ERITPAQALNHPFLTGTS  509 (586)
T ss_pred             hcCCHHHHhcCccccccc
Confidence            999999999999999544

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=392.16  Aligned_cols=273  Identities=33%  Similarity=0.583  Sum_probs=233.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEEE
Confidence            5999999999999999999999999999999997654444456678899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcc
Confidence            999999999999888889999999999999999999999999999999999999   888999999999987654332  


Q ss_pred             ----------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH
Q 015898          258 ----------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (398)
Q Consensus       258 ----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  308 (398)
                                                  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                        2234679999999999885 58999999999999999999999999888877


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCccCCCCCCCCCCCHHHHHH
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT-AHEVLCHPWICENGVAPDRSLDPAVLSR  377 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-~~eiL~hp~~~~~~~~~~~~~~~~~~~~  377 (398)
                      ....+..............+++++.+||.+||. ||.+||+ +.++|+||||.+..+.......+++.+.
T Consensus       238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~~~~~~~~~~  306 (350)
T cd05573         238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPE  306 (350)
T ss_pred             HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence            777777632222222233478999999999997 9999999 9999999999986654444433444333

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-49  Score=379.34  Aligned_cols=249  Identities=31%  Similarity=0.553  Sum_probs=222.2

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++. ||||+++++++...+..|+||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999999999999999997655445566778889999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccccC
Q 015898          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGS  265 (398)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~gt  265 (398)
                      |.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......+||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   8888999999999875432 2233456799


Q ss_pred             CcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCC
Q 015898          266 PYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP  344 (398)
Q Consensus       266 ~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  344 (398)
                      +.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+......++.    .+++++.+||.+||+.||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcCCCH
Confidence            99999999875 5899999999999999999999999998888888888776655443    478999999999999999


Q ss_pred             CCCC---CHHHHhcCCCccCCC
Q 015898          345 SERL---TAHEVLCHPWICENG  363 (398)
Q Consensus       345 ~~Rp---s~~eiL~hp~~~~~~  363 (398)
                      ++||   ++.|+|.||||.+..
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCCC
Confidence            9997   579999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-51  Score=363.25  Aligned_cols=270  Identities=39%  Similarity=0.684  Sum_probs=241.3

Q ss_pred             ccccccee-cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe----
Q 015898           96 NIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----  170 (398)
Q Consensus        96 ~~~~~y~~-~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~----  170 (398)
                      .+.++|.+ -++||-|-.|.|..|.++.+++.+|+|++...        .+.++|+++--..++|||||.++++|+    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            34556777 46899999999999999999999999988532        456778887777778999999999986    


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      ...++.+|||.++||.|+..+..++.  |++.++..|++||..|+.|||+.+|.||||||+|+|++....+..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence            45679999999999999999988765  9999999999999999999999999999999999999888889999999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCC
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~  323 (398)
                      +|+.........+.+-||.|.|||++.. +|+..+|+||+||+||-|++|.+||+...    ..++...|..+.+.|+.+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            9998776677788899999999999984 69999999999999999999999998654    467889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHH
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA  373 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~  373 (398)
                      .|..+|+.++|+|+++|..+|.+|.|+++++.|||+.+....|.-.+.+.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~  339 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTS  339 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhh
Confidence            99999999999999999999999999999999999998776666554443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-49  Score=388.36  Aligned_cols=261  Identities=31%  Similarity=0.522  Sum_probs=222.2

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            4889999999999999999999999999999997665555666778999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC---
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~---  256 (398)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   78889999999987532100   


Q ss_pred             ---------------------------------------------CcccccccCCcccCcccccc-cCCCcccHHHHHHH
Q 015898          257 ---------------------------------------------QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVI  290 (398)
Q Consensus       257 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~i  290 (398)
                                                                   ......+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123579999999999875 58999999999999


Q ss_pred             HHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHhcCCCccCCCC
Q 015898          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS--QPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       291 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      +|||++|..||...........+..............+++++.+||.+||+.  +|..|+++.|+++||||.+..+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9999999999988777666666654332233333345789999999997655  4555999999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-49  Score=380.92  Aligned_cols=251  Identities=31%  Similarity=0.539  Sum_probs=222.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997655445566778899999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999   8888999999999875322 22334567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+......++.    .++.++.+||.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCC
Confidence            9999999999874 5899999999999999999999999988887777777666554443    4789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCCccCCC
Q 015898          343 QPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       343 dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ||++|+     ++.++++||||.+..
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999997     899999999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-51  Score=365.30  Aligned_cols=279  Identities=36%  Similarity=0.626  Sum_probs=244.7

Q ss_pred             ccccccee-cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           96 NIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        96 ~~~~~y~~-~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .|.+.|++ .+.||+|+++.|-.|....+|..+|||++.+.   ......++.+|++++.+.++|+||+.++++|+++..
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            45566777 57899999999999999999999999999765   455678899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +|||||-+.||+|..+|.++..|++.++..+.+.|+.||.+||.+||.||||||+|||....+.-..+|||||.++.-..
T Consensus       151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999766666789999999875443


Q ss_pred             CC--------CcccccccCCcccCccccc---c---cCCCcccHHHHHHHHHHHHhCCCCCCCc---------------C
Q 015898          255 PG--------QIFTDVVGSPYYVAPEVLL---K---HYGPEADVWTAGVILYILLSGVPPFWAE---------------T  305 (398)
Q Consensus       255 ~~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwSlG~il~elltg~~pf~~~---------------~  305 (398)
                      .+        ....+.+|+..|||||+..   +   .|+.++|.||||+|+|-|++|.+||.+.               .
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence            22        1234578899999999864   2   4999999999999999999999999553               2


Q ss_pred             hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHH
Q 015898          306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRL  378 (398)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~  378 (398)
                      +..+++.|..+.+.|+...|..+|.+++|||..+|..|+.+|.++.++++|||+.....+.-.. +|+++.+.
T Consensus       311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp-tp~v~~r~  382 (463)
T KOG0607|consen  311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP-TPQVLQRN  382 (463)
T ss_pred             HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC-CCcccccC
Confidence            4678999999999999999999999999999999999999999999999999998876554333 33444443

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-49  Score=379.04  Aligned_cols=252  Identities=31%  Similarity=0.537  Sum_probs=223.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.++.+++.||||++.+.........+.+..|+.++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654434455677888999998876799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~~  263 (398)
                      ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   888899999999987532 223334567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+......++.    .++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccc
Confidence            9999999999875 5899999999999999999999999999888888888876655443    4789999999999999


Q ss_pred             CCCCCCCH------HHHhcCCCccCCC
Q 015898          343 QPSERLTA------HEVLCHPWICENG  363 (398)
Q Consensus       343 dP~~Rps~------~eiL~hp~~~~~~  363 (398)
                      ||++||++      ++++.||||.+..
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99999998      9999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-49  Score=379.44  Aligned_cols=251  Identities=33%  Similarity=0.548  Sum_probs=222.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.+. ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999997655445556677889999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   7888999999999875322 22334567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++.    .+++++.+||.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence            9999999999874 5899999999999999999999999988888877777766555443    4789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCCccCCC
Q 015898          343 QPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       343 dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ||++|+     ++.++++||||.+..
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999998     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.7e-50  Score=381.63  Aligned_cols=281  Identities=27%  Similarity=0.454  Sum_probs=232.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||+|+||.||+|.+..+|+.||+|++.+..............|..++..+.+||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997644323344566778888888765699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   8888999999999875322 22345577


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||.+.........+......++.    .++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccC
Confidence            9999999999985 5899999999999999999999999988888877777665443332    4789999999999999


Q ss_pred             CCCCCCCH-HHHhcCCCccCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHh
Q 015898          343 QPSERLTA-HEVLCHPWICENGVAP--DRSLDPAVLSRLKQFSAMNKLKKMAL  392 (398)
Q Consensus       343 dP~~Rps~-~eiL~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (398)
                      ||++||++ +++++||||+...+..  ...+.+++.++.+.......+.+..+
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFL  286 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence            99999998 5899999998864322  23344555566555555555544443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.6e-49  Score=377.11  Aligned_cols=257  Identities=27%  Similarity=0.458  Sum_probs=226.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..+..|++|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            38899999999999999999999999999999976544445566788899999999985667999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~  258 (398)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   788899999999986532 2233


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++.    .+++++.++|.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            345679999999999885 5899999999999999999999999998888888888776655443    47899999999


Q ss_pred             HhcccCCCCCCCH-----HHHhcCCCccCCC
Q 015898          338 KMLCSQPSERLTA-----HEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rps~-----~eiL~hp~~~~~~  363 (398)
                      +||+.||.+|++.     +++++||||....
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999986     8999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-49  Score=387.86  Aligned_cols=260  Identities=32%  Similarity=0.550  Sum_probs=224.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.++||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence            4889999999999999999999999999999997654444556778999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC---
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~---  256 (398)
                      ||+++|+|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   88899999999997532100   


Q ss_pred             ---------------------------------------------CcccccccCCcccCcccccc-cCCCcccHHHHHHH
Q 015898          257 ---------------------------------------------QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVI  290 (398)
Q Consensus       257 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~i  290 (398)
                                                                   ......+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00123579999999999875 59999999999999


Q ss_pred             HHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCC
Q 015898          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT---AHEVLCHPWICENGV  364 (398)
Q Consensus       291 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eiL~hp~~~~~~~  364 (398)
                      +|||++|..||...+..+....+..............+++++.++|.+|+ .+|.+|++   +.++++||||++..+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            99999999999988877776666654433333334568899999999986 59999997   999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-49  Score=377.33  Aligned_cols=252  Identities=28%  Similarity=0.506  Sum_probs=223.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997654444556677888999998876799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      ++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   8889999999999875432 23344567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+......++.    .++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence            9999999999875 5899999999999999999999999999988888888876654443    3789999999999999


Q ss_pred             CCCCCC-------CHHHHhcCCCccCCC
Q 015898          343 QPSERL-------TAHEVLCHPWICENG  363 (398)
Q Consensus       343 dP~~Rp-------s~~eiL~hp~~~~~~  363 (398)
                      ||++||       ++.++++||||....
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            999999       899999999997743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-49  Score=387.16  Aligned_cols=259  Identities=30%  Similarity=0.525  Sum_probs=222.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.+. |+||+++++.+.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence            4999999999999999999999999999999997554434445677889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC---
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~---  256 (398)
                      ||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|..+...   
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   88889999999997432100   


Q ss_pred             -----------------------------------------CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHH
Q 015898          257 -----------------------------------------QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYIL  294 (398)
Q Consensus       257 -----------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~el  294 (398)
                                                               ......+||+.|+|||++.+ .++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     00123579999999999975 589999999999999999


Q ss_pred             HhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCC
Q 015898          295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCHPWICENG  363 (398)
Q Consensus       295 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eiL~hp~~~~~~  363 (398)
                      ++|..||.+....+....+..............+++++.++|.+|+ .+|.+|+   ++.++++||||++..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            9999999988877766666554433333334468899999999987 5999999   999999999998743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.8e-50  Score=383.30  Aligned_cols=269  Identities=30%  Similarity=0.472  Sum_probs=229.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. |+||+++++++.+.+..|+||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEEE
Confidence            5899999999999999999999999999999997655444556677889999999887 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCc
Confidence            999999999999775 679999999999999999999999999999999999999   8889999999999987654332


Q ss_pred             --ccccccCCcccCccccc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          259 --FTDVVGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       259 --~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                        .....||+.|+|||++.       ..++.++|||||||++|+|++|..||........+..+............+.++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence              23357899999999985       247889999999999999999999998888777777776644322222234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHH
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA  373 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~  373 (398)
                      .++.+||.+||+ ||++|||+.+++.||||.+..+.......++
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~~~  280 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPP  280 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCCCC
Confidence            999999999998 9999999999999999997654443333333

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.9e-49  Score=374.99  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=227.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+..|++|+.+++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            38889999999999999999999999999999976544444556677888899888877899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~  258 (398)
                      ||+++|+|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||+   ++++.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   8889999999999975432 223


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.........+......++.    .++.++.+|+.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence            345789999999999885 5899999999999999999999999998888888888877665543    47899999999


Q ss_pred             HhcccCCCCCCCH-----HHHhcCCCccCCC
Q 015898          338 KMLCSQPSERLTA-----HEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rps~-----~eiL~hp~~~~~~  363 (398)
                      +||+.||++|++.     .++++||||+...
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999984     8999999998644

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.9e-49  Score=369.24  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=212.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||.|+||.||+|.+..++..||+|++....  .......+.+|+.+++++. ||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            35999999999999999999999999999999986443  2223456778999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999975 8988886544 47899999999999999999999999999999999999   78889999999999764432 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc---------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------------  319 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------  319 (398)
                      .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+.+..+.+..+......               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22345678999999998864  4899999999999999999999999887766655544321110               


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 ----FES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 ----~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                          ++.       ...+.++.++++||.+||++||.+|||++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                000       1123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.5e-49  Score=382.31  Aligned_cols=260  Identities=32%  Similarity=0.502  Sum_probs=225.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEE
Confidence            46999999999999999999999999999999997544334445566889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++|+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCCc
Confidence            999999999988765 458999999999999999999999999999999999999   888999999999998754332 


Q ss_pred             -cccccccCCcccCcccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                       .....+||+.|+|||++.+     .++.++|||||||++|||++|..||.+......+..+..............++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence             2235679999999999863     3788999999999999999999999998888888888765433333333457899


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSE--RLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||..+|++  |+|++|+++||||++..
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            999999999999988  99999999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-49  Score=387.00  Aligned_cols=260  Identities=30%  Similarity=0.516  Sum_probs=224.0

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.............+..|+.++..+. ||+|+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence            5889999999999999999999999999999997654444556678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   888999999999986442110  


Q ss_pred             ----------------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCC
Q 015898          258 ----------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW  302 (398)
Q Consensus       258 ----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~  302 (398)
                                                        .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                              0123579999999999875 58999999999999999999999999


Q ss_pred             CcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCCC
Q 015898          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCHPWICENGV  364 (398)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eiL~hp~~~~~~~  364 (398)
                      .......+..+..............+++++++||.+|+ .||.+|+   ++.|+++||||++..+
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence            98888887777654322222222247899999999987 5999998   4799999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=373.75  Aligned_cols=246  Identities=30%  Similarity=0.405  Sum_probs=212.0

Q ss_pred             ceecceecccCceEEEEEEEccCCcE-EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-eEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIE-FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CVHIV  178 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-~~~lv  178 (398)
                      ..+.+.||.|+||+||+|.+  .|+. ||||++......... .+.+.+|+.+|.+|+ |||||+++|++.+.. .++||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEE
Confidence            44566799999999999985  5566 999999765543333 789999999999998 999999999999887 79999


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEeecCCCc-cEEEeecCCceecC
Q 015898          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLG-VMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFK  254 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~-iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~~  254 (398)
                      |||+++|+|.+++..  ...++...+..++.+|+.|++|||+.+ ||||||||+|||+   +.++ ++||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceeec
Confidence            999999999999988  578999999999999999999999999 9999999999999   8886 99999999998766


Q ss_pred             CC-CcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PG-QIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .. ...+...||+.|||||++.+   .|+.++||||||++||||+||..||.+....+....+..........  ..+++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCH
Confidence            54 34455789999999999984   49999999999999999999999999988866666665433322211  13789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+..|+..||+.||+.||++.+++.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999988764

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.8e-49  Score=377.87  Aligned_cols=251  Identities=32%  Similarity=0.541  Sum_probs=222.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+. ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997655445556677889999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~  262 (398)
                      ++|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   888899999999987532 22333456


Q ss_pred             ccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      .||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......++.    .+++++.+||.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence            79999999999874 5899999999999999999999999988887777777766555443    478999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCCccCCC
Q 015898          342 SQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       342 ~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      .||++|+     ++.++++||||.+..
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            9999997     999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.3e-49  Score=359.73  Aligned_cols=263  Identities=28%  Similarity=0.419  Sum_probs=223.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC-eeEEeEEEecCC----
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSL----  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n-iv~l~~~~~~~~----  173 (398)
                      ..|...++||+|+||+||+|+.+.+|+.||+|.+...... +-.-....+|+.+|+.|+ |+| |+.+++++...+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            3477888999999999999999999999999999754321 112345789999999998 999 999999998777    


Q ss_pred             --eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          174 --CVHIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       174 --~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                        .+++|+||+ .-+|..++....    .++...++.+++||+.||+|||+++|+||||||.|||+   ++.|.+||+||
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeecc
Confidence              899999999 458988887654    47788999999999999999999999999999999999   88999999999


Q ss_pred             CCceecC-CCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC
Q 015898          248 GLSVFFK-PGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       248 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (398)
                      |+|+... +...++..++|.+|+|||++.+  .|+...||||+|||++||++++..|.+....+.+..|.+-.-......
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9999776 4455788899999999999985  499999999999999999999999999988887777765322222222


Q ss_pred             CC--------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          325 WP--------------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       325 ~~--------------------------~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      |+                          ..+....+++.+||+.+|.+|.|++.+|.||||.+......
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence            22                          23358999999999999999999999999999988764443

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-48  Score=375.38  Aligned_cols=251  Identities=27%  Similarity=0.477  Sum_probs=215.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997655445556677889999999997799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec-CCCCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~-~~~~~~~~~~  263 (398)
                      ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++... .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   78889999999998752 2233345578


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---------ChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---------TQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...         ........+.......+    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            9999999999885 5899999999999999999999999531         11223444444444333    24789999


Q ss_pred             HHHHHhcccCCCCCCC------HHHHhcCCCccCC
Q 015898          334 DLIRKMLCSQPSERLT------AHEVLCHPWICEN  362 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps------~~eiL~hp~~~~~  362 (398)
                      ++|.+||+.||.+|++      +.++++||||...
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999999997      7899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.8e-49  Score=383.49  Aligned_cols=261  Identities=31%  Similarity=0.490  Sum_probs=223.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEE
Confidence            456999999999999999999999999999999997644434445567889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|.......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccCC
Confidence            99999999999988654 58999999999999999999999999999999999999   888999999999998764332


Q ss_pred             c--ccccccCCcccCcccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          258 I--FTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .  ....+||+.|+|||++.+     .++.++|||||||++|+|++|..||...+..+.+..+..............++.
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence            2  235679999999999863     278899999999999999999999998888888888876543333333345789


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 015898          331 SAKDLIRKMLCSQPSE--RLTAHEVLCHPWICENG  363 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~  363 (398)
                      .++++|.+||..++.+  |+++.|+++||||+...
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            9999999999865544  89999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-48  Score=372.86  Aligned_cols=252  Identities=29%  Similarity=0.528  Sum_probs=222.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||+||+|.+..+++.||||++.+...........+..|+.++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654444555677889999999886799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   ++++.+||+|||++..... .......+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   8888999999999875322 22334567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      |++.|+|||++.+ .++.++|||||||++|+|++|..||...........+......++.    .++.++.+||.+||+.
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccC
Confidence            8999999999975 5899999999999999999999999988888888877766554432    4789999999999999


Q ss_pred             CCCCCCCH-----HHHhcCCCccCCC
Q 015898          343 QPSERLTA-----HEVLCHPWICENG  363 (398)
Q Consensus       343 dP~~Rps~-----~eiL~hp~~~~~~  363 (398)
                      ||++|||+     .+++.||||....
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999     9999999998854

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-51  Score=379.06  Aligned_cols=273  Identities=26%  Similarity=0.414  Sum_probs=233.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|+..+.||+|+||.||+|.+..+++.||+|++....  ....++.+..|+.+|.++. ++||.++|+.|..+..+|++|
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHHH
Confidence            4777899999999999999999999999999997655  5566788999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc-
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-  258 (398)
                      |||.||++.+.+.....+.+..+..++++++.||.|||..+.+|||||+.|||+   ..+|.+||+|||.+........ 
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechhhc
Confidence            999999999999888878999999999999999999999999999999999999   6678999999999987765433 


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ..+++|||.|||||++.. .|+.++||||||++.+||++|.+||....+..++..|-+...+   .....+++.+++|+.
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP---~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP---RLDGDFSPPFKEFVE  244 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC---ccccccCHHHHHHHH
Confidence            367999999999999986 6999999999999999999999999887775444444333222   222268899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHH
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAM  384 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (398)
                      .||+.||+.||||.++|+|+|++... ....  =.....|.++|..+
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~a~-k~s~--L~~~i~r~~~~~~~  288 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKRAK-KTSE--LKELIDRYKRWRVK  288 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHhcC-CchH--HHHHHHHHHHHhhc
Confidence            99999999999999999999998822 2221  12555666666654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.9e-50  Score=365.72  Aligned_cols=255  Identities=30%  Similarity=0.441  Sum_probs=217.2

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-----Ce
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----LC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-----~~  174 (398)
                      .|.-.+++|.|+||.||.|....+++.||||.+-...-       --.+|+.+|+.+. |||||++..+|...     -+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhH
Confidence            37778999999999999999999999999998865432       2236999999887 99999999988532     24


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          175 VHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      ..+||||++ .+|+..+..    +..++...++-++.||++||.|||+.||+||||||.|||+.  .+.|.+||||||+|
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcc
Confidence            668999995 589888875    56789999999999999999999999999999999999993  34589999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC-----------
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-----------  317 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-----------  317 (398)
                      +....++...++..|+.|+|||.+.+  .|+.+.||||.||+++||+-|++.|.+.+..+.+..+.+--           
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            99998888889999999999999985  59999999999999999999999999998888877776510           


Q ss_pred             ---------CcCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          318 ---------IDFESD-----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       318 ---------~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                               ..+...     .....++++.+|+.++|..+|.+|.++.|+|.||||.+....
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                     001111     123468999999999999999999999999999999886544

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-48  Score=371.45  Aligned_cols=252  Identities=31%  Similarity=0.497  Sum_probs=218.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654334445566777888887665699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-Ccccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~  263 (398)
                      ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... ......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   78889999999999764322 3334567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999875 589999999999999999999999998888888877766543333    24789999999999999


Q ss_pred             CCCCCCCH-HHHhcCCCccCCC
Q 015898          343 QPSERLTA-HEVLCHPWICENG  363 (398)
Q Consensus       343 dP~~Rps~-~eiL~hp~~~~~~  363 (398)
                      ||++||++ .++++||||....
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             CHHHcCCChHHHHcCcccCCCC
Confidence            99999986 5889999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.8e-49  Score=374.69  Aligned_cols=253  Identities=28%  Similarity=0.463  Sum_probs=218.3

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+++.||||++................|..++..+.+||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654323344566777888888765699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      |+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999887789999999999999999999999999999999999999   7888999999999875322 22334567


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            9999999999875 589999999999999999999999998888777777765543332    24789999999999999


Q ss_pred             CCCCCCCHH-HHhcCCCccCCCC
Q 015898          343 QPSERLTAH-EVLCHPWICENGV  364 (398)
Q Consensus       343 dP~~Rps~~-eiL~hp~~~~~~~  364 (398)
                      ||++||++. ++++||||.+..+
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCCCH
Confidence            999999996 9999999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-48  Score=366.26  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=212.0

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence            59999999999999999999999999999999865432 3344567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||++++.+..+......+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence            999887665554445679999999999999999999999999999999999999   788899999999998754322  


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC------------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------------------  318 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------  318 (398)
                      ......|++.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+.....                  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            2334678999999999875 589999999999999999999999987665544333322100                  


Q ss_pred             -cCCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 -DFESD---------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 -~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                       .++..         ....++.++.+||.+||++||++|||++|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             00000         012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-48  Score=372.33  Aligned_cols=254  Identities=30%  Similarity=0.500  Sum_probs=220.3

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHH---HhcCCCCeeEEeEEEecCCeEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH---HLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~---~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      |++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++.   .+. ||||+++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEE
Confidence            678899999999999999999999999999997654434455667778877664   444 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-C
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-G  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~  256 (398)
                      ||||+++++|...+.. +.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..... .
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence            9999999999877754 569999999999999999999999999999999999999   8888999999999865322 2


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ......+|++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..+....+......++.    .++.++.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l  231 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISI  231 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence            23345789999999999875 5899999999999999999999999998888888888776655443    478999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      |.+||+.||++||     ++.++++||||++..
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            9999999999999     799999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4e-48  Score=367.04  Aligned_cols=258  Identities=26%  Similarity=0.379  Sum_probs=209.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.+. ||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc--ccccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence            56999999999999999999999999999999986543  2222346778999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+. ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||+   ++++.+||+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC
Confidence            99995 5787777654 568999999999999999999999999999999999999   78889999999998754322 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHcCCCc--------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHID--------------  319 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~--------------  319 (398)
                      .......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+... .+.+..+......              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            23345678999999999864  488999999999999999999999976433 2222222110000              


Q ss_pred             CCCCC--------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          320 FESDP--------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       320 ~~~~~--------------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +....              ....++++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            00000              002356889999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.2e-48  Score=372.10  Aligned_cols=252  Identities=26%  Similarity=0.464  Sum_probs=215.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998665445556677889999998886699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~~  263 (398)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999998888889999999999999999999999999999999999999   888999999999987532 223334568


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---------ChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---------TQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...         ........+......++    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            9999999999875 5899999999999999999999999521         12223444444444333    24789999


Q ss_pred             HHHHHhcccCCCCCCC------HHHHhcCCCccCCC
Q 015898          334 DLIRKMLCSQPSERLT------AHEVLCHPWICENG  363 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps------~~eiL~hp~~~~~~  363 (398)
                      +||.+||+.||++||+      +.++++||||.+..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            9999999999999998      57999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-49  Score=369.84  Aligned_cols=271  Identities=33%  Similarity=0.580  Sum_probs=245.4

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ...+.+.|.+.+.||+|-|+.|-+|++.-+|+.||||++.+.+. +......+..|+..|+..+ |||||++|++.....
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQT   90 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccc
Confidence            34577789999999999999999999999999999999988765 4444567889999999887 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .+|||+|+=.+|+|+++|.+. ..+.+..+.+++.||+.|+.|||+.++|||||||+||.+.  .+-|-+||.|||++..
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK  168 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence            999999999999999999764 4599999999999999999999999999999999999986  5568999999999999


Q ss_pred             cCCCCcccccccCCcccCccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          253 FKPGQIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      +.+++...+.||+..|-|||++++. | .+++||||||||||.|.+|++||...+..+.+-.|+.-++..+.    .++.
T Consensus       169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~  244 (864)
T KOG4717|consen  169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSK  244 (864)
T ss_pred             CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhH
Confidence            9999999999999999999999974 5 46899999999999999999999999999999999998887765    4899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCH
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP  372 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~  372 (398)
                      +++|||..||..||.+|.|.++|..|+|++.....+.-.++-
T Consensus       245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPL  286 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPL  286 (864)
T ss_pred             HHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCce
Confidence            999999999999999999999999999999877665544433

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-48  Score=374.06  Aligned_cols=257  Identities=31%  Similarity=0.533  Sum_probs=216.1

Q ss_pred             cceecceecccCceEEEEEEEc---cCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .|++.+.||+|+||.||+|.+.   .+++.||+|++.+.... .....+.+..|+.++..+.+|++|+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            3889999999999999998864   47899999998654322 2234567889999999997799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   7888999999999976433


Q ss_pred             CC--cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCCCCCC
Q 015898          256 GQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|||++|..||....    .......+......+    ...
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----PSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----CCC
Confidence            22  2335679999999999874  37889999999999999999999996432    233334444333222    235


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ++..+.++|.+||+.||++||     +++++++||||.+..
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            789999999999999999999     888999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.8e-48  Score=369.95  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=225.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+.+|++|+++++++...+.+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            77889999999999999999999999999999765443445567788899999988767889999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-Ccc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~~~  259 (398)
                      |+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... ...
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCccc
Confidence            99999999999888889999999999999999999999999999999999999   88889999999998754322 223


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++.    .++.++.+++.+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~  234 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG  234 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence            45679999999999874 5899999999999999999999999998888888888776655443    478999999999


Q ss_pred             hcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          339 MLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       339 ~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      ||+.||.+|++     ..++++||||....
T Consensus       235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         235 LMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            99999999997     47999999999854

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.7e-48  Score=371.71  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=212.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-----Ce
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----LC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-----~~  174 (398)
                      +|++.++||+|+||.||+|.+..++..||||.+.... .......++.+|+.+++.++ ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            4899999999999999999999999999999986432 23334567889999999997 99999999987543     35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            899999994 6899999888889999999999999999999999999999999999999   888999999999997543


Q ss_pred             CCC----cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHc------------
Q 015898          255 PGQ----IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK------------  315 (398)
Q Consensus       255 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~------------  315 (398)
                      ...    .....+||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+.........+..            
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    2245679999999998863   589999999999999999999999977654333222111            


Q ss_pred             ---------------CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          316 ---------------GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       316 ---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                     .........++.+++++.++|.+||+.||++|||+.|+|+||||++...
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                           0000011123456788999999999999999999999999999988554

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-48  Score=362.45  Aligned_cols=259  Identities=30%  Similarity=0.469  Sum_probs=218.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.++||+|+||.||++.+..+++.||+|++.............+.+|+.+++.+. ||||+++++.+...+.+++|||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEEe
Confidence            888999999999999999999999999999986544333334456788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCc
Confidence            99999998887653  358999999999999999999999999999999999999   7888999999999987655544


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+..............++..+.+||.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR  237 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence            455688999999999874 5889999999999999999999999876654433333222111122223357899999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      +||..||++||     +++++++||||.+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             HHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            99999999999     899999999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-48  Score=370.54  Aligned_cols=251  Identities=29%  Similarity=0.520  Sum_probs=217.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHH-HHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI-MHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      ++||+|+||+||+|.+..+|+.||+|++.+...........+..|..+ ++.+. ||||+++++++...+..|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999976544334444556666654 56676 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCccccc
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~  262 (398)
                      +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   888999999999987532 22334456


Q ss_pred             ccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      +||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+........    +.++.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            79999999999875 589999999999999999999999999888888888877655433    3478999999999999


Q ss_pred             cCCCCCCCH----HHHhcCCCccCCC
Q 015898          342 SQPSERLTA----HEVLCHPWICENG  363 (398)
Q Consensus       342 ~dP~~Rps~----~eiL~hp~~~~~~  363 (398)
                      .||.+||++    .++++||||....
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            999999998    6999999998744

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.6e-48  Score=368.55  Aligned_cols=251  Identities=33%  Similarity=0.576  Sum_probs=218.8

Q ss_pred             ceecccCceEEEEEEEc---cCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          105 RKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      +.||+|+||.||+|.+.   .+++.||+|++.+.... .......+.+|+.+++.+. ||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence            67999999999999864   47889999998754321 2233456788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~  259 (398)
                      |+++++|.+++...+.+.+..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence            99999999999888889999999999999999999999999999999999999   8889999999999875332 2233


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+..+...++.    .+++++.+||.+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            45679999999999875 5889999999999999999999999988888888888777655443    478999999999


Q ss_pred             hcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          339 MLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       339 ~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ||+.||++||     ++.+++.||||....
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999     899999999998643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-47  Score=381.66  Aligned_cols=262  Identities=26%  Similarity=0.360  Sum_probs=206.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc-----CCCCeeEEeEEE
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-----GHKNIVTIKGAY  169 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~niv~l~~~~  169 (398)
                      +...++|++.++||+|+||+||+|.+..+++.||||++...    .........|+.++..+.     +|.++++++++|
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            33457899999999999999999999999999999998542    122345566888877775     245689999988


Q ss_pred             ecC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecC----------
Q 015898          170 EDS-LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD----------  237 (398)
Q Consensus       170 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~----------  237 (398)
                      ... ..+++|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||+...+          
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            754 5789999998 77999999888889999999999999999999998 5999999999999994321          


Q ss_pred             ---CCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Q 015898          238 ---DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (398)
Q Consensus       238 ---~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~  313 (398)
                         +.+.+||+|||.+....  ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence               11259999999886432  23356789999999999985 5999999999999999999999999877665544443


Q ss_pred             HcCCCcCCC-------------------------C-----------CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          314 LKGHIDFES-------------------------D-----------PW--PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       314 ~~~~~~~~~-------------------------~-----------~~--~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+....++.                         .           ..  ...++.+.|||.+||++||++|||+.|+|+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            321110000                         0           00  011456789999999999999999999999


Q ss_pred             CCCccCCC
Q 015898          356 HPWICENG  363 (398)
Q Consensus       356 hp~~~~~~  363 (398)
                      ||||.+..
T Consensus       438 Hp~~~~~~  445 (467)
T PTZ00284        438 HPYVLKYY  445 (467)
T ss_pred             CccccccC
Confidence            99998854

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-47  Score=366.32  Aligned_cols=261  Identities=24%  Similarity=0.339  Sum_probs=219.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....  .....+.+.+|+.+++++. ||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            356999999999999999999999999999999986532  3455678999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+++++|.+++.....+++..+..++.+++.||.|||+. +|+||||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   77889999999998765432


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc----------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------------  319 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------  319 (398)
                       ......|++.|+|||++.+ .++.++|||||||++|||++|+.||......+....+......                
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             2345678999999999875 5899999999999999999999999765544432222110000                


Q ss_pred             ----------------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          320 ----------------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       320 ----------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                                  .+......+++++++||.+||++||++|||+.|+|+||||+.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  310 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE  310 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence                                        0000112367899999999999999999999999999999876544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-47  Score=374.16  Aligned_cols=260  Identities=31%  Similarity=0.471  Sum_probs=222.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997544434445566889999999987 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       122 ~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         122 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCc
Confidence            999999999988765 458999999999999999999999999999999999999   788999999999998764332 


Q ss_pred             -cccccccCCcccCcccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                       .....+||+.|+|||++..     .++.++|||||||++|||++|..||...+....+..+..............++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence             2235679999999999863     2788999999999999999999999998888888888765433333334468999


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSE--RLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||..++.+  |+++.|+++||||++..
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            999999999844433  78999999999998743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-47  Score=360.12  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=209.3

Q ss_pred             cceecceecccCceEEEEEEEcc-CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEe-----c
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYE-----D  171 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~-----~  171 (398)
                      +|++.+.||+|+||.||+|.+.. ++..||+|.+..... .......+.+|+.+++.+.  .||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            59999999999999999999854 468899999865432 2223345667888877764  4999999999885     3


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      ...+++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccc
Confidence            456899999996 5898888653  348999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------  322 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------  322 (398)
                      +.............||+.|+|||.+.+ .++.++|||||||++|||++|.+||.+....+.+..+.........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            987665544556778999999999874 5899999999999999999999999988777766666542111000      


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          323 -----------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       323 -----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                       ...+.++..+.+||.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             0113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-49  Score=353.64  Aligned_cols=260  Identities=32%  Similarity=0.546  Sum_probs=243.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      -++|...++||+|.||+|-+|+.+.+++.+|+|++++.-+.....+..-..|-++|+..+ ||.+..+...|+..+++|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence            356889999999999999999999999999999999998888888889999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee-cCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~-~~~~  256 (398)
                      ||||..||.|+.+|.+.+.|++...+.+...|+.||.|||+++||+||||.+|+|+   |.+|++||.|||+++. +..+
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc
Confidence            99999999999999999999999999999999999999999999999999999999   9999999999999964 3445


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      .....+||||.|+|||++.. .|+.+.|.|.+||+||||++|++||+..+...++..|.-..+.|+..    ++++++.|
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~----ls~eAktL  398 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT----LSPEAKTL  398 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc----CCHHHHHH
Confidence            66788999999999999985 69999999999999999999999999999999999999999988875    89999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCCccCCCCC
Q 015898          336 IRKMLCSQPSERL-----TAHEVLCHPWICENGVA  365 (398)
Q Consensus       336 i~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~~~  365 (398)
                      +..+|.+||.+|.     .+.||.+|+||....|.
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence            9999999999998     68999999999987653

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-48  Score=372.77  Aligned_cols=251  Identities=30%  Similarity=0.529  Sum_probs=218.4

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ||+|+||+||+|.+..+++.||||++.+..............|..++..+.  +||||+.+++++...+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997654434444556667777777654  699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~  263 (398)
                      ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   7888999999999875322 23334577


Q ss_pred             cCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          264 GSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       264 gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||......+.+..+..+...++..   .+++++.+||.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcC
Confidence            9999999999874  48999999999999999999999999988888888887776655433   478999999999999


Q ss_pred             cCCCCCC----CHHHHhcCCCccCCC
Q 015898          342 SQPSERL----TAHEVLCHPWICENG  363 (398)
Q Consensus       342 ~dP~~Rp----s~~eiL~hp~~~~~~  363 (398)
                      .||++||    ++.++++||||.+..
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCCC
Confidence            9999998    789999999998743

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-48  Score=369.19  Aligned_cols=261  Identities=28%  Similarity=0.519  Sum_probs=220.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++..+. |+||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence            35999999999999999999999999999999997544434455667889999999987 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999876 4569999999999999999999999999999999999999   788899999999987654432


Q ss_pred             c--ccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC-CCCCCCC
Q 015898          258 I--FTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-SDPWPLI  328 (398)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  328 (398)
                      .  .....||+.|+|||++.      +.++.++|||||||++|+|++|..||......+.+..+......+. ......+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            2  22356899999999986      2478899999999999999999999998887777777665432221 1122347


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 015898          329 SDSAKDLIRKMLCSQPSE--RLTAHEVLCHPWICENG  363 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~  363 (398)
                      +.++.++|.+||+.++++  |+++.++++||||.+..
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            899999999999765544  88999999999998754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-47  Score=366.72  Aligned_cols=252  Identities=25%  Similarity=0.456  Sum_probs=215.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++.+||||+.+++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998665445556778899999999997799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec-CCCCcccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~-~~~~~~~~~~  263 (398)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++... .........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999   78889999999998753 2233345678


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-------ChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-------TQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..||...       ........+......++    ..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            9999999999875 5899999999999999999999999532       12233444444333332    2478999999


Q ss_pred             HHHhcccCCCCCCC------HHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLT------AHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps------~~eiL~hp~~~~~~  363 (398)
                      |.+||+.||++|++      +.+++.||||....
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999999998      46999999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-47  Score=358.48  Aligned_cols=254  Identities=29%  Similarity=0.450  Sum_probs=210.2

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||+|+||+||+|.+..+++.||+|.+...........+.+..|+.+++.+. |+||+++.+++.....+++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999999999999999987654434445567889999999997 9999999999999999999999999999


Q ss_pred             hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-cccc
Q 015898          187 LFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-IFTD  261 (398)
Q Consensus       187 L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~~~~  261 (398)
                      |.+.+..    ...+++..+..++.||+.||.|||+.||+||||||+||++   ++++.++|+|||++....... ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9877743    3458999999999999999999999999999999999999   778899999999997654432 2334


Q ss_pred             cccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhc
Q 015898          262 VVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML  340 (398)
Q Consensus       262 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  340 (398)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..............++.++.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            678999999999975 5899999999999999999999999765432222222221111112222357899999999999


Q ss_pred             ccCCCCCC-----CHHHHhcCCCccCCCC
Q 015898          341 CSQPSERL-----TAHEVLCHPWICENGV  364 (398)
Q Consensus       341 ~~dP~~Rp-----s~~eiL~hp~~~~~~~  364 (398)
                      +.||++||     +++++++||||++..+
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            99999999     8899999999988543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.4e-47  Score=370.36  Aligned_cols=266  Identities=27%  Similarity=0.446  Sum_probs=214.7

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC---
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~---  172 (398)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++...   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence            45577999999999999999999999999999999986432 24455677889999999997 99999999998644   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ..+|+||||+.+ +|...+.  ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence               357999999965 6666653  348899999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC------------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG------------  316 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~------------  316 (398)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...            
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            976554444556788999999999875 5899999999999999999999999876544333222111            


Q ss_pred             ----------CCcCC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          317 ----------HIDFE----------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       317 ----------~~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                                .....                .......++++.+||.+||+.||++|||+.|+|+||||..+..+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~  328 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE  328 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccccc
Confidence                      00000                001112467899999999999999999999999999998755444433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-47  Score=367.51  Aligned_cols=251  Identities=28%  Similarity=0.498  Sum_probs=217.2

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHH-HHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI-MHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ++.+. ||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999976544344445566667654 55676 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCccccc
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~  262 (398)
                      +++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||+   ++++.+||+|||++.... ........
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   888899999999987532 22333456


Q ss_pred             ccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      +||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+........    +..+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            79999999999875 589999999999999999999999999888888888877654433    3478999999999999


Q ss_pred             cCCCCCCCH----HHHhcCCCccCCC
Q 015898          342 SQPSERLTA----HEVLCHPWICENG  363 (398)
Q Consensus       342 ~dP~~Rps~----~eiL~hp~~~~~~  363 (398)
                      .||.+||++    .+++.||||....
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            999999987    5999999998743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-46  Score=364.70  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=209.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.++||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.+. |+||+++++++...+.+++|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEE
Confidence            44888999999999999999999999999999985432  3445577899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++++|.+.    ....+..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++....... 
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence            999999988642    335788889999999999999999999999999999999   788899999999998754332 


Q ss_pred             cccccccCCcccCcccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ......||..|+|||.+..      ..+.++|||||||++|||++|+.||......+....+..............++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2345679999999998742      2456899999999999999999999744332222222111111222223457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            99999999999999999999999999999864

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-47  Score=367.02  Aligned_cols=262  Identities=27%  Similarity=0.475  Sum_probs=222.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..+. |++|+.+++++...+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            36999999999999999999999999999999987543334445566888999999887 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999977 4678999999999999999999999999999999999999   788899999999997665433


Q ss_pred             cc--cccccCCcccCcccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC-CCCCCCC
Q 015898          258 IF--TDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-SDPWPLI  328 (398)
Q Consensus       258 ~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  328 (398)
                      ..  ....||+.|+|||++.+      .++.++|||||||++|+|++|..||......+.+..+......+. ......+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  23579999999998863      478899999999999999999999998888777777766443222 1223457


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCCC
Q 015898          329 SDSAKDLIRKMLCSQPSE--RLTAHEVLCHPWICENGV  364 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~~  364 (398)
                      ++++.+||.+||+.++++  |++++++++||||.+..+
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            899999999999976654  579999999999987543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-47  Score=366.55  Aligned_cols=260  Identities=27%  Similarity=0.487  Sum_probs=221.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.++||+|+||.||++.+..+++.||+|++.+...........+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999986543334444556888999999987 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      ||+++|+|.+++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCCc
Confidence            99999999999976 4678999999999999999999999999999999999999   788899999999987653322 


Q ss_pred             -cccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-CCCCCCC
Q 015898          258 -IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLIS  329 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  329 (398)
                       .....+||+.|+|||++.      ..++.++|||||||++|||++|..||......+.+..+......+.. .....++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence             223457999999999885      24889999999999999999999999988888888877665433221 2233578


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSE--RLTAHEVLCHPWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~  363 (398)
                      +++.+||.+||+.++++  |+++.|+++||||.+..
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            99999999999765554  68999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-47  Score=364.64  Aligned_cols=250  Identities=28%  Similarity=0.515  Sum_probs=214.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHH-HHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ-IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+. ||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999997543323333345555554 456676 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCccccc
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~  262 (398)
                      +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   788899999999987532 22334456


Q ss_pred             ccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      +||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+......+.    +.++.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence            79999999999875 589999999999999999999999999888888887766544433    3578999999999999


Q ss_pred             cCCCCCCCHH----HHhcCCCccCC
Q 015898          342 SQPSERLTAH----EVLCHPWICEN  362 (398)
Q Consensus       342 ~dP~~Rps~~----eiL~hp~~~~~  362 (398)
                      .||.+|+++.    ++++|+||...
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCCC
Confidence            9999999876    89999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.7e-47  Score=367.89  Aligned_cols=261  Identities=28%  Similarity=0.406  Sum_probs=214.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+. ||||+++++++...  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~   97 (364)
T cd07875          20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence            345677999999999999999999999999999999986432 24445677889999999997 99999999987543  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       173 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                          ..+|+||||+.+ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG  171 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  171 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCC
Confidence                457999999965 77776643  47899999999999999999999999999999999999   788899999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-------
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------  320 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------  320 (398)
                      ++.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......       
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9987655444456789999999999875 58999999999999999999999998877666555543311000       


Q ss_pred             -------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          321 -------------------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       321 -------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                                     ........+.++++||.+||+.||.+|||+.|+|+||||..+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                                           0000112346789999999999999999999999999998644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-47  Score=363.65  Aligned_cols=251  Identities=28%  Similarity=0.499  Sum_probs=215.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHH-HHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ-IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      ++||+|+||.||+|.+..+++.||+|++.+...........+..|+. +++.+. ||||+++++++...+..|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999999999999999997654333344455666665 566776 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCCccccc
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~  262 (398)
                      +++|...+.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   888899999999987532 22233456


Q ss_pred             ccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      +||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++.    ..+.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG----GKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcc
Confidence            79999999999875 5899999999999999999999999998888888887776544432    467899999999999


Q ss_pred             cCCCCCCCH----HHHhcCCCccCCC
Q 015898          342 SQPSERLTA----HEVLCHPWICENG  363 (398)
Q Consensus       342 ~dP~~Rps~----~eiL~hp~~~~~~  363 (398)
                      .||.+||++    .++++|+||....
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            999999976    5999999997644

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-47  Score=366.01  Aligned_cols=250  Identities=29%  Similarity=0.508  Sum_probs=218.4

Q ss_pred             ceecccCceEEEEEEEc---cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          105 RKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      +.||+|+||.||++.+.   .+|+.||+|++..... .......+..|+.+++++. ||||+++++++...+.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            57999999999998863   5789999999975432 2233456788999999997 99999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-Cccc
Q 015898          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFT  260 (398)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~~~~  260 (398)
                      +++++|.+++.+...+++..+..++.||+.||.|||+.||+||||||+|||+   ++++.+||+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence            9999999999888889999999999999999999999999999999999999   78889999999998765433 2334


Q ss_pred             ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHh
Q 015898          261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (398)
Q Consensus       261 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  339 (398)
                      ...||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+......++.    .+++++.+||.+|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHH
Confidence            5679999999999875 5889999999999999999999999988888888887776654443    4789999999999


Q ss_pred             cccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          340 LCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       340 L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      |+.||++||+     +.+++.||||....
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            9999999999     67899999998743

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.2e-47  Score=355.44  Aligned_cols=256  Identities=32%  Similarity=0.509  Sum_probs=215.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.++||+|+||.||+|.+..+++.||+|.+.............+.+|+.++++++ |++|+.+++.+...+..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEEE
Confidence            778899999999999999999999999999987654434444566788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCcc
Confidence            99999999888543  358999999999999999999999999999999999999   7888999999999987655444


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---GIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||......   ..........   .......+++++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  234 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDARS  234 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHHH
Confidence            455689999999999874 5899999999999999999999999764432   1222221111   11122357889999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      |+.+||+.||++|||     ++|+++||||++..
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence            999999999999999     89999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.8e-47  Score=378.96  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=207.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-----  172 (398)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.+. ||||+++++++...     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence            356999999999999999999999999999999885321       23357999999997 99999999987432     


Q ss_pred             ---CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC-ccEEE
Q 015898          173 ---LCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKA  244 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~-~~~kL  244 (398)
                         ..+++||||+++ +|.+++.    ....+++..++.++.||+.||.|||+.||+||||||+|||+   +.+ +.+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl---~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI---DPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE---cCCCCceee
Confidence               257799999965 6766664    24568999999999999999999999999999999999999   544 47999


Q ss_pred             eecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC-----
Q 015898          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-----  317 (398)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-----  317 (398)
                      +|||+|.............||+.|+|||++.+  .|+.++|||||||++|||++|.+||.+....+.+..+.+..     
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987665555556788999999998864  58999999999999999999999998877665555543311     


Q ss_pred             ------------CcCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          318 ------------IDFESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       318 ------------~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                  ..++..        .....++++++||.+||++||.+|||+.|+|+||||.+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                        011100        0113578999999999999999999999999999997643

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-47  Score=370.15  Aligned_cols=252  Identities=18%  Similarity=0.300  Sum_probs=206.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ...|++.+.||+|+||.||+|.+..+++.||+|...         ...+.+|+.++++|. ||||++++++|......++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence            356999999999999999999999999999999653         234678999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|...... 
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence            999994 6898988888889999999999999999999999999999999999999   77889999999999653221 


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-------hHHHHHHHHcCC----------
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-------QQGIFDAVLKGH----------  317 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~-------~~~~~~~~~~~~----------  317 (398)
                       .......||+.|+|||++.+ .++.++|||||||++|||++|..||....       ....+..+....          
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence             23345689999999999875 58999999999999999999998875432       111111111100          


Q ss_pred             ----------------CcCCC--C---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          318 ----------------IDFES--D---PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       318 ----------------~~~~~--~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                      ...+.  .   ....++.++.+||.+||++||.+|||+.|+|+||||+...
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                            00000  0   0112467899999999999999999999999999998753

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.7e-47  Score=366.23  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=213.3

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC---
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~---  172 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.+. ||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence            45678999999999999999999999999999999986432 24445677889999999997 99999999988643   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ...|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence               357999999965 67666643  48899999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC----------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI----------  318 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------  318 (398)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.....          
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            987655544556789999999999875 589999999999999999999999987665444332221100          


Q ss_pred             ------------c----------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          319 ------------D----------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       319 ------------~----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                  .                .........+.++.+||.+||+.||++|||+.|+|+||||..+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence                        0                000011224567899999999999999999999999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.3e-47  Score=354.47  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=208.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEec-----C
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYED-----S  172 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~-----~  172 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            48899999999999999999999999999999865432 2222334567787777664  49999999998864     3


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          173 LCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      ..+++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            46899999996 4888888653  348999999999999999999999999999999999999   78889999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc----------
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------  319 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------  319 (398)
                      .............+|..|+|||++.+ .++.++|||||||++|+|++|.+||......+.+..+......          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            87655444456678999999999874 5899999999999999999999999877766655554331100          


Q ss_pred             ------CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 ------FE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 ------~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                            +.       ....+.++.++.+||.+||++||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00       01123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-46  Score=350.63  Aligned_cols=250  Identities=28%  Similarity=0.463  Sum_probs=209.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||+|+||.||++.+..+|+.||+|.+.............+..|+++++++. ||||++++++++.+..+++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999986544333333445667999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccccc
Q 015898          187 LFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG  264 (398)
Q Consensus       187 L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~g  264 (398)
                      |.+++....  .+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            988875543  48899999999999999999999999999999999999   7788999999999987665554455678


Q ss_pred             CCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh----HHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHh
Q 015898          265 SPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (398)
Q Consensus       265 t~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  339 (398)
                      +..|+|||++.+ .++.++|||||||++|||++|..||.....    .............+.   ...++.++.+||.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence            999999999874 589999999999999999999999975432    223333333332222   235789999999999


Q ss_pred             cccCCCCCCCH----HHHhcCCCccCCC
Q 015898          340 LCSQPSERLTA----HEVLCHPWICENG  363 (398)
Q Consensus       340 L~~dP~~Rps~----~eiL~hp~~~~~~  363 (398)
                      |+.||++||++    ++++.||||+...
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCCC
Confidence            99999999999    7788999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-46  Score=351.36  Aligned_cols=259  Identities=30%  Similarity=0.466  Sum_probs=219.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++ |+||+.+.+.+..++..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence            677889999999999999999999999999987654433444556788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCCc
Confidence            99999998888653  359999999999999999999999999999999999999   7788999999999976654444


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+..............++.++.+|+.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            456688999999999874 5899999999999999999999999876654443333332222222233457889999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      +||+.||++||+     +.+++.|+||....
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999999     88999999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-46  Score=357.96  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=215.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.+. ||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc--cCCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            45999999999999999999999999999999986543  2223345778999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999965 888877654 348999999999999999999999999999999999999   78889999999999764332 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC-----------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-----------------  317 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-----------------  317 (398)
                      .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||...+..+....+....                 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            22334567899999998864  48899999999999999999999998776655544443210                 


Q ss_pred             --CcCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          318 --IDFES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       318 --~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                        ..++.       ...+.++.++.+||.+||+.||.+|||+.|+|+||||.......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence              00010       11234788999999999999999999999999999998866443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-46  Score=367.20  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=214.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-----eE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----CV  175 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-----~~  175 (398)
                      |++.+.||+|+||.||+|.+..+++.||||.+... .......+++.+|+.+++.++ |+||+++++++...+     ..
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            78899999999999999999999999999998543 223445678899999999997 999999999998776     79


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |+||||+. ++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence            99999995 5888888877889999999999999999999999999999999999999   8889999999999976543


Q ss_pred             CC--cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC---------------
Q 015898          256 GQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG---------------  316 (398)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~---------------  316 (398)
                      ..  ......+++.|+|||.+.+  .++.++|||||||++|||++|+.||.+.+..+.+..+.+.               
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22  2334568899999999875  4889999999999999999999999887766555444321               


Q ss_pred             --------CCcCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          317 --------HIDFES-----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       317 --------~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                              ....+.     ......++++.+||.+||+.||++|||+.|+|+||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                    000000     1122457899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-47  Score=350.17  Aligned_cols=254  Identities=41%  Similarity=0.669  Sum_probs=214.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++++.||+|+||+||+|.+..+++.||+|++..... .........+|+.+++++. ||||+++++++......++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence            7889999999999999999999999999999976532 2222334466999999996 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec-CCCCcc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~-~~~~~~  259 (398)
                      ++++++|.+++...+.+++..+..++.||+.||.+||+.||+|+||||+||++   +.++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999888889999999999999999999999999999999999999   88899999999999763 334455


Q ss_pred             cccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcC---hHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          260 TDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ....++..|+|||++.  ..++.++||||||+++|+|++|..||....   .......................+.++.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            6678899999999987  468999999999999999999999998773   33333333332222222211123489999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +|.+||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-46  Score=358.10  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=215.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+++++.+. ||||+++++++...+.+++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence            356999999999999999999999999999999886532  3445677999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+++++|.+++...+.+++..+..++.+++.||.|||+. +|+||||||+|||+   ++++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence            999999999999998888899999999999999999999975 79999999999999   77889999999998754322


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHc---CC---------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK---GH---------------  317 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~---~~---------------  317 (398)
                       ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+..   +.               
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence             2344678999999999875 589999999999999999999999976544333221100   00               


Q ss_pred             ----------------------C--cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          318 ----------------------I--DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       318 ----------------------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                            .  ..+......++.++.+||.+||+.||++|||+.|++.||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                  0  000000113568899999999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-47  Score=363.83  Aligned_cols=255  Identities=30%  Similarity=0.518  Sum_probs=232.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe-EEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC-VHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~-~~l  177 (398)
                      +.|.+++++|+|+||.++++.++.+++.+++|.+....... ...+....|+.+++++. |||||.+.+.|++++. ++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            45999999999999999999999999999999998766533 34457889999999998 9999999999999888 999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||+||+||+|.+.+.+.+  .|+++.+..++.|++.|+.|||+++|+|||||+.||++   ..+..|||+|||+|+...+
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCC
Confidence            999999999999997644  59999999999999999999999999999999999999   6777889999999999887


Q ss_pred             CC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. ...+++||+.|+.||++.+ .|+.++|||||||++|||++-+.+|...+...+..++.++.......   ..+.+++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~---~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS---MYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc---cccHHHH
Confidence            76 7788999999999999997 59999999999999999999999999999999999999987544433   5789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .+|..||..+|..||++.++|.+|.+..
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9999999999999999999999998874

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-46  Score=361.96  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=213.4

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC---
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~---  172 (398)
                      .+.++|++.+.||.|+||.||+|.+..++..||||.+.... ........+.+|+.+++++. ||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence            45678999999999999999999999999999999986432 23344567889999999998 99999999987543   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ...|+++|++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence               4579999998 778877664 4569999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc--------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID--------  319 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------  319 (398)
                      +......  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+......        
T Consensus       165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9875432  345678999999999875  4889999999999999999999999876655444433221100        


Q ss_pred             ---------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          320 ---------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       320 ---------------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                     .+.    ..+...++.+.+||.+||+.||++|||+.|+|.||||......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                           000    0112356778999999999999999999999999999886543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-45  Score=348.20  Aligned_cols=254  Identities=35%  Similarity=0.641  Sum_probs=226.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+++++++. ||||+++++++..++.+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence            5899999999999999999999999999999987655444556678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|.||++   ++++.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--C
Confidence            999999999999888889999999999999999999999999999999999999   78889999999999876544  3


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..+...++.    .++..+.++|.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~  231 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHHH
Confidence            45578999999998874 5788999999999999999999999887777777777665554433    368999999999


Q ss_pred             hcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          339 MLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       339 ~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ||..||.+|+     +++|+++||||....
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            9999999999     999999999998755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=359.98  Aligned_cols=245  Identities=27%  Similarity=0.409  Sum_probs=212.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.+++.+.||+|.||.||+|... ....||+|.++....    ..+.+.+|+++|++|+ |++||++++++..+..+||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEE
Confidence            345788899999999999999953 234899999975432    2356779999999998 9999999999999889999


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||++.|+|.++|..  ...+...+...++.||++|++||+++++|||||...||||   +++..+||+|||+|+...+
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCC
Confidence            9999999999999987  4569999999999999999999999999999999999999   8889999999999996554


Q ss_pred             CCccccccc--CCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQIFTDVVG--SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      +......-+  ...|.|||.+. +.++.+||||||||+||||+| |+.||.+.+..++++.+.++..-..+   ..+|++
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP~~  432 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCPDE  432 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCCHH
Confidence            443222212  23599999998 679999999999999999999 99999999999999999998654443   368999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHh
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVL  354 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL  354 (398)
                      +.+++..||+.+|++|||++.+.
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHH
Confidence            99999999999999999998543

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-46  Score=354.37  Aligned_cols=272  Identities=34%  Similarity=0.539  Sum_probs=232.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+..|+++++.+. |+||+++++.+......|+||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence            5889999999999999999999999999999997665444456678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcccccc
Confidence            999999999988754  468999999999999999999999999999999999999   778899999999986543211


Q ss_pred             ------------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh
Q 015898          258 ------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ  306 (398)
Q Consensus       258 ------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~  306 (398)
                                                    ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          1113468889999999875 588999999999999999999999988887


Q ss_pred             HHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCCccCCCCCCCCCCCHHHHHH
Q 015898          307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT----AHEVLCHPWICENGVAPDRSLDPAVLSR  377 (398)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eiL~hp~~~~~~~~~~~~~~~~~~~~  377 (398)
                      ...+..+......++..  ..++.++.++|.+||+.||++|||    ++|+|.||||++..+......++|..++
T Consensus       238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~  310 (316)
T cd05574         238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPR  310 (316)
T ss_pred             HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCC
Confidence            77777766555444332  236899999999999999999999    9999999999998777766666655543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-46  Score=372.06  Aligned_cols=254  Identities=28%  Similarity=0.404  Sum_probs=220.5

Q ss_pred             ccceecceecccCceEEEEEEEccC-CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ..|.+.+.||+|+||.||+|.+..+ +..||+|.+...   .......+.+|+.+++.+. ||||+++++++...+.+||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEE
Confidence            3499999999999999999998877 788999976432   3445567888999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceec
Confidence            9999999999887754    3468999999999999999999999999999999999999   78889999999999876


Q ss_pred             CCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          254 KPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       254 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ....   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..+..+.....   ...++
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s  296 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVS  296 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCC
Confidence            4432   2345679999999999875 589999999999999999999999998888888888776654322   12478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .++.+||.+||+.||++||++.++|.|||++..
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999999999753

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-45  Score=361.50  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=207.4

Q ss_pred             cccccceecceecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .+..+|++.+.||+|+||.||+|...  .++..||+|.+...        ....+|+.++++|. ||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            35567999999999999999999754  35678999987532        23457999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ..++|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++...
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccccc
Confidence            9999999995 6888888777889999999999999999999999999999999999999   88889999999999765


Q ss_pred             CCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHHcC----CCcCCC
Q 015898          254 KPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---GIFDAVLKG----HIDFES  322 (398)
Q Consensus       254 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~~~~~----~~~~~~  322 (398)
                      ....   ......||+.|+|||++.. .|+.++|||||||++|||++|..||.+....   ..+..+.+.    ...++.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            4332   1234679999999999874 5899999999999999999999999765421   222222110    000100


Q ss_pred             C--------------------C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          323 D--------------------P------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       323 ~--------------------~------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .                    .      ...++.++.++|.+||..||++|||+.|+|.||||.+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            0                    0      012467889999999999999999999999999997744

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=393.49  Aligned_cols=276  Identities=29%  Similarity=0.490  Sum_probs=247.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|.+.++||+|+||.|.+++++.+++.||+|++.+...........|..|-.+|..-. .+-|++++..|++..++|+
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence            467999999999999999999999999999999998766555666678899999998765 8999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||++||+|..++.+..++++..++.++..|+.||..||+.|+|||||||+|||+   |..|++||+|||.+-.+..+.
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence            99999999999999988899999999999999999999999999999999999999   999999999999987766433


Q ss_pred             --cccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC--CCcCCCCCCCC
Q 015898          258 --IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPL  327 (398)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~  327 (398)
                        .....+|||.|++||++.      +.|+..+|.||+||++|||+.|..||+...-.+.+.+|.+-  .+.||.  ...
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~--~~~  307 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD--ETD  307 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc--ccc
Confidence              345679999999999995      35999999999999999999999999999999999999875  566662  335


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCCCCCCCCCHHHHHHHHH
Q 015898          328 ISDSAKDLIRKMLCSQPSERLT---AHEVLCHPWICENGVAPDRSLDPAVLSRLKQ  380 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps---~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~  380 (398)
                      +|+++++||.++|+ +|+.|..   ++|+-.||||.+..|..-+...||+.|.++.
T Consensus       308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence            99999999999995 6788888   9999999999999999888888888887653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.4e-46  Score=372.60  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=222.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC---
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL---  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~---  173 (398)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++..... +......+.+|+.++..+. |+||+++++.+....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence            34579999999999999999999999999999999875443 4556678889999999997 999999988775332   


Q ss_pred             -----eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEE
Q 015898          174 -----CVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       174 -----~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                           .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence                 478999999999999988643    468999999999999999999999999999999999999   77889999


Q ss_pred             eecCCceecCCC---CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC
Q 015898          245 IDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       245 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      +|||++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|..||........+..+..+....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999999765432   22345689999999999985 59999999999999999999999999888888888777665432


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .   .+.+++++.+|+.+||+.||.+||++.++++|||++..
T Consensus       265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            2   23578999999999999999999999999999998763

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-45  Score=339.19  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=216.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccC--CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .|++.+.||+|++|.||.|.+..+++.||+|.+......  .....+.+.+|+.+++++. ||||++++++++.....++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEE
Confidence            488999999999999999999999999999998654321  2234567889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |+||+++++|.+++...+.+++..+..++.+++.||.|||+.||+||||+|+||++   ++++.++|+|||++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccccc
Confidence            99999999999999888889999999999999999999999999999999999999   778899999999987654322


Q ss_pred             c----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          258 I----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       258 ~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .    .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......  .....++.++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPDA  236 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHHH
Confidence            1    133567889999999975 48899999999999999999999997766555444443332221  1223578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .++|.+||..+|++|||+.++++||||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-45  Score=342.03  Aligned_cols=270  Identities=28%  Similarity=0.450  Sum_probs=226.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+. |+||+++++++.+...+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            35889999999999999999999999999999986543  3445667889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      +||+++++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||++   ++++.++|+|||++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999988765 78999999999999999999999999999999999999   88889999999999876543 2


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+..........  ..++.++.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHHHHHH
Confidence            3345678889999999875 58999999999999999999999998766655555554443221111  12688999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHH
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ  380 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~  380 (398)
                      .+||..||++|||+.++++||||.+....   ...+.+.-++|+
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~---~~~~~~~~~~~~  272 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKT---SYLTLLIERIKK  272 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcc---cHHHHHHHHHHh
Confidence            99999999999999999999999875533   333344444444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=361.29  Aligned_cols=262  Identities=33%  Similarity=0.574  Sum_probs=236.0

Q ss_pred             cccccee--cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           97 IRDLYTL--GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        97 ~~~~y~~--~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +...|++  .++||+|.||+||-|+++.+|+.||||++.+..+.. ....++++|+.||+.+. ||.||.+.-.|+..+.
T Consensus       560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~-HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLH-HPGIVNLECMFETPER  637 (888)
T ss_pred             HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence            3344665  579999999999999999999999999998876643 34478999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          175 VHIVMELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      +++|||-+.| ++.+.+.  +.+++++.....++.||+.||.|||.++|+|+||||+|||+...+.--.+||||||+|++
T Consensus       638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence            9999999955 5656553  356799999999999999999999999999999999999997766667899999999999


Q ss_pred             cCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          253 FKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      +.+.....+++|||.|+|||++.+ .|....|+||.|||+|--++|..||...  +++-++|.+..+-++..+|..++.+
T Consensus       717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~  794 (888)
T KOG4236|consen  717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPE  794 (888)
T ss_pred             cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHH
Confidence            998888889999999999999985 5999999999999999999999999643  4567788889999999999999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++|||..+|+..-.+|.|.+..|.|||+++..
T Consensus       795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            99999999999999999999999999999865

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.1e-45  Score=347.94  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=213.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            45999999999999999999999999999999986443  2223346778999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||++ ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++...... 
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence            99996 5888887654 458999999999999999999999999999999999999   78889999999998764322 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC----------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI----------------  318 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------------  318 (398)
                      .......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||...+..+....+.....                
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            22234567889999998864  478899999999999999999999987766554443322100                


Q ss_pred             ---cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          319 ---DFES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       319 ---~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                         .++.       ...+.+++++.+||.+||+.||.+|||+.|+|+||||...+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence               0000       111346889999999999999999999999999999987764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=353.60  Aligned_cols=264  Identities=30%  Similarity=0.466  Sum_probs=231.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|+.-++||+|+||.||-+..+.+|+.+|.|.+.++.+..........+|-.||.++. .+.||.+-..|+..+.+++|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence            45888899999999999999999999999999998776655556667889999999997 89999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |..|+||+|..+|...+  .|++..++.++.+|+.||++||..+||+|||||+|||+   |+.|+++|+|+|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence            99999999988887655  69999999999999999999999999999999999999   99999999999999999999


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ......+||.+|||||++.+ .|+...|.|||||++|||+.|..||.......-.+.+.+....-+......+|+++++|
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            88888899999999999985 59999999999999999999999996554433333333333333333334689999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCCccCCCCCC
Q 015898          336 IRKMLCSQPSERL-----TAHEVLCHPWICENGVAP  366 (398)
Q Consensus       336 i~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~~~~  366 (398)
                      .+.+|++||.+|.     .++++.+||||++..+..
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence            9999999999998     567999999999976543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.1e-45  Score=345.65  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=215.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+....  ......++.+|++++++++ ||||+++++++..++.+++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence            5899999999999999999999999999999986432  3445667889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||+   ++++.++|+|||++...... .
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-c
Confidence            999999999999888889999999999999999999997 699999999999999   77889999999998765332 2


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-----------------
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-----------------  320 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-----------------  320 (398)
                      .....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...................                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            345678999999998875 58899999999999999999999997555433322221110000                 


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          321 -----------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       321 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                       +..+...++.++.+|+.+||..||++|||+.++++||||.++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  295 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL  295 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence                             00011236788999999999999999999999999999987543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-45  Score=350.46  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=193.5

Q ss_pred             cceecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeEEEEE
Q 015898          104 GRKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCVHIVM  179 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~~lv~  179 (398)
                      +++||+|+||.||+|.++  .+++.||+|.+....     ....+.+|+.+++++. ||||+++++++..  ...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999965  467899999986432     1245678999999997 9999999999853  56789999


Q ss_pred             eccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec-CCCccEEEeecCC
Q 015898          180 ELCAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DDDFSLKAIDFGL  249 (398)
Q Consensus       180 e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~-~~~~~~kL~DFG~  249 (398)
                      ||+. ++|.+++...         ..+++..+..++.||+.||.|||+.||+||||||+|||+... +..+.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9985 5887776532         248899999999999999999999999999999999999543 3557899999999


Q ss_pred             ceecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---------HHHHHHHH
Q 015898          250 SVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ---------QGIFDAVL  314 (398)
Q Consensus       250 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~---------~~~~~~~~  314 (398)
                      +.......    ......||+.|+|||++.+  .++.++||||+||++|+|++|.+||.....         ...+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            98754321    2345678999999999874  489999999999999999999999964321         11111111


Q ss_pred             cCCC----------------------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          315 KGHI----------------------------------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       315 ~~~~----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ....                                  .+........+.++.+||.+||++||++|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1000                                  00000011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-45  Score=353.00  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             cccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.++||+|+||.||+|.+.     .++..||||++....  .......+.+|+.++..+.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            467999999999999999999752     345689999986432  3445677999999999995599999999988754


Q ss_pred             -CeEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 015898          173 -LCVHIVMELCAGGELFDRIIQR---------------------------------------------------------  194 (398)
Q Consensus       173 -~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  194 (398)
                       ..+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999988652                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc---ccccccCC
Q 015898          195 -----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSP  266 (398)
Q Consensus       195 -----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~  266 (398)
                           ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++........   .....+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 237788899999999999999999999999999999999   7788999999999976533221   12334567


Q ss_pred             cccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH-HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccC
Q 015898          267 YYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (398)
Q Consensus       267 ~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  343 (398)
                      .|+|||++.+ .++.++|||||||++|||++ |..||.+..... ....+..+....   ....+++++.+|+.+||+.|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCC
Confidence            8999998874 58999999999999999997 999998755433 333333332211   12357889999999999999


Q ss_pred             CCCCCCHHHHhc
Q 015898          344 PSERLTAHEVLC  355 (398)
Q Consensus       344 P~~Rps~~eiL~  355 (398)
                      |++|||+.|+++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-45  Score=381.84  Aligned_cols=263  Identities=32%  Similarity=0.502  Sum_probs=217.5

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SL  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~  173 (398)
                      .+.++|++.+.||+|+||+||+|.+..++..||+|++..... .......+..|+.+++.|. ||||++++++|..  ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCC
Confidence            345679999999999999999999999999999999875433 4455678899999999998 9999999998854  46


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCcEEEeec------
Q 015898          174 CVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSL-------GVMHRDLKPENFLLVNK------  236 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~-------~iiHrDikp~NIll~~~------  236 (398)
                      .+||||||+++++|.++|..    ...+++..++.|+.||+.||.|||+.       +||||||||+||||...      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            79999999999999998865    25699999999999999999999985       49999999999999431      


Q ss_pred             --------CCCccEEEeecCCceecCCCCcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcC
Q 015898          237 --------DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAET  305 (398)
Q Consensus       237 --------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~  305 (398)
                              +..+.+||+|||++.............||+.|+|||++.+   .++.++||||||||||+|++|..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    2244699999999987655444456789999999999863   48899999999999999999999997655


Q ss_pred             hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ....+..........   +....+.++.+||.+||..+|.+||++.|+|.||||+...
T Consensus       248 ~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        248 NFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             cHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            443333333322222   2234689999999999999999999999999999998654

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5e-45  Score=338.96  Aligned_cols=254  Identities=30%  Similarity=0.452  Sum_probs=214.0

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...   .......+.+|+.+++.+. ||||+++++++...+.+|+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence            34699999999999999999999999999999998643   2334456788999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence            99999999999999888889999999999999999999999999999999999999   77889999999998765432 


Q ss_pred             CcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-CCCCCCCHH
Q 015898          257 QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLISDS  331 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  331 (398)
                      .......|+..|+|||.+.    +.++.++|+|||||++|+|++|..||...................+. .....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence            1223457899999999874    34888999999999999999999999765544433333333222111 111246788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      +.++|.+||..||++|||+.++++|||
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-45  Score=347.96  Aligned_cols=262  Identities=31%  Similarity=0.490  Sum_probs=224.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.+. ||||+++++.+...+.+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence            4889999999999999999999999999999987654333445667889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||++|++|.+++...+.+++..+..++.+++.||.|||+.|++||||||+||++   +.++.++|+|||++.......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence            999999999999888889999999999999999999999999999999999999   778899999999886421100  


Q ss_pred             --------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          258 --------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       258 --------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                                    ......++..|+|||.+.+ .++.++|+|||||++|||++|..||.+....+....+.......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          0112457888999998874 5899999999999999999999999988888877777766555444


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCCCC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLT---AHEVLCHPWICENGVAP  366 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eiL~hp~~~~~~~~~  366 (398)
                      ... .++.++.++|.+||+.||++||+   +.++|+||||....+..
T Consensus       238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence            322 57899999999999999999998   79999999997755433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7e-45  Score=341.05  Aligned_cols=256  Identities=28%  Similarity=0.477  Sum_probs=212.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++. |+|++++++++.....+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            368999999999999999999999999999999864321 2223456789999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||++++.|..++.....+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999998887776666679999999999999999999999999999999999999   778899999999998765443 


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC-----------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-----------------  318 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------------  318 (398)
                      ......++..|+|||.+.+  .++.++|||||||++|+|++|..||.+....+....+.....                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            3334567889999999864  478999999999999999999999987765544433322100                 


Q ss_pred             --cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 --DFES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 --~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                        ..+.        ...+.++..+.+||.+||++||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0000        0123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=335.42  Aligned_cols=254  Identities=33%  Similarity=0.537  Sum_probs=217.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||.|+||.||+|.+..+++.||+|.+.+...........+..|..++....+|+|++++++++..++.+|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999999999999999986544333334445566666655554599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccccc
Q 015898          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG  264 (398)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~g  264 (398)
                      ++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.++|+|||++.....   .....+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   7788999999999876433   234568


Q ss_pred             CCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccC
Q 015898          265 SPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (398)
Q Consensus       265 t~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  343 (398)
                      +..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+......+.......+++++.++|.+||+.|
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            889999999875 4789999999999999999999999888888777777766665555555568899999999999999


Q ss_pred             CCCCCCH---HHHhcCCCccCCCC
Q 015898          344 PSERLTA---HEVLCHPWICENGV  364 (398)
Q Consensus       344 P~~Rps~---~eiL~hp~~~~~~~  364 (398)
                      |++||++   .|+|.||||.+..+
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhcCCC
Confidence            9999955   79999999987543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-44  Score=335.47  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=214.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCC------HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS------REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+.......      ....+.+.+|+.+++++. ||||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            4788899999999999999998899999999886543322      123467889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ..++||||+++++|.+++...+.+++..+..++.+++.||.|||+.|++||||+|+||++   ++++.++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888889999999999999999999999999999999999999   78889999999998766


Q ss_pred             CCCC-------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          254 KPGQ-------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       254 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      ....       ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.....   ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCC
Confidence            4221       1123457889999999874 588899999999999999999999987665554444433221   1222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ..++.++.++|.+||+.||++||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            3578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.6e-44  Score=332.00  Aligned_cols=252  Identities=26%  Similarity=0.491  Sum_probs=215.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-CCeEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVHIV  178 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~~~~~lv  178 (398)
                      .|++.+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|+.++++++ |+|++++++.+.. ...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            38899999999999999999999999999999864332 3445667889999999997 9999999998864 4568999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++++|.+++...  ..+++.++..++.+++.||.+||+.|++||||||+||++   +.++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence            9999999999988763  458999999999999999999999999999999999999   77889999999999766432


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       .......+++.|+|||.+.+ .++.++|||||||++++|++|..||...+.......+..+....   ....+++++.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence             22334568899999999875 58899999999999999999999998877766666665554322   12357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +|.+||+.||++|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-44  Score=331.78  Aligned_cols=251  Identities=26%  Similarity=0.435  Sum_probs=219.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |.+.+.||+|+||.||+|.+..+++.|++|.+..... .......+.+|+.+++.++ ||||+++++++...+..++|||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEEE
Confidence            7888999999999999999999999999999865433 3455678999999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+.|++||||||+||++   ++++.++|+|||++....... 
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence            99999999998764  568999999999999999999999999999999999999   777899999999988765432 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......+++.|+|||++.+ .++.++|+|||||++|+|++|..||...........+..+.......   .++.++.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i  233 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ---MYSQQLAQLI  233 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---ccCHHHHHHH
Confidence            2234568899999999874 58899999999999999999999998888777777766654332221   4788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCc
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .+||+.+|++||++.++++|||+
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-44  Score=335.09  Aligned_cols=253  Identities=35%  Similarity=0.585  Sum_probs=218.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++.+.++..+++||||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            799999999999999889999999997655444556678999999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCC
Q 015898          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP  266 (398)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~  266 (398)
                      |.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.++|+|||++.............+++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99999888789999999999999999999999999999999999999   778899999999998765543334567889


Q ss_pred             cccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccC
Q 015898          267 YYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (398)
Q Consensus       267 ~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  343 (398)
                      .|+|||.+.+ .++.++|+||||+++|+|++|..||....  .......+..+......  ....++++.++|.+||+.|
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC--CcccCHHHHHHHHHHccCC
Confidence            9999999864 58999999999999999999999998766  55666666532222111  1234789999999999999


Q ss_pred             CCCCCC-----HHHHhcCCCccCCCCC
Q 015898          344 PSERLT-----AHEVLCHPWICENGVA  365 (398)
Q Consensus       344 P~~Rps-----~~eiL~hp~~~~~~~~  365 (398)
                      |++||+     +.|+++||||++..++
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            999999     9999999999986543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=342.21  Aligned_cols=267  Identities=27%  Similarity=0.426  Sum_probs=216.9

Q ss_pred             eeccccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-C----Cee
Q 015898           89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-K----NIV  163 (398)
Q Consensus        89 ~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~----niv  163 (398)
                      .+-...+.+..+|++..++|+|.||.|..+.+..++..||||+++.-    ....+..+-|+.+|.++..+ |    -++
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            33445566788999999999999999999999999999999998632    23345677799999999522 2    488


Q ss_pred             EEeEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC----
Q 015898          164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----  237 (398)
Q Consensus       164 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~----  237 (398)
                      .+.++|+..++.+||+|.+ |.++++++..++  +++...++.+++|++.++++||+.+++|.||||+|||+...+    
T Consensus       155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence            8999999999999999998 779999998765  589999999999999999999999999999999999994321    


Q ss_pred             -------------CCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC
Q 015898          238 -------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA  303 (398)
Q Consensus       238 -------------~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~  303 (398)
                                   ....++|+|||.|......  ....+.|..|+|||++++ .|+.++||||+||||+||++|...|..
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                         2456899999999885543  367889999999999997 699999999999999999999999988


Q ss_pred             cChHHHH---HHHHc------------------CCCcCCCCCCC---------------------CCCHHHHHHHHHhcc
Q 015898          304 ETQQGIF---DAVLK------------------GHIDFESDPWP---------------------LISDSAKDLIRKMLC  341 (398)
Q Consensus       304 ~~~~~~~---~~~~~------------------~~~~~~~~~~~---------------------~~~~~~~~li~~~L~  341 (398)
                      ....+.+   +.+..                  +.+.++.....                     ....++.|||++||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            7766633   22221                  11111110000                     012468999999999


Q ss_pred             cCCCCCCCHHHHhcCCCccCC
Q 015898          342 SQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       342 ~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +||.+|+|+.|+|.||||+..
T Consensus       392 fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  392 FDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cCccccccHHHHhcCHHhhcC
Confidence            999999999999999999764

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-44  Score=339.87  Aligned_cols=254  Identities=27%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.+. ||||+++++++..++.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            38889999999999999999999999999999864322 2333467889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||++ ++|.+++...   ..+++..++.++.||+.||.|||+.||+||||||+||++   +.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9997 5888877542   458999999999999999999999999999999999999   78889999999998765332


Q ss_pred             -CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC---------------
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI---------------  318 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------------  318 (398)
                       .......+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.....               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             22234467889999998864  478899999999999999999999987655433322211100               


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 ----------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 ----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                .........+++++.++|.+||+.||++|||+.+|+.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      00011123478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-47  Score=363.67  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=226.0

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|.|+..||.|+||+||+|..+.++...|-|++...   +.+.++.+..||.||..+. ||+||++++.|...+.+|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceE
Confidence            446689999999999999999999999989999988543   7788999999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-  254 (398)
                      |+.|||.||-+..++.. ...+++.++.-+++|++.||.|||+++|||||||..|||+   .-+|.++|+|||.+.... 
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchh
Confidence            99999999988777765 4569999999999999999999999999999999999999   777889999999875432 


Q ss_pred             CCCcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ......+++|||+|||||+.+      ..|++++||||||++|.||..+.+|....++-.++-++.+...+.... ...+
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~W  261 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSHW  261 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cchh
Confidence            223446799999999999885      249999999999999999999999998888888888877765443322 3357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +..+.|||.+||.+||..||++.++|+||||...
T Consensus       262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            8999999999999999999999999999999754

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.9e-45  Score=336.97  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=212.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++++. ||||+++++++......++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE---PGDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC---ccchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence            34699999999999999999999999999999998643   2234456889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||++   ++++.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccc
Confidence            99999999999999888889999999999999999999999999999999999999   778889999999997654321


Q ss_pred             -cccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-CCCCCCCHH
Q 015898          258 -IFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLISDS  331 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  331 (398)
                       ......+++.|+|||.+.    ..++.++|||||||++|||++|..||...........+.......+. .....++.+
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence             223457889999999874    23788999999999999999999999765544333222222222111 111246789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      +.+||.+||+.||++|||++++|+|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.6e-45  Score=342.95  Aligned_cols=265  Identities=28%  Similarity=0.443  Sum_probs=219.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccC--CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      +|++.+.||+|+||.||+|.+..+++.||||.+......  .......+..|+.+++.+. |+||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            488889999999999999999999999999999755432  1223456778999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||++   +.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence            99999 889999987765 79999999999999999999999999999999999999   77889999999999876543


Q ss_pred             -CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC------------
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE------------  321 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------  321 (398)
                       .......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+....+.+..+........            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence             23334466888999998853  478999999999999999999888877665555444432110000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          322 ------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       322 ------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                                  .......+.++.++|.+||.+||++|||+.|+|.||||.+...++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~  295 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS  295 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence                        001123578899999999999999999999999999999988777644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-45  Score=352.67  Aligned_cols=249  Identities=20%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|++.+.||+|+||.||+|.+..++..||+|+....         ....|+.+++++. ||||+++++++......++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence            3599999999999999999999999999999975432         2245899999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence            99995 588887765 4568999999999999999999999999999999999999   788899999999997644433


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-ChH---------HHHHHHHcC-C---CcCCC
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-TQQ---------GIFDAVLKG-H---IDFES  322 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-~~~---------~~~~~~~~~-~---~~~~~  322 (398)
                      ......||+.|+|||++.+ .++.++|||||||++|||+++..|+... ...         ..+..+... .   ..++.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4455679999999999875 5899999999999999999865554322 110         111111110 0   00000


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          323 --------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       323 --------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                                                .....++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                      001135677889999999999999999999999999975

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-44  Score=339.91  Aligned_cols=260  Identities=26%  Similarity=0.369  Sum_probs=216.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++. |+||+++++.+...+.+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence            35899999999999999999999899999999886432  4445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          179 MELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||+++++|..++...   ..+++..+..++.+++.||.|||+ .||+||||||+||++   +.++.++|+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence            9999999998887653   368999999999999999999997 599999999999999   778899999999987654


Q ss_pred             CCCcccccccCCcccCcccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .. ......+++.|+|||.+.+       .++.++|||||||++|+|++|..||...........+............+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            32 2334568889999998752       257899999999999999999999976555444433322111112222335


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      ++.++.+||.+||+.+|++||++.+++.||||......
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            78999999999999999999999999999999887755

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.9e-44  Score=337.71  Aligned_cols=261  Identities=28%  Similarity=0.438  Sum_probs=219.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.++||.|+||.||+|.+..+++.||+|.+...   +....+.+.+|+.+++.+. ||||+++++.+..++.++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence            446799999999999999999999999999999998643   4556778899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+++++|..++.. ...+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence            99999999999887754 4568999999999999999999999999999999999999   7788999999999865432


Q ss_pred             C-CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          256 G-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      . .......+++.|+|||.+.      ..++.++|||||||++|+|++|..||...........+....... ......+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCccc
Confidence            2 2234456888999999884      236889999999999999999999998776665555554432221 1112346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      +.++.++|.+||+.||++||++.++++||||......
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            7899999999999999999999999999999765543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=338.10  Aligned_cols=257  Identities=32%  Similarity=0.486  Sum_probs=220.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||.|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.+. ||||+++++++......|+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            45699999999999999999999889999999998543   4556678899999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence            99999999999988664 569999999999999999999999999999999999999   78889999999988654322


Q ss_pred             -CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          257 -QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                       .......+++.|+|||.+.      ..++.++|+|||||++|+|++|..||...........+........ .....++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCC
Confidence             2234457899999999874      2367899999999999999999999988777666666655432211 1223578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .++.++|.+||+.||++||++.++|+||||.+.
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            899999999999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.1e-44  Score=334.05  Aligned_cols=255  Identities=29%  Similarity=0.426  Sum_probs=216.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||.|+||+||+|....++..+|+|++.....  ....+.+.+|+.+++.+. |+||+++++.+......++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            358999999999999999999888999999999865432  226678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          179 MELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||++++++|.+++...   ..+++..+..++.|++.||.+||+.|++||||+|+||++   ++++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence            9999999999998763   458999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CCc-----ccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC--CC
Q 015898          256 GQI-----FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--WP  326 (398)
Q Consensus       256 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~  326 (398)
                      ...     .....|+..|+|||.+..  .++.++|+|||||++|+|++|..||........+..............  +.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            322     134568899999998874  588999999999999999999999987766665555555432211111  23


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .+++++.+++.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            578899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-44  Score=346.89  Aligned_cols=256  Identities=20%  Similarity=0.248  Sum_probs=206.8

Q ss_pred             ecceeccc--CceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          103 LGRKLGQG--QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       103 ~~~~iG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      ++++||+|  +|++||++.+..+|+.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  789999999999999999999865432 3445567888999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.++++|||.+....... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence            99999999988653  458999999999999999999999999999999999999   777899999998654321110 


Q ss_pred             -------cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-----
Q 015898          258 -------IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-----  322 (398)
Q Consensus       258 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  322 (398)
                             ......++..|+|||++.+   .++.++|||||||++|||++|..||..............+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   1122356778999999864   4889999999999999999999999765544443333322211000     


Q ss_pred             -------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          323 -------------------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       323 -------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                                           .....+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                 00112467899999999999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.1e-44  Score=336.58  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=218.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||.|+||.||+|.+..++..+++|.+...   .....+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence            3478899999999999999999999999999998543   3455678889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+++++|...+.. ...+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999887765 4568999999999999999999999999999999999999   77889999999998654322 


Q ss_pred             CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          257 QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .......++..|+|||.+.      ..++.++|||||||++|+|++|..||...+..+....+......... ....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence            2223457889999999874      23778999999999999999999999887766665555443322111 1234788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ++.+||.+||+.||++||++.++++||||.....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            9999999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-44  Score=335.71  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=210.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------  171 (398)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+..|+.+++++.+|+||+++++++..      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            456889999999999999999999999999999986432    2345788899999999669999999999864      


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      ...+|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCC
Confidence            34689999999999999988763  358999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCC-CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          250 SVFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       250 a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      +...... .......|++.|+|||++.      ..++.++|||||||++|||++|..||................  ...
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~  235 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APR  235 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCC
Confidence            9765432 2234567899999999885      247889999999999999999999997665544444333322  111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .....++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2223578899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.3e-44  Score=336.08  Aligned_cols=254  Identities=25%  Similarity=0.348  Sum_probs=211.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.++||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++++. ||||+++++++...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEE
Confidence            4788999999999999999999999999999986432  3445667999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||+   +.++.++|+|||++...... ..
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IA  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cc
Confidence            99999988543    357899999999999999999999999999999999999   78889999999999765433 23


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh-------HHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-------QGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ....++..|+|||.+.+ .++.++|+|||||++|+|++|..||.....       ......+.....  ........+++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  228 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK  228 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence            45688999999999875 589999999999999999999999964321       122222222211  11112346789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      +.+++.+||+.||++||+++|+++||||......+
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence            99999999999999999999999999998775433

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2e-44  Score=338.58  Aligned_cols=241  Identities=17%  Similarity=0.231  Sum_probs=208.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec----CCeEEEEEe
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SLCVHIVME  180 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e  180 (398)
                      ..||+|++|.||+|..  +|+.||||.+...........+.+.+|+.+|+++. ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5799999999999985  78899999997654434444678889999999998 9999999999876    457899999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      |+++|+|.+++...+.+++.....++.+++.||.|||+ .+++||||||+|||+   ++++.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            99999999999888889999999999999999999998 499999999999999   888999999999987654322  


Q ss_pred             cccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ....|+..|+|||++.+   .++.++|||||||++|||++|..||.+.+..+.+..+......+...  ..+++++.+|+
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            34568899999999864   58999999999999999999999999888888887776554433322  24789999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 015898          337 RKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+||+.||++|||+.|+++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999974

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-44  Score=338.44  Aligned_cols=254  Identities=32%  Similarity=0.485  Sum_probs=213.1

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||+|+||+||+|.+..+|+.||+|.+.............+..|+.+++.++ ||||+++++++...+.+|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999999999999999987544333344556778999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccccc
Q 015898          187 LFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG  264 (398)
Q Consensus       187 L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~g  264 (398)
                      |.+++....  .+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999887765  69999999999999999999999999999999999999   7888999999999876654444445667


Q ss_pred             CCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccC
Q 015898          265 SPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (398)
Q Consensus       265 t~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  343 (398)
                      +..|+|||.+.+ .++.++|||||||++|+|++|..||...........+..............+++.+.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            889999999874 5889999999999999999999999765442222223232222233333457899999999999999


Q ss_pred             CCCCC-----CHHHHhcCCCccCCCC
Q 015898          344 PSERL-----TAHEVLCHPWICENGV  364 (398)
Q Consensus       344 P~~Rp-----s~~eiL~hp~~~~~~~  364 (398)
                      |++||     ++.+++.||||....+
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcCCh
Confidence            99999     8899999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-44  Score=337.39  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=219.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++. ||||+++++++.+....++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence            35888999999999999999999999999999986432  3455678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++++|.+++.. +++++..+..++.+++.||.|||+.+++|+||+|+||++   ++++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence            999999999998864 568999999999999999999999999999999999999   778899999999997654433 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......++..|+|||.+.+ .++.++|+|||||++|||++|..||...........+.....   ......++..+.+++
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  233 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEFI  233 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHHH
Confidence            2234567889999999874 588999999999999999999999987776655554433221   122234678899999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      .+||+.+|++||++.+++.||||......
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            99999999999999999999999877755

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-44  Score=338.94  Aligned_cols=275  Identities=30%  Similarity=0.467  Sum_probs=223.6

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ....+|++.+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.+. |+||+++++++...+..
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEE
Confidence            34467999999999999999999999999999999986432   233466889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||||+++++|.+++.. ..+++..+..++.+++.||.|||+.|++||||||+||++   +.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccC
Confidence            999999999999988754 458999999999999999999999999999999999999   7888999999999876543


Q ss_pred             CCc-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...........+..... ........++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  246 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPERLSAVFR  246 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCCccccCHHHH
Confidence            322 234568889999998875 588999999999999999999999977654333222222111 11112234678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHH
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQF  381 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~  381 (398)
                      +|+.+||..||++||++.++++||||........  +.+++...+.-+
T Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~--~~~~~~~~~~~~  292 (297)
T cd06656         247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS--LTPLIIAAKEAI  292 (297)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCchhcccccccc--cCHHHHHHHHHH
Confidence            9999999999999999999999999976654444  445554444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.1e-44  Score=329.00  Aligned_cols=252  Identities=30%  Similarity=0.471  Sum_probs=221.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||.+.+..+++.+++|.+..... +......+.+|+.+++++. |+||+++++++.+.+.++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence            48899999999999999999999999999999865433 4455677889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence            999999999998764  458999999999999999999999999999999999999   778899999999998664433


Q ss_pred             -cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+..+......   ..++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence             2345678999999999875 5888999999999999999999999888887777777766544322   4578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCc
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      |.+||+.+|++||++.++|+|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-45  Score=354.15  Aligned_cols=258  Identities=38%  Similarity=0.642  Sum_probs=238.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|.+.+.||+|.|++|.+|++..++..||||++.+... +....+.+.+|+++|+.|. |||||+++.+.+....+|+|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeEEE
Confidence            459999999999999999999999999999999987654 4445566999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||+.+|.+++++.+.+...+..+..++.|+..|++|||+++|||||||++|||+   +.+.++||+|||++..+..+..
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeeccccc
Confidence            9999999999999999999999999999999999999999999999999999999   8888999999999999998888


Q ss_pred             ccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ..+++|++.|.|||++.+.  -++.+|+||+|+++|-|+.|.+||.+.+..+.....+.+.+..+..    ++-++.+||
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~----ms~dce~lL  286 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY----MSCDCEDLL  286 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce----eechhHHHH
Confidence            8999999999999999863  5789999999999999999999999999888888888887766653    778999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      +++|..+|.+|++++++..|.|.......
T Consensus       287 rk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  287 RKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHhhccCccccCCHHHhhhhcccchhhhh
Confidence            99999999999999999999999876544

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.4e-45  Score=341.32  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=207.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.+...+++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            48889999999999999999999999999999865422 2233456778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      ||++ ++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++...... .
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            9996 578787765 4668999999999999999999999999999999999999   77889999999998765432 2


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCC-CcChHHHHHHHHcCCC--------------c-
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHI--------------D-  319 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~-~~~~~~~~~~~~~~~~--------------~-  319 (398)
                      ......+++.|+|||.+.+  .++.++|||||||++|+|++|..||. +.+....+..+.+...              . 
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2334567889999998864  37899999999999999999988864 3343333333321100              0 


Q ss_pred             --CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 --FE--------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 --~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                        +.        ....+.+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              00        01123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.3e-45  Score=335.44  Aligned_cols=252  Identities=30%  Similarity=0.477  Sum_probs=219.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++++. ||||+++++.+......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            3889999999999999999999899999999997665545556788999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||+++++|.+++.....+++..+..++.+++.||.|||++|++|+||+|+||++   ++++.++|+|||.+.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999877789999999999999999999999999999999999999   88889999999998876554444


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---HHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ....|+..|+|||.+.. .++.++|+||||+++|+|++|..||.....   .............    ....++.++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL----YPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc----CcccCcHHHHHH
Confidence            55678889999999874 489999999999999999999999987663   3333222212222    223477999999


Q ss_pred             HHHhcccCCCCCCCH--HHHhcCCCc
Q 015898          336 IRKMLCSQPSERLTA--HEVLCHPWI  359 (398)
Q Consensus       336 i~~~L~~dP~~Rps~--~eiL~hp~~  359 (398)
                      |.+||..||.+||++  +|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.5e-44  Score=338.28  Aligned_cols=258  Identities=31%  Similarity=0.470  Sum_probs=216.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ...+|++.+.||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.+. |+||+++++.+......+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEEE
Confidence            4457999999999999999999999999999999986543   233567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++......
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccc
Confidence            99999999999998754 468999999999999999999999999999999999999   77889999999998764432


Q ss_pred             C-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      . ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .......++..+.+
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  248 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHHHHH
Confidence            2 2234578899999998875 4889999999999999999999999877664443333322211 11122357789999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |+.+||..||++|||+.|++.||||....
T Consensus       249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            99999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.4e-44  Score=328.95  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=218.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+..... +......+.+|+.+++.+. ||||+++++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            48899999999999999999999999999999875443 3445678999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+++++|.+++...  ..+++..+..++.+++.||.|||++|++||||+|+||++.  ++++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence            999999999999764  3489999999999999999999999999999999999993  234568999999998776554


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......++..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+........   ...++.++.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHHHH
Confidence            4445678999999999875 478899999999999999999999988777666666655433211   224788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCc
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .+||+.||++|||+.|+++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-44  Score=349.95  Aligned_cols=264  Identities=27%  Similarity=0.432  Sum_probs=214.7

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC---
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~---  172 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.+. ||||++++++|...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence            45678999999999999999999999999999999986432 23445567888999999997 99999999988643   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ...|+||||+. ++|.+.+...  +++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~  164 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  164 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence               35799999995 5888877543  8999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc---------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------  319 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------  319 (398)
                      +.............+++.|+|||.+.+ .++.++|||||||++|+|++|..||...+....+..+......         
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            987655444445678899999999875 5899999999999999999999999876654444333221000         


Q ss_pred             -------------C--------------CCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          320 -------------F--------------ESD---PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       320 -------------~--------------~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                                   .              +..   .....+.++.++|.+||++||++|||+.|+|.||||..+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence                         0              000   01124567899999999999999999999999999987665433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.6e-44  Score=340.76  Aligned_cols=263  Identities=27%  Similarity=0.393  Sum_probs=215.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVH  176 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~~  176 (398)
                      +.|++.+.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++++. |+||+++++++...  +.++
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEE
Confidence            459999999999999999999999999999999864432 2222335667999999998 99999999998754  5689


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||++   ++++.+||+|||++.....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCC
Confidence            99999964 78887765 3568999999999999999999999999999999999999   7888999999999987654


Q ss_pred             C-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC--------------
Q 015898          256 G-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--------------  318 (398)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------  318 (398)
                      . .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||...+..+.+..+.....              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            3 22233456788999999864  478999999999999999999999988877776665544211              


Q ss_pred             -----cCCCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          319 -----DFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       319 -----~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                           ......       ....++++.+||.+||++||++|||+.|+|.||||.+...+-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~  301 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE  301 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence                 001000       1235788999999999999999999999999999998776644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.9e-44  Score=331.39  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=212.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEeccccc---CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +|++.+.||.|+||.||+|.+ .+++.+|+|.+.....   ........+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            378899999999999999985 5788999998864321   12334567899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-  255 (398)
                      +||||+++++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||++   ++++.++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999887889999999999999999999999999999999999999   7888999999999865421 


Q ss_pred             ------CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          256 ------GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       256 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                            ........++..|+|||.+.+ .++.++|||||||++|+|++|..||...........+....... ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCCC
Confidence                  112234568899999999875 58899999999999999999999998765544443333321111 1122357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +.++.++|.+||+.+|++||++.++|.||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.5e-44  Score=336.14  Aligned_cols=253  Identities=28%  Similarity=0.402  Sum_probs=204.0

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHh--cCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL--AGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .||+|+||.||++.+..+++.||+|.+.+.............+|..+++.+  .+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998765433233233344555444433  249999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccc
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  263 (398)
                      +++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||+   ++++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   788899999999987554332 23457


Q ss_pred             cCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          264 GSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       264 gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      |+..|+|||.+.+  .++.++|||||||++|+|++|..||......... .+..............++.++.++|.+||+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            8999999998863  4889999999999999999999999754322111 111111122222334578999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCCccCCC
Q 015898          342 SQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       342 ~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      .||++||     |++++++||||++..
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            9999999     699999999999855

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.6e-44  Score=335.51  Aligned_cols=255  Identities=30%  Similarity=0.510  Sum_probs=213.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++++. ||||+++++++......++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            48899999999999999999999999999999875432 2344567899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      ||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||++   ++++.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence            999 9999998865 3568999999999999999999999999999999999999   778899999999988765433 


Q ss_pred             -cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC----------------
Q 015898          258 -IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI----------------  318 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------------  318 (398)
                       ......++..|+|||.+.+  .++.++|||||||++|+|++|.+||.+......+..+.....                
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             2345678999999998863  378999999999999999999888877665554444332110                


Q ss_pred             ---cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          319 ---DFES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       319 ---~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                         .+..       ...+..+.++.+||.+||..||++|||+.++|+||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence               0110       11234678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.5e-44  Score=336.79  Aligned_cols=257  Identities=32%  Similarity=0.493  Sum_probs=218.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.+. ||||+++++++.....+++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence            356999999999999999999999999999999986432   233567889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |+||+++++|..++.. ..+++..+..++.+++.||.|||+.|++||||||+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccc
Confidence            9999999999887754 458999999999999999999999999999999999999   778899999999987654332


Q ss_pred             c-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 I-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      . .....++..|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .......++..+.+|
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  248 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFRDF  248 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHHHH
Confidence            2 234568889999999874 5889999999999999999999999887765554444433221 112233578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |.+||..||++|||+.+++.||||....
T Consensus       249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999999999998744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.9e-44  Score=328.35  Aligned_cols=252  Identities=25%  Similarity=0.509  Sum_probs=218.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++...+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            48899999999999999999999999999999865433 3345568899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+.+++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999887643  57899999999999999999999999999999999999   777889999999997654432


Q ss_pred             -cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       ......|++.|+|||++.+ .++.++|+|||||++++|++|..||......+....+..+.....   ...++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence             2234567889999999874 588899999999999999999999988887777777766654322   23478899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCc
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      |.+||+.+|++||++.||++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-44  Score=329.70  Aligned_cols=254  Identities=31%  Similarity=0.474  Sum_probs=216.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++...   .....+.+.+|+.+++.+. ||||+++++++.....+|+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence            35699999999999999999999889999999998654   2335678999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||++   ++++.++|+|||++......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999988776 679999999999999999999999999999999999999   78889999999998765432


Q ss_pred             C-cccccccCCcccCccccc-c---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-CCCCCCCH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLL-K---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLISD  330 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  330 (398)
                      . ......++..|+|||.+. .   .++.++|+|||||++|+|++|..||...........+......... .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 234467888999999886 3   5888999999999999999999999877665555544443222111 11223567


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      ++.++|.+||..||.+|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=343.63  Aligned_cols=274  Identities=28%  Similarity=0.471  Sum_probs=247.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      .+|.++.+||+|+||+|.+|..+.+.+.+|||++++.-+....+++--+.|-++|......|.++++...|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            34888999999999999999999999999999999888877788888888999998777788999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||+.||+|..++.+-++|.+..+..++..|+.||-+||++|||+||||.+||++   +.+|++||.|||+++..- .+.
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   999999999999997532 344


Q ss_pred             cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ...+++|||.|+|||++. ..|+..+|.||+||+||||+.|.+||.+++..+++..|......++..    +|.++.++.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs----lSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS----LSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc----ccHHHHHHH
Confidence            567899999999999998 469999999999999999999999999999999999999988888765    899999999


Q ss_pred             HHhcccCCCCCCCH-----HHHhcCCCccCCCCC--CCCCCCHHHHHHHH
Q 015898          337 RKMLCSQPSERLTA-----HEVLCHPWICENGVA--PDRSLDPAVLSRLK  379 (398)
Q Consensus       337 ~~~L~~dP~~Rps~-----~eiL~hp~~~~~~~~--~~~~~~~~~~~~~~  379 (398)
                      +.+|.+.|.+|..+     .+|-.||||....|.  ...-+.|++.|++|
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k  631 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK  631 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence            99999999999854     789999999875544  33456677777774

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=345.57  Aligned_cols=289  Identities=30%  Similarity=0.443  Sum_probs=221.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~----  172 (398)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.++++++ |+||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            4567999999999999999999999999999999985322  2344567888999999998 99999999987543    


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 -LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                       ...|+|+||+. ++|...+. ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence             35899999995 47877664 4569999999999999999999999999999999999999   888899999999987


Q ss_pred             ecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC--------
Q 015898          252 FFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH--------  317 (398)
Q Consensus       252 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--------  317 (398)
                      ......    ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+.......+....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            654322    1233578899999998753  58899999999999999999999997765433332221100        


Q ss_pred             --------------CcCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC---CHHHH
Q 015898          318 --------------IDFES-----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL---DPAVL  375 (398)
Q Consensus       318 --------------~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~---~~~~~  375 (398)
                                    .....     ...+.++.++.++|.+||+.||++|||+.|+++||||.....+.....   +.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  314 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFD  314 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChh
Confidence                          00000     012346788999999999999999999999999999988654322111   22233


Q ss_pred             HHHHHHHHHHHHHHHHhh
Q 015898          376 SRLKQFSAMNKLKKMALR  393 (398)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~  393 (398)
                      =+.-+..++-++|+.+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~  332 (336)
T cd07849         315 FELFDDLPKEKLKELIFE  332 (336)
T ss_pred             hccccccCHHHHHHHHHH
Confidence            233344446666666653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-43  Score=329.57  Aligned_cols=254  Identities=30%  Similarity=0.483  Sum_probs=210.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEeccccc--CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~  175 (398)
                      .|++.+.||+|+||.||+|.+..++..||+|.+.....  ........+.+|+.+++.++ ||||+++++++..  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            48889999999999999999999999999998864432  12344567899999999997 9999999998865  4678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++++||+++++|.+++...+.+++..+..++.|++.||.|||+.+|+||||+|+||++   +.++.++|+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccccc
Confidence            9999999999999999887789999999999999999999999999999999999999   7888999999999875432


Q ss_pred             C----CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          256 G----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       256 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .    .......++..|+|||.+.+ .++.++|||||||++|+|++|..||..................  ......+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISE  236 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcCH
Confidence            1    11233567889999999875 5889999999999999999999999876554444433322111  111234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      .+.++| +||..+|++||+++||++||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            889998 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.7e-44  Score=334.75  Aligned_cols=252  Identities=31%  Similarity=0.487  Sum_probs=207.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVHIV  178 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~~lv  178 (398)
                      |++.+.||+|+||.||+|.+..++..||+|.+..... +.. .....+|+.++.++.+|+|++++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6788999999999999999999999999999865321 222 234457899999997799999999999887  889999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||++ ++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||++   ++ +.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCC
Confidence            99996 5888877653 568999999999999999999999999999999999999   66 899999999998765554


Q ss_pred             cccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC------------------
Q 015898          258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------------------  317 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~------------------  317 (398)
                      ......++..|+|||.+.  +.++.++|||||||++|||++|..||.+.+..+....+....                  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            445567889999999775  347889999999999999999999998776655544443211                  


Q ss_pred             CcCCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          318 IDFESD-------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       318 ~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ..++..       ..+.++.++.+||.+||++||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000000       012467899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=353.72  Aligned_cols=253  Identities=27%  Similarity=0.449  Sum_probs=224.3

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |.=.+.||.|+||.||.|.+..+.+.||||.+......+.+..+.+.+|+.+|++|. |||++.+.|+|-.....|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHHHH
Confidence            555789999999999999999999999999998877778888899999999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          181 LCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      ||- |+-.|++. ..+++.+.++..|+.+.+.||.|||+.+.||||||..|||+   .+.|.|||+|||.|....+   .
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---A  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---A  179 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc---h
Confidence            994 57777774 45679999999999999999999999999999999999999   8899999999999987654   4


Q ss_pred             cccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      .+++|||+|||||++.    ++|+-++||||||++..||.-.++|++..+.-..+.-|.....+.  -..+.++..++.|
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~eWS~~F~~F  257 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYFRNF  257 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCchhHHHHHHH
Confidence            5789999999999986    579999999999999999999999998888776666665543322  2234678999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +..||++-|.+|||.+++|+|+|+.-..
T Consensus       258 vd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            9999999999999999999999996544

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.1e-44  Score=336.04  Aligned_cols=257  Identities=28%  Similarity=0.395  Sum_probs=207.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe----
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC----  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~----  174 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            358999999999999999999999999999998865321 223345788899999999868999999999876655    


Q ss_pred             -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeec
Q 015898          175 -VHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDF  247 (398)
Q Consensus       175 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DF  247 (398)
                       .|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||+.||+||||+|+||++   +. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~---~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---ecCCCeEEEeec
Confidence             8999999975 788877542     357999999999999999999999999999999999999   55 789999999


Q ss_pred             CCceecCCC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC----
Q 015898          248 GLSVFFKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF----  320 (398)
Q Consensus       248 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----  320 (398)
                      |++...... .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.........+.......    
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            998765322 22233467889999998863  47899999999999999999999998766554443332210000    


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          321 --------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       321 --------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                                          .....+.++.++.+||.+||.+||.+||++.|+|.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                0011134788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-44  Score=332.50  Aligned_cols=260  Identities=28%  Similarity=0.491  Sum_probs=217.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEecCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~~~~~~l  177 (398)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+.  .|||++++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            3788899999999999999999999999999986432  3445667889999999986  59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++++|.+++.. +.+++..+..++.+++.||.|||+.||+|+||+|+||++   ++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            9999999999988755 478999999999999999999999999999999999999   778899999999998765432


Q ss_pred             -cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       ......|+..|+|||.+.+  .++.++|+|||||++|+|++|..||...........+....  .+.-....++.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCHHHHH
Confidence             2234578899999998863  37889999999999999999999998766555443332221  111111236789999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ++.+||+.||++||++.|++.||||++....+.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~  266 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHSKTPV  266 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccccCch
Confidence            999999999999999999999999988665443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-45  Score=349.57  Aligned_cols=251  Identities=24%  Similarity=0.399  Sum_probs=215.2

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...+...+...||+|.||+||+|.+.+   .||||++..... +.+..+.|++|+..+++-+ |.||+-+.|++..... 
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-  462 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-
Confidence            344557889999999999999999876   599999987654 6778999999999999998 9999999999998887 


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec-
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-  253 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~-  253 (398)
                      .||+-||+|-+|+.+++- +.+|.....+.|++||+.|+.|||.++|||||||..||++   .+++.|||+|||++..- 
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeee
Confidence            999999999999999864 4569999999999999999999999999999999999999   88899999999998642 


Q ss_pred             --CCCCcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC-CCCCC
Q 015898          254 --KPGQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-SDPWP  326 (398)
Q Consensus       254 --~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  326 (398)
                        ..........|...|||||++.    ..|++.+|||||||++|||++|..||......+++-.+-+|..... .....
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence              3334455677888999999997    2499999999999999999999999997766666666655533222 22334


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+++++++|+..||.+++++||...+||.
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            57789999999999999999999999887

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-43  Score=330.92  Aligned_cols=256  Identities=28%  Similarity=0.436  Sum_probs=213.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccC-------CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-------SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+......       .....+.+.+|+.+++.+. |||++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            488899999999999999999889999999988532111       1123456889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          173 LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      +..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   7888999999999876


Q ss_pred             cCCCC---cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC--CCcCCCCC
Q 015898          253 FKPGQ---IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDP  324 (398)
Q Consensus       253 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~  324 (398)
                      .....   ......++..|+|||.+..   .++.++|+||||+++|++++|..||...........+...  ...++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43221   1234567889999998863   3788999999999999999999999765554433333222  22223333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .+.++.++.++|.+||.+||++|||++++|+||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            34578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-43  Score=327.02  Aligned_cols=254  Identities=31%  Similarity=0.458  Sum_probs=217.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEeccccc--CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      +|+..+.||+|+||.||+|.+..++..|++|.+.....  ...+..+.+.+|+.+++.+. |+||+++++++.....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            47788999999999999999988999999999865332  23455678999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      +|||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||++   +.++.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   788899999999988765544


Q ss_pred             cccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ......++..|+|||.+.. . ++.++|+|||||++|+|++|..||...........+....  ........+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHH
Confidence            4456678999999998864 4 8899999999999999999999997766544444443311  1112223578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCc
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +.+||+.+|++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.8e-43  Score=332.94  Aligned_cols=256  Identities=24%  Similarity=0.376  Sum_probs=211.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~----  172 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++...    ......+.+|+.++.++.+|||++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            356699999999999999999999999999999998542    223456778999999996699999999998643    


Q ss_pred             -CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          173 -LCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       173 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                       +.+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++||||||+||++   ++++.+||+||
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~df  172 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDF  172 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeec
Confidence             468999999999999988753    3568999999999999999999999999999999999999   77888999999


Q ss_pred             CCceecCCCC-cccccccCCcccCcccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC
Q 015898          248 GLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       248 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      |++....... ......|+..|+|||.+..      .++.++|||||||++|+|++|+.||...........+.+.....
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            9987654322 2234568889999998752      26889999999999999999999998776655555554432221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      .. ....++..+.+||.+||+.||++||++.|+++||||+
T Consensus       253 ~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 LL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            11 1224667899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-43  Score=333.10  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=208.9

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-----
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-----  170 (398)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+||||+++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            34567999999999999999999999999999999875421    223567789999999966999999999873     


Q ss_pred             cCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      .++.+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.++|+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEcc
Confidence            45679999999999999887753    3468899999999999999999999999999999999999   7778899999


Q ss_pred             cCCceecCCCC-cccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc
Q 015898          247 FGLSVFFKPGQ-IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID  319 (398)
Q Consensus       247 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  319 (398)
                      ||++....... ......|++.|+|||++.      ..++.++|||||||++|+|++|..||........+.........
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            99987654322 223456899999999874      23788999999999999999999999876554443333222111


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                       .......++.++.+||.+||+.||++|||+.|+++|+||
T Consensus       248 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 -TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             -cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             111112357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=343.74  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=212.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|++.++||+||.++||++.. .+...+|+|.+.. ...+...+..+.+||..|.+|.+|.+|+++++|-..++.+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            4599999999999999999984 4556677776643 3346777889999999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||= ..+|..+|.+... +....++.+..|++.|+.++|..||||.||||.|+|+.    .|.+||+|||.|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCccc
Confidence            9984 5689998887654 34358999999999999999999999999999999994    4689999999998877654


Q ss_pred             ---cccccccCCcccCcccccc------------cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcCC
Q 015898          258 ---IFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE  321 (398)
Q Consensus       258 ---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~  321 (398)
                         .....+||+.||+||.+..            +.+.++||||||||||+|+.|+.||..-. ...-+..|......+.
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence               2346799999999999851            14678999999999999999999995433 3444555555533222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ....+ -..+++++++.||.+||++|||+.++|+|||++......+
T Consensus       594 fp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~  638 (677)
T KOG0596|consen  594 FPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVE  638 (677)
T ss_pred             ccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccch
Confidence            22211 1245999999999999999999999999999987544333

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.3e-44  Score=336.69  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=211.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.++||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEE
Confidence            58899999999999999999988999999999865432 2234567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-Cc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~~  258 (398)
                      ||++++.|..+......+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.++|+|||++...... ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccc
Confidence            999998888777666679999999999999999999999999999999999999   78889999999998765433 23


Q ss_pred             ccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC------------------
Q 015898          259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------------------  318 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------  318 (398)
                      .....++..|+|||++.+  .++.++|||||||++|+|++|.+||......+....+.....                  
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            344568889999999874  478899999999999999999999976554333222221000                  


Q ss_pred             -cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 -DFES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 -~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                       ..+.        ...+.++..+.+|+.+||+.||++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             0000        1123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9e-44  Score=327.98  Aligned_cols=251  Identities=28%  Similarity=0.454  Sum_probs=213.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+...     ...+.+.+|+.+++.+. |+||+++++++.....+|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence            4699999999999999999999888999999998643     22678999999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      +||+++++|.+++.. ...+++..+..++.+++.||.|||+.|++||||+|+||++   ++++.++|+|||++.......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence            999999999998865 4568999999999999999999999999999999999999   778899999999988765433


Q ss_pred             -cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       ......++..|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......++.++.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence             2334567889999999875 5889999999999999999999999876655444333222111 111123467899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCc
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      |.+||+.||++|||+.|+|.||||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-43  Score=327.10  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=218.0

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe--cCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~--~~~~~~l  177 (398)
                      +|++.+.||.|+||.||+|.+..++..||+|.+..... .....+++..|+.+++.+. ||||+++++++.  .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            38889999999999999999999999999999865433 4555678899999999998 999999999775  4567899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACH-----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH-----~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      +|||+++++|.+++..    ...+++..+..++.+|+.||.|||     +.+++|+||+|+||++   ++++.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence            9999999999998865    356899999999999999999999     9999999999999999   778899999999


Q ss_pred             CceecCCCCc-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          249 LSVFFKPGQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       249 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      ++........ .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..+.....   ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI---PY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC---cc
Confidence            9987655443 345678999999999874 588999999999999999999999988877777777666543322   23


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .++.++.+++.+||..+|++||++.+|++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            577899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-43  Score=326.97  Aligned_cols=254  Identities=29%  Similarity=0.462  Sum_probs=214.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.+. |+||+++++++...+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            48889999999999999999988999999999875543 3456788999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc-
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-  258 (398)
                      ||+++++|.+++.....+++..+..++.+++.||.|||+.||+|+||+|+||++   ++++.+||+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887778999999999999999999999999999999999999   7788999999999877543322 


Q ss_pred             ----ccccccCCcccCcccccc-c---CCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCCCcCCCCCCCCCC
Q 015898          259 ----FTDVVGSPYYVAPEVLLK-H---YGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       259 ----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                          .....++..|+|||.+.+ .   ++.++||||||+++|++++|..||...... .....+.. ...........++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                123567889999999873 3   788999999999999999999999755322 22222222 2111222233458


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ..+.++|.+||+.||++|||+.|++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.2e-44  Score=332.09  Aligned_cols=255  Identities=26%  Similarity=0.371  Sum_probs=215.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....  ......++.+|+.+++.+. ||||+++++.+...+.+++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence            4888899999999999999999999999999986543  3355677899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+++++|.+++... ..+++..+..++.+++.||.|||+ .|++|+||||+||++   ++++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHH
Confidence            999999999998775 779999999999999999999999 999999999999999   778899999999987654322


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-----ChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      . ....++..|+|||.+.+ .++.++||||||+++|+|++|..||...     ........+......  ......++.+
T Consensus       156 ~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  232 (265)
T cd06605         156 A-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSPD  232 (265)
T ss_pred             h-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCHH
Confidence            2 22678889999999875 5899999999999999999999999654     223333333332211  1111127889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.++|.+||..||++|||+.+++.||||+.+.
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.3e-44  Score=339.55  Aligned_cols=249  Identities=25%  Similarity=0.414  Sum_probs=192.0

Q ss_pred             cceecccCceEEEEEEEcc--CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe--cCCeEEEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCVHIVM  179 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~--~~~~~~lv~  179 (398)
                      +.+||+|+||.||+|.+..  ++..||+|.+....     ....+.+|+.+++.+. ||||+++++++.  .....++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            4689999999999999654  56789999886432     2245778999999998 999999999884  456789999


Q ss_pred             eccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec-CCCccEEEeecCC
Q 015898          180 ELCAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DDDFSLKAIDFGL  249 (398)
Q Consensus       180 e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~-~~~~~~kL~DFG~  249 (398)
                      ||+. ++|.+.+...         ..+++..+..++.||+.||.|||+.||+||||||+|||+... +.++.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9985 4777776421         247899999999999999999999999999999999999433 3567899999999


Q ss_pred             ceecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---------HHHHHHH
Q 015898          250 SVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------GIFDAVL  314 (398)
Q Consensus       250 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------~~~~~~~  314 (398)
                      +.......    ......+|+.|+|||++.+  .++.++|||||||++|||++|.+||......         ..+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98654332    2234578999999999874  4899999999999999999999999643211         1111111


Q ss_pred             cCCC--------------------------cC--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          315 KGHI--------------------------DF--------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       315 ~~~~--------------------------~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ....                          ..        ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000                          00        000011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.3e-44  Score=330.61  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=211.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccC---CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      |+..+.||+|+||.||+|.+..+++.||+|++......   .....+.+.+|+.++++++ |+||+++++++.+.+.+++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEEE
Confidence            77889999999999999999999999999998643321   1224578999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-cEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~~~~  256 (398)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||++   +.++ .++|+|||.+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~---~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEcccccccccccc
Confidence            99999999999999888889999999999999999999999999999999999999   5544 6999999998765432


Q ss_pred             C-----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC-CcCCCCCCCCCC
Q 015898          257 Q-----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-IDFESDPWPLIS  329 (398)
Q Consensus       257 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  329 (398)
                      .     ......++..|+|||.+.+ .++.++|||||||++|+|++|..||...........+.... ..........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     1223567889999999874 58899999999999999999999996544333222222111 111122223478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      +++.+++.+||..+|++||++.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-43  Score=333.15  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=216.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+++++.+. ||||+++++++...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            45999999999999999999999999999999886432  3445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++...+.+++..+..++.+++.||.|||+ .+++||||+|+||++   ++++.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence            9999999999998887889999999999999999999997 689999999999999   77889999999998654322 


Q ss_pred             cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChH-----------HHHHHHHcCCCcCCCCCC
Q 015898          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-----------GIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~  325 (398)
                      ......|+..|+|||.+. ..++.++|||||||++|+|++|..||......           +....+......  ....
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPS  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCc
Confidence            223457899999999886 46889999999999999999999999764431           222233222111  1111


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      ..++.++.+|+.+||+.||++|||+.|+++|+||.......
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            23678999999999999999999999999999998765443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.1e-43  Score=332.63  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=212.6

Q ss_pred             cceecceecccCceEEEEEEEccCC-----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.++..+. ||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~   82 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCCc
Confidence            5889999999999999999876655     689999886432  4445667899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          175 VHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      .+++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.|++||||||+||++   ++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence            99999999999999998764                457889999999999999999999999999999999999   77


Q ss_pred             CccEEEeecCCceecCCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHH
Q 015898          239 DFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~  313 (398)
                      ++.++|+|||++.......   ......+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8899999999997653322   223445678899999886 468999999999999999998 99999988888888777


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ..+.....   ...++.++.+|+.+||+.||++||++.||+++
T Consensus       240 ~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            76554322   23578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-44  Score=354.38  Aligned_cols=250  Identities=19%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ..+.+|+.+|++|. |+||+++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            3469999999999999999999999999999996421         23567999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence            999994 6888888654 469999999999999999999999999999999999999   77889999999999765432


Q ss_pred             C---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--------hHHHHHHHHcCCCc---CC
Q 015898          257 Q---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--------QQGIFDAVLKGHID---FE  321 (398)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~--------~~~~~~~~~~~~~~---~~  321 (398)
                      .   ......||+.|+|||++.+ .++.++|||||||+||||++|..|+....        ...+...+......   ++
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            2   1234579999999999875 58999999999999999999886653321        12233333221111   00


Q ss_pred             ------------------------CCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          322 ------------------------SDPW---PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       322 ------------------------~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                                              ...|   ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    0011   135568999999999999999999999999999964

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.5e-44  Score=347.38  Aligned_cols=252  Identities=22%  Similarity=0.352  Sum_probs=204.1

Q ss_pred             cccceecceecccCceEEEEEEE-----ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.+.||+|+||.||+|.+     ..++..||||++....  .....+.+.+|+.++..+.+||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            34699999999999999999974     3456789999986433  2334567889999999995599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG---------------------------------------------------------  195 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  195 (398)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886432                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          196 ------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       196 ------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                                        .+++..+..++.||+.||.|||+.||+||||||+|||+   ++++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence                              36788899999999999999999999999999999999   677889999999998654332


Q ss_pred             cc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          258 IF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       258 ~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ..   ....++..|+|||.+.+ .++.++|||||||++|||++ |..||........+...........  .....+.++
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  346 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM  346 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence            11   12334567999999875 58999999999999999998 8899977654433333333322211  123467899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .+||.+||+.||++|||+.|+++.
T Consensus       347 ~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         347 YDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-43  Score=331.67  Aligned_cols=252  Identities=26%  Similarity=0.443  Sum_probs=208.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe------cC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE------DS  172 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~------~~  172 (398)
                      +.|++.+.||.|+||.||+|.+..+++.||+|++...    ......+..|+.+++++.+|+||+++++++.      ..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            4699999999999999999999999999999998542    3344678899999999977999999999985      35


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          173 LCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      ..+|++|||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+||||+|+||++   ++++.++|+|||++
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcch
Confidence            6789999999999999988653  348889999999999999999999999999999999999   77889999999998


Q ss_pred             eecCCC-CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC
Q 015898          251 VFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       251 ~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (398)
                      ...... .......|++.|+|||.+.      ..++.++|||||||++|+|++|..||...........+.....  ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~  246 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--PKL  246 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--CCC
Confidence            754321 2234467899999999875      2478899999999999999999999976655444333332211  111


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ....++.++.+||.+||+.||.+|||+.|+|+||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            123578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=329.20  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=212.0

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~----  173 (398)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++....    ...+.+.+|+.+++++.+|+||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            467999999999999999999998899999999986432    234678899999999966999999999997544    


Q ss_pred             --eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          174 --CVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       174 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                        .+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCC
Confidence              58999999999999988765    3578999999999999999999999999999999999999   77889999999


Q ss_pred             CCceecCCC-CcccccccCCcccCcccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC
Q 015898          248 GLSVFFKPG-QIFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       248 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      |++...... .......++..|+|||.+..      .++.++|||||||++|+|++|..||...........+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            998765432 22334668899999998742      36789999999999999999999998766555555554443221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      . .....++.++.+||.+||..||++|||+.++++|||+
T Consensus       238 ~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1 1112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.9e-43  Score=334.96  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             cccceecceecccCceEEEEEEEcc----------------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA----------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN  161 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n  161 (398)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++.+++ |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence            4569999999999999999997532                34579999986532  4455678999999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015898          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-------------------HYSERKAAELTRIIVGVVEACHSLGVM  222 (398)
Q Consensus       162 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~~i~~al~~lH~~~ii  222 (398)
                      |+++++++.+.+..++||||+++++|.+++....                   .+++..+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886531                   367788999999999999999999999


Q ss_pred             eccCCCCcEEEeecCCCccEEEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh--
Q 015898          223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--  296 (398)
Q Consensus       223 HrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt--  296 (398)
                      ||||||+|||+   ++++.+||+|||++........   .....++..|+|||.+. +.++.++|||||||++|||++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   7788999999999976543322   12334577899999886 468999999999999999987  


Q ss_pred             CCCCCCCcChHHHHHHHHcC----CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          297 GVPPFWAETQQGIFDAVLKG----HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       297 g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +..||......+....+...    .........+.++..+.+|+.+||+.||++|||+.+|.+
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            56788776666555443221    111111122357889999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-43  Score=329.31  Aligned_cols=248  Identities=20%  Similarity=0.301  Sum_probs=209.2

Q ss_pred             ccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ..|++.+.||+|+||.||+|.+.   ..+..||+|.+....  +......+.+|+..++++. ||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence            35899999999999999999865   446689999986532  3445567899999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+|||+   +.++.++|+|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence            9999999999999988764 568999999999999999999999999999999999999   778899999999876543


Q ss_pred             CCCccc--ccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQIFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ......  ...++..|+|||.+. ..++.++|||||||++||+++ |..||......+....+..+....   ....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCH
Confidence            222222  233457899999887 468999999999999999875 999999888888777776553221   2345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+.+++.+||+.+|++||++.+|++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.8e-44  Score=335.08  Aligned_cols=255  Identities=28%  Similarity=0.420  Sum_probs=216.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+....  .....+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEE
Confidence            45888999999999999999998899999999986432  3345678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++++|.+++.. +.+++..+..++.+++.||.|||++|++|+||+|+||++   ++++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence            999999999888754 568999999999999999999999999999999999999   777899999999997654332 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......++..|+|||.+.+ .++.++|||||||++|||++|..||...........+......   .....++.++.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li  233 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEFV  233 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHHH
Confidence            2233567889999999875 5889999999999999999999999766655544444333211   11224678999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .+||+.+|++||++.++++||||....
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            999999999999999999999997755

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.6e-44  Score=347.14  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=204.5

Q ss_pred             cccceecceecccCceEEEEEEEccC-----CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+.+|+||+++++++...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            35699999999999999999986543     3579999986543  3344677899999999995599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 015898          173 LCVHIVMELCAGGELFDRIIQR----------------------------------------------------------  194 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  194 (398)
                      +..++||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc---
Q 015898          195 ------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF---  259 (398)
Q Consensus       195 ------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~---  259 (398)
                                  ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++.........   
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence                        136788899999999999999999999999999999999   77889999999999765433211   


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ....++..|+|||++.+ .++.++|||||||++|+|++ |..||........+...........  ....+++++.+++.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  349 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMK  349 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHH
Confidence            12234567999998874 69999999999999999997 9999987655444444433322221  12246899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 015898          338 KMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~  355 (398)
                      +||+.||++|||+.++++
T Consensus       350 ~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         350 MCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.8e-43  Score=331.19  Aligned_cols=256  Identities=25%  Similarity=0.293  Sum_probs=206.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+.....  .....++..|+.++.+..+||||+++++++..++..|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            58899999999999999999999999999999865432  2233456667776555555999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          180 ELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       180 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ||++ ++|.+++..    ...+++..+..++.|++.||.|||++ +++||||||+||++   +.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccc
Confidence            9996 578776654    24689999999999999999999997 99999999999999   888899999999998665


Q ss_pred             CCCcccccccCCcccCcccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .........++..|+|||.+.+     .++.++|+|||||++|+|++|..||... ...+.+.....+...  ......+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  233 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP--QLPAEKF  233 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC--CCCcccc
Confidence            4333344678899999998752     3688999999999999999999999642 222333333332111  1111247


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.++.++|.+||..+|++||++.+++.||||....
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            89999999999999999999999999999998865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-43  Score=329.38  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=217.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||.|+||.||+|.+..++..||+|.+....  .......+.+|+.++.++. ||||+++++++..+...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            34888999999999999999998899999999885432  2345567899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++++|.+++.. ..+++..+..++.+++.|+.+||+.|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence            999999999888754 568999999999999999999999999999999999999   778899999999987654332 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......++..|+|||.+.. .++.++|+|||||++|+|++|..||...........+......   .....++.++.+++
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHHH
Confidence            2234567889999999874 5788999999999999999999999876665555555443221   11234688999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      .+||+.+|++||++.++++||||.+....
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence            99999999999999999999999886433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.5e-43  Score=333.00  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=216.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+........+..+.+.+|+.+++.+. ||||+++.+++...+..+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeEE
Confidence            3356999999999999999999998899999999986554445556678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+. +++.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||++   ++++.++|+|||++.....
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence            9999996 577776654 4568999999999999999999999999999999999999   8888999999999876543


Q ss_pred             CCcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      .   ....+++.|+|||++.    +.++.++||||||+++|+|++|..||...........+......  ......++.+
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  242 (307)
T cd06607         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWSDY  242 (307)
T ss_pred             C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhCHH
Confidence            2   3456788999999874    34889999999999999999999999877665554444332211  1112236789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.++|.+||..||++||++.+++.||||....
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.1e-44  Score=336.27  Aligned_cols=261  Identities=28%  Similarity=0.480  Sum_probs=218.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|.....||+|+||.||++.+..++..||||.+...   .....+.+.+|+.+++.+. |+||+++++.+...+..+
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW   95 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence            445566678899999999999999899999999998543   3445667889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++. .+.+++..+..++.+|+.||.|||++||+||||||+||++   ++++.++|+|||++......
T Consensus        96 lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          96 VVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccc
Confidence            9999999999988774 4568999999999999999999999999999999999999   77889999999998654322


Q ss_pred             C-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      . ......++..|+|||.+.+ .++.++||||||+++|||++|..||........+..+..... ........++..+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHH
Confidence            1 2234568899999999875 588999999999999999999999988776665555443221 111222346889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      ++.+||..||.+|||+.++++||||.....+.
T Consensus       251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         251 FLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            99999999999999999999999998776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.6e-43  Score=325.54  Aligned_cols=254  Identities=30%  Similarity=0.494  Sum_probs=211.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEeccccc--CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~  175 (398)
                      .|++.+.||+|+||.||+|.+..++..||||.+.....  ......+.+.+|+.+++++. ||||+++++++.+  ...+
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCceE
Confidence            58899999999999999999999999999998854321  12345678899999999997 9999999998876  3578


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +++|||+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||||+||++   +.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccccc
Confidence            8999999999999999887788999999999999999999999999999999999999   7788999999999875432


Q ss_pred             C----CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          256 G----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       256 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .    .......++..|+|||.+.+ .++.++|||||||++|+|++|..||..................  ......++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVSD  236 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhCH
Confidence            1    11234568889999999874 5889999999999999999999999876555444443322211  112234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      .+.++|.+|| .+|++||++.|+++|||+.
T Consensus       237 ~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         237 HCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence            8999999999 4999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-44  Score=312.80  Aligned_cols=257  Identities=25%  Similarity=0.338  Sum_probs=223.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      .+.+..||.|+-|.|+++..+.+|...|||.+.+..  +.+..+++...+.++..-.++|+||+.+|+|..+..+++.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            566778999999999999999999999999997554  778888999999988877668999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACH-SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH-~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      .| ...+..++.. .+++++..+-++...++.||.||- ++||||||+||+|||+   |+.|.+||||||.+...-+...
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc
Confidence            98 4455555544 456999999999999999999997 4689999999999999   9999999999999988877777


Q ss_pred             ccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          259 FTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .+...|-+.|||||.+.    ..|+..+||||||++++||.||..||.+ ....+++-++.+... .....-..+++.++
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQ  326 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHH
Confidence            78889999999999986    2599999999999999999999999987 456677888877443 22222234899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      +|+..||.+|+.+||...++|+|||+.....
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            9999999999999999999999999987663

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-43  Score=328.50  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             ccceeccee--cccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           99 DLYTLGRKL--GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        99 ~~y~~~~~i--G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.|++.+.+  |.|+||.||++.++.++..+|+|.+.......        .|+.....+.+||||+++++.+...+..+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            446666666  99999999999999999999999986542211        12323333335999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-cEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~~~  255 (398)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||++   +.++ .++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY---DRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---eCCCCeEEEecCccceecCC
Confidence            999999999999999887789999999999999999999999999999999999999   5556 899999999876543


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIF-DAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .   ....++..|+|||.+.+ .++.++||||||+++|+|++|..||......... ...... ........+.+++.+.
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQKKLPFIKNVSKNAN  238 (267)
T ss_pred             C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-hcccCCcccccCHHHH
Confidence            2   23468899999999874 5899999999999999999999999755433221 111111 1222233346889999


Q ss_pred             HHHHHhcccCCCCCCC-HHHHhcCCCccC
Q 015898          334 DLIRKMLCSQPSERLT-AHEVLCHPWICE  361 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps-~~eiL~hp~~~~  361 (398)
                      +||.+||++||.+||+ ++++|+||||+.
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 699999999963

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=333.15  Aligned_cols=255  Identities=29%  Similarity=0.457  Sum_probs=211.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.++||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.+. |+||+++++++...+..++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence            58999999999999999999999999999998864322 3444578899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ||++++.+.........+++..+..++.+++.||.|||+.|++||||+|+||++   ++++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence            999887666655555679999999999999999999999999999999999999   788999999999988765443  


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC-----------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-----------------  318 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------------  318 (398)
                      ......++..|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+.....                 
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            3345678899999999873  578999999999999999999999976655443332221000                 


Q ss_pred             --cCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 --DFES---------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 --~~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                        .+..         .....++.++.+||++||..+|++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              0000         0011247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=332.11  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=204.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+. |+||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            459999999999999999999998999999999865331  222345678999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++...... 
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence            999975 898888654 468999999999999999999999999999999999999   78889999999998654321 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCc--------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHID--------------  319 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~--------------  319 (398)
                      .......++..|+|||.+.+  .++.++||||+||++|+|++|..||.... ..+....+.+....              
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            12223456888999998864  47899999999999999999999997654 22222222110000              


Q ss_pred             -----CC-------CCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 -----FE-------SDPWPLIS--DSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 -----~~-------~~~~~~~~--~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                           ..       ....+.++  .++.++|.+||++||++|||+.++|.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                 00       00011234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-43  Score=327.53  Aligned_cols=251  Identities=35%  Similarity=0.571  Sum_probs=219.2

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||.|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++++. ||||+++++.+..+...|++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999998889999999997654444456778999999999998 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC---------
Q 015898          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---------  257 (398)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~---------  257 (398)
                      |.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887789999999999999999999999999999999999999   788899999999987543321         


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......++..|+|||.+.. .++.++||||||+++|+|++|..||...........+..+...++..  ..++.++.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence            2234567889999998874 48889999999999999999999999888888888877755544332  12489999999


Q ss_pred             HHhcccCCCCCCCH---HHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLTA---HEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps~---~eiL~hp~~~~~~  363 (398)
                      .+||+.+|++|||+   .++|+||||.+..
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            99999999999999   9999999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.7e-43  Score=328.86  Aligned_cols=256  Identities=28%  Similarity=0.494  Sum_probs=217.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|...+.||+|++|.||+|.+..+++.||+|.+...   .....+.+.+|+.+++.+. ||||+++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEE
Confidence            455668999999999999999899999999988533   3344567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-c
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~  258 (398)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||++   +.++.++|+|||.+....... .
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCcc
Confidence            99999999998876 678999999999999999999999999999999999999   788899999999886543321 2


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+........ .....++..+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  250 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFLD  250 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHHH
Confidence            234568899999999875 588999999999999999999999988777666666655422221 112237889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      +||+.+|++|||+.++++||||.++..
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCCC
Confidence            999999999999999999999988764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-44  Score=342.04  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=208.0

Q ss_pred             CCCCcceeeeccccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC
Q 015898           81 GIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK  160 (398)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~  160 (398)
                      ....+++.++..++++|..    ...||+|+||.||+|.. .+|..||||.+.......   ..+|.+|+.++.+++ ||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~----~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~  131 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSE----SNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HP  131 (361)
T ss_pred             CcceeeHHHHHHHHhCCch----hcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-Cc
Confidence            4455677777777776554    68999999999999994 566899999876543211   455999999999998 99


Q ss_pred             CeeEEeEEEecCC-eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEe
Q 015898          161 NIVTIKGAYEDSL-CVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLLV  234 (398)
Q Consensus       161 niv~l~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~---iiHrDikp~NIll~  234 (398)
                      |+|+|+|||.+.+ ..+||+||+++|+|.++|....  .++|....+|+.+++.||+|||...   ||||||||+|||+ 
T Consensus       132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL-  210 (361)
T KOG1187|consen  132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL-  210 (361)
T ss_pred             CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE-
Confidence            9999999999998 5999999999999999998765  8999999999999999999999854   9999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCC-CCccccc-ccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC---hHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET---QQG  308 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~  308 (398)
                        |+++.+||+|||+|..... ....... .||.+|+|||++. +..+.++||||||++|+||+||+.+.....   ...
T Consensus       211 --D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  211 --DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             --CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence              9999999999999976554 3332333 8999999999997 679999999999999999999998876432   111


Q ss_pred             HHH----HHHcCCCcCCCCCC---CCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          309 IFD----AVLKGHIDFESDPW---PLIS-----DSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       309 ~~~----~~~~~~~~~~~~~~---~~~~-----~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ...    .+.++......++.   ...+     ..+..+..+|++.+|.+||++.||++
T Consensus       289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            111    22222211111111   1122     23667888999999999999999754

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-43  Score=329.60  Aligned_cols=253  Identities=28%  Similarity=0.395  Sum_probs=204.9

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHH---HHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI---MHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~---l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      +||+|+||.||+|.+..+++.||+|.+.+..............|..+   ++.. +||+|+.+++++...+.+++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence            48999999999999999999999999876543222222233344433   3334 4999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccc
Q 015898          183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV  262 (398)
Q Consensus       183 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~  262 (398)
                      +|++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.++|+|||++....... ....
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~  155 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHAS  155 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCc
Confidence            999999999888889999999999999999999999999999999999999   778899999999987654322 2345


Q ss_pred             ccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcC---hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          263 VGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       263 ~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .|+..|+|||.+.+  .++.++||||+||++|+|++|..||....   ..............    ....++.++.+++.
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~  231 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRSLLE  231 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHHHHH
Confidence            78999999999863  48899999999999999999999997653   22222222222222    22346899999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCCccCCCCCCC
Q 015898          338 KMLCSQPSERL-----TAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       338 ~~L~~dP~~Rp-----s~~eiL~hp~~~~~~~~~~  367 (398)
                      +||..+|.+||     ++.++++||||++..+...
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~  266 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV  266 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence            99999999999     9999999999988664433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-43  Score=332.88  Aligned_cols=258  Identities=24%  Similarity=0.292  Sum_probs=208.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|+..+.||+|+||.||++.+..+++.||+|.+....  .......+.+|+.++.++.+|+||+++++++......+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc--ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4667889999999999999999999999999986543  22456678899999999977999999999999999999999


Q ss_pred             eccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          180 ELCAGGELFDRI---I--QRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       180 e~~~~~~L~~~l---~--~~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||+. +++.++.   .  ....+++..+..++.+++.||+|||+. +++||||||+||++   +.++.++|+|||++...
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHh
Confidence            9985 4554432   2  235699999999999999999999974 99999999999999   77889999999999765


Q ss_pred             CCCCcccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHcCCC-cCCCCCCCC
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHI-DFESDPWPL  327 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~-~~~~~~~~~  327 (398)
                      ..........|+..|+|||.+.+    .++.++|||||||++|+|++|..||..... .+....+..+.. .........
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            54443345578899999999863    488999999999999999999999965431 122222222211 112222234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++.++.+||.+||+.||++|||++++++||||.+..
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            789999999999999999999999999999998755

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=334.27  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=217.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      -|.+..+||+|+||.||+|.++.+|+.||||.+..     ..+++++.+||.|++++. .|++|++||.|.....+||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeeh
Confidence            37788999999999999999999999999999864     346789999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||..|++.+++.. ++++++.++..+++..+.||+|||...-||||||..|||+   +.+|+.||+|||.|..+.... 
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH
Confidence            99999999999865 5679999999999999999999999999999999999999   888999999999997664432 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ...+++|||.|||||++.. .|+.++||||||++..||.-|++||.+-.+-..+-.+-. ..+........++.++.|+|
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHH
Confidence            2356899999999999986 699999999999999999999999976554322211111 11111111234788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++||-++|++|.|+.++++|||++.+.
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            999999999999999999999998754

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-43  Score=333.81  Aligned_cols=255  Identities=29%  Similarity=0.423  Sum_probs=210.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVH  176 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~~  176 (398)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++++. ||||+++++++...  +..|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc-cccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            358999999999999999999999999999999865432 2223345678999999998 99999999998877  8999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++.....
T Consensus        83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            9999996 48988886643 58999999999999999999999999999999999999   7888999999999887654


Q ss_pred             C-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-------------
Q 015898          256 G-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-------------  319 (398)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------------  319 (398)
                      . .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||......+....+......             
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 23344567889999998864  3688999999999999999999999877665555444321100             


Q ss_pred             -------------CCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 -------------FESDPWPL--ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 -------------~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                   ......+.  +++.+.++|.+||+.||++|||+.|+|.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         00011122  47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-43  Score=331.83  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=207.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||.|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++ ||||+++++++.+.+..++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEee
Confidence            7889999999999999999999999999998864322 2333457889999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          181 LCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       181 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      |+. ++|.+++..  ...+++..+..++.+++.||+|||+.|++||||+|+||++   ++++.+||+|||++...... .
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc
Confidence            995 588888765  3468999999999999999999999999999999999999   88889999999998765432 2


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc----------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------------  319 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------  319 (398)
                      ......+++.|+|||.+.+  .++.++|||||||++|+|+||..||...........+......                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            2334457889999998864  3688999999999999999999999776654433332211000                


Q ss_pred             --CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 --FE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 --~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                        ++       ....+.++.++.++|.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              00       01123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3e-43  Score=331.88  Aligned_cols=262  Identities=28%  Similarity=0.415  Sum_probs=212.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++.....+|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            358999999999999999999999999999999865432 2233467888999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||++ ++|.+++.....  +++..+..++.||+.||.|||++|++||||+|+||++.  ..++.+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCC
Confidence            99995 578887765443  57888999999999999999999999999999999993  13457999999999764332


Q ss_pred             -CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-------------
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------------  320 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------  320 (398)
                       .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||......+....+.......             
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22344567889999998864  47889999999999999999999998776655554432210000             


Q ss_pred             --------C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          321 --------E----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       321 --------~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                              .    ....+.+++++.++|.+||+.||++||++.++++||||.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence                    0    00123467889999999999999999999999999999887654

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-43  Score=330.86  Aligned_cols=253  Identities=35%  Similarity=0.615  Sum_probs=221.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++.+||||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            58999999999999999999999999999999976555455556788899999999977999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      |++++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++.......  
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcccc
Confidence            999999999999888889999999999999999999999999999999999999   778899999999987654322  


Q ss_pred             -------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC
Q 015898          258 -------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH  317 (398)
Q Consensus       258 -------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~  317 (398)
                                         ......++..|+|||.+.. .++.++||||||++++++++|..||........+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence                               1223467889999998874 58889999999999999999999998877666666666544


Q ss_pred             CcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q 015898          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTA----HEVLCHPWI  359 (398)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~----~eiL~hp~~  359 (398)
                      ..++.    .+++.+.+||.+||+.||++|||+    .++++||||
T Consensus       239 ~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 YSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44332    468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=359.82  Aligned_cols=258  Identities=33%  Similarity=0.473  Sum_probs=214.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEE-Eec------C
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-YED------S  172 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~-~~~------~  172 (398)
                      +++|.+.|.+|||+.||+|.+...|..||+|++...   +.+..+.+.+||.+|+.|++|+|||.++|. ...      .
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            488899999999999999999888899999988543   788899999999999999999999999993 321      2


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          173 LCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      -.++|.||||+||.|.|++..+  ..|++.++++|++++++|+.+||...  |||||||-+||||   ..++.+||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCccc
Confidence            3588999999999999999753  45999999999999999999999998  9999999999999   888899999999


Q ss_pred             CceecCCCC----------cccccccCCcccCccccc---c-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHH
Q 015898          249 LSVFFKPGQ----------IFTDVVGSPYYVAPEVLL---K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL  314 (398)
Q Consensus       249 ~a~~~~~~~----------~~~~~~gt~~y~aPE~~~---~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~  314 (398)
                      .|.-.-...          ..-....|+.|+|||.+.   + ..+.|+|||+|||+||-|+....||++...    -.|+
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIl  267 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAIL  267 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEE
Confidence            986432111          011235689999999885   3 489999999999999999999999976533    2566


Q ss_pred             cCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                      ++.+.++..  +..+..+.+||+.||+.||++||++-+++.+-+-......+...
T Consensus       268 ng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~  320 (738)
T KOG1989|consen  268 NGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD  320 (738)
T ss_pred             eccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence            777777654  56889999999999999999999999998865544444333333

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-43  Score=341.02  Aligned_cols=263  Identities=30%  Similarity=0.443  Sum_probs=214.0

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~----  172 (398)
                      +.++|++.+.||+|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.+. |+||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            34579999999999999999999999999999999864322 3334567788999999997 99999999987644    


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 -LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                       ...|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++   +.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence             35899999995 6898988887889999999999999999999999999999999999999   778899999999998


Q ss_pred             ecCCC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC-----------
Q 015898          252 FFKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-----------  317 (398)
Q Consensus       252 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-----------  317 (398)
                      ..... .......++..|+|||.+..  .++.++|||||||++|+|++|..||.+.+.......+....           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65443 23345578889999998863  58899999999999999999999997655433222221100           


Q ss_pred             -----------CcC-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          318 -----------IDF-----ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       318 -----------~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                 ...     .....+.+++++.+||.+||++||++|||+.++|+||||......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                       000     001124578899999999999999999999999999999875433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=327.11  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=209.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~~l  177 (398)
                      +|+..+.||.|++|.||+|.+..+++.||+|.+....  ......++.+|+++++.+. ||||+++++++..  .+.+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence            5888999999999999999999999999999986542  3345677899999999997 9999999998854  457899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||||+++++|.+++..    ...+++..+..++.+|+.||.|||+.|++|+||+|+||++   ++++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccc
Confidence            9999999999887653    3458999999999999999999999999999999999999   77788999999998754


Q ss_pred             CCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-----ChHHHHHHHHcCCCcC-CCCCC-
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDF-ESDPW-  325 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~-~~~~~-  325 (398)
                      .... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||...     ...+....+....... ..... 
T Consensus       156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd06621         156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN  234 (287)
T ss_pred             cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence            4322 234567889999998874 5899999999999999999999999755     2233444433322111 11111 


Q ss_pred             -CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          326 -PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       326 -~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                       ..+++++.++|.+||..||++|||+.|++.||||+...
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence             13467899999999999999999999999999995544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.9e-43  Score=325.41  Aligned_cols=252  Identities=25%  Similarity=0.445  Sum_probs=211.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            35999999999999999999999999999999886554445566677899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          179 MELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||+++++|.+++..    ...+++..+..++.+++.||.|||++|++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999887753    3448899999999999999999999999999999999999   778889999999988764


Q ss_pred             CCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||....  .......+....  ++......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            332 1234568889999998874 58899999999999999999999996543  234444443322  22222234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .+.+++.+||+.+|++||++.+|++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            89999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.6e-43  Score=324.54  Aligned_cols=254  Identities=28%  Similarity=0.389  Sum_probs=219.0

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||+|++|.||+|.+..+++.||+|++....  .......+.+|+..+..+. |+||+++++++...+.+++||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc--chHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence            4888999999999999999999999999999986543  2245678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||++   +.++.++|+|||.+........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence            999999999999887889999999999999999999999 999999999999999   7888999999999987654332


Q ss_pred             c-cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---ChHHHHHHHHcCCCcCCCCCCCC-CCHHH
Q 015898          259 F-TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFESDPWPL-ISDSA  332 (398)
Q Consensus       259 ~-~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  332 (398)
                      . ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...   ...+....+........   ... ++..+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  232 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---PAEEFSPEF  232 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---CcccCCHHH
Confidence            2 24567889999999875 5888999999999999999999999766   44445555443322211   123 78899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .++|.+||..+|++|||+.++++||||+..
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-43  Score=333.40  Aligned_cols=270  Identities=28%  Similarity=0.498  Sum_probs=222.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|.....||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++..+. ||||+++++++..++..++||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEEE
Confidence            3556678999999999999998899999999986432   233466889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-c
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~  258 (398)
                      ||+++++|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++....... .
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccccc
Confidence            99999999886644 568999999999999999999999999999999999999   888899999999986543322 2


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....++..|+|||.+.+ .++.++|||||||++|||++|..||...........+...... .......++..+.++|.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDFLE  252 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHHHH
Confidence            234678999999999874 5899999999999999999999999877766666655443222 22223457889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHH
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAM  384 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (398)
                      +||+.+|++||++.++++||||.+.....      ...+..+++.++
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~~------~~~~~~~~~~~~  293 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQTGLPE------CLVPLIQQYRKR  293 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccCCCcc------cccchHHHHhhh
Confidence            99999999999999999999998776522      234455555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.9e-44  Score=342.30  Aligned_cols=266  Identities=27%  Similarity=0.418  Sum_probs=216.0

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe----cCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----DSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~----~~~  173 (398)
                      .++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++.    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence            4679999999999999999999999999999999865322 3344567888999999998 999999999875    345


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+++||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||++   ++++.+||+|||++...
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL  157 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence            7899999995 6898988877789999999999999999999999999999999999999   88899999999998765


Q ss_pred             CCCC-----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC----------
Q 015898          254 KPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG----------  316 (398)
Q Consensus       254 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~----------  316 (398)
                      ....     ......++..|+|||.+.+  .++.++|||||||++|+|++|+.||.+......+..+...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            3321     1234578899999998863  4889999999999999999999999776543332221110          


Q ss_pred             -------------CCcCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          317 -------------HIDFES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       317 -------------~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                                   ......    ...+.++.++.++|.+||+.||++|||+.+++.||||.+........
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~  307 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP  307 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc
Confidence                         000000    01234688999999999999999999999999999998866555433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.9e-43  Score=333.02  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=203.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-----  172 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+++++. ||||+++++++...     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccccc
Confidence            3459999999999999999999999999999999864322 2222345678999999997 99999999988654     


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                         ...++||||+. ++|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||++   +.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg  164 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFG  164 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCC
Confidence               34699999995 47877776543 68999999999999999999999999999999999999   788899999999


Q ss_pred             CceecCCCC-----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          249 LSVFFKPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       249 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                      ++.......     ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...........+..-...++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            987653322     1234567888999998864  378899999999999999999999977665444333322110000


Q ss_pred             -------------------CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          322 -------------------SDP---------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       322 -------------------~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                         ...         ....++.+.+||.+||+.||++|||++++|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                               000         01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.6e-43  Score=333.16  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=205.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcE--EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .|++.+.||+|+||.||+|.+..++..  +|+|.+..  .........+.+|+.++.++.+|+||+++++++..++.+|+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            488999999999999999998877765  56666542  22455567888999999999559999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc
Q 015898          178 VMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                      ||||+++++|.+++...+                .+++..+..++.|++.||+|||++|++||||||+|||+   ++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence            999999999999987542                47899999999999999999999999999999999999   77889


Q ss_pred             EEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCc
Q 015898          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHID  319 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  319 (398)
                      +||+|||++.............++..|+|||.+.+ .++.++|||||||++|||+| |..||......+....+....  
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--  240 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--  240 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--
Confidence            99999999864322111112234567999998874 48899999999999999998 999998887777766654432  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                       .......+++++.+||.+||+.+|++||++.++|.+
T Consensus       241 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 -RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             111222468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.4e-43  Score=322.19  Aligned_cols=248  Identities=30%  Similarity=0.498  Sum_probs=214.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||++.+..++..||+|.+....  .....+.+.+|+.+++.+. |+||+++++.+...+.+|++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            4888999999999999999999999999999986433  3445678889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+++++|.+.+...  ..+++..+..++.+++.||.|||++||+|+||||+||++   ++++.++|+|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999888653  358999999999999999999999999999999999999   788899999999997664332


Q ss_pred             -cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       ......+++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+..+......   ..++..+.+|
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence             2334678899999999875 5889999999999999999999999888777777776665443222   2477899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 015898          336 IRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~h  356 (398)
                      |.+||+.||++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.5e-43  Score=335.97  Aligned_cols=267  Identities=27%  Similarity=0.401  Sum_probs=216.6

Q ss_pred             cccccce-ecceecccCceEEEEEEEccCCcEEEEEEecccccCCHh-----------hHHHHHHHHHHHHHhcCCCCee
Q 015898           96 NIRDLYT-LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----------DVEDVRREIQIMHHLAGHKNIV  163 (398)
Q Consensus        96 ~~~~~y~-~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~Ei~~l~~l~~h~niv  163 (398)
                      .+.++|. +.+.||.|+||.||+|.+..+++.||||.+.........           ....+.+|+.+++.+. |+||+
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence            3556676 457899999999999999999999999998654321100           1125778999999997 99999


Q ss_pred             EEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEE
Q 015898          164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (398)
Q Consensus       164 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~k  243 (398)
                      ++++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||++   +.++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~k  159 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICK  159 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEE
Confidence            99999999999999999996 5899999887789999999999999999999999999999999999999   7888999


Q ss_pred             EeecCCceecCCC---------------CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCh
Q 015898          244 AIDFGLSVFFKPG---------------QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ  306 (398)
Q Consensus       244 L~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~  306 (398)
                      |+|||++......               .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||...+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999998765411               11223456788999999874  378999999999999999999999988777


Q ss_pred             HHHHHHHHcCCCcCCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          307 QGIFDAVLKGHIDFES------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       307 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .+.+..+.........                        ...+..+.++.++|.+||+.||++|||++|+|.||||+..
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            6655544331110000                        0112457889999999999999999999999999999987


Q ss_pred             CCCCC
Q 015898          363 GVAPD  367 (398)
Q Consensus       363 ~~~~~  367 (398)
                      .....
T Consensus       320 ~~~~~  324 (335)
T PTZ00024        320 PLPCD  324 (335)
T ss_pred             CCCCC
Confidence            65433

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.4e-43  Score=326.91  Aligned_cols=248  Identities=22%  Similarity=0.369  Sum_probs=211.4

Q ss_pred             ccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +.|.+.+.||+|+||.||+|.+..     ++..||+|.+....  ..+..+.+.+|+++++.+. |+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            458899999999999999998643     45789999986432  3445678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC
Q 015898          174 CVHIVMELCAGGELFDRIIQRG--------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~  239 (398)
                      ..++||||+++++|.+++...+              .+++..+..++.+++.||.|||++|++||||||+||++   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence            9999999999999999987542              37889999999999999999999999999999999999   788


Q ss_pred             ccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHH
Q 015898          240 FSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL  314 (398)
Q Consensus       240 ~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~  314 (398)
                      +.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||......+....+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999999976433221   123345678999999874 58999999999999999998 999999888888888777


Q ss_pred             cCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+......   ..++.++.+++.+||+.||++||++.|+++
T Consensus       239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66544332   357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-43  Score=328.29  Aligned_cols=253  Identities=28%  Similarity=0.462  Sum_probs=209.2

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|++|.||+|.+..+|..||||.+....  .......+.+|+.+++++. |+||+++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc--cccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            3888999999999999999999999999999986543  2233456778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+||++   ++++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99975 888877654   358999999999999999999999999999999999999   78889999999998754332


Q ss_pred             -CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-----------
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-----------  322 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----------  322 (398)
                       .......++..|+|||.+.+  .++.++|||||||++|+|++|..||.+.+..+....+.........           
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             12234567889999998864  4788999999999999999999999877766555444321100000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          323 --------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       323 --------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                    ...+.++.++.++|.+||+.||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          0012357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.6e-43  Score=327.96  Aligned_cols=254  Identities=27%  Similarity=0.408  Sum_probs=202.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.+. |+||+++++++......|+|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence            459999999999999999999999999999999865432  222345678999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence            99995 677776654 3457889999999999999999999999999999999999   77889999999998754322 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCC--------------Cc
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGH--------------ID  319 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~--------------~~  319 (398)
                      .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||...... +.+..+....              ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            22234567889999999864  4788999999999999999999999754432 2221111000              00


Q ss_pred             CCCC------------CCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 FESD------------PWP--LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 ~~~~------------~~~--~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +...            .+.  ..+.++.+++.+||..||++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0000            000  125689999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-44  Score=348.02  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=224.3

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEeccccc-CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe--EEEE
Q 015898          102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC--VHIV  178 (398)
Q Consensus       102 ~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~--~~lv  178 (398)
                      +...+||+|+|-+||+|.|..+|..||--.++.... .++...+++..|+.+|+.|. ||||++++++|.+...  +.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence            557789999999999999999999998766554333 35666799999999999998 9999999999986554  8899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +|++..|+|..++++.+......+..|++||+.||.|||++.  |||||||-+||+|+  ...|.|||+|+|+|......
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence            999999999999999999999999999999999999999985  99999999999995  45689999999999886654


Q ss_pred             CcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      . ...++|||.|||||.+...|+..+||||||++|+||.|+..||.. .++.++++++..|..+-....  .-++++++|
T Consensus       200 ~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~f  276 (632)
T KOG0584|consen  200 H-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREF  276 (632)
T ss_pred             c-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHH
Confidence            4 455899999999999999999999999999999999999999964 567788889888875533332  236899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |.+||.. .++|+|+.|+|.||||....
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhcccc
Confidence            9999999 99999999999999999863

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=351.72  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=218.1

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCC
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG  185 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~  185 (398)
                      +||+|.||+||.|+|..+....|||.+..+   .....+-+..||.+-++|+ |.|||+++|.+.+++.+-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            699999999999999999999999999654   4556678999999999998 999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccc
Q 015898          186 ELFDRIIQR-GHY--SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTD  261 (398)
Q Consensus       186 ~L~~~l~~~-~~~--~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~  261 (398)
                      +|.+++... +++  .+..+..+.+||++||.|||++.|||||||-+|||+.  +=.|.+||+|||.++.... +....+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999988653 666  8899999999999999999999999999999999995  4468999999999876643 334567


Q ss_pred             cccCCcccCccccc-c--cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          262 VVGSPYYVAPEVLL-K--HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       262 ~~gt~~y~aPE~~~-~--~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      +.||..|||||++- +  .|+.++|||||||++.||.||++||.... +...+-+  -+.+....+....++.+++.+|.
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--VGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--VGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--hcceecCCCCcHHHHHHHHHHHH
Confidence            89999999999997 2  59999999999999999999999996432 3332222  23344344444457889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD  371 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~  371 (398)
                      +|+.+||.+||++.++|.+||++...-.+-..++
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls  847 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS  847 (1226)
T ss_pred             HHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence            9999999999999999999999987544433333

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=328.07  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=208.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.+. |||++++++++.+.+..|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            6678899999999999999999999999999865432 2333456788999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          181 LCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      |++ ++|.+++....  .+++..+..++.|++.||.|||+.+++||||+|+||++   ++++.++|+|||++...... .
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence            995 68998887665  68999999999999999999999999999999999999   77889999999998765322 2


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC-----------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-----------------  318 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------------  318 (398)
                      ......++..|+|||++.+  .++.++||||||+++|+|++|..||...........+.+...                 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2234456889999998864  378899999999999999999999987665443333222100                 


Q ss_pred             --------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 --------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                              .......+.++.++.++|.+||+.||.+|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                    00111124567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-43  Score=339.92  Aligned_cols=281  Identities=27%  Similarity=0.443  Sum_probs=226.2

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+......+.+|+.+++.+. ||||+++.+++...
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   86 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA   86 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence            34456778999999999999999999999999999999886432 23445567888999999997 99999999988655


Q ss_pred             Ce------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          173 LC------VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       173 ~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ..      .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~d  161 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILD  161 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcc
Confidence            54      89999998 6799887765 569999999999999999999999999999999999999   7788999999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC---
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE---  321 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---  321 (398)
                      ||++......  .....++..|+|||.+.+  .++.++|||||||++|+|++|+.||......+.+..+........   
T Consensus       162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9999865432  345577889999998864  478899999999999999999999987776655554433211000   


Q ss_pred             --------------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHH
Q 015898          322 --------------------S----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSR  377 (398)
Q Consensus       322 --------------------~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~  377 (398)
                                          .    .....++.++.+||.+||+.||++|||+.+|+.||||.++.........+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~~  319 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPPYDQS  319 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccccccCcc
Confidence                                0    0112358899999999999999999999999999999998877665554444444


Q ss_pred             HHHHH
Q 015898          378 LKQFS  382 (398)
Q Consensus       378 ~~~~~  382 (398)
                      ...++
T Consensus       320 ~~~~~  324 (343)
T cd07851         320 FESRD  324 (343)
T ss_pred             hhhhh
Confidence            33333

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=295.03  Aligned_cols=258  Identities=27%  Similarity=0.471  Sum_probs=219.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|...++||+|.||+||+|++..+++.||+|.+..... +...-....+||.+|+.|. |.|||+++++...+..+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            36667899999999999999999999999999875432 2223356789999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      ||| ..+|..+... ++.+..+.++.++.|++.||.++|++++.|||+||.|+|+   +.+|.+||+|||+|+.+.-.- 
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE
Confidence            999 4477666654 5679999999999999999999999999999999999999   889999999999998776543 


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCC--------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP--------  326 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  326 (398)
                      .++.-+.|.+|++|.++.+  -|+...|+||.|||+.|+.. |++.|.+.+..+.+..+.+---....+.|+        
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            4556678999999999985  39999999999999999998 888899999888888886633333333332        


Q ss_pred             -----------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          327 -----------------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       327 -----------------~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                       .++...+||++++|.-+|..|++++++|+||||.+..
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                             2345678999999999999999999999999998754

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-42  Score=318.14  Aligned_cols=252  Identities=29%  Similarity=0.518  Sum_probs=220.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+++++.+. |+|++++.+.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            48889999999999999999998999999999865432 3456678899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          180 ELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       180 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||+++++|.+.+...    ..+++..+..++.+++.||.+||+.|++|+||+|+||++   ++++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence            999999999988764    679999999999999999999999999999999999999   7788999999999977654


Q ss_pred             CC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. ......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||.....................   ..++.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            33 3334578889999998874 5889999999999999999999999887777777776665433222   25789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +++.+||..+|++|||+.++|.||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.2e-42  Score=325.19  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=212.0

Q ss_pred             cccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.+.||+|+||.||+|..+.     .+..||+|.+....  .......+.+|+.+++.+. ||||+++++++...
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            4679999999999999999997542     34589999875432  3334456888999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          173 LCVHIVMELCAGGELFDRIIQR----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                      +..++||||+++|+|.+++...          ..++...+..++.|++.||.|||++||+||||||+||++   ++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence            9999999999999999999653          234667889999999999999999999999999999999   778899


Q ss_pred             EEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCC
Q 015898          243 KAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH  317 (398)
Q Consensus       243 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  317 (398)
                      +|+|||++........   .....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+....+....+..+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999875433221   122345677999999874 68999999999999999998 789998888777777766553


Q ss_pred             CcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCccCCC
Q 015898          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC------HPWICENG  363 (398)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~------hp~~~~~~  363 (398)
                      .....   ..+++++.+++.+||+.||++|||+.++++      ||||.+..
T Consensus       239 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         239 YLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            32211   246789999999999999999999999987      99998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=326.19  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=210.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVHIV  178 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~~lv  178 (398)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+. |+|++++++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            677889999999999999999999999999997543 23334467889999999998 99999999999888  899999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++ +|.+++... ..+++..+..++.+|+.||+|||+.|++|+||+|+||++   ++++.++|+|||++.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            999964 888888665 579999999999999999999999999999999999999   888999999999998765432


Q ss_pred             --cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC---------
Q 015898          258 --IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP---------  324 (398)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  324 (398)
                        ......++..|+|||.+.+  .++.++||||||+++|+|++|..||...........+.+.........         
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2344567888999998764  478999999999999999999999988776665555443211111000         


Q ss_pred             -----------------CCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          325 -----------------WPL-ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       325 -----------------~~~-~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                       ... ++.++.++|.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                             111 37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-44  Score=321.60  Aligned_cols=263  Identities=28%  Similarity=0.426  Sum_probs=207.7

Q ss_pred             cceecceecccCceEEEEEEEccCC----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-CCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~~~  174 (398)
                      .|++...||+|.||.||+|..++++    +.+|||.++.++..+. .-....+|+.+++.|+ |||++.+..+|-. +..
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccCce
Confidence            4899999999999999999755443    3789999876543211 1235678999999998 9999999999876 888


Q ss_pred             EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-cCCCccEEEeecC
Q 015898          175 VHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN-KDDDFSLKAIDFG  248 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~-~~~~~~~kL~DFG  248 (398)
                      +++++||.+. +|..+++..     +.++...+..|+.||+.|+.|||++-|+||||||.|||+.. ..+.|.|||+|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999976 888887542     35899999999999999999999999999999999999932 1235999999999


Q ss_pred             CceecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---------HHHHHHH
Q 015898          249 LSVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ---------QGIFDAV  313 (398)
Q Consensus       249 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~---------~~~~~~~  313 (398)
                      +|+.+.+.-    ....++.|.+|+|||.+.+  .|+.+.||||+|||+.||++-.+.|.+...         .+.++.|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            999876542    2345778999999999985  699999999999999999999888854321         2334444


Q ss_pred             HcCCCcCCCCCCCC---------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          314 LKGHIDFESDPWPL---------------------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       314 ~~~~~~~~~~~~~~---------------------------------~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      .+-.-....+.|+.                                 -++.+.+|+.+||..||.+|+|+.++|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            33111111111111                                 245589999999999999999999999999999


Q ss_pred             CCCCC
Q 015898          361 ENGVA  365 (398)
Q Consensus       361 ~~~~~  365 (398)
                      +...+
T Consensus       342 ~d~lp  346 (438)
T KOG0666|consen  342 EDPLP  346 (438)
T ss_pred             cCCCC
Confidence            87554

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-42  Score=326.07  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=209.4

Q ss_pred             ccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +.|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+.+++++. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            45899999999999999999852     34567999988543   3455678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          174 CVHIVMELCAGGELFDRIIQRG-------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      .+++||||+++++|.+++...+             .+++..+..++.|++.||+|||+.|++||||||+||++   ++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence            9999999999999999887543             38999999999999999999999999999999999999   7888


Q ss_pred             cEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHc
Q 015898          241 SLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~  315 (398)
                      .++|+|||++........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976533221   123345678999999874 58999999999999999998 9999988888888888777


Q ss_pred             CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.....   ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            653322   2247889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-42  Score=324.58  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=208.4

Q ss_pred             ccccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+. ||||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            34679999999999999999998642     35679999885432  3344567889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRG----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                      ....++||||+++++|.+++....          .+++..+..++.+++.||.|||+.|++||||||+||++   ++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence            999999999999999999886532          35778899999999999999999999999999999999   77889


Q ss_pred             EEEeecCCceecCCCCcc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcC
Q 015898          242 LKAIDFGLSVFFKPGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG  316 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~  316 (398)
                      ++|+|||++.........   ....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.+.........+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998755432221   12345678999999874 58999999999999999999 78999888877777766665


Q ss_pred             CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .....   ...++..+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43222   23477899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.7e-43  Score=334.79  Aligned_cols=288  Identities=27%  Similarity=0.393  Sum_probs=222.0

Q ss_pred             cceecceecccCceEEEEEEEccC--CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec----CC
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SL  173 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~----~~  173 (398)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+.... ......+.+.+|+.+++++.+||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            388899999999999999999888  8999999986422 2333456788899999999779999999987532    24


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+|+++||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||++   ++++.+||+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            5889999985 6899988887889999999999999999999999999999999999999   78889999999999765


Q ss_pred             CCCC-----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC--------
Q 015898          254 KPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--------  318 (398)
Q Consensus       254 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------  318 (398)
                      ....     ......|+..|+|||.+.+  .++.++|||||||++|+|++|..||........+..+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4321     1234578999999998764  488999999999999999999999987664444333222100        


Q ss_pred             -------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC-CHHHHHHH
Q 015898          319 -------------------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL-DPAVLSRL  378 (398)
Q Consensus       319 -------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~-~~~~~~~~  378 (398)
                                         .......+.++..+.+++.+||+.||++|||+.+++.||||..+..+..... ..++..-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~  315 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSF  315 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCc
Confidence                               0001122346789999999999999999999999999999987664322111 12222222


Q ss_pred             HHHHHHHHHHHHHh
Q 015898          379 KQFSAMNKLKKMAL  392 (398)
Q Consensus       379 ~~~~~~~~~~~~~~  392 (398)
                      ..=..++.+|+++.
T Consensus       316 ~~~~~~~~~~~~~~  329 (332)
T cd07857         316 ESEDSMEELRDMII  329 (332)
T ss_pred             cccccHHHHHHHHh
Confidence            33345666777664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=348.04  Aligned_cols=275  Identities=31%  Similarity=0.512  Sum_probs=250.4

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      .+++..||.|+||.|=++.-......+|+|++++..+....+.+.+..|-.||..++ .|.||++|..|.+..++|+.||
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhHH
Confidence            667889999999999999866655569999999999999999999999999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT  260 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~  260 (398)
                      -|-||.|...+..++.|.+..++.++..+++|++|||++|||+|||||+|.++   +.+|.+||.|||+|+.+..+...-
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999   999999999999999999888888


Q ss_pred             ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHh
Q 015898          261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (398)
Q Consensus       261 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  339 (398)
                      ++||||.|.|||++.+ ..+.++|.||||+++|||++|.+||.+.++-..+..|+++.-.+..+  ..+++.+.+||+++
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~L  655 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKKL  655 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHHH
Confidence            9999999999999875 58999999999999999999999999999999999999986443332  35889999999999


Q ss_pred             cccCCCCCCC-----HHHHhcCCCccCCCCCC--CCCCCHHHHHHHHHH
Q 015898          340 LCSQPSERLT-----AHEVLCHPWICENGVAP--DRSLDPAVLSRLKQF  381 (398)
Q Consensus       340 L~~dP~~Rps-----~~eiL~hp~~~~~~~~~--~~~~~~~~~~~~~~~  381 (398)
                      ...+|.+|..     +.||-+|-||.+..|..  ...++||+.+.++.+
T Consensus       656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p  704 (732)
T KOG0614|consen  656 CRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP  704 (732)
T ss_pred             HhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence            9999999985     79999999999977654  456777777766544

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-43  Score=337.14  Aligned_cols=271  Identities=27%  Similarity=0.429  Sum_probs=219.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-  173 (398)
                      ..+.++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.+. ||||+++++++.... 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   88 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLS   88 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcc
Confidence            346778999999999999999999999999999999985432 23344567889999999997 999999999987553 


Q ss_pred             -----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          174 -----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       174 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                           .+++||||+ +++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg  163 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG  163 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecc
Confidence                 468999998 778877765 4568999999999999999999999999999999999999   778899999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC------
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF------  320 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------  320 (398)
                      ++......  .....+++.|+|||.+.+  .++.++|+|||||++|+|++|..||...........+.+.....      
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99765432  234567899999998874  48899999999999999999999998766544444332211100      


Q ss_pred             ---------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHH
Q 015898          321 ---------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV  374 (398)
Q Consensus       321 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~  374 (398)
                                           .....+.+++++.++|.+||+.||++|||+.+++.||||+...........+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY  316 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence                                 001123577889999999999999999999999999999987665554443333

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=344.00  Aligned_cols=256  Identities=35%  Similarity=0.524  Sum_probs=219.7

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +..+.+.|++...+|.|+|+.|-.+.+..+++..++|++.+..       ....+|+.++....+||||+++.+++.+..
T Consensus       317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCc
Confidence            3356778999999999999999999999999999999997652       223457878888888999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ..|+|||++.|+.+.+.+.....+. ..+..|+++|+.|+.|||++|+|||||||+|||+.  ++.++++|+|||.+...
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhC
Confidence            9999999999999988887766666 88889999999999999999999999999999994  36789999999999876


Q ss_pred             CCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...  ....+-|..|.|||++.. .|+.++||||||++||+||+|..||...... ++...+..+...      ..+|++
T Consensus       467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~  538 (612)
T KOG0603|consen  467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDE  538 (612)
T ss_pred             chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHH
Confidence            554  345567889999999985 5999999999999999999999999876655 555555544433      368999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      +++||.+||+.||.+|+++.+++.||||-.....+.
T Consensus       539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p~  574 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPALRLGADEIGAHPWFLSHPTFPP  574 (612)
T ss_pred             HHHHHHHhccCChhhCcChhhhccCcchhcCCCCCc
Confidence            999999999999999999999999999955444333

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-42  Score=327.61  Aligned_cols=256  Identities=30%  Similarity=0.540  Sum_probs=214.1

Q ss_pred             ceecceecccCceEEEEEEEc---cCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      |++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.++.++.+|+||+.+++.+..+..++
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            788999999999999999875   47899999998653321 12334678889999999977999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||+   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecccc
Confidence            999999999999999888889999999999999999999999999999999999999   77889999999999765443


Q ss_pred             C--cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCCCCCC
Q 015898          257 Q--IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .  ......|+..|+|||.+..   .++.++||||||+++|+|++|..||....    .......+......++    ..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~  234 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QE  234 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----cc
Confidence            2  2234568899999999863   36789999999999999999999996432    2333333333332222    24


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ++..+.+++.+||..||++||     ++++++.||||....
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            788999999999999999997     899999999998876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-42  Score=320.88  Aligned_cols=252  Identities=27%  Similarity=0.498  Sum_probs=214.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++ |+||+++++.+......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            48889999999999999999999999999999865432 2234567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC-ccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~-~~~kL~DFG~a~~~~~~  256 (398)
                      ||+++++|.+++....  .+++..+..++.+++.||.|||+.+++|+||||+||++   +++ ..++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL---SKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---cCCCCeEEecccccchhccCC
Confidence            9999999999887643  47899999999999999999999999999999999999   555 35799999998765443


Q ss_pred             C-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      . ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.......   ..+.++.++.+
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRS  232 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHH
Confidence            2 2234568889999998874 58899999999999999999999998777666666655544322   12356789999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +|.+||..+|++|||+.|+++||||
T Consensus       233 ~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         233 LISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=332.60  Aligned_cols=255  Identities=28%  Similarity=0.426  Sum_probs=203.0

Q ss_pred             cceecceecccCceEEEEEEEcc--CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~  175 (398)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+...........+.+.+|+.+++.+. ||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            48889999999999999999988  89999999997643223334467788999999997 99999999999988  889


Q ss_pred             EEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC----CccEEEee
Q 015898          176 HIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD----DFSLKAID  246 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~----~~~~kL~D  246 (398)
                      ++||||+++ +|.+.+...     ..+++..+..++.|++.||.|||+.+|+||||||+||++   +.    ++.+||+|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~---~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV---MGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE---cCCCCccceEEECC
Confidence            999999965 676666432     258999999999999999999999999999999999999   55    88999999


Q ss_pred             cCCceecCCCCc----ccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH---------HHH
Q 015898          247 FGLSVFFKPGQI----FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQG---------IFD  311 (398)
Q Consensus       247 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---------~~~  311 (398)
                      ||++........    .....++..|+|||.+.+  .++.++|||||||++|+|++|..||.+.....         .+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876543221    234567889999998764  47899999999999999999999997544321         111


Q ss_pred             HHHc--------------------------CCCcCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          312 AVLK--------------------------GHIDFES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       312 ~~~~--------------------------~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      .+..                          ....+..       ..+...+.++.++|.+||++||++|||+.|++.|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            1100                          0000000       000145678999999999999999999999999999


Q ss_pred             c
Q 015898          359 I  359 (398)
Q Consensus       359 ~  359 (398)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-42  Score=323.94  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=209.0

Q ss_pred             ccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +.|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+. |+||+++++++.+.+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            458999999999999999999877     77889999875432  3444567889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          174 CVHIVMELCAGGELFDRIIQRG-------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ..++||||+++++|.+++...+       .+++..+..++.||+.||.|||+++++||||||+||++....+...+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999987643       488999999999999999999999999999999999995443445799999


Q ss_pred             cCCceecCCCCcc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          247 FGLSVFFKPGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       247 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                      ||++.........   .....+..|+|||++.+ .++.++|||||||++|||++ |..||......+....+......  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL--  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence            9999865332211   12233467999999874 59999999999999999997 99999888777776666543221  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                       .....++.++.+++.+||+.+|++|||+.++++|
T Consensus       241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             1223578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7e-43  Score=363.19  Aligned_cols=149  Identities=26%  Similarity=0.428  Sum_probs=138.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.++||+|+||.||+|.+..+++.||||++.............+..|+.++..+. ||||+++++++...+.+|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence            45999999999999999999999999999999997665556666778999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      |||+.+++|.+++...+.+++..++.++.||+.||.|||..|||||||||+|||+   +.++.+||+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999   778899999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-42  Score=327.47  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=207.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCc--EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ++|++.++||+|+||.||+|.+..++.  .+++|.+...  ......+.+.+|+.++.++.+||||+++++++...+.++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            458999999999999999999877765  4788877532  244456778999999999966999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          177 IVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +||||+++++|.+++....                .+++..+..++.|++.||+|||++||+||||||+|||+   ++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999986532                47889999999999999999999999999999999999   7788


Q ss_pred             cEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCC
Q 015898          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  318 (398)
                      .+||+|||++..............+..|+|||.+.. .++.++|||||||++|||++ |..||...........+..+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999999864322111112233457999998874 58999999999999999997 9999998888877777765432


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .   .....++.++.+|+.+||..||.+|||+.++++.
T Consensus       237 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1   1223578999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.4e-42  Score=327.23  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=215.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++ |||++++++++.+....|+
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEE
Confidence            345777888999999999999999999999999987654445556678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+. +++.+.+.. ...+++..+..++.||+.||.|||+.|++||||+|+||++   ++++.+||+|||++..... 
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC-
Confidence            999995 577777754 4568999999999999999999999999999999999999   7788999999999865332 


Q ss_pred             CcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                        .....|+..|+|||.+.    +.++.++|||||||++|+|++|..||...........+......  ......++..+
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  249 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDSF  249 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHHH
Confidence              23467889999999874    35888999999999999999999999877665555555443221  22223467889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .+|+.+||+.+|.+||++.+++.||||....
T Consensus       250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         250 RGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-43  Score=335.75  Aligned_cols=264  Identities=30%  Similarity=0.453  Sum_probs=220.9

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-----e
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----C  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-----~  174 (398)
                      +|++.+.||.|+||.||+|.+..+++.||||.+.... ......+.+.+|+.+++.+. |+||+++++++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            4889999999999999999998899999999986432 23445678899999999997 999999999987765     7


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +|+||||++ ++|.+++.....+++..+..++.+|+.||.+||+.||+||||||.|||+   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            899999996 5898888877789999999999999999999999999999999999999   778999999999998765


Q ss_pred             CCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC-----
Q 015898          255 PGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD-----  323 (398)
Q Consensus       255 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----  323 (398)
                      ...    ......++..|+|||.+.+  .++.++|+||||+++|+|++|..||......+.+..+..........     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            442    2345678889999999874  58899999999999999999999998877666555544321111100     


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          324 ----------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       324 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                                            ..+.++.++.++|.+||++||++|||+.+++.||||.+....+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~  302 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP  302 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence                                  1233678899999999999999999999999999999876654433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=315.69  Aligned_cols=252  Identities=31%  Similarity=0.493  Sum_probs=217.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|++++.++. |+|++++++++...+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            48889999999999999999998999999999976543 3356678999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc-
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-  258 (398)
                      ||+++++|.+++.....+++..+..++.|++.||.+||+.||+||||+|+||++   +.++.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence            999999999999888889999999999999999999999999999999999999   7788999999999987654332 


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..................   .....++.++.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence            234567889999998864 4788999999999999999999999876655444444332221   222357899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCc
Q 015898          338 KMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-42  Score=322.79  Aligned_cols=250  Identities=26%  Similarity=0.470  Sum_probs=209.2

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+.||.|+||.||+|.+..++..||||.+.............+.+|+.+++.+. ||||+++++++...+..+++|
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEEE
Confidence            5889999999999999999999999999999886554444555678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          180 ELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       180 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||+++++|.+++..    ...+++..+..++.+|+.||.|||++|++|+||||+||++   +.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhcccc
Confidence            99999999988863    3458999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh--HHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      .. ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+...  ......+...  .++......++++
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  236 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEE  236 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccHH
Confidence            32 2234578899999999874 588999999999999999999999975433  2333333322  1222223357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.++|.+||+.||++|||+.+|++
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.2e-42  Score=320.43  Aligned_cols=247  Identities=28%  Similarity=0.460  Sum_probs=202.7

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      ...||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.++ |+||+++++++...+..++|+||++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCC
Confidence            35799999999999999999999999988643   3445678999999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeecCCceecCCCC-c
Q 015898          184 GGELFDRIIQR-GHY--SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPGQ-I  258 (398)
Q Consensus       184 ~~~L~~~l~~~-~~~--~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DFG~a~~~~~~~-~  258 (398)
                      +++|.+++... ..+  ++..+..++.||+.||.|||+.||+||||||+||++   +. ++.++|+|||++....... .
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~---~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCeEEEecchhheecccCCCc
Confidence            99999988764 445  888999999999999999999999999999999999   43 5689999999987654322 2


Q ss_pred             ccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGI-FDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .....++..|+|||.+.+   .++.++||||||+++|+|++|..||........ ....  ............+++++.+
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV--GMFKIHPEIPESLSAEAKN  243 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh--hhhccCCCCCcccCHHHHH
Confidence            234567889999999853   378899999999999999999999965432211 1111  1111111122347889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ++.+||+.+|++|||+.|++.||||
T Consensus       244 li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         244 FILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.5e-42  Score=315.43  Aligned_cols=253  Identities=34%  Similarity=0.517  Sum_probs=216.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~~l  177 (398)
                      +|++.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.+++++. |+||+++++.+...  ..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            37788999999999999999998999999999865432 2456788999999999998 99999999999988  89999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ++||+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   778899999999998776554


Q ss_pred             c---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          258 I---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       258 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .   .....++..|+|||.+.. .++.++||||||+++|+|++|..||.... .......+....  ........++.++
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG--EPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC--CCcCCCcccCHHH
Confidence            3   445678899999999875 48999999999999999999999997665 222222222111  1111223468999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .++|.+||..||++||++.|++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=318.07  Aligned_cols=245  Identities=39%  Similarity=0.686  Sum_probs=216.6

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||.|+||.||++.+..+++.+|+|++.............+..|+.+++.+. |+||+++++.++.+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            799999999999998889999999997765555556778999999999998 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-CcccccccC
Q 015898          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGS  265 (398)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt  265 (398)
                      |.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99999888789999999999999999999999999999999999999   77889999999999776443 234456788


Q ss_pred             CcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCC
Q 015898          266 PYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP  344 (398)
Q Consensus       266 ~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  344 (398)
                      ..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+......++.    .++..+.++|++||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence            89999999875 4788999999999999999999999877776666776664433332    358899999999999999


Q ss_pred             CCCCCH---HHHhcCCCc
Q 015898          345 SERLTA---HEVLCHPWI  359 (398)
Q Consensus       345 ~~Rps~---~eiL~hp~~  359 (398)
                      ++||++   .+++.||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-42  Score=339.47  Aligned_cols=251  Identities=25%  Similarity=0.343  Sum_probs=203.8

Q ss_pred             cccceecceecccCceEEEEEEEccC-----CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|+++++||+|+||.||+|.+...     +..||||++....  .....+.+.+|+.+++++..||||+++++++...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            45699999999999999999986433     3579999986432  3445578999999999996699999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 015898          173 LCVHIVMELCAGGELFDRIIQR----------------------------------------------------------  194 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  194 (398)
                      +..|+||||+++|+|.+++...                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999888642                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec
Q 015898          195 --------------------------------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK  236 (398)
Q Consensus       195 --------------------------------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~  236 (398)
                                                            ..+++..+..++.|++.||.|||+.+|+||||||+|||+   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence                                                  136778889999999999999999999999999999999   


Q ss_pred             CCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHH
Q 015898          237 DDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFD  311 (398)
Q Consensus       237 ~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~  311 (398)
                      ++++.+||+|||++........   .....++..|+|||.+.+ .++.++|||||||++|||++ |..||........+.
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            7778899999999976543221   123446678999998874 58999999999999999997 999997765443333


Q ss_pred             HHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..........  ....++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3323222221  22357889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-43  Score=352.86  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=197.1

Q ss_pred             ccccccceecceecccCceEEEEEEEccCC-cEEEEE--------------EecccccCCHhhHHHHHHHHHHHHHhcCC
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATG-IEFACK--------------SISKRKLISREDVEDVRREIQIMHHLAGH  159 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vavK--------------~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h  159 (398)
                      +.+.++|++++.||+|+||+||+|..+... ..+++|              .+.+...........+.+|+.+|+++. |
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence            345577999999999999999998754322 222222              111111112334567889999999997 9


Q ss_pred             CCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       160 ~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                      |||+++++++...+..|+|+|++. ++|.+++...     .......+..++.||+.||.|||++|||||||||+|||+ 
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl-  300 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-  300 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence            999999999999999999999984 5777776542     223467788999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCCc--ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC-c--ChHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA-E--TQQG  308 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~-~--~~~~  308 (398)
                        +.++.+||+|||++..+.....  .....||..|+|||++.+ .++.++|||||||++|||++|..++.. .  ....
T Consensus       301 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 --NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             --CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence              7888999999999987654322  234679999999999975 599999999999999999998865432 2  1112


Q ss_pred             HHHHHHcCC----CcCCC------------------C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          309 IFDAVLKGH----IDFES------------------D------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       309 ~~~~~~~~~----~~~~~------------------~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      .+..+....    ..++.                  .      ....++..+.++|.+||++||.+|||+.|+|.||||.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            222211110    00000                  0      0012456788899999999999999999999999997


Q ss_pred             CCC
Q 015898          361 ENG  363 (398)
Q Consensus       361 ~~~  363 (398)
                      ...
T Consensus       459 ~~~  461 (501)
T PHA03210        459 AEE  461 (501)
T ss_pred             cCC
Confidence            754

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.3e-42  Score=325.33  Aligned_cols=259  Identities=25%  Similarity=0.324  Sum_probs=211.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++.+.||+|+||.||+|.+..+++.||||.+....  .......+..|+.++.++.+||||+++++++......|+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            356999999999999999999998889999999986543  233455677788877777679999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+. +++.+++.. ...+++..+..++.+++.||.|||+ .||+||||+|+||++   ++++.+||+|||++.....
T Consensus        92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccC
Confidence            999985 467666654 4568999999999999999999997 699999999999999   7888999999999876654


Q ss_pred             CCcccccccCCcccCcccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ........++..|+|||.+.+     .++.++||||||+++|+|++|+.||.... ..+.+..+........ .....++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCC
Confidence            433344567889999999863     27889999999999999999999996533 2344444444432211 1112468


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .++.+|+.+||+.||++||++++++.||||..+.
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            8999999999999999999999999999998655

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.7e-42  Score=313.58  Aligned_cols=251  Identities=34%  Similarity=0.514  Sum_probs=214.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|++|.||+|.+..+++.+++|++....   ......+.+|+.+++.+. |+|++++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            3788899999999999999998899999999986542   245678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||+++++|.+++... ..+++..+..++.+++.||.+||+.|++||||+|+||++   ++++.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence            999999999988776 579999999999999999999999999999999999999   7788999999999987655433


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...+................ .....++.++.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHH
Confidence            345678899999999874 578999999999999999999999987755444444433222111 111224789999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      +||+.||++|||+.|+|.|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.6e-42  Score=317.93  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+....    .....+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            34888999999999999999864 56689999875432    22356888999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++... +.+++..+..++.+++.||+|||++||+||||||+||++   ++++.+||+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence            9999999999988653 468999999999999999999999999999999999999   778899999999987654332


Q ss_pred             cc--cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 IF--TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ..  ....++..|+|||.+.. .++.++||||||+++|+|++ |..||...+..+....+..+......   ...+.++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence            21  12234567999999874 58999999999999999999 89999888888888887765433222   23678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++.+||+.||++||++.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-42  Score=317.23  Aligned_cols=242  Identities=25%  Similarity=0.353  Sum_probs=202.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +.||+|+||.||+|.+..+++.||+|.+...  ...+....+.+|+.+++.+. ||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence            4699999999999999999999999987533  24555678999999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccc---
Q 015898          185 GELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT---  260 (398)
Q Consensus       185 ~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~---  260 (398)
                      ++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999987644 58999999999999999999999999999999999999   778899999999987644322111   


Q ss_pred             ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       261 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ....+..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+......   .....++..+.+|+.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHH
Confidence            1122456999998874 58999999999999999998 88999877766665555543221   1223468899999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q 015898          339 MLCSQPSERLTAHEVLC  355 (398)
Q Consensus       339 ~L~~dP~~Rps~~eiL~  355 (398)
                      ||+.||++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.4e-42  Score=322.91  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=208.4

Q ss_pred             ccceecceecccCceEEEEEEEc----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +.|++.+.||+|+||.||+|...    .++..||+|.+....  .......+.+|+.+++.+. ||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            34889999999999999999853    456789999986432  4455678899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC
Q 015898          175 VHIVMELCAGGELFDRIIQR-----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~  237 (398)
                      .|+||||+++++|.+++...                 ..+++..+..++.+++.||.|||++|++||||||+|||+   +
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence            99999999999999988532                 237888999999999999999999999999999999999   7


Q ss_pred             CCccEEEeecCCceecCCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHH
Q 015898          238 DDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~  312 (398)
                      +++.+||+|||++.......   ......++..|+|||.+. ..++.++|||||||++|||++ |..||.+.........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            78899999999997653322   123344567799999987 458999999999999999998 9999988777666666


Q ss_pred             HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +.......   ....+++++.+++.+||+.||++||++.+|+++
T Consensus       239 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            66544322   223578999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-42  Score=334.75  Aligned_cols=261  Identities=30%  Similarity=0.440  Sum_probs=209.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~----  172 (398)
                      +..+|++.+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++ ||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence            4567999999999999999999999999999999986543   244567889999999997 99999999876543    


Q ss_pred             ----------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          173 ----------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       173 ----------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                                ...|+||||++ ++|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+||++.  .+++.+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceE
Confidence                      35899999996 588877653 4689999999999999999999999999999999999993  245679


Q ss_pred             EEeecCCceecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC
Q 015898          243 KAIDFGLSVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG  316 (398)
Q Consensus       243 kL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  316 (398)
                      ||+|||++.......    ......++..|+|||.+..  .++.++|||||||++|+|++|..||...........+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999997653221    1123467889999998753  4888999999999999999999999877655544443321


Q ss_pred             CCc----------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          317 HID----------------------FE----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       317 ~~~----------------------~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      ...                      ..    ....+.++.++.+||.+||+.||.+|||+.|+|.||||+....+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            100                      00    00123477899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-42  Score=334.02  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             cccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-c
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-D  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-~  171 (398)
                      .++|++.++||+|+||.||+|.+..     +++.||+|++....  .....+.+.+|+.++.++.+|+||+++++++. .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            4579999999999999999997443     45789999986432  34455678899999999965999999999875 4


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR---------------------------------------------------------  194 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  194 (398)
                      +..++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            56789999999999999888542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc---ccccccCCc
Q 015898          195 ----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPY  267 (398)
Q Consensus       195 ----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~  267 (398)
                          ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.++|+|||++........   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                257889999999999999999999999999999999999   7788999999999976533221   123345678


Q ss_pred             ccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCC
Q 015898          268 YVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS  345 (398)
Q Consensus       268 y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  345 (398)
                      |+|||.+.+ .++.++|||||||++|||++ |..||.+....+.+............  ....++++.+++.+||+.+|+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence            999998874 59999999999999999998 99999775544433333332222111  124678999999999999999


Q ss_pred             CCCCHHHHhcC
Q 015898          346 ERLTAHEVLCH  356 (398)
Q Consensus       346 ~Rps~~eiL~h  356 (398)
                      +||++.|+++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-42  Score=327.01  Aligned_cols=257  Identities=32%  Similarity=0.485  Sum_probs=214.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.+. ||||+++++++...+..|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence            46799999999999999999998889999999998543   2334567889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |+||+++++|.+++.. ..+++..+..++.+++.||.|||++|++||||+|+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence            9999999999988765 357899999999999999999999999999999999999   778899999999887554332


Q ss_pred             -cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       ......+++.|+|||.+.+ .++.++|+|||||++|++++|..||...........+..... ........++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHH
Confidence             2234568889999998874 588999999999999999999999977655443333322211 1111223467889999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |.+||..+|++||++.+++.||||+...
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999999997655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-42  Score=329.57  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=204.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcE----EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIE----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +|++.+.||+|+||.||+|.+..++..    ||+|.+...  ......+.+.+|+.+++.+. ||||+++++++... ..
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~~   83 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-Cc
Confidence            499999999999999999997766654    899988533  24455678899999999997 99999999998765 56


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++++||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||+   ++++.+||+|||++....
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccccc
Confidence            7999999999999999774 458899999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCcc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          255 PGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       255 ~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .....   ....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+....+....+..+. ..+.  .+.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~  237 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPICT  237 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCCCC
Confidence            43321   12234567999998874 58999999999999999998 999998877666554444332 2221  23467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .++.+++.+||..||++||++.+++.+
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.3e-42  Score=318.83  Aligned_cols=245  Identities=23%  Similarity=0.342  Sum_probs=209.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|.+.+.||.|+||.||+|.+..+++.||+|.+...    ......+.+|+.+++.+. |+||+++++++...+.++++|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEEE
Confidence            488899999999999999999999999999998642    234567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++   ++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence            999999999988654  358999999999999999999999999999999999999   778899999999997765432


Q ss_pred             ccc--ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 IFT--DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ...  ...++..|+|||.+.+ .++.++|||||||++|||++ |..||.+....+....+.....   ......++.++.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  235 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPKVY  235 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHH
Confidence            211  1233567999998874 58899999999999999998 9999988887777777665421   122335789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++|.+||..||++|||+.++++
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.8e-42  Score=358.62  Aligned_cols=253  Identities=28%  Similarity=0.341  Sum_probs=206.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||.||+|.+..+++.||+|++...........+++.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            46999999999999999999999999999999997544334455678999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          179 MELCAGGELFDRIIQR-----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                      |||++|++|.+++...           ..++...+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988641           235567789999999999999999999999999999999   88889999999


Q ss_pred             CCceecCCCC-------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH
Q 015898          248 GLSVFFKPGQ-------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ  307 (398)
Q Consensus       248 G~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~  307 (398)
                      |++.......                   .....+||+.|+|||.+.+ .++.++|||||||++|||++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   1123579999999999875 5899999999999999999999999775544


Q ss_pred             HHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          308 GIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ......... ......+...+++.+.+++.+||+.||++|++..+.+.+
T Consensus       238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332221111 111112234578999999999999999999877665543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-42  Score=325.27  Aligned_cols=257  Identities=28%  Similarity=0.496  Sum_probs=216.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |....+||+|+||.||++....+++.||||.+...   .......+.+|+.+++.+. |+||+++++.+...+..++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEe
Confidence            44457899999999999999999999999987533   3344567899999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-cc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-IF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~~  259 (398)
                      |+++++|.+++. ...+++..+..++.|++.||+|||+.|++||||+|+||++   +.++.++|+|||++....... ..
T Consensus        98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccccc
Confidence            999999988764 4568999999999999999999999999999999999999   778899999999887654322 22


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.... .........++..+.+++.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CcccCCcccCCHHHHHHHHH
Confidence            34568899999998864 58899999999999999999999998776665555443322 11222234578999999999


Q ss_pred             hcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          339 MLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       339 ~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      ||+.||.+||++.++|.||||.+...++
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            9999999999999999999999988544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.9e-41  Score=323.47  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=219.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.+. |||++++++++......++|
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEEE
Confidence            34788899999999999999999999999999987654445556678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+.+ +|.+.+.. ...+++..+..++.+++.||.|||+.||+||||+|+||++   +.++.++|+|||++...... 
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc-
Confidence            999965 77777654 4568999999999999999999999999999999999999   77889999999998754432 


Q ss_pred             cccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                        ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+........  ....+++.+.
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  254 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFR  254 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHH
Confidence              3456888999999874    3588999999999999999999999988776666666555433221  1234678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      +||.+||+.+|.+||++.++++|+|+......+.
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            9999999999999999999999999977665554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-44  Score=340.81  Aligned_cols=241  Identities=27%  Similarity=0.405  Sum_probs=207.9

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .+-||.|+.|.||+|+  -.++.||||.+...          -..+|+-|++|+ ||||+.|.|+|....+++||||||.
T Consensus       129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------kETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------KETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeee--ccCceehhHHHhhh----------hhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            4569999999999998  45779999987422          235889999998 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccc
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  263 (398)
                      .|.|+..|+....++......+..+|+.|+.|||.+.|||||||.-||||.   -+..|||+|||.++........-.++
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999994   44579999999998877666666899


Q ss_pred             cCCcccCccccccc-CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||..|||||++.+. .+.|+|||||||+|||||||..||.+.+...++--+-...+..+  ....+++.++-||++||+-
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHHHHhc
Confidence            99999999999864 88999999999999999999999977666554433333333322  2235889999999999999


Q ss_pred             CCCCCCCHHHHhcCCCccCC
Q 015898          343 QPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       343 dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .|..||++.+||.|-=+...
T Consensus       351 KpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             CCCCCccHHHHHHHHhhcCH
Confidence            99999999999999665443

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=318.13  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=210.1

Q ss_pred             ccceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|++.+.||+|+||+||+|.+..+   ...||||.+....  .......+.+|+.+++.+. ||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            4588999999999999999997644   4579999886432  4445667889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... +.+++..+..++.+++.||.|||++||+||||||+||++   ++++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence            9999999999999998664 468999999999999999999999999999999999999   788899999999998764


Q ss_pred             CC-Cccc--ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          255 PG-QIFT--DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       255 ~~-~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .. ....  ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||...........+.......   ....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---PPMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence            21 1111  2234568999998874 58999999999999999998 999998888777777776543221   123578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ..+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.7e-42  Score=317.04  Aligned_cols=251  Identities=25%  Similarity=0.463  Sum_probs=210.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+++++++. |+|++++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            45999999999999999999998899999999987555445555778999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          179 MELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||+++++|.+++..    ...+++..+..++.+++.||.|||+.||+||||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            999999999988854    3458999999999999999999999999999999999999   778899999999987654


Q ss_pred             CCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||....  .....+.+..+...  ..+...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence            332 2234568889999998874 58999999999999999999999996543  23344444433222  122225678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.++|.+||+.+|++|||+.+|++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-42  Score=316.43  Aligned_cols=243  Identities=26%  Similarity=0.391  Sum_probs=211.2

Q ss_pred             ceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          105 RKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      +.||+|+||.||+|.+...   +..||+|.+....  .....+.+.+|+.++..++ |+||+++++++.....+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeecccc--chhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4699999999999998866   8899999987543  2225678999999999998 99999999999999999999999


Q ss_pred             cCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          182 CAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       182 ~~~~~L~~~l~~~---------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      +++++|.+++...         ..+++..+..++.|++.||+|||++|++||||+|+||++   ++++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999875         679999999999999999999999999999999999999   7889999999999987


Q ss_pred             cCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          253 FKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       253 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .....   ......++..|+|||.+.. .++.++|||||||++|+|++ |..||...........+..+...   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            65432   2334567889999998874 68999999999999999999 69999988888888877764322   22235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++.++.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            68999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-42  Score=321.38  Aligned_cols=254  Identities=29%  Similarity=0.449  Sum_probs=208.4

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEecCCe----
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLC----  174 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~~~~----  174 (398)
                      |++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++.  +|+||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6778999999999999999988899999999965432 2223345667888887774  49999999999987776    


Q ss_pred             -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          175 -VHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       175 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                       ++++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence             9999999964 8888886643  48999999999999999999999999999999999999   777899999999998


Q ss_pred             ecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-----CC----
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----FE----  321 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~----  321 (398)
                      ............++..|+|||.+.+ .++.++|+|||||++|+|++|.+||.+....+....+......     ++    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            7655444445567889999999874 5889999999999999999999999887776666555432110     00    


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          322 --------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       322 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                    ....+.++..+.++|.+||+.||++||++.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00112346788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.7e-42  Score=331.95  Aligned_cols=264  Identities=30%  Similarity=0.441  Sum_probs=214.0

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SL  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~  173 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++++.+||||+++++++..  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            45678999999999999999999998899999999885432 2334456678899999999449999999998864  34


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+|+||||++ ++|..++... .+.+..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL  157 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence            6899999996 5898887665 78899999999999999999999999999999999999   88899999999998765


Q ss_pred             CCCC------cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC--------
Q 015898          254 KPGQ------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH--------  317 (398)
Q Consensus       254 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--------  317 (398)
                      ....      ......|+..|+|||.+.+  .++.++|||||||++|+|++|..||.+.........+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4322      2234568899999998763  47889999999999999999999997665544333322211        


Q ss_pred             -------------------CcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          318 -------------------IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       318 -------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                         ........+.++.++.++|.+||+.||++|||+.++++||||.+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                               111112223468899999999999999999999999999999886433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.4e-42  Score=322.83  Aligned_cols=248  Identities=19%  Similarity=0.329  Sum_probs=209.7

Q ss_pred             cceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .|++.+.||+|+||.||+|.+..     .+..||+|.+....  .....+.+.+|+.++..+. ||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence            48889999999999999998754     35789999986432  3444567889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          175 VHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      .++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+.||+||||||+||++   ++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence            99999999999999888532                247888999999999999999999999999999999999   77


Q ss_pred             CccEEEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHH
Q 015898          239 DFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~  313 (398)
                      ++.+||+|||++........   .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            78899999999876543221   12344577899999886 468999999999999999998 88899888888888888


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .........   ..++.++.+|+.+||+.+|++||++++|+..
T Consensus       240 ~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            776544322   3578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.5e-42  Score=321.52  Aligned_cols=258  Identities=34%  Similarity=0.498  Sum_probs=219.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.+.||+|+||.||+|.+..++..||+|++.....    ..+.+.+|+.+++.+. |+|++++++.+......|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEEE
Confidence            45568899999999999999999988899999999864321    4567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +|+||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhcc
Confidence            9999999999999998876 79999999999999999999999999999999999999   7788999999998865443


Q ss_pred             CC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+....... ......++.++.
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  247 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEFK  247 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHHH
Confidence            22 2234457889999998875 58999999999999999999999998776655555544333221 112233788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++|.+||+.+|.+|||+.++++|+||.+..
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            999999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.8e-42  Score=322.70  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=208.2

Q ss_pred             ccceecceecccCceEEEEEEEccCC----------------cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATG----------------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI  162 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~ni  162 (398)
                      ++|++.+.||+|+||.||+|.+...+                ..||+|.+....  .....+.+.+|+.+++++. ||||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCCE
Confidence            46999999999999999999876533                568999986543  3456678999999999998 9999


Q ss_pred             eEEeEEEecCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 015898          163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (398)
Q Consensus       163 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NI  231 (398)
                      +++++++..++..+++||++++++|.+++....           .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999987755           689999999999999999999999999999999999


Q ss_pred             EEeecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh--CCCCCCCcC
Q 015898          232 LLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS--GVPPFWAET  305 (398)
Q Consensus       232 ll~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt--g~~pf~~~~  305 (398)
                      ++   ++++.++|+|||++.......   ......+++.|+|||.+.+ .++.++|||||||++|||++  |..||....
T Consensus       162 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99   777899999999987654332   1223456778999998874 68999999999999999998  778988776


Q ss_pred             hHHHHHHHHcC----CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          306 QQGIFDAVLKG----HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       306 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ....+......    ...........++.++.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66666555432    111111122346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=315.54  Aligned_cols=253  Identities=30%  Similarity=0.478  Sum_probs=211.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccc--cCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK--LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~  175 (398)
                      .|++.+.||+|+||.||+|.+..++..||+|.+....  .........+.+|+.+++++. |+||+++++++...  ..+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCEE
Confidence            5899999999999999999999999999999875322  123445678899999999997 99999999998653  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++++||+++++|.+.+...+.+++..+..++.+++.||.|||+.|++|+||||+||++   +.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccccc
Confidence            9999999999999999887789999999999999999999999999999999999999   7788999999999976432


Q ss_pred             C----CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          256 G----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       256 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .    .......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.....  .......+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~  236 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVSD  236 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccCH
Confidence            1    12234568899999999875 588999999999999999999999987665555544433221  1122345789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ++.++|.+||. +|..||++.+++.|||.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.7e-42  Score=324.19  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=210.0

Q ss_pred             cccceecceecccCceEEEEEEEccCC-----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.+.||+|+||.||+|.+...+     ..+|+|.+....  .......+.+|+.+++++.+|+||+++++++...
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            356899999999999999999876433     689999986432  3445667899999999995599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec
Q 015898          173 LCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK  236 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~  236 (398)
                      +.++++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.||+||||||+||++   
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence            9999999999999999988642                358899999999999999999999999999999999999   


Q ss_pred             CCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHH
Q 015898          237 DDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFD  311 (398)
Q Consensus       237 ~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~  311 (398)
                      ++++.+||+|||++........   .....++..|+|||.+.+ .++.++|||||||++|||++ |..||......+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            7788999999999986544321   122234567999998774 58999999999999999998 999998888777777


Q ss_pred             HHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .+..+...   .....++.++.+|+.+||..||++|||+.|++++
T Consensus       246 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            76654322   1223467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-42  Score=319.46  Aligned_cols=249  Identities=23%  Similarity=0.312  Sum_probs=209.0

Q ss_pred             cccceecceecccCceEEEEEEEccC-----CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+. ||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence            45699999999999999999997643     3789999985432  3344567889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                      ...++||||+++++|.+++....          .+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence            99999999999999999886532          36788999999999999999999999999999999999   788999


Q ss_pred             EEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCC
Q 015898          243 KAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH  317 (398)
Q Consensus       243 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  317 (398)
                      ||+|||++........   .....++..|+|||.+. +.++.++|||||||++|||++ |..||.........+.+..+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            9999999876543321   22345678899999887 468999999999999999998 999998888877777776443


Q ss_pred             CcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ....   ...++.++.+++.+||+.+|++|||+.+++.
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2211   2246899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.8e-42  Score=315.71  Aligned_cols=251  Identities=29%  Similarity=0.480  Sum_probs=217.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.+. |+||+++.+++......++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            48889999999999999999999999999999865433 3445667889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          180 ELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       180 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||+++++|.+++..    ...+++..+..++.+++.||.|||+.|++|+||+|.||++   ++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhcc
Confidence            99999999988866    3568999999999999999999999999999999999999   6678899999999977654


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      . ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+..+......   ..++.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence            4 3344668889999999875 5888999999999999999999999888777666666554433222   257789999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ++.+||+.+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-41  Score=324.04  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=215.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ...|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.+. |+|++++++++......++
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeEE
Confidence            345888899999999999999999999999999986543334555677889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+. +++.+.+.. ...+++..+..++.+++.||.|||+.+++||||+|+||++   +.++.++|+|||++......
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc
Confidence            999996 578777654 4568999999999999999999999999999999999999   77889999999998765432


Q ss_pred             CcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                         ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+.......  .....++..+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  243 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEYF  243 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC--cCcccccHHH
Confidence               3456788999999874    357889999999999999999999997766555444444433221  1123577899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      .+||.+||+.+|++||++.++++|||+.....
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            99999999999999999999999999988543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-42  Score=334.06  Aligned_cols=261  Identities=29%  Similarity=0.446  Sum_probs=211.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--  172 (398)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.+. ||||+++++++...  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~   88 (342)
T cd07879          11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVS   88 (342)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheeccccc
Confidence            345567999999999999999999999999999999986532 22333456889999999997 99999999998654  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       173 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                          ..+++|+||+. .+|..++  ...+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg  162 (342)
T cd07879          89 GDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFG  162 (342)
T ss_pred             CCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCC
Confidence                34699999995 4666554  3468999999999999999999999999999999999999   788999999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC--------
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--------  318 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------  318 (398)
                      ++.....  ......+++.|+|||.+.+  .++.++|||||||++|||++|+.||.+......+..+.....        
T Consensus       163 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         163 LARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9876432  2234577889999999864  488999999999999999999999987765554444332100        


Q ss_pred             ---------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          319 ---------------DFESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       319 ---------------~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                     ..+..    .++.++.++.+||.+||+.||++||++.+++.||||.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                           00000    123467889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.1e-42  Score=325.25  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=208.6

Q ss_pred             cccceecceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      .++|.+.+.||+|+||.||+|.+..       +...+|+|.+....  .......+.+|+.+++.+.+||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4679999999999999999998643       23579999986432  34456778899999999966999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                      ..+..|+||||+++++|.+++....                .+++..+..++.|++.||+|||+.|++||||||+||++ 
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-  173 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  173 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence            9999999999999999999997532                47889999999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~  309 (398)
                        ++++.+||+|||.+........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+.
T Consensus       174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence              7788999999999876543221   112234568999998875 58999999999999999998 8899988777777


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ...+......   .....++.++.+|+.+||+.+|++|||+.+++++
T Consensus       252 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7666554321   2223578999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.6e-42  Score=325.51  Aligned_cols=256  Identities=29%  Similarity=0.493  Sum_probs=208.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~----  173 (398)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++.+..    
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhh
Confidence            4569999999999999999999999999999999865432 2223356778999999997 999999999987654    


Q ss_pred             ------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          174 ------CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       174 ------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                            .+++|+||+++ ++...+... ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCc
Confidence                  79999999976 676766543 468999999999999999999999999999999999999   8888999999


Q ss_pred             cCCceecCCCC--cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          247 FGLSVFFKPGQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       247 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      ||++.......  ......++..|+|||.+.+  .++.++|||||||++|+|++|+.||......+.+..+.........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99997654332  2233456788999998863  4789999999999999999999999876665555444332111000


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          323 --------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       323 --------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                                                ..+..++..+.++|.+||+.||++||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                      1123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8e-42  Score=316.38  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=207.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||.||+|.+ .++..||+|.+...    ....+.+.+|+.+++.+. |+||+++++.+...+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCC----chhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence            5699999999999999999985 45678999987543    223567899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++++|.+++...  ..+++..+..++.+++.||.|||+.|++||||||+||++   ++++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCC
Confidence            9999999999988653  458899999999999999999999999999999999999   78889999999999876543


Q ss_pred             Cc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          257 QI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ..  .....++..|+|||.+. +.++.++|||||||++|+|++ |..||......+....+.....   ......++.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHH
Confidence            21  12234566899999887 458899999999999999998 9999988877777777665432   12233578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+++.+||..+|++||+++++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-42  Score=317.47  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=205.8

Q ss_pred             ceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe---
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC---  174 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~---  174 (398)
                      |++.+.||+|+||.||+|....+   +..||+|.+.... ........+.+|+.+++.+. ||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            56789999999999999987653   4789999986532 24555678999999999997 9999999998765443   


Q ss_pred             ---EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          175 ---VHIVMELCAGGELFDRIIQR------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       175 ---~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                         .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+.|++||||||+||++   ++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               79999999999998887442      358999999999999999999999999999999999999   788899999


Q ss_pred             ecCCceecCCCCcc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcC
Q 015898          246 DFGLSVFFKPGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       246 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      |||++.........   ....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+....+.++.+..+....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999865433221   12234568999999874 58999999999999999999 889998888777777776654222


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                         ....++.++.+++.+||+.||++|||+.|++++
T Consensus       236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               223578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-42  Score=320.45  Aligned_cols=245  Identities=29%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             eecceecccCceEEEEEEEc----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          102 TLGRKLGQGQFGTTYLCTEI----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       102 ~~~~~iG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ++.+.||.|+||.||+|...    ..+..|+||.+...  ...+..+.+.+|++.+++++ ||||++++|++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence            35678999999999999987    45678999999542  25556889999999999996 9999999999998888999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|+||+++||++   ++++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            99999999999999887  679999999999999999999999999999999999999   7788999999999987632


Q ss_pred             CCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          256 GQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       256 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ...   .........|+|||.+.. .++.++||||||+++|||++ |..||......+....+.++.....   ...++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence            221   223456678999999874 58999999999999999999 7899988888888888766544222   235789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+.++|.+||..||++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=308.37  Aligned_cols=250  Identities=28%  Similarity=0.368  Sum_probs=209.1

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-----cC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----DS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-----~~  172 (398)
                      .++|++.+.||+|||+-||+++...++..+|+|.+...   +.++.+..++|++.-+++. |||+++++++..     ..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence            46799999999999999999999999999999999765   4677889999999999998 999999998763     23


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEee
Q 015898          173 LCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ...||+++|...|+|.+.+...    ..+++.++.+|+.+|++||++||+..  ++||||||.|||+   .+.+.++|.|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEEEe
Confidence            4599999999999999988652    36999999999999999999999999  9999999999999   6678999999


Q ss_pred             cCCceecCC----CC------cccccccCCcccCccccc-c---cCCCcccHHHHHHHHHHHHhCCCCCCCcChH--HHH
Q 015898          247 FGLSVFFKP----GQ------IFTDVVGSPYYVAPEVLL-K---HYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIF  310 (398)
Q Consensus       247 FG~a~~~~~----~~------~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~~  310 (398)
                      ||++....-    ..      ....-..|..|+|||.+. +   ..+.++|||||||+||.|+.|..||......  .+.
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            999875421    10      112335688999999986 2   4789999999999999999999999543221  223


Q ss_pred             HHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      -.+.++.+.++.+..  +++.+.+||+.||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            344555666666543  88999999999999999999999999864

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.1e-42  Score=317.78  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=204.4

Q ss_pred             ceecceecccCceEEEEEEEccCCc--EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------C
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------S  172 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------~  172 (398)
                      |.++++||+|+||.||+|.+..++.  .||+|.+.... .+....+.+.+|+.+++.++ |+||+++++++..      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence            3467899999999999999877765  69999886432 35566788999999999997 9999999997642      2


Q ss_pred             CeEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          173 LCVHIVMELCAGGELFDRIIQ------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ...+++|||+++++|.+++..      ...+++..+..++.|++.||.|||++||+||||||+|||+   ++++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence            357899999999999887743      2347899999999999999999999999999999999999   7788999999


Q ss_pred             cCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          247 FGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       247 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                      ||++........   .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||...........+..+.... 
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  234 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK-  234 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            999987644322   122345678999999875 58999999999999999999 889998877777777776654321 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                        ....++..+.++|.+||+.||++|||+.+++++
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              123577899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-41  Score=314.89  Aligned_cols=241  Identities=24%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             eecccCceEEEEEEE--ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          106 KLGQGQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .||+|+||.||+|.+  ..++..||+|++.... ......+.+.+|+.+++.+. ||||+++++++.. ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCcEEEEecCC
Confidence            599999999999964  4567899999986432 24455678999999999997 9999999998754 46789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc----c
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI----F  259 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~----~  259 (398)
                      +++|.+++.....+++..+..++.|++.||.|||++||+||||||.||++   ++++.+||+|||++........    .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence            99999999887889999999999999999999999999999999999999   7788999999999976543321    1


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ....++..|+|||.+.. .++.++|||||||++|||++ |..||......+....+.++...   .....+++++.+||.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHHH
Confidence            12233578999998874 58889999999999999998 99999888777777777665432   122357899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 015898          338 KMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~  355 (398)
                      +||+.||++||++.+|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=321.49  Aligned_cols=253  Identities=31%  Similarity=0.462  Sum_probs=209.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||.|+||.||+|....+++.||||.+..... . .......+|+..++++.+|+||+++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            6788999999999999999988999999999864322 1 2223455789999999779999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |+ +++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||++   ++++.++|+|||.+........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 789999887754  68999999999999999999999999999999999999   8889999999999987665545


Q ss_pred             ccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC----------------
Q 015898          259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF----------------  320 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------------  320 (398)
                      .....++..|+|||.+.+  .++.++|+||||+++++|++|..||......+.+..+.......                
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            556678999999998853  47899999999999999999999997766554443332210000                


Q ss_pred             ---C-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          321 ---E-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       321 ---~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                         +       ....+..+..+.++|.+||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence               0       00112236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.3e-42  Score=330.25  Aligned_cols=255  Identities=18%  Similarity=0.244  Sum_probs=203.3

Q ss_pred             ceeccc--CceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          105 RKLGQG--QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       105 ~~iG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      ..||.|  +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||++++++|..++..++||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            457777  999999999999999999999865432 3455678999999999997 999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-c-
Q 015898          183 AGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I-  258 (398)
Q Consensus       183 ~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~-  258 (398)
                      .+++|.+++...  ..+++..+..++.|++.||+|||+.||+||||||+||++   +.++.++++|||.+....... . 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence            999999988764  348999999999999999999999999999999999999   777899999998643221110 0 


Q ss_pred             ------ccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC--------
Q 015898          259 ------FTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--------  321 (398)
Q Consensus       259 ------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------  321 (398)
                            .....++..|+|||++.+   .++.++|||||||++|+|++|..||...................+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  011234567999999874   378999999999999999999999977655444433322211000        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          322 -----------------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       322 -----------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                                         ......+++.+.+||.+||+.||++|||+.|+|+||||.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                               0011235678999999999999999999999999999976543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=337.62  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=214.1

Q ss_pred             cceecceecccCceEEEEEEEccCCc---E-EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGI---E-FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +..+.++||+|+||.||+|..+..+.   . ||||..........+.+.++.+|+++|++|. |||||+++|+......+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCcc
Confidence            45667899999999999999765432   3 8999987655567889999999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+|.||+|.++|.+.+. ++..+...++.+.+.||+|||++++|||||-..|+|+   ..++.+||+|||+++...
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCCc
Confidence            999999999999999998874 9999999999999999999999999999999999999   777779999999997654


Q ss_pred             CCCccc-ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          255 PGQIFT-DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       255 ~~~~~~-~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...... ...-...|+|||.+.. .|+.++|||||||++||+++ |..||.+....++...+.......+..  ...+.+
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~  391 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKE  391 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHH
Confidence            211111 1223468999999984 69999999999999999999 889999999999999995544333322  256789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +..++.+|+..||++|||+.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999998765

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.4e-42  Score=315.48  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=207.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+.. +..+|+|.+....    ...+.+.+|+.+++++. ||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            358899999999999999998643 4569999886432    12356889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||++   ++++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999988764 468999999999999999999999999999999999999   778899999999987654432


Q ss_pred             cc--cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 IF--TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ..  ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..+......   ...+..+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            21  12234567999999874 68999999999999999998 99999887777777777665443322   23678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +++.+||+.||++||++.+++.+
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.7e-42  Score=321.31  Aligned_cols=246  Identities=22%  Similarity=0.373  Sum_probs=207.6

Q ss_pred             cceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +|.+.+.||+|+||.||+|.+.     .++..+++|.+...   .....+.+.+|+.+++++. |+||+++++++.....
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   81 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCc
Confidence            4888999999999999999854     34567999987533   3344567889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          175 VHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      .++||||+++++|.+++....                .+++..+..++.+|+.||.|||++||+||||||+||++   ++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence            999999999999999986532                37899999999999999999999999999999999999   78


Q ss_pred             CccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHH
Q 015898          239 DFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~  313 (398)
                      ++.++|+|||++.......   ......++..|+|||.+.+ .++.++|||||||++|||++ |..||.........+.+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            8899999999997654322   1223456788999998874 58899999999999999999 99999888877777777


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+.....   ...++..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            66544322   2346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.4e-43  Score=350.28  Aligned_cols=245  Identities=24%  Similarity=0.400  Sum_probs=215.1

Q ss_pred             cceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..++.+.||+|+||+||+|.-.     .....||||.++...  +....++|.+|++++..|. |||||+|+|++.+++-
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCe
Confidence            3566789999999999999843     234679999986543  5557889999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          175 VHIVMELCAGGELFDRIIQRG--------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +++|+|||..|+|.++|....              +++..+...|+.||+.|++||-++.+|||||-..|+||   .++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccce
Confidence            999999999999999996532              27889999999999999999999999999999999999   8889


Q ss_pred             cEEEeecCCceecCCCCccccc---ccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHc
Q 015898          241 SLKAIDFGLSVFFKPGQIFTDV---VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~  315 (398)
                      .|||+|||+++..-..+.+...   .-..+|||||.|+ ++|+.+||||||||+|||+++ |..||++...+++++.+.+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            9999999999876554444322   2345899999887 789999999999999999999 9999999999999999999


Q ss_pred             CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015898          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV  353 (398)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  353 (398)
                      +..-..   ...+|.++.+|+..||+.+|.+||++.||
T Consensus       721 g~lL~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  721 GQLLSC---PENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             CCcccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            987333   34689999999999999999999999997

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-42  Score=331.30  Aligned_cols=263  Identities=25%  Similarity=0.426  Sum_probs=212.3

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++...  
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~   90 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS   90 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccc
Confidence            345678999999999999999999999999999999986432 23334567889999999997 99999999988543  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       173 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                          ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.+||+|||
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg  165 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG  165 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccc
Confidence                4578899987 7789776654 468999999999999999999999999999999999999   778899999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC--------
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--------  318 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------  318 (398)
                      ++.....  ......++..|+|||.+.+  .++.++|||||||++|+|++|..||...........+.....        
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         166 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9876432  2344678899999998764  478899999999999999999999977665444433322110        


Q ss_pred             ---------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          319 ---------------DFES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       319 ---------------~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                                     ..+.    ......++++.++|.+||+.||.+||++.+++.||||++...+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence                           0000    01123578899999999999999999999999999999755443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-41  Score=318.01  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=205.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCc----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ++|++.++||+|+||+||+|.+..++.    .||+|++....  .......+.+|+.++..+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence            458899999999999999999877776    48999886432  4445677889999999997 99999999988754 4


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++++||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||+   ++++.+||+|||++...
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceeec
Confidence            77999999999999998764 568999999999999999999999999999999999999   77788999999999876


Q ss_pred             CCCCcc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          254 KPGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       254 ~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ......   ....++..|+|||.+.+ .++.++|||||||++|||++ |..||...........+.......   ....+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  236 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP---QPPIC  236 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC---CCccC
Confidence            433221   12234567999999874 58999999999999999998 899998777766666555543221   12357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.++.+++.+||+.||++||++.+++.
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=321.84  Aligned_cols=253  Identities=23%  Similarity=0.350  Sum_probs=207.6

Q ss_pred             cccccceecceecccCceEEEEEEE-----ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ...++|.+.+.||+|+||.||+|.+     ..++..||+|.+....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3446799999999999999999975     2345689999886432  34456778999999999955999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      ..+..++||||+.+++|.+++....  .+++..+..++.+++.||.|||+++|+|+||||+|||+   ++++.++|+|||
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg  186 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFG  186 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCc
Confidence            9999999999999999999987643  38999999999999999999999999999999999999   778899999999


Q ss_pred             CceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCC
Q 015898          249 LSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       249 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (398)
                      ++........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||........+...........  
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--  264 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--  264 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--
Confidence            9976543321   122345678999998874 58999999999999999998 9999987766554444443322221  


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .....++++.+++.+||.++|++|||+.|++.
T Consensus       265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=316.64  Aligned_cols=243  Identities=24%  Similarity=0.357  Sum_probs=200.4

Q ss_pred             ceecccCceEEEEEEEccCCc--EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          105 RKLGQGQFGTTYLCTEIATGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      ++||+|+||.||+|.+..++.  .+|+|.+...  ......+.+.+|+.++.++.+||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            369999999999999887776  4688877532  244556788899999999966999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          183 AGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       183 ~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ++++|.+++....                .+++..+..++.+++.||+|||+.|++||||||+||++   ++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence            9999999987543                37889999999999999999999999999999999999   8888999999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCC
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (398)
                      ||++..............+..|+|||++.. .++.++|||||||++|||++ |..||.+.+..+....+.....   ...
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC---CCC
Confidence            999863321111112233567999998874 58899999999999999997 9999988877777776654321   112


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-41  Score=322.20  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=209.6

Q ss_pred             cccceecceecccCceEEEEEEEc-------cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI-------ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      .++|.+.+.||+|+||.||+|.+.       .++..||+|.+....  .......+.+|+.+++.+.+||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            456999999999999999999743       234579999886432  34556789999999999955999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                      .....++||||+++++|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||++ 
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili-  170 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV-  170 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence            999999999999999999998753                246788899999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~  309 (398)
                        ++++.+||+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       171 --~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         171 --TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             --cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence              7788999999999986643221   122345678999998874 58999999999999999998 8899988888887


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ...+..+....   ....++.++.+|+.+||+.+|++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            77776553221   123578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-41  Score=323.06  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             ccccceecceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..++|.+.+.||+|+||.||+|.+..       ....||+|.+....  .......+.+|+.+++.+.+||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34679999999999999999998532       34579999886432  3455677899999999996699999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      ...+.+++||||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999998653                247889999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~  308 (398)
                         ++++.+||+|||++........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               7778999999999976543221   112234467999998874 58999999999999999999 899998888877


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+..+..+...   .....++.++.+|+.+||..||++|||+.++++
T Consensus       245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            77777655321   112357789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-43  Score=340.47  Aligned_cols=266  Identities=30%  Similarity=0.511  Sum_probs=229.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      -|..++.||-|+||.|.++....+...+|+|.+.+.....+.++..++.|-.||.... .+-||+||..|++++.+|+||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEE
Confidence            4888999999999999999999999999999999988888888999999999999987 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec------
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------  253 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~------  253 (398)
                      ||++||++..+|.+.+-|.+..++.++..+.+|+++.|+.|+|||||||+||||   |.+|++||.|||++.-+      
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecccc
Confidence            999999999999999999999999999999999999999999999999999999   99999999999997533      


Q ss_pred             ---CCCC----------------------------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHH
Q 015898          254 ---KPGQ----------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILL  295 (398)
Q Consensus       254 ---~~~~----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell  295 (398)
                         ..+.                                  .....+||+.|+|||++.+ .|+..+|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence               1110                                  0123589999999999985 6999999999999999999


Q ss_pred             hCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCCCCCCCCC
Q 015898          296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCHPWICENGVAPDRSL  370 (398)
Q Consensus       296 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eiL~hp~~~~~~~~~~~~~  370 (398)
                      .|+.||...+..+.-.++.+-...........+++++.++|.+++ -+++.|.   -++||..||||++..+...+..
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq  942 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQ  942 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhhhc
Confidence            999999887776655555444333333444578999999999976 4677887   5778999999998765544433

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-41  Score=313.24  Aligned_cols=246  Identities=23%  Similarity=0.293  Sum_probs=206.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++.+.||.|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++++. ||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence            356999999999999999999864 55789999986432    23456889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++++|.+++....  .+++..+..++.+++.||.+||+.|++||||||+||++   ++++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence            999999999999987644  68999999999999999999999999999999999999   7788999999999987653


Q ss_pred             CCcc--cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQIF--TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ....  .....+..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.........+......   .....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---PCPPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHH
Confidence            2211  11122357999998874 58999999999999999999 99999888877777766554221   122357899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-41  Score=317.59  Aligned_cols=247  Identities=21%  Similarity=0.344  Sum_probs=207.1

Q ss_pred             ccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+.+++.+. |+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence            35888999999999999999742     35678999987543   4455678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRIIQRG---------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      ..+++|||+++++|.+++....               .+++..+..++.|++.||.|||+.|++||||||+|||+   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence            9999999999999999887542               47899999999999999999999999999999999999   77


Q ss_pred             CccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHH
Q 015898          239 DFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~  313 (398)
                      ++.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            88999999999876543221   122334678999998874 58999999999999999998 99999887777777776


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+....   ....+++.+.+||.+||+.||++||++.|+++
T Consensus       238 ~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6553321   12357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.6e-41  Score=324.12  Aligned_cols=264  Identities=30%  Similarity=0.467  Sum_probs=213.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-CCeE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCV  175 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~~~~  175 (398)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ......+.+.+|+.+++.+. ||||++++++|.. ....
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCcE
Confidence            5677999999999999999999999999999999886432 23334567889999999998 9999999999865 5678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.||+||||+|.||++   ++++.++|+|||.+.....
T Consensus        86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC
Confidence            9999998 5688776653 458899999999999999999999999999999999999   7888999999999875433


Q ss_pred             CCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC-----------------
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG-----------------  316 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-----------------  316 (398)
                        ......++..|+|||.+.+  .++.++|||||||++|+|++|..||...........+.+.                 
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence              2234567889999998764  5899999999999999999999999766543322211110                 


Q ss_pred             ----------CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          317 ----------HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       317 ----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                                .........+.++.++.++|.+||+.+|++|||+.+++.||||..+..++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence                      00000111234678999999999999999999999999999998887775543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.5e-42  Score=325.27  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=205.1

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------  171 (398)
                      .++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+++++.++ ||||+++++++..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            3569999999999999999999999999999999865432 2222345678999999997 9999999998743      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                        ...+++||||+.+ +|...+.. ...+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence              3357999999964 67666654 3469999999999999999999999999999999999999   888999999999


Q ss_pred             CceecCCCC------------cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHH
Q 015898          249 LSVFFKPGQ------------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL  314 (398)
Q Consensus       249 ~a~~~~~~~------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~  314 (398)
                      ++.......            ..+...+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987543221            1223466888999998764  47899999999999999999999998777665554443


Q ss_pred             cCCCcCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          315 KGHIDFES--------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       315 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ........                          ..+..+++.+.++|.+||+.||.+|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            21110000                          0012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=313.62  Aligned_cols=245  Identities=25%  Similarity=0.379  Sum_probs=205.0

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+.....    ....+.+|+.+++.+. ||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence            4888999999999999999875 466899998864322    2346778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++   ++++.+||+|||++........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccc
Confidence            999999999998763 468999999999999999999999999999999999999   7888999999999976543322


Q ss_pred             cc--ccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          259 FT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       259 ~~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ..  ...++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+......   .....++.++.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPTEVYT  232 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence            11  112345799999887 468999999999999999999 89999887777777666554221   122347899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++.+||+.+|++|||+.|+++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-42  Score=319.76  Aligned_cols=253  Identities=31%  Similarity=0.494  Sum_probs=211.1

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+++.+. |+||+++++++...+..++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            5677899999999999999988999999999865432 3344567889999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-c
Q 015898          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~  258 (398)
                      |+++ +|.+.+... ..+++..+..++.+++.||.|||+.||+|+||+|+||++   ++++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9965 888877663 578999999999999999999999999999999999999   778899999999997765443 3


Q ss_pred             ccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-----------------
Q 015898          259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----------------  319 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------------  319 (398)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|++|..||...+..+.+..+......                 
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            344567889999998863  5889999999999999999999999877765554443321100                 


Q ss_pred             --CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          320 --FE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       320 --~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                        ++       ....+.++.++.++|.+||++||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence              00       01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-44  Score=313.54  Aligned_cols=260  Identities=27%  Similarity=0.451  Sum_probs=215.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe--------
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--------  170 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~--------  170 (398)
                      ..|+-..+||+|.||.||+|..+++|+.||+|++..+... .-.-....+|+++|..|. |+|++.+++.|.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence            4577788999999999999999999999999987543211 112235678999999998 999999998874        


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      +...+|+|+++|+. +|..++... .+++..++.+++.+++.||.|+|+..|+|||+||+|+|+   +.+|.+||+|||+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecccc
Confidence            23459999999965 788877654 569999999999999999999999999999999999999   8899999999999


Q ss_pred             ceecCCC-----CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          250 SVFFKPG-----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       250 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      ++.+...     ..++..+.|.+|++||.+.+  .|+++.|||..||+|.||++|.+.+.+.+....+..|..-.-.+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9655322     24567788999999999985  5999999999999999999999999998888777766553333333


Q ss_pred             CCCCCC-------------------------------CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          323 DPWPLI-------------------------------SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       323 ~~~~~~-------------------------------~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      +.||.+                               ++++.||+.+||..||.+|++++++|+|.||.....
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            333321                               357899999999999999999999999999977543

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-41  Score=325.36  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=209.0

Q ss_pred             cccceecceecccCceEEEEEEEccC-------CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ..+|++.+.||+|+||.||+|.+...       +..||+|.+...  ......+.+.+|+.+++++.+||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            34699999999999999999986432       236899987643  244556789999999999955999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                      ..+..+++|||+++++|.+++....                .+++..+..++.|++.||.|||++||+||||||+|||+ 
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill-  167 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV-  167 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence            9999999999999999999987532                37788899999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~  309 (398)
                        ++++.+||+|||++........   .....++..|+|||++.+ .++.++|||||||++|||++ |..||.+.+..+.
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence              7778999999999976543321   122334567999999875 58999999999999999998 8899988888887


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHP  357 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp  357 (398)
                      ...+..+...   .....++.++.+|+.+||+.+|++|||+.|++.+-
T Consensus       246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         246 FKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            7777654322   11234678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.8e-42  Score=321.28  Aligned_cols=257  Identities=31%  Similarity=0.503  Sum_probs=211.2

Q ss_pred             ceecceecccCceEEEEEEEc---cCCcEEEEEEecccccCC-HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      |++.+.||+|+||.||+|.+.   .+++.||||.+.+..... ....+.+.+|+.++.++.+||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            788999999999999999864   467889999986543222 2334568899999999977999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|.||++   +.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccccc
Confidence            999999999999999887789999999999999999999999999999999999999   77889999999998765433


Q ss_pred             Cc--ccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCCCCCC
Q 015898          257 QI--FTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ..  .....|+..|+|||.+.+   ..+.++||||||+++|+|++|..||....    .......+......    ....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~  234 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----FPKT  234 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----CCcc
Confidence            21  223568899999999864   26889999999999999999999995432    22333333333222    2234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLT---AHEVLCHPWICENGV  364 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps---~~eiL~hp~~~~~~~  364 (398)
                      ++.++.++|.+||+.||++|||   +.++|+||||+...+
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            7889999999999999999998   567799999988764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.1e-41  Score=316.07  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=203.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCc----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ++|++.+.||+|+||.||+|.+..++.    .|++|.+...  .......++..|+.++.++. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEECC-Cc
Confidence            358889999999999999999877776    4677766422  12344567888998999997 9999999998754 55


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++++||+++|+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||+   ++++.+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            78899999999999999764 568999999999999999999999999999999999999   78889999999999765


Q ss_pred             CCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          254 KPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       254 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....   ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+.......+.+.++......   ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence            4322   123345677899999987 469999999999999999998 99999888777666666554433222   246


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.++.+++.+||..||++|||+.|+++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            788999999999999999999999866

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=320.09  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             ccceecceecccCceEEEEEEEccC--------------CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIAT--------------GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT  164 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~  164 (398)
                      ++|++.+.||+|+||.||+|.+...              ...||+|.+....  .......+.+|+++++++. |+|+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            4699999999999999999986543              2358999986432  4455677999999999998 999999


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEE
Q 015898          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRG------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFL  232 (398)
Q Consensus       165 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIl  232 (398)
                      +++++...+..++||||+.+++|.+++....            .+++..+..++.+++.||.|||+.|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886532            3678899999999999999999999999999999999


Q ss_pred             EeecCCCccEEEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCcCh
Q 015898          233 LVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--GVPPFWAETQ  306 (398)
Q Consensus       233 l~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~  306 (398)
                      +   ++++.+||+|||++........   .....++..|+|||.+. +.++.++|||||||++|+|++  |..||.....
T Consensus       162 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 V---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             E---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9   7788999999999876543321   12234467899999887 468999999999999999998  6788887766


Q ss_pred             HHHHHHHHcC----CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          307 QGIFDAVLKG----HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       307 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+....+..-    .........+..++.+.+|+.+||..||++|||+++|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            6655544321    111111223346889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-41  Score=313.92  Aligned_cols=248  Identities=22%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+.+++++. ||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            458899999999999999999765443   79999886432  3445678899999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||+   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999999999998764 458999999999999999999999999999999999999   778899999999997654


Q ss_pred             CCCc--c--cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI--F--TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~--~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....  .  ....++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+....+.++.. .  .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-L--PAPMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-C--CCCCCC
Confidence            3321  1  11223567999999874 68999999999999999887 9999988877777777665422 1  222357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.8e-41  Score=317.98  Aligned_cols=247  Identities=21%  Similarity=0.310  Sum_probs=204.9

Q ss_pred             cceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            37889999999999999998653     23578999886432  3445678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015898          175 VHIVMELCAGGELFDRIIQR------------------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPEN  230 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~N  230 (398)
                      .+++|||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999987642                        247889999999999999999999999999999999


Q ss_pred             EEEeecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcC
Q 015898          231 FLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAET  305 (398)
Q Consensus       231 Ill~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~  305 (398)
                      ||+   ++++.+||+|||++........   .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999   7788999999999876433221   122345678999998764 58999999999999999998 999998888


Q ss_pred             hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .......+......   .....++.++.+++.+||+.||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            77777666544221   122357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-43  Score=334.71  Aligned_cols=277  Identities=24%  Similarity=0.364  Sum_probs=235.9

Q ss_pred             ccccCCCCcceeeeccccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHh
Q 015898           77 IMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL  156 (398)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l  156 (398)
                      .+..+|++...++-....+.+..+|.+....|+|-|++|..|.+...|..||||+|..    +....+.-++|++||++|
T Consensus       410 ~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn----NE~M~KtGl~EleiLkKL  485 (752)
T KOG0670|consen  410 GLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN----NEVMHKTGLKELEILKKL  485 (752)
T ss_pred             ccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec----chHHhhhhhHHHHHHHHh
Confidence            3455677777777777788889999999999999999999999999999999999975    344456677899999999


Q ss_pred             cC-----CCCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 015898          157 AG-----HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (398)
Q Consensus       157 ~~-----h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp  228 (398)
                      ..     .-|+++|+..|...+++|||+|.+ ..+|.+.|++.+.   +....+..+++|++.||..|-..||+|.||||
T Consensus       486 ~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKP  564 (752)
T KOG0670|consen  486 NDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKP  564 (752)
T ss_pred             hccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCc
Confidence            72     458999999999999999999998 6799999988654   88899999999999999999999999999999


Q ss_pred             CcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH
Q 015898          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ  307 (398)
Q Consensus       229 ~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~  307 (398)
                      .||||.  .....+||||||.|.....++. +.+..+..|+|||++++ .|+...|+||.||+||||.||+..|.+.+..
T Consensus       565 DNiLVN--E~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  565 DNILVN--ESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             cceEec--cCcceeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            999994  4456899999999998776654 66777888999999997 5999999999999999999999999999999


Q ss_pred             HHHHHHHcCCCcCCCCCC-------------------------------------------------CCC-------CHH
Q 015898          308 GIFDAVLKGHIDFESDPW-------------------------------------------------PLI-------SDS  331 (398)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~-------------------------------------------------~~~-------~~~  331 (398)
                      +++...+.-.-.|+....                                                 +.+       -..
T Consensus       642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~  721 (752)
T KOG0670|consen  642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ  721 (752)
T ss_pred             HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence            888776653333322110                                                 001       135


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      +++||.+||..||++|.|..++|.||||.+
T Consensus       722 ~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            889999999999999999999999999975

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-41  Score=314.59  Aligned_cols=246  Identities=21%  Similarity=0.336  Sum_probs=209.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|++.++||.|+||.||+|.+.. +..+|+|.+...   .......+.+|+.+++.++ |+||+++++++.....+++|
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEE
Confidence            459999999999999999999877 889999998654   2334567889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++++|.+++...  ..+++..+..++.+|+.||.|||++|++||||||+||++   ++++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCc
Confidence            9999999999998753  458999999999999999999999999999999999999   78889999999999765433


Q ss_pred             Cc-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          257 QI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       257 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+.+..+..+...   .....++.++.
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---PCPAKCPQEIY  234 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---CCCCCCCHHHH
Confidence            21 123345667999998874 58899999999999999998 89999888877777777654221   12235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++.+||+.||++|||+.++++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-41  Score=327.84  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=200.8

Q ss_pred             cccceecceecccCceEEEEEEE-----ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-  171 (398)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||++....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            45799999999999999999984     3567899999986432  334466788999999999769999999998754 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR---------------------------------------------------------  194 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  194 (398)
                      +...++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45689999999999999988642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc---ccc
Q 015898          195 ----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTD  261 (398)
Q Consensus       195 ----------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~  261 (398)
                                ..+++..+..++.|++.||.|||++||+||||||+|||+   ++++.+||+|||++........   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence                      136778889999999999999999999999999999999   7788999999999876432211   112


Q ss_pred             cccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChH-HHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          262 VVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       262 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ..++..|+|||.+.+ .++.++|||||||++|+|++ |..||...... .....+..+... ..  ....++++.+++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RA--PDYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CC--CCCCCHHHHHHHHH
Confidence            334667999998864 58999999999999999997 99999765433 233333333221 11  12367899999999


Q ss_pred             hcccCCCCCCCHHHHhcC
Q 015898          339 MLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       339 ~L~~dP~~Rps~~eiL~h  356 (398)
                      ||+.||++|||+.|+++|
T Consensus       318 cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         318 CWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=368.15  Aligned_cols=260  Identities=28%  Similarity=0.422  Sum_probs=226.6

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++.-+|.-...||.|.||.||.|.+..+|+..|+|.+...... ......+.+|..++..|. |||+|+++|+-......
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHHH
Confidence            4455678888999999999999999999999999998765543 555678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +|.||||++|+|.+.+...+..++.....+..|++.|+.|||++|||||||||+||++   +.+|.+|++|||.|..+.+
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecC
Confidence            9999999999999999888878889999999999999999999999999999999999   8889999999999988765


Q ss_pred             CC-----cccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHHHcCCCcCCCCCC
Q 015898          256 GQ-----IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       256 ~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      +.     .....+||+.|||||++.+    ....+.|||||||++.||+||+.||... +.-+++..+..+..+..++  
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~-- 1464 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE-- 1464 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch--
Confidence            42     2346799999999999974    3567899999999999999999999643 4456666666666544333  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                       .++.+.+|||..||..||+.|.++.|+|+|.|-+...
T Consensus      1465 -~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1465 -RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             -hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence             3899999999999999999999999999999986543

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.2e-41  Score=312.98  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.++||+|+||.||+|.+..+ ..||+|.+.....    ..+.+.+|+.+++.+. ||||+++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence            45699999999999999999987655 4699999864322    2356889999999997 9999999998754 55899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++++|.+++...  ..+++..+..++.+++.||.|||+.|++||||||+||++   ++++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence            99999999999999753  357899999999999999999999999999999999999   7788999999999976654


Q ss_pred             CCcc--cccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQIF--TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ....  ....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+......   .....++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCccccCHH
Confidence            3321  2234567899999886 468999999999999999999 88899887777777666554321   112357899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.+|+.+||+.||++||++.++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-41  Score=323.32  Aligned_cols=256  Identities=21%  Similarity=0.255  Sum_probs=201.4

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |.+++.+|.|+  .||.+....+++.||||++.... ......+.+.+|+.+++.++ |+||+++++++...+..+++||
T Consensus         4 ~~i~~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           4 TLIGKCFEDLM--IVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhhHhhcCCc--eEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEe
Confidence            33444454444  45555555799999999987542 24566788999999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||.+....... 
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccc
Confidence            99999999988753  458999999999999999999999999999999999999   777899999999886543221 


Q ss_pred             -------cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC------
Q 015898          258 -------IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE------  321 (398)
Q Consensus       258 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------  321 (398)
                             ......++..|+|||++..   .++.++|||||||++|||++|..||..............+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence                   1233456778999999864   488999999999999999999999987654433322222111000      


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          322 ------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       322 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                              ......++.++.+|+.+||++||++|||+.++|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                    000012346789999999999999999999999999998665

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.5e-41  Score=311.99  Aligned_cols=248  Identities=21%  Similarity=0.356  Sum_probs=207.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +.|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+..|+.+++++. |+||+++.+++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            358889999999999999999876654   79999885432  3445677899999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... +.+++..+..++.+++.||.|||+.|++||||||+||++   ++++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence            9999999999999988654 568999999999999999999999999999999999999   778899999999987654


Q ss_pred             CCCc--cc--ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI--FT--DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~--~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....  ..  ....+..|+|||.+.. .++.++|||||||++|||++ |..||......+....+......   .....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC---CCCCCC
Confidence            3221  11  1223457999998874 68999999999999999997 99999888887777777654322   112247


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.++.+++.+||..+|++||++.+|++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.2e-41  Score=309.48  Aligned_cols=246  Identities=28%  Similarity=0.433  Sum_probs=211.0

Q ss_pred             ceecceecccCceEEEEEEEccCC----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +++.+.||.|+||.||+|.+...+    ..||+|.+....  .....+.+..|+.++..+. |+||+++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence            356789999999999999988766    899999986442  3335678999999999996 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++|||+++++|.+++.....  +++..+..++.|++.||.+||+.|++||||||+||++   ++++.++|+|||++....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence            99999999999999876544  8999999999999999999999999999999999999   788899999999998765


Q ss_pred             CCCcccc--cccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQIFTD--VVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~~~~--~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .......  ..+++.|+|||.+.. .++.++||||||+++|+|++ |..||...........+.........   ..++.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCH
Confidence            5432222  336788999998864 58999999999999999998 88999888887777777665543222   24789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+++.+||..||++|||+.|+++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.9e-41  Score=313.27  Aligned_cols=247  Identities=22%  Similarity=0.366  Sum_probs=207.6

Q ss_pred             cceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      .|++.+.||+|+||.||+|.+..++.   .||||.+....  .......+..|+.+++.+. ||||+++++++..+...+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence            48899999999999999999877665   59999986432  4556678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++   ++++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence            999999999999888753 568999999999999999999999999999999999999   7888999999999876543


Q ss_pred             CCcc---cccc---cCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          256 GQIF---TDVV---GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       256 ~~~~---~~~~---gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ....   ....   .+..|+|||.+.. .++.++|||||||++||+++ |..||+.....+....+.... .  ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~--~~~~~~  235 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-R--LPPPMD  235 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c--CCCccc
Confidence            2211   1111   1347999999874 68999999999999999886 999999888777777765432 1  122235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++..+.+++.+||..+|++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=317.90  Aligned_cols=253  Identities=30%  Similarity=0.490  Sum_probs=211.0

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |++.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+..|+.+++.+. |+|++++++++...+..++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            567789999999999999999999999999987543 22334567788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-c
Q 015898          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~  258 (398)
                      |++ ++|.+++... ..+++..+..++.+++.||.+||+.||+||||+|+||++   ++++.++|+|||++....... .
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            997 5899999876 579999999999999999999999999999999999999   778899999999987654432 3


Q ss_pred             ccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC------------------
Q 015898          259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------------------  318 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------------  318 (398)
                      .....++..|+|||.+.+  .++.++|||||||++|||++|..||......+.+..+.....                  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            334556788999998863  588999999999999999999999987776555444432100                  


Q ss_pred             cCC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          319 DFE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       319 ~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .++       ....+.++..+.++|.+||..||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            000       01123457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-41  Score=309.80  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=201.6

Q ss_pred             ceecccCceEEEEEEEccCC---cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          105 RKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      ++||+|+||.||+|....++   ..||+|.+.....  ....+.+.+|+.+++.+. |+||+++++++. ....++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999876554   7899999875442  245567899999999997 999999999876 4568999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc-c
Q 015898          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-T  260 (398)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~-~  260 (398)
                      +++++|.+++.....+++..+..++.|++.||.|||..|++||||||+|||+   +.++.+||+|||++......... .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999887789999999999999999999999999999999999999   77889999999999766433221 1


Q ss_pred             ---ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          261 ---DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       261 ---~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                         ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+......   .....++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence               1123457999998874 58999999999999999998 99999887777776666554322   2233578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 015898          336 IRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~  355 (398)
                      |.+||..||++||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=309.52  Aligned_cols=242  Identities=25%  Similarity=0.347  Sum_probs=207.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||.|+||.||+|..  .|+.||+|.+....    ...+++.+|+.+++.+. |+||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            3588899999999999999985  47899999986432    25678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccc
Confidence            99999999999987765  68999999999999999999999999999999999999   78889999999999876332


Q ss_pred             CcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .  .....+..|+|||.+. +.++.++||||||+++|++++ |..||......+....+......   .....+++++.+
T Consensus       156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  230 (256)
T cd05039         156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM---EAPEGCPPEVYK  230 (256)
T ss_pred             c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCccCCCHHHHH
Confidence            2  2334456799999887 468899999999999999997 99999888777776666554221   222357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 015898          335 LIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +|.+||..+|++|||+.|+++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.8e-41  Score=309.97  Aligned_cols=240  Identities=23%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             eecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          106 KLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++++. ||||++++++++. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            3899999999999765  445679999986442  3445577999999999997 9999999998864 57899999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc----
Q 015898          184 GGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI----  258 (398)
Q Consensus       184 ~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~----  258 (398)
                      +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||+   +.++.+||+|||++........    
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            9999998875 4568999999999999999999999999999999999999   7788999999999976543321    


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....++..|+|||.+.. .++.++|||||||++|+|++ |..||......+....+..+...   ...+.+++++.++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHH
Confidence            111223568999998874 58899999999999999996 99999888877777776665422   12235689999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 015898          337 RKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+||..||++||++.+|++
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-41  Score=315.82  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=207.8

Q ss_pred             ccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ++|++.+.||.|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++++. ||||+++++++..+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~   81 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVGK   81 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCC
Confidence            468999999999999999998743     67889999986432  3445677999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 015898          174 CVHIVMELCAGGELFDRIIQRG----------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NI  231 (398)
                      ..++||||+++++|.+++....                      .+++..+..++.+++.||.|||++|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999986432                      367888999999999999999999999999999999


Q ss_pred             EEeecCCCccEEEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCh
Q 015898          232 LLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ  306 (398)
Q Consensus       232 ll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~  306 (398)
                      ++   ++++.++|+|||++........   ......+..|+|||.+. ..++.++|||||||++|+|++ |..||.+...
T Consensus       162 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         162 LV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             Ee---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99   7888999999999875432221   12233456799999877 468999999999999999998 8889988887


Q ss_pred             HHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+....+..+.....   ...++.++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            777777766554321   1246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.6e-41  Score=310.54  Aligned_cols=241  Identities=24%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE-ecCCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY-EDSLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~-~~~~~~~l  177 (398)
                      ++|++.+.||+|+||.||+|..  .+..||+|.+...     ...+.+.+|+.+++++. |+|++++++++ ..++..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            3588999999999999999974  4788999988532     23467889999999997 99999999975 45677999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++++|.+++....  .+++..+..++.+++.||.|||++|++||||||+||++   ++++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999987644  37899999999999999999999999999999999999   7888999999999876443


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ..  ....++..|+|||++.+ .++.++|||||||++|+|++ |..||......+....+..+..   ....+.+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  23344568999998875 58899999999999999998 9999988777777766655422   222345789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++.+||+.+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.2e-41  Score=310.35  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+. .+..||+|.+.....    ..+.+.+|+.+++++. |+|++++++++.. ...+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEECC-CCcE
Confidence            3457999999999999999999864 567799999865332    2356889999999997 9999999998754 5688


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++|||+++++|.+++...  ..+++..+..++.+++.||.|||+.|++||||||+||++   ++++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeecc
Confidence            999999999999988753  358999999999999999999999999999999999999   778899999999997654


Q ss_pred             CCCcc--cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQIF--TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .....  ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+......   ......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCH
Confidence            33211  12334567999998864 58899999999999999999 89999888877777776654221   11235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+.+|+.+||+.||++|||+.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.5e-42  Score=298.19  Aligned_cols=255  Identities=28%  Similarity=0.508  Sum_probs=213.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCe
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLC  174 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~  174 (398)
                      -.++|++.+++|.|-++.||.|....+.++++||+++.      -..+.+.+|++||..|++||||++++++..+  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            34569999999999999999999999999999999853      3457899999999999999999999999865  456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +.+|+||+++.+...+.   ..++...++.++.+++.||.|||+.||+|||+||.|+++.  ...-.++|+|+|+|.+..
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcC
Confidence            88999999886654433   4588899999999999999999999999999999999994  334579999999999999


Q ss_pred             CCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCC-CcChHHHHHHHHc-------------CCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLK-------------GHI  318 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~-~~~~~~~~~~~~~-------------~~~  318 (398)
                      ++..+...+.++.|-.||.+..  .|+...|+|||||+|+.|+..+.||. +.++.+.+-++.+             -.+
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            9988888899999999999984  59999999999999999999998875 4455554444432             000


Q ss_pred             c-------------------CC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          319 D-------------------FE-SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       319 ~-------------------~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .                   |. .+....+++++.|||.++|..|..+|+|++|++.||||...
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            0                   11 11112357999999999999999999999999999999653

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.5e-41  Score=329.93  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             cccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|.+.++||+|+||.||+|.+.     ..++.||||++....  .....+.+.+|+.+|.++..||||+++++++...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            345888999999999999999854     345689999996532  3344567889999999997799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG---------------------------------------------------------  195 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  195 (398)
                      +..++||||+++|+|.+++.+.+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999986532                                                         


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          196 -----------------------------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       196 -----------------------------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                                                               .+++..+..++.||+.||.|||+.+|+||||||+|||+ 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl-  272 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI-  272 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence                                                     25667788999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~  309 (398)
                        ++++.+||+|||++........   .....++..|+|||.+.+ .++.++|||||||++|||++ |..||......+.
T Consensus       273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence              7778999999999976532211   123456788999998874 58899999999999999998 8899976655554


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ...........  .....++.++.+|+.+||+.+|.+||++.||++.
T Consensus       351 ~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         351 FYNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44433332221  1223478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.8e-41  Score=310.11  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=205.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.++||+|+||.||+|.. .+++.||+|.+....    .....+.+|+.+++++. |+||+++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC----CcHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcE
Confidence            456799999999999999999985 467889999986433    23457889999999997 999999999874 45689


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++|||+++++|.+++...  ..+++..+..++.+++.||+|||+.|++||||||+||++   ++++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence            999999999999988653  358999999999999999999999999999999999999   788899999999997765


Q ss_pred             CCCc--ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ....  .....++..|+|||.+.. .++.++||||||+++|||++ |..||.+....+....+......   .....++.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCH
Confidence            3221  123345678999998874 58899999999999999999 99999888777777666554321   12234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+++.+||+.+|++|||+++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6e-41  Score=314.46  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=196.0

Q ss_pred             ccc-eecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--
Q 015898           99 DLY-TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--  171 (398)
Q Consensus        99 ~~y-~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--  171 (398)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+.+++.+. ||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            455 889999999999998764    34578899999986432  2334567889999999997 9999999998765  


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      ...+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~  155 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK  155 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence            34689999999999999988654 59999999999999999999999999999999999999   778899999999998


Q ss_pred             ecCCCCc----ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChH--HH------------HHH
Q 015898          252 FFKPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ--GI------------FDA  312 (398)
Q Consensus       252 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~--~~------------~~~  312 (398)
                      .......    .....++..|+|||.+. ..++.++||||||+++|+|++|..||......  +.            ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            6544321    12234566799999887 45899999999999999999999998543211  00            000


Q ss_pred             HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .......  ......++.++.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         236 LLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0111111  1112346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=315.15  Aligned_cols=267  Identities=27%  Similarity=0.481  Sum_probs=212.3

Q ss_pred             ccccccc-ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-------CCee
Q 015898           92 HKTDNIR-DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-------KNIV  163 (398)
Q Consensus        92 ~~~~~~~-~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-------~niv  163 (398)
                      ...+.|. .+|.+.++||+|-|++||+|+|....+.||+|+++.    .....+....||++|++++.+       .+||
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            3556677 899999999999999999999999999999999863    344567788999999998732       4799


Q ss_pred             EEeEEEe----cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeec
Q 015898          164 TIKGAYE----DSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNK  236 (398)
Q Consensus       164 ~l~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~  236 (398)
                      +|++.|.    .+.+++||+|++ |.+|+.+|....  .++...++.|++|||.||.|||. .||||.||||+|||+...
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            9999996    467899999999 889999998753  48999999999999999999996 699999999999999433


Q ss_pred             C-------------------------------------------------------------------------------
Q 015898          237 D-------------------------------------------------------------------------------  237 (398)
Q Consensus       237 ~-------------------------------------------------------------------------------  237 (398)
                      +                                                                               
T Consensus       225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n  304 (590)
T KOG1290|consen  225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN  304 (590)
T ss_pred             ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence            1                                                                               


Q ss_pred             --------------------------------C-----------------------------------------------
Q 015898          238 --------------------------------D-----------------------------------------------  238 (398)
Q Consensus       238 --------------------------------~-----------------------------------------------  238 (398)
                                                      .                                               
T Consensus       305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~  384 (590)
T KOG1290|consen  305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI  384 (590)
T ss_pred             cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence                                            0                                               


Q ss_pred             -----CccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC------h
Q 015898          239 -----DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET------Q  306 (398)
Q Consensus       239 -----~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~------~  306 (398)
                           +..+||+|||-|+...  ..++..+.|+.|+|||++.+ .|+..+||||++|++|||+||...|....      .
T Consensus       385 ~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD  462 (590)
T KOG1290|consen  385 PLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD  462 (590)
T ss_pred             CCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence                 1136888888887643  45677788999999999996 69999999999999999999999884321      2


Q ss_pred             HHHHHHHHc------------CCCc--C-----------CCCCCCC---------C----CHHHHHHHHHhcccCCCCCC
Q 015898          307 QGIFDAVLK------------GHID--F-----------ESDPWPL---------I----SDSAKDLIRKMLCSQPSERL  348 (398)
Q Consensus       307 ~~~~~~~~~------------~~~~--~-----------~~~~~~~---------~----~~~~~~li~~~L~~dP~~Rp  348 (398)
                      .+.+..|..            +...  |           ....|+.         +    ..++.+||.-||+.+|++||
T Consensus       463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            233333322            1000  0           0111211         1    24678999999999999999


Q ss_pred             CHHHHhcCCCccCCCCC
Q 015898          349 TAHEVLCHPWICENGVA  365 (398)
Q Consensus       349 s~~eiL~hp~~~~~~~~  365 (398)
                      ||.++|+|||+....-+
T Consensus       543 tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  543 TAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             cHHHHhcCccccCCCCC
Confidence            99999999999987665

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-40  Score=308.75  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=202.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+ ..+|+|.+....    ...+.+.+|+.+++.+. |+|++++++++.. +..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcEE
Confidence            35699999999999999999987554 469999875432    22356788999999997 9999999998754 56889


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +|||+.+++|.+++....  .+++..+..++.+++.||.|||+.|++||||||+||++   ++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence            999999999999987643  47899999999999999999999999999999999999   8888999999999976543


Q ss_pred             CCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...  .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+......   ......+..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPES  231 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHH
Confidence            321  12234567899999887 458999999999999999999 99999888777777666554221   122357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.+++.+||..||++||+++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=308.26  Aligned_cols=247  Identities=24%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+....    ...+.+.+|+.+++++. |+||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence            3467999999999999999999964 56789999986432    23467889999999998 999999999999989999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+++++|.+++....  .+++..+..++.+++.||.|||++|++|+||||+||++   ++++.++|+|||++....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceecc
Confidence            9999999999999987643  68999999999999999999999999999999999999   788999999999997765


Q ss_pred             CCCcc--cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQIF--TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .....  ....++..|+|||.+.+ .++.++|||||||++|+|++ |+.||.+.........+.......   .....+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP---RPPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCH
Confidence            32211  12234567999998874 58899999999999999998 999998888777777776543221   1224688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+++.+||+.+|++||++++++.
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=310.76  Aligned_cols=247  Identities=22%  Similarity=0.284  Sum_probs=207.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCc----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ++|++.+.||+|+||.||+|.+..+|.    .||+|.+....  .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence            458999999999999999999876665    58999876443  3455678899999999997 9999999999887 78


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||++   ++++.+||+|||.+...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcccccc
Confidence            89999999999999998764 468999999999999999999999999999999999999   77889999999999876


Q ss_pred             CCCCccc---ccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          254 KPGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       254 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .......   ...++..|+|||.+. ..++.++|+|||||++||+++ |..||......+....+..+.....   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCC
Confidence            5332211   122356799999886 468999999999999999998 9999998887777777765432211   2246


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.++.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            789999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.7e-41  Score=311.71  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=209.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccC--CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      +|.+.+.||+|+||.||++.+...+..+++|+++.....  .......+..|+.+++.+. ||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            588999999999999999998888777777776543221  2233446778999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||++   ++ +.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili---~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL---KN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe---ec-CCEeecccCceeec
Confidence            9999999999888753    3568999999999999999999999999999999999999   43 45999999998765


Q ss_pred             CCC-CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          254 KPG-QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       254 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ... .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..+.....   ...++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence            433 22334568889999998864 478899999999999999999999987766666666554432221   2346789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      +.++|.+||..||++||++.|+++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-40  Score=311.91  Aligned_cols=249  Identities=22%  Similarity=0.267  Sum_probs=207.1

Q ss_pred             cccceecceecccCceEEEEEEEcc----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-C
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-S  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~  172 (398)
                      .++|++.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++.+. |+||+++++++.. .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            3569999999999999999999775    3578999987532  25566778899999999997 9999999998765 5


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEE
Q 015898          173 LCVHIVMELCAGGELFDRIIQR--------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                      ...++++||+++++|.+++...        ..+++..+..++.+++.||+|||+.+++||||||+||++   ++++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence            7789999999999999988653        358899999999999999999999999999999999999   77889999


Q ss_pred             eecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCc
Q 015898          245 IDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHID  319 (398)
Q Consensus       245 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  319 (398)
                      +|||+++.......   .....++..|+|||.+.+ .++.++|||||||++||+++ |..||......+....+..+.. 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR-  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-
Confidence            99999976533221   122345667999998874 58999999999999999999 9999988777776666555421 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..  ....+++++.+++.+||..||++|||+.++++
T Consensus       238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11  22346889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.8e-41  Score=311.47  Aligned_cols=250  Identities=20%  Similarity=0.341  Sum_probs=210.1

Q ss_pred             ccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +.|++.+.||.|+||.||+|..+.     +.+.||+|.+....  .....+.+.+|+.+++++. |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            458899999999999999999653     34679999875432  3335678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEE
Q 015898          174 CVHIVMELCAGGELFDRIIQRG---------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                      ..++||||+++++|.+++....         .+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence            9999999999999999997655         68999999999999999999999999999999999999   77889999


Q ss_pred             eecCCceecCCCC--cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcC
Q 015898          245 IDFGLSVFFKPGQ--IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       245 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      +|||++.......  ......++..|+|||.+.+ .++.++||||||+++|+|++ |..||...........+..+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986543221  2233455677999998864 58889999999999999999 888998777777777766555443


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ..  ...++..+.+++.+||+.||++|||+.|++.+
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            32  23578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-40  Score=314.92  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=201.7

Q ss_pred             cccceecceecccCceEEEEEEEcc----------------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA----------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN  161 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n  161 (398)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+....  .......+.+|+.+++.+. |+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            3569999999999999999986432                34579999986432  3445678899999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCc
Q 015898          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPEN  230 (398)
Q Consensus       162 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~N  230 (398)
                      |+++++++...+..++||||+++++|.+++....           .+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999887542           36678899999999999999999999999999999


Q ss_pred             EEEeecCCCccEEEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCc
Q 015898          231 FLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--GVPPFWAE  304 (398)
Q Consensus       231 Ill~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt--g~~pf~~~  304 (398)
                      ||+   ++++.++|+|||++........   .....++..|+|||... +.++.++|||||||++|||++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            999   7788999999999876543221   12233467899999766 568999999999999999998  77899776


Q ss_pred             ChHHHHHHHHc----CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          305 TQQGIFDAVLK----GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       305 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ...+.......    ............+++.+.+|+.+||+.||++||++.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66555443321    0011111112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-40  Score=307.36  Aligned_cols=242  Identities=26%  Similarity=0.365  Sum_probs=203.4

Q ss_pred             ceecccCceEEEEEEEcc-CC--cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          105 RKLGQGQFGTTYLCTEIA-TG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      ++||+|++|.||+|.+.. .+  ..||||.+......  ...+.+.+|+.+++++. ||||+++++++.. ..+++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999998765 33  36999998765432  56778999999999998 9999999999988 899999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          182 CAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       182 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      +++++|.+++....  .+++..+..++.|++.||.|||++|++||||+|+||++   +.++.+||+|||++.......  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence            99999999997754  68999999999999999999999999999999999999   777899999999997764421  


Q ss_pred             --cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 --IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                        ......++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+........  ....++..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence              1123456778999999874 58999999999999999998 9999988777777666654322221  1234678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.3e-42  Score=353.17  Aligned_cols=255  Identities=32%  Similarity=0.454  Sum_probs=210.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-----  172 (398)
                      ..+|+..+.||+||||.||+++++-+|+.||||.|....  +.....++.+|+..|.+|. |||||+++..|.+.     
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCccc
Confidence            345888999999999999999999999999999997554  5666788999999999997 99999998766210     


Q ss_pred             --------------------------------------------------------------------------------
Q 015898          173 --------------------------------------------------------------------------------  172 (398)
Q Consensus       173 --------------------------------------------------------------------------------  172 (398)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 015898          173 ----------------------------------LCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVEACH  217 (398)
Q Consensus       173 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~~i~~al~~lH  217 (398)
                                                        ..+||-||||+...|.+++..+... ....+++++++|++||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1368999999886666655554433 47899999999999999999


Q ss_pred             hCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-------------------CCCcccccccCCcccCcccccc--
Q 015898          218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------------PGQIFTDVVGSPYYVAPEVLLK--  276 (398)
Q Consensus       218 ~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~--  276 (398)
                      +.|||||||||.||++   +++..|||+|||+|....                   +....+..+||.-|+|||++.+  
T Consensus       715 ~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999   888899999999998621                   1124567899999999999973  


Q ss_pred             --cCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015898          277 --HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV  353 (398)
Q Consensus       277 --~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  353 (398)
                        .|+.|+|+|||||+|+||+.   ||.. +....++..+.++.++++...+..--+.-..+|+.||+.||++||||.|+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence              59999999999999999987   6753 34456677777777776644333334567889999999999999999999


Q ss_pred             hcCCCccC
Q 015898          354 LCHPWICE  361 (398)
Q Consensus       354 L~hp~~~~  361 (398)
                      |++.||..
T Consensus       869 L~s~llpp  876 (1351)
T KOG1035|consen  869 LNSELLPP  876 (1351)
T ss_pred             hhccCCCc
Confidence            99999974

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.6e-40  Score=303.22  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||+|+||.||+|.. .++..||+|.+....  .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence            3699999999999985 568899999886432  3444557889999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc--cc
Q 015898          185 GELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TD  261 (398)
Q Consensus       185 ~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~--~~  261 (398)
                      ++|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||++   ++++.+||+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999988653 457999999999999999999999999999999999999   77889999999998754432211  12


Q ss_pred             cccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHh
Q 015898          262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (398)
Q Consensus       262 ~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  339 (398)
                      ..++..|+|||.+. +.++.++||||||+++|++++ |..||...........+......   .....++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence            23356799999987 458899999999999999998 99999887777666666554221   22235789999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 015898          340 LCSQPSERLTAHEVLCH  356 (398)
Q Consensus       340 L~~dP~~Rps~~eiL~h  356 (398)
                      |..+|++||++.|+++.
T Consensus       231 l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         231 WDYKPENRPKFSELQKE  247 (250)
T ss_pred             cccCcccCCCHHHHHHH
Confidence            99999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-40  Score=305.53  Aligned_cols=245  Identities=25%  Similarity=0.414  Sum_probs=206.1

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++.+.||.|+||.||+|.+. ++..+|+|.+.....    ....+.+|+++++++. |||++++++++......++||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence            4888999999999999999874 467899998864322    2346788999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||+++++|.+++... +.+++..+..++.+++.||+|||+.|++||||||+||++   +.++.++|+|||++........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc
Confidence            999999999988754 468999999999999999999999999999999999999   7788999999999876543221


Q ss_pred             --ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          259 --FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       259 --~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                        .....++..|+|||.+. +.++.++||||||+++|||++ |..||...........+..+...+..   ...+.++.+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYE  232 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHH
Confidence              11223456899999887 468899999999999999998 99999888877777777654332222   236789999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      |+.+||+.+|++|||+.|++++
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-40  Score=307.55  Aligned_cols=248  Identities=26%  Similarity=0.338  Sum_probs=205.4

Q ss_pred             ccceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|.+.+.||+|+||.||+|.+...   ...||||......  .....+.+.+|+.+++.+. ||||+++++++.. ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence            4588999999999999999987544   3468999875432  3455678999999999997 9999999998876 457


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++.... .+++..+..++.+++.||.|||+.|++||||||+||++   +.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeecc
Confidence            89999999999999997644 58999999999999999999999999999999999999   777899999999997654


Q ss_pred             CCCccc--ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQIFT--DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ......  ...++..|+|||.+.. .++.++|||||||++|||++ |..||......+....+.++....   ....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~  235 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCPP  235 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCH
Confidence            432221  2233467999998864 58999999999999999986 999998887777776666543221   2235789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++.+++.+||..+|++|||+.+++..
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-40  Score=311.27  Aligned_cols=248  Identities=26%  Similarity=0.404  Sum_probs=199.2

Q ss_pred             cceecceecccCceEEEEEEE----ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--C
Q 015898          100 LYTLGRKLGQGQFGTTYLCTE----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--L  173 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~  173 (398)
                      .|++.+.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+. ||||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            378899999999999999973    4578899999986432  3445678999999999997 99999999998765  6


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ..++||||+++++|.+++.+. ..+++..+..++.+++.||.|||++|++||||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccc
Confidence            789999999999999988664 358999999999999999999999999999999999999   7788999999999976


Q ss_pred             cCCCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---------------hHHHHHH
Q 015898          253 FKPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---------------QQGIFDA  312 (398)
Q Consensus       253 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~---------------~~~~~~~  312 (398)
                      ......    .....++..|+|||.+.+ .++.++|||||||++|+|+++..|+....               .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            543321    123456678999998874 58899999999999999999876642210               1111122


Q ss_pred             HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +..+. .  ......++..+.+|+.+||+.||++|||+.+++++
T Consensus       239 ~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         239 LEEGK-R--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHcCc-c--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            22221 1  11233578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=302.95  Aligned_cols=241  Identities=25%  Similarity=0.343  Sum_probs=201.7

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      ++||.|+||.||+|.+.. ++.||+|.+....  .......+.+|+.+++++. |+||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL--PPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999877 9999999886543  2345678999999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc---c
Q 015898          185 GELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF---T  260 (398)
Q Consensus       185 ~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~---~  260 (398)
                      ++|.+++... ..+++..+..++.+++.||.|||++|++||||||+||++   +.++.++|+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998653 458899999999999999999999999999999999999   78889999999999765422211   1


Q ss_pred             ccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       261 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ...++..|+|||.+.+ .++.++|+|||||++|+|++ |..||...........+......   .....++.++.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM---PAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---CCCccCCHHHHHHHHH
Confidence            1223556999998874 58999999999999999999 88999877766666665543211   1123578899999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q 015898          339 MLCSQPSERLTAHEVLC  355 (398)
Q Consensus       339 ~L~~dP~~Rps~~eiL~  355 (398)
                      ||+.+|++|||+.|+++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.4e-40  Score=304.78  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=205.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+ ..+..+|+|.+...    ....+.+.+|+.+++.+. |+||+++++++.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            456799999999999999999985 45667999987642    234567889999999997 9999999999887 7789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++|||+++++|.+++...  ..+++..+..++.+++.||.|||+.|++||||||+||++   +.++.+||+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeecc
Confidence            999999999999998763  357888999999999999999999999999999999999   788899999999997654


Q ss_pred             CCCc--ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ....  .....++..|+|||.+.. .++.++|+|||||++|++++ |..||...........+..+...   ......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccCCH
Confidence            3321  122344567999999874 58889999999999999999 99999887777777666554322   22235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+++.+||+.+|++||++.+++.
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=304.94  Aligned_cols=258  Identities=25%  Similarity=0.460  Sum_probs=231.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      .+|.+.++||.|+|++|.++..+.+.+.+|+|+++++-....+++.-+..|-.+..+.++||.+|-+...|+....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            34899999999999999999999999999999999988888888888899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee-cCCCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~-~~~~~  257 (398)
                      .||++||+|..++.+.++++++.++.+...|+.||.|||+.|||+||||.+|+|+   |..|++||.|+|+++. +.++.
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCCc
Confidence            9999999999999999999999999999999999999999999999999999999   9999999999999865 35567


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC--------cChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA--------ETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~--------~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ..++++|||.|.|||++.+ .|....|.|+|||+|+||+.|+.||.-        .+..=+++-++...+.++..    +
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs----l  482 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS----L  482 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce----e
Confidence            7789999999999999996 599999999999999999999999941        22333556666666655543    6


Q ss_pred             CHHHHHHHHHhcccCCCCCCC------HHHHhcCCCccCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLT------AHEVLCHPWICENG  363 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps------~~eiL~hp~~~~~~  363 (398)
                      +-.+..+++..|++||.+|..      ..++..|+||....
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            778889999999999999974      57999999998644

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.5e-40  Score=306.24  Aligned_cols=244  Identities=22%  Similarity=0.293  Sum_probs=193.0

Q ss_pred             ceecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          105 RKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      +.||+|+||.||+|...  .++..+|+|.+....  .......+.+|+.++++++ ||||+++++++.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            36999999999999854  345679999886443  2334457888999999997 999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          183 AGGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       183 ~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.|++||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999886532     35677888999999999999999999999999999999   778899999999986543322


Q ss_pred             c---ccccccCCcccCcccccc--------cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcC-CCcCCCCC
Q 015898          258 I---FTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG-HIDFESDP  324 (398)
Q Consensus       258 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~  324 (398)
                      .   .....++..|+|||++.+        .++.++|||||||++|||++ |..||......+........ ........
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123456788999998852        25789999999999999996 99999776655544333222 22222211


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       325 -~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                       ....++.+.+++.+|+ .+|++|||++||+.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1235788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.8e-40  Score=305.28  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=210.4

Q ss_pred             ceecceecccCceEEEEEEEcc-CCcEEEEEEeccccc-------CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKL-------ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      |++.+.||+|+||.||+|.+.. .++.+|+|.+.....       .......++..|+.++.+..+||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7889999999999999999877 678999998854321       23345567788999887644599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          173 LCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                      +..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||++   +.++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEecc
Confidence            999999999999999887743    3458999999999999999999996 789999999999999   78889999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      |++.............++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.........  ..
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  236 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--EG  236 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--cc
Confidence            99987655544456678999999999874 5889999999999999999999999877776666666554433221  12


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .++.++.++|.+||+.||++||++.|+..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            467899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.9e-40  Score=305.87  Aligned_cols=244  Identities=20%  Similarity=0.290  Sum_probs=193.3

Q ss_pred             eecccCceEEEEEEEcc--CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          106 KLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.+. |+||+++++.+.....+++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeCC
Confidence            59999999999996432  34578888775332  3444567889999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          184 GGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       184 ~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      +++|.+++....     .+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh
Confidence            999999987643     24678889999999999999999999999999999999   8888999999999865432211


Q ss_pred             ---ccccccCCcccCccccc--------ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCC-CcCCCC-C
Q 015898          259 ---FTDVVGSPYYVAPEVLL--------KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH-IDFESD-P  324 (398)
Q Consensus       259 ---~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~-~  324 (398)
                         .....++..|+|||++.        ..++.++|||||||++|||++ |..||......+.+....... ...+.. .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence               12234567799999864        246789999999999999999 788988776666555544332 222221 1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ...+++.+.+++..|+ .||++|||+++|++-
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            2357788999999998 599999999999763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-41  Score=309.41  Aligned_cols=240  Identities=21%  Similarity=0.254  Sum_probs=192.2

Q ss_pred             ceecccCceEEEEEEEccCCc-------EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      +.||.|+||.||+|.+...+.       .||+|.+...   .....+.+..|+.+++.+. ||||+++++++..+...++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            469999999999999765543       4888887532   2344567888999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-----CccEEEeecCCce
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-----DFSLKAIDFGLSV  251 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-----~~~~kL~DFG~a~  251 (398)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||++..++.     .+.++++|||.+.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999987654 5899999999999999999999999999999999999943221     1237999999987


Q ss_pred             ecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCC-CCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .....   ....++..|+|||.+.+  .++.++|||||||++|+|++|. .||........... ......++.    ..
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~----~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLPA----PK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCCC----CC
Confidence            55432   23567889999999874  4789999999999999999985 66655544433322 222222222    35


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +.++.+||.+||+.||++|||++++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            5789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.1e-40  Score=303.75  Aligned_cols=242  Identities=26%  Similarity=0.370  Sum_probs=195.5

Q ss_pred             ceecccCceEEEEEEEcc---CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-cCCeEEEEEe
Q 015898          105 RKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-DSLCVHIVME  180 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-~~~~~~lv~e  180 (398)
                      +.||+|+||.||+|.+..   .+..||+|.+...  ......+.+.+|+.+++.+. ||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            468999999999998653   3457999987532  24455678889999999997 999999999765 5566899999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc-
Q 015898          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-  258 (398)
                      |+.+++|.+++... ..+++..+..++.+++.||.|||+.+++||||||+|||+   ++++.+||+|||++........ 
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            99999999998764 346788889999999999999999999999999999999   7788999999999875432211 


Q ss_pred             ----ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          259 ----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       259 ----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                          .....++..|+|||.+. ..++.++|||||||++|||++ |.+||......+....+..+.....   ...+++.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence                12334567899999886 468999999999999999999 5667777666666666655432211   12467899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+++.+||+.+|++||++.|++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5e-40  Score=303.26  Aligned_cols=240  Identities=28%  Similarity=0.383  Sum_probs=202.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.+.||+|+||.||++.  .+++.||+|.+...     ...+.+.+|+.+++++. |||++++++++.... .++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence            358999999999999999987  57889999998532     23457889999999997 999999999987654 7999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999987643  47899999999999999999999999999999999999   77889999999998764332


Q ss_pred             CcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                        ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||......+....+.++...   .....++.++.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM---EPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC---CCCCcCCHHHHH
Confidence              12334456799999887 468899999999999999998 99999888777777666554321   223457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 015898          335 LIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+||+.+|++||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.6e-40  Score=307.42  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=196.2

Q ss_pred             cceecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CC
Q 015898          100 LYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SL  173 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~  173 (398)
                      .|++.+.||+|+||.||+|.    +..++..||+|.+...   .....+.+.+|+.+++.+. ||||+++++++..  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCC
Confidence            58899999999999999987    4467889999998643   4455678899999999997 9999999998643  45


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccc
Confidence            689999999999999998764 458999999999999999999999999999999999999   7888999999999987


Q ss_pred             cCCCCcc----cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---------------HHHHH
Q 015898          253 FKPGQIF----TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GIFDA  312 (398)
Q Consensus       253 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------------~~~~~  312 (398)
                      .......    ....++..|+|||.+.+ .++.++|||||||++|||++|..|+......               ..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            6433211    11223446999999874 5899999999999999999987765322110               00111


Q ss_pred             HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .......+  .....++.++.+|+.+||..+|++|||+.|+++
T Consensus       238 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 LLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11111111  112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=344.10  Aligned_cols=249  Identities=27%  Similarity=0.397  Sum_probs=214.2

Q ss_pred             cccceecceecccCceEEEEEEEccCC-----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .+..++.+.||+|+||.||.|.-....     ..||||.+.+.  .+......|.+|..+|+.+. |||||+++|++-+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence            345778899999999999999865432     24888888643  37788899999999999998 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          173 LCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      ...+|++|||+||+|..+|.+.       ..++..+.+.++.+|+.|++||+++++|||||...|+|+   +....+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence            9999999999999999999875       348999999999999999999999999999999999999   888999999


Q ss_pred             ecCCceecCCCCcccc-c--ccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcC
Q 015898          246 DFGLSVFFKPGQIFTD-V--VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       246 DFG~a~~~~~~~~~~~-~--~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      |||+|+.+...+.+.. .  .-...|||||.+. +.++.++|||||||++||++| |..||....+.+++.-...+.   
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---
Confidence            9999995544333221 1  2234699999998 579999999999999999999 999999999999988666655   


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+....++..+.+++.+||+.+|++||++..|++
T Consensus       922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            33344568999999999999999999999999887

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.1e-40  Score=306.14  Aligned_cols=245  Identities=25%  Similarity=0.356  Sum_probs=198.8

Q ss_pred             ceecccCceEEEEEEEccCC------cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATG------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.||+|+||.||+|.+....      +.+|+|.+....  .......+.+|+.+++.+. ||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence            36999999999999976443      689999885432  2344667889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC--CCccEEEeecCC
Q 015898          179 MELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGL  249 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~--~~~~~kL~DFG~  249 (398)
                      |||+++++|.+++...       ..+++..+..++.+++.||.|||+.+++|+||||+||++...+  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999988642       2378899999999999999999999999999999999994322  123899999999


Q ss_pred             ceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCC
Q 015898          250 SVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       250 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (398)
                      +........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+..+...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence            875533221   122345678999998874 68999999999999999998 99999877776666665443221   12


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ...++..+.++|.+||..+|++||+++++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2357899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8e-40  Score=310.21  Aligned_cols=248  Identities=21%  Similarity=0.273  Sum_probs=202.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCc----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +.|+..+.||+|+||.||+|.+..++.    .||+|.+....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence            347889999999999999999877776    47888875432  3344457889999999997 99999999988754 4


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence            678999999999999987644 58999999999999999999999999999999999999   77788999999999865


Q ss_pred             CCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          254 KPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       254 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .....   .....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+.........+..+... +  ..+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL-P--QPPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCC
Confidence            43321   122345678999998874 58999999999999999997 89999877666655555443322 1  12346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +..+.+++.+||..+|++||++.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-40  Score=307.24  Aligned_cols=239  Identities=18%  Similarity=0.198  Sum_probs=190.4

Q ss_pred             eecccCceEEEEEEEcc------------------------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC
Q 015898          106 KLGQGQFGTTYLCTEIA------------------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN  161 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n  161 (398)
                      .||+|+||.||+|....                        ....||+|++...   .......+.+|+.+++.+. |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCC-CCC
Confidence            69999999999987432                        1245889987543   2334567888999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec----
Q 015898          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK----  236 (398)
Q Consensus       162 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~----  236 (398)
                      |+++++++......++||||+++++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+...    
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999888865 4568999999999999999999999999999999999999432    


Q ss_pred             CCCccEEEeecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHH-hCCCCCCCcChHHHHHHH
Q 015898          237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILL-SGVPPFWAETQQGIFDAV  313 (398)
Q Consensus       237 ~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~  313 (398)
                      .....+||+|||++......   ....++..|+|||.+.+  .++.++|||||||++|||+ +|..||............
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            12235899999988643222   23457788999998864  4899999999999999995 699999876655443332


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .. ....+.    ..++++.++|.+||+.+|++|||+.++|++
T Consensus       235 ~~-~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 EK-KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             Hh-ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22 222221    245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.3e-40  Score=301.77  Aligned_cols=228  Identities=25%  Similarity=0.348  Sum_probs=188.5

Q ss_pred             cCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCChHH
Q 015898          110 GQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD  189 (398)
Q Consensus       110 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~  189 (398)
                      |.||.||+|.+..+++.||+|.+....        ...+|...+.... ||||+++++++...+..++||||+++++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999986532        1223444444454 9999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCccc
Q 015898          190 RIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV  269 (398)
Q Consensus       190 ~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~  269 (398)
                      ++.....+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   77889999999987654432  23445677899


Q ss_pred             Ccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 015898          270 APEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL  348 (398)
Q Consensus       270 aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  348 (398)
                      |||.+.+ .++.++|+||+||++|||++|..|+......     + ......  .....+++.+.++|.+||+.||++||
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTL--NIPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-cccccc--CCcccCCHHHHHHHHHHccCCHHHhc
Confidence            9999874 5889999999999999999999887543211     0 000111  11134788999999999999999999


Q ss_pred             CH-----HHHhcCCCc
Q 015898          349 TA-----HEVLCHPWI  359 (398)
Q Consensus       349 s~-----~eiL~hp~~  359 (398)
                      ++     +++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            96     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-40  Score=303.06  Aligned_cols=234  Identities=18%  Similarity=0.206  Sum_probs=190.4

Q ss_pred             ceecccCceEEEEEEEccCC----------cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          105 RKLGQGQFGTTYLCTEIATG----------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +.||+|+||.||+|.+..++          ..|++|.+....    .....+.+|+.+++.+. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            46999999999999987766          357888765332    11578889999999997 9999999999888 77


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-------cEEEee
Q 015898          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-------SLKAID  246 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-------~~kL~D  246 (398)
                      .++||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||++   +.++       .+||+|
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill---~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV---ARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE---ecCccccCCceeEEeCC
Confidence            899999999999999997765 78999999999999999999999999999999999999   4444       799999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      ||++.....   .....++..|+|||++.+   .++.++|||||||++|+|++ |..||................ ..+.
T Consensus       152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~  227 (259)
T cd05037         152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLPM  227 (259)
T ss_pred             CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCCC
Confidence            999986543   223456778999999874   48899999999999999999 578886665433333322211 1111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                          .....+.++|.+||..+|++|||+.++++
T Consensus       228 ----~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 ----PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ----CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                12378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.2e-40  Score=303.34  Aligned_cols=240  Identities=18%  Similarity=0.212  Sum_probs=189.8

Q ss_pred             ceecccCceEEEEEEEcc------------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898          105 RKLGQGQFGTTYLCTEIA------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      +.||+|+||.||+|+...            ....||+|.+...   .......+.+|+.++..+. ||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            368999999999998432            2335889987543   2344557888999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC----CCccEEEeec
Q 015898          173 LCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----DDFSLKAIDF  247 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~----~~~~~kL~DF  247 (398)
                      ...++||||+++++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+....    ....++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999999887765 35689999999999999999999999999999999999994321    1123899999


Q ss_pred             CCceecCCCCcccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHH-hCCCCCCCcChHHHHHHHHcCCCcCCCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILL-SGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (398)
                      |++......   ....++..|+|||.+.  ..++.++|||||||++|||+ +|..||......+... .........   
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~---  229 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV---  229 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC---
Confidence            998654322   2356788899999886  35899999999999999998 5888887655443322 222222211   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                       ...++++.+||.+||+.||++||++.+|+++
T Consensus       230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence             1245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=330.99  Aligned_cols=200  Identities=32%  Similarity=0.507  Sum_probs=179.3

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC------e
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL------C  174 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~------~  174 (398)
                      |...+.||+|+||.||+|.++.+|+.||||.+....  .....+.+.+|+++|++|. |+|||+++++-++..      .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccccc
Confidence            666789999999999999999999999999987544  4556788999999999998 999999999866544      5


Q ss_pred             EEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEEEeecCCc
Q 015898          175 VHIVMELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLS  250 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~DFG~a  250 (398)
                      ..+|||||.||+|+..+.+.   ..+++.+.+.++..+..||.|||++|||||||||.||++.... .....||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            78999999999999999753   2499999999999999999999999999999999999995433 4557899999999


Q ss_pred             eecCCCCcccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA  303 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~~pf~~  303 (398)
                      +..+.+....+.+||+.|.+||.+.  +.|+..+|.|||||++|+.+||..||..
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999999999999999999999998  4699999999999999999999999954

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=307.58  Aligned_cols=250  Identities=15%  Similarity=0.138  Sum_probs=188.3

Q ss_pred             cccccceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhH--------HHHHHHHHHHHHhcCCCCeeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDV--------EDVRREIQIMHHLAGHKNIVT  164 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~--------~~~~~Ei~~l~~l~~h~niv~  164 (398)
                      ...++|++.++||+|+||.||+|.+..+   +..+|+|+............        .....+...+..+. |+++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCc
Confidence            3456799999999999999999998877   66788886432221100000        11122333444555 999999


Q ss_pred             EeEEEecCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          165 IKGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       165 l~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +++.+....    ..++++|++ ..++.+.+.....+++..+..++.|++.||.|||+.+|+||||||+|||+   +.++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~  163 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNN  163 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCC
Confidence            998765443    457888887 34676766665557889999999999999999999999999999999999   7788


Q ss_pred             cEEEeecCCceecCCCC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HH--
Q 015898          241 SLKAIDFGLSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-QG--  308 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~--  308 (398)
                      .++|+|||+|.......        ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ..  
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999997653221        1123469999999998875 589999999999999999999999976632 21  


Q ss_pred             ------HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          309 ------IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       309 ------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                            ....+..+...     .+..++++.+++..|+..+|++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                  22233332222     2346799999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-39  Score=302.76  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=201.8

Q ss_pred             ceecceecccCceEEEEEEEc---cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC----
Q 015898          101 YTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~----  173 (398)
                      |++.++||+|+||.||+|.+.   .+++.||||++.... ......+++.+|+.+++.+. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            567889999999999999864   357899999986433 34556778899999999997 999999999886432    


Q ss_pred             --eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          174 --CVHIVMELCAGGELFDRIIQR------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       174 --~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                        ..++++||+.+++|.+++...      ..+++..+..++.|++.||+|||+.||+||||||+||++   ++++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              357899999999998877432      147889999999999999999999999999999999999   778899999


Q ss_pred             ecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcC
Q 015898          246 DFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       246 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      |||++........   .....+++.|++||.+.+ .++.++|||||||++|+|++ |..||......+....+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999886543321   122344567999998874 58889999999999999999 889998877777666665543221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                         ..+..+..+.+++.+||..+|++|||+.+++.+
T Consensus       236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               113467899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=327.13  Aligned_cols=276  Identities=25%  Similarity=0.421  Sum_probs=230.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-----c
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----D  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-----~  171 (398)
                      ..+.|++.++||.|.+|.||+++++.+++.+|+|+....    .+..+++..|..+|+.+.+|||++.++++|.     .
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            345699999999999999999999999999999998653    3445678889999999999999999999985     3


Q ss_pred             CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      ++.+|||||||.||+..|+++.  ...+.|..+..|++.++.||.+||.+.++|||||-.|||+   +.++.|||+|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeee
Confidence            5789999999999999998865  4568999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCC-CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          250 SVFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       250 a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      +...... ....+.+|||.|||||++.      ..|+..+|+||||++..||--|.+|+.+..+-..+-.|-+. .+...
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkL  248 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL  248 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccc
Confidence            8776543 2345689999999999985      24788999999999999999999999888775555444222 22222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNK  386 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (398)
                      ..+..++.++.++|..||.+|-.+||+..++|+|||+.+..      ...++...++...-++-
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~------~e~qir~~ik~~~~~~r  306 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP------NERQVRIQIKDHIDRSR  306 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc------cHHHHHHHHHHHHhhcc
Confidence            33456789999999999999999999999999999998222      55566666666665553

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=297.10  Aligned_cols=259  Identities=24%  Similarity=0.265  Sum_probs=215.8

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      ...||.|+||+|++..++.+|+..|||.+....  .....+++..|.+...+-.+.||||+++|..-.++..||.||+| 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-  145 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-  145 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence            578999999999999999999999999996543  45567789999998888888999999999998889999999999 


Q ss_pred             CCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          184 GGELFDRI-----IQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       184 ~~~L~~~l-----~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ..+|..+.     .+...++++.+-.|+...+.||.||-. .+|||||+||+|||+   +..|.+||||||.+....+.-
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHH
Confidence            45663322     234569999999999999999999974 689999999999999   999999999999998776655


Q ss_pred             cccccccCCcccCccccc--c-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcCCCCCC--CCCCHH
Q 015898          258 IFTDVVGSPYYVAPEVLL--K-HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPW--PLISDS  331 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~--~-~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~  331 (398)
                      ..+.-.|-..|||||.+.  + .|+.++||||||++|||+.||+.||.+-+ ..+.+..+..+..+......  -.++..
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~  302 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS  302 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence            566778899999999996  3 49999999999999999999999986432 33445555555443322211  236889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR  368 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~  368 (398)
                      ++.+|.-||.+|.+.||...+++.+||+........+
T Consensus       303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~  339 (361)
T KOG1006|consen  303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD  339 (361)
T ss_pred             HHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence            9999999999999999999999999999998876665

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=299.36  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=214.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~----  172 (398)
                      +..+|.-.+.+|.|+- .|..|.|.-.++.||+|.+... .......++..+|+.++..+. |+||++++.+|...    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence            4456888899999998 8888999999999999998655 556667788999999999997 99999999998543    


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          173 --LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       173 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                        ...|+|||++ ..+|...+.  -.++...+..|..|+++|+.|||+.||+||||||+||++   ..++.+||+|||+|
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLA  165 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhh
Confidence              4589999999 568887776  347889999999999999999999999999999999999   88899999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc----------
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------  319 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------  319 (398)
                      +.-...-..+.++.|+.|+|||++.+ .|...+||||+||++.||++|...|.+.+..+.+.++......          
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            87665556788999999999999986 5999999999999999999999999887766655554331000          


Q ss_pred             ---------------------CCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          320 ---------------------FESDPWP-------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       320 ---------------------~~~~~~~-------~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                                           ++...++       .-...++|++.+||..||++|.|++++|+||||+-|
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence                                 1111111       123468999999999999999999999999999843

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.8e-39  Score=298.36  Aligned_cols=243  Identities=21%  Similarity=0.296  Sum_probs=192.3

Q ss_pred             eecccCceEEEEEEEccCC--cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          106 KLGQGQFGTTYLCTEIATG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .||+|+||.||+|....++  ..+++|.+....  .....+.+.+|+.+++.+. ||||+++++.+......++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence            5999999999999754332  346677664332  3345678999999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          184 GGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       184 ~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      +++|.+++.+.    ..+++..+..++.||+.||.|||+.+++||||||+|||+   +.++.++|+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence            99999998753    235677888999999999999999999999999999999   778899999999986432211  


Q ss_pred             -cccccccCCcccCcccccc--------cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCC-cC-CCCCC
Q 015898          258 -IFTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI-DF-ESDPW  325 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~  325 (398)
                       ......++..|+|||++..        .++.++|||||||++|||++ |..||......+.+..+..+.. .. .....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1234567889999998742        35778999999999999997 5778877777666666544322 11 11222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+++.+.+++..|| .+|++||++.+|++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            346788999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-39  Score=302.55  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=200.1

Q ss_pred             ccceecceecccCceEEEEEEEc----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--C
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--S  172 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~  172 (398)
                      +.|++.+.||+|+||.||+|...    .++..||||.+.....  ....+.+.+|+.+++.+. |+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            34788899999999999999854    3478999999875432  245678999999999997 9999999999877  6


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      ...++||||+++++|.+++.... .+++..+..++.+++.||.|||++|++||||||+||++   +.++.++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence            67999999999999999987654 58999999999999999999999999999999999999   778899999999998


Q ss_pred             ecCCCCcc----cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---------------HHHH
Q 015898          252 FFKPGQIF----TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GIFD  311 (398)
Q Consensus       252 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------------~~~~  311 (398)
                      ........    ....++..|+|||.+.. .++.++|||||||++|||++|..|+......               ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76533211    12234566999998874 5889999999999999999999998543211               1122


Q ss_pred             HHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+. .....+  ....++.++.+|+.+||+.+|++|||+.|+++
T Consensus       238 ~~~-~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLK-EGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHH-cCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            222 222211  12346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=316.47  Aligned_cols=247  Identities=28%  Similarity=0.413  Sum_probs=212.7

Q ss_pred             cccceecceecccCceEEEEEEEcc--CCc--EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA--TGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ++..++.+.||+|.||.||.|....  .|+  -||||.-+..  ...+..+.|..|..+|+.+. ||||++++|++.+. 
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-
Confidence            3456677899999999999998432  343  4778876543  36667889999999999998 99999999998765 


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ..|||||+++-|.|..+|..++ .++......++.||+.||.|||+.++|||||-..|||+   .....+||+|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhh
Confidence            5799999999999999998765 48899999999999999999999999999999999999   6666899999999999


Q ss_pred             cCCCCcccccccCC--cccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          253 FKPGQIFTDVVGSP--YYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       253 ~~~~~~~~~~~gt~--~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      +.....+....|..  -|||||.++ .+++.++|||-|||.|||+++ |..||.+..+.+++-.+.+|.....   .+.+
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nC  617 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNC  617 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCC
Confidence            88877666555543  599999998 679999999999999999988 9999999999999888888765433   3478


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHh
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVL  354 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL  354 (398)
                      ++.+..|+.+||..||.+||...++.
T Consensus       618 Pp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  618 PPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ChHHHHHHHHHhccCcccCCcHHHHH
Confidence            99999999999999999999998864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=307.18  Aligned_cols=266  Identities=28%  Similarity=0.468  Sum_probs=223.8

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC----HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ..+.++|-+..+||+|||+.||+|.+....+.||+|+-...+...    ....+...+|..|-+.|. ||.||++|++|.
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfs  537 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFS  537 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeee
Confidence            346688999999999999999999999999999999865433221    223456789999999997 999999999996


Q ss_pred             -cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCcEEEeecCCCccEEEeec
Q 015898          171 -DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--GVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       171 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~--~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                       +.+.+|-|+|||+|.+|..+|+..+.+++.+++.|+.||+.||.||.+.  .|||-||||.|||+...+..|.+||.||
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence             5667899999999999999999999999999999999999999999976  4999999999999988788899999999


Q ss_pred             CCceecCCCC--------cccccccCCcccCccccc-c----cCCCcccHHHHHHHHHHHHhCCCCCCCc-ChHHHHHH-
Q 015898          248 GLSVFFKPGQ--------IFTDVVGSPYYVAPEVLL-K----HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDA-  312 (398)
Q Consensus       248 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~----~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~-  312 (398)
                      |++++++.+.        ......||.+|++||.+. +    ..+.++||||+|||+|..+.|+.||... ...++++. 
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            9999876542        345678999999999875 3    4788999999999999999999999644 33333322 


Q ss_pred             -H-HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          313 -V-LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       313 -~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                       | ......|+..  +.++.++++||++||..--++|+...++-.||||....
T Consensus       698 TIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  698 TILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             chhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence             1 2233445544  57899999999999999999999999999999997643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.1e-39  Score=326.41  Aligned_cols=257  Identities=21%  Similarity=0.321  Sum_probs=177.7

Q ss_pred             cccceecceecccCceEEEEEEEccC----CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEE-----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-----  168 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~-----  168 (398)
                      .+.|++.++||+|+||.||+|.+..+    +..||+|.+.....     .+....|  .+.... +.++..++..     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence            35699999999999999999999888    89999998753211     1111111  111111 2222222221     


Q ss_pred             -EecCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 015898          169 -YEDSLCVHIVMELCAGGELFDRIIQRGH--------------------YSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (398)
Q Consensus       169 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~~i~~al~~lH~~~iiHrDik  227 (398)
                       ......+++||||+.+++|.+++.....                    .....+..++.||+.||.|||+.||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             2456779999999999999998865321                    1234567899999999999999999999999


Q ss_pred             CCcEEEeecCCCccEEEeecCCceecCCC--CcccccccCCcccCcccccc-----------------------cCCCcc
Q 015898          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPG--QIFTDVVGSPYYVAPEVLLK-----------------------HYGPEA  282 (398)
Q Consensus       228 p~NIll~~~~~~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-----------------------~~~~~~  282 (398)
                      |+|||+.  ++++.+||+|||+|.....+  .......+++.|+|||.+..                       .++.++
T Consensus       283 P~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999993  23578999999999765432  22345788999999996531                       133456


Q ss_pred             cHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-----------CCC------CCCCCCCHHHHHHHHHhcccCCC
Q 015898          283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----------FES------DPWPLISDSAKDLIRKMLCSQPS  345 (398)
Q Consensus       283 DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----------~~~------~~~~~~~~~~~~li~~~L~~dP~  345 (398)
                      |||||||+||||+++..++... .......+......           ...      ......+..+.+||.+||+.||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999977665322 11111111111000           000      00111234566999999999999


Q ss_pred             CCCCHHHHhcCCCccCCCCC
Q 015898          346 ERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       346 ~Rps~~eiL~hp~~~~~~~~  365 (398)
                      +|||+.|+|+||||.+....
T Consensus       440 kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        440 QRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999986654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=295.85  Aligned_cols=256  Identities=24%  Similarity=0.410  Sum_probs=211.3

Q ss_pred             eecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-----eEE
Q 015898          102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----CVH  176 (398)
Q Consensus       102 ~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-----~~~  176 (398)
                      +-.+.||-|+||.||.+.|..+|+.||+|.+.. ...+-..-+++.+|+++|..++ |.|++..++......     .+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHH
Confidence            345789999999999999999999999998853 2334455678999999999998 999999998876443     478


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +++|++. .+|..++.....++...+.-+++||++||+|||+.+|.||||||.|+|+   +.+..+||||||+|+..+.+
T Consensus       134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchh
Confidence            8999994 5888888888889999999999999999999999999999999999999   88999999999999876544


Q ss_pred             C--cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHc-----------------
Q 015898          257 Q--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK-----------------  315 (398)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~-----------------  315 (398)
                      +  ..+.-+.|-+|+|||++++  +|+.+.||||.|||+.||+..+..|....+.+.++.|.+                 
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            3  3455677889999999995  599999999999999999999999987777666665543                 


Q ss_pred             ------CCCcCCC-CCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          316 ------GHIDFES-DPW------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       316 ------~~~~~~~-~~~------~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                            +....+. ...      ..-.-+..+++.+||.+||++|++..+++.|+|+.+..
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                  1111000 000      11234788999999999999999999999999987644

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=303.60  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ++...+.++||+|-||.|.+|. ...+..||||.++...  .......|.+||++|.+|+ ||||+.++|+|..++.+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHH
Confidence            4557889999999999999998 3457999999997654  4555688999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |+||++.|+|..++.+...  ........|+.||+.|++||.+.++|||||.+.|+|+   ++++++||+|||+++..-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence            9999999999999987632  3456677799999999999999999999999999999   9999999999999986655


Q ss_pred             CCccc---ccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCcChHHHHHHHHcCC----CcCCCCCC
Q 015898          256 GQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--GVPPFWAETQQGIFDAVLKGH----IDFESDPW  325 (398)
Q Consensus       256 ~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~  325 (398)
                      ++.+.   ..+-..+|||||.+. ++++.++|+|+||++|||+++  ...||...+.++..+....-.    ........
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            54332   234567899999765 889999999999999999876  778998888877766653311    11112233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +-++.++.+++.+||..|-++||+.+++-.
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            457899999999999999999999999743

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=322.13  Aligned_cols=246  Identities=23%  Similarity=0.389  Sum_probs=216.9

Q ss_pred             ceecceecccCceEEEEEEEccCC---cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ..|.++||.|.||.||+|..+..|   ..||||.++...  ...+...|+.|+.||-++. ||||++|.|+.....-++|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEE
Confidence            578899999999999999987666   469999996443  5667788999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |+|||++|+|..+|..+ ++|+..++.-+++.|+.|++||-+.|+|||||-..|||+   +.+..+|++|||+++..+++
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence            99999999999988764 679999999999999999999999999999999999999   99999999999999987654


Q ss_pred             C--ccccccc--CCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          257 Q--IFTDVVG--SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       257 ~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .  .++..-|  ..+|.|||.+. ++++.++||||+|++|||.++ |..|||+..++++++.+.++-.-.+   ...++.
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---PmDCP~  861 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---PMDCPA  861 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---CCCCcH
Confidence            3  2222222  35799999987 679999999999999999998 9999999999999999988754333   336899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+-+|+..||++|-.+||.+.+|+.
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            9999999999999999999988765

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.2e-38  Score=284.34  Aligned_cols=242  Identities=46%  Similarity=0.727  Sum_probs=208.4

Q ss_pred             CceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCChHHH
Q 015898          111 QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR  190 (398)
Q Consensus       111 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~  190 (398)
                      +||.||+|.+..+++.+|+|++.......  ..+.+.+|+..++++. |+|++++++.+......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999987543221  1678999999999996 99999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccC
Q 015898          191 IIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA  270 (398)
Q Consensus       191 l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~a  270 (398)
                      +.....+++..+..++.+++.++.+||+.+++|+||+|.||++   ++++.++|+|||.+.............++..|+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            8876668999999999999999999999999999999999999   7778999999999988766545566778899999


Q ss_pred             ccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 015898          271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL  348 (398)
Q Consensus       271 PE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  348 (398)
                      ||.+. ..++.++||||||+++++|++|..||.. .......+.+.......... ...++.++.+++.+||..+|++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-cccCCHHHHHHHHHHccCCchhcc
Confidence            99887 4688899999999999999999999977 55555565555544433222 112778999999999999999999


Q ss_pred             CHHHHhcCCCc
Q 015898          349 TAHEVLCHPWI  359 (398)
Q Consensus       349 s~~eiL~hp~~  359 (398)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=313.96  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=216.4

Q ss_pred             ccceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +..++.++||+|+||.|++|.+...   ...||||.+......  .....|.+|+.+|.+|. |+|+++|||+.-+ ..+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence            3467789999999999999987743   246999999765432  25678999999999998 9999999998877 678


Q ss_pred             EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          176 HIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+|||+++.|+|.+.|.+  ...|-......++.||+.|+.||.++++|||||-..|+|+   -..-.|||||||+.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceecc
Confidence            899999999999999987  3458889999999999999999999999999999999999   55668999999999988


Q ss_pred             CCCCcccccc----cCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          254 KPGQIFTDVV----GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       254 ~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ..++.+....    -...|+|||.+. ..++.++|||+|||++|||+| |+.||.+....++++.+.++..-...   +.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP---k~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP---KY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC---CC
Confidence            7665443222    234699999998 579999999999999999999 88999999999999999866543333   35


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +++.+.++++.||..+|++|||+.+|.+.-++.++.
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~eaq  375 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ  375 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence            899999999999999999999999987666655544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-37  Score=307.88  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=186.9

Q ss_pred             cccceecceecccCceEEEEEEEc----------------cCCcEEEEEEecccccCCHh-----------hHHHHHHHH
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI----------------ATGIEFACKSISKRKLISRE-----------DVEDVRREI  150 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~Ei  150 (398)
                      .++|++.++||+|+||+||+|.+.                ..++.||||.+.........           ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            467999999999999999999742                34568999998643211000           112234577


Q ss_pred             HHHHHhcCCCC-----eeEEeEEEec--------CCeEEEEEeccCCCChHHHHHhc-----------------------
Q 015898          151 QIMHHLAGHKN-----IVTIKGAYED--------SLCVHIVMELCAGGELFDRIIQR-----------------------  194 (398)
Q Consensus       151 ~~l~~l~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-----------------------  194 (398)
                      .++.++. |.+     +++++++|..        .+..++||||+++++|.+++...                       
T Consensus       224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7777776 443     4677777643        35689999999999999888642                       


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccc--cccCCcccCc
Q 015898          195 -GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD--VVGSPYYVAP  271 (398)
Q Consensus       195 -~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~--~~gt~~y~aP  271 (398)
                       ..+++..+..++.|++.||.|||+.+|+||||||+|||+   +.++.+||+|||++.....+.....  ..+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             123567788999999999999999999999999999999   7778999999999976543322222  3347899999


Q ss_pred             cccccc---------------------CC--CcccHHHHHHHHHHHHhCCC-CCCCcChH-----------HHHHHHHcC
Q 015898          272 EVLLKH---------------------YG--PEADVWTAGVILYILLSGVP-PFWAETQQ-----------GIFDAVLKG  316 (398)
Q Consensus       272 E~~~~~---------------------~~--~~~DiwSlG~il~elltg~~-pf~~~~~~-----------~~~~~~~~~  316 (398)
                      |.+...                     |.  .+.||||+||++|+|++|.. ||......           .........
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            987521                     11  24699999999999999875 66432111           111111122


Q ss_pred             CCcCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCCcc
Q 015898          317 HIDFESDPWPLISDSAKDLIRKMLCSQP---SERLTAHEVLCHPWIC  360 (398)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rps~~eiL~hp~~~  360 (398)
                      ..  ....+...++.+.||+.+||..+|   .+|+|+.|+|+||||.
T Consensus       460 ~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        460 KY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            22  223455678999999999999866   6899999999999994

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=303.55  Aligned_cols=241  Identities=25%  Similarity=0.397  Sum_probs=213.1

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      .....+||-|.||.||.|.++.-...||||.++.    +...+++|+.|..+|+.+. |||+|+|+|+|....-+|||+|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEe
Confidence            5566789999999999999999899999999864    3456789999999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          181 LCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||..|+|.++|.+..+  ++.-....++.||..|++||..+++|||||-..|.|+   .++..+|++|||+++++..+. 
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT-  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT-  419 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc-
Confidence            9999999999987543  6777888999999999999999999999999999999   788899999999999876543 


Q ss_pred             cccccc---CCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          259 FTDVVG---SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       259 ~~~~~g---t~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ++...|   ..-|.|||.+. +.++.++|||+|||+|||+.| |-.||.+.+..+++..+.++.   ..+....+++.+.
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy---RM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY---RMDGPEGCPPKVY  496 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---cccCCCCCCHHHH
Confidence            333333   34599999987 679999999999999999999 889999999999999888874   3344457999999


Q ss_pred             HHHHHhcccCCCCCCCHHHH
Q 015898          334 DLIRKMLCSQPSERLTAHEV  353 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~ei  353 (398)
                      .|++.||+|.|.+||++.|+
T Consensus       497 eLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHH
Confidence            99999999999999999886

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=317.81  Aligned_cols=251  Identities=30%  Similarity=0.449  Sum_probs=201.2

Q ss_pred             ceecceecccCceE-EEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGT-TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      |.-.+++|.|+-|+ ||+|.  ..|+.||||.+.      .+......+|+..|+.-..|||||++++.-.+....||+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLL------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHh------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            34467899999885 88888  678899999884      3445678899999999989999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC--CCccEEEeecCCceec
Q 015898          180 ELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGLSVFF  253 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~--~~~~~kL~DFG~a~~~  253 (398)
                      |+|. .+|.+++.....    ......+.++.|++.||++||+.+||||||||.||||...+  ....++|+|||+++.+
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9995 599999876311    12255688999999999999999999999999999997643  3468999999999988


Q ss_pred             CCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhC-CCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          254 KPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       254 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ..+.    ......||.+|+|||++.. .-+.++|||||||++|+.++| ..||.+....+  ..|.++......-. +.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~-~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLE-PL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeec-cC
Confidence            7654    2356789999999999985 466799999999999999995 89996544332  23444443322110 11


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ...++.|||.+||++||..||+|.+||.||+|....
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            223899999999999999999999999999998765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.2e-37  Score=287.71  Aligned_cols=261  Identities=27%  Similarity=0.443  Sum_probs=204.3

Q ss_pred             cccccccccceecceecccCceEEEEEEEcc---CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEE
Q 015898           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA  168 (398)
Q Consensus        92 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~  168 (398)
                      .....+...|.++.+||+|.|++||++.+..   ..+.||+|.+....     ...++.+|+++|..+.++.||+++.+.
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhh
Confidence            3344556679999999999999999999887   78899999986432     345689999999999999999999999


Q ss_pred             EecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          169 YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       169 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      +...+...+|+||++.....++...   ++...+..+++.++.||.++|.+|||||||||.|+|+....  +.-.|+|||
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t--~rg~LvDFg  178 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT--QRGVLVDFG  178 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc--CCceEEech
Confidence            9999999999999999887776643   67999999999999999999999999999999999996443  456889999


Q ss_pred             CceecCC-------------------C--------------------------CcccccccCCcccCcccccc--cCCCc
Q 015898          249 LSVFFKP-------------------G--------------------------QIFTDVVGSPYYVAPEVLLK--HYGPE  281 (398)
Q Consensus       249 ~a~~~~~-------------------~--------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~  281 (398)
                      +|...+.                   +                          .......||++|+|||++.+  .-+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9862110                   0                          00113579999999999984  57889


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHH--------------cCC-------------------CcC-------
Q 015898          282 ADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVL--------------KGH-------------------IDF-------  320 (398)
Q Consensus       282 ~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~--------------~~~-------------------~~~-------  320 (398)
                      +||||.|+|+.-++++..||..... .+.+..+.              .+.                   ...       
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999843211 11100000              000                   000       


Q ss_pred             -------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          321 -------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       321 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                             ........+..+.||+.+||..||.+|+|++|+|.||||.+.
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence                   000111234589999999999999999999999999999843

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=323.63  Aligned_cols=239  Identities=23%  Similarity=0.260  Sum_probs=184.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|...++||+|+||.||+|.+..++..||||.+.....       ....|+.++++++ ||||+++++++.+.+..|+||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEEE
Confidence            46667899999999999999989999999998854321       1124688899997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||+++|+|.+++.   .+++..+..++.+++.||+|||   +.+|+||||||+||++   +.++..++. ||.+......
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccccC
Confidence            9999999999985   3889999999999999999999   6799999999999999   666667764 6655433221


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh--HHHHH---HHHc---------CCCcCC
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFD---AVLK---------GHIDFE  321 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~--~~~~~---~~~~---------~~~~~~  321 (398)
                         ....+|+.|+|||++.+ .++.++|||||||++|||++|+.||.....  .....   ....         ......
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence               23467899999999874 599999999999999999999999853211  11111   1000         000000


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .........++.+++.+||+.||++|||+.||++.
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000112357789999999999999999999865

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=300.03  Aligned_cols=247  Identities=23%  Similarity=0.407  Sum_probs=208.4

Q ss_pred             ceecceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..+.+.||+|+||.|++|.-..       ....||||.++...  ...+.+.+..|+++|+.+..|+||+.++|++...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            4567799999999999997331       14579999986544  34677899999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC
Q 015898          174 CVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~  237 (398)
                      .+++|+||++.|+|.+++...+                .++..+...++.||+.|++||++.++|||||-..|||+   .
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---T  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---c
Confidence            9999999999999999998766                38889999999999999999999999999999999999   7


Q ss_pred             CCccEEEeecCCceecCCCCccc--cccc--CCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcC-hHHHH
Q 015898          238 DDFSLKAIDFGLSVFFKPGQIFT--DVVG--SPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAET-QQGIF  310 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~-~~~~~  310 (398)
                      ++..+||+|||+|+.......+.  ...+  ...|||||.+.. .|+.++|||||||+|||++| |..||.+.. ..+++
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            77899999999999765554443  2222  234999999985 69999999999999999999 889998855 66677


Q ss_pred             HHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.+.++.....+   ..++.++.++++.||+.+|++||+..++.+
T Consensus       533 ~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  533 EFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            767666543332   257899999999999999999999988754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=249.92  Aligned_cols=212  Identities=26%  Similarity=0.327  Sum_probs=179.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +...-+..||.|++|.|-+.++..+|...|+|.+...-  +....+++.+|+.+..+...+|.+|.++|.+......||.
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            44555678999999999999999999999999996432  4555678888999888877899999999999999999999


Q ss_pred             EeccCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          179 MELCAGGELFD----RIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       179 ~e~~~~~~L~~----~l~~~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||.| ..+|..    .+.+.+.+++..+-+|+..++.||+|||++ .+||||+||+|||+   +.+|.+|+||||.+..+
T Consensus       124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYL  199 (282)
T ss_pred             HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceee
Confidence            9999 456643    334567799999999999999999999975 89999999999999   89999999999999887


Q ss_pred             CCCCcccccccCCcccCccccc-----ccCCCcccHHHHHHHHHHHHhCCCCCC-CcChHHHHHHHHcC
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLL-----KHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKG  316 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlG~il~elltg~~pf~-~~~~~~~~~~~~~~  316 (398)
                      .+.-..+-..|--.|||||.+.     ..|+.++||||||+++.||.+++.||. ..++.+.+.++.+.
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            7655555567888999999986     259999999999999999999999995 34556666666543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=294.68  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=226.8

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +.+++|++...+|.|.+|.||+++++.+++..|+|+++..   ....+.-+..||-+++..+ ||||+.+++.|-..+.+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            4566799999999999999999999999999999999654   4456677889999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |++||||.||+|.+...--+++++.++..+.+..+.+|+|||+.|-+|||||-.|||+   .+.|.+||.|||.+..+..
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence            9999999999999988888899999999999999999999999999999999999999   8888999999998865543


Q ss_pred             C-CcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-CCCCCCC
Q 015898          256 G-QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLIS  329 (398)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  329 (398)
                      . .....+.||+.|||||+..    +.|...+|||++|++..||---.+|..+..+...+..+.+..+..+. .....++
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            2 2346789999999999864    46999999999999999998888888777777777666665544332 2223577


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +.+-+|++.+|..+|++|||++.+|.|||....
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            889999999999999999999999999999765

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=273.63  Aligned_cols=239  Identities=25%  Similarity=0.352  Sum_probs=185.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc-CCCCeeEEeEEEecCC----eE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-GHKNIVTIKGAYEDSL----CV  175 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~h~niv~l~~~~~~~~----~~  175 (398)
                      .++.++||+|.||.||+|.  -+++.||||++.      ....+.+.+|-.|..... .|+||++++++-+-..    .+
T Consensus       212 l~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhh--ccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            6678899999999999998  456899999994      455677888887776432 4999999999876554    79


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEeecCCCccEEEee
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---------GVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~---------~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      +||+||.+.|+|.++|..+. +++....+++..+++||+|||+-         .|+|||||..||||   ..++...|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeec
Confidence            99999999999999998754 89999999999999999999963         59999999999999   8899999999


Q ss_pred             cCCceecCCCC---cccccccCCcccCccccccc--CC-----CcccHHHHHHHHHHHHhCCC------------CCCC-
Q 015898          247 FGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLKH--YG-----PEADVWTAGVILYILLSGVP------------PFWA-  303 (398)
Q Consensus       247 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~-----~~~DiwSlG~il~elltg~~------------pf~~-  303 (398)
                      ||+|..+..+.   .....+||.+|||||++.+.  +.     .+.||||+|.+|||++++..            ||.. 
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            99998876543   23457999999999999863  22     35799999999999998543            2321 


Q ss_pred             ----cChHHHHHHHHcCC-CcCCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHH
Q 015898          304 ----ETQQGIFDAVLKGH-IDFESDPWPL--ISDSAKDLIRKMLCSQPSERLTAH  351 (398)
Q Consensus       304 ----~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~  351 (398)
                          -+..++...+...+ .+...+.|..  -..-+.+.++.||..||+.|.|+.
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                11223333332221 1111122221  124588999999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=269.38  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=187.6

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHH--HhcCCCCeeEEeEEEecC--
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH--HLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~--~l~~h~niv~l~~~~~~~--  172 (398)
                      +....++.+.||+|.||.||+|.  ..|+.||||++...      +.+.+.+|.+|.+  .|+ |+||+.+++.-..+  
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR------DERSWFRETEIYQTVMLR-HENILGFIAADNKDNG  279 (513)
T ss_pred             hhheeEEEEEecCccccceeecc--ccCCceEEEEeccc------chhhhhhHHHHHHHHHhc-cchhhhhhhccccCCC
Confidence            55668899999999999999998  56889999999532      3356777777776  466 99999999875433  


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEeecCCCccE
Q 015898          173 --LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--------GVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       173 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~--------~iiHrDikp~NIll~~~~~~~~~  242 (398)
                        ..+|||++|.+.|||+|+|.+ ..++.+...+++..++.||++||-.        .|.|||||..||||   .+++.+
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C  355 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC  355 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcE
Confidence              258999999999999999987 5689999999999999999999952        59999999999999   889999


Q ss_pred             EEeecCCceecCCCC-----cccccccCCcccCccccccc-----CC--CcccHHHHHHHHHHHHhC----------CCC
Q 015898          243 KAIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLLKH-----YG--PEADVWTAGVILYILLSG----------VPP  300 (398)
Q Consensus       243 kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-----~~--~~~DiwSlG~il~elltg----------~~p  300 (398)
                      .|+|+|+|.......     .....+||.+|||||++...     +.  ..+||||||.++||+.-.          .+|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            999999998765442     23567999999999999642     21  357999999999999753          367


Q ss_pred             CCCcChH-----HHHHHHHcCCC-cCCCCCCCCC--CHHHHHHHHHhcccCCCCCCCHHHHh
Q 015898          301 FWAETQQ-----GIFDAVLKGHI-DFESDPWPLI--SDSAKDLIRKMLCSQPSERLTAHEVL  354 (398)
Q Consensus       301 f~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rps~~eiL  354 (398)
                      |++..+.     ++.+-+--..+ +.....|...  -..+..|++.||..||..|.|+--|.
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            7654322     22222211111 1222233221  13566789999999999999986553

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-35  Score=288.44  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=208.6

Q ss_pred             ceecceecccCceEEEEEEEccCCc----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      .+..++||+|+||+||+|.+...|+    +||+|++....  ......++.+|+-+|..|. |||++++++++.... +.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence            3446899999999999999876665    58999886433  5556678999999999998 999999999998776 88


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||++|+++|+|.++++.. ..+.......|..||+.|+.|||+++++||||-..||||   .+..++||.|||+|+....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCc
Confidence            999999999999999764 569999999999999999999999999999999999999   6667899999999998765


Q ss_pred             CCc-cccccc--CCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          256 GQI-FTDVVG--SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       256 ~~~-~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ... +....|  .+-|||=|.+. ..|+.++|||||||++||++| |..|+.+....++.+.+.++..   ....+.++-
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiCti  927 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPICTI  927 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCccH
Confidence            432 222222  34588888887 469999999999999999999 9999999999999998888765   233446889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.-++.+||..|++.||+++++..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999988643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=282.97  Aligned_cols=199  Identities=32%  Similarity=0.520  Sum_probs=177.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhh-----HHHHHHHHHHHHHhc--CCCCeeEEeEEEecCC
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-----VEDVRREIQIMHHLA--GHKNIVTIKGAYEDSL  173 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~~~  173 (398)
                      |...+.+|+|+||.|++|.++.+...|+||.+.++.+.-...     +-.+..||.||..|.  .|+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            999999999999999999999999999999998765532222     224667999999986  4899999999999999


Q ss_pred             eEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELC-AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .+||+||-. +|.+|++++.....+++.++..|++|++.|+++||+.||||||||-+|+.+   +.+|.+||+|||.|..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccchhh
Confidence            999999986 456999999999999999999999999999999999999999999999999   9999999999999988


Q ss_pred             cCCCCcccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCC
Q 015898          253 FKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWA  303 (398)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~  303 (398)
                      ...+ .+..++||..|.|||++.+.  .+..-|||+||++||.++....||+.
T Consensus       720 ~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7655 45789999999999999863  57889999999999999999999863

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=252.08  Aligned_cols=245  Identities=24%  Similarity=0.408  Sum_probs=198.1

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEE-EecCCe
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-YEDSLC  174 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~-~~~~~~  174 (398)
                      .+.+.|.+.+.||+|.||.+.+|.++.++..+++|.+...    ......|.+|..---.|+.|.||+.-|++ |+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            4567899999999999999999999999999999998753    34567888998877778889999998875 788889


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +++++||++.|+|..-+...+ +.+.....++.|++.||.|||++++||||||.+||||...| ...+||||||.....+
T Consensus        97 YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKVG  174 (378)
T ss_pred             EEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccccC
Confidence            999999999999988776644 78999999999999999999999999999999999997644 4589999999987543


Q ss_pred             CCCcccccccCCcccCccccc----c--cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLL----K--HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~  324 (398)
                      .  .....--+..|.+||...    +  ...+.+|||.||+++|..+||.+||....    .--.+.+..++...-.+..
T Consensus       175 ~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~  252 (378)
T KOG1345|consen  175 T--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK  252 (378)
T ss_pred             c--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence            2  222233456799999764    2  25778999999999999999999996321    1222334444444444444


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERL  348 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rp  348 (398)
                      +..+++.+..+.++-|.++|++|.
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccc
Confidence            556889999999999999999994

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5.2e-32  Score=240.01  Aligned_cols=210  Identities=44%  Similarity=0.718  Sum_probs=185.4

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      ||+|++|.||++....+++.+++|++......  ...+.+.+|+..++.+. |++++++++++......++++|++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS--SLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccch--hHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            68999999999998888999999998654321  14578999999999998 9999999999999999999999999899


Q ss_pred             hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeecCCceecCCCC-cccccc
Q 015898          187 LFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPGQ-IFTDVV  263 (398)
Q Consensus       187 L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DFG~a~~~~~~~-~~~~~~  263 (398)
                      |.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||++   +. ++.++|+|||.+....... ......
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhccc
Confidence            99988765 468999999999999999999999999999999999999   65 6789999999998765432 133456


Q ss_pred             cCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcc
Q 015898          264 GSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (398)
Q Consensus       264 gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  341 (398)
                      +...|++||.+..  .++.+.|+|++|+++++|                                   ..+.+++.+|++
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            7889999999875  688999999999999998                                   678999999999


Q ss_pred             cCCCCCCCHHHHhcCC
Q 015898          342 SQPSERLTAHEVLCHP  357 (398)
Q Consensus       342 ~dP~~Rps~~eiL~hp  357 (398)
                      .||++||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=4.4e-31  Score=237.83  Aligned_cols=211  Identities=45%  Similarity=0.716  Sum_probs=182.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+......  ...+.+.+|+..++.+. |+|++++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence            56778999999999999999888999999999754322  35678999999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC--
Q 015898          181 LCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~--  257 (398)
                      ++++++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|.||++   +.++.++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence            9999999999987666 8999999999999999999999999999999999999   777899999999998765543  


Q ss_pred             cccccccCCcccCcccc-c-ccCCCcccHHHHHHHHHHHHhCCCCCCC--cChHHHHHHHHcCC
Q 015898          258 IFTDVVGSPYYVAPEVL-L-KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQGIFDAVLKGH  317 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwSlG~il~elltg~~pf~~--~~~~~~~~~~~~~~  317 (398)
                      ......++..|++||.+ . ..++.++|+|+||+++++|++|+.||..  .+...+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33456778899999987 3 3577899999999999999999999977  44446666666654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=240.59  Aligned_cols=250  Identities=20%  Similarity=0.255  Sum_probs=206.4

Q ss_pred             ccccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-  170 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-  170 (398)
                      -++++++..++-+|.||.||.|.+..     +.+.|-+|.++...  ++-++..+..|...+..+. |||+..+.++.. 
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie  358 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE  358 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEee
Confidence            34678889999999999999997653     33567788775433  6777888999999999998 999999999875 


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQR--------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                      +....++++.++.-|+|..++...        ..++..+...++.|++.|++|||+.|+||.||-..|.++   ++...+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqV  435 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQV  435 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeE
Confidence            556789999999889999888731        236778888899999999999999999999999999999   888999


Q ss_pred             EEeecCCceecCCCCcc---cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCC
Q 015898          243 KAIDFGLSVFFKPGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH  317 (398)
Q Consensus       243 kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  317 (398)
                      ||+|=.+++..=+.+..   ..-.-...||+||.+.+ .|+.++|+||||++||||+| |+.||-.-++.++...+.+|.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy  515 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY  515 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence            99999998765332211   01112336999999985 69999999999999999999 999999999999998888875


Q ss_pred             CcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .-   ...-++++++..++..||..+|++||+..++..
T Consensus       516 Rl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            32   223368999999999999999999999998753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=7.1e-32  Score=286.89  Aligned_cols=197  Identities=19%  Similarity=0.211  Sum_probs=146.8

Q ss_pred             CCeeEEeEEE-------ecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 015898          160 KNIVTIKGAY-------EDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (398)
Q Consensus       160 ~niv~l~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NI  231 (398)
                      +||.+++++|       .....+++++|++ +++|.+++.. ...+++.++..+++||+.||+|||++|||||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777777777       2334678889987 6699999965 34599999999999999999999999999999999999


Q ss_pred             EEee----------------cCCCccEEEeecCCceecCCC-----------------CcccccccCCcccCcccccc-c
Q 015898          232 LLVN----------------KDDDFSLKAIDFGLSVFFKPG-----------------QIFTDVVGSPYYVAPEVLLK-H  277 (398)
Q Consensus       232 ll~~----------------~~~~~~~kL~DFG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-~  277 (398)
                      ||..                .+.++.+||+|||+++.....                 ......+||+.|+|||++.+ .
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9942                123456777788877542110                 00112468899999999874 6


Q ss_pred             CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015898          278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHP  357 (398)
Q Consensus       278 ~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp  357 (398)
                      |+.++|||||||+||||++|..|+....  ..+..+.....  +.... .......+++.+||++||.+||++.|+|+||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999988875322  12222222111  11111 1245678999999999999999999999999


Q ss_pred             CccCC
Q 015898          358 WICEN  362 (398)
Q Consensus       358 ~~~~~  362 (398)
                      ||.+.
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=4.9e-27  Score=221.33  Aligned_cols=258  Identities=37%  Similarity=0.576  Sum_probs=211.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~~~~~~~~~lv~  179 (398)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.++..+. |+ +++++.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            678889999999999999976   789999997765544446788999999999998 66 8999999998888899999


Q ss_pred             eccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-cEEEeecCCceecCC
Q 015898          180 ELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKP  255 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~~~  255 (398)
                      +++.++++.+.+....   .+.......++.+++.++.|+|+.+++||||||+||++   +..+ .++++|||.+.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCC
Confidence            9999999997776654   79999999999999999999999999999999999999   6666 699999999975544


Q ss_pred             CC-------cccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCh----HHHHHHHHcCCCc-
Q 015898          256 GQ-------IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHID-  319 (398)
Q Consensus       256 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~-  319 (398)
                      ..       ......|+..|+|||.+.+    .+....|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            32       3467889999999999874    588899999999999999999999876653    4555555444433 


Q ss_pred             CCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          320 FESDPWPLI----SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       320 ~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      .........    ...+.+++.+++..+|..|.+..+...++|.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence            222211111    2578999999999999999999999988776664433

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.6e-30  Score=261.77  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=203.9

Q ss_pred             ccc-eecceecccCceEEEEEEEccCCcEEEEEEeccc--ccCCHh-hHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLY-TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR--KLISRE-DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y-~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~-~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +.| ....++|.|++|.|+.+......+.++.|.+...  ...+.. ....+..|..+-..|. |||++..+..+.+...
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG  395 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence            345 4577899999999999888777777777765422  111222 2233778888888898 9999888877776666


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .+-+||||++ +|+..+...+.++..++..+++|++.||+|||+.||.||||||+|+++   ..+|.+||+|||.+..+.
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence            6666999999 999999888889999999999999999999999999999999999999   788899999999987664


Q ss_pred             CC-----CcccccccCCcccCcccccc-cCCC-cccHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHHcCCCc---CCC
Q 015898          255 PG-----QIFTDVVGSPYYVAPEVLLK-HYGP-EADVWTAGVILYILLSGVPPFWAETQQGIF--DAVLKGHID---FES  322 (398)
Q Consensus       255 ~~-----~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~---~~~  322 (398)
                      .+     ......+|+..|+|||++.+ .|++ ..||||.|+++..|++|+.||......+..  ...-.....   -+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            33     23456889999999999985 5654 689999999999999999999654433221  111111111   112


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ..+..++.+.+.+|.+||++||.+|+|+++|++.+||+...
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            22345788899999999999999999999999999998855

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-27  Score=227.32  Aligned_cols=253  Identities=25%  Similarity=0.301  Sum_probs=194.1

Q ss_pred             cceecceecccCceEEEEEEEccCC-cEEEEEEecccccCCHhhHHHHHHHHHHHHHhc---CCCCeeEEeEEE-ecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISREDVEDVRREIQIMHHLA---GHKNIVTIKGAY-EDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---~h~niv~l~~~~-~~~~~  174 (398)
                      +|++.++||+|+||.||.|.+..++ ..+|+|.........   ...+..|+.++..+.   +.+++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            6999999999999999999987775 679999876432111   126778899998887   246999999999 58888


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC--CCccEEEeecCCc
Q 015898          175 VHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGLS  250 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~--~~~~~kL~DFG~a  250 (398)
                      .|+||+++ |.+|.++....  +.|+..++..|+.|++.+|++||+.|++||||||+|++++...  ....+.|.|||+|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 88999977543  5799999999999999999999999999999999999996543  1257999999999


Q ss_pred             eecC---CCC-------c-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC
Q 015898          251 VFFK---PGQ-------I-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI  318 (398)
Q Consensus       251 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~  318 (398)
                      +.+.   ...       . .....||..|+++....+ ..+.+.|+||++.++.+|+.|..||.................
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8321   111       1 234569999999998875 589999999999999999999999966553322222222222


Q ss_pred             cCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          319 DFESD-PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       319 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ..... .....+.++..+...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            21211 222345778888888878899999988776544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.1e-28  Score=214.90  Aligned_cols=162  Identities=26%  Similarity=0.312  Sum_probs=128.6

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccc
Q 015898          185 GELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (398)
Q Consensus       185 ~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~  263 (398)
                      |+|.+++... ..+++..++.++.|++.||.|||+.+      ||+|||+   +.++.+|+  ||++......    ...
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~----~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE----QSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc----cCC
Confidence            6889988764 45999999999999999999999998      9999999   88888998  9999875432    236


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHcCCCcCCCC---CCCCCCH--HHHHHH
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESD---PWPLISD--SAKDLI  336 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~li  336 (398)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||..... ...+..+..........   ....++.  ++.++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            8999999999975 589999999999999999999999975533 23333333322221111   1112333  699999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .+||..||++||++.|+++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-28  Score=218.17  Aligned_cols=244  Identities=19%  Similarity=0.303  Sum_probs=192.2

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|+++++||+|+||..+.|++..+++.||||.-..+     ....++..|....+.|.+.++|..++.+..++.+-.|||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            499999999999999999999999999999976533     235678889999999998999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec--CCCccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~--~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |++ |.+|+|++.= .+.|+.+.+..++.|++.-++|+|++.+|+|||||+|+||+..  .+...+.|+|||+|+.+.+.
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            998 8899988854 4569999999999999999999999999999999999999532  23347899999999887654


Q ss_pred             Cc--------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---ChHHHHHHHHcCCCcCC-CC
Q 015898          257 QI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFE-SD  323 (398)
Q Consensus       257 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~-~~  323 (398)
                      ..        ..+..||.+||+-.-.++ .-+...|+-|||-+++++|-|.+||.+.   +..+-+++|-..+...+ ..
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~  262 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV  262 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence            32        346789999999887665 4788999999999999999999999764   34455555544332211 11


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCC
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLT  349 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps  349 (398)
                      ....++.++..-+.-.-..+-.+-|.
T Consensus       263 Lc~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  263 LCEGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             HHhcCHHHHHHHHHHHHhcCcccCCC
Confidence            22334555555444444444444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-28  Score=209.84  Aligned_cols=250  Identities=21%  Similarity=0.253  Sum_probs=202.3

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .....|+++++||.|+||.+|+|....+|+.||||+-...     ....++..|..+...|++...|+.+..++.+..+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            3456799999999999999999999999999999986532     23346778999999999888999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .+|||++ |.+|.+++.- .+.|+..++.-++.|++.-++|+|.+++|||||||+|+|.+-......+.|+|||+|+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 8899988853 5679999999999999999999999999999999999999765566689999999998664


Q ss_pred             CCC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---HHHHHHHHcCCCcCCC
Q 015898          255 PGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFES  322 (398)
Q Consensus       255 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~  322 (398)
                      +..        ......||.+|.+-....+ .-+...|+-|+|.+|.++.-|..||.+...   .+-+++|...+...+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            322        2245689999998877664 467889999999999999999999987543   4455555554444332


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 015898          323 -DPWPLISDSAKDLIRKMLCSQPSERLTAH  351 (398)
Q Consensus       323 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~  351 (398)
                       .....+|.|+.-.+.-|-..--++-|...
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence             23445778888888888777666767643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-29  Score=246.89  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=217.5

Q ss_pred             eecccCceEEEEEEE---ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          106 KLGQGQFGTTYLCTE---IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      ++|+|+||.|+++..   ...+.-+|+|+..+......... .-..|..++...++||.++++...++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            479999999998652   24566799999877655444333 56678888888888999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccc
Q 015898          183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV  262 (398)
Q Consensus       183 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~  262 (398)
                      .||.|+..+.....+.+.....+...++.|++++|+.+|+|||+|++||++   +.+|++++.|||+++..-..+..   
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence            999999999888889999999999999999999999999999999999999   99999999999999876544332   


Q ss_pred             ccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          263 VGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       263 ~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      |||..|||||++. ....+.|.||||++++||++|..||..    +....|.+.....+.    .++..+.+++..++..
T Consensus       154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence            9999999999998 567889999999999999999999977    677777776666554    3678899999999999


Q ss_pred             CCCCCCCH-----HHHhcCCCccCCCCC--CCCCCCHHHHHHH
Q 015898          343 QPSERLTA-----HEVLCHPWICENGVA--PDRSLDPAVLSRL  378 (398)
Q Consensus       343 dP~~Rps~-----~eiL~hp~~~~~~~~--~~~~~~~~~~~~~  378 (398)
                      +|.+|.-.     .|+++|+||+...+.  ......+++.+.+
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~  267 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS  267 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence            99999854     799999999987666  4445555555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=8.8e-27  Score=223.14  Aligned_cols=166  Identities=19%  Similarity=0.169  Sum_probs=130.5

Q ss_pred             ccccccceecceecccCceEEEEEEEcc-CCcEEEEEEeccccc--CCHhhHHHHHHHHHHHHHhcCCCCeeE-EeEEEe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVT-IKGAYE  170 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~niv~-l~~~~~  170 (398)
                      ..+.+.|.+.+.||+|+||+||+|.+.. +++.||||++.....  ........+.+|+.+|++|. |+|++. ++++  
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~--   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT--   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc--
Confidence            3456679999999999999999998776 677889998753211  12334567999999999998 999885 5432  


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEeecCCCccEEEeecCC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL-KPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDi-kp~NIll~~~~~~~~~kL~DFG~  249 (398)
                        +..|+||||++|++|.. +.   ...   ...++.+++.||.|||+.||+|||| ||+|||+   +.++.+||+|||+
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl  158 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL  158 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence              45799999999999863 21   111   2567899999999999999999999 9999999   7778899999999


Q ss_pred             ceecCCCC---------cccccccCCcccCccccc
Q 015898          250 SVFFKPGQ---------IFTDVVGSPYYVAPEVLL  275 (398)
Q Consensus       250 a~~~~~~~---------~~~~~~gt~~y~aPE~~~  275 (398)
                      |.......         ......+++.|+|||.+.
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            98664332         124567888899999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=236.88  Aligned_cols=235  Identities=23%  Similarity=0.315  Sum_probs=182.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccc-cCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK-LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      .|...+.||.+.|=+|.+|++. .|. |+||++-+.. ..+-....+-..|++ .... ++||++++.-+.+.....|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            4777899999999999999964 454 9999987654 344455555666666 3334 499999999888888889999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec--CC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--KP-  255 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~--~~-  255 (398)
                      -+|.. .+|+|.+.-+..+...+.++|+.||+.||.-+|..||+|||||.+|||+   ..-..+.|+||...+..  .. 
T Consensus       100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence            99985 4999999888889999999999999999999999999999999999999   67778999999976432  11 


Q ss_pred             -CCccccc----ccCCcccCcccccc------------cCCCcccHHHHHHHHHHHHh-CCCCCCC-----------cCh
Q 015898          256 -GQIFTDV----VGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLS-GVPPFWA-----------ETQ  306 (398)
Q Consensus       256 -~~~~~~~----~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~ellt-g~~pf~~-----------~~~  306 (398)
                       ...++-+    .--..|+|||.+..            ..+++.||||+||+++||++ |++||.-           ...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence             1112222    22235999998742            14678999999999999999 7888831           112


Q ss_pred             HHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +..+++|              -+..++.+|..|++.||++|.+|++.|+-
T Consensus       256 e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2222222              23478999999999999999999999984

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=5e-26  Score=232.24  Aligned_cols=239  Identities=32%  Similarity=0.492  Sum_probs=184.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ..|..+++|..|++|.||.+.++.+.+.+|+| +.++.+.        .+.  |+.... .|.+|               
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~-npfvv---------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAG-NPFVV---------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccC-Cccee---------------
Confidence            45888999999999999999999999999995 4333211        111  232222 44444               


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC---
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP---  255 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~---  255 (398)
                            |+-...++.-++++...        +.+++|+|+.||+|||+||+|.+|   ..-|++|+.|||++...-.   
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence                  33334444444444443        789999999999999999999999   7889999999998764311   


Q ss_pred             -----CC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          256 -----GQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       256 -----~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                           +.        ....++||+.|+|||++.. .|+..+|+|++|+|+||++-|..||.+.+.++++..+....+.++
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                 10        1235799999999999875 599999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHH
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS  382 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~  382 (398)
                      ...+ -++++++++|.++|+.+|..|.   .+-++.+|+||+...+....-..-+|.+++..++
T Consensus       279 E~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~ed  341 (1205)
T KOG0606|consen  279 EEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESED  341 (1205)
T ss_pred             ccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccc
Confidence            8854 4789999999999999999995   6789999999999877643333334444444433

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=3.7e-25  Score=197.86  Aligned_cols=176  Identities=16%  Similarity=0.166  Sum_probs=136.6

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHH------HHHHHHHHHHhcCCCCeeEEeEE
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGHKNIVTIKGA  168 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~Ei~~l~~l~~h~niv~l~~~  168 (398)
                      +.+.++|++.++||.|+||.||++.+  ++..+|||++.......+.....      +.+|+..+.+|. |++|..+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence            34678899999999999999999664  47789999997655434444344      579999999997 9999999998


Q ss_pred             EecC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          169 YEDS--------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       169 ~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +...        +..+|||||++|.+|.++.    .+++    ....+++.+|..||+.|++||||+|+||++   ++++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~g  172 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKNG  172 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCCC
Confidence            6533        3589999999999997763    2333    346699999999999999999999999999   6666


Q ss_pred             cEEEeecCCceecCCCCcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh
Q 015898          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS  296 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt  296 (398)
                       ++|+|||.............           +++ ..|..+.|+||||+++..+..
T Consensus       173 -i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHHH
Confidence             99999998876533221111           222 347789999999999887643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=4e-25  Score=203.38  Aligned_cols=233  Identities=26%  Similarity=0.353  Sum_probs=155.1

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcC---------CCCeeEEeEEEe-
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG---------HKNIVTIKGAYE-  170 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~---------h~niv~l~~~~~-  170 (398)
                      ...++.||.|+++.||.+.+..+++.+|||++...........+++++|.-....+.+         |-.++.-++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            5668899999999999999999999999999876664455567778877765555432         222333333321 


Q ss_pred             --------cC---Ce-----EEEEEeccCCCChHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 015898          171 --------DS---LC-----VHIVMELCAGGELFDRII---QRGH----YSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (398)
Q Consensus       171 --------~~---~~-----~~lv~e~~~~~~L~~~l~---~~~~----~~~~~~~~i~~~i~~al~~lH~~~iiHrDik  227 (398)
                              ..   ..     .+++|+-+ .++|.+.+.   ....    +.......+..|++..+++||+.|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                    11   12     36778777 457766643   2222    2234445666899999999999999999999


Q ss_pred             CCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccc---------cCCCcccHHHHHHHHHHHHhCC
Q 015898          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---------HYGPEADVWTAGVILYILLSGV  298 (398)
Q Consensus       228 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwSlG~il~elltg~  298 (398)
                      |+|+++   +.+|.++|+||+.....+.  .......+..|.+||....         .++.+.|.|+||+++|.|++|.
T Consensus       173 ~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            999999   8899999999998775433  2232455678999997632         3788999999999999999999


Q ss_pred             CCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 015898          299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER  347 (398)
Q Consensus       299 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  347 (398)
                      .||...........        .......+++.+++||.+||++||.+|
T Consensus       248 lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99975543221111        122233688999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.1e-24  Score=192.01  Aligned_cols=143  Identities=22%  Similarity=0.218  Sum_probs=110.7

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHh-----------------------hHHHHHHHHHHHHHhcCCC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----------------------DVEDVRREIQIMHHLAGHK  160 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~~h~  160 (398)
                      ...||+|+||.||+|.+. +|+.||||++.........                       .......|+.++.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            468999999999999986 8999999999754211111                       0122345999999997 77


Q ss_pred             CeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEEEeecCCC
Q 015898          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       161 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~l-H~~~iiHrDikp~NIll~~~~~~  239 (398)
                      ++.....+....  .+|||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+|||+   + +
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli---~-~  153 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY---H-D  153 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---E-C
Confidence            664333322222  389999999887765545566799999999999999999999 79999999999999999   4 3


Q ss_pred             ccEEEeecCCceecC
Q 015898          240 FSLKAIDFGLSVFFK  254 (398)
Q Consensus       240 ~~~kL~DFG~a~~~~  254 (398)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            579999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.7e-23  Score=183.38  Aligned_cols=187  Identities=21%  Similarity=0.251  Sum_probs=141.5

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEecccccCCH-hhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      +...|+.|+||+||.+..  .+.+++.+.+........ .....+.+|+++|++|.+|+++++++++    +..+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            467899999999998773  777888777654322111 1122578999999999867999999886    346999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCcEEEeecCCCccEEEeecCCceecCCCCcc-
Q 015898          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL-KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-  259 (398)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDi-kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~-  259 (398)
                      +.|.+|...+..       ....++.+++.+|.++|++||+|||| ||+|||+   +.++.++|+|||+|......... 
T Consensus        80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchHH
Confidence            999888654321       12357889999999999999999999 7999999   77788999999999865543210 


Q ss_pred             -------------cccccCCcccCccccc--ccCC-CcccHHHHHHHHHHHHhCCCCCCCcC
Q 015898          260 -------------TDVVGSPYYVAPEVLL--KHYG-PEADVWTAGVILYILLSGVPPFWAET  305 (398)
Q Consensus       260 -------------~~~~gt~~y~aPE~~~--~~~~-~~~DiwSlG~il~elltg~~pf~~~~  305 (398)
                                   .-...++.|++|+.-.  ...+ ...+.++.|+-+|.++|+..++++..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                         0123577788887543  3334 56789999999999999999987544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.7e-23  Score=183.55  Aligned_cols=144  Identities=19%  Similarity=0.147  Sum_probs=113.1

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCC---------------------H--hhHHHHHHHHHHHHHhcCCC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---------------------R--EDVEDVRREIQIMHHLAGHK  160 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---------------------~--~~~~~~~~Ei~~l~~l~~h~  160 (398)
                      .+.||+|+||.||+|.+. +|+.||||++.......                     .  .....+..|...+.++. |+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            568999999999999976 89999999987642110                     0  00223468999999998 88


Q ss_pred             CeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCC
Q 015898          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       161 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~  239 (398)
                      ++.....+....  .++||||++|+++.........++...+..++.+++.++.++|+ .||+||||||+|||+   + +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~-~  153 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H-D  153 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E-C
Confidence            875444433332  48999999887654443345668889999999999999999999 999999999999999   5 5


Q ss_pred             ccEEEeecCCceecCC
Q 015898          240 FSLKAIDFGLSVFFKP  255 (398)
Q Consensus       240 ~~~kL~DFG~a~~~~~  255 (398)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            7899999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-23  Score=192.50  Aligned_cols=191  Identities=27%  Similarity=0.357  Sum_probs=139.7

Q ss_pred             cCCCCeeEEeEEEec---------------------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 015898          157 AGHKNIVTIKGAYED---------------------------SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII  209 (398)
Q Consensus       157 ~~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i  209 (398)
                      ..|||||++.++|.+                           ...+|+||.-.. .+|..++-.+ ..+....+-++.|+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHH
Confidence            359999999998743                           235899998874 4888877654 36788888999999


Q ss_pred             HHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeecCCceecCCC-------CcccccccCCcccCcccccccC---
Q 015898          210 VGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPG-------QIFTDVVGSPYYVAPEVLLKHY---  278 (398)
Q Consensus       210 ~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---  278 (398)
                      ++|+.|||++||.|||+|.+|||+.-+++ --.+.|+|||++--.+..       ......-|....||||+.....   
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999999999999999999965433 346889999987543321       1122345677799999986321   


Q ss_pred             ----CCcccHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 015898          279 ----GPEADVWTAGVILYILLSGVPPFWAETQQGIF-DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE  352 (398)
Q Consensus       279 ----~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  352 (398)
                          -.++|.|+.|.+.||+++...||+.......- ....+..++   .....+++.+++|+..+|+.||++|++++=
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP---alp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP---ALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC---CCcccCChHHHHHHHHHhcCCccccCCccH
Confidence                13789999999999999999999873221100 001111111   112247889999999999999999998753

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=8.6e-22  Score=175.43  Aligned_cols=138  Identities=18%  Similarity=0.209  Sum_probs=108.2

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc----CCCCeeEEeEEEecCC---e-E
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----GHKNIVTIKGAYEDSL---C-V  175 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~h~niv~l~~~~~~~~---~-~  175 (398)
                      .++||+|+||.||.  +..++.. +||++....   ....+.+.+|+.+++.|.    .||||++++++++++.   . +
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46899999999995  6677666 699886542   224567899999999994    3799999999998863   4 4


Q ss_pred             EEEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCcEEEeecC-CCccEEEeecCCc
Q 015898          176 HIVMEL--CAGGELFDRIIQRGHYSERKAAELTRIIVGVV-EACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLS  250 (398)
Q Consensus       176 ~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al-~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~DFG~a  250 (398)
                      .+|+||  +.+++|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||||+|||+...+ .++.++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            478999  5578999999653 46655  35677877777 999999999999999999996433 3458999994433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3e-22  Score=208.26  Aligned_cols=197  Identities=23%  Similarity=0.316  Sum_probs=161.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|.|.+.||+|+||+||.|.+.. |+.||+|+-+......-.-..+++..++ +..   -+.|+.+...+...+.-++
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccCCccee
Confidence            3569999999999999999999765 9999999875543322222233444343 221   3667777777778888899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee----cCCCccEEEeecCCcee-
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVF-  252 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~----~~~~~~~kL~DFG~a~~-  252 (398)
                      |+||.+.|+|.+++...+.+++..+..++.|++..|+.||..+|||+||||+|.||..    +.+...++|+|||.+.. 
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999999999998888999999999999999999999999999999999999943    22345799999999854 


Q ss_pred             --cCCCCcccccccCCcccCccccccc-CCCcccHHHHHHHHHHHHhCCC
Q 015898          253 --FKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVP  299 (398)
Q Consensus       253 --~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~elltg~~  299 (398)
                        +.++..+...++|-.+--+|...++ |++..|.|.|+.+++-||.|+.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              3455677888999999999999875 9999999999999999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=4.1e-22  Score=191.38  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=171.5

Q ss_pred             cceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEe--E----EE-
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK--G----AY-  169 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~--~----~~-  169 (398)
                      .+.+.+..+..+++.+....-...   .+.++-+.....   +........+++-.+.....|+..+..-  .    .+ 
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~  321 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK  321 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence            345556666777776665543222   233333332211   2133445555666665555344443322  0    11 


Q ss_pred             ----ecCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          170 ----EDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       170 ----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                          ....++||.|++|.-.+|.+||.++.   ..+......++.|+..|++|   +|.+|||+||.||++   ..+..+
T Consensus       322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~  395 (516)
T KOG1033|consen  322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQL  395 (516)
T ss_pred             ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhh
Confidence                12346899999999999999997654   36778899999999999999   999999999999999   566689


Q ss_pred             EEeecCCceecCCCC-------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHH
Q 015898          243 KAIDFGLSVFFKPGQ-------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (398)
Q Consensus       243 kL~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~  313 (398)
                      ||+|||+........       ..+...||..||+||.+.+ .|+.++||||||++|+||+. -..+|   .....+..+
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~  472 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDI  472 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhh
Confidence            999999987765544       4567899999999999995 69999999999999999998 22222   223344445


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      ..+.++  ...+.. .++-.+|+.+||.+.|.+||++.+.-.|+|.+
T Consensus       473 r~g~ip--~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  473 RDGIIP--PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             hcCCCC--hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            555443  111112 24567999999999999999998888888763

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=3.4e-21  Score=175.46  Aligned_cols=146  Identities=21%  Similarity=0.148  Sum_probs=114.7

Q ss_pred             cceecceecccCceEEEEEE-EccCCcEEEEEEecccccCC-------------------H--hhHHHHHHHHHHHHHhc
Q 015898          100 LYTLGRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLIS-------------------R--EDVEDVRREIQIMHHLA  157 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~-~~~~~~~vavK~~~~~~~~~-------------------~--~~~~~~~~Ei~~l~~l~  157 (398)
                      .|.+.+.||+|+||.||+|. +..+|+.||||++.......                   .  .....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 67899999999987542100                   0  01234678999999997


Q ss_pred             CC--CCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCcEEEe
Q 015898          158 GH--KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG-VMHRDLKPENFLLV  234 (398)
Q Consensus       158 ~h--~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~-iiHrDikp~NIll~  234 (398)
                       +  ..++++++.   . ..++||||++|.+|.........+....+..++.|++.+|.+||+.| |+||||||+||++ 
T Consensus       109 -~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli-  182 (237)
T smart00090      109 -EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV-  182 (237)
T ss_pred             -hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE-
Confidence             4  234444442   2 34899999999888665544455677778899999999999999999 9999999999999 


Q ss_pred             ecCCCccEEEeecCCceecC
Q 015898          235 NKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~  254 (398)
                        + ++.++|+|||.+....
T Consensus       183 --~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 --H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             --E-CCCEEEEEChhhhccC
Confidence              5 5689999999987544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.5e-20  Score=166.49  Aligned_cols=239  Identities=19%  Similarity=0.254  Sum_probs=182.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      ..+..+|.+.-.|..|+|++  .|..+++|++..+.. +...-..|..|.-.|+-++ ||||+.+++.+.....+.++..
T Consensus       192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            44566789999999999985  455788888866544 2223346777888888887 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEe--ecCCceecC
Q 015898          181 LCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFK  254 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~--DFG~a~~~~  254 (398)
                      |++.|+|+..+++...  .+..++.+++.++++|+.|||+..  |----|....+++   |++...+|+  |--++..  
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq--  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee--
Confidence            9999999999987654  577899999999999999999875  3344678889999   888777763  3222211  


Q ss_pred             CCCcccccccCCcccCccccccc----CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                          .....-.|.||+||.+.+.    --.++|+|||++++|||.|...||.+-.+-+.--++.-..+  .....+.++.
T Consensus       343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl--rv~ippgis~  416 (448)
T KOG0195|consen  343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL--RVHIPPGISR  416 (448)
T ss_pred             ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc--cccCCCCccH
Confidence                1233457889999999742    23578999999999999999999987666544333322222  2223356889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHh
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVL  354 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL  354 (398)
                      .+..|+.-|+.-||.+||..+.|+
T Consensus       417 hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999999887654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.8e-19  Score=161.65  Aligned_cols=137  Identities=31%  Similarity=0.369  Sum_probs=113.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHh-----hHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +.||+|++|.||+|.+  .|..|++|+.........+     ....+.+|+.++..+. |++++....++......+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999985  7778999986543322211     2346788999999998 888877777777777889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ||++|++|.+.+....   . ....++.+++.+|.+||+.|++|||++|.|||+   + ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence            9999999998886533   2 888999999999999999999999999999999   4 56799999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=5.7e-22  Score=201.94  Aligned_cols=257  Identities=31%  Similarity=0.497  Sum_probs=210.1

Q ss_pred             ceecceecccCceEEEEEEEcc-CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      |.+.+.||+|+|+.|-.+.... ....+|+|.+.... ........+..|..+-+.+.+|+|++.+++........++++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            7778889999999999887543 34457777775443 345556677788888888888999999999999999999999


Q ss_pred             eccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEeecCCCc-cEEEeecCCceecCC
Q 015898          180 ELCAGGELFDRI-IQRG-HYSERKAAELTRIIVGVVEACH-SLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKP  255 (398)
Q Consensus       180 e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~~i~~al~~lH-~~~iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~~~  255 (398)
                      +|..|+++++-+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.++   +..+ .++++|||+|..+..
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccccc
Confidence            999999999888 5554 6788899999999999999999 9999999999999999   6667 899999999987654


Q ss_pred             -CC---ccccccc-CCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHHcCCCcCCCCCCCC
Q 015898          256 -GQ---IFTDVVG-SPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGI-FDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       256 -~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  327 (398)
                       ..   .....+| ++.|+|||...+  ...+..|+||.|+++.-+++|..||........ +.........+....|..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             22   3345678 999999999986  467889999999999999999999865443321 122222223334566778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      ++....+++.++|..+|..|.+..++-.+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8999999999999999999999999999999988

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=3.6e-19  Score=158.17  Aligned_cols=134  Identities=27%  Similarity=0.297  Sum_probs=106.3

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEecccccCCH-----hhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      .||+|+||.||+|.  .++..|++|..........     ....++.+|+.++..+. |+++.....++......++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            48999999999998  4678999998654322111     12366789999999998 7765544444555666789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||++   + ++.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcCC
Confidence            9999999887754321       889999999999999999999999999999   5 678999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.8e-19  Score=158.04  Aligned_cols=139  Identities=23%  Similarity=0.255  Sum_probs=107.9

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH-------------------hhHHHHHHHHHHHHHhcCCC-
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-------------------EDVEDVRREIQIMHHLAGHK-  160 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~Ei~~l~~l~~h~-  160 (398)
                      |.+.+.||+|+||.||+|.. .+|+.||||++........                   ........|+.++..+. |+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            78889999999999999986 4799999998764321000                   01123678899999986 66 


Q ss_pred             -CeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC
Q 015898          161 -NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       161 -niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~  239 (398)
                       .++..++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||++   +++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence             4444444    234589999999998865432      14567888999999999999999999999999999   778


Q ss_pred             ccEEEeecCCceecC
Q 015898          240 FSLKAIDFGLSVFFK  254 (398)
Q Consensus       240 ~~~kL~DFG~a~~~~  254 (398)
                      +.++|+|||.+....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            899999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=3.2e-19  Score=174.44  Aligned_cols=198  Identities=23%  Similarity=0.312  Sum_probs=157.6

Q ss_pred             HHhcCCCCeeEEeEEEecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCcE
Q 015898          154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGV-MHRDLKPENF  231 (398)
Q Consensus       154 ~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~i-iHrDikp~NI  231 (398)
                      +.+. |.|+.+++|.+.++...++|.+||..|+|.|.+.. .-.+++.-...++++|+.||.|+|...| .|+.++..|.
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4566 99999999999999999999999999999999977 4458888899999999999999998876 9999999999


Q ss_pred             EEeecCCCccEEEeecCCceecCC---CCcccccccCCcccCccccccc--------CCCcccHHHHHHHHHHHHhCCCC
Q 015898          232 LLVNKDDDFSLKAIDFGLSVFFKP---GQIFTDVVGSPYYVAPEVLLKH--------YGPEADVWTAGVILYILLSGVPP  300 (398)
Q Consensus       232 ll~~~~~~~~~kL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwSlG~il~elltg~~p  300 (398)
                      ++   +....+||.|||+......   ........-...|.|||.+...        .+.+.||||||++++|+++...|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   9999999999999877542   1111222234569999998642        46789999999999999999999


Q ss_pred             CCCc----ChHHHHHHHHc-CCCcCCCCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          301 FWAE----TQQGIFDAVLK-GHIDFESDPWP--LISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       301 f~~~----~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      |...    ...++...+.+ +...+.+..+.  .+.+++..+++.||.-+|..||++++|-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9652    22345555555 33223332221  35567999999999999999999998754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.3e-18  Score=175.52  Aligned_cols=139  Identities=24%  Similarity=0.266  Sum_probs=110.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCC-----HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .|...++||+|+||.||+|....  ..+++|+........     ....+++.+|+.++..+. |++++....++.....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCCC
Confidence            35668899999999999998543  345555432221111     122456889999999998 9999888777777777


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||+   + ++.++|+|||++...
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl---~-~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV---R-DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE---E-CCcEEEEeCcccccC
Confidence            899999999999988774        457789999999999999999999999999999   3 357999999999763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=2.1e-18  Score=151.69  Aligned_cols=141  Identities=21%  Similarity=0.223  Sum_probs=100.3

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHH---------------------HHHHHHHHHHHhcCC-CC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE---------------------DVRREIQIMHHLAGH-KN  161 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~~h-~n  161 (398)
                      .+.||+|+||.||+|.+. +++.||||++............                     ....|...+..+..+ ..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999976 8999999998653221111111                     114567777776522 23


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCC
Q 015898          162 IVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       162 iv~l~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~  239 (398)
                      +.+.++.    ...++||||++++.+.. .+... .. ...+..++.+++.++.++|. .||+||||||+||++   + +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~-~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D-D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-C
Confidence            4555443    23589999999854321 11111 11 16788999999999999999 999999999999999   5 6


Q ss_pred             ccEEEeecCCceecCC
Q 015898          240 FSLKAIDFGLSVFFKP  255 (398)
Q Consensus       240 ~~~kL~DFG~a~~~~~  255 (398)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            7899999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=7.3e-18  Score=165.05  Aligned_cols=259  Identities=22%  Similarity=0.241  Sum_probs=201.5

Q ss_pred             cccccceecceecc--cCceEEEEEEE--ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           96 NIRDLYTLGRKLGQ--GQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        96 ~~~~~y~~~~~iG~--G~fg~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      .+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+. .......-..-.+|+.-.+.+..|++.++.+..++.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCccccc
Confidence            34556777889999  99999999988  88899999997322 111222333445677777778789999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCcEEEeecCCC-ccEEEe
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVG----VVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAI  245 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~----al~~lH~~~iiHrDikp~NIll~~~~~~-~~~kL~  245 (398)
                      .+..|+-+|+| +.+|..+...... ++...++....+...    ||.++|+.+++|-|+||.||+.   .++ ...+++
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~~  265 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKLT  265 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeecC
Confidence            99999999999 5678777766544 888999999999999    9999999999999999999999   566 789999


Q ss_pred             ecCCceecCCCCcc------cccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc
Q 015898          246 DFGLSVFFKPGQIF------TDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID  319 (398)
Q Consensus       246 DFG~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  319 (398)
                      |||+...+..+...      ....|...|++||.+.+-++..+|||++|.++.+..++-.+......... ..+.+.  .
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~--~  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQG--Y  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccc--c
Confidence            99998877665422      22357778999999999999999999999999999988766543311111 111111  1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .+.+.....+.++...+..|++.+|-.|++++.+++|+++..-
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            2333333456777789999999999999999999999999753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=9.5e-17  Score=146.55  Aligned_cols=139  Identities=22%  Similarity=0.296  Sum_probs=104.9

Q ss_pred             cceec-ccCceEEEEEEEccCCcEEEEEEeccccc----------CCHhhHHHHHHHHHHHHHhcCCCCe--eEEeEEEe
Q 015898          104 GRKLG-QGQFGTTYLCTEIATGIEFACKSISKRKL----------ISREDVEDVRREIQIMHHLAGHKNI--VTIKGAYE  170 (398)
Q Consensus       104 ~~~iG-~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~Ei~~l~~l~~h~ni--v~l~~~~~  170 (398)
                      ...|| .||.|+||.+..  .+..++||.+.....          .+.....++.+|+.++.+|. |++|  +..+++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~  112 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARV  112 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeee
Confidence            35687 888999998874  477899998854221          11233457889999999997 7774  66776643


Q ss_pred             cC-C---eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          171 DS-L---CVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       171 ~~-~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      .. .   ..++|||+++| .+|.+++.. ..+++..    +.+|+.+|.+||+.||+||||||.|||+   +.++.++|+
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LI  184 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLI  184 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEE
Confidence            32 2   23599999997 588777654 3455543    5789999999999999999999999999   666789999


Q ss_pred             ecCCceec
Q 015898          246 DFGLSVFF  253 (398)
Q Consensus       246 DFG~a~~~  253 (398)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99998763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=1.2e-18  Score=178.72  Aligned_cols=276  Identities=28%  Similarity=0.387  Sum_probs=220.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.+.+.+.+-.|+++.++.+....+|...++|+..........+.+.+..+-.++-.-. +|-++...-.+......+|+
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchh
Confidence            34677788999999999999888888777777665444333334444444444444333 56666655555567778999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC----
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK----  254 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~----  254 (398)
                      ++|..+++|...++..+..+.+.++.....+..++++||...+.|||++|.|+|.   ..+++.++.|||......    
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccC
Confidence            9999999999999888878888888899999999999999999999999999999   778899999998432110    


Q ss_pred             -----------------C---------C--CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC
Q 015898          255 -----------------P---------G--QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET  305 (398)
Q Consensus       255 -----------------~---------~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~  305 (398)
                                       .         +  .......+|+.|.+||.+.+ .....+|+|++|++++|.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                             0         0  01224678999999999985 57889999999999999999999999999


Q ss_pred             hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCccCCCCCCCCCCCHHHHHHHH
Q 015898          306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH---EVLCHPWICENGVAPDRSLDPAVLSRLK  379 (398)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~---eiL~hp~~~~~~~~~~~~~~~~~~~~~~  379 (398)
                      .+..++.+.++...++.... ..+.++.+++..+|..+|.+|..+.   ++-.|+||++..+.......-.++++..
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~-~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPE-EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPE 1115 (1205)
T ss_pred             hhhhhhccccCCCCCCCCcc-ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccCCCCC
Confidence            99999999998888776543 4688999999999999999999988   9999999999888877666556666554

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.5e-16  Score=133.79  Aligned_cols=133  Identities=24%  Similarity=0.305  Sum_probs=111.4

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CCeeEEeEEEecCCeEEEEEec
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      +.+.||.|.++.||++...  +..+++|.+.....     ...+.+|+.++..+..+ .+++++++++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            3578999999999999963  37899998854321     45788999999999833 6899999988888899999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ++++.+...       +......++.+++.+|.+||..   +++|+|++|.||++   ++.+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence            988777543       5667788899999999999985   79999999999999   5567899999998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3e-14  Score=141.13  Aligned_cols=144  Identities=19%  Similarity=0.207  Sum_probs=97.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCC--------------------------H-hh----HH------HHH
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--------------------------R-ED----VE------DVR  147 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~-~~----~~------~~~  147 (398)
                      +.||.|++|.||+|+. .+|+.||||+....-...                          . ..    ..      .+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999985 589999999975431000                          0 00    00      134


Q ss_pred             HHHHHHHHhc----CCCCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 015898          148 REIQIMHHLA----GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVG-VVEACHSLGV  221 (398)
Q Consensus       148 ~Ei~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~-al~~lH~~~i  221 (398)
                      +|...+.++.    +++++.-..-++......+|||||++|++|.+..... ...   ....++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            4555555543    2344322222223345578999999999998766432 112   23456666665 4678999999


Q ss_pred             eeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       222 iHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +|+|++|.||++   ++++.++|+|||++.....
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            999999999999   7788999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=1.8e-14  Score=144.59  Aligned_cols=145  Identities=20%  Similarity=0.259  Sum_probs=93.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccC--------------------------C-H----hhHHHH--
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--------------------------S-R----EDVEDV--  146 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~-~----~~~~~~--  146 (398)
                      .|.. +.||+|++|.||+|+.+.+|+.||||++.+.-..                          + .    +..+.+  
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 7899999999999998877999999998643100                          0 0    112223  


Q ss_pred             ----HHHHHHHHHhc---CCCCeeEEeEEE-ecCCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 015898          147 ----RREIQIMHHLA---GHKNIVTIKGAY-EDSLCVHIVMELCAGGELFDR--IIQRG----HYSERKAAELTRIIVGV  212 (398)
Q Consensus       147 ----~~Ei~~l~~l~---~h~niv~l~~~~-~~~~~~~lv~e~~~~~~L~~~--l~~~~----~~~~~~~~~i~~~i~~a  212 (398)
                          .+|+..+.++.   .+...+.+-.++ +.....+|||||+.|+.+.+.  +...+    .+.+..+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence                33444444443   122233333333 234567899999999999764  33322    13333333344443   


Q ss_pred             HHHHHhCCceeccCCCCcEEEeecCCCc----cEEEeecCCceecCC
Q 015898          213 VEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDFGLSVFFKP  255 (398)
Q Consensus       213 l~~lH~~~iiHrDikp~NIll~~~~~~~----~~kL~DFG~a~~~~~  255 (398)
                          ...|++|+|++|.||++   +.++    .++++|||++.....
T Consensus       277 ----f~~GffHaDpHPGNIlv---~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ----FRDGFFHADMHPGNIFV---SYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HhCCeeeCCCChHHeEE---ecCCCCCCeEEEEecceEEECCH
Confidence                46899999999999999   5555    899999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.54  E-value=1.5e-13  Score=120.48  Aligned_cols=143  Identities=13%  Similarity=0.085  Sum_probs=103.7

Q ss_pred             cceecccCceEEEEEEEcc------CCcEEEEEEecccccC-------------------CHhhHHHHH----HHHHHHH
Q 015898          104 GRKLGQGQFGTTYLCTEIA------TGIEFACKSISKRKLI-------------------SREDVEDVR----REIQIMH  154 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~~~-------------------~~~~~~~~~----~Ei~~l~  154 (398)
                      ...||.|--+.||.|....      .+..+|||+++.....                   .......+.    +|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543      3579999997532110                   011122333    8999999


Q ss_pred             HhcCC-CCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEE
Q 015898          155 HLAGH-KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFL  232 (398)
Q Consensus       155 ~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~l-H~~~iiHrDikp~NIl  232 (398)
                      ++... -+++.++++    ..-+|||||+.+..+.....+...++......+..+++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            98743 467777764    45679999997654433222333456677788899999999988 8999999999999999


Q ss_pred             EeecCCCccEEEeecCCceecC
Q 015898          233 LVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       233 l~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +   . ++.+.|+|||.+....
T Consensus       158 ~---~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 W---H-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             E---E-CCcEEEEECCCceeCC
Confidence            9   3 3569999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=1.2e-14  Score=142.70  Aligned_cols=253  Identities=20%  Similarity=0.191  Sum_probs=186.6

Q ss_pred             ccccceecceecccCceEEEEEEEc-cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...+|..+..||.|.|+.|+.+... .++..+++|.+.+.... ......-..|+.+...+.-|.+++.+...|......
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456888999999999999987755 67788999988654332 222333455777777777799999999988888888


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |+--|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+  .+..+++|||++..+.-
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhccccccccccce
Confidence            8999999999887666444558889999999999999999999999999999999999432  28899999999864221


Q ss_pred             CCcccccccCCccc-Ccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          256 GQIFTDVVGSPYYV-APEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       256 ~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .  .......-++. .+|++..  .+..+.|++|||..+.+.+++...-+....   ...+..+....    .+....++
T Consensus       420 ~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~----~~~~~~~~  490 (524)
T KOG0601|consen  420 S--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPN----LPGLKLQL  490 (524)
T ss_pred             e--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccC----CCchHHhh
Confidence            1  11222333444 3666654  477899999999999999998754322211   11222222211    12344788


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      ..+.+.++..++..|+.+.+...|.=|..
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhhh
Confidence            89999999999999999999988876643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=1.8e-13  Score=118.03  Aligned_cols=129  Identities=20%  Similarity=0.159  Sum_probs=95.7

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .+.|+.|.++.||++..  .+..|++|+......    ......+|+.+++.+.+...+++++.+..  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            35789999999999884  477899998754321    12245789999998873333455665543  23479999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV-----MHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~i-----iHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      |.++.+.        ......++.+++.+|..||..++     +|+|++|.||++   + ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL---D-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE---E-CCeEEEEecccccC
Confidence            9887542        11123457889999999999985     999999999999   4 45699999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.48  E-value=8.2e-13  Score=131.15  Aligned_cols=183  Identities=15%  Similarity=0.129  Sum_probs=137.0

Q ss_pred             ceecceecccCceEEE-EEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGTTY-LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      |.+ ...+-++.+ +| .|..+.++.+|.|..++...   .+....+.+.++-|+.|+ ||||+++++.++..+..|||+
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence            555 344444444 44 46677889999999886543   255667888999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH-SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH-~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |-+.  .|..++.+.   +...+...+.||+.||.+|| +.+++|++|....|+|   +..|..||++|-++........
T Consensus        89 ErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   89 ERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA  160 (690)
T ss_pred             eccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc
Confidence            9884  456666553   47788889999999999997 7789999999999999   8899999999988754332111


Q ss_pred             -ccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCC
Q 015898          259 -FTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV  298 (398)
Q Consensus       259 -~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~  298 (398)
                       ......--.|..|+.+... ....|.|-|||++++++.|.
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence             1111112235566554311 13469999999999999983

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1e-13  Score=126.52  Aligned_cols=236  Identities=17%  Similarity=0.208  Sum_probs=155.7

Q ss_pred             EEEEEEEccCCcEEEEEEecccccCCHhh-HHHHHHHHHHHHHhcCCCCeeEEeEEEecC-----CeEEEEEeccCCCCh
Q 015898          114 TTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----LCVHIVMELCAGGEL  187 (398)
Q Consensus       114 ~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e~~~~~~L  187 (398)
                      .||++-+...|.+|+--.+......+... -+....-...|.++- |.||++++.||.+.     ....++.||+..|++
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            46776666666655443332111111111 111122223445565 99999999988544     457899999999999


Q ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-----
Q 015898          188 FDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-----  256 (398)
Q Consensus       188 ~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-----  256 (398)
                      ...|++-    ..+......+|+.||+.||.|||+..  |+|+++.-.-|++   ..+|-+|++---.. .....     
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~-s~h~s~~~~~  235 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPD-STHPSVNSTR  235 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCcc-ccchhhhhhh
Confidence            9988763    34788999999999999999999875  9999999999999   67777887321111 11100     


Q ss_pred             -CcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCC-CCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                       .......+-++|.|||.=. ...+-++|||+||....+|.-+... -........-..+.+-.+..       ....-+
T Consensus       236 ~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-------en~lqr  308 (458)
T KOG1266|consen  236 EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-------ENGLQR  308 (458)
T ss_pred             HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-------cCcccc
Confidence             0112234567899999754 3567799999999999999887654 22222111112221111111       123346


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      +++.+||+..|..||++.++|.||.+-+
T Consensus       309 ~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  309 GSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             CcCcccccCCCCCCcchhhhhcCceeee
Confidence            7899999999999999999999998755

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=3.8e-12  Score=108.24  Aligned_cols=136  Identities=26%  Similarity=0.294  Sum_probs=99.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhh-----HHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-----VEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      ..+++|+-+.+|.+..  -|..+++|.=.++....++.     ..+-.+|..++.++. --.|...+=++.+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            3688999999999864  45557777644443333332     235667999999886 334444344445666778999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ||++|..|.+.+...       ...+++.+=..+.-||..||||+||.++||++   .+. .+.++|||++...+
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl---~~~-~i~~IDfGLg~~s~  142 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL---SGG-RIYFIDFGLGEFSD  142 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEE---eCC-cEEEEECCcccccc
Confidence            999998888877654       25667777777888999999999999999999   332 39999999998643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=3.8e-11  Score=101.83  Aligned_cols=148  Identities=21%  Similarity=0.235  Sum_probs=108.4

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEecccccCC-----HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ...+|-+|+-+.|+++.  ..|+...||.=..+...-     .-...+..+|+++|.++. --.|.-..=+|.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            35678899999999988  578888887533222222     223456778999999886 4444444444555556678


Q ss_pred             EEeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          178 VMELCAG-GELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       178 v~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      +|||++| .++.+++...  ..........+++.|-+.+.-||.++|||+||..+||++.+.+....+.|+|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999976 3666666543  22334444789999999999999999999999999999977666677799999998654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=4.6e-11  Score=107.46  Aligned_cols=141  Identities=28%  Similarity=0.389  Sum_probs=103.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CCeeEEeEEEecC---CeEEEEEe
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDS---LCVHIVME  180 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~niv~l~~~~~~~---~~~~lv~e  180 (398)
                      +.||.|..+.||++.. .+|..+++|.......  ......+..|..+++.+..+ ..+++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGAL--LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEe-cCCcceEEEeCCCccc--CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            5689999999999985 3468899998754321  12345788999999999732 3467777776654   36789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS------------------------------------------  218 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~------------------------------------------  218 (398)
                      |++|.++.+.+.. ..++......++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888664432 345666677777777777777763                                          


Q ss_pred             --------------CCceeccCCCCcEEEeecCC--CccEEEeecCCcee
Q 015898          219 --------------LGVMHRDLKPENFLLVNKDD--DFSLKAIDFGLSVF  252 (398)
Q Consensus       219 --------------~~iiHrDikp~NIll~~~~~--~~~~kL~DFG~a~~  252 (398)
                                    ..++|+|+.|.||++   +.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLF---HPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEE---cCCCCcEEEEEecccccc
Confidence                          246999999999999   54  56689999998865

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=2.4e-12  Score=128.31  Aligned_cols=158  Identities=19%  Similarity=0.297  Sum_probs=115.3

Q ss_pred             HHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc-----c-----ccccCCcccCcccccc-
Q 015898          209 IVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----T-----DVVGSPYYVAPEVLLK-  276 (398)
Q Consensus       209 i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~-  276 (398)
                      ++.|+.|+|. .++||+.|.|++|.+   +..+.+||+.|+++.....+..+     .     ...-...|.|||++.. 
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             ccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3389999995 589999999999999   88899999999988765442211     1     1223456999999986 


Q ss_pred             cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015898          277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE-SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL  354 (398)
Q Consensus       277 ~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL  354 (398)
                      ..+.++|+||+||++|.+.. |+..+......... .......... ......++.++++-|.++|..++.-||++.+++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            47889999999999999995 44444333221111 1111111100 111136889999999999999999999999999


Q ss_pred             cCCCccCCCCCCCCCC
Q 015898          355 CHPWICENGVAPDRSL  370 (398)
Q Consensus       355 ~hp~~~~~~~~~~~~~  370 (398)
                      ..|||.+......+.+
T Consensus       264 ~~~ff~D~~~~aLrfL  279 (700)
T KOG2137|consen  264 SIPFFSDPGLKALRFL  279 (700)
T ss_pred             cccccCCchhhhhhhc
Confidence            9999999887776554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=4.8e-10  Score=108.58  Aligned_cols=212  Identities=16%  Similarity=0.202  Sum_probs=155.4

Q ss_pred             CceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe----cCCeEEEEEeccCC-C
Q 015898          111 QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----DSLCVHIVMELCAG-G  185 (398)
Q Consensus       111 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~----~~~~~~lv~e~~~~-~  185 (398)
                      .-.+.|++....+|..|++|++......+.   .....-++.++++. |+|+|++.++|.    .+..+++|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            446799999999999999999954332222   23334567888998 999999999986    34568999999976 5


Q ss_pred             ChHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          186 ELFDRIIQ---------------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       186 ~L~~~l~~---------------~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      +|++..-.               ....++..+|.++.|+..||.++|+.|+..+-|.|.+||+   +.+.+++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccce
Confidence            77665432               1246789999999999999999999999999999999999   66667888887777


Q ss_pred             eecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHHcCCCcCCCCCCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .....+..             |-+.  --.+-|.-.||.+++.|.||..--+..+  ....++.+..           .+
T Consensus       441 Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------~y  494 (655)
T KOG3741|consen  441 DVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------TY  494 (655)
T ss_pred             eeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------hh
Confidence            66554330             1111  1236689999999999999865422221  1121333222           46


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +.+++++|.-+...++++ -++.+++.|
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            789999999999998887 777777764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=1.5e-09  Score=100.42  Aligned_cols=139  Identities=22%  Similarity=0.180  Sum_probs=96.1

Q ss_pred             CceEEEEEEEccCCcEEEEEEecccccC----C----HhhHHHHHHHHHHHHHhcCCCC--eeEEeEEEec-----CCeE
Q 015898          111 QFGTTYLCTEIATGIEFACKSISKRKLI----S----REDVEDVRREIQIMHHLAGHKN--IVTIKGAYED-----SLCV  175 (398)
Q Consensus       111 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~~~~Ei~~l~~l~~h~n--iv~l~~~~~~-----~~~~  175 (398)
                      ....|+++.  -.|+.|.||........    +    ......+.+|...+.+|. .-+  .+.++.+++.     ....
T Consensus        34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s  110 (268)
T PRK15123         34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTS  110 (268)
T ss_pred             CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCcccee
Confidence            334466654  46778999976432200    0    011124778888888885 223  2334445442     2357


Q ss_pred             EEEEeccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee----cCCCccEEEeecC
Q 015898          176 HIVMELCAGG-ELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFG  248 (398)
Q Consensus       176 ~lv~e~~~~~-~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~----~~~~~~~kL~DFG  248 (398)
                      ++|||++++. +|.+++..  ....+......++.+++..+.-||..||+|+|+++.|||+..    .+++..+.|+||+
T Consensus       111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            8999999875 78887753  344667788899999999999999999999999999999953    1235789999999


Q ss_pred             Ccee
Q 015898          249 LSVF  252 (398)
Q Consensus       249 ~a~~  252 (398)
                      .+..
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=4.7e-10  Score=98.06  Aligned_cols=130  Identities=25%  Similarity=0.237  Sum_probs=82.8

Q ss_pred             EEEEEEEccCCcEEEEEEecccccC----------------------C-HhhHHHHHHHHHHHHHhcCC-CCeeEEeEEE
Q 015898          114 TTYLCTEIATGIEFACKSISKRKLI----------------------S-REDVEDVRREIQIMHHLAGH-KNIVTIKGAY  169 (398)
Q Consensus       114 ~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~-~~~~~~~~~Ei~~l~~l~~h-~niv~l~~~~  169 (398)
                      .||.|.. .+|..+|||+.......                      . ........+|.+.|.++... -++++++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899885 67889999987542110                      0 11134577899999999843 2577777543


Q ss_pred             ecCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          170 EDSLCVHIVMELCA--GGELFDRIIQRGHYSERKAAELTRIIVGVVEA-CHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       170 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~-lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                        .  -.|||||++  |..+.. +.... ++......++.+++..+.. +|+.||+|+||.+.|||+   +++ .+.|+|
T Consensus        80 --~--~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv---~~~-~~~iID  149 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILV---DDG-KVYIID  149 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEE---ETT-CEEE--
T ss_pred             --C--CEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEe---ecc-eEEEEe
Confidence              2  369999998  555543 33221 2245667778888885554 689999999999999999   444 799999


Q ss_pred             cCCceecC
Q 015898          247 FGLSVFFK  254 (398)
Q Consensus       247 FG~a~~~~  254 (398)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=3.6e-09  Score=100.31  Aligned_cols=240  Identities=18%  Similarity=0.222  Sum_probs=160.5

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEE------E-ecCC
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA------Y-EDSL  173 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~------~-~~~~  173 (398)
                      ...++.||+|+-+.+|..-...   ..+-|++..-.   .....+   -+..|...-.||-+-.-+.+      . ..+.
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pp---pa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPP---PAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             cCCCccccCCccceeeecchhh---chhheeecCCC---chHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            3457789999999999754322   34557765432   111111   22233333335543321111      0 1223


Q ss_pred             eEEEEEeccCCCChHHHHH----hc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          174 CVHIVMELCAGGELFDRII----QR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~----~~---~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ...+.|..+.|..--..+.    ++   ..+.|.-..++++.++.+...||..|.+-+|++++|+|+   .+++.+.|.|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEc
Confidence            3778888887652222221    11   237889999999999999999999999999999999999   7788999999


Q ss_pred             cCCceecCCCCcccccccCCcccCccccc-c-----cCCCcccHHHHHHHHHHHHhC-CCCCCCcChH----HHHH-HHH
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K-----HYGPEADVWTAGVILYILLSG-VPPFWAETQQ----GIFD-AVL  314 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwSlG~il~elltg-~~pf~~~~~~----~~~~-~~~  314 (398)
                      -..-....++..+...+|.+.|.+||... +     .-+...|.|.||+++++|+.| +.||.+....    ..++ .|.
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            88776667777888899999999999765 2     356788999999999999986 8999653211    1111 222


Q ss_pred             cCCCc------------CCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHH
Q 015898          315 KGHID------------FESDPWPLISDSAKDLIRKMLCS--QPSERLTAHE  352 (398)
Q Consensus       315 ~~~~~------------~~~~~~~~~~~~~~~li~~~L~~--dP~~Rps~~e  352 (398)
                      .+.+.            ...-++.-+++.+..|..+|+..  ++.-|||++.
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            22111            11223445788999999999864  3678999864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.02  E-value=2.7e-09  Score=96.31  Aligned_cols=140  Identities=22%  Similarity=0.252  Sum_probs=103.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeccccc-----------------CC--HhhHHHHHHHHHHHHHhcCC-C
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-----------------IS--REDVEDVRREIQIMHHLAGH-K  160 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----------------~~--~~~~~~~~~Ei~~l~~l~~h-~  160 (398)
                      +.++.+||.|--|.||.|.+ .+|.++|||.-.....                 .+  ........+|.++|.+|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            66788999999999999996 4789999996321100                 01  11234567899999999733 3


Q ss_pred             CeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       161 niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      .++..++    .+.-.+|||+++|..|...-     +..+....++..|++-+.-+-..||||+|+.+=||++   +++|
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            5666655    34567999999997775422     2456666777777777766668999999999999999   8888


Q ss_pred             cEEEeecCCceec
Q 015898          241 SLKAIDFGLSVFF  253 (398)
Q Consensus       241 ~~kL~DFG~a~~~  253 (398)
                      .+.++||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            8999999876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=1.8e-08  Score=90.04  Aligned_cols=111  Identities=22%  Similarity=0.283  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEEeEEEecC----CeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 015898          143 VEDVRREIQIMHHLAG-HKNIVTIKGAYEDS----LCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVGVVEAC  216 (398)
Q Consensus       143 ~~~~~~Ei~~l~~l~~-h~niv~l~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~i~~al~~l  216 (398)
                      ..+..+|...+..|.. .=.++..+.+.+..    ...++|+|++++. +|.+++......+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3467788888777751 12345555555442    2468999999874 7888887655577888999999999999999


Q ss_pred             HhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       217 H~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      |..||+|+|+++.|||+...++...+.|+||+-+...
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999955444458999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.74  E-value=1.8e-07  Score=82.82  Aligned_cols=142  Identities=20%  Similarity=0.235  Sum_probs=91.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHH------HHHHHHHHHHHhc--CCCCeeEEeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE------DVRREIQIMHHLA--GHKNIVTIKGA  168 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~------~~~~Ei~~l~~l~--~h~niv~l~~~  168 (398)
                      +...|++.+++-......|.+..  .+|..+++|....+.........      ...+++..+..+.  +-..+..++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            45668888888777777777655  67889999987544321111111      1234444444443  12222232222


Q ss_pred             E-----ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEE
Q 015898          169 Y-----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (398)
Q Consensus       169 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~k  243 (398)
                      .     ......+++|||++|..|.+...    +++    .++..+..++.-||+.|++|+|..|.|+++   .++ .++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv---~~~-~i~  174 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV---SNN-GIR  174 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE---ECC-cEE
Confidence            2     23345679999999988866431    222    355667788999999999999999999999   433 499


Q ss_pred             EeecCCcee
Q 015898          244 AIDFGLSVF  252 (398)
Q Consensus       244 L~DFG~a~~  252 (398)
                      ++||+..+.
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999987754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=2.3e-07  Score=81.89  Aligned_cols=140  Identities=15%  Similarity=0.109  Sum_probs=98.7

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCC---HhhHHHHHHHHHHHHHhcCC-CCeeEEeEEEe---c--CCeEEE
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---REDVEDVRREIQIMHHLAGH-KNIVTIKGAYE---D--SLCVHI  177 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~h-~niv~l~~~~~---~--~~~~~l  177 (398)
                      -|.||-+.|+...  -.|+.+-+|.-......+   +-....+.+|+..|.+|... -.++++. ++.   .  .-..+|
T Consensus        26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            4678888899866  344468888754211111   33457889999999988721 1244444 232   1  224689


Q ss_pred             EEeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc--EEEeecCCcee
Q 015898          178 VMELCAG-GELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLSVF  252 (398)
Q Consensus       178 v~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~--~kL~DFG~a~~  252 (398)
                      |+|-+.| .+|.+++...  .+.+......++.+++.++.-||+.|+.|+|+.+.|||+   +.++.  +.++||--++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll---~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV---KTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee---cCCCCeeEEEEEhhccch
Confidence            9997754 5887777552  345788889999999999999999999999999999999   43344  99999986653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.71  E-value=1e-09  Score=108.77  Aligned_cols=245  Identities=16%  Similarity=0.149  Sum_probs=170.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC-eeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~  179 (398)
                      |....-+++|+.+++++.+...+...+ .+.+...        ....-++++|.++. ||| .+..++-++.+...++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccchhh
Confidence            555667899999999998865554444 6655321        34556889999997 999 777777778888999999


Q ss_pred             eccCCC-ChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          180 ELCAGG-ELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       180 e~~~~~-~L~~-~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      +++.++ +... .....-.+.+-+...+.+.-+.+++++|+.-=+|||    ||+..    .+..++.||+....+....
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCccc
Confidence            999877 2221 111122344556666677777889999998778999    88873    2568999999988777665


Q ss_pred             cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC---CCCCCCCHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES---DPWPLISDSAK  333 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  333 (398)
                      ......+++.++|||+.. +.+....|+|++|+-..++--|.+|-..  +......+-.+.-.+..   ..|..  ..-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~--~~~~  461 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSP--VFHR  461 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCc--cccc
Confidence            567788999999999776 5689999999999877777777766432  11111111111100000   11111  1112


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ++...|+...|..|+....++-|.+|.+.....+
T Consensus       462 ~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i~  495 (829)
T KOG0576|consen  462 DFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRIH  495 (829)
T ss_pred             CCcccccCCCCCCCcchhhHHHHHHhccCcccce
Confidence            5788899999999999999999999988765544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.67  E-value=4.7e-07  Score=82.00  Aligned_cols=73  Identities=19%  Similarity=0.207  Sum_probs=55.0

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEEEecCCeEEEEEeccC
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      ..||.|..+.||+.    .+..+++|......     ....+.+|.++++.+.... .+.+.+++.+..+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999983    24467889875321     2345688999999987333 25778888888888899999998


Q ss_pred             CCC
Q 015898          184 GGE  186 (398)
Q Consensus       184 ~~~  186 (398)
                      |..
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.66  E-value=2e-07  Score=98.51  Aligned_cols=212  Identities=20%  Similarity=0.183  Sum_probs=154.1

Q ss_pred             hHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 015898          142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH  217 (398)
Q Consensus       142 ~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH  217 (398)
                      .+.....|+..+..+. |+|++.++.|.-+....    .+..++|...++...+..-+..+....+.+..++++||.|+|
T Consensus       225 ~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            3445566777788887 99999999987554433    344578888899999988888999999999999999999999


Q ss_pred             hCCceeccCCCCcEEEeecCCCccEEEe--ecCCceecCCCCcccccccCCcccCccccccc---CCCcccHHHHHHHHH
Q 015898          218 SLGVMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH---YGPEADVWTAGVILY  292 (398)
Q Consensus       218 ~~~iiHrDikp~NIll~~~~~~~~~kL~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~  292 (398)
                      +....|.-+...-..-...+..+.+.++  ||+.+..............+..+.+||.....   .....|+|.+|..+.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            9976666555552222223566777777  99988877766655556667778888887643   334469999999999


Q ss_pred             HHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          293 ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       293 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      .+..|..+-...   ......+.       .   ....+..+++.+|+.-++++|+++.+++.|+|.........
T Consensus       384 ~~~~~~~i~~~~---~~~~~~l~-------~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  384 QLSQGEDISEKS---AVPVSLLD-------V---LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhcCcccccc---cchhhhhc-------c---ccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            998876542110   01111111       0   11226889999999999999999999999999987654443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=2.4e-07  Score=92.90  Aligned_cols=144  Identities=19%  Similarity=0.219  Sum_probs=93.9

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccC--------------------------C-HhhH----HH------HH
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--------------------------S-REDV----ED------VR  147 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~-~~~~----~~------~~  147 (398)
                      +.|+.++-|.||+|+. .+|+.||||+....-..                          + .+.+    +.      +.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            6799999999999995 56999999996432110                          0 0011    11      33


Q ss_pred             HHHHHHHHhc----CCCCeeEEeEEEecCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 015898          148 REIQIMHHLA----GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAAELTRIIVGV-VEACHSLG  220 (398)
Q Consensus       148 ~Ei~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~~i~~a-l~~lH~~~  220 (398)
                      +|...+.+++    +.+++.--.=+++..+.-.|+|||+.|..+.+..  .. ..++...   ++..++.+ +.-+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence            4444444443    3444433333445566778999999998887764  33 3344333   33333332 23334479


Q ss_pred             ceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       221 iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ++|.|..|.||++   +.+|.+.+.|||+.....+.
T Consensus       286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            9999999999999   78899999999998876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.60  E-value=9.7e-07  Score=79.69  Aligned_cols=79  Identities=24%  Similarity=0.222  Sum_probs=56.7

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEEE---ecCCeEEEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAY---EDSLCVHIVM  179 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~~---~~~~~~~lv~  179 (398)
                      ++.|+.|..+.||++....  ..+++|....     ......+.+|..+++.|..+. .++.++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-----~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-----PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESS-----HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCC-----CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            3579999999999988543  5899998642     245677889999999887442 356666643   3344589999


Q ss_pred             eccCCCChHH
Q 015898          180 ELCAGGELFD  189 (398)
Q Consensus       180 e~~~~~~L~~  189 (398)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999887766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=8.3e-07  Score=79.57  Aligned_cols=140  Identities=19%  Similarity=0.153  Sum_probs=93.2

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEecccccCCHh-------------------h-H-HHHHHHHHHHHHhcC-CCCee
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-------------------D-V-EDVRREIQIMHHLAG-HKNIV  163 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~-------------------~-~-~~~~~Ei~~l~~l~~-h~niv  163 (398)
                      .|++|--+.||+|.. .++..||||++......-..                   . + .=..+|...|+++.. +-.++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            566777788999883 67899999998653321110                   0 1 113467777877752 34455


Q ss_pred             EEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccE
Q 015898          164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       164 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                      +-+.+..    -.|||||+....+-.-..+.-.+...++..+..+++..+.-|-. .++||+||..=|||+   . ++.+
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~---~-~~~p  205 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV---H-DGEP  205 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE---E-CCeE
Confidence            5555432    36899999543111111111223444788888888888887765 999999999999999   5 5679


Q ss_pred             EEeecCCceecC
Q 015898          243 KAIDFGLSVFFK  254 (398)
Q Consensus       243 kL~DFG~a~~~~  254 (398)
                      .|+|||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999987654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.55  E-value=1.2e-06  Score=80.17  Aligned_cols=75  Identities=16%  Similarity=0.130  Sum_probs=55.1

Q ss_pred             ecccCc-eEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCC
Q 015898          107 LGQGQF-GTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG  185 (398)
Q Consensus       107 iG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~  185 (398)
                      |-.|.. +.||++..  .+..+.||+.....      ...+.+|+.+++.+..+--+++++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            444555 78999873  34688888764321      3456789999999976666778888887777789999999987


Q ss_pred             ChHH
Q 015898          186 ELFD  189 (398)
Q Consensus       186 ~L~~  189 (398)
                      ++..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=1.6e-06  Score=73.76  Aligned_cols=132  Identities=26%  Similarity=0.297  Sum_probs=90.2

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      -++.+.||+|.+|.||+|.+  .|..+|+|+-..     ......+..|.++|..+.+-.--.+++.+.++    ++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            34567899999999999984  566999997643     23356788999999999855555666665443    34599


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CC-cEEEeecCCCccEEEeecCCceecC
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLK-PE-NFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDik-p~-NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |+.|-+|.++-...   ...+    ...++++---|-..||-|..|. |. ||++   . +..+.|+||..|..-.
T Consensus        93 ~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv---~-~~~~~iIDFd~At~k~  157 (201)
T COG2112          93 YIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLV---N-DRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEe---c-CCcEEEEEccchhhcc
Confidence            99988886544321   2222    3334444444667799999886 33 5555   2 3369999999998543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=2.7e-06  Score=85.20  Aligned_cols=143  Identities=18%  Similarity=0.207  Sum_probs=88.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccC----------------------------CHhhHHHHH------HHH
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----------------------------SREDVEDVR------REI  150 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~------~Ei  150 (398)
                      +.||.-+.|.||+|+.+ +|+.||||+-+..-..                            -.+..+.+.      +|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            68999999999999965 4999999985432110                            001112222      233


Q ss_pred             HHHH----HhcCCCC------eeEEeEEEecCCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHH-HHHH
Q 015898          151 QIMH----HLAGHKN------IVTIKGAYEDSLCVHIVMELCAGGELFDR--IIQRGHYSERKAAELTRIIVGVV-EACH  217 (398)
Q Consensus       151 ~~l~----~l~~h~n------iv~l~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~i~~~i~~al-~~lH  217 (398)
                      +...    .+. |-+      |++++  +.....-.|+||||+|..+.|.  +.+.+ ++...+   +..+.++. +-|-
T Consensus       246 ~Nae~~~~~f~-~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i---~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFK-DFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDI---LNKLVEAYLEQIF  318 (538)
T ss_pred             HhHHHHHHHHH-hcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC-CCHHHH---HHHHHHHHHHHHH
Confidence            2222    222 444      33332  2334567899999999877553  44433 555533   33333332 2344


Q ss_pred             hCCceeccCCCCcEEEeec-CCCccEEEeecCCceecCC
Q 015898          218 SLGVMHRDLKPENFLLVNK-DDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       218 ~~~iiHrDikp~NIll~~~-~~~~~~kL~DFG~a~~~~~  255 (398)
                      ..|++|+|-.|.||++.++ ..++.+.+.|||+......
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            6789999999999999643 3567899999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.38  E-value=1.9e-05  Score=69.75  Aligned_cols=135  Identities=22%  Similarity=0.291  Sum_probs=95.4

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeccccc-------------CCHhhHHHHHHHHHHHHHhc-----CCCCeeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-------------ISREDVEDVRREIQIMHHLA-----GHKNIVTI  165 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~Ei~~l~~l~-----~h~niv~l  165 (398)
                      ...||+|+.=.||.  + .......||+......             .......+..+|+.-...+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35799999999996  3 3455678998865540             01122455666666555553     37899999


Q ss_pred             eEEEecCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC
Q 015898          166 KGAYEDSLCVHIVMELCAG------GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       166 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~  239 (398)
                      +|+.+.+.-..+|+|.+.+      .+|.+++.. +.++.    .+...+-+-..||-+.+|+.+|++|.||++...++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998743      366676643 44555    334444455678889999999999999999776655


Q ss_pred             c-cEEEee
Q 015898          240 F-SLKAID  246 (398)
Q Consensus       240 ~-~~kL~D  246 (398)
                      . .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence            5 688887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.32  E-value=1.1e-05  Score=70.76  Aligned_cols=129  Identities=22%  Similarity=0.272  Sum_probs=90.2

Q ss_pred             ccceecceecccCc-eEEEEEEEccCCcEEEEEEecccccCCH------------------hhHHHHHHHHHHHHHhc--
Q 015898           99 DLYTLGRKLGQGQF-GTTYLCTEIATGIEFACKSISKRKLISR------------------EDVEDVRREIQIMHHLA--  157 (398)
Q Consensus        99 ~~y~~~~~iG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------~~~~~~~~Ei~~l~~l~--  157 (398)
                      ..++..+.||.|.- |.||++.  -.|+.+|+|++..-.....                  ....-|..|.+...+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            45888999999999 9999988  5788999999322111000                  12335777888777776  


Q ss_pred             CCCCe--eEEeEEEecC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 015898          158 GHKNI--VTIKGAYEDS------------------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH  217 (398)
Q Consensus       158 ~h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH  217 (398)
                      ++.++  ++.+||..-.                  ....||.||.+...         .++...    +.+|++-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            24555  8999987321                  12568888876643         123333    456667778899


Q ss_pred             hCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       218 ~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      +.||+-+|+++.|..=        -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999643        488999965

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=2e-05  Score=84.70  Aligned_cols=81  Identities=22%  Similarity=0.312  Sum_probs=56.6

Q ss_pred             cceecccCceEEEEEEEccCC--cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCe--eEEeEEEecC---CeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI--VTIKGAYEDS---LCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~ni--v~l~~~~~~~---~~~~  176 (398)
                      .+.|+.|.+..+|+......+  ..+++|+......  ......+.+|..+++.|.+|.++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            467899999999998754332  4677776543221  11234678999999999655554  7788877654   4678


Q ss_pred             EEEeccCCCC
Q 015898          177 IVMELCAGGE  186 (398)
Q Consensus       177 lv~e~~~~~~  186 (398)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.11  E-value=2.4e-05  Score=71.31  Aligned_cols=74  Identities=18%  Similarity=0.122  Sum_probs=46.8

Q ss_pred             ceecccCce-EEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEecC---CeEEEE
Q 015898          105 RKLGQGQFG-TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDS---LCVHIV  178 (398)
Q Consensus       105 ~~iG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~~---~~~~lv  178 (398)
                      +.|+.|+.. .||+..     ..+++|.....     .....+.+|.+++..|.++  --+..+++.....   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            457777776 588752     25777865321     1245788999999988743  1345555544332   245889


Q ss_pred             EeccCCCChH
Q 015898          179 MELCAGGELF  188 (398)
Q Consensus       179 ~e~~~~~~L~  188 (398)
                      |++++|.++.
T Consensus        73 ~~~i~G~~l~   82 (235)
T cd05155          73 YRWLEGETAT   82 (235)
T ss_pred             EEeecCCCCC
Confidence            9999986663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=9.2e-05  Score=69.94  Aligned_cols=77  Identities=10%  Similarity=0.047  Sum_probs=56.3

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEec---CCeEEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYED---SLCVHIV  178 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~---~~~~~lv  178 (398)
                      .+.||.|..+.||.... .++ .+.+|..+.     ......+..|...|+.|.++  -.++++++++..   .+..+||
T Consensus        19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYD-SQG-NPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEc-CCC-CEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            56799999999999763 333 577777432     11235788999999999754  368888987754   3668999


Q ss_pred             EeccCCCCh
Q 015898          179 MELCAGGEL  187 (398)
Q Consensus       179 ~e~~~~~~L  187 (398)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999988654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.00  E-value=6.4e-05  Score=68.31  Aligned_cols=76  Identities=13%  Similarity=0.200  Sum_probs=50.1

Q ss_pred             cceecccCceEEEEEEEcc-CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          104 GRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      ++.|..|-...+|++.... ++..|++|+.....   . ..-...+|+.+++.+..+.-.+++++.+..    .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---E-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---c-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence            3567788888999987432 35789999765321   1 111234688899988645555666654432    3799999


Q ss_pred             CCCCh
Q 015898          183 AGGEL  187 (398)
Q Consensus       183 ~~~~L  187 (398)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            88665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.95  E-value=3.7e-05  Score=67.41  Aligned_cols=99  Identities=21%  Similarity=0.253  Sum_probs=79.2

Q ss_pred             HHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 015898          148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR---IIQRGHYSERKAAELTRIIVGVVEACHS---LGV  221 (398)
Q Consensus       148 ~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i  221 (398)
                      .|.-+++.+.+.+++++++|+|-.    ++|.||...+++...   +..--..+|..+.+|+.++++.+++++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            488889999866899999998832    568899977666421   1222236899999999999999999987   457


Q ss_pred             eeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       222 iHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .-.|++|+|+-+   ++++.+|++|...+...
T Consensus        84 ~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEE---eCCCcEEEEechhcchh
Confidence            889999999999   77889999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.95  E-value=0.00028  Score=68.96  Aligned_cols=80  Identities=15%  Similarity=0.160  Sum_probs=55.1

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccC--C--HhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEecCCeEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--S--REDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~--~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~~~~~~lv  178 (398)
                      +.||.|.+..||++.....++.|+||.-......  .  +...++...|.+.|..+..+  .++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999997543358999985321110  1  23456778888888876533  467778776  33557899


Q ss_pred             EeccCCCC
Q 015898          179 MELCAGGE  186 (398)
Q Consensus       179 ~e~~~~~~  186 (398)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.95  E-value=9.4e-07  Score=95.54  Aligned_cols=155  Identities=19%  Similarity=0.132  Sum_probs=115.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEEeEEEe--cCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 015898          143 VEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEAC  216 (398)
Q Consensus       143 ~~~~~~Ei~~l~~l~~h~niv~l~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~l  216 (398)
                      .+....|...++.+. |+++.....-..  +....|..++|+.+|.+++.+.+.    ..+...-+.....+.+.+..-+
T Consensus      1273 kemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            344555555566666 888887666443  344578999999999999998664    2344455555555556666776


Q ss_pred             HhCC-----ceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CCcccccccCCcccCcccccc-cCCCcccHHHHHH
Q 015898          217 HSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGV  289 (398)
Q Consensus       217 H~~~-----iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~  289 (398)
                      |+..     .+|+++|+.|.++   ..+..+|++++|+.+...+ ........+++.|++|++... .++.++|+|..|+
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            6542     6899999999999   7777899999999994332 234455678888999998876 5888899999999


Q ss_pred             HHHHHHhCCCCC
Q 015898          290 ILYILLSGVPPF  301 (398)
Q Consensus       290 il~elltg~~pf  301 (398)
                      .+|++..|..+|
T Consensus      1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhcccHHH
Confidence            999999988887

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.91  E-value=5.4e-05  Score=69.87  Aligned_cols=134  Identities=21%  Similarity=0.157  Sum_probs=76.8

Q ss_pred             ecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCC
Q 015898          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (398)
Q Consensus       107 iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~  186 (398)
                      +..|-...+|+..  .++..+++|......   ....-...+|..+++.+..+.-.++++....    -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            5567788999876  456788898754321   1110124678899998874433455555432    268999998865


Q ss_pred             hHH--------------HHHh---c----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeccCC
Q 015898          187 LFD--------------RIIQ---R----GHYSE-RKAAELTRII---------VGVVEACHS--------LGVMHRDLK  227 (398)
Q Consensus       187 L~~--------------~l~~---~----~~~~~-~~~~~i~~~i---------~~al~~lH~--------~~iiHrDik  227 (398)
                      +..              .+.+   .    .+++. ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            431              1111   0    01111 1111221111         111222221        258999999


Q ss_pred             CCcEEEeecCCCccEEEeecCCceec
Q 015898          228 PENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       228 p~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      |.||++   ++++ +.|+||..|...
T Consensus       155 ~~Nil~---~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVV---TPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEE---eCCC-CEEEeccccCcC
Confidence            999999   5555 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.90  E-value=1.4e-05  Score=74.24  Aligned_cols=138  Identities=21%  Similarity=0.235  Sum_probs=98.5

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEeccc-----------------ccCCHhhH--HHHHHHHHHHHHhcCCC
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR-----------------KLISREDV--EDVRREIQIMHHLAGHK  160 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~--~~~~~Ei~~l~~l~~h~  160 (398)
                      -+.++..||-|--+.||.+.+ ..|.+.++|.-...                 ...+.-.+  -...+|...|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            477899999999999999985 56889999963211                 11111111  23557888898887443


Q ss_pred             C-eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC
Q 015898          161 N-IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       161 n-iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~  239 (398)
                      . +++.++    .+.-++|||++.|..|...-      ....+..+...++..+.-|..+|+||+|..-=||++   +++
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd  238 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD  238 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeee------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence            2 344443    45668999999988775432      123455566677777788899999999999999999   777


Q ss_pred             ccEEEeecCCce
Q 015898          240 FSLKAIDFGLSV  251 (398)
Q Consensus       240 ~~~kL~DFG~a~  251 (398)
                      +.++++||--..
T Consensus       239 ~~i~vIDFPQmv  250 (465)
T KOG2268|consen  239 DKIVVIDFPQMV  250 (465)
T ss_pred             CCEEEeechHhh
Confidence            889999997543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.83  E-value=0.00017  Score=67.98  Aligned_cols=138  Identities=20%  Similarity=0.203  Sum_probs=82.6

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEE------EecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA------YEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~------~~~~~~~~  176 (398)
                      .+.|..|....+|+...  ++..+++|+...      .....+..|+.++..|..+. .+++++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            45677788889999763  345788998753      12345677888888886331 24454432      23345678


Q ss_pred             EEEeccCCCChHH----HH----------Hh-cCCC----------CHHHH----------HHHHHHHHHHHHHHHh---
Q 015898          177 IVMELCAGGELFD----RI----------IQ-RGHY----------SERKA----------AELTRIIVGVVEACHS---  218 (398)
Q Consensus       177 lv~e~~~~~~L~~----~l----------~~-~~~~----------~~~~~----------~~i~~~i~~al~~lH~---  218 (398)
                      +|+++++|..+..    ..          +. ...+          .+...          ......+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999998865421    11          00 0000          00000          0011112334444443   


Q ss_pred             ----CCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          219 ----LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       219 ----~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                          .+++|+|+.|.|||+   ++++.+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEE---eCCceEEEeehhhhcC
Confidence                479999999999999   6666678999998864

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.66  E-value=0.00037  Score=66.15  Aligned_cols=139  Identities=19%  Similarity=0.209  Sum_probs=80.3

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEE------EecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA------YEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~------~~~~~~~~  176 (398)
                      .+.++.|....+|++.. .+| .+++|+.....  +   ...+..|+.++..|.++. .+++++..      ....+..+
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            56677887789998763 344 67789764321  1   234556777887775221 24444442      12345678


Q ss_pred             EEEeccCCCChH----H-------H---HHh-cCCC--------CHHHHH---------------HHHHHHHHHHHHHH-
Q 015898          177 IVMELCAGGELF----D-------R---IIQ-RGHY--------SERKAA---------------ELTRIIVGVVEACH-  217 (398)
Q Consensus       177 lv~e~~~~~~L~----~-------~---l~~-~~~~--------~~~~~~---------------~i~~~i~~al~~lH-  217 (398)
                      +++||++|..+.    .       .   ++. ...+        ......               .....+...++++. 
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885431    1       1   110 0001        000000               00112233445553 


Q ss_pred             ------hCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          218 ------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       218 ------~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                            ..+++|+|+.+.||++   ++++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEE---ECCceEEEeecccccC
Confidence                  2689999999999999   5566678999998854

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.63  E-value=0.00048  Score=65.11  Aligned_cols=76  Identities=14%  Similarity=0.155  Sum_probs=49.2

Q ss_pred             ceecccCceEEEEEEEcc------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIA------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|..|-...||++....      .++.+++|+.....    .......+|..++..+..+.-..++++++..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            345566667888877432      25789999875421    1223556788889888754445566666542    358


Q ss_pred             EeccCCCChH
Q 015898          179 MELCAGGELF  188 (398)
Q Consensus       179 ~e~~~~~~L~  188 (398)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999886653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.41  E-value=0.0054  Score=58.43  Aligned_cols=76  Identities=17%  Similarity=0.184  Sum_probs=45.3

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CCeeEEeE------EEecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKG------AYEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~niv~l~~------~~~~~~~~~  176 (398)
                      .+.|+.|....+|+... .+| .+++|++. ..  .   .+.+..|+.++..|..+ -.+++++.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RL--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEec-cC--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            35577788889999763 334 68899874 11  2   23344566666666421 12334332      123356689


Q ss_pred             EEEeccCCCCh
Q 015898          177 IVMELCAGGEL  187 (398)
Q Consensus       177 lv~e~~~~~~L  187 (398)
                      +++||++|..+
T Consensus        99 ~l~~~l~G~~~  109 (319)
T PRK05231         99 AIVTFLEGKWP  109 (319)
T ss_pred             EEEEecCCCCC
Confidence            99999988643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.36  E-value=0.0024  Score=59.64  Aligned_cols=31  Identities=29%  Similarity=0.419  Sum_probs=24.8

Q ss_pred             CceeccCCCCcEEEeecCCCcc-EEEeecCCceec
Q 015898          220 GVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF  253 (398)
Q Consensus       220 ~iiHrDikp~NIll~~~~~~~~-~kL~DFG~a~~~  253 (398)
                      .++|+|+.|.|||+   ++++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv---~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILI---DEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEE---eCCCCEEEEECcHhcccC
Confidence            48999999999999   54344 569999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.34  E-value=0.0022  Score=60.68  Aligned_cols=146  Identities=17%  Similarity=0.255  Sum_probs=80.6

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcC-CCCeeEEeEEEecCC--eEEEEEe
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDSL--CVHIVME  180 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-h~niv~l~~~~~~~~--~~~lv~e  180 (398)
                      .+.+-.|..-.+|....  +++.+++. ... ............+|..+++.+.. -.-+...++.+.++.  ..|.||+
T Consensus        30 v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          30 VEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            34443444444555443  37778887 321 12233445677789999988753 123444556665554  6799999


Q ss_pred             ccCCCChHHH------------------HHhc--------------CCCCHHHHHHHHHHH--------------HHHHH
Q 015898          181 LCAGGELFDR------------------IIQR--------------GHYSERKAAELTRII--------------VGVVE  214 (398)
Q Consensus       181 ~~~~~~L~~~------------------l~~~--------------~~~~~~~~~~i~~~i--------------~~al~  214 (398)
                      |++|..+.+.                  |..-              +.+...++..+..+.              .....
T Consensus       106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~  185 (321)
T COG3173         106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK  185 (321)
T ss_pred             EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence            9988322211                  1100              000111111111111              11233


Q ss_pred             HHHh--------CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          215 ACHS--------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       215 ~lH~--------~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +++.        ..++|+|+.+.||++   ++...+=+.||+++...++-
T Consensus       186 Wl~~~~p~~~~~~~lvHGD~~~gNlii---~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         186 WLEANRPPWAGPPVLVHGDYRPGNLII---DPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHhcCCCcCCCceeeeCCcccCCEEE---eCCCeeEEEeccccccCCcH
Confidence            3432        258999999999999   55555888999999875543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.29  E-value=0.0031  Score=60.07  Aligned_cols=143  Identities=24%  Similarity=0.257  Sum_probs=94.4

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEecccccC----------------------CHhhHHH-HHHHHHHHHHhcCC
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----------------------SREDVED-VRREIQIMHHLAGH  159 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~-~~~Ei~~l~~l~~h  159 (398)
                      +..-|..|--+-||.|. ..+|..+|||+++..-+.                      .+..++. ...|+..|++|. .
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N  225 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence            34457788888999998 578899999997532111                      1111222 346888888886 3


Q ss_pred             CCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEEEeecCC
Q 015898          160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       160 ~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~l-H~~~iiHrDikp~NIll~~~~~  238 (398)
                      ..|.-.--.. -. .-.|||+++.......-..+.-.++...+..+-.+++.-+.-| |..++||.||.-=|+|+   . 
T Consensus       226 aGIP~PePIl-Lk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly---h-  299 (520)
T KOG2270|consen  226 AGIPCPEPIL-LK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY---H-  299 (520)
T ss_pred             cCCCCCCcee-ee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE---E-
Confidence            3332211111 11 2358999995433333333445577778888888887777665 67899999999999999   3 


Q ss_pred             CccEEEeecCCceec
Q 015898          239 DFSLKAIDFGLSVFF  253 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~  253 (398)
                      +|.+.|+|.+-+...
T Consensus       300 dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEH  314 (520)
T ss_pred             CCEEEEEEccccccC
Confidence            578999999877654

>PLN02236 choline kinase

Probab=97.23  E-value=0.0024  Score=61.66  Aligned_cols=138  Identities=12%  Similarity=0.144  Sum_probs=80.8

Q ss_pred             ceecccCceEEEEEEEcc----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      +.|-.|-.-.+|++....    .++.|++|+.....   ...+.+ .+|..+++.+..+.--.++++.+..+    .|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            345457788899876432    34689999875431   222222 67899999888555556777766443    5789


Q ss_pred             ccCCCChHHH----------H-------HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH----
Q 015898          181 LCAGGELFDR----------I-------IQRG------HYSERKAAELTRII-----------------VGVVEAC----  216 (398)
Q Consensus       181 ~~~~~~L~~~----------l-------~~~~------~~~~~~~~~i~~~i-----------------~~al~~l----  216 (398)
                      |+++.++...          +       +...      ......+..+..++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9877665311          0       0000      01122232332211                 1111111    


Q ss_pred             ----HhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          217 ----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       217 ----H~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                          +...++|+|+++.|||+.  ++++.+.|+||..|..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence                123589999999999993  2246799999998865

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.23  E-value=0.0056  Score=58.84  Aligned_cols=77  Identities=14%  Similarity=0.052  Sum_probs=49.9

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEeccccc----CCHhhHHHHHHHHHHHHHhcCC-C-CeeEEeEEEecCCeEEEEE
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKL----ISREDVEDVRREIQIMHHLAGH-K-NIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~Ei~~l~~l~~h-~-niv~l~~~~~~~~~~~lv~  179 (398)
                      .||-|....||++.+...++.|+||.-...-.    ..+-...+..-|...|+..... | .+++++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            48999999999999754336899997532111    1233456677788888776532 3 4555554  3344456899


Q ss_pred             eccCC
Q 015898          180 ELCAG  184 (398)
Q Consensus       180 e~~~~  184 (398)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.20  E-value=0.0013  Score=65.09  Aligned_cols=165  Identities=21%  Similarity=0.180  Sum_probs=105.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEEeEEEecC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 015898          144 EDVRREIQIMHHLAGHKNIVTIKGAYEDS-LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM  222 (398)
Q Consensus       144 ~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~ii  222 (398)
                      .++.-...+++.+. |+|...++++-... ....+|||++ +.+|++.+..+. +-.....                  +
T Consensus        27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A   85 (725)
T ss_pred             HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence            34556678888888 99999999977543 3478899999 679999886554 2111111                  2


Q ss_pred             eccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCC
Q 015898          223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFW  302 (398)
Q Consensus       223 HrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~  302 (398)
                      ||= -+-||+.          .+| -++..    .  ....               .+++||||+|.++.++.-|...+.
T Consensus        86 ~~~-~~~~~~~----------~td-~~~t~----~--~~~~---------------~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   86 HGV-LHLNIIY----------ITD-HFLTK----Y--PSPI---------------GPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             ccc-ceehhhh----------ccc-ccccc----C--CCCC---------------CcchhhhhHHHHHHHHHHhhHHHH
Confidence            221 1123222          233 11100    0  1111               249999999999999999988776


Q ss_pred             CcChHHHHHHHHcCCCcCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          303 AETQQGIFDAVLKGHIDFESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      ..........+.+-.......        ..-.++....+++.+|+-..|..||...++.+++-|.+.
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            655555555544421110000        001256778899999999999999999999999999776

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.05  E-value=0.0047  Score=57.92  Aligned_cols=74  Identities=15%  Similarity=0.121  Sum_probs=48.8

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEecCCeEEEEEec
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      .+.+|-|....+|+..  .+++.+.||+-..      .....+..|..-|+.|.  ..-.+++++++....+..+|||||
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            5678889999999977  7788999998642      22346778888888884  245688899988877778999999


Q ss_pred             cCCC
Q 015898          182 CAGG  185 (398)
Q Consensus       182 ~~~~  185 (398)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.02  E-value=0.01  Score=58.07  Aligned_cols=77  Identities=12%  Similarity=0.077  Sum_probs=52.1

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccC-C---HhhHHHHHHHHHHHHHhcC--CCCeeEEeEEEecCCeEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-S---REDVEDVRREIQIMHHLAG--HKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~---~~~~~~~~~Ei~~l~~l~~--h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.||-|....||+..+  .+..|+||.-...... .   +....+...|...|+.+..  ...+++++.+..+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            46789999999999885  3456999975422111 1   1245566667777776542  2578888887774  3567


Q ss_pred             EEeccCC
Q 015898          178 VMELCAG  184 (398)
Q Consensus       178 v~e~~~~  184 (398)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.84  E-value=0.0076  Score=57.84  Aligned_cols=75  Identities=12%  Similarity=0.158  Sum_probs=45.9

Q ss_pred             ceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          105 RKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      +.|..|-.-.+|++.....   +..|++++.....   .. .-.-.+|..+++.+..+.--+++++++.. +   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---Ce-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehh
Confidence            3454477778888764332   3478899875421   11 11234688888888754444667776632 2   58899


Q ss_pred             cCCCCh
Q 015898          182 CAGGEL  187 (398)
Q Consensus       182 ~~~~~L  187 (398)
                      ++|..|
T Consensus        92 i~g~~l   97 (330)
T PLN02421         92 INARTL   97 (330)
T ss_pred             hcCCCC
Confidence            877654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.79  E-value=0.034  Score=52.58  Aligned_cols=30  Identities=33%  Similarity=0.495  Sum_probs=24.8

Q ss_pred             CCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       219 ~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .+++|+|+.+.||++   ++ +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~---~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILL---KD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEE---eC-CcEEEEECccccc
Confidence            578999999999999   44 4578999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.41  E-value=0.012  Score=56.78  Aligned_cols=126  Identities=17%  Similarity=0.118  Sum_probs=79.0

Q ss_pred             ceecccCceEEEEEEE---------------ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898          105 RKLGQGQFGTTYLCTE---------------IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..||.|+-+.||+|.-               +...+.+|+|+.++.      ..+++...+.||.....-+|++.-..+.
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~------V~~~ir~Dl~Il~f~Akl~~~vP~l~wL  268 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPN------VEKQIRLDLGILGFGAKLINNVPDLSWL  268 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCcc------HHHHHHHHHHHHhhhhhhhhhcCccccc
Confidence            4799999999999852               223457999987542      2334445555554433333333322221


Q ss_pred             e----------------------------------------------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHH
Q 015898          170 E----------------------------------------------DSLCVHIVMELCAGGELFDRIIQRGHYSERKAA  203 (398)
Q Consensus       170 ~----------------------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  203 (398)
                      .                                              ......++-+|..|.++..++...+ .++....
T Consensus       269 ~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~k  347 (565)
T KOG1236|consen  269 SLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS-QPEALVK  347 (565)
T ss_pred             cCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc-ChHHHHH
Confidence            0                                              1123456777888888877776544 3566677


Q ss_pred             HHHHHHHHHHHH-HHhCCceeccCCCCcEEEeecC
Q 015898          204 ELTRIIVGVVEA-CHSLGVMHRDLKPENFLLVNKD  237 (398)
Q Consensus       204 ~i~~~i~~al~~-lH~~~iiHrDikp~NIll~~~~  237 (398)
                      .++.-...|+-- +--.+++|.|+.|.||++...+
T Consensus       348 kva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  348 KVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             HHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            777766666544 3345799999999999996533

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.36  E-value=0.032  Score=54.41  Aligned_cols=79  Identities=14%  Similarity=0.120  Sum_probs=52.4

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeccccc---CCHhhHHHHHHHHHHHHHhcCC-C-CeeEEeEEEecCCeEEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMHHLAGH-K-NIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~Ei~~l~~l~~h-~-niv~l~~~~~~~~~~~lv  178 (398)
                      .+.||-|.-.-||++.+...+..|+||.-...-.   .-+-..++..-|...|+.+... | .+++++.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            4578999999999999743356799997432111   1234467778888888876532 3 5666665  344455688


Q ss_pred             EeccCC
Q 015898          179 MELCAG  184 (398)
Q Consensus       179 ~e~~~~  184 (398)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.33  E-value=0.014  Score=52.09  Aligned_cols=56  Identities=18%  Similarity=0.135  Sum_probs=34.2

Q ss_pred             CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCCh
Q 015898          124 GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL  187 (398)
Q Consensus       124 ~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L  187 (398)
                      ++.|+|++....    .+..-.-..|..+++.+..+..-+++++.+..+    +|++|++|..|
T Consensus         2 ~~~~~~Ri~g~~----t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEG----TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESC----GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred             CCEEEEEeCCCC----cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence            457888887543    223345567888888888666667777766443    56688866543

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.09  E-value=0.096  Score=49.67  Aligned_cols=30  Identities=27%  Similarity=0.368  Sum_probs=26.9

Q ss_pred             CceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       220 ~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      +++|+|+.+.|||+   ++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            79999999999999   7777889999998865

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.03  E-value=0.15  Score=48.86  Aligned_cols=72  Identities=14%  Similarity=0.077  Sum_probs=43.1

Q ss_pred             cCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeE---EeE--EEecCCeEEEEEeccC
Q 015898          110 GQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVT---IKG--AYEDSLCVHIVMELCA  183 (398)
Q Consensus       110 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~---l~~--~~~~~~~~~lv~e~~~  183 (398)
                      +.-..||+.. ..++..+++|+.....    .....+..|+..+..|..+. .++.   .-|  +...++..+.++++++
T Consensus        36 s~eN~vy~v~-~~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFG-DEDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEe-cCCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            3446688876 3567789999875321    13456677888888776321 1122   111  2233567888999998


Q ss_pred             CCC
Q 015898          184 GGE  186 (398)
Q Consensus       184 ~~~  186 (398)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            753

>PTZ00384 choline kinase; Provisional

Probab=95.82  E-value=0.076  Score=51.96  Aligned_cols=75  Identities=19%  Similarity=0.214  Sum_probs=46.5

Q ss_pred             ceecccCceEEEEEEEccC-CcE-----EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIAT-GIE-----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|..|-...+|++..... +..     |.+.+....   ....+ .-.+|+.+++.|..+..-.++++.+..    +++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence            4555588889999864332 122     444432111   11111 234689999999866677788887753    589


Q ss_pred             EeccCCCCh
Q 015898          179 MELCAGGEL  187 (398)
Q Consensus       179 ~e~~~~~~L  187 (398)
                      .||++|.+|
T Consensus       128 ~efIeGr~l  136 (383)
T PTZ00384        128 QEWVEGNTM  136 (383)
T ss_pred             EEEeccccC
Confidence            999988665

>PRK06148 hypothetical protein; Provisional

Probab=95.45  E-value=0.26  Score=54.49  Aligned_cols=78  Identities=14%  Similarity=0.200  Sum_probs=44.5

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CC--eeEEeE--------EEec-C
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KN--IVTIKG--------AYED-S  172 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~n--iv~l~~--------~~~~-~  172 (398)
                      +.|+ |..-.+|+.. ..+|..+++|+.....     ....+..|..+|..|..+ +.  +.+++-        .... .
T Consensus        31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             eecC-CcCCceEEEE-eCCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            4564 4457788876 4567789999986431     223444566677666532 22  223221        1111 2


Q ss_pred             C--eEEEEEeccCCCChHH
Q 015898          173 L--CVHIVMELCAGGELFD  189 (398)
Q Consensus       173 ~--~~~lv~e~~~~~~L~~  189 (398)
                      +  ..+-+++|++|..+.+
T Consensus       104 G~~~~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLAE  122 (1013)
T ss_pred             CceEEEEEEeccCCCcHHh
Confidence            2  5677899999876654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.39  E-value=0.21  Score=44.84  Aligned_cols=74  Identities=16%  Similarity=0.152  Sum_probs=50.4

Q ss_pred             eecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcC--CCCeeEEeEEEecCCeEEEEEeccC
Q 015898          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       106 ~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~--h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .+.-|.--..|...  .....+.||.=      ..+....+..|+.-|..+..  .-.+.+++.+....++.|+||||++
T Consensus        23 ~v~gG~inea~~v~--dg~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~   94 (286)
T COG3001          23 EVSGGDINEAWRLR--DGTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP   94 (286)
T ss_pred             ccCCccccceeEee--cCCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence            34444444445443  22346888853      44556778888887777652  3467888999999999999999998


Q ss_pred             CCCh
Q 015898          184 GGEL  187 (398)
Q Consensus       184 ~~~L  187 (398)
                      -+.+
T Consensus        95 ~~~~   98 (286)
T COG3001          95 TGPL   98 (286)
T ss_pred             CCCC
Confidence            7554

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.34  E-value=0.13  Score=49.36  Aligned_cols=112  Identities=17%  Similarity=0.232  Sum_probs=73.9

Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      +..+.|++|++. |+++.- +   ..-..+++..++.+-+..++-+.. ...=|||+...|||+   + +|.+.|+||-+
T Consensus       297 e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkl  367 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKL  367 (488)
T ss_pred             CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeee
Confidence            445678888886 666632 2   223567888888887777766654 358999999999999   7 78999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV  298 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~  298 (398)
                      ++.-..+..    +.....-.|-.+.+.-+..-|||-+   |--|+.|.
T Consensus       368 sRl~~~q~~----isy~rldhp~lF~G~dd~QFeIYrl---Mr~l~~g~  409 (488)
T COG5072         368 SRLSYSQGI----ISYNRLDHPDLFNGVDDYQFEIYRL---MRRLLKGR  409 (488)
T ss_pred             eecccCCce----eeccccCchhhhcCccceeeeHHHH---HHHHhcCc
Confidence            985332221    1122344555565555666677764   34444443

>PTZ00296 choline kinase; Provisional

Probab=94.33  E-value=0.35  Score=48.31  Aligned_cols=76  Identities=9%  Similarity=0.054  Sum_probs=46.1

Q ss_pred             cceecccCceEEEEEEEcc--------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898          104 GRKLGQGQFGTTYLCTEIA--------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++.|..|-.-.+|++....        .++.|.+++.....   ...+ .-..|..+++.+..+.--.++++.+. +   
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g---  181 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G---  181 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence            4566667777888887432        15679999875421   1111 23457778877774443456666553 2   


Q ss_pred             EEEEeccCCCCh
Q 015898          176 HIVMELCAGGEL  187 (398)
Q Consensus       176 ~lv~e~~~~~~L  187 (398)
                      +.|.||++|..|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            357899887533

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.49  E-value=0.33  Score=43.42  Aligned_cols=102  Identities=16%  Similarity=0.158  Sum_probs=65.6

Q ss_pred             EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHH
Q 015898          126 EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL  205 (398)
Q Consensus       126 ~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i  205 (398)
                      ...+|.+....+.-  ...-+..+..++.++.   .|+++..  ...-.+.++.|.|-.....            .. .+
T Consensus        87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh---GilrL~N--Dn~~~yGvIlE~Cy~~~i~------------~~-N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH---GILRLKN--DNNYKYGVILERCYKIKIN------------FS-NF  146 (308)
T ss_pred             hhhhhhccCCCccc--chhhhhhhhhHHHHhh---heeEeec--CCCceeEEEEeeccCcccc------------hh-HH
Confidence            45566554333221  1234577888888763   6777773  2445678999998443221            11 11


Q ss_pred             HHHHHHHHHHHHh--CCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          206 TRIIVGVVEACHS--LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       206 ~~~i~~al~~lH~--~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      +..=+.+|.-.|+  .+.+|+|-.|+||+-   |+.|.+||.|=++.
T Consensus       147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~---D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMC---DKFGYLKLVDPVCL  190 (308)
T ss_pred             HHHhHHHHHHhhccCCCeecCCCChhheee---cCCCCEEecChhhh
Confidence            1122356777884  479999999999999   99999999997653

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	398
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-63
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-62
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-62
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-61
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-59
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-59
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-59
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-58
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-57
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-57
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-57
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-57
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-56
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-56
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-56
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-56
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-56
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-56
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-56
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-55
2jam_B	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-55
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-55
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-54
3soa_A	444	Full-Length Human Camkii Length = 444		2e-53
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-53
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-53
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-52
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-51
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-51
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-51
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-51
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-51
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-51
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-51
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-51
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-51
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-51
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-51
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-51
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-51
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-51
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-51
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-51
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-51
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-51
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-50
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-50
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-50
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-50
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-50
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-50
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-48
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-48
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-48
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-48
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-48
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-47
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-47
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-46
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-46
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-45
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-43
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-43
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-43
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-42
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-42
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-42
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-41
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-41
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-41
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-41
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-41
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-41
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-41
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-41
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-41
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-41
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-40
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-40
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-40
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-39
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-39
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-39
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-39
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-39
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-39
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-39
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-39
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-39
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-39
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-39
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-39
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-39
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-39
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-39
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-39
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-38
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-38
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-37
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-37
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-37
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-37
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-37
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-37
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-37
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-37
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-36
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-36
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-36
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-36
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-36
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-36
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-36
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-36
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-36
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-36
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-36
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-36
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-36
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-36
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-36
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-36
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-36
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-36
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-35
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-35
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-35
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-35
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-35
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-35
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-35
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-35
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-35
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-35
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-35
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-34
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-34
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-33
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-33
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-32
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-32
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-31
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-31
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-31
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-31
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-31
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-31
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-31
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-31
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-31
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-31
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-31
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-31
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-31
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-31
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-31
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-31
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-31
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-31
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-31
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-31
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-31
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-31
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-31
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-31
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-31
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-31
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-31
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-31
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-31
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-31
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-31
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-30
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-30
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-30
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-30
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-30
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-30
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-30
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-30
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-30
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-30
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-30
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-30
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-30
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-30
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-30
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-30
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-30
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-30
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-30
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-30
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-30
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-30
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-30
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-30
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-30
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-30
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-30
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-30
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-30
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-30
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-30
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-30
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-30
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-30
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-30
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-29
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-29
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-29
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-29
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-29
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-29
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-29
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-28
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-28
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-28
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-27
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-27
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-27
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-27
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-27
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-27
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-26
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-26
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-26
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-26
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-26
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-26
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-26
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-26
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-26
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-26
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-26
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-26
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-25
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-25
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-25
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-25
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-25
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-25
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-24
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-24
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-24
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-24
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-24
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-24
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-24
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-24
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-24
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-24
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-24
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-23
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-23
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-23
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-23
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-23
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-23
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-23
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-23
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-23
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-23
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-23
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-23
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-23
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-23
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-23
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-23
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-23
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-23
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-23
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-23
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-23
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-23
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-23
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-23
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-23
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-23
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-22
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-22
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-22
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-22
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-21
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-20
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-19
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-19
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-19
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-19
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-19
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-19
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-19
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-18
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-18
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-18
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-18
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-18
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-18
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-17
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-17
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-16
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-16
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-16
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-16
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-16
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-16
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-16
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-16
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-16
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-16
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-16
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-16
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-16
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-16
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-16
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-16
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-16
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-15
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-15
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-15
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-15
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-15
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-15
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-15
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-15
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-15
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-15
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-15
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-15
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-15
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-15
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-15
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-15
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-15
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-15
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-15
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-15
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-15
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-13
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-13
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-13
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		8e-13
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		8e-13
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		8e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-13
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-13
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-12
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-12
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-09
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		4e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-08
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		6e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-08
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		7e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-04
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-04
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-04
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-04
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-04

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  237 bits (604), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 132/305 (43%), Positives = 179/305 (58%), Gaps = 6/305 (1%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 42  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 101
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 102 LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 161 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 220
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 221 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 280
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI---CENGVAPDR-SLDPAVLSRLKQFSAMNKL 387
           AKDLIRKML   PS R++A + L H WI    +  ++ D  SLD A+L+ ++QF    KL
Sbjct: 281 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKL 339
Query: 388 KKMAL 392
            + AL
Sbjct: 340 AQAAL 344

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 132/305 (43%), Positives = 179/305 (58%), Gaps = 6/305 (1%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 43  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 102
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 103 LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 162 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 221
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 222 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 281
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI---CENGVAPDR-SLDPAVLSRLKQFSAMNKL 387
           AKDLIRKML   PS R++A + L H WI    +  ++ D  SLD A+L+ ++QF    KL
Sbjct: 282 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKL 340
Query: 388 KKMAL 392
            + AL
Sbjct: 341 AQAAL 345

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  236 bits (603), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 132/305 (43%), Positives = 179/305 (58%), Gaps = 6/305 (1%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 79  LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 198 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI---CENGVAPDR-SLDPAVLSRLKQFSAMNKL 387
           AKDLIRKML   PS R++A + L H WI    +  ++ D  SLD A+L+ ++QF    KL
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKL 316
Query: 388 KKMAL 392
            + AL
Sbjct: 317 AQAAL 321

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  233 bits (595), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 132/310 (42%), Positives = 178/310 (57%), Gaps = 6/310 (1%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI  +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 79  LLKQL-DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAP 197
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 198 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI---CENGVAPDR-SLDPAVLSRLKQFSAMNKL 387
           AKDLIRK L   PS R++A + L H WI    +  ++ D  SLD A+L+ ++QF    KL
Sbjct: 258 AKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAILN-IRQFQGTQKL 316
Query: 388 KKMALRVSAS 397
            + AL    S
Sbjct: 317 AQAALLYXGS 326

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 120/268 (44%), Positives = 159/268 (59%), Gaps = 1/268 (0%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 25  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 84
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 85  LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 143
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 144 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 203
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 204 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 263
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           AKDLIRKML   PS R++A + L H WI
Sbjct: 264 AKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  226 bits (575), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 126/301 (41%), Positives = 170/301 (56%), Gaps = 6/301 (1%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +  T  E+A K I+K    ++ D   + RE++++  L  H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +   +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+APEVL   Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
           + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 341 CSQPSERLTAHEVLCHPWI----CENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSA 396
              PS R+TA + L HPWI     E     D     + ++ ++QF A  KL + AL   A
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMA 321
Query: 397 S 397
           S
Sbjct: 322 S 322

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  224 bits (572), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 113/286 (39%), Positives = 166/286 (58%), Gaps = 4/286 (1%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +  Y  G    +I   YTL   +G+G +G   +  +  T I  A K I K  +   EDV+
Sbjct: 12  ENLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVD 68
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
             ++EI+IM  L  H NI+ +   +ED+  +++VMELC GGELF+R++ +  + E  AA 
Sbjct: 69  RFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR 127
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + + ++  V  CH L V HRDLKPENFL +    D  LK IDFGL+  FKPG++    VG
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 187
Query: 265 SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           +PYYV+P+VL   YGPE D W+AGV++Y+LL G PPF A T   +   + +G   F    
Sbjct: 188 TPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKD 247
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
           W  +S  A+ LIR++L   P +R+T+ + L H W  +   +  R+L
Sbjct: 248 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 293

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  223 bits (567), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 112/280 (40%), Positives = 164/280 (58%), Gaps = 4/280 (1%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
           G    +I   YTL   +G+G +G   +  +  T I  A K I K  +   EDV+  ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +IM  L  H NI+ +   +ED+  +++VMELC GGELF+R++ +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             V  CH L V HRDLKPENFL +    D  LK IDFGL+  FKPG++    VG+PYYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 271 PEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           P+VL   YGPE D W+AGV++Y+LL G PPF A T   +   + +G   F    W  +S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
            A+ LIR++L   P +R+T+ + L H W  +   +  R+L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  220 bits (561), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 118/298 (39%), Positives = 174/298 (58%), Gaps = 5/298 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K+ L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK 389
           AKD IR ++   P +R T  + L HPWI  +  A D+++  +V  ++K+  A +K K+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD-TALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 5/298 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K  L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK 389
           AKD IR ++   P +R T  + L HPWI  +  A D+++  +V  ++K+  A +K K+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD-TALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 5/298 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K  L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK 389
           AKD IR ++   P +R T  + L HPWI  +  A D+++  +V  ++K+  A +K K+
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGD-TALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  218 bits (556), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 112/298 (37%), Positives = 177/298 (59%), Gaps = 5/298 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++I+ ++     LG G F    L  E ATG  FA K I K+ L  +E    +  EI +
Sbjct: 16  QAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  +  H+NIV ++  YE    +++VM+L +GGELFDRI+++G Y+E+ A+ L R ++  
Sbjct: 74  LRKIK-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA 132
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V   H +G++HRDLKPEN L  ++D++  +   DFGLS     G + +   G+P YVAPE
Sbjct: 133 VYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE 192
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS 252
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK 389
           AKD IR ++   P++R T  +   HPWI  +  A ++++  +V +++++  A +K ++
Sbjct: 253 AKDFIRNLMEKDPNKRYTCEQAARHPWIAGD-TALNKNIHESVSAQIRKNFAKSKWRQ 309

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  217 bits (552), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 121/299 (40%), Positives = 170/299 (56%), Gaps = 4/299 (1%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y L  +LG+G F     C +I TG E+A K I+ +KL +R D + + RE +I   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR-DHQKLEREARICR- 58
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+   + I+  V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVL 274
           CH  G++HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMAL 392
           DLI KML   P++R+TA E L HPWIC+             +  LK+F+A  KLK   L
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAIL 297

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  217 bits (552), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 117/295 (39%), Positives = 170/295 (57%), Gaps = 4/295 (1%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y L   +G+G F     C ++ TG E+A K I+ +KL +R D + + RE +I   
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSAR-DHQKLEREARICR- 58
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+   + I+  V  
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVL 274
           CH +GV+HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
           +LI +ML   P++R+TAHE L HPW+C+             +  LK+F+A  KLK
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLK 293

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  215 bits (548), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 121/299 (40%), Positives = 170/299 (56%), Gaps = 4/299 (1%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y L  +LG+G F     C +I TG E+A K I+ +KL +R D + + RE +I   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR-DHQKLEREARICR- 58
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+   + I+  V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVL 274
           CH  G++HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMAL 392
           DLI KML   P++R+TA E L HPWIC+             +  LK+F+A  KLK   L
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAIL 297

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  214 bits (546), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 115/259 (44%), Positives = 153/259 (59%), Gaps = 2/259 (0%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +  T  E+A K I+K    ++ D   + RE++++  L  H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +   +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+APEVL   Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
           + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 341 CSQPSERLTAHEVLCHPWI 359
              PS R+TA + L HPWI
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  214 bits (545), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 117/305 (38%), Positives = 167/305 (54%), Gaps = 5/305 (1%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y   +KLG G +G   LC +  TG E A K I K  + +  +   +  E+ ++  L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NI+ +   +ED    ++VME+  GGELFD II R  +SE  AA + + ++      
Sbjct: 62  -DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H   ++HRDLKPEN LL +K  D  +K +DFGLS  F+ G    + +G+ YY+APEVL K
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y  + DVW+ GVILYILL G PPF  +T Q I   V KG   F+   W  +SD AK L+
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 337 RKMLCSQPSERLTAHEVLCHPWIC----ENGVAPDRSLDPAVLSRLKQFSAMNKLKKMAL 392
           + ML  +PS+R++A E L HPWI     +      +      L  +K+F +  KL + A+
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAAM 300
Query: 393 RVSAS 397
               S
Sbjct: 301 LFMGS 305

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  214 bits (545), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 115/259 (44%), Positives = 153/259 (59%), Gaps = 2/259 (0%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +  T  E+A K I+K    ++ D   + RE++++  L  H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +   +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+APEVL   Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
           + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 341 CSQPSERLTAHEVLCHPWI 359
              PS R+TA + L HPWI
Sbjct: 262 TFHPSLRITATQCLEHPWI 280

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  214 bits (545), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 162/283 (57%), Gaps = 9/283 (3%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K  L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           AKD IR ++   P +R T  + L HPWI     A D +LD  +
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI-----AGDTALDKNI 286

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  211 bits (537), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 110/265 (41%), Positives = 154/265 (58%), Gaps = 1/265 (0%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y   +KLG G +G   LC +  TG E A K I K  + +  +   +  E+ ++  L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NI+ +   +ED    ++VME+  GGELFD II R  +SE  AA + + ++      
Sbjct: 79  -DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H   ++HRDLKPEN LL +K  D  +K +DFGLS  F+ G    + +G+ YY+APEVL K
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 197
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y  + DVW+ GVILYILL G PPF  +T Q I   V KG   F+   W  +SD AK L+
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 257
Query: 337 RKMLCSQPSERLTAHEVLCHPWICE 361
           + ML  +PS+R++A E L HPWI +
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  210 bits (535), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 119/301 (39%), Positives = 169/301 (56%), Gaps = 4/301 (1%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG +    + +Y L  +LG+G F     C ++  G E+A K I+ +KL +R D + + RE
Sbjct: 13  LGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSAR-DHQKLERE 71
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
            +I   L  H NIV +  +  +    +++ +L  GGELF+ I+ R +YSE  A+   + I
Sbjct: 72  ARICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 130
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYY 268
           +  V  CH +GV+HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y
Sbjct: 131 LEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 190
Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           ++PEVL K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 250
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKL 387
           ++  AKDLI KML   PS+R+TA E L HPWI               +  LK+F+A  KL
Sbjct: 251 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 310
Query: 388 K 388
           K
Sbjct: 311 K 311

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 116/309 (37%), Positives = 175/309 (56%), Gaps = 6/309 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K  ++ ++Y   +KLG G +G   LC +  T +E A K I K   +S      +  E+ +
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAV 89
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  L  H NI+ +   +ED    ++VME   GGELFD II R  ++E  AA + + ++  
Sbjct: 90  LK-LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V   H   ++HRDLKPEN LL +K+ D  +K +DFGLS  F+  +   + +G+ YY+APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
Query: 273 VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           VL K Y  + DVW+ GVIL+ILL+G PPF  +T Q I   V KG   F+S  W  +S+ A
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD-PAV---LSRLKQFSAMNKLK 388
           KDLI++ML      R++A + L HPWI E     +  ++ P++   +  +++F    KL 
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328
Query: 389 KMALRVSAS 397
           + AL   AS
Sbjct: 329 QAALLYMAS 337

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 117/296 (39%), Positives = 165/296 (55%), Gaps = 4/296 (1%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L  +LG+G F     C ++  G E+A   I+ +KL +R D + + RE +I   L  H 
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICR-LLKHP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +  +  +    +++ +L  GGELF+ I+ R +YSE  A+   + I+  V  CH +G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HR+LKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL K  Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           G   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AKDLI K
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRV 394
           ML   PS+R+TA E L HPWI               +  LK+F+A  KLK   L V
Sbjct: 251 MLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTV 306

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 119/314 (37%), Positives = 172/314 (54%), Gaps = 10/314 (3%)
Query: 87  YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           Y++ G   D + D + +  +LG+G     Y C +  T   +A K + K       D + V
Sbjct: 41  YWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIV 95
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           R EI ++  L+ H NI+ +K  +E    + +V+EL  GGELFDRI+++G+YSER AA+  
Sbjct: 96  RTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + I+  V   H  G++HRDLKPEN L      D  LK  DFGLS   +   +   V G+P
Sbjct: 155 KQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 267 YYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP 324
            Y APE+L    YGPE D+W+ G+I YILL G  PF+ E   Q +F  +L     F S  
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAM 384
           W  +S +AKDL+RK++   P +RLT  + L HPW+   G A +         +L++F+A 
Sbjct: 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV--TGKAANFVHMDTAQKKLQEFNAR 332
Query: 385 NKLKKMALRVSASA 398
            KLK     V AS+
Sbjct: 333 RKLKAAVKAVVASS 346

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  204 bits (519), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 112/295 (37%), Positives = 161/295 (54%), Gaps = 3/295 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 86
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMAL 392
            ML   P +R+TA + L  PWIC              +  LK+F+A  KLK   L
Sbjct: 267 SMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAIL 321

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 116/309 (37%), Positives = 172/309 (55%), Gaps = 19/309 (6%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAM 384
           +   S  AKD IR++L   P +R+T  + L HPWI               LSR      M
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ-------QALSRKASAVNM 293
Query: 385 NKLKKMALR 393
            K KK A R
Sbjct: 294 EKFKKFAAR 302

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  199 bits (507), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  199 bits (507), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  199 bits (507), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 61
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 62  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 61
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 62  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  198 bits (504), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 108/273 (39%), Positives = 160/273 (58%), Gaps = 6/273 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK-LISREDV--EDVRRE 149
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+   SR  V  E++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           + I+  +  H NI+T+   YE+   V +++EL +GGELFD + Q+   SE +A    + I
Sbjct: 66  VSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + +  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
            S+ AKD IRK+L  +  +RLT  E L HPWI 
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 161/276 (58%), Gaps = 12/276 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           +   S+ AKD IRK+L  +  +RLT  E L HPWI 
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 161/276 (58%), Gaps = 12/276 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           +   S+ AKD IRK+L  +  +RLT  E L HPWI 
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 121/335 (36%), Positives = 173/335 (51%), Gaps = 14/335 (4%)
Query: 71  PSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK 130
            S ++N+  +GI       +  K   I + Y   RKLG G +G   LC E     E A K
Sbjct: 8   SSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 131 SISKRKL----ISREDV------EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
            I K +      S ++       E++  EI ++  L  H NI+ +   +ED    ++V E
Sbjct: 68  VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYLVTE 126
Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
              GGELF++II R  + E  AA + + I+  +   H   ++HRD+KPEN LL NK+   
Sbjct: 127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           ++K +DFGLS FF       D +G+ YY+APEVL K Y  + DVW+ GVI+YILL G PP
Sbjct: 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP 246
Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI- 359
           F  +  Q I   V KG   F+ + W  ISD AK+LI+ ML    ++R TA E L   WI 
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
Query: 360 --CENGVAPDRSLDPAVLSRLKQFSAMNKLKKMAL 392
               N    D+      LS +++F    KL + A+
Sbjct: 307 KYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAI 341

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 161/276 (58%), Gaps = 12/276 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           +   S+ AKD IRK+L  +  +RLT  E L HPWI 
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 161/276 (58%), Gaps = 12/276 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           +   S+ AKD IRK+L  +  +RLT  E L HPWI 
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 163/275 (59%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG G+F     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 107/276 (38%), Positives = 161/276 (58%), Gaps = 12/276 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
           +   S+ AKD IRK+L  +  +RLT  E L HPWI 
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 104/263 (39%), Positives = 150/263 (57%), Gaps = 3/263 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 63
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 338 KMLCSQPSERLTAHEVLCHPWIC 360
            ML   P +R+TA + L  PWIC
Sbjct: 244 SMLTVNPKKRITADQALKVPWIC 266

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 107/275 (38%), Positives = 162/275 (58%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V ++ EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 104/263 (39%), Positives = 150/263 (57%), Gaps = 3/263 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 63
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 338 KMLCSQPSERLTAHEVLCHPWIC 360
            ML   P +R+TA + L  PWIC
Sbjct: 244 SMLTVNPKKRITADQALKVPWIC 266

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 104/263 (39%), Positives = 150/263 (57%), Gaps = 3/263 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 62
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 242
Query: 338 KMLCSQPSERLTAHEVLCHPWIC 360
            ML   P +R+TA + L  PWIC
Sbjct: 243 SMLTVNPKKRITADQALKVPWIC 265

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 111/296 (37%), Positives = 162/296 (54%), Gaps = 4/296 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L  +LG+G F     C +     E+A K I+ +KL +R D + + RE +I   L  
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR-DHQKLEREARICR-LLK 88
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+     I+  V   H 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH 277
             ++HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL K 
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK+LI
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 337 RKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMAL 392
            +ML   P++R+TA + L HPW+C+             +  L++F+A  KLK   L
Sbjct: 269 NQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAIL 324

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  196 bits (497), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 106/275 (38%), Positives = 162/275 (58%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG G F     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 102/271 (37%), Positives = 160/271 (59%), Gaps = 12/271 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDVRREI 150
           + D Y +G +LG GQF     C +  TG E+A K I KR+L      +SRE++E   RE+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE---REV 59
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            I+  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  + I+
Sbjct: 60  NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
             V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+P +V
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           APE++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + +   
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           S+ AKD IR++L   P  R+T  + L H WI
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 170/309 (55%), Gaps = 10/309 (3%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMH 154
             D+Y L   +G+G F     C    TG +FA K +   K  S   +  ED++RE  I H
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIV 210
            L  H +IV +   Y     +++V E   G +L   I++R      YSE  A+   R I+
Sbjct: 82  MLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYV 269
             +  CH   ++HRD+KPEN LL +K++   +K  DFG+++   + G +    VG+P+++
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           APEV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F+ ++KG        W  I
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHI 259
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
           S+SAKDL+R+ML   P+ER+T +E L HPW+ E      +   P  + +L++F+A  KLK
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319
Query: 389 KMALRVSAS 397
              L   +S
Sbjct: 320 GAVLAAVSS 328

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 153/281 (54%), Gaps = 16/281 (5%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVR-- 147
           H T    + Y     LG+G       C    T  E+A K   ++     S E+V+++R  
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 148 --REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
             +E+ I+  ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
            R ++ V+ A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G+
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGT 186
Query: 266 PYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
           P Y+APE++          YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+ 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            F S  W   SD+ KDL+ + L  QP +R TA E L HP+ 
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 162/275 (58%), Gaps = 12/275 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +++ D Y +G +LG GQF     C +  TG E+A K I KR+L      +SRE++E  
Sbjct: 6   RQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  
Sbjct: 64  -REVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   S+ AKD IR++L   P  R+   + L H WI
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 152/281 (54%), Gaps = 16/281 (5%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVR-- 147
           H T    + Y     LG+G       C    T  E+A K   ++     S E+V+++R  
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 148 --REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
             +E+ I+  ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
            R ++ V+ A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+    V G+
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGT 186
Query: 266 PYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
           P Y+APE++          YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+ 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            F S  W   SD+ KDL+ + L  QP +R TA E L HP+ 
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 101/271 (37%), Positives = 159/271 (58%), Gaps = 12/271 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDVRREI 150
           + D Y +G +LG GQF     C +  TG E+A K I KR+L      +SRE++E   RE+
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE---REV 80
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            I+  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  + I+
Sbjct: 81  NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 139
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
             V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+P +V
Sbjct: 140 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 199
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           APE++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + +   
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 259
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           S+ AKD IR++L   P  R+   + L H WI
Sbjct: 260 SELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 149/266 (56%), Gaps = 16/266 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVR----REIQIMHHLAGHK 160
           LG+G       C    T  E+A K   ++     S E+V+++R    +E+ I+  ++GH 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++ R ++ V+ A H L 
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL----- 275
           ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G+P Y+APE++      
Sbjct: 132 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 276 --KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
               YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+  F S  W   SD+ K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWI 359
           DL+ + L  QP +R TA E L HP+ 
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 147/265 (55%), Gaps = 15/265 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +G+G       C   ATG EFA K +    + +S E +E+VR    RE  I+  +AGH +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           I+T+  +YE S  + +V +L   GELFD + ++   SE++   + R ++  V   H+  +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL------ 275
           +HRDLKPEN LL   DD+  ++  DFG S   +PG+   ++ G+P Y+APE+L       
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
              YG E D+W  GVIL+ LL+G PPFW   Q  +   +++G   F S  W   S + KD
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWI 359
           LI ++L   P  RLTA + L HP+ 
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 108/307 (35%), Positives = 167/307 (54%), Gaps = 10/307 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHHL 156
           D+Y L   +G+G F     C    TG +FA K +   K  S   +  ED++RE  I H L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGV 212
             H +IV +   Y     +++V E   G +L   I++R      YSE  A+   R I+  
Sbjct: 86  K-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +  CH   ++HRD+KP   LL +K++   +K   FG+++   + G +    VG+P+++AP
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F+ ++KG        W  IS+
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISE 263
Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKM 390
           SAKDL+R+ML   P+ER+T +E L HPW+ E      +   P  + +L++F+A  KLK  
Sbjct: 264 SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 323
Query: 391 ALRVSAS 397
            L   +S
Sbjct: 324 VLAAVSS 330

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 108/309 (34%), Positives = 167/309 (54%), Gaps = 10/309 (3%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMH 154
             D+Y L   +G+G F     C    TG +FA K +   K  S   +  ED++RE  I H
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIV 210
            L  H +IV +   Y     +++V E   G +L   I++R      YSE  A+   R I+
Sbjct: 82  MLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYV 269
             +  CH   ++HRD+KP   LL +K++   +K   FG+++   + G +    VG+P+++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           APEV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F+ ++KG        W  I
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHI 259
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
           S+SAKDL+R+ML   P+ER+T +E L HPW+ E      +   P  + +L++F+A  KLK
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319
Query: 389 KMALRVSAS 397
              L   +S
Sbjct: 320 GAVLAAVSS 328

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 155/280 (55%), Gaps = 9/280 (3%)
Query: 87  YYVLGHKTDNIRDLYTLGRK--LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           + ++  K   +   YT+ +   LG G+FG  + C E ATG++ A K I  R +   +D E
Sbjct: 75  HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKE 131
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAA 203
           +V+ EI +M+ L  H N++ +  A+E    + +VME   GGELFDRII   +  +E    
Sbjct: 132 EVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
              + I   +   H + ++H DLKPEN L VN+D    +K IDFGL+  +KP +      
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNF 249
Query: 264 GSPYYVAPEVLLKHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           G+P ++APEV+   +     D+W+ GVI Y+LLSG+ PF  +      + +L    D E 
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
           + +  IS+ AK+ I K+L  + S R++A E L HPW+ ++
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 108/304 (35%), Positives = 159/304 (52%), Gaps = 24/304 (7%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT +E+A K I K K        D   EI+I+     
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQ 79
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  HS
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 219 LGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +   L+  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 196
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFW---AETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ G++LY +L+G  PF    ++T + I   +  G        W  +S
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVS 256
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLK-----QFSAM 384
           ++AKDL+ KML   P +RLTA +VL HPW+ +    P   L    L  +K      +SA+
Sbjct: 257 ETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSAL 316
Query: 385 NKLK 388
           N  K
Sbjct: 317 NSSK 320

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 108/304 (35%), Positives = 159/304 (52%), Gaps = 24/304 (7%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT +E+A K I K K        D   EI+I+     
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQ 79
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  HS
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 219 LGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +   L+  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 196
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFW---AETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ G++LY +L+G  PF    ++T + I   +  G        W  +S
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVS 256
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLK-----QFSAM 384
           ++AKDL+ KML   P +RLTA +VL HPW+ +    P   L    L  +K      +SA+
Sbjct: 257 ETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSAL 316
Query: 385 NKLK 388
           N  K
Sbjct: 317 NSSK 320

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 105/282 (37%), Positives = 149/282 (52%), Gaps = 19/282 (6%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT +EFA K I K K        D   EI+I+     
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 219 LGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +  S++  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ GV+LY +L+G  PF     +T + I   +  G        W  +S
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD 371
           D+AKDL+ KML   P +RLTA  VL HPWI      P   L+
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLN 293

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 108/289 (37%), Positives = 152/289 (52%), Gaps = 21/289 (7%)
Query: 97  IRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           + D Y L ++ LG G  G    C    TG + A K +         D    R+E+     
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQ 77
Query: 156 LAGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRII 209
            +G  +IV I   YE+      C+ I+ME   GGELF RI +RG   ++ER+AAE+ R I
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              ++  HS  + HRD+KPEN L  +K+ D  LK  DFG +       + T    +PYYV
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYV 196
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK----GHIDFESDP 324
           APEVL  + Y    D+W+ GVI+YILL G PPF++ T Q I   + +    G   F +  
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA 373
           W  +S+ AK LIR +L + P+ERLT  + + HPWI ++ V P   L  A
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 305

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 108/289 (37%), Positives = 152/289 (52%), Gaps = 21/289 (7%)
Query: 97  IRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           + D Y L ++ LG G  G    C    TG + A K +         D    R+E+     
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQ 58
Query: 156 LAGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRII 209
            +G  +IV I   YE+      C+ I+ME   GGELF RI +RG   ++ER+AAE+ R I
Sbjct: 59  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              ++  HS  + HRD+KPEN L  +K+ D  LK  DFG +       + T    +PYYV
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYV 177
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK----GHIDFESDP 324
           APEVL  + Y    D+W+ GVI+YILL G PPF++ T Q I   + +    G   F +  
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA 373
           W  +S+ AK LIR +L + P+ERLT  + + HPWI ++ V P   L  A
Sbjct: 238 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 286

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 149/268 (55%), Gaps = 8/268 (2%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            I DL+   RKLG G FG  +L  E ++G+E   K+I+K +  S+  +E +  EI+++  
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKS 76
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ---RGH-YSERKAAELTRIIVG 211
           L  H NI+ I   +ED   ++IVME C GGEL +RI+    RG   SE   AEL + ++ 
Sbjct: 77  L-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   HS  V+H+DLKPEN L  +      +K IDFGL+  FK  +  T+  G+  Y+AP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EV  +    + D+W+AGV++Y LL+G  PF   + + +         ++  +  PL +  
Sbjct: 196 EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL-TPQ 254
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           A DL+++ML   P  R +A +VL H W 
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/270 (35%), Positives = 142/270 (52%), Gaps = 15/270 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL    + LG+G F     C    +   FA K ISKR         + ++EI  +    G
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEG 64
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +   + D L   +VMEL  GGELF+RI ++ H+SE +A+ + R +V  V   H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGSPYYVAPEVLLKH 277
           +GV+HRDLKPEN L  +++D+  +K IDFG +    P  Q       + +Y APE+L ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQ-------GIFDAVLKGHIDFESDPWPLIS 329
            Y    D+W+ GVILY +LSG  PF +  +         I   + KG   FE + W  +S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             AKDLI+ +L   P++RL    +  + W+
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 110/315 (34%), Positives = 160/315 (50%), Gaps = 19/315 (6%)
Query: 57  KENPKKDNS--APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGT 114
           K  P  +NS  A  +S +K        +D+Q+ Y        +RD Y + + LG G  G 
Sbjct: 110 KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVY-----PKALRDEYIMSKTLGSGACGE 164
Query: 115 TYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQIMHHLAGHKNIVTIKGAY 169
             L  E  T  + A + ISKRK     +RE     +V  EI+I+  L  H  I+ IK  +
Sbjct: 165 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 223
Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPE 229
            D+   +IV+EL  GGELFD+++      E         ++  V+  H  G++HRDLKPE
Sbjct: 224 -DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE 282
Query: 230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVW 285
           N LL ++++D  +K  DFG S       +   + G+P Y+APEVL+      Y    D W
Sbjct: 283 NVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 342
Query: 286 TAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           + GVIL+I LSG PPF    TQ  + D +  G  +F  + W  +S+ A DL++K+L   P
Sbjct: 343 SLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 402
Query: 345 SERLTAHEVLCHPWI 359
             R T  E L HPW+
Sbjct: 403 KARFTTEEALRHPWL 417

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 104/282 (36%), Positives = 146/282 (51%), Gaps = 19/282 (6%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT  EFA K I K K        D   EI+I+     
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 219 LGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +  S++  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ GV+LY  L+G  PF     +T + I   +  G        W  +S
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD 371
           D+AKDL+ K L   P +RLTA  VL HPWI      P   L+
Sbjct: 252 DTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLN 293

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 110/315 (34%), Positives = 160/315 (50%), Gaps = 19/315 (6%)
Query: 57  KENPKKDNS--APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGT 114
           K  P  +NS  A  +S +K        +D+Q+ Y        +RD Y + + LG G  G 
Sbjct: 96  KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVY-----PKALRDEYIMSKTLGSGACGE 150
Query: 115 TYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQIMHHLAGHKNIVTIKGAY 169
             L  E  T  + A + ISKRK     +RE     +V  EI+I+  L  H  I+ IK  +
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 209
Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPE 229
            D+   +IV+EL  GGELFD+++      E         ++  V+  H  G++HRDLKPE
Sbjct: 210 -DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE 268
Query: 230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVW 285
           N LL ++++D  +K  DFG S       +   + G+P Y+APEVL+      Y    D W
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 286 TAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           + GVIL+I LSG PPF    TQ  + D +  G  +F  + W  +S+ A DL++K+L   P
Sbjct: 329 SLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 345 SERLTAHEVLCHPWI 359
             R T  E L HPW+
Sbjct: 389 KARFTTEEALRHPWL 403

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 144/273 (52%), Gaps = 12/273 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +S+ A DL++K+L   P  R T  E L HPW+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 144/273 (52%), Gaps = 12/273 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 67  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +S+ A DL++K+L   P  R T  E L HPW+
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 144/273 (52%), Gaps = 12/273 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +S+ A DL++K+L   P  R T  E L HPW+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 144/273 (52%), Gaps = 12/273 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +S+ A DL++K+L   P  R T  E L HPW+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 144/273 (52%), Gaps = 12/273 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 74  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +S+ A DL++K+L   P  R T  E L HPW+
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 142/278 (51%), Gaps = 8/278 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ 
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQT 101
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVG 211
           M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R +  
Sbjct: 102 MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 160
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + AP
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 219
Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS+
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 279
Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR 368
             KD IRK+L + P+ R+T H+ L HPW+   G AP R
Sbjct: 280 DGKDFIRKLLLADPNTRMTIHQALEHPWLTP-GNAPGR 316

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 142/278 (51%), Gaps = 8/278 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ 
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQT 207
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVG 211
           M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R +  
Sbjct: 208 MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + AP
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS+
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR 368
             KD IRK+L + P+ R+T H+ L HPW+   G AP R
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTP-GNAPGR 422

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  160 bits (406), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 149/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A + I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G    +  GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  +++   W+  N    D  L P V
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM--NVGHEDDELKPYV 280

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 103/276 (37%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  +++   W+  N    D  L P V
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM--NVGHEDDELKPYV 280

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 103/276 (37%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  +++   W+  N    D  L P V
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM--NVGHEDDELKPYV 280

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 111
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 146/285 (51%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 65
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T+   +PYYVA
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVA 185
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A + I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  +++   W+  N    D  L P V
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM--NVGHEDDELKPYV 280

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 117
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 118 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 238 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 297
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 298 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  +++   W+  N    D  L P V
Sbjct: 247 FLILNPSKRGTLEQIMKDRWM--NVGHEDDELKPYV 280

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 65
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 185
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 71
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 72  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 191
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 192 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 251
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 252 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 72
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 73  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 192
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 193 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 252
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 253 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 73
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 74  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 193
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 194 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 253
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 254 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 103/276 (37%), Positives = 148/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 127 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 239
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  +++   W+  N    D  L P V
Sbjct: 240 FLILNPSKRGTLEQIMKDRWM--NVGHEDDELKPYV 273

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 66
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 67  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 186
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 187 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 246
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 247 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 98/285 (34%), Positives = 145/285 (50%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 81
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 82  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 201
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 202 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 261
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 262 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 99/276 (35%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L +   ++ + RE++IM  L  H 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    ++++ME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 132 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L+++
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKR 244
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   P +R T  +++   WI  N    +  L P V
Sbjct: 245 FLVLNPIKRGTLEQIMKDRWI--NAGHEEDELKPFV 278

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 97/303 (32%), Positives = 150/303 (49%), Gaps = 35/303 (11%)
Query: 96  NIRDLYTLGRKL-GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
              D+Y L  +L G+G +        +  G E+A K I K+   SR  V    RE++ ++
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV---FREVETLY 65
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
              G+KNI+ +   +ED    ++V E   GG +   I ++ H++ER+A+ + R +   ++
Sbjct: 66  QCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALD 125
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV--------GSP 266
             H+ G+ HRDLKPEN L  + +    +K  DF L    K     T +         GS 
Sbjct: 126 FLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 267 YYVAPEVL------LKHYGPEADVWTAGVILYILLSGVPPF---------WAE------T 305
            Y+APEV+         Y    D+W+ GV+LYI+LSG PPF         W         
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA 365
           Q  +F+++ +G  +F    W  IS  AKDLI K+L     +RL+A +VL HPW+   G A
Sbjct: 246 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV--QGQA 303
Query: 366 PDR 368
           P++
Sbjct: 304 PEK 306

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/276 (35%), Positives = 147/276 (53%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L +   ++ + RE++IM  L  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    ++++ME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+    K+ 
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKR 247
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   P +R T  +++   WI  N    +  L P V
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWI--NAGHEEDELKPFV 281

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    GE++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 97/285 (34%), Positives = 139/285 (48%), Gaps = 19/285 (6%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVELHWRA 111
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IV E   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D W+ GVI YILL G PPF++        G    +  G  +F +  W
Sbjct: 232 PEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEW 291
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
             +S+  K LIR +L ++P++R T  E   HPWI ++   P   L
Sbjct: 292 SEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPL 336

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 139/269 (51%), Gaps = 7/269 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K  ++ D Y +  +LG G FG  + C E ATG  F  K I+    +   D   V+ EI I
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISI 101
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVG 211
           M+ L  H  ++ +  A+ED   + +++E  +GGELFDRI    +  SE +     R    
Sbjct: 102 MNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            ++  H   ++H D+KPEN +   K    S+K IDFGL+    P +I      +  + AP
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           E++ +   G   D+W  GV+ Y+LLSG+ PF  E        V +   +F+ D +  +S 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            AKD I+ +L  +P +RLT H+ L HPW+
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 145/278 (52%), Gaps = 10/278 (3%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           ++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     +
Sbjct: 63  VEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSV-HAPSSRRTTLCGTLDYL 177
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            PE++  + +  + D+W+ GV+ Y  L G+PPF A T Q  +  + +    F       +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FV 233
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP 366
           ++ A+DLI ++L    S+RLT  EVL HPWI  N   P
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    GE++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLXGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P     D+ G+  Y+ PE++  + + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 266
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 267 LKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 210
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 266
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 267 LKHNPSQRPMLREVLEHPWITANSSKP 293

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 85
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 146 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 201
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 257
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 258 LKHNPSQRPMLREVLEHPWITANSSKP 284

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T++ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 246 LKHNPSQRPMLREVLEHPWITANSSKP 272

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 139/265 (52%), Gaps = 13/265 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGH 159
           Y +   LG+G FG   L T   T  + A K IS R+L+ + D+   V REI  +  L  H
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLK-LLRH 68
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +         + +V+E  AGGELFD I+++   +E +     + I+  +E CH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL--LKH 277
            ++HRDLKPEN LL   DD+ ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ G++LY++L G  PF  E    +F  V    +    D    +S  A+ LIR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMPD---FLSPGAQSLIR 240
Query: 338 KMLCSQPSERLTAHEVLCHPWICEN 362
           +M+ + P +R+T  E+   PW   N
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVN 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 100/276 (36%), Positives = 143/276 (51%), Gaps = 13/276 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++I   L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIXKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++V E  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+   +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYXSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
            L   PS+R T  ++    W   N    D  L P V
Sbjct: 247 FLILNPSKRGTLEQIXKDRW--XNVGHEDDELKPYV 280

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 72
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 132 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 244
Query: 338 KMLCSQPSERLTAHEVLCHPW 358
           +ML   P  R++ HE++   W
Sbjct: 245 RMLIVNPLNRISIHEIMQDDW 265

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 144/278 (51%), Gaps = 11/278 (3%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG +   + D + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE
Sbjct: 3   LGSRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           ++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     +
Sbjct: 62  VEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P     D+ G+  Y+
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYL 176
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            PE++  + +  + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FV 232
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP 366
           ++ A+DLI ++L   PS+R    EVL HPWI  N   P
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 73
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 133 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 245
Query: 338 KMLCSQPSERLTAHEVLCHPW 358
           +ML   P  R++ HE++   W
Sbjct: 246 RMLIVNPLNRISIHEIMQDDW 266

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 103/331 (31%), Positives = 156/331 (47%), Gaps = 60/331 (18%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISRED 142
           +  Y  G     ++  Y L   +GQG +G   +  E  T    A K ++K K+  I+ +D
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI----------- 191
           VE ++ E+++M  L  H NI  +   YED   + +VMELC GG L D++           
Sbjct: 72  VERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 192 ---------------------------------IQRGHYSERKAAELTRIIVGVVEACHS 218
                                            +QR    E+  + + R I   +   H+
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR----EKLISNIMRQIFSALHYLHN 186
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFK--PGQIF--TDVVGSPYYVAPEV 273
            G+ HRD+KPENFL  + +  F +K +DFGLS  F+K   G+ +  T   G+PY+VAPEV
Sbjct: 187 QGICHRDIKPENFLF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 274 LL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           L    + YGP+ D W+AGV+L++LL G  PF           VL   + FE+  + ++S 
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP 305
Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
            A+DL+  +L     ER  A   L HPWI +
Sbjct: 306 LARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 143/279 (51%), Gaps = 10/279 (3%)
Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            +G K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RR
Sbjct: 2   AMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 61
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     
Sbjct: 62  EVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +   +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDY 176
Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           + PE++  + +  + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----F 232
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP 366
           +++ A+DLI ++L   PS+R    EVL HPWI  N   P
Sbjct: 233 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 271

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE +  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 246 LKHNPSQRPXLREVLEHPWITANSSKP 272

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 10/270 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG S    P    T + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSC-HAPSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAPDRS 369
           L   PS+R    EVL HPWI  N   P  S
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSSKPSNS 271

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 63
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 123 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 235
Query: 338 KMLCSQPSERLTAHEVLCHPW 358
           +ML   P  R++ HE++   W
Sbjct: 236 RMLIVNPLNRISIHEIMQDDW 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 67
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 128 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 239
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 240 LKHNPSQRPMLREVLEHPWITANSSKP 266

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 144/278 (51%), Gaps = 10/278 (3%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           ++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     +
Sbjct: 63  VEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSV-HAPSSRRDTLCGTLDYL 177
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            PE++  + +  + D+W+ GV+ Y  L G+PPF A T Q  +  + +    F       +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FV 233
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP 366
           ++ A+DLI ++L    S+RLT  EVL HPWI  N   P
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKP 271

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/261 (36%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 67
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 127 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 239
Query: 338 KMLCSQPSERLTAHEVLCHPW 358
           +ML   P  R++ HE++   W
Sbjct: 240 RMLIVNPLNRISIHEIMQDDW 260

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D + +GR LG+G+FG  YL  E       A K + K +L  +E VE  +RREI+I  HL 
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLR 73
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H NI+ +   + D   +++++E    GEL+  + + G + E+++A     +   +  CH
Sbjct: 74  -HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 132
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K 276
              V+HRD+KPEN L+  K +   LK  DFG SV   P      + G+  Y+ PE++  K
Sbjct: 133 ERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +  + D+W AGV+ Y  L G+PPF + +       ++   + F     P +SD +KDLI
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 244
Query: 337 RKMLCSQPSERLTAHEVLCHPWICEN 362
            K+L   P +RL    V+ HPW+  N
Sbjct: 245 SKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  +FG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 186
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 242
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 243 LKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + DS  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 242
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 243 LKHNPSQRPMLREVLEHPWITANSSKP 269

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  +FG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 244 LKHNPSQRPMLREVLEHPWITANSSKP 270

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIEGRMHD 185
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSSKP 268

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 139/264 (52%), Gaps = 10/264 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  +RREIQ +  L  H 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +         + +VME  +GGELFD I + G   E+++  L + I+  V+ CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL--LKHY 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+    + 
Sbjct: 137 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W++GVILY LL G  PF  +    +F  +  G   F +  +  ++ S   L++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249
Query: 339 MLCSQPSERLTAHEVLCHPWICEN 362
           ML   P +R T  ++  H W  ++
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQD 273

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 138/263 (52%), Gaps = 10/263 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVLCHPWICEN 362
           L   PS+R    EVL HPWI  N
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVLCHPWICENGVAP 366
           L   PS+R    EVL HPWI  N   P
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKP 267

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 86/218 (39%), Positives = 121/218 (55%), Gaps = 7/218 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   + TG E A K I K +L +   ++ + RE++IM  L  H 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 135 IVHRDLKAENLLL---DGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG 316
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 137/264 (51%), Gaps = 10/264 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  ++REIQ +  L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +           +VME  +GGELFD I + G   E +A  L + I+  V+ CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+   D  GSP Y APEV+    + 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ GVILY LL G  PF  E    +F  + +G + +  +    ++ S   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPE---YLNRSVATLLMH 244
Query: 339 MLCSQPSERLTAHEVLCHPWICEN 362
           ML   P +R T  ++  H W  ++
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/315 (32%), Positives = 156/315 (49%), Gaps = 36/315 (11%)
Query: 94  TDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           +    D+Y L    LG+G       C  + T  E+A K I K+    R  V    RE+++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVEM 63
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           ++   GH+N++ +   +E+    ++V E   GG +   I +R H++E +A+ + + +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--------VG 264
           ++  H+ G+ HRDLKPEN L  + +    +K  DFGL    K     + +         G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 265 SPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPF---------W------A 303
           S  Y+APEV+         Y    D+W+ GVILYILLSG PPF         W       
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
             Q  +F+++ +G  +F    W  IS +AKDLI K+L     +RL+A +VL HPW+   G
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV--QG 301
Query: 364 VAPDRSL-DPAVLSR 377
            AP+ +L  P VL R
Sbjct: 302 CAPENTLPTPMVLQR 316

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 10/263 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E       A K + K +L        +RRE++I  HL  H 
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 126 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 237
Query: 340 LCSQPSERLTAHEVLCHPWICEN 362
           L   PS+R    EVL HPWI  N
Sbjct: 238 LKHNPSQRPMLREVLEHPWITAN 260

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 144/265 (54%), Gaps = 11/265 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +G  LG+G F   Y    I TG+E A K I K+ +     V+ V+ E++I H    H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI-HCQLKHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
           +I+ +   +EDS  V++V+E+C  GE+   +  R   +SE +A      I+  +   HS 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH- 277
           G++HRDL   N LL     + ++K  DFGL+   K P +    + G+P Y++PE+  +  
Sbjct: 132 GILHRDLTLSNLLLTR---NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +G E+DVW+ G + Y LL G PPF  +T +   + V+    D+E   +  +S  AKDLI 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLIH 244
Query: 338 KMLCSQPSERLTAHEVLCHPWICEN 362
           ++L   P++RL+   VL HP++  N
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRN 269

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 137/263 (52%), Gaps = 10/263 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVLCHPWICEN 362
           L   PS+R    EVL HPWI  N
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D + + R LG+G+FG  YL  E       A K + K +L  +E VE  +RREI+I  HL 
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLR 72
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H NI+ +   + D   +++++E    GEL+  + + G + E+++A     +   +  CH
Sbjct: 73  -HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K 276
              V+HRD+KPEN L+  K +   LK  DFG SV   P      + G+  Y+ PE++  K
Sbjct: 132 ERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +  + D+W AGV+ Y  L G+PPF + +       ++   + F     P +SD +KDLI
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 243
Query: 337 RKMLCSQPSERLTAHEVLCHPWICEN 362
            K+L   P +RL    V+ HPW+  N
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 136/264 (51%), Gaps = 10/264 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  ++REIQ +  L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +           +VME  +GGELFD I + G   E +A  L + I+  V+ CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+    + 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ GVILY LL G  PF  E    +F  + +G + +  +    ++ S   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPE---YLNRSVATLLMH 244
Query: 339 MLCSQPSERLTAHEVLCHPWICEN 362
           ML   P +R T  ++  H W  ++
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/315 (31%), Positives = 155/315 (49%), Gaps = 36/315 (11%)
Query: 94  TDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           +    D+Y L    LG+G       C  + T  E+A K I K+    R  V    RE+++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVEM 63
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           ++   GH+N++ +   +E+    ++V E   GG +   I +R H++E +A+ + + +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--------VG 264
           ++  H+ G+ HRDLKPEN L  + +    +K  DF L    K     + +         G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 265 SPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPF---------W------A 303
           S  Y+APEV+         Y    D+W+ GVILYILLSG PPF         W       
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
             Q  +F+++ +G  +F    W  IS +AKDLI K+L     +RL+A +VL HPW+   G
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV--QG 301
Query: 364 VAPDRSL-DPAVLSR 377
            AP+ +L  P VL R
Sbjct: 302 CAPENTLPTPMVLQR 316

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 135/284 (47%), Gaps = 38/284 (13%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 157 AGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG                     A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------A 167
Query: 271 PEVLLKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWP 326
            E   + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W 
Sbjct: 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
            +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 137/261 (52%), Gaps = 8/261 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G+FG  + C E ++   +  K +     +   D   V++EI I++ +A H+
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILN-IARHR 61
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSL 219
           NI+ +  ++E    + ++ E  +G ++F+RI       +ER+       +   ++  HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYG 279
            + H D++PEN +   +    ++K I+FG +   KPG  F  +  +P Y APEV      
Sbjct: 122 NIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 280 PEA-DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             A D+W+ G ++Y+LLSG+ PF AET Q I + ++     F+ + +  IS  A D + +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 339 MLCSQPSERLTAHEVLCHPWI 359
           +L  +   R+TA E L HPW+
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F TT L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 93/268 (34%), Positives = 134/268 (50%), Gaps = 10/268 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I     E+V+REI I H    
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSLR 72
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLLK  
Sbjct: 133 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 251
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICEN 362
           LI ++  + P++R++  E+  H W  +N
Sbjct: 252 LISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 93/268 (34%), Positives = 134/268 (50%), Gaps = 10/268 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I     E+V+REI I H    
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK   FG S          D VG+P Y+APEVLLK  
Sbjct: 134 MQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICEN 362
           LI ++  + P++R++  E+  H W  +N
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 67
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 128 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 240
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 241 EKLLVLDATKRLGCEEM 257

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 130 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 242
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 243 EKLLVLDATKRLGCEEM 259

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 241
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 242 EKLLVLDATKRLGCEEM 258

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 267 EKLLVLDATKRLGCEEM 283

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 131 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 243
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 244 EKLLVLDATKRLGCEEM 260

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 263 EKLLVLDATKRLGCEEM 279

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  +++E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFGL+   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 267 EKLLVLDATKRLGCEEM 283

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 263 EKLLVLDATKRLGCEEM 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 143/279 (51%), Gaps = 15/279 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D + +GR LG+G+FG  YL  E  +    A K + K + I +E VE  +RREI+I  HL 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ-IEKEGVEHQLRREIEIQAHL- 80
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H NI+ +   + D   +++++E    GEL+  + +   + E++ A +   +   +  CH
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K 276
              V+HRD+KPEN   +       LK  DFG SV   P      + G+  Y+ PE++  +
Sbjct: 141 GKKVIHRDIKPEN---LLLGLKGELKIADFGWSV-HAPSLRRKTMCGTLDYLPPEMIEGR 196
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +  + D+W  GV+ Y LL G PPF + +    +  ++K  + F +     +   A+DLI
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS----VPTGAQDLI 252
Query: 337 RKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVL 375
            K+L   PSERL   +V  HPW+  N     R L P+ L
Sbjct: 253 SKLLRHNPSERLPLAQVSAHPWVRANS---RRVLPPSAL 288

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 134/268 (50%), Gaps = 10/268 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I+     +V+REI I H    
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIA----ANVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLLK  
Sbjct: 134 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICEN 362
           LI ++  + P++R++  E+  H W  +N
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 74
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 135 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 247
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 248 EKLLVLDATKRLGCEEM 264

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +T + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 95
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 156 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF +  +P     A+DL+
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KARDLV 268
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 269 EKLLVLDATKRLGCEEM 285

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 97
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 158 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 270
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 271 EKLLVLDATKRLGCEEM 287

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 142/285 (49%), Gaps = 9/285 (3%)
Query: 81  GIDNQTYYVLGHKTDNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS 139
           G+D  T  +     +N  + Y L  ++LG+G+F     C   +TG E+A K + KR+   
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-G 68
Query: 140 REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHY 197
           ++   ++  EI ++        ++ +   YE++  + +++E  AGGE+F   +       
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           SE     L + I+  V   H   ++H DLKP+N LL +      +K +DFG+S       
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 258 IFTDVVGSPYYVAPEVLLKHYGP---EADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
              +++G+P Y+APE+L  +Y P     D+W  G+I Y+LL+   PF  E  Q  +  + 
Sbjct: 189 ELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246
Query: 315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++D+  + +  +S  A D I+ +L   P +R TA   L H W+
Sbjct: 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 85
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +T + G+P Y+APE++L K 
Sbjct: 146 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKG 200
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 256
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWFA 284

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 142/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  +++E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    ++  DFGL+   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 133/268 (49%), Gaps = 10/268 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I     E+V+REI I H    
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK   FG S            VG+P Y+APEVLLK  
Sbjct: 134 MQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICEN 362
           LI ++  + P++R++  E+  H W  +N
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 132/268 (49%), Gaps = 10/268 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +       A K I + + I     E+V+REI I H    
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKID----ENVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V   H+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLLK  
Sbjct: 134 MQVAHRDLKLENTLL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICEN 362
           LI ++  + P++R++  E+  H W  +N
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G  +T + G+P Y+APE++L K Y    D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GATWT-LCGTPEYLAPEIILSKGYNKAVD 241
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 297
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWFA 319

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 127/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     G L   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + +G G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LAGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  FA K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  FA K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  FA K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWFA 298

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LXGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 92
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 152
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D+   ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 153 DLKPENLLI---DEQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 207
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 208 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 263
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 264 LTKRFGNLKNGVNDIKNHKWFA 285

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +  ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +  ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 278 LTKRFGNLKNGVNDIKNHKWFA 299

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLPNGVNDIKNHKWFA 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIXNHKWFA 299

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 137/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG G FG   L     TG  +A K + K+K++  + +E    E +I      
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI-QQAVN 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++V+E   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + +G G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GG++F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 120
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 181 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 235
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 291
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 319

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 207
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 263
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 291

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + +G G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GG++F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 139/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G ++E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +  ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 299

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 241
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 297
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 298 LTKRFGNLKNGVNDIKNHKWFA 319

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 130/237 (54%), Gaps = 11/237 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLL 273

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 100
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 160
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 161 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 215
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 216 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 271
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 272 LTKRFGNLKNGVNDIKNHKWFA 293

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 138/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN ++   D    ++  DFG +   K G+ +  + G+P Y+APE+++ K Y    D
Sbjct: 166 DLKPENLII---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIIISKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+AP ++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPAIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 207
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 263
Query: 338 KMLCSQPSERL-----TAHEVLCHPWIC 360
            +L    ++R        +++  H W  
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 291

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 16/262 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P  +APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEALAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL-----TAHEVLCHPWIC 360
            ++R        +++  H W  
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 129/274 (47%), Gaps = 22/274 (8%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y   + +G G FG   L  +  T    A K I +   I     E+V+REI I H    
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREI-INHRSLR 74
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + I+ME  +GGEL++RI   G +SE +A    + ++  V  CHS
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + + HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLL+  
Sbjct: 135 MQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 277 HYGPEADVWTAGVILYILLSGVPPF--------WAETQQGIFDAVLKGHIDFESDPWPLI 328
           + G  ADVW+ GV LY++L G  PF        + +T Q I         D        I
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR------I 247
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
           S     LI ++  + P+ R++  E+  H W  +N
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 141/284 (49%), Gaps = 12/284 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 102
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+   D+ G+P Y+APEVL K  +
Sbjct: 163 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 275
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
           ML + P+ R +  E+L   +   +G AP R L  + L+   +FS
Sbjct: 276 MLHADPTLRPSVAELLTDEFFT-SGYAPMR-LPTSCLTVPPRFS 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 141/284 (49%), Gaps = 12/284 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 86
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+   D+ G+P Y+APEVL K  +
Sbjct: 147 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 259
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
           ML + P+ R +  E+L   +   +G AP R L  + L+   +FS
Sbjct: 260 MLHADPTLRPSVAELLTDEFFT-SGYAPMR-LPTSCLTVPPRFS 301

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 130/267 (48%), Gaps = 16/267 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + R LG G FG  +L      G  +A K + K  ++  + VE    E ++M  +  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIVTHP 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            I+ + G ++D+  + ++M+   GGELF  + +   +    A      +   +E  HS  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL-LKHYG 279
           +++RDLKPEN LL   D +  +K  DFG + +     +   + G+P Y+APEV+  K Y 
Sbjct: 127 IIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W+ G+++Y +L+G  PF+       ++ +L   + F     P  ++  KDL+ ++
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRL 237
Query: 340 LCSQPSERL-----TAHEVLCHPWICE 361
           +    S+RL        +V  HPW  E
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 93/284 (32%), Positives = 140/284 (49%), Gaps = 12/284 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 102
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+    + G+P Y+APEVL K  +
Sbjct: 163 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 275
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
           ML + P+ R +  E+L   +   +G AP R L  + L+   +FS
Sbjct: 276 MLHADPTLRPSVAELLTDEFFT-SGYAPMR-LPTSCLTVPPRFS 317

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 93/284 (32%), Positives = 140/284 (49%), Gaps = 12/284 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 102
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+    + G+P Y+APEVL K  +
Sbjct: 163 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 275
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
           ML + P+ R +  E+L   +   +G AP R L  + L+   +FS
Sbjct: 276 MLHADPTLRPSVAELLTDEFFT-SGYAPMR-LPTSCLTVPPRFS 317

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 132/262 (50%), Gaps = 19/262 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL-----TAHEVLCHPWI 359
            P +RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 132/262 (50%), Gaps = 19/262 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL-----TAHEVLCHPWI 359
            P +RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 132/262 (50%), Gaps = 19/262 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 74
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 75  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 133 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 189
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 190 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 245
Query: 343 QPSERL-----TAHEVLCHPWI 359
            P +RL      A EV+ H + 
Sbjct: 246 DPKQRLGGGPSDAKEVMEHRFF 267

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 19/259 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL-----TAHEVLCH 356
            P +RL      A EV+ H
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 132/262 (50%), Gaps = 19/262 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL-----TAHEVLCHPWI 359
            P +RL      A EV+ H + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 19/259 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 76
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 77  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 135 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 191
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 247
Query: 343 QPSERL-----TAHEVLCH 356
            P +RL      A EV+ H
Sbjct: 248 DPKQRLGGGPSDAKEVMEH 266

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 19/259 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL-----TAHEVLCH 356
            P +RL      A EV+ H
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 89/262 (33%), Positives = 134/262 (51%), Gaps = 22/262 (8%)
Query: 97  IRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
           IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  +V
Sbjct: 121 DIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVV 178
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYY 268
             ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 269 VAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFE 321
           ++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + F 
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 295
Query: 322 SDPWPLISDSAKDLIRKMLCSQ 343
            D    IS  AK+LI   L  +
Sbjct: 296 DD--NDISKEAKNLICAFLTDR 315

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 22/264 (8%)
Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 298
Query: 320 FESDPWPLISDSAKDLIRKMLCSQ 343
           F  D    IS  AK+LI   L  +
Sbjct: 299 FPDD--NDISKEAKNLICAFLTDR 320

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 22/264 (8%)
Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 298
Query: 320 FESDPWPLISDSAKDLIRKMLCSQ 343
           F  D    IS  AK+LI   L  +
Sbjct: 299 FPDD--NDISKEAKNLICAFLTDR 320

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 132/260 (50%), Gaps = 20/260 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 214
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 215 YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 273 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 329
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 385
Query: 342 SQPSERL-----TAHEVLCH 356
             P +RL      A E++ H
Sbjct: 386 KDPKQRLGGGSEDAKEIMQH 405

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 133/264 (50%), Gaps = 20/264 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 74
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 75  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 133 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 189
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 245
Query: 342 SQPSERL-----TAHEVLCHPWIC 360
             P +RL      A E++ H +  
Sbjct: 246 KDPKQRLGGGSEDAKEIMQHRFFA 269

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 132/260 (50%), Gaps = 20/260 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 217
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 218 YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 276 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 332
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 388
Query: 342 SQPSERL-----TAHEVLCH 356
             P +RL      A E++ H
Sbjct: 389 KDPKQRLGGGSEDAKEIMQH 408

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 133/264 (50%), Gaps = 20/264 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 75
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 76  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 134 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 246
Query: 342 SQPSERL-----TAHEVLCHPWIC 360
             P +RL      A E++ H +  
Sbjct: 247 KDPKQRLGGGSEDAKEIMQHRFFA 270

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 133/264 (50%), Gaps = 20/264 (7%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 76
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 77  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 135 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 191
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 247
Query: 342 SQPSERL-----TAHEVLCHPWIC 360
             P +RL      A E++ H +  
Sbjct: 248 KDPKQRLGGGSEDAKEIMQHRFFA 271

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 136/291 (46%), Gaps = 17/291 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG   L     TG  +A K + K  ++  +DVE    E +I+     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H  +  +   ++    +  VME   GG+L   I +   + E +A      I+  +   H 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH 277
            G+++RDLK +N LL   D +   K  DFG+       G       G+P Y+APE+L + 
Sbjct: 143 KGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            YGP  D W  GV+LY +L G  PF AE +  +F+A+L   + + +  W  + + A  ++
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LHEDATGIL 255
Query: 337 RKMLCSQPSERLTA------HEVLCHPWICENGVAP--DRSLDPAVLSRLK 379
           +  +   P+ RL +      H +L HP+  E   A    R ++P    R+K
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 137/270 (50%), Gaps = 18/270 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + + +G+G FG   L    A+   +A K +SK ++I R D      E  IM   A   
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 135
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +  A++D   +++VME   GG+L + ++      E+ A   T  +V  ++A HS+G
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDV-VGSPYYVAPEVLLK-- 276
           ++HRD+KP+N LL   D    LK  DFG  +   + G +  D  VG+P Y++PEVL    
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 277 ---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDS 331
              +YG E D W+ GV L+ +L G  PF+A++  G +  ++  K  + F  D    IS  
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED--AEISKH 309
Query: 332 AKDLIRKMLCSQPSE--RLTAHEVLCHPWI 359
           AK+LI   L  +     R    E+  HP+ 
Sbjct: 310 AKNLICAFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 135/262 (51%), Gaps = 22/262 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHL 156
           + L + LG G +G  +L  +I+   TG  +A K + K  ++ + +  E  R E Q++ H+
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR  ++E +       IV  +E  
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F   +     D  G+  Y+AP+++
Sbjct: 176 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 275 L---KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV++Y LL+G  PF  +    +Q  I   +LK        P+P 
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----EPPYPQ 287
Query: 328 -ISDSAKDLIRKMLCSQPSERL 348
            +S  AKDLI+++L   P +RL
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRL 309

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 63
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 124 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 240 LHKILVENPSARITIPDIKKDRW 262

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 87
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 148 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 260
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 261 TARPTINELL 270

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 256
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 257 TARPTINELL 266

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 256
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 257 TARPTINELL 266

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +     E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NAMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 105
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 166 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 278
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 279 TARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 168 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 280
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 281 TARPTINELL 290

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 33/272 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   L  E  +G + A K +  RK   RE + +   E+ IM     H N+V +
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQ-HFNVVEM 107
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + ++ME   GG L D I+ +   +E + A +   ++  +   H+ GV+HRD
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLKH-Y 278
           +K ++ LL     D  +K  DFG        QI  DV      VG+PY++APEV+ +  Y
Sbjct: 167 IKSDSILLTL---DGRVKLSDFGFC-----AQISKDVPKRKXLVGTPYWMAPEVISRSLY 218
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK----- 333
             E D+W+ G+++  ++ G PP+++       D+ ++        P P + +S K     
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFS-------DSPVQAMKRLRDSPPPKLKNSHKVSPVL 271
Query: 334 -DLIRKMLCSQPSERLTAHEVLCHPWICENGV 364
            D + +ML   P ER TA E+L HP++ + G+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGL 303

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 137/270 (50%), Gaps = 19/270 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLI-SREDVEDVRREIQIMHHL 156
           + L R LG+G +G  +   ++    TG  FA K + K  ++ + +D    + E  I+  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    +++++E  +GGELF ++ + G + E  A      I   +   
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL 275
           H  G+++RDLKPEN +L ++     +K  DFGL       G +     G+  Y+APE+L+
Sbjct: 138 HQKGIIYRDLKPENIMLNHQG---HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +    D W+ G ++Y +L+G PPF  E ++   D +LK  ++      P ++  A+D
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARD 250
Query: 335 LIRKMLCSQPSERL-----TAHEVLCHPWI 359
           L++K+L    + RL      A EV  HP+ 
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 137/270 (50%), Gaps = 19/270 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLI-SREDVEDVRREIQIMHHL 156
           + L R LG+G +G  +   ++    TG  FA K + K  ++ + +D    + E  I+  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    +++++E  +GGELF ++ + G + E  A      I   +   
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL 275
           H  G+++RDLKPEN +L ++     +K  DFGL       G +     G+  Y+APE+L+
Sbjct: 138 HQKGIIYRDLKPENIMLNHQG---HVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +    D W+ G ++Y +L+G PPF  E ++   D +LK  ++      P ++  A+D
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEARD 250
Query: 335 LIRKMLCSQPSERL-----TAHEVLCHPWI 359
           L++K+L    + RL      A EV  HP+ 
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 12/263 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G  G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLCHPW 358
           + K+L   PS R+T  ++    W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 142 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 254
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 255 TARPTINELL 264

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 213
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 273 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 383
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           +L   P++R TA E+L HP++ + G  P  S+ P
Sbjct: 384 LLVRDPAQRATAAELLKHPFLAKAG--PPASIVP 415

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 142/277 (51%), Gaps = 15/277 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 77
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   +++VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 251
Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           + L     +R +A E+L H ++      P  SL P +
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFL--KIAKPLSSLTPLI 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 136
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 196 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 306
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           +L   P++R TA E+L HP++ + G  P  S+ P
Sbjct: 307 LLVRDPAQRATAAELLKHPFLAKAG--PPASIVP 338

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 91
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 151 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 261
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           +L   P++R TA E+L HP++ + G  P  S+ P
Sbjct: 262 LLVRDPAQRATAAELLKHPFLAKAG--PPASIVP 293

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 93
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 153 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 263
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           +L   P++R TA E+L HP++ + G  P  S+ P
Sbjct: 264 LLVRDPAQRATAAELLKHPFLAKAG--PPASIVP 295

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 82
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 252
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           +L   P++R TA E+L HP++ + G  P  S+ P
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAG--PPASIVP 284

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 141/277 (50%), Gaps = 15/277 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 77
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 251
Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           + L     +R +A E+L H ++      P  SL P +
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFL--KIAKPLSSLTPLI 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 141/274 (51%), Gaps = 23/274 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 86
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 146 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 256
Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           +L   P++R TA E+L HP++ + G  P  S+ P
Sbjct: 257 LLVRDPAQRATAAELLKHPFLAKAG--PPASIVP 288

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 141/277 (50%), Gaps = 15/277 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 77
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 251
Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           + L     +R +A E+L H ++      P  SL P +
Sbjct: 252 RCLEMDVEKRGSAKELLQHQFL--KIAKPLSSLTPLI 286

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 124/246 (50%), Gaps = 9/246 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A  + +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HSL +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +     +   G+P Y+APEVL K  Y    D 
Sbjct: 166 KPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +  +    P I++SA+ L+  +L    
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278
Query: 345 SERLTA 350
           ++RL A
Sbjct: 279 TKRLGA 284

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 138/262 (52%), Gaps = 26/262 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+ + + + +G+G FG   +         FA K ++K +++ R +    R E  ++ +  
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-G 131
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVV 213
             K I T+  A++D   +++VM+   GG+L   +     + +R   E+ R     +V  +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIAI 188
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAP 271
           ++ H L  +HRD+KP+N L+   D +  ++  DFG  +   + G + + V VG+P Y++P
Sbjct: 189 DSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 272 EVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           E+L         YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---F 302
Query: 326 PL----ISDSAKDLIRKMLCSQ 343
           P     +S++AKDLIR+++CS+
Sbjct: 303 PTQVTDVSENAKDLIRRLICSR 324

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 141/277 (50%), Gaps = 15/277 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 78
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 138 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 252
Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           + L     +R +A E++ H ++      P  SL P +
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFL--KIAKPLSSLTPLI 287

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 218
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 272
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 273 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 29/265 (10%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + TE  TG + A K +  RK   RE + +   E+ IM     H N+V +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYH-HDNVVDM 107
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APEV+ +  Y
Sbjct: 167 IKSDSILLTS---DGRIKLSDFGFC-----AQVSKEVPKRKXLVGTPYWMAPEVISRLPY 218
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           G E D+W+ G+++  ++ G PP++ E      + I D++     D        +S   + 
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHK-----VSSVLRG 273
Query: 335 LIRKMLCSQPSERLTAHEVLCHPWI 359
            +  ML  +PS+R TA E+L HP++
Sbjct: 274 FLDLMLVREPSQRATAQELLGHPFL 298

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 190
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 244
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 245 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 191
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 245
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 246 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 210
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 264
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 265 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 258 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 190
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 244
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 245 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 191
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 245
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 246 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 141/277 (50%), Gaps = 15/277 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 78
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HR++K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 138 VIHRNIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           GP+ D+W+ G++   ++ G PP+  E   + ++     G  + + +P  L S   +D + 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKL-SAIFRDFLN 252
Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
           + L     +R +A E++ H ++      P  SL P +
Sbjct: 253 RCLEMDVEKRGSAKELIQHQFL--KIAKPLSSLTPLI 287

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 218
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 272
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 273 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 131/289 (45%), Gaps = 37/289 (12%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---------------------- 138
           YTL  ++G+G +G   L         +A K +SK+KLI                      
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 139 -SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM--ELCAGGELFDRIIQRG 195
             R  +E V +EI I+  L  H N+V +    +D    H+ M  EL   G + + +    
Sbjct: 75  QPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             SE +A    + ++  +E  H   ++HRD+KP N L+    +D  +K  DFG+S  FK 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFKG 189
Query: 256 GQ-IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
              + ++ VG+P ++APE L +      G   DVW  GV LY  + G  PF  E    + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             +    ++F   P   I++  KDLI +ML   P  R+   E+  HPW+
Sbjct: 250 SKIKSQALEFPDQPD--IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 24/268 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 158 -GHKNIVTIKGAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            G   ++ +   +E  DS  V I+  +    +LFD I +RG   E  A      ++  V 
Sbjct: 70  SGFSGVIRLLDWFERPDSF-VLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 215 ACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
            CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 184
Query: 274 LLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S  
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSE 234
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            + LIR  L  +PS+R T  E+  HPW+
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 48  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 107
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 108 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 167
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 223
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 277
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 278 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 236
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 149/290 (51%), Gaps = 20/290 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   +K+G+G FG   L      G ++  K I+  ++ S+E  E+ RRE+ ++ ++  H 
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMK-HP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRG-HYSERKAAELTRIIVGVVEACHS 218
           NIV  + ++E++  ++IVM+ C GG+LF RI  Q+G  + E +  +    I   ++  H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-K 276
             ++HRD+K +N  L     D +++  DFG++ V     ++    +G+PYY++PE+   K
Sbjct: 144 RKILHRDIKSQNIFLTK---DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDL 335
            Y  ++D+W  G +LY L +    F A + + +   ++ G       P  L  S   + L
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLRSL 256
Query: 336 IRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSR---LKQFS 382
           + ++    P +R + + +L   +I +     ++ L P +++    LK FS
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAKR---IEKFLSPQLIAEEFCLKTFS 303

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHH 155
           Y+    LG G FG  +   +     E   K I K K++    +ED     V  EI I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           +  H NI+ +   +E+     +VME    G +LF  I +     E  A+ + R +V  V 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
                 ++HRD+K EN ++    +DF++K IDFG + + + G++F    G+  Y APEVL
Sbjct: 145 YLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +   + GPE ++W+ GV LY L+    PF  E ++ +  A+          P  L+S   
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYLVSKEL 251
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             L+  +L   P  R T  +++  PW+ +
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 259 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 259 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 258 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 258 R----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 236
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 185
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 235
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 236 QHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 236
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 259 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 259 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 258 R----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 135/277 (48%), Gaps = 22/277 (7%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 191
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 245
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +S   + LIR  L  +P +R T  E+  HPW+
Sbjct: 246 R----VSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 208
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSXEC 258
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 259 QHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 231
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSXEC 231
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 184
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 234
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 235 QHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 14/285 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D D  +K  DFG+      G   T +  G+P Y+APE+LL + Y
Sbjct: 140 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-WPLISDSAKDLIR 337
               D W+ GV+LY +L G  PF  + ++ +F ++    +D    P W  +   AKDL+ 
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRW--LEKEAKDLLV 251
Query: 338 KMLCSQPSERLTAH-EVLCHPWICE-NGVAPDR-SLDPAVLSRLK 379
           K+   +P +RL    ++  HP   E N    +R  +DP    ++K
Sbjct: 252 KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 296

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 14/285 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D D  +K  DFG+      G   T+   G+P Y+APE+LL + Y
Sbjct: 139 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKY 195
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-WPLISDSAKDLIR 337
               D W+ GV+LY +L G  PF  + ++ +F ++    +D    P W  +   AKDL+ 
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRW--LEKEAKDLLV 250
Query: 338 KMLCSQPSERLTAH-EVLCHPWICE-NGVAPDR-SLDPAVLSRLK 379
           K+   +P +RL    ++  HP   E N    +R  +DP    ++K
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 295

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 22/267 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F       +S   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR----VSSEC 231
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + LIR  L  +PS+R T  E+  HPW+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 24/282 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VRREIQIMHHLA 157
           Y LG  LG+G FGT +    +   ++ A K I + +++    + D      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 158 ---GHKNIVTIKGAYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
              GH  ++ +   +E      +V+E      +LFD I ++G   E  +      +V  +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           + CHS GV+HRD+K EN L+  +      K IDFG        + +TD  G+  Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEW 209
Query: 274 LLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           + +H  +   A VW+ G++LY ++ G  PF  E  Q I +A L     F +     +S  
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEAELH----FPAH----VSPD 259
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA 373
              LIR+ L  +PS R +  E+L  PW+     A D  L+P+
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWM--QTPAEDVPLNPS 299

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 119/244 (48%), Gaps = 9/244 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++  L     +  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    ++ VME   GG+L   I Q G + E +A      I   +   H  G+++RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADV 284
           K +N +L   D +  +K  DFG+       G    +  G+P Y+APE++  + YG   D 
Sbjct: 147 KLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV+LY +L+G PPF  E +  +F ++++ ++ +       +S  A  + + ++   P
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKHP 259
Query: 345 SERL 348
           ++RL
Sbjct: 260 AKRL 263

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 16/263 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G   + E +A      I   +E  H   
Sbjct: 249 LAYAYETKDALC--LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G +LY +++G  PF    ++   + V +   +   +     S  A+ L  ++
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 340 LCSQPSERL-----TAHEVLCHP 357
           LC  P+ERL     +A EV  HP
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHP 446

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 137/262 (52%), Gaps = 26/262 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+ + + + +G+G FG   +     T   +A K ++K +++ R +    R E  ++ +  
Sbjct: 89  REDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-G 147
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VV 213
             + I  +  A++D   +++VM+   GG+L   +     + ++   ++ R  +G     +
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEMVLAI 204
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAP 271
           ++ H L  +HRD+KP+N LL   D +  ++  DFG  +     G + + V VG+P Y++P
Sbjct: 205 DSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISP 261
Query: 272 EVL------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           E+L      +  YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---F 318
Query: 326 PL----ISDSAKDLIRKMLCSQ 343
           P     +S+ AKDLI++++CS+
Sbjct: 319 PSHVTDVSEEAKDLIQRLICSR 340

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 16/263 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G   + E +A      I   +E  H   
Sbjct: 249 LAYAYETKDALC--LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G +LY +++G  PF    ++   + V +   +   +     S  A+ L  ++
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 340 LCSQPSERL-----TAHEVLCHP 357
           LC  P+ERL     +A EV  HP
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHP 446

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 137/262 (52%), Gaps = 26/262 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+ + + + +G+G FG   +     T   +A K ++K +++ R +    R E  ++ +  
Sbjct: 73  REDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-G 131
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VV 213
             + I  +  A++D   +++VM+   GG+L   +     + ++   ++ R  +G     +
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEMVLAI 188
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAP 271
           ++ H L  +HRD+KP+N LL   D +  ++  DFG  +     G + + V VG+P Y++P
Sbjct: 189 DSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISP 245
Query: 272 EVL------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           E+L      +  YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---F 302
Query: 326 PL----ISDSAKDLIRKMLCSQ 343
           P     +S+ AKDLI++++CS+
Sbjct: 303 PSHVTDVSEEAKDLIQRLICSR 324

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVE-DVRREIQIMHHL 156
           + L + LGQG FG  +L  +I+       +A K + K  L  R+ V   + R+I +    
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--- 82
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    ++++++   GG+LF R+ +   ++E         +   ++  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 143 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255
Query: 335 LIRKMLCSQPSERLTA 350
           L+R +    P+ RL A
Sbjct: 256 LLRMLFKRNPANRLGA 271

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVE-DVRREIQIMHHL 156
           + L + LGQG FG  +L  +I+       +A K + K  L  R+ V   + R+I +    
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--- 83
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    ++++++   GG+LF R+ +   ++E         +   ++  
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 144 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 256
Query: 335 LIRKMLCSQPSERLTA 350
           L+R +    P+ RL A
Sbjct: 257 LLRMLFKRNPANRLGA 272

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVE-DVRREIQIMHHL 156
           + L + LGQG FG  +L  +I+       +A K + K  L  R+ V   + R+I +    
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--- 82
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    ++++++   GG+LF R+ +   ++E         +   ++  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 143 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255
Query: 335 LIRKMLCSQPSERLTA 350
           L+R +    P+ RL A
Sbjct: 256 LLRMLFKRNPANRLGA 271

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/313 (28%), Positives = 136/313 (43%), Gaps = 65/313 (20%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR---REIQIMHH 155
           D + + R  GQG FGT  L  E +TG+  A K +          ++D R   RE+QIM  
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQD 72
Query: 156 LA--GHKNIVTIKGAY-------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           LA   H NIV ++  +          + +++VME     +   R   R +Y  + A    
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCC-RNYYRRQVAPPPI 129
Query: 207 RIIVGVVEACHSLG--------VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI 258
            I V + +   S+G        V HRD+KP N +LVN+ D  +LK  DFG +    P + 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADG-TLKLCDFGSAKKLSPSEP 187
Query: 259 FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK- 315
               + S YY APE++   +HY    D+W+ G I   ++ G P F  +   G    +++ 
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 316 --------------GHIDFE-----SDPWP-LISD-------SAKDLIRKMLCSQPSERL 348
                          H D +       PW  + SD        A DL+  +L   P ER+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 349 TAHEVLCHPWICE 361
             +E LCHP+  E
Sbjct: 308 KPYEALCHPYFDE 320

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 133/255 (52%), Gaps = 18/255 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           + L + LGQG FG  +L  ++    +G  +A K + K  L  R+ V   + E  I+  + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKMERDILADV- 87
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEAC 216
            H  +V +  A++    ++++++   GG+LF R+ +   ++E      L  + +G+ +  
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGL-DHL 146
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPYYVAPEVL 274
           HSLG+++RDLKPEN LL   D++  +K  DFGLS        + ++   G+  Y+APEV+
Sbjct: 147 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAPEVV 202
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEAQ 258
Query: 334 DLIRKMLCSQPSERL 348
            L+R +    P+ RL
Sbjct: 259 SLLRALFKRNPANRL 273

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 141/285 (49%), Gaps = 36/285 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD + + + +G+G F    +     TG  +A K ++K  ++ R +V   R E  ++ +  
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-G 118
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVV 213
             + I  +  A++D   +++VME   GG+L   + + G   ER  AE+ R     IV  +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAI 175
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAP 271
           ++ H LG +HRD+KP+N LL   D    ++  DFG  +  +  G + + V VG+P Y++P
Sbjct: 176 DSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 272 EVL--------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFE 321
           E+L           YGPE D W  GV  Y +  G  PF+A++    +  ++  K H+   
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL- 291
Query: 322 SDPWPLISDS----AKDLIRKMLCSQPSERL---TAHEVLCHPWI 359
               PL+ +     A+D I+++LC  P  RL    A +   HP+ 
Sbjct: 292 ----PLVDEGVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 47/290 (16%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           K+G+G +G  + C    TG     + ++ +K +  ED   ++    REI+++  L  H N
Sbjct: 10  KIGEGSYGVVFKCRNRDTG-----QIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPN 63
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V +   +     +H+V E C    L   DR  QRG   E     +T   +  V  CH  
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRG-VPEHLVKSITWQTLQAVNFCHKH 121
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--K 276
             +HRD+KPEN L+        +K  DFG +     P   + D V + +Y +PE+L+   
Sbjct: 122 NCIHRDVKPENILITKHS---VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAET--------QQGIFDAVLKGHIDFES------ 322
            YGP  DVW  G +   LLSGVP +  ++        ++ + D + +    F +      
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 323 ----DP---------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               DP         +P IS  A  L++  L   P+ERLT  ++L HP+ 
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 7/216 (3%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I + Y +  KLG G   T YL  +    I+ A K+I        E ++   RE+     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           + H+NIV++    E+  C ++VME   G  L + I   G  S   A   T  I+  ++  
Sbjct: 69  S-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVL 274
           H + ++HRD+KP+N L+   D + +LK  DFG++       +     V+G+  Y +PE  
Sbjct: 128 HDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 275 LKHYGPE-ADVWTAGVILYILLSGVPPFWAETQQGI 309
                 E  D+++ G++LY +L G PPF  ET   I
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 141/293 (48%), Gaps = 38/293 (12%)
Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T    +++ +  KLG+G +G+ Y      TG   A K +         D++++ +EI IM
Sbjct: 24  TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIM 78
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
                  ++V   G+Y  +  + IVME C  G + D I  R    +E + A + +  +  
Sbjct: 79  QQ-CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-------VVGS 265
           +E  H +  +HRD+K  N LL   + +   K  DFG++     GQ+ TD       V+G+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA-----GQL-TDXMAKRNXVIGT 188
Query: 266 PYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P+++APEV+ +  Y   AD+W+ G+    +  G PP+ A+         ++      ++P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY-ADIHP------MRAIFMIPTNP 241
Query: 325 WP------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI-CENGVAPDRSL 370
            P      L SD+  D +++ L   P +R TA ++L HP++    GV+  R L
Sbjct: 242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDL 294

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++   +    I    +   K +   K         ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KNKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 13/257 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D + + R +G+G FG   +  +  T   +A K ++K+K + R +V +V +E+QIM  L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE- 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H  +V +  +++D   + +V++L  GG+L   + Q  H+ E         +V  ++   +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
             ++HRD+KP+N LL   D+   +   DF ++         T + G+  Y+APE+     
Sbjct: 134 QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 278 ---YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--WPLISDSA 332
              Y    D W+ GV  Y LL G  P+   +     + V        + P  W   S   
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW---SQEM 247
Query: 333 KDLIRKMLCSQPSERLT 349
             L++K+L   P +R +
Sbjct: 248 VSLLKKLLEPNPDQRFS 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 9/244 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    ++ VME   GG+L   I Q G + E  A      I   +    S G+++RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADV 284
           K +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   D 
Sbjct: 469 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV+LY +L+G  PF  E +  +F ++++ ++ +       +S  A  + + ++   P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 581
Query: 345 SERL 348
            +RL
Sbjct: 582 GKRL 585

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 20/285 (7%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVE 214
              H NIV +  A+     + I++E CAGG +   +++     +E +   + +  +  + 
Sbjct: 91  -CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEV 273
             H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++APEV
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 206
Query: 274 LL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--W 325
           ++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P  W
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
              S + KD ++K L      R T  ++L HP++  +   P R L
Sbjct: 267 ---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 308

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 20/285 (7%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVE 214
              H NIV +  A+     + I++E CAGG +   +++     +E +   + +  +  + 
Sbjct: 91  -CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEV 273
             H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++APEV
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEV 206
Query: 274 LL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--W 325
           ++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P  W
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
              S + KD ++K L      R T  ++L HP++  +   P R L
Sbjct: 267 ---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 308

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 149 EIQIMHHLAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII----QRGHYSERKA 202
           E+ ++  L  H NIV       D  +  ++IVME C GG+L   I     +R +  E   
Sbjct: 55  EVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 203 AELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +   +   ++ CH        V+HRDLKP N  L  K +   +K  DFGL+      +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDE 170
Query: 258 IFT-DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            F  + VG+PYY++PE + +  Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           G   F   P+   SD   ++I +ML  +   R +  E+L +P I E
Sbjct: 231 GK--FRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/177 (33%), Positives = 93/177 (52%), Gaps = 17/177 (9%)
Query: 186 ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKA 244
           +LFD I +RG   E  A      ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK 
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKL 199
Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFW 302
           IDFG     K   ++TD  G+  Y  PE +  H  +G  A VW+ G++LY ++ G  PF 
Sbjct: 200 IDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258
Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            + +      +++G + F       +S   + LIR  L  +PS+R T  E+  HPW+
Sbjct: 259 HDEE------IIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 136/314 (43%), Gaps = 63/314 (20%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMH 154
           Y    K+G+G +G  Y   + + G   A K I       R D ED        REI ++ 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-------RLDAEDEGIPSTAIREISLLK 74
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVG 211
            L  H NIV++        C+ +V E         +++   + G    +    L +++ G
Sbjct: 75  ELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
           V   CH   ++HRDLKP+N LL+N D   +LK  DFGL+  F  P + +T  V + +Y A
Sbjct: 132 VAH-CHQHRILHRDLKPQN-LLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPF-----------------------WAET 305
           P+VL+  K Y    D+W+ G I   +++G P F                       W + 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 306 QQGIFDAVLKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           Q+          + FE  PW    P       DL+  MLC  P++R++A + + HP+   
Sbjct: 248 QELPLWKQRTFQV-FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-- 304
Query: 362 NGVAPDRSLDPAVL 375
                 + LDP ++
Sbjct: 305 ------KDLDPQIM 312

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 20/285 (7%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVE 214
              H NIV +  A+     + I++E CAGG +   +++     +E +   + +  +  + 
Sbjct: 91  -CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEV 273
             H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++APEV
Sbjct: 150 YLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEV 206
Query: 274 LL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--W 325
           ++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P  W
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
              S + KD ++K L      R T  ++L HP++  +   P R L
Sbjct: 267 ---SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 308

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 9/244 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    ++ VME   GG+L   I Q G + E  A      I   +    S G+++RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADV 284
           K +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   D 
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV+LY +L+G  PF  E +  +F ++++ ++ +       +S  A  + + ++   P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 260
Query: 345 SERL 348
            +RL
Sbjct: 261 GKRL 264

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/327 (27%), Positives = 144/327 (44%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +   T  +   Y   + +G G  G      +   GI  A K +S R  
Sbjct: 3   KSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ ++     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYREL-VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           I      ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IHMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPF--------W 302
                 + T  V + YY APEV+L   Y    D+W+ G I+  L+ G   F        W
Sbjct: 175 TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQW 234
Query: 303 AE------TQQGIFDAVLKGHID--FESDP-------------WPLISDS---------A 332
            +      T    F A L+  +    E+ P             W   S+S         A
Sbjct: 235 NKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P +R++  E L HP+I
Sbjct: 295 RDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 139/298 (46%), Gaps = 45/298 (15%)
Query: 78  MRRGID-NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK 136
           +RR +D N+ + ++G              +LG G FG  Y      TG   A K I  + 
Sbjct: 11  VRRDLDPNEVWEIVG--------------ELGDGAFGKVYKAKNKETGALAAAKVIETK- 55
Query: 137 LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI---IQ 193
             S E++ED   EI+I+     H  IV + GAY     + I++E C GG + D I   + 
Sbjct: 56  --SEEELEDYIVEIEILA-TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELD 111
Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-F 252
           RG  +E +   + R ++  +   HS  ++HRDLK  N L+  + D   ++  DFG+S   
Sbjct: 112 RG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN 167
Query: 253 FKPGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            K  Q     +G+PY++APEV++        Y  +AD+W+ G+ L  +    PP      
Sbjct: 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVLCHPWI 359
             +   + K      SDP  L++ S      +D ++  L   P  R +A ++L HP++
Sbjct: 228 MRVLLKIAK------SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 135/313 (43%), Gaps = 63/313 (20%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMH 154
           Y    K+G+G +G  Y   + + G   A K I       R D ED        REI ++ 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-------RLDAEDEGIPSTAIREISLLK 74
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVG 211
            L  H NIV++        C+ +V E         +++   + G    +    L +++ G
Sbjct: 75  ELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
           V   CH   ++HRDLKP+N LL+N D   +LK  DFGL+  F  P + +T  V + +Y A
Sbjct: 132 VAH-CHQHRILHRDLKPQN-LLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPF-----------------------WAET 305
           P+VL+  K Y    D+W+ G I   +++G P F                       W + 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 306 QQGIFDAVLKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           Q+          + FE  PW    P       DL+  MLC  P++R++A + + HP+   
Sbjct: 248 QELPLWKQRTFQV-FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-- 304
Query: 362 NGVAPDRSLDPAV 374
                 + LDP +
Sbjct: 305 ------KDLDPQI 311

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 23/268 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 127 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 239
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHP 357
             A  +++  L   P ERL      CHP
Sbjct: 240 VKAASVLKSFLNKDPKERLG-----CHP 262

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 23/268 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 243
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHP 357
             A  +++  L   P ERL      CHP
Sbjct: 244 VKAASVLKSFLNKDPKERLG-----CHP 266

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 20/226 (8%)
Query: 149 EIQIMHHLAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII----QRGHYSERKA 202
           E+ ++  L  H NIV       D  +  ++IVME C GG+L   I     +R +  E   
Sbjct: 55  EVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 203 AELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +   +   ++ CH        V+HRDLKP N  L  K +   +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDT 170
Query: 258 IFTDV-VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            F    VG+PYY++PE + +  Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           G   F   P+   SD   ++I +ML  +   R +  E+L +P I E
Sbjct: 231 GK--FRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 139/298 (46%), Gaps = 45/298 (15%)
Query: 78  MRRGID-NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK 136
           +RR +D N+ + ++G              +LG G FG  Y      TG   A K I  + 
Sbjct: 3   VRRDLDPNEVWEIVG--------------ELGDGAFGKVYKAKNKETGALAAAKVIETK- 47
Query: 137 LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI---IQ 193
             S E++ED   EI+I+     H  IV + GAY     + I++E C GG + D I   + 
Sbjct: 48  --SEEELEDYIVEIEILA-TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELD 103
Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-F 252
           RG  +E +   + R ++  +   HS  ++HRDLK  N L+  + D   ++  DFG+S   
Sbjct: 104 RG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN 159
Query: 253 FKPGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            K  Q     +G+PY++APEV++        Y  +AD+W+ G+ L  +    PP      
Sbjct: 160 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 219
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVLCHPWI 359
             +   + K      SDP  L++ S      +D ++  L   P  R +A ++L HP++
Sbjct: 220 MRVLLKIAK------SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 20/226 (8%)
Query: 149 EIQIMHHLAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII----QRGHYSERKA 202
           E+ ++  L  H NIV       D  +  ++IVME C GG+L   I     +R +  E   
Sbjct: 55  EVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 203 AELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +   +   ++ CH        V+HRDLKP N  L  K +   +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDT 170
Query: 258 IFTDV-VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            F    VG+PYY++PE + +  Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           G   F   P+   SD   ++I +ML  +   R +  E+L +P I E
Sbjct: 231 GK--FRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 146/334 (43%), Gaps = 54/334 (16%)
Query: 72  SKKDNIMRRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK 130
           +K  N+ +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K
Sbjct: 34  AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAG 184
            +S R   ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL   
Sbjct: 94  KLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151
Query: 185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA 244
                ++IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK 
Sbjct: 152 N--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG 297
           +DFGL+       + T  V + YY APEV+L   Y    D+W+ G I+       IL  G
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 298 -----------------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP------ 326
                             P F  + Q  + + V        L     F    +P      
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 327 -LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            L +  A+DL+ KML   P++R++  + L HP+I
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 23/268 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A + + K  +   ED++ V+ E  +    + H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 174 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 286
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHP 357
             A  +++  L   P ERL      CHP
Sbjct: 287 VKAASVLKSFLNKDPKERLG-----CHP 309

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 143/330 (43%), Gaps = 60/330 (18%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++VG+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLVGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ GVI+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQ------------------QGIFDAVLKGHIDFESDPWPLIS 329
                      P F  + Q                  + +F  VL      +S+   L +
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKA 291
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             A+DL+ KML    S+R++  E L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 146/334 (43%), Gaps = 54/334 (16%)
Query: 72  SKKDNIMRRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK 130
           +K  N+ +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K
Sbjct: 34  AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAG 184
            +S R   ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL   
Sbjct: 94  KLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151
Query: 185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA 244
                ++IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK 
Sbjct: 152 N--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG 297
           +DFGL+       + T  V + YY APEV+L   Y    D+W+ G I+       IL  G
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 298 -----------------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP------ 326
                             P F  + Q  + + V        L     F    +P      
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 327 -LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            L +  A+DL+ KML   P++R++  + L HP+I
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 132/270 (48%), Gaps = 20/270 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGH 159
           Y +G  LG+G +G      +  T    A K + K+KL    + E +V++EIQ++  L  H
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65
Query: 160 KNIVTIKGAY--EDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           KN++ +      E+   +++VME C  G  E+ D + ++     +      ++I G+ E 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL-EY 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP---GQIFTDVVGSPYYVAPE 272
            HS G++H+D+KP N LL       +LK    G++    P           GSP +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG---TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 273 V---LLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           +   L    G + D+W+AGV LY + +G+ PF  +    +F+ + KG      D  P +S
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               DL++ ML  +P++R +  ++  H W 
Sbjct: 242 ----DLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 91/330 (27%), Positives = 143/330 (43%), Gaps = 60/330 (18%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++VG+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLVGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ GVI+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQ------------------QGIFDAVLKGHIDFESDPWPLIS 329
                      P F  + Q                  + +F  VL      +S+   L +
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKA 291
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             A+DL+ KML    S+R++  E L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 123/253 (48%), Gaps = 18/253 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y    +  G+  A K +    L+  +   D  +EI ++  L  H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRII-----QRGHYSERKAAELTRIIVGVVEA 215
           N++    ++ +   ++IV+EL   G+L  R+I     Q+    ER   +    +   +E 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVL 274
            HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            ++ Y  ++D+W+ G +LY + +   PF+ + +  ++    K     + D  PL SD   
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIE---QCDYPPLPSDHYS 264
Query: 334 DLIRKM--LCSQP 344
           + +R++  +C  P
Sbjct: 265 EELRQLVNMCINP 277

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 22/291 (7%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 110 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL    +   +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 169 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 222
Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S  W   S
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 279
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ 380
           +  ++ +   L   P +R T+  +L H ++        R   P V+  L Q
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-------RERPPTVIMDLIQ 323

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 143/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLXGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 143/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           ++ L   +G G +G  Y    + TG   A K +     ++ ++ E++++EI ++   + H
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHH 80
Query: 160 KNIVTIKGAY--------EDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAAELTRII 209
           +NI T  GA+        +D L   +VME C  G + D I   +     E   A + R I
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVGSPY 267
           +  +   H   V+HRD+K +N LL    ++  +K +DFG+S       G+  T  +G+PY
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPY 194
Query: 268 YVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDF 320
           ++APEV+     P+A      D+W+ G+    +  G PP       + +F          
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +S  W   S   +  I   L    S+R    +++ HP+I
Sbjct: 255 KSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 22/291 (7%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL    +   +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 183
Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S  W   S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 240
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ 380
           +  ++ +   L   P +R T+  +L H ++        R   P V+  L Q
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-------RERPPTVIMDLIQ 284

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 142/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLXGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 18/259 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 142 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----MS 254
Query: 330 DSAKDLIRKMLCSQPSERL 348
             A  +++  L   P ERL
Sbjct: 255 VKAASVLKSFLNKDPKERL 273

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 89/324 (27%), Positives = 143/324 (44%), Gaps = 54/324 (16%)
Query: 82  IDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR 140
           +D+Q Y V +   T  +   Y   + +G G  G      +   GI  A K +S R   ++
Sbjct: 4   MDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQ 62
Query: 141 EDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQR 194
              +   RE+ ++     HKNI+++   +      E+   V++VMEL        ++I  
Sbjct: 63  THAKRAYREL-VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHM 119
Query: 195 GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
               ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+    
Sbjct: 120 ELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAS 175
Query: 255 PGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPF--------WAE- 304
              + T  V + YY APEV+L   Y    D+W+ G I+  L+ G   F        W + 
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235
Query: 305 -----TQQGIFDAVLKGHID--FESDP-------------WPLISDS---------AKDL 335
                T    F A L+  +    E+ P             W   S+S         A+DL
Sbjct: 236 IEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDL 295
Query: 336 IRKMLCSQPSERLTAHEVLCHPWI 359
           + KML   P +R++  E L HP+I
Sbjct: 296 LSKMLVIDPDKRISVDEALRHPYI 319

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 143/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 133/332 (40%), Gaps = 83/332 (25%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L +KLG+G +G  +   +  TG   A K I      +  D +   REI I+  L+GH+
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGHE 69
Query: 161 NIVTIKGAYE-----DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NIV +          D   V   ME      +   I++  H        +   ++ V++ 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH-----KQYVVYQLIKVIKY 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---------------------- 253
            HS G++HRD+KP N LL   + +  +K  DFGLS  F                      
Sbjct: 125 LHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 254 KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
               I TD V + +Y APE+LL    Y    D+W+ G IL  +L G P F   +     +
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 312 AVLKGHIDFES--------------------------------------------DPWPL 327
            ++ G IDF S                                            +P   
Sbjct: 242 RII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            ++ A DL+ K+L   P++R++A++ L HP++
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 142/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 142/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 4   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 62
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 63  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 119
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 235
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 295
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 296 RDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 142/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 147/301 (48%), Gaps = 31/301 (10%)
Query: 95  DNIRD---LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVR 147
           +NI D   L+T   ++G+G FG      E+  GI+   + +   K+I      +++ED++
Sbjct: 16  NNIADPEELFTKLERIGKGSFG------EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ 69
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
           +EI ++        +    G+Y     + I+ME   GG   D +++ G + E + A + +
Sbjct: 70  QEITVLSQ-CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLK 127
Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSP 266
            I+  ++  HS   +HRD+K  N LL  + D   +K  DFG++      QI  +  VG+P
Sbjct: 128 EILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTP 184
Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           +++APEV+ +  Y  +AD+W+ G+    L  G PP        +   + K      ++P 
Sbjct: 185 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK------NNPP 238
Query: 326 PLISD---SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
            L+ D   S K+ I   L   PS R TA E+L H +I +N  +   S    ++ R K++ 
Sbjct: 239 TLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKN--SKKTSYLTELIDRFKRWK 296
Query: 383 A 383
           A
Sbjct: 297 A 297

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 142/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 4   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 62
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 63  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 119
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 235
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 295
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 296 RDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 90/330 (27%), Positives = 142/330 (43%), Gaps = 60/330 (18%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++VG+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLVGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQ------------------QGIFDAVLKGHIDFESDPWPLIS 329
                      P F  + Q                  + +F  VL      +S+   L +
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKA 291
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             A+DL+ KML    S+R++  E L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 142/327 (43%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 2   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 60
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 61  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 117
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 118 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 173
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 174 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 233
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 234 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 293
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML   P++R++  + L HP+I
Sbjct: 294 RDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 93  KTDNIRDL-YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           KT   R++ YT  + +G G FG  +    + +  E A K + + K           RE+Q
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN-------RELQ 84
Query: 152 IMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAA 203
           IM  +  H N+V +K  +      +D + +++V+E           + R   HY++ K  
Sbjct: 85  IMR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP------ETVYRASRHYAKLKQT 137
Query: 204 ELTRII-------VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
               +I       +  +   HS+G+ HRD+KP+N LL        LK IDFG +     G
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAG 195
Query: 257 QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
           +     + S YY APE++    +Y    D+W+ G ++  L+ G P F  E+       ++
Sbjct: 196 EPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII 255
Query: 315 K------------------GHIDFESDPWPL-------ISDSAKDLIRKMLCSQPSERLT 349
           K                   H   +  P P            A DLI ++L   PS RLT
Sbjct: 256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 350 AHEVLCHPWICE 361
           A E LCHP+  E
Sbjct: 316 AIEALCHPFFDE 327

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 133/312 (42%), Gaps = 58/312 (18%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIM 153
           NI   + L   LG+G +G     T   TG   A K I    + L +   +    REI+I+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKIL 63
Query: 154 HHLAGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            H   H+NI+TI       ++E+   V+I+ EL        R+I     S+         
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---------KPGQI- 258
            +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+              GQ  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 259 -FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFD 311
             T+ V + +Y APEV+L    Y    DVW+ G IL  L    P F    +      IF 
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 312 AVLKGHID--------------------FESDP----WPLISDSAKDLIRKMLCSQPSER 347
            +   H D                    + + P    +P ++    DL+++ML   P++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 348 LTAHEVLCHPWI 359
           +TA E L HP++
Sbjct: 298 ITAKEALEHPYL 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 133/312 (42%), Gaps = 58/312 (18%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIM 153
           NI   + L   LG+G +G     T   TG   A K I    + L +   +    REI+I+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKIL 63
Query: 154 HHLAGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            H   H+NI+TI       ++E+   V+I+ EL        R+I     S+         
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---------KPGQI- 258
            +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+              GQ  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 259 -FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFD 311
             T+ V + +Y APEV+L    Y    DVW+ G IL  L    P F    +      IF 
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 312 AVLKGHID--------------------FESDP----WPLISDSAKDLIRKMLCSQPSER 347
            +   H D                    + + P    +P ++    DL+++ML   P++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 348 LTAHEVLCHPWI 359
           +TA E L HP++
Sbjct: 298 ITAKEALEHPYL 309

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 140/323 (43%), Gaps = 54/323 (16%)
Query: 83  DNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++ 
Sbjct: 1   DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQT 59
Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRG 195
             +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ  
Sbjct: 60  HAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME 116
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+     
Sbjct: 117 LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGT 172
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG----------- 297
             + T  V + YY APEV+L   Y    D+W+ G I+       IL  G           
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232
Query: 298 ------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLI 336
                  P F  + Q  + + V        L     F    +P       L +  A+DL+
Sbjct: 233 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 292
Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
            KML   P++R++  + L HP+I
Sbjct: 293 SKMLVIDPAKRISVDDALQHPYI 315

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAGHKNI 162
           K+G+G +G  Y       G  FA K I     + +ED        REI I+  L  H NI
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIR----LEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEA 215
           V +   Y+    +H    L    E  D+ +++       G  S    + L +++ G+   
Sbjct: 63  VKL---YD---VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-Y 115
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  V + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS--- 329
           +  K Y    D+W+ G I   +++G P F   ++      + +      S  WP ++   
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 330 ----------------------DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
                                 +S  DL+ KML   P++R+TA + L H +  EN
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAGHKNI 162
           K+G+G +G  Y       G  FA K I     + +ED        REI I+  L  H NI
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIR----LEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEA 215
           V +   Y+    +H    L    E  D+ +++       G  S    + L +++ G+   
Sbjct: 63  VKL---YD---VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-Y 115
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  V + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS--- 329
           +  K Y    D+W+ G I   +++G P F   ++      + +      S  WP ++   
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 330 ----------------------DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
                                 +S  DL+ KML   P++R+TA + L H +  EN
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAGHKNI 162
           K+G+G +G  Y       G  FA K I     + +ED        REI I+  L  H NI
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIR----LEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEA 215
           V +   Y+    +H    L    E  D+ +++       G  S    + L +++ G+   
Sbjct: 63  VKL---YD---VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-Y 115
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  + + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS--- 329
           +  K Y    D+W+ G I   +++G P F   ++      + +      S  WP ++   
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 330 ----------------------DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
                                 +S  DL+ KML   P++R+TA + L H +  EN
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/330 (26%), Positives = 141/330 (42%), Gaps = 60/330 (18%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQ------------------QGIFDAVLKGHIDFESDPWPLIS 329
                      P F  + Q                  + +F  VL      +S+   L +
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKA 291
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             A+DL+ KML    S+R++  E L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 59
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 60  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMEL 116
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 117 DHERMSYLLYQMLXGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTS 172
Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 298 -----VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLIR 337
                 P F  + Q  + + V        L     F    +P       L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 338 KMLCSQPSERLTAHEVLCHPWI 359
           KML   P++R++  + L HP+I
Sbjct: 293 KMLVIDPAKRISVDDALQHPYI 314

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 132/312 (42%), Gaps = 58/312 (18%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIM 153
           NI   + L   LG+G +G     T   TG   A K I    + L +   +    REI+I+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKIL 63
Query: 154 HHLAGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            H   H+NI+TI       ++E+   V+I+ EL        R+I     S+         
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---------KPGQI- 258
            +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+              GQ  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 259 -FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFD 311
              + V + +Y APEV+L    Y    DVW+ G IL  L    P F    +      IF 
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 312 AVLKGHID--------------------FESDP----WPLISDSAKDLIRKMLCSQPSER 347
            +   H D                    + + P    +P ++    DL+++ML   P++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 348 LTAHEVLCHPWI 359
           +TA E L HP++
Sbjct: 298 ITAKEALEHPYL 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 123/300 (41%), Gaps = 56/300 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           KLG G + T Y      TG+  A K +   KL S E       REI +M  L  H+NIV 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELK-HENIVR 67
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI------IVGVVEACHS 218
           +         + +V E     +L   +  R   +  +  EL  +      ++  +  CH 
Sbjct: 68  LYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-- 275
             ++HRDLKP+N LL+NK     LK  DFGL+  F  P   F+  V + +Y AP+VL+  
Sbjct: 127 NKILHRDLKPQN-LLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP----WPLISDS 331
           + Y    D+W+ G IL  +++G P F         +  LK   D    P    WP ++  
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 332 AK------------------------------DLIRKMLCSQPSERLTAHEVLCHPWICE 361
            K                              D +  +L   P  RL+A + L HPW  E
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 89/330 (26%), Positives = 140/330 (42%), Gaps = 60/330 (18%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQ------------------QGIFDAVLKGHIDFESDPWPLIS 329
                      P F  + Q                  + +F  VL      +S+   L +
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKA 291
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             A+DL+ KML    S+R++  E L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/327 (27%), Positives = 139/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G +G  Y   +++  +  A K I +R   SR   + +  EI +  HL  HKNIV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYS-QPLHEEIALHKHLK-HKNIVQYL 85
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-----LTRIIVGVVEACHSLGV 221
           G++ ++  + I ME   GG L    + R  +   K  E      T+ I+  ++  H   +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 222 MHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLLKH- 277
           +HRD+K +N L+    + +S  LK  DFG S         T+   G+  Y+APE++ K  
Sbjct: 144 VHRDIKGDNVLI----NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 278 --YGPEADVWTAGVILYILLSGVPPFW--AETQQGIFD-AVLKGHIDFESDPWPLISDSA 332
             YG  AD+W+ G  +  + +G PPF+   E Q  +F   + K H +        +S  A
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES----MSAEA 255
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           K  I K     P +R  A+++L   ++
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 2   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 60
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 61  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMEL 117
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 118 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 173
Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233
Query: 298 -----VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLIR 337
                 P F  + Q  + + V        L     F    +P       L +  A+DL+ 
Sbjct: 234 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 293
Query: 338 KMLCSQPSERLTAHEVLCHPWI 359
           KML   P++R++  + L HP+I
Sbjct: 294 KMLVIDPAKRISVDDALQHPYI 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 59
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 60  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMEL 116
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 117 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 172
Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 298 -----VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLIR 337
                 P F  + Q  + + V        L     F    +P       L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 338 KMLCSQPSERLTAHEVLCHPWI 359
           KML   P++R++  + L HP+I
Sbjct: 293 KMLVIDPAKRISVDDALQHPYI 314

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 140/295 (47%), Gaps = 28/295 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIM 153
            +L+T   K+G+G FG      E+  GI+   + +   K+I      +++ED+++EI ++
Sbjct: 21  EELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                   +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  +
Sbjct: 75  SQ-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPE 272
           +  HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APE
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---I 328
           V+ +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNY 243
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSA 383
           S   K+ +   L  +PS R TA E+L H +I  N  A   S    ++ R K++ A
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN--AKKTSYLTELIDRYKRWKA 296

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 28/267 (10%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G +G  Y   +++  +  A K I +R   SR   + +  EI +  HL  HKNIV   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYS-QPLHEEIALHKHLK-HKNIVQYL 71
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-----LTRIIVGVVEACHSLGV 221
           G++ ++  + I ME   GG L    + R  +   K  E      T+ I+  ++  H   +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 222 MHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLLKH- 277
           +HRD+K +N L+    + +S  LK  DFG S         T+   G+  Y+APE++ K  
Sbjct: 130 VHRDIKGDNVLI----NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 278 --YGPEADVWTAGVILYILLSGVPPFW--AETQQGIFD-AVLKGHIDFESDPWPLISDSA 332
             YG  AD+W+ G  +  + +G PPF+   E Q  +F   + K H +        +S  A
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES----MSAEA 241
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           K  I K     P +R  A+++L   ++
Sbjct: 242 KAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/327 (27%), Positives = 139/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/327 (27%), Positives = 139/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 4   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 62
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 63  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 119
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 295
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 296 RDLLSKMLVIDASKRISVDEALQHPYI 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/327 (27%), Positives = 139/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 141/294 (47%), Gaps = 28/294 (9%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMH 154
           +L+T   K+G+G FG      E+  GI+   + +   K+I    + +++ED+++EI ++ 
Sbjct: 7   ELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  ++
Sbjct: 61  Q-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 118
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    S
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNYS 229
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSA 383
              K+ +   L  +PS R TA E+L H +I  N  A   S    ++ R K++ A
Sbjct: 230 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN--AKKTSYLTELIDRYKRWKA 281

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 89/330 (26%), Positives = 140/330 (42%), Gaps = 60/330 (18%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 298 ----------VPPFWAETQ------------------QGIFDAVLKGHIDFESDPWPLIS 329
                      P F  + Q                  + +F  VL      +S+   L +
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL---FPADSEHNKLKA 291
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             A+DL+ KML    S+R++  E L HP+I
Sbjct: 292 SQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 141/294 (47%), Gaps = 28/294 (9%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMH 154
           +L+T   K+G+G FG      E+  GI+   + +   K+I    + +++ED+++EI ++ 
Sbjct: 7   ELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  ++
Sbjct: 61  Q-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 118
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    S
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNYS 229
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSA 383
              K+ +   L  +PS R TA E+L H +I  N  A   S    ++ R K++ A
Sbjct: 230 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN--AKKTSYLTELIDRYKRWKA 281

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 26/275 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIM 153
            +L+T   K+G+G FG      E+  GI+   + +   K+I      +++ED+++EI ++
Sbjct: 26  EELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 79
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                   +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  +
Sbjct: 80  SQ-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 137
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPE 272
           +  HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APE
Sbjct: 138 DYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---I 328
           V+ +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNY 248
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
           S   K+ +   L  +PS R TA E+L H +I  N 
Sbjct: 249 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 283

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 91/327 (27%), Positives = 139/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 8   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 66
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 67  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 123
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 124 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 179
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 180 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQW 239
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 240 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 299
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 300 RDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 88/327 (26%), Positives = 138/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 5   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 63
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 64  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 120
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 121 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 176
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG------------- 297
                 +    V + YY APEV+L   Y    D+W+ G I+  ++ G             
Sbjct: 177 TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 236
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 237 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 296
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 297 RDLLSKMLVIDASKRISVDEALQHPYI 323

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 86/317 (27%), Positives = 137/317 (43%), Gaps = 47/317 (14%)
Query: 81  GIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR 140
           G+  +   V G   D +   YT  + +G+G +G      +       A K IS  +   +
Sbjct: 26  GVPGEVEMVKGQPFD-VGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE--HQ 82
Query: 141 EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC-----VHIVMELCAGGELFDRIIQRG 195
              +   REIQI+     H+N++ I+     S       V+IV +L    +L+  +  + 
Sbjct: 83  TYCQRTLREIQILLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQ 140
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             ++     L +I+ G+ +  HS  V+HRDLKP N LL+N   D  LK  DFGL+    P
Sbjct: 141 LSNDHICYFLYQILRGL-KYIHSANVLHRDLKPSN-LLINTTCD--LKICDFGLARIADP 196
Query: 256 GQ----IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
                   T+ V + +Y APE++L  K Y    D+W+ G IL  +LS  P F  +     
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 256
Query: 310 FDAVL-----------------KGHIDFESDP----------WPLISDSAKDLIRKMLCS 342
            + +L                 K     +S P          +P     A DL+ +ML  
Sbjct: 257 LNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTF 316
Query: 343 QPSERLTAHEVLCHPWI 359
            P++R+T  E L HP++
Sbjct: 317 NPNKRITVEEALAHPYL 333

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 42/288 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD Y L   +G G               + A K I+  K   +  ++++ +EIQ M    
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-C 70
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD---RIIQRGHYS-----ERKAAELTRII 209
            H NIV+   ++     + +VM+L +GG + D    I+ +G +      E   A + R +
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG------QIFTDVV 263
           +  +E  H  G +HRD+K  N LL    +D S++  DFG+S F   G      ++    V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 264 GSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           G+P ++APEV+  ++ Y  +AD+W+ G+    L +G  P+       +        +  +
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 241
Query: 322 SDPWPLISDSAKDL---------IRKM--LCSQ--PSERLTAHEVLCH 356
           +DP P +    +D           RKM  LC Q  P +R TA E+L H
Sbjct: 242 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 101
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V++V  L  G +L+ ++++  H S          I+  ++ 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHL-MGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 90/323 (27%), Positives = 138/323 (42%), Gaps = 54/323 (16%)
Query: 83  DNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++ 
Sbjct: 1   DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQT 59
Query: 142 DVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
             +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++IQ  
Sbjct: 60  HAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME 116
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+     
Sbjct: 117 LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGT 172
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG----------- 297
             + T  V + YY APEV+L   Y    D+W+ G I+       IL  G           
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 232
Query: 298 ------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSAKDLI 336
                  P F  + Q  +   V             L   + F +D     L +  A+DL+
Sbjct: 233 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 292
Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
            KML    S+R++  E L HP+I
Sbjct: 293 SKMLVIDASKRISVDEALQHPYI 315

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 42/288 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD Y L   +G G               + A K I+  K   +  ++++ +EIQ M    
Sbjct: 9   RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-C 65
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD---RIIQRGHYS-----ERKAAELTRII 209
            H NIV+   ++     + +VM+L +GG + D    I+ +G +      E   A + R +
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG------QIFTDVV 263
           +  +E  H  G +HRD+K  N LL    +D S++  DFG+S F   G      ++    V
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 264 GSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           G+P ++APEV+  ++ Y  +AD+W+ G+    L +G  P+       +        +  +
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 236
Query: 322 SDPWPLISDSAKDL---------IRKM--LCSQ--PSERLTAHEVLCH 356
           +DP P +    +D           RKM  LC Q  P +R TA E+L H
Sbjct: 237 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 41/286 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  +G + A K +S R   S    +   RE+ ++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQ-HENVIGLL 107
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMH 223
             +  +  +    +           +Q+     +SE K   L   ++  ++  HS GV+H
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVH 167
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPE 281
           RDLKP N L VN  +D  LK +DFGL+         T  V + +Y APEV+L   HY   
Sbjct: 168 RDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 282 ADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHI---- 318
            D+W+ G I+  +L+G   F                     E  Q + D   K +I    
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282
Query: 319 -----DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                DF +  +P  S  A DL+ KML     +RLTA + L HP+ 
Sbjct: 283 QTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++   +    I    + A K +   K    +      REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIK------REIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N L+ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 90/327 (27%), Positives = 139/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 +    V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  + + V             L   + F +D     L +  A
Sbjct: 235 NKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 123/300 (41%), Gaps = 36/300 (12%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLA 157
           D Y    KLG+G +G  Y   +  T    A K I  R     E V     RE+ ++  L 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLKELQ 91
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+NI+ +K     +  +H++ E  A  +L   + +    S R        ++  V  CH
Sbjct: 92  -HRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 218 SLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           S   +HRDLKP+N LL   D   +  LK  DFGL+  F  P + FT  + + +Y  PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD-- 330
           L  +HY    D+W+   I   +L   P F  +++      + +     +   WP ++   
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 331 ---------SAKDLIR---------------KMLCSQPSERLTAHEVLCHPWICENGVAP 366
                      K L R                ML   P +R++A   L HP+   N   P
Sbjct: 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFR-HE 83
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGI 258
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           + ++             PW    P     A DL+ KML   P +R+   + L HP++ +
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 126/286 (44%), Gaps = 41/286 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  +G + A K +S R   S    +   RE+ ++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQ-HENVIGLL 89
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMH 223
             +  +  +    +           +Q+     +SE K   L   ++  ++  HS GV+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPE 281
           RDLKP N L VN  +D  LK +DFGL+         T  V + +Y APEV+L   HY   
Sbjct: 150 RDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 282 ADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHI---- 318
            D+W+ G I+  +L+G   F                     E  Q + D   K +I    
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264
Query: 319 -----DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                DF +  +P  S  A DL+ KML     +RLTA + L HP+ 
Sbjct: 265 QTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 35  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 88
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 145
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 41  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 94
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 95  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 151
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 152 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 209
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 210 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 269
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 270 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 35  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 88
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 145
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 34  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 87
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 144
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++  R   ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A D + K+L      RLTA E + HP+ 
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 248
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 308
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 309 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 364
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYXQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 310 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 107
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 162
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
Query: 360 CE 361
            E
Sbjct: 341 DE 342

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 90/327 (27%), Positives = 138/327 (42%), Gaps = 54/327 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 +    V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  +   V             L   + F +D     L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +DL+ KML    S+R++  E L HP+I
Sbjct: 295 RDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 107
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 162
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 220
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
Query: 360 CE 361
            E
Sbjct: 341 DE 342

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 111
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 166
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 167 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 284
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 285 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 344
Query: 360 CE 361
            E
Sbjct: 345 DE 346

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 109
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 164
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 165 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 282
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 283 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 342
Query: 360 CE 361
            E
Sbjct: 343 DE 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 152
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 207
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 208 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 325
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 326 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 385
Query: 360 CE 361
            E
Sbjct: 386 DE 387

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 46/299 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFR-HE 83
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 258
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           + ++             PW    P     A DL+ KML   P +R+   + L HP++ +
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 310 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 310 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 101
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 156
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 157 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 274
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 275 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 334
Query: 360 CE 361
            E
Sbjct: 335 DE 336

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 89
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 264
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 265 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 83
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 258
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 85
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 140
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 259 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318
Query: 360 CE 361
            E
Sbjct: 319 DE 320

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 101
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 78
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 133
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 134 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 191
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 251
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 252 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 311
Query: 360 CE 361
            E
Sbjct: 312 DE 313

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 81
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 136
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 137 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 194
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 254
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 255 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 314
Query: 360 CE 361
            E
Sbjct: 315 DE 316

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 92
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 147
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 148 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 205
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 265
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 266 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 325
Query: 360 CE 361
            E
Sbjct: 326 DE 327

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 86
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 261
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 262 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 87
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 262
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 263 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 78
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 253
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 254 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 123/297 (41%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 79
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD------ 323
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +L      E +      
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCII 254
Query: 324 -----------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                            PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 255 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 85
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 140
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 259 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318
Query: 360 CE 361
            E
Sbjct: 319 DE 320

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 79
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 254
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 255 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 86
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 141
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 142 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 199
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 259
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 260 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 319
Query: 360 CE 361
            E
Sbjct: 320 DE 321

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +  +LG G FG         TG + A K    R+ +S ++ E    EIQIM  L  H 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHP 73
Query: 161 NIVTIKGAYEDSL-------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           N+V+ +    D L          + ME C GG+L   + Q  +    K   +  ++  + 
Sbjct: 74  NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 214 EAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
            A    H   ++HRDLKPEN +L         K ID G +     G++ T+ VG+  Y+A
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPF---WAETQ 306
           PE+L  K Y    D W+ G + +  ++G  PF   W   Q
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 232

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +  +LG G FG         TG + A K    R+ +S ++ E    EIQIM  L  H 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 161 NIVTIKGAYEDSL-------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           N+V+ +    D L          + ME C GG+L   + Q  +    K   +  ++  + 
Sbjct: 73  NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 214 EAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
            A    H   ++HRDLKPEN +L         K ID G +     G++ T+ VG+  Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPF---WAETQ 306
           PE+L  K Y    D W+ G + +  ++G  PF   W   Q
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 77
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 132
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 133 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 190
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 250
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 251 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 310
Query: 360 CE 361
            E
Sbjct: 311 DE 312

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 80  RGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS 139
           RG  NQ      H   +  +L+T   ++G+G FG      E+  GI+   K +   K+I 
Sbjct: 6   RGFANQ------HSRVDPEELFTKLDRIGKGSFG------EVYKGIDNHTKEVVAIKIID 53
Query: 140 ----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
                +++ED+++EI ++        I    G+Y  S  + I+ME   GG   D +++ G
Sbjct: 54  LEEAEDEIEDIQQEITVLSQ-CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPG 111
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              E   A + R I+  ++  HS   +HRD+K  N LL  + D   +K  DFG++     
Sbjct: 112 PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTD 168
Query: 256 GQIFTD-VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPP 300
            QI  +  VG+P+++APEV+ +  Y  +AD+W+ G+    L  G PP
Sbjct: 169 TQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A + IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 145/320 (45%), Gaps = 54/320 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++RE++I+ +L 
Sbjct: 37  QDDYQLVRKLGRGKY------SEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR 90
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+ +    +D  S    +V E     + F ++ Q    ++         ++  ++ 
Sbjct: 91  GGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDY 147
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS G+MHRD+KP N ++ ++     L+ ID+GL+ F+ P Q +   V S Y+  PE+L+
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLV 205
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFWAETQ--------------QGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++  + K HID
Sbjct: 206 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHID 265
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW- 358
            +                    S+   L+S  A DL+ K+L     +RLTA E + HP+ 
Sbjct: 266 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325
Query: 359 --ICENGVAPDRSLDPAVLS 376
             + +    P  S D AVLS
Sbjct: 326 YPVVKEQSQP--SADNAVLS 343

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 74
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 129
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 130 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 187
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 247
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 248 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 307
Query: 360 CE 361
            E
Sbjct: 308 DE 309

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 126/284 (44%), Gaps = 47/284 (16%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHHLAGHKN 161
           LG+GQF T Y   +  T    A K I   KL  R + +D       REI+++  L+ H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELS-HPN 73
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----SERKAAELTRIIVGVVEACH 217
           I+ +  A+     + +V +        + II+        S  KA  L  + +  +E  H
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYML--MTLQGLEYLH 129
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              ++HRDLKP N LL   D++  LK  DFGL+  F  P + +   V + +Y APE+L  
Sbjct: 130 QHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFG 186
Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFDAV-------------LKGH 317
            + YG   D+W  G IL  LL  VP    ++       IF+ +             L  +
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246
Query: 318 IDFESDP-WPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + F+S P  PL        D   DLI+ +    P  R+TA + L
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 134/306 (43%), Gaps = 66/306 (21%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMH 154
           Y    K+G+G +GT +      T    A K +       R D +D        REI ++ 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLK 56
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELC----------AGGELFDRIIQRGHYSERKAAE 204
            L  HKNIV +         + +V E C            G+L   I++         + 
Sbjct: 57  ELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK---------SF 106
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVV 263
           L +++ G+   CHS  V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + ++  V
Sbjct: 107 LFQLLKGL-GFCHSRNVLHRDLKPQN-LLINRNGE--LKLADFGLARAFGIPVRCYSAEV 162
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA-----ETQQGIFDAV--- 313
            + +Y  P+VL   K Y    D+W+AG I   L +   P +      +  + IF  +   
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTP 222
Query: 314 -------LKGHIDFESDPW-----------PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                  +    D++  P            P ++ + +DL++ +L   P +R++A E L 
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 356 HPWICE 361
           HP+  +
Sbjct: 283 HPYFSD 288

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV--- 163
           +G G +G+     ++ +G++ A K +S R   S    +   RE++++ H+  H+N++   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 116
Query: 164 ---TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
              T   + E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 174
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 175 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 229
Query: 279 GPEADVWTAGVILYIL---------------------LSGVPPFWAETQQGIFDAVLKGH 317
               D+W+ G I+  L                     L+G PP    ++    +A  + +
Sbjct: 230 NMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEA--RNY 287
Query: 318 ID-FESDPWPLISDS-------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           I+     P    +D        A DL+ KML     +R+TA E L HP+  +
Sbjct: 288 INSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 47/295 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKNI 162
           +G+G +G    C    TG     + ++ +K +  +D + V+    REI+++  L  H+N+
Sbjct: 33  VGEGSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENL 86
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           V +    +     ++V E      L D  +   G   +     L +II G+   CHS  +
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI-GFCHSHNI 145
Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           +HRD+KPEN L+        +K  DFG +     PG+++ D V + +Y APE+L+    Y
Sbjct: 146 IHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 279 GPEADVWTAGVILYILLSGVPPFWAET------------------------QQGIFDAVL 314
           G   DVW  G ++  +  G P F  ++                        +  +F  V 
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 315 KGHIDFESDP----WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA 365
              I  E +P    +P +S+   DL +K L   P +R    E+L H +   +G A
Sbjct: 263 LPEIK-EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG 158
           Y    ++G+G +G  +   ++  G  F   ++ + ++ + E+   +   RE+ ++ HL  
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 159 --HKNIVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELT 206
             H N+V +       +   E  L +   H+  +L       D++ + G  +E     + 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMF 127
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           +++ G+ +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + 
Sbjct: 128 QLLRGL-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTL 183
Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHIDF 320
           +Y APEVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 321 ESD------------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             D              P+      I +  KDL+ K L   P++R++A+  L HP+ 
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 124/302 (41%), Gaps = 56/302 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++         R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVY--RVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H + 
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 360 CE 361
            E
Sbjct: 307 DE 308

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P         + V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 46/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 86
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P         + V + +Y AP
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 261
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + ++             PW    P     A DL+ KML   P +R+   + L HP++
Sbjct: 262 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++RE++I+ +L 
Sbjct: 42  QDDYQLVRKLGRGKY------SEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR 95
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+ +    +D  S    +V E     + F ++ Q    ++         ++  ++ 
Sbjct: 96  GGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDY 152
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS G+MHRD+KP N ++ ++     L+ ID+GL+ F+ P Q +   V S Y+  PE+L+
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLV 210
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFWAETQ--------------QGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++  + K HID
Sbjct: 211 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHID 270
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +                    S+   L+S  A DL+ K+L     +RLTA E + HP+ 
Sbjct: 271 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+ L   LGQG     +      TG  FA K  +    +   DV+   RE +++  L  H
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NH 66
Query: 160 KNIVTIKGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           KNIV +    E++   H  ++ME C  G L+  + +  +      +E   ++  VV   +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSL-KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
            L   G++HR++KP N + V  +D  S+ K  DFG +   +  + F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 274 L---------LKHYGPEADVWTAGVILYILLSGVPPF 301
                      K YG   D+W+ GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 261 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+ L   LGQG     +      TG  FA K  +    +   DV+   RE +++  L  H
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NH 66
Query: 160 KNIVTIKGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           KNIV +    E++   H  ++ME C  G L+  + +  +      +E   ++  VV   +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSL-KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
            L   G++HR++KP N + V  +D  S+ K  DFG +   +  + F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 274 L---------LKHYGPEADVWTAGVILYILLSGVPPF 301
                      K YG   D+W+ GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 84
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 145 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 196
Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP-WP--LISDS 331
            HY  ++D+W+ G+ L  +  G  P  + +    IF+  L  +I  E  P  P  + S  
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFE--LLDYIVNEPPPKLPSGVFSLE 254
Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            +D + K L   P+ER    +++ H +I
Sbjct: 255 FQDFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG 158
           Y    ++G+G +G  +   ++  G  F   ++ + ++ + E+   +   RE+ ++ HL  
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 159 --HKNIVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELT 206
             H N+V +       +   E  L +   H+  +L       D++ + G  +E     + 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMF 127
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           +++ G+ +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + 
Sbjct: 128 QLLRGL-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTL 183
Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHIDF 320
           +Y APEVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 321 ESD------------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             D              P+      I +  KDL+ K L   P++R++A+  L HP+ 
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 47/292 (16%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG--HKN 161
           ++G+G +G  +   ++  G  F   ++ + ++ + E+   +   RE+ ++ HL    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 162 IVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +V +       +   E  L +   H+  +L       D++ + G  +E     + +++ G
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           + +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + +Y AP
Sbjct: 133 L-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHIDFESD-- 323
           EVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D+  D  
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 324 ----------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                       P+      I +  KDL+ K L   P++R++A+  L HP+ 
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKGHIDFESDPWP-----L 327
            HY  ++D+W+ G+ L  +  G   +PP  A+       A+ +      ++P P     +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV 237
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            S   +D + K L   P+ER    +++ H +I
Sbjct: 238 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 129/299 (43%), Gaps = 44/299 (14%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            +R +Y   + +G G +G      +  TG + A K +  R   S    +   RE++++ H
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80
Query: 156 LAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           +  H+N++ +   +      +D    ++VM     G    ++++     E +   L   +
Sbjct: 81  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 137
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  +   H+ G++HRDLKP N L VN  +D  LK +DFGL+   +        V + +Y 
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--QADSEMXGXVVTRWYR 192
Query: 270 APEVLLK--HYGPEADVWTAGVILYILLSG---------------------VPP--FWAE 304
           APEV+L    Y    D+W+ G I+  +++G                      PP  F   
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 305 TQQGIFDAVLKGHIDFESDPWPLI----SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            Q       +KG  + E   +  I    S  A +L+ KML     +R+TA E L HP+ 
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 33/267 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+  ++    VG+  Y++PE L  
Sbjct: 129 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDEMANEFVGTRSYMSPERLQG 180
Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD---PWPLISDSA 332
            HY  ++D+W+ G+ L  +  G  P        IF+  L  +I  E     P  + S   
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFE--LLDYIVNEPPPKLPSAVFSLEF 235
Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +D + K L   P+ER    +++ H +I
Sbjct: 236 QDFVNKCLIKNPAERADLKQLMVHAFI 262

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL          T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVNEDSE--LKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 261 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL-SFCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVNEDSE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 203 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 262
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 263 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 73
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 74  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 132
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 133 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 70
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 71  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 129
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 130 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 73
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 74  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 132
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 133 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G G +G+     +     + A K +S R   S        RE++++ HL  H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLK-HENVIG 91
Query: 165 IKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           +   +      ED   V++V  L   G   + I++    S+     L   ++  ++  HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N   V  ++D  L+ +DFGL+   +  +  T  V + +Y APE++L   
Sbjct: 150 AGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 277 HYGPEADVWTAGVILYILLSGVPPF 301
           HY    D+W+ G I+  LL G   F
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVNEDSE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 98
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 157 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 211
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 212 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 271
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 272 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 133/301 (44%), Gaps = 66/301 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGH 159
           K+G+G +GT +      T    A K +       R D +D        REI ++  L  H
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELK-H 60
Query: 160 KNIVTIKGAYEDSLCVHIVMELC----------AGGELFDRIIQRGHYSERKAAELTRII 209
           KNIV +         + +V E C            G+L   I++         + L +++
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK---------SFLFQLL 111
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYY 268
            G+   CHS  V+HRDLKP+N LL+N++ +  LK  +FGL+  F  P + ++  V + +Y
Sbjct: 112 KGL-GFCHSRNVLHRDLKPQN-LLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 269 VAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA-----ETQQGIFDAV-------- 313
             P+VL   K Y    D+W+AG I   L +   P +      +  + IF  +        
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 314 --LKGHIDFESDPW-----------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
             +    D++  P            P ++ + +DL++ +L   P +R++A E L HP+  
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 361 E 361
           +
Sbjct: 288 D 288

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 33/308 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++     D+V   H+    DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----DSVAYQHV--REDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSERL-TAHEVLCHPWICENGVAPDRSLDPAVLSR 377
            P       +S     ++ K L   P  R  TA E+        NG  P+    P VL+ 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA---PKVLTD 293
Query: 378 LKQFSAMN 385
            ++ S ++
Sbjct: 294 AERTSLLS 301

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 99
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 158 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 273 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 99
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 158 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 273 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 98
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 157 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 211
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 212 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 271
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 272 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAMHY 200
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 201 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 260
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 261 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 84
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 143 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 197
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 198 NQTVDIWSVGCIMAELLTG 216

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 85
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 144 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 198
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 199 NQTVDIWSVGCIMAELLTG 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G G +G+     +     + A K +S R   S        RE++++ HL  H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLK-HENVIG 91
Query: 165 IKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           +   +      ED   V++V  L   G   + I++    S+     L   ++  ++  HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N   V  ++D  L+ +DFGL+   +  +  T  V + +Y APE++L   
Sbjct: 150 AGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 277 HYGPEADVWTAGVILYILLSGVPPF 301
           HY    D+W+ G I+  LL G   F
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 84
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 143 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 197
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 198 NQTVDIWSVGCIMAELLTG 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +SK    S    +   RE++++ H+  H+N++ + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHMK-HENVIGLL 99
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 158 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 213 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 272
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 273 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 106
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 165 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 220 NQTVDIWSVGCIMAELLTG 238

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 86
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 145 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 199
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 200 NQTVDIWSVGCIMAELLTG 218

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 114
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
                           P++DVW+ G ILY +  G  PF     Q I + + K H   + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 284
Query: 324 ---PWPLISDS-AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               +P I +   +D+++  L   P +R++  E+L HP++
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 107
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 166 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 221 NQTVDIWSVGCIMAELLTG 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G G +G+     +     + A K +S R   S        RE++++ HL  H+N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLK-HENVIG 83
Query: 165 IKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           +   +      ED   V++V  L   G   + I++    S+     L   ++  ++  HS
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N   V  ++D  L+ +DFGL+   +  +  T  V + +Y APE++L   
Sbjct: 142 AGIIHRDLKPSN---VAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 196
Query: 277 HYGPEADVWTAGVILYILLSGVPPF 301
           HY    D+W+ G I+  LL G   F
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 114
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
                           P++DVW+ G ILY +  G  PF     Q I + + K H   + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 284
Query: 324 ---PWPLISDS-AKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               +P I +   +D+++  L   P +R++  E+L HP++
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 110
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 169 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 223
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 224 NQTVDIWSVGCIMAELLTG 242

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 114
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 284
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F   P        +D+++  L   P +R++  E+L HP++
Sbjct: 285 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 56/294 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA--------- 215
           +         +++V E           + +   +   A+ LT I + ++++         
Sbjct: 66  LLDVIHTENKLYLVFEH----------VHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 216 --CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPE 272
             CHS  V+HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 273 VLL--KHYGPEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDF 320
           +LL  K+Y    D+W+ G I   +++   + P  +E  Q        G  D V+   +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 321 ESD------PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             D       W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 237
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F   P        +D+++  L   P +R++  E+L HP++
Sbjct: 238 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 70
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 71  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 129
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 130 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 86
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 256
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F   P        +D+++  L   P +R++  E+L HP++
Sbjct: 257 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 13  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 70
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 71  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 130 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 240
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F   P        +D+++  L   P +R++  E+L HP++
Sbjct: 241 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 86
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 256
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F   P        +D+++  L   P +R++  E+L HP++
Sbjct: 257 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K+G+G FG  Y           A K ++    I+ E++
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 73
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++M     H+N+V + G   D   + +V      G L DR+           
Sbjct: 74  KQQFDQEIKVMAK-CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT 189
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
            + + +VG+  Y+APE L     P++D+++ GV+L  +++G+P
Sbjct: 190 VMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A   I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A   I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 56/294 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA--------- 215
           +         +++V E           + +   +   A+ LT I + ++++         
Sbjct: 70  LLDVIHTENKLYLVFEF----------LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 216 --CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPE 272
             CHS  V+HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE
Sbjct: 120 AFCHSHRVLHRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 273 VLL--KHYGPEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDF 320
           +LL  K+Y    D+W+ G I   +++   + P  +E  Q        G  D V+   +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 321 ESD------PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             D       W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/322 (22%), Positives = 133/322 (41%), Gaps = 49/322 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--------------EDV 146
           Y + R L QG+F    LC +      +A K   K  L  + D               +D 
Sbjct: 33  YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDR--IIQRGHYSERKA 202
           + E+QI+  +      +T +G   +   V+I+ E      +  FD    +   +Y+    
Sbjct: 91  KNELQIITDIKNEY-CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 203 AELTRIIVGVVEACHSL-----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
            ++ + I+  V    S       + HRD+KP N L+   D +  +K  DFG S +    +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKK 206
Query: 258 IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAV 313
           I     G+  ++ PE       + G + D+W+ G+ LY++   V PF  +     +F+ +
Sbjct: 207 I-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 314 LKGHIDFESDP----WPL-----------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
              +I++  D     +PL           +S+   D ++  L   P+ER+T+ + L H W
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 359 ICENGVAPDRSLDPAVLSRLKQ 380
           + +  +   R     +  + K+
Sbjct: 326 LADTNIEDLREFSKELYKKRKK 347

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
            + +++ +  K+G+G F + YL T ++  G E   + I+ + LI       +  E+Q + 
Sbjct: 18  QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPE---EKIALKHLIPTSHPIRIAAELQCLT 74
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
              G  N++ +K  +  +  V I M         D I+    + E +   L   +   ++
Sbjct: 75  VAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLD-ILNSLSFQEVREYMLN--LFKALK 131
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL------------------------- 249
             H  G++HRD+KP NFL   +   ++L  +DFGL                         
Sbjct: 132 RIHQFGIVHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQSEAQQERCS 189
Query: 250 ----SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW 302
               S+     Q      G+P + APEVL K  +     D+W+AGVI   LLSG  PF+
Sbjct: 190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 53/276 (19%)
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI--------------KGAYEDSLCVH 176
           +I K  L   + V+   REI+I+  L  H NIV +               G+  +   V+
Sbjct: 40  AIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IV E          ++++G   E  A      ++  ++  HS  V+HRDLKP N L +N 
Sbjct: 99  IVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT 155
Query: 237 DDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGV 289
           +D   LK  DFGL+    P     G +   +V + +Y +P +LL   +Y    D+W AG 
Sbjct: 156 ED-LVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 290 ILYILLSG-------------------VPPFWAETQQGIFDAV---LKGHIDFESDPW-- 325
           I   +L+G                   +P    E +Q +   +   ++  +     P   
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ 273
Query: 326 --PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             P IS  A D + ++L   P +RLTA E L HP++
Sbjct: 274 LLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D+GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 110
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 169 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWMHY 223
Query: 279 GPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHID 319
               D+W+ G I+  LL+G   F                    AE  + I     + +I 
Sbjct: 224 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 283
Query: 320 FESDPWPLISDS---------AKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             +   P ++ +         A DL+ KML     +R+TA + L H +  +
Sbjct: 284 SLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K+G+G FG  Y           A K ++    I+ E++
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 73
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++M     H+N+V + G   D   + +V      G L DR+           
Sbjct: 74  KQQFDQEIKVMAK-CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT 189
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
            +   +VG+  Y+APE L     P++D+++ GV+L  +++G+P
Sbjct: 190 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 9   IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 66
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 67  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 126 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 236
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F   P        +D+++  L   P +R++  E+L HP++
Sbjct: 237 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 155 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 211
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNA 271
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 272 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 331
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 332 EAMTHPYF 339

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 131/308 (42%), Gaps = 33/308 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSERL-TAHEVLCHPWICENGVAPDRSLDPAVLSR 377
            P       +S     ++ K L   P  R  TA E+        NG  P+    P VL+ 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA---PKVLTD 293
Query: 378 LKQFSAMN 385
            ++ S ++
Sbjct: 294 AERTSLLS 301

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K+G+G FG  Y           A K ++    I+ E++
Sbjct: 10  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 67
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++M     H+N+V + G   D   + +V      G L DR+           
Sbjct: 68  KQQFDQEIKVMAK-CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 127 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQX 183
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
            +   +VG+  Y+APE L     P++D+++ GV+L  +++G+P
Sbjct: 184 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVILYILLS--GVPPFWAETQQ--------GIFDAVLKGHIDFESD------ 323
              D+W+ G I   +++   + P  +E  Q        G  D V+   +    D      
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 324 PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W         P + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 106
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 165 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 220 NQTVDIWSVGCIMAELLTG 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 107
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 166 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 221 NQTVDIWSVGCIMAELLTG 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 97
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 155
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 156 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 210
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 211 NQTVDIWSVGCIMAELLTG 229

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 135 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 311
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 312 EAMTHPYF 319

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 136 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 192
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 193 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 252
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 253 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 312
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 313 EAMTHPYF 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 311 EAMTHPYF 318

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 131/308 (42%), Gaps = 33/308 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSERL-TAHEVLCHPWICENGVAPDRSLDPAVLSR 377
            P       +S     ++ K L   P  R  TA E+        NG  P+    P VL+ 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA---PKVLTD 293
Query: 378 LKQFSAMN 385
            ++ S ++
Sbjct: 294 AERTSLLS 301

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 135 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 251
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 252 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 311
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 312 EAMTHPYF 319

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 311 EAMTHPYF 318

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 131/308 (42%), Gaps = 33/308 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSERL-TAHEVLCHPWICENGVAPDRSLDPAVLSR 377
            P       +S     ++ K L   P  R  TA E+        NG  P+    P VL+ 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA---PKVLTD 293
Query: 378 LKQFSAMN 385
            ++ S ++
Sbjct: 294 AERTSLLS 301

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 311 EAMTHPYF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 311 EAMTHPYF 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 311 EAMTHPYF 318

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/323 (23%), Positives = 133/323 (41%), Gaps = 70/323 (21%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK-RKLISRE-DVEDVRREIQIM----- 153
           Y+LG+ LG G FG      +I +G  FA K + +  +  +RE D+  V   + I+     
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 154 -----------------HHLAGHKN--------IVTIKGAYEDSLCVHIVMELCAGGELF 188
                            H+  G KN         V +  +    L  +++ME     +  
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL--NVIMEYVP--DTL 124
Query: 189 DRIIQRGHYSERK-AAELTRIIV----GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK 243
            ++++    S R     L  I +      V   HSLG+ HRD+KP+N L+ +KD+  +LK
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLK 182
Query: 244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
             DFG +    P +     + S +Y APE++L    Y P  D+W+ G +   L+ G P F
Sbjct: 183 LCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
Query: 302 WAETQQGIF------------DAVLKGHIDFESDPWPLISDS-------------AKDLI 336
             ET                 + +++ +  +    +P +                A DL+
Sbjct: 243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302
Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
            ++L  +P  R+  +E + HP+ 
Sbjct: 303 EQILRYEPDLRINPYEAMAHPFF 325

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 40/188 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNV 250
Query: 312 AVLKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 251 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 352 EVLCHPWI 359
           E + HP+ 
Sbjct: 311 EAMTHPYF 318

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 111/286 (38%), Gaps = 63/286 (22%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G FG  +       G  +  + +       + + E   RE++ +  L  H NIV   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRV-------KYNNEKAEREVKALAKL-DHVNIVHYN 71
Query: 167 GAYE----------DSL-------------------CVHIVMELCAGGELFDRIIQRGHY 197
           G ++          DSL                   C+ I ME C  G L   I +R   
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 198 SERK--AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              K  A EL   I   V+  HS  ++HRDLKP N  LV   D   +K  DFGL    K 
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV---DTKQVKIGDFGLVTSLKN 188
Query: 256 GQIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILYILLS------GVPPFWAETQQG 308
               T   G+  Y++PE +  + YG E D++  G+IL  LL           F+ + + G
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 248
Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           I   +                   K L++K+L  +P +R    E+L
Sbjct: 249 IISDIF--------------DKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK + FGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 33/308 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N L+   +   ++K +DFG++      G        V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSERL-TAHEVLCHPWICENGVAPDRSLDPAVLSR 377
            P       +S     ++ K L   P  R  TA E+        NG  P+    P VL+ 
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA---PKVLTD 293
Query: 378 LKQFSAMN 385
            ++ S ++
Sbjct: 294 AERTSLLS 301

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPL 131
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   + ++G   E +A       +  +E  HS  ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG +V  +P  +  D++      G+  ++APEV+L +  
Sbjct: 192 VKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL--- 335
             + DVW++  ++  +L+G  P+   TQ   F   L   I  E  P   I  S   L   
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPW---TQ--FFRGPLCLKIASEPPPVREIPPSCAPLTAQ 304
Query: 336 -IRKMLCSQPSERLTAHEV 353
            I++ L  +P  R++A E+
Sbjct: 305 AIQEGLRKEPIHRVSAAEL 323

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            +G K+    + + L  K+G G+FG+ + C +   G  +A K  SK+ L    D ++  R
Sbjct: 2   AMGMKSRYTTEFHEL-EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALR 59
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTR 207
           E+     L  H ++V    A+ +   + I  E C GG L D I +     S  K AEL  
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 208 IIVGV---VEACHSLGVMHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFF 253
           +++ V   +   HS+ ++H D+KP N  +              +DD++   + F +    
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 254 KPGQIFTDVV--GSPYYVAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WA 303
              +I +  V  G   ++A EVL ++Y   P+AD++   + + +  +G  P       W 
Sbjct: 180 HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWH 238
Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
           E +QG    + +           ++S    +L++ M+   P  R +A  ++ H
Sbjct: 239 EIRQGRLPRIPQ-----------VLSQEFTELLKVMIHPDPERRPSAMALVKH 280

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
            +  K+G G FGT +       G + A K + ++   + E V +  RE+ IM  L  H N
Sbjct: 40  NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLR-HPN 95
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHS 218
           IV   GA      + IV E  + G L+  + + G      ER+   +   +   +   H+
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 219 LG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
               ++HRDLK  N L+   D  +++K  DFGLS       + +    G+P ++APEVL 
Sbjct: 156 RNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 276 KHYGPE-ADVWTAGVILYILLSGVPPF 301
                E +DV++ GVIL+ L +   P+
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------- 159
           LGQG FG             +A K I      + E +  +  E+ ++  L          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 160 -----KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER-KAAELTRIIVGVV 213
                +N V    A +    + I ME C  G L+D I       +R +   L R I+  +
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQI-- 258
              HS G++HRDLKP N  +   D+  ++K  DFGL+                 PG    
Sbjct: 130 SYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 259 FTDVVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLK 315
            T  +G+  YVA EVL    HY  + D+++ G+I + +   + PF    ++  I   +  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILKKLRS 243
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F  D         K +IR ++   P++R  A  +L   W+
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 127
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 188 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 239
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 283

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 107
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 166 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWMHY 220
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 221 NQTVDIWSVGCIMAELLTG 239

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 108/273 (39%), Gaps = 50/273 (18%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G FG  +       G  +  K +       + + E   RE++ +  L  H NIV   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKL-DHVNIVHYN 70
Query: 167 GAYE----------------DSLCVHIVMELCAGGELFDRIIQRGHYSERK--AAELTRI 208
           G ++                 + C+ I ME C  G L   I +R      K  A EL   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           I   V+  HS  +++RDLKP N  LV   D   +K  DFGL    K         G+  Y
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 269 VAPE-VLLKHYGPEADVWTAGVILYILLS------GVPPFWAETQQGIFDAVLKGHIDFE 321
           ++PE +  + YG E D++  G+IL  LL           F+ + + GI   +        
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF------- 240
Query: 322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                      K L++K+L  +P +R    E+L
Sbjct: 241 -------DKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     L  H ++V  
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV---VEACHSLGV 221
             A+ +   + I  E C GG L D I +     S  K AEL  +++ V   +   HS+ +
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 222 MHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFFKPGQIFTDVV--GSPYY 268
           +H D+KP N  +              +DD++   + F +       +I +  V  G   +
Sbjct: 133 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRF 192
Query: 269 VAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WAETQQGIFDAVLKGHIDF 320
           +A EVL ++Y   P+AD++   + + +  +G  P       W E +QG    + +     
Sbjct: 193 LANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGRLPRIPQ----- 246
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
                 ++S    +L++ M+   P  R +A  ++ H
Sbjct: 247 ------VLSQEFTELLKVMIHPDPERRPSAMALVKH 276

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++     + + ++  + E+ ++     H N
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRK-TRHVN 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y  +  + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 66  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 125 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     L  H ++V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV---VEACHSLGV 221
             A+ +   + I  E C GG L D I +     S  K AEL  +++ V   +   HS+ +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 222 MHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFFKPGQIFTDVV--GSPYY 268
           +H D+KP N  +              +DD++   + F +       +I +  V  G   +
Sbjct: 135 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRF 194
Query: 269 VAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WAETQQGIFDAVLKGHIDF 320
           +A EVL ++Y   P+AD++   + + +  +G  P       W E +QG    + +     
Sbjct: 195 LANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRIPQ----- 248
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
                 ++S    +L++ M+   P  R +A  ++ H
Sbjct: 249 ------VLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 38/276 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     L  H ++V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV---VEACHSLGV 221
             A+ +   + I  E C GG L D I +     S  K AEL  +++ V   +   HS+ +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 222 MHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFFKPGQIFTDVV--GSPYY 268
           +H D+KP N  +              +DD++   + F +       +I +  V  G   +
Sbjct: 135 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRF 194
Query: 269 VAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WAETQQGIFDAVLKGHIDF 320
           +A EVL ++Y   P+AD++   + + +  +G  P       W E +QG    + +     
Sbjct: 195 LANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRIPQ----- 248
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
                 ++S    +L++ M+   P  R +A  ++ H
Sbjct: 249 ------VLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 38  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 92
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 93  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 152 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 71  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 130 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 66/314 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 78
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 134
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 354 LCHPWICENGVAPD 367
           L H +   + +  D
Sbjct: 311 LNHDFFWSDPMPSD 324

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 93
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 94  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 153 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 71  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 130 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 67
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 68  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 127 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 92
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 153 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 204
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 69
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  +      +  +K  ++ R     ++  H+  
Sbjct: 70  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 129 IIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++     + + ++  + E+ ++     H N
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRK-TRHVN 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 66  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 125 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 81
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y  +  + IV + C G  L+  +      +  +K  ++ R     ++  H+  
Sbjct: 82  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 141 IIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPL 150
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   + ++G   E +A       +  +E  HS  ++H D
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG +V  +P  +   ++      G+  ++APEV+L +  
Sbjct: 211 VKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL--- 335
             + DVW++  ++  +L+G  P+   TQ   F   L   I  E  P   I  S   L   
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPW---TQ--FFRGPLCLKIASEPPPVREIPPSCAPLTAQ 323
Query: 336 -IRKMLCSQPSERLTAHEV 353
            I++ L  +P  R++A E+
Sbjct: 324 AIQEGLRKEPIHRVSAAEL 342

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 135/314 (42%), Gaps = 58/314 (18%)
Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T ++ D Y +   +G G +G         TG + A K I     +   + +   RE++I+
Sbjct: 50  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKIL 108
Query: 154 HHLAGHKNIVTIKG------AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
            H   H NI+ IK        Y +   V++V++L        +II   H S+    E  R
Sbjct: 109 KHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQII---HSSQPLTLEHVR 162
Query: 208 I----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ---I 258
                ++  ++  HS  V+HRDLKP N LLVN  ++  LK  DFG++  +   P +    
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSN-LLVN--ENCELKIGDFGMARGLCTSPAEHQYF 219
Query: 259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVI---------------------LYILL 295
            T+ V + +Y APE++L    Y    D+W+ G I                     L +++
Sbjct: 220 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279
Query: 296 SGVPPFWAETQQGIFDAVLKGHIDF----ESDPW----PLISDSAKDLIRKMLCSQPSER 347
            G P       Q +    ++ +I      +  PW    P     A  L+ +ML  +PS R
Sbjct: 280 LGTPS--PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR 337
Query: 348 LTAHEVLCHPWICE 361
           ++A   L HP++ +
Sbjct: 338 ISAAAALRHPFLAK 351

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 85
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 86  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 145 IIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 93
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 94  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 153 IIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DF L+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 135/314 (42%), Gaps = 58/314 (18%)
Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T ++ D Y +   +G G +G         TG + A K I     +   + +   RE++I+
Sbjct: 49  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKIL 107
Query: 154 HHLAGHKNIVTIKG------AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
            H   H NI+ IK        Y +   V++V++L        +II   H S+    E  R
Sbjct: 108 KHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQII---HSSQPLTLEHVR 161
Query: 208 I----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ---I 258
                ++  ++  HS  V+HRDLKP N LLVN  ++  LK  DFG++  +   P +    
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSN-LLVN--ENCELKIGDFGMARGLCTSPAEHQYF 218
Query: 259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVI---------------------LYILL 295
            T+ V + +Y APE++L    Y    D+W+ G I                     L +++
Sbjct: 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278
Query: 296 SGVPPFWAETQQGIFDAVLKGHIDF----ESDPW----PLISDSAKDLIRKMLCSQPSER 347
            G P       Q +    ++ +I      +  PW    P     A  L+ +ML  +PS R
Sbjct: 279 LGTPS--PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR 336
Query: 348 LTAHEVLCHPWICE 361
           ++A   L HP++ +
Sbjct: 337 ISAAAALRHPFLAK 350

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 18/232 (7%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D  +Y  + H  D++   Y + + +G+G FG      +       A K +   K   R+ 
Sbjct: 83  DQGSYVQVPH--DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 143 VEDVRREIQIMHHLAGHK-----NIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
            E    EI+I+ HL         N++ +     + + +C+   +      EL  +   +G
Sbjct: 141 AE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            +S     +    I+  ++A H   ++H DLKPEN LL  +     +K IDFG S + + 
Sbjct: 197 -FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSCY-EH 253
Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            +++T  + S +Y APEV+L   YG   D+W+ G IL  LL+G P    E +
Sbjct: 254 QRVYT-XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 130/312 (41%), Gaps = 62/312 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 77
Query: 162 IVTI-----KGAYEDSLC---VHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVG 211
           +V +       A   + C   +++V + C      L   ++ +   SE K   + ++++ 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--RVMQMLLN 135
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVVGS 265
            +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV +
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 191
Query: 266 PYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
            +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +       +
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 324 PWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEVLC 355
            WP + +                             A DLI K+L   P++R+ + + L 
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 356 HPWICENGVAPD 367
           H +   + +  D
Sbjct: 312 HDFFWSDPMPSD 323

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAEL 205
           RE+Q++     H N++      +D    +I +ELCA   L + + Q+   H        L
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYVEQKDFAHLGLEPITLL 124
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFKPGQ----IF 259
            +   G+    HSL ++HRDLKP N L+   +    +KA+  DFGL      G+      
Sbjct: 125 QQTTSGLAH-LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 260 TDVVGSPYYVAPEVLLKHYGPE----ADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
           + V G+  ++APE+L +          D+++AG + Y ++S G  PF    Q+     +L
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NIL 241
Query: 315 KGHIDFES-DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            G    +   P       A++LI KM+   P +R +A  VL HP+ 
Sbjct: 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 66  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 125 IIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 81
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  +      +  +K  ++ R     ++  H+  
Sbjct: 82  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 141 IIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 66/314 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 78
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 134
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 354 LCHPWICENGVAPD 367
           L H +   + +  D
Sbjct: 311 LNHDFFWSDPMPSD 324

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 66/314 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 78
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 134
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 354 LCHPWICENGVAPD 367
           L H +   + +  D
Sbjct: 311 LNHDFFWSDPMPSD 324

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 30/286 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--RADLARDPSFYLRFRREAQNA 83
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 84  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 253
Query: 325 WPL------ISDSAKDLIRKMLCSQPSERL-TAHEVLCHPWICENG 363
            P       +S     ++ K L   P  R  TA E+        NG
Sbjct: 254 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 299

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+T+ GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 18/232 (7%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D  +Y  + H  D++   Y + + +G+G FG      +       A K +   K   R+ 
Sbjct: 83  DQGSYVQVPH--DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 143 VEDVRREIQIMHHLAGHK-----NIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
            E    EI+I+ HL         N++ +     + + +C+   +      EL  +   +G
Sbjct: 141 AE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            +S     +    I+  ++A H   ++H DLKPEN LL  +     +K IDFG S + + 
Sbjct: 197 -FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSCY-EH 253
Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            +++T  + S +Y APEV+L   YG   D+W+ G IL  LL+G P    E +
Sbjct: 254 QRVYT-XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 137/318 (43%), Gaps = 47/318 (14%)
Query: 73  KKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI 132
           +K+ I  RG  + +YY     ++ +     L  ++G G FGT Y       G      ++
Sbjct: 15  EKNKIRPRGQRDSSYYWEIEASEVM-----LSTRIGSGSFGTVY------KGKWHGDVAV 63
Query: 133 SKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
              K++  + E  +  R E+ ++     H NI+   G Y     + IV + C G  L+  
Sbjct: 64  KILKVVDPTPEQFQAFRNEVAVLRK-TRHVNILLFMG-YMTKDNLAIVTQWCEGSSLYKH 121
Query: 191 I-IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
           + +Q   +   +  ++ R     ++  H+  ++HRD+K  N  L    +  ++K  DFGL
Sbjct: 122 LHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGL 178
Query: 250 SVF---FKPGQIFTDVVGSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPF- 301
           +     +   Q      GS  ++APEV+       +  ++DV++ G++LY L++G  P+ 
Sbjct: 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238
Query: 302 WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
               +  I   V +G+        P +S   K+      C +  +RL A         C 
Sbjct: 239 HINNRDQIIFMVGRGYAS------PDLSKLYKN------CPKAMKRLVAD--------CV 278
Query: 362 NGVAPDRSLDPAVLSRLK 379
             V  +R L P +LS ++
Sbjct: 279 KKVKEERPLFPQILSSIE 296

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + ED+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEEDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 18/232 (7%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D  +Y  + H  D++   Y + + +G+G FG      +       A K +   K   R+ 
Sbjct: 83  DQGSYVQVPH--DHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 143 VEDVRREIQIMHHLAGHK-----NIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
            E    EI+I+ HL         N++ +     + + +C+   +      EL  +   +G
Sbjct: 141 AE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            +S     +    I+  ++A H   ++H DLKPEN LL  +     +K IDFG S +   
Sbjct: 197 -FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSCY--E 252
Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            Q     + S +Y APEV+L   YG   D+W+ G IL  LL+G P    E +
Sbjct: 253 HQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K G+G FG  Y           A K ++    I+ E++
Sbjct: 7   SFYELKNVTNNFDERPISVGGNKXGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 64
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++      H+N+V + G   D   + +V      G L DR+           
Sbjct: 65  KQQFDQEIKVXAKCQ-HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 124 HXRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQX 180
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
              + +VG+  Y APE L     P++D+++ GV+L  +++G+P
Sbjct: 181 VXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               + +         ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 45/281 (16%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED--VRREIQIMHHLAGHKNI 162
           R L +G F   Y   ++ +G E+A K     +L+S E+ ++  + +E+  M  L+GH NI
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALK-----RLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 163 VTIKGAY----EDSLCVH----IVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGV 212
           V    A     E+S        ++ ELC G   E   ++  RG  S     ++       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 213 VEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-----------KPGQIF 259
           V+  H     ++HRDLK EN LL N+    ++K  DFG +              +   + 
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG---TIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 260 TDVV--GSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV 313
            ++    +P Y  PE++  +     G + D+W  G ILY+L     PF    + G    +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRI 261
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G   +   P          LIR ML   P ERL+  EV+
Sbjct: 262 VNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 41/284 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------- 159
           LGQG FG             +A K I      + E +  +  E+ ++  L          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 160 -----KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER-KAAELTRIIVGVV 213
                +N V    A +    + I ME C    L+D I       +R +   L R I+  +
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQI-- 258
              HS G++HRDLKP N  +   D+  ++K  DFGL+                 PG    
Sbjct: 130 SYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 259 FTDVVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLK 315
            T  +G+  YVA EVL    HY  + D+++ G+I + +   + PF    ++  I   +  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILKKLRS 243
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F  D         K +IR ++   P++R  A  +L   W+
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           TL   +G G FG  Y    I   +          + IS + +E+VR+E ++   L  H N
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLK-HPN 67
Query: 162 IVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS- 218
           I+ ++G    E +LC  +VME   GG L +R++                I   +   H  
Sbjct: 68  IIALRGVCLKEPNLC--LVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 219 --LGVMHRDLKPENFLLVNK--DDDFS---LKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
             + ++HRDLK  N L++ K  + D S   LK  DFGL+  +      +   G+  ++AP
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGAYAWMAP 183
Query: 272 EVL-LKHYGPEADVWTAGVILYILLSGVPPF 301
           EV+    +   +DVW+ GV+L+ LL+G  PF
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 32/234 (13%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL----------ISREDVEDVRREIQ 151
           T+ R +G G+FG      E+ +G     K   KR+L           + +   D   E  
Sbjct: 25  TIERVIGAGEFG------EVCSG---RLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEAS 75
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRII 209
           IM     H NI+ ++G    S  V IV E    G L D  +++  G ++  +   + R I
Sbjct: 76  IMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGI 133
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGS-P 266
              ++    +G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G  P
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 267 Y-YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             + APE +  + +   +DVW+ G++++ ++S G  P+W  T Q +  AV +G+
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGY 244

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 39/297 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG--HKN 161
           ++G G +GT Y   +  +G   A KS+             +   RE+ ++  L    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 162 IVTIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           +V +      S     + V +V E          D+    G  +E    +L R  +  ++
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLD 134
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             H+  ++HRDLKPEN L+ +     ++K  DFGL+  +      T VV + +Y APEVL
Sbjct: 135 FLHANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKGHIDFESD----- 323
           L+  Y    D+W+ G I   +    P F   ++      IFD + L    D+  D     
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251
Query: 324 -------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
                  P P+      + +S   L+ +ML   P +R++A   L H ++ ++   P+
Sbjct: 252 GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 308

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 36/222 (16%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G         +G+      I  RKLI  E    +R    RE+Q++H       
Sbjct: 23  ELGAGNGGVVTKVQHRPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-LTRIIVGVVEACHSL- 219
           IV   GA+     + I ME   GG L D++++    ++R   E L ++ + V+     L 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE---AKRIPEEILGKVSIAVLRGLAYLR 131
Query: 220 ---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPE 272
               +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y+APE
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMAPE 183
Query: 273 VLL-KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIF 310
            L   HY  ++D+W+ G+ L  L  G   +PP  A+  + IF
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI--------------IQRGHYSER 200
           HL  H+NIV + GA      V ++ E C  G+L + +              I     S R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPG 256
                +  +   +    S   +HRD+   N LL N    K  DF L       S +   G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
                V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 NARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 138/330 (41%), Gaps = 62/330 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T Y      T    A K I   +L   E       RE+ ++  L  H NIVT
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 64
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELT--RIIVGVVEACH 217
           +         +H    L    E  D+ +++     G+       +L   +++ G+   CH
Sbjct: 65  LHD------IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA-YCH 117
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL- 275
              V+HRDLKP+N LL+N+  +  LK  DFGL+     P + + + V + +Y  P++LL 
Sbjct: 118 RQKVLHRDLKPQN-LLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-------- 326
              Y  + D+W  G I Y + +G P F   T +     + +       + WP        
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 327 -------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
                              L SD A DL+ K+L  +   R++A + + HP+    G    
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGA-DLLTKLLQFEGRNRISAEDAMKHPFFLSLG---- 289
Query: 368 RSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
                  + +L   +++  LK++ L+  AS
Sbjct: 290 -----ERIHKLPDTTSIFALKEIQLQKEAS 314

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI--------------IQRGHYSER 200
           HL  H+NIV + GA      V ++ E C  G+L + +              I     S R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPG 256
                +  +   +    S   +HRD+   N LL N    K  DF L       S +   G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
                V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 NARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 16  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 73
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 74  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 190
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 250
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 251 FKLLKEGH 258

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 137
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 254
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 315 FKLLKEGH 322

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 131/313 (41%), Gaps = 30/313 (9%)
Query: 58  ENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYL 117
           E P+  ++ PR   SK        I NQ + V   K D++  +  LGR    G +G    
Sbjct: 21  EQPQTSSTPPRDLDSKA----CISIGNQNFEV---KADDLEPIMELGR----GAYGVVEK 69
Query: 118 CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI 177
              + +G   A K I  R  ++ ++ + +  ++ I          VT  GA      V I
Sbjct: 70  MRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 127
Query: 178 VMEL--CAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLL 233
            MEL   +  + + ++I +G    E    ++   IV  +E  HS L V+HRD+KP N L+
Sbjct: 128 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 187
Query: 234 VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL-----LKHYGPEADVWTAG 288
              +    +K  DFG+S +       T   G   Y+APE +      K Y  ++D+W+ G
Sbjct: 188 ---NALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 244
Query: 289 VILYILLSGVPPF--WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSE 346
           + +  L     P+  W    Q +   V +      +D +   S    D   + L     E
Sbjct: 245 ITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEFVDFTSQCLKKNSKE 301
Query: 347 RLTAHEVLCHPWI 359
           R T  E++ HP+ 
Sbjct: 302 RPTYPELMQHPFF 314

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 21  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 78
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENN---VMKIADFGLARDIN 195
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 255
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 256 FKLLKEGH 263

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----SERKAAELTRIIV 210
           HL  H+NIV + GA      V ++ E C  G+L + + ++        + +  EL  ++ 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPGQIFT 260
              +    +  +      HRD+   N LL N    K  DF L       S +   G    
Sbjct: 165 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 PVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 38/295 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIV 163
           ++G G +GT Y   +  +G   A KS+          +  VR E+ ++  L    H N+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 164 TIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            +      S     + V +V E          D+    G  +E    +L R  +  ++  
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLDFL 128
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRDLKPEN L+ +     ++K  DFGL+  +        VV + +Y APEVLL+
Sbjct: 129 HANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQ 185
Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKGHIDFESD------- 323
             Y    D+W+ G I   +    P F   ++      IFD + L    D+  D       
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 245
Query: 324 -----PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
                P P+      + +S   L+ +ML   P +R++A   L H ++ ++   P+
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 300

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    ++  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMRIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 69
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 186
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 247 FKLLKEGH 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 19  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 76
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 77  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 193
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 254 FKLLKEGH 261

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 23  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 80
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 197
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 257
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 258 FKLLKEGH 265

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 20  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 77
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 78  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 194
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 255 FKLLKEGH 262

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 26  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 83
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 200
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 260
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 261 FKLLKEGH 268

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 37  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----SERKAAELTRIIV 210
           HL  H+NIV + GA      V ++ E C  G+L + + ++        + +  EL  ++ 
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPGQIFT 260
              +    +  +      HRD+   N LL N    K  DF L       S +   G    
Sbjct: 157 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 217 PV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
                           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 125
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 242
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 303 FKLLKEGH 310

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 38/295 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIV 163
           ++G G +GT Y   +  +G   A KS+          +  VR E+ ++  L    H N+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 164 TIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            +      S     + V +V E          D+    G  +E    +L R  +  ++  
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLDFL 128
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRDLKPEN L+ +     ++K  DFGL+  +        VV + +Y APEVLL+
Sbjct: 129 HANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQ 185
Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKGHIDFESD------- 323
             Y    D+W+ G I   +    P F   ++      IFD + L    D+  D       
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 245
Query: 324 -----PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
                P P+      + +S   L+ +ML   P +R++A   L H ++ ++   P+
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 300

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
                           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----------------GHYS 198
           HL  H+NIV + GA      V ++ E C  G+L + + ++                   S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 199 ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFK 254
            R     +  +   +    S   +HRD+   N LL N    K  DF L       S +  
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            G     V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 KGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y+       +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 89
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +IV E    G L D  R   R   +      +   I   +E     
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK 149
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVLLK 276
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 150 NFIHRDLAARNCLV---GENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 205
Query: 277 H-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           + +  ++DVW  GV+L+ I   G+ P+       ++D + KG+
Sbjct: 206 NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGY 248

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPL 129
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   I Q G   E +A       +  +E  H+  ++H D
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG ++  +P  +   ++      G+  ++APEV++ K  
Sbjct: 190 VKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
             + D+W++  ++  +L+G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 126/295 (42%), Gaps = 38/295 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIV 163
           ++G G +GT Y   +  +G   A KS+          +  VR E+ ++  L    H N+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 164 TIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            +      S     + V +V E          D+    G  +E    +L R  +  ++  
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLDFL 128
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRDLKPEN L+ +     ++K  DFGL+  +        VV + +Y APEVLL+
Sbjct: 129 HANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQ 185
Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKGHIDFESD------- 323
             Y    D+W+ G I   +    P F   ++      IFD + L    D+  D       
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 245
Query: 324 -----PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
                P P+      + +S   L+ +ML   P +R++A   L H ++ ++   P+
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE 300

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV--- 251
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
                +  T+      ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  FT   G+ +   + APE L  
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAY 184
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++   + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 111/284 (39%), Gaps = 41/284 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------- 159
           LGQG FG             +A K I      + E +  +  E+ ++  L          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVXLLASLNHQYVVRYYA 69
Query: 160 -----KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER-KAAELTRIIVGVV 213
                +N V    A +    + I  E C    L+D I       +R +   L R I+  +
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQI-- 258
              HS G++HR+LKP N  +   D+  ++K  DFGL+                 PG    
Sbjct: 130 SYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 259 FTDVVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLK 315
            T  +G+  YVA EVL    HY  + D ++ G+I +     + PF    ++  I   +  
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKLRS 243
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
             I+F  D         K +IR ++   P++R  A  +L   W+
Sbjct: 244 VSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 19  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 75
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 134 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 27/273 (9%)
Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI-RDLYTLGRKLGQGQFGTTYL 117
           N K+   +  +S S+ D+      +  TY +   +   I R+   LGR +G+GQFG  + 
Sbjct: 349 NEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 118 CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI 177
              ++        +I   K  + + V +   +  +      H +IV + G   ++  V I
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWI 467
Query: 178 VMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEACHSLGVM------HRDLKPEN 230
           +MELC  GEL      R     RK + +L  +I+   +   +L  +      HRD+   N
Sbjct: 468 IMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 231 FLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPEVL-LKHYGPEADVWTA 287
            L+ + D    +K  DFGLS + +    +    G  P  ++APE +  + +   +DVW  
Sbjct: 522 VLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 288 GVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIE 606

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 277
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HR+L   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 338 NFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 450
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 451 LMRACWQWNPSDRPSFAEI 469

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 31/254 (12%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I DL  LG ++G G  G  +      TG   A K +  R+  ++E+ + +  ++ ++   
Sbjct: 24  INDLENLG-EMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKS 80
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVE 214
                IV   G +  +  V I MEL   G   +++ +R  G   ER   ++T   V +V+
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMT---VAIVK 135
Query: 215 ACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
           A + L    GV+HRD+KP N LL   D+   +K  DFG+S      +      G   Y+A
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 271 PEVL------LKHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLK-------G 316
           PE +         Y   ADVW+ G+ L  L +G  P+   +T   +   VL+       G
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 317 HIDFESDPWPLISD 330
           H+ F  D    + D
Sbjct: 253 HMGFSGDFQSFVKD 266

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 54/279 (19%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +  Y  G K  ++ D Y +   +G+G +G  YL  +  T    A K ++ R      D +
Sbjct: 12  ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCK 70
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLC----VHIVMELCAGG--ELFDRIIQRGHYS 198
            + REI I++ L     I        D L     ++IV+E+      +LF   I      
Sbjct: 71  RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--E 128
Query: 199 ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF----- 253
           E     L  +++G     H  G++HRDLKP N LL   + D S+K  DFGL+        
Sbjct: 129 EHIKTILYNLLLGE-NFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKD 184
Query: 254 -----------KPG-------QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYI 293
                      +PG       +  T  V + +Y APE++L  ++Y    D+W+ G I   
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244
Query: 294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           LL+                +L+ HI+  ++ +PL   S+
Sbjct: 245 LLN----------------MLQSHINDPTNRFPLFPGSS 267

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++   + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPL 115
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   I Q G   E +A       +  +E  H+  ++H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG ++  +P  +   ++      G+  ++APEV++ K  
Sbjct: 176 VKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
             + D+W++  ++  +L+G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 19  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 75
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 134 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 238

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 29/268 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+  TL ++LG GQFG   L  +     + A K I +  +   ED  +  +E Q M  L+
Sbjct: 7   REEITLLKELGSGQFGVVKL-GKWKGQYDVAVKMIKEGSM--SED--EFFQEAQTMMKLS 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V   G       ++IV E  + G L + +   G     K  E ++++    + C 
Sbjct: 62  -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCE 115
Query: 218 SLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---Y 268
            +  +      HRDL   N L+   D D  +K  DFG++ +    Q +   VG+ +   +
Sbjct: 116 GMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKW 171
Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
            APEV     Y  ++DVW  G++++ + S G  P+   T   +   V +GH  +      
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH--- 228
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
           L SD+   ++       P +R T  ++L
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLL 256

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPL 131
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   I Q G   E +A       +  +E  H+  ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG ++  +P  +   ++      G+  ++APEV++ K  
Sbjct: 192 VKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
             + D+W++  ++  +L+G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 46  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 102
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 161 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 265

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 36  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 92
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 151 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 255

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I++E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 135 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 190
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 56/295 (18%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMHHLAGHKNIVTI 165
           LG+G FG  +          +A K I   +L +RE   E V RE++ +  L  H  IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLE-HPGIVRY 68
Query: 166 KGAYEDS------------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             A+ +             + ++I M+LC    L D +  R    ER+ +    I + + 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 214 EAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL----------SVFFKPGQIF- 259
           EA    HS G+MHRDLKP N      D    +K  DFGL               P   + 
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 260 --TDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG 316
             T  VG+  Y++PE +  + Y  + D+++ G+IL+ LL    PF  + ++      ++ 
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER------VRT 236
Query: 317 HIDFESDPWPLISDSAKD----LIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
             D  +  +P +          +++ ML   P ER  A  ++      EN V  D
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII------ENAVFED 285

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---SP-YYVA 270
              +   +HRDL   N L+ N++    +K  DFGL+      + F  V     SP ++ A
Sbjct: 129 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGV 298
           PE L +  +   +DVW+ GV+LY L + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 37  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 90
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 91  LTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 143
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 200
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 254

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 107 LGQGQFG---TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +G G+FG   + +L       I  A K++  +   + +   D   E  IM     H N++
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQF-DHPNVI 97
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVM 222
            ++G    S  V I+ E    G L   + Q  G ++  +   + R I   ++    +  +
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIFTDVVGSPY---YVAPEVL-L 275
           HRDL   N L+   + +   K  DFGLS F +       +T  +G      + APE +  
Sbjct: 158 HRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 276 KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           + +   +DVW+ G++++ ++S G  P+W  T Q + +A+
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIV 163
           R +G G+FG          G      +I   K+  + +   D   E  IM     H N+V
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQF-DHPNVV 107
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGV 221
            ++G       V IV+E    G L D  +++  G ++  +   + R I   +     +G 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY 166
Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGS--PYYVAPEVL-LK 276
           +HRDL   N L+   + +   K  DFGLS   +  P  ++T   G     + APE +  +
Sbjct: 167 VHRDLAARNILV---NSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            +   +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++G+G FG  +    +      A KS+    S+ +    E  ++ +RE+ IM +L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +      + 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ 139
Query: 221 -----VMHRDLKPENFLLVNKDDDFSL--KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
                ++HRDL+  N  L + D++  +  K  DFGLS   +     + ++G+  ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 274 L---LKHYGPEADVWTAGVILYILLSGVPPF 301
           +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 90  LGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
           LG+ +  I  +DL T  ++LG GQFG      +     + A K I +  +   E +E   
Sbjct: 14  LGYGSWEIDPKDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE--- 68
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELT 206
            E ++M +L+ H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ 
Sbjct: 69  -EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + +   +E   S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSK 182
Query: 267 Y---YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   +  PEVL+   +  ++D+W  GV+++ + S G  P+
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 40/240 (16%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 62
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRII 209
             M     H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I
Sbjct: 63  LTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGEL------RSFLQVRKYSLDLASLI 114
Query: 210 VGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
           +   +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASK 171
Query: 264 GS-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           G  P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 11  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 64
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 65  LTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 117
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 174
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   LGR +G+GQFG  +    ++        +I   K  + + V +   +  +     
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEAC 216
            H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I+   +  
Sbjct: 69  DHPHIVKLIGVITEN-PVWIIMELCTLGEL------RSFLQVRKYSLDLASLILYAYQLS 121
Query: 217 HSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-Y 268
            +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G  P  +
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 269 VAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           +APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 14  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 67
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 68  LTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 120
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 231

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 131 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLA 186
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 33/288 (11%)
Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
           +KK  ++      +  +VL H+     DL  LG ++G+G FG  +     A     A KS
Sbjct: 93  TKKSGVVLHRAVPKDKWVLNHE-----DL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146
Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
              R+ +  +      +E +I+   + H NIV + G       ++IVMEL  GG+    +
Sbjct: 147 C--RETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 192 IQRGHYSERKAAELTRII---VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
              G  +  +   L +++      +E   S   +HRDL   N L+  K+    LK  DFG
Sbjct: 204 RTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFG 258
Query: 249 LS------VFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPP 300
           +S      V+   G +    V    + APE L    Y  E+DVW+ G++L+   S G  P
Sbjct: 259 MSREEADGVYAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 301 FWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRKMLCSQPSER 347
           +   + Q   + V KG       P P L  D+   L+ +    +P +R
Sbjct: 316 YPNLSNQQTREFVEKGG----RLPCPELCPDAVFRLMEQCWAYEPGQR 359

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 59
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 60  LTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 112
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 12  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 65
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 66  LTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 118
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 175
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 229

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 27/273 (9%)
Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI-RDLYTLGRKLGQGQFGTTYL 117
           N K+   +  +S S+ D+      +  TY +   +   I R+   LGR +G+GQFG  + 
Sbjct: 349 NEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 118 CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI 177
              ++        +I   K  + + V +   +  +      H +IV + G   ++  V I
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWI 467
Query: 178 VMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEACHSLGVM------HRDLKPEN 230
           +MELC  GEL      R     RK + +L  +I+   +   +L  +      HRD+   N
Sbjct: 468 IMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 231 FLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPEVL-LKHYGPEADVWTA 287
            L+   D    +K  DFGLS + +    +    G  P  ++APE +  + +   +DVW  
Sbjct: 522 VLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 288 GVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIE 606

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 132 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLA 187
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 8   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 62  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 120
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS +   +  PEV
Sbjct: 121 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 176
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 316
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HR+L   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 376 KNFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 431
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
              +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVY 488
Query: 334 DLIRKMLCSQPSERLTAHEV 353
           +L+R      PS+R +  E+
Sbjct: 489 ELMRACWQWNPSDRPSFAEI 508

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQFG  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L  
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 184
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 135 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 190
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 9   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 63  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS +   +  PEV
Sbjct: 122 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 177
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 90  LGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
           LG+ +  I  +DL T  ++LG GQFG      +     + A K I +  +   E +E   
Sbjct: 5   LGYGSWEIDPKDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE--- 59
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELT 206
            E ++M +L+ H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ 
Sbjct: 60  -EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 117
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + +   +E   S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS 
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSK 173
Query: 267 Y---YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   +  PEVL+   +  ++D+W  GV+++ + S G  P+
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 4   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 57
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 58  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS +   +  PEV
Sbjct: 117 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 172
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 135 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 190
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 74
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 134 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 185
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 83
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 143 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 198
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 132 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 187
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 132 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 187
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 62/267 (23%)
Query: 83  DNQTYYV------LGHKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKS 131
           DN+ +YV         K +  R+    G+ LG G FG     T Y  ++    I+ A K 
Sbjct: 23  DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 82
Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
           + K K  S E  E +  E+++M  L  H+NIV + GA   S  ++++ E C  G+L + +
Sbjct: 83  L-KEKADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 192 -IQRGHYSE--------RKAAELTRIIVGVVE--ACHSLGV------------MHRDLKP 228
             +R  +SE        ++  E   + V   E   C +  V            +HRDL  
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200
Query: 229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV------------APEVLLK 276
            N L+ +      +K  DFGL+          D++    YV            APE L +
Sbjct: 201 RNVLVTHGK---VVKICDFGLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 277 H-YGPEADVWTAGVILYILLS-GVPPF 301
             Y  ++DVW+ G++L+ + S GV P+
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGL+   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 185
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   S      +   I   +E     
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L  
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 184
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 12  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 71  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 126
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R+LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L + + +   + ER    K  + T  I   +E
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK---HKERIDHIKLLQYTSQICKGME 131
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 187
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   LGR +G+GQFG  +    ++        +I   K  + + V +   +  +     
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEAC 216
            H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I+   +  
Sbjct: 69  DHPHIVKLIGVITEN-PVWIIMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLS 121
Query: 217 HSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-Y 268
            +L  +      HRD+   N L+   D    +K  DFGLS + +    +    G  P  +
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 269 VAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           +APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGL    +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 18  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 77  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 132
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 18  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 77  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 132
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 15/182 (8%)
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           D   E  IM     H NI+ ++G         IV E    G L D  + R H  +    +
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL-RTHDGQFTIMQ 152
Query: 205 LTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIF 259
           L  ++ GV   +     LG +HRDL   N L+   D +   K  DFGLS   +  P   +
Sbjct: 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 260 TDVVGS-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLK 315
           T   G  P  + APE +  + +   +DVW+ GV+++ +L  G  P+W  T + +  +V +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
Query: 316 GH 317
           G+
Sbjct: 270 GY 271

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG    +    + ++ME    G L D +  + H       +L +    + +    
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEY 132
Query: 219 LGV---MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYVA 270
           LG    +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ A
Sbjct: 133 LGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYA 188
Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGV 298
           PE L +  +   +DVW+ GV+LY L + +
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   LGR +G+GQFG  +    ++        +I   K  + + V +   +  +     
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEAC 216
            H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I+   +  
Sbjct: 69  DHPHIVKLIGVITEN-PVWIIMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLS 121
Query: 217 HSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-Y 268
            +L  +      HRD+   N L+ + D    +K  DFGLS + +         G  P  +
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 269 VAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           +APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 124/323 (38%), Gaps = 70/323 (21%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +   G       I K   + R   E  R EIQ++ HL    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRY-CEAARSEIQVLEHLNTTD 72
Query: 161 NIVTIKGA-----YEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGVV 213
              T +       +E    + IV EL  G   +D I + G    R     ++   I   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 214 EACHSLGVMHRDLKPENFLLVNKD-----------DDFSL-----KAIDFGLSVFFKPGQ 257
              HS  + H DLKPEN L V  D           D+ +L     K +DFG + +    +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DDE 189
Query: 258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL---YILLSGVPPFWAETQQGIFDAV 313
             + +V + +Y APEV+L   +    DVW+ G IL   Y+  +  P   ++    + + +
Sbjct: 190 HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 314 L-------------KGHIDFESDPWPLISDSAK------------------------DLI 336
           L             + +   +   W   S + +                        DLI
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
           +KML   P++R+T  E L HP+ 
Sbjct: 310 QKMLEYDPAKRITLREALKHPFF 332

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 131
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 187
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 8   KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 67  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 12  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 71  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 126
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I++E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L 
Sbjct: 131 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLA 186
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 8   KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 67  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 179
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 102
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 159
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 160 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 215
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 70
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 127
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 128 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 183
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 184
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 78
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 135
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 136 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 191
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFTYI 221

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
           +KK  ++      +  +VL H+     DL  LG ++G+G FG  +     A     A KS
Sbjct: 93  TKKSGVVLHRAVPKDKWVLNHE-----DL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146
Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
              R+ +  +      +E +I+   + H NIV + G       ++IVMEL  GG+    +
Sbjct: 147 C--RETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 192 IQRGHYSERKAAELTRII---VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
              G  +  +   L +++      +E   S   +HRDL   N L+  K+    LK  DFG
Sbjct: 204 RTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFG 258
Query: 249 LS------VFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPP 300
           +S      V    G +    V    + APE L    Y  E+DVW+ G++L+   S G  P
Sbjct: 259 MSREEADGVXAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 301 FWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRKMLCSQPSER 347
           +   + Q   + V KG       P P L  D+   L+ +    +P +R
Sbjct: 316 YPNLSNQQTREFVEKGG----RLPCPELCPDAVFRLMEQCWAYEPGQR 359

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 76
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 133
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 134 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 189
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 77
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 134
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 135 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 190
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 75
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 132
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 133 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 188
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 69
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 126
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 127 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 182
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 184
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLC----TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 89
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 146
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 147 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 202
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG       +    ++  K ++ +++ S  + +    E++ +  +  H NIV + 
Sbjct: 16  VGRGAFG-------VVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLY 67
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSL-- 219
           GA  + +C  +VME   GG L++  +  G     +Y+   A          V   HS+  
Sbjct: 68  GACLNPVC--LVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
             ++HRDLKP N LLV       LK  DFG +   +     T+  GS  ++APEV    +
Sbjct: 124 KALIHRDLKPPNLLLVAGGT--VLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSN 179
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK---D 334
           Y  + DV++ G+IL+ +++   PF  E     F  +   H        PLI +  K    
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRP---PLIKNLPKPIES 235
Query: 335 LIRKMLCSQPSERLTAHEVL 354
           L+ +     PS+R +  E++
Sbjct: 236 LMTRCWSKDPSQRPSMEEIV 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++G+G FG  +    +      A KS+    S+ +    E  ++ +RE+ IM +L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +      + 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ 139
Query: 221 -----VMHRDLKPENFLLVNKDDDFSL--KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
                ++HRDL+  N  L + D++  +  K  DFG S   +     + ++G+  ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 274 L---LKHYGPEADVWTAGVILYILLSGVPPF 301
           +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 107 LGQGQFG---TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +G G+FG   + +L       I  A K++  +   + +   D   E  IM     H N++
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQF-DHPNVI 71
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVM 222
            ++G    S  V I+ E    G L   + Q  G ++  +   + R I   ++    +  +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY---YVAPEVL-L 275
           HR L   N L+   + +   K  DFGLS F +       +T  +G      + APE +  
Sbjct: 132 HRALAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 276 KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           + +   +DVW+ G++++ ++S G  P+W  T Q + +A+
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 8   KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 67  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG       +    ++  K ++ +++ S  + +    E++ +  +  H NIV + 
Sbjct: 17  VGRGAFG-------VVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLY 68
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSL-- 219
           GA  + +C  +VME   GG L++  +  G     +Y+   A          V   HS+  
Sbjct: 69  GACLNPVC--LVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
             ++HRDLKP N LLV       LK  DFG +   +     T+  GS  ++APEV    +
Sbjct: 125 KALIHRDLKPPNLLLVAGGT--VLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSN 180
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK---D 334
           Y  + DV++ G+IL+ +++   PF  E     F  +   H        PLI +  K    
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRP---PLIKNLPKPIES 236
Query: 335 LIRKMLCSQPSERLTAHEVL 354
           L+ +     PS+R +  E++
Sbjct: 237 LMTRCWSKDPSQRPSMEEIV 256

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++G+G FG  +    +      A KS+    S+ +    E  ++ +RE+ IM +L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +      + 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ 139
Query: 221 -----VMHRDLKPENFLLVNKDDDFSL--KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
                ++HRDL+  N  L + D++  +  K  DF LS   +     + ++G+  ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 274 L---LKHYGPEADVWTAGVILYILLSGVPPF 301
           +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 36/236 (15%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 30  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----------------- 197
           HL  H+NIV + GA      V ++ E C  G+L + + ++                    
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 198 SERKAAELTRIIVGVVEACHSLGVM------HRDLKPENFLLVN----KDDDFSLKAIDF 247
            + +  EL  ++    +    +  +      HRD+   N LL N    K  DF L     
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
             S +   G     V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 210 NDSNYIVKGNARLPV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/359 (22%), Positives = 138/359 (38%), Gaps = 84/359 (23%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISRE 141
           D+   +++ H  D +++ Y +   LG+G FG    C +   G    A K I   +     
Sbjct: 17  DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK-- 74
Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV------MELCAGGEL-----FDR 190
             E  R EI ++         +  K     +LCV +         +C   EL     FD 
Sbjct: 75  --EAARLEINVLEK-------INEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDF 125
Query: 191 IIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------- 237
           +    +  Y   +   +   +   V+  H   + H DLKPEN L VN D           
Sbjct: 126 LKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKR 185
Query: 238 DDFSLKA-----IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL 291
           D+ S+K+     +DFG + F    +  + +V + +Y APEV+L+  +    DVW+ G I+
Sbjct: 186 DERSVKSTAVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCII 243
Query: 292 YILLSGVPPFWAETQQ---GIFDAVL------------------KGHIDFESDPWP---- 326
           +    G   F     +    + + +L                  +G +D++ +       
Sbjct: 244 FEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYV 303
Query: 327 ----------LISDSAK-----DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
                     L S++ +     DLI  ML  +P++RLT  E L HP+       P   L
Sbjct: 304 RENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKL 362

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 202
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 89
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 146
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 147 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 202
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 90  LGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
           LG+ +  I  +DL T  ++LG GQFG      +     + A K I +  +   E +E   
Sbjct: 14  LGYGSWEIDPKDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE--- 68
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELT 206
            E ++M +L+ H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ 
Sbjct: 69  -EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + +   +E   S   +HRDL   N L+   +D   +K  DFGLS +    +  T  VGS 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEE-TSSVGSK 182
Query: 267 Y---YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   +  PEVL+   +  ++D+W  GV+++ + S G  P+
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L 
Sbjct: 135 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLA 190
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 202
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 72
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 129
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---SP-YYVA 270
              +   +HR+L   N L+ N++    +K  DFGL+      + +  V     SP ++ A
Sbjct: 130 YLGTKRYIHRNLATRNILVENEN---RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGV 298
           PE L +  +   +DVW+ GV+LY L + +
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 50/289 (17%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL  LG ++G+G +G+        +G   A K I  R  +  ++ + +  ++ ++   + 
Sbjct: 23  DLKDLG-EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE---LTRIIVGVVEA 215
              IV   GA        I MEL +    FD+  +  +           L +I +  V+A
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 216 CH----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV-----GSP 266
            +    +L ++HRD+KP N LL   D   ++K  DFG+S     GQ+   +      G  
Sbjct: 138 LNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCR 189
Query: 267 YYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD---AVLKGHI 318
            Y+APE +      + Y   +DVW+ G+ LY L +G  P+       +FD    V+KG  
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKG-- 245
Query: 319 DFESDPWPLISDSAK--------DLIRKMLCSQPSERLTAHEVLCHPWI 359
               DP P +S+S +        + +   L    S+R    E+L HP+I
Sbjct: 246 ----DP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LGRK+G G FG  YL T+IA G E A K    +    +  +E      +I   + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGV 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            I TI+    +     +VMEL      +LF+   ++  +S +    L   ++  +E  HS
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              +HRD+KP+NFL+        +  IDFGL+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 28  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 87
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 204
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 9   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 63  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T   GS +   +  PEV
Sbjct: 122 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEV 177
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LGRK+G G FG  YL T+IA G E A K    +    +  +E      +I   + G  
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGV 63
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            I TI+    +     +VMEL      +LF+   ++  +S +    L   ++  +E  HS
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              +HRD+KP+NFL+        +  IDFGL+
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 123/323 (38%), Gaps = 70/323 (21%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +   G       I K   + R   E  R EIQ++ HL    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRY-CEAARSEIQVLEHLNTTD 72
Query: 161 NIVTIKGA-----YEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGVV 213
              T +       +E    + IV EL  G   +D I + G    R     ++   I   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 214 EACHSLGVMHRDLKPENFLLVNKD-----------DDFSL-----KAIDFGLSVFFKPGQ 257
              HS  + H DLKPEN L V  D           D+ +L     K +DFG + +    +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DDE 189
Query: 258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL---YILLSGVPPFWAETQQGIFDAV 313
             + +V   +Y APEV+L   +    DVW+ G IL   Y+  +  P   ++    + + +
Sbjct: 190 HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 314 L-------------KGHIDFESDPWPLISDSAK------------------------DLI 336
           L             + +   +   W   S + +                        DLI
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
           +KML   P++R+T  E L HP+ 
Sbjct: 310 QKMLEYDPAKRITLREALKHPFF 332

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 63  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 122
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 239
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   LC        TG + A KS+          + D+++EI+I+ +L  H+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 83
Query: 161 NIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG    +    + ++ME    G L + + +      +    L + +   V+ C  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKG 138
Query: 219 LGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---KPGQIFTDVVGSP-YY 268
           +  +      HRDL   N L+   + +  +K  DFGL+      K      D   SP ++
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 269 VAPEVLLK-HYGPEADVWTAGVILYILLS 296
            APE L++  +   +DVW+ GV L+ LL+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + ++ E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL---- 156
           Y L RKLG G F T +L  ++      A K +   K+ + E  ED   EI+++  +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAED---EIKLLQRVNDAD 76
Query: 157 ------AGHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL--- 205
                  G  +I+ +   +  +    VH+VM     GE    +I++  Y  R    +   
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVK 134
Query: 206 ---TRIIVGVVEACHSLGVMHRDLKPENFLLV---NKDDDFSLKAIDFGLSVFFKPGQIF 259
               ++++G+       G++H D+KPEN L+    + ++   +K  D G + ++   + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG 297
           T+ + +  Y +PEVLL   +G  AD+W+   +++ L++G
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL---- 156
           Y L RKLG G F T +L  ++      A K +   K+ + E  ED   EI+++  +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAED---EIKLLQRVNDAD 76
Query: 157 ------AGHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL--- 205
                  G  +I+ +   +  +    VH+VM     GE    +I++  Y  R    +   
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVK 134
Query: 206 ---TRIIVGVVEACHSLGVMHRDLKPENFLLV---NKDDDFSLKAIDFGLSVFFKPGQIF 259
               ++++G+       G++H D+KPEN L+    + ++   +K  D G + ++   + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG 297
           T+ + +  Y +PEVLL   +G  AD+W+   +++ L++G
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 15/182 (8%)
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           D   E  IM     H NI+ ++G         IV E    G L D  + R H  +    +
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL-RTHDGQFTIMQ 152
Query: 205 LTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIF 259
           L  ++ GV   +     LG +HRDL   N L+   D +   K  DFGLS   +  P    
Sbjct: 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 260 TDVVGSP--YYVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLK 315
           T   G     + APE +  + +   +DVW+ GV+++ +L  G  P+W  T + +  +V +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
Query: 316 GH 317
           G+
Sbjct: 270 GY 271

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + ++ E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   LC        TG + A KS+          + D+++EI+I+ +L  H+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 71
Query: 161 NIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG    +    + ++ME    G L + + +      +    L + +   V+ C  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKG 126
Query: 219 LGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---KPGQIFTDVVGSP-YY 268
           +  +      HRDL   N L+   + +  +K  DFGL+      K      D   SP ++
Sbjct: 127 MDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 269 VAPEVLLK-HYGPEADVWTAGVILYILLS 296
            APE L++  +   +DVW+ GV L+ LL+
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 27  RDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 86
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGV 212
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K  E        
Sbjct: 87  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 213 VE--ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPG 256
           +E   C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPD 203
Query: 257 QIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
            +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 35/254 (13%)
Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
           S ++N+  +G D++  +    K   + + + + RK+G G FG   LC  I     +A K 
Sbjct: 9   SGRENLYFQG-DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV 67
Query: 132 ISKRKLISRE-DVE-DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD 189
           +   K  +R   +E D+ ++IQ       +      K  Y D +C  ++ E   G  L++
Sbjct: 68  VRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC--LIFE-PLGPSLYE 124
Query: 190 RIIQRGHYSERKAAELTRIIVGVVEACHSLGVM---HRDLKPENFLL------------- 233
            II R +Y+     ++    + +++A + L  M   H DLKPEN LL             
Sbjct: 125 -IITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 234 ---------VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEAD 283
                    + +     +K IDFG + F         ++ +  Y APEV+L   +   +D
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSD 241
Query: 284 VWTAGVILYILLSG 297
           +W+ G +L  L +G
Sbjct: 242 MWSFGCVLAELYTG 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 35/262 (13%)
Query: 83  DNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACK 130
           D    Y    KT +I DL        TL R LG G FG  Y           + ++ A K
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
           ++ +  + S +D  D   E  I+  L  H+NIV   G    SL   I++EL AGG+L   
Sbjct: 68  TLPE--VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 124
Query: 191 IIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNK 236
           + +        S     +L  +   +   C  L     +HRD+   N LL       V K
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 184
Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             DF +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + 
Sbjct: 185 IGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 296 S-GVPPFWAETQQGIFDAVLKG 316
           S G  P+ +++ Q + + V  G
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG 262

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 70
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I+MEL AGG+L   + +  
Sbjct: 71  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 189 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+  L  H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 86  -VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 204 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I+MEL AGG+L   + +  
Sbjct: 86  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 143
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 204 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 48/296 (16%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 30  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 81
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 82  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 257 QI-----FTDVVGSPYYVAPEVL----LKHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
           Q        +  G+  + APE+L     +      D+++ G + Y +LS G  PF  +  
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 307 QGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVLCHP 357
           +     +++G   F  D    + D      A DLI +M+   P +R TA +VL HP
Sbjct: 260 RE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 90  LGHKTDNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLISREDVEDV 146
           L  + + + DL+   G K+G+G +G  Y         +  +A K I    +         
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-----SA 65
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAE 204
            REI ++  L  H N+++++  +       + +           II+  R   + +K  +
Sbjct: 66  CREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 205 LTR-----IIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF-- 253
           L R     ++  +++  H L    V+HRDLKP N L++ +  +   +K  D G +  F  
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 254 --KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
             KP      VV + +Y APE+LL  +HY    D+W  G I   LL+  P F
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 20/267 (7%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G F T Y   +  T +E A   +  RKL ++ + +  + E + +  L  H NIV  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEXLKGLQ-HPNIVRF 90
Query: 166 KGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             ++E ++    C+ +V EL   G L   + +      +      R I+  ++  H+   
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 221 -VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYG 279
            ++HRDLK +N  +       S+K  D GL+   K       V+G+P + APE   + Y 
Sbjct: 151 PIIHRDLKCDNIFITGPTG--SVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKYD 207
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQG--IFDAVLKG--HIDFESDPWPLISDSAKDL 335
              DV+  G       +   P+ +E Q    I+  V  G     F+    P +    K++
Sbjct: 208 ESVDVYAFGXCXLEXATSEYPY-SECQNAAQIYRRVTSGVKPASFDKVAIPEV----KEI 262
Query: 336 IRKMLCSQPSERLTAHEVLCHPWICEN 362
           I   +     ER +  ++L H +  E 
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQEE 289

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 48/296 (16%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 30  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 81
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 82  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 257 QI-----FTDVVGSPYYVAPEVL----LKHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
           Q        +  G+  + APE+L     +      D+++ G + Y +LS G  PF  +  
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 307 QGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVLCHP 357
           +     +++G   F  D    + D      A DLI +M+   P +R TA +VL HP
Sbjct: 260 RE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDP 202
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 195
Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 196 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 252
Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            PL   D   DL+R+    +P ER +  ++L
Sbjct: 253 -PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 205
Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 262
Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            PL   D   DL+R+    +P ER +  ++L
Sbjct: 263 -PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 33/282 (11%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++  +  LGR    G +G       + +G   A K I  R  ++ ++ + +  ++ I
Sbjct: 5   KADDLEPIMELGR----GAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDI 58
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMEL--CAGGELFDRIIQRGH-YSERKAAELTRII 209
                     VT  GA      V I MEL   +  + + ++I +G    E    ++   I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 210 VGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---- 264
           V  +E  HS L V+HRD+KP N L+   +    +K  DFG+S     G +  DV      
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS-----GYLVDDVAKDIDA 170
Query: 265 ------SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPF--WAETQQGIFDAVLKG 316
                 +P  + PE+  K Y  ++D+W+ G+ +  L     P+  W    Q +   V + 
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230
Query: 317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                +D +   S    D   + L     ER T  E++ HP+
Sbjct: 231 SPQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 43/297 (14%)
Query: 48  QQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL------- 100
           Q+L + +   ++P+      ++S  +   IM    D    Y    KT +I DL       
Sbjct: 7   QELQAMQMELQSPEY-----KLSKLRTSTIM---TDYNPNYSFAGKTSSISDLKEVPRKN 58
Query: 101 YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            TL R LG G FG  Y           + ++ A K++ +  + S +D  D   E  I+  
Sbjct: 59  ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISK 116
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVG 211
              H+NIV   G    SL   I++EL AGG+L   + +        S     +L  +   
Sbjct: 117 F-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 212 VVEACHSLG---VMHRDLKPENFLL-------VNKDDDFSLKAIDFGLSVFFKPGQIFTD 261
           +   C  L     +HRD+   N LL       V K  DF +    +  S + K G     
Sbjct: 176 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 235
Query: 262 VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           V   P    PE  ++  +  + D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 236 VKWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 288

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 38/277 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 12  KLSKLRTSTIM---TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 68
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 69  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 125
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 126 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 185
Query: 229 ENFLL-------VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGP 280
            N LL       V K  DF +    +  S + K G     V     ++ PE  ++  +  
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTS 241
Query: 281 EADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           + D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 242 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 278

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+  K    + ++ E    E  IM 
Sbjct: 7   REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 64
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGV 212
           +L  H +IV + G  E+     I+MEL   GEL       GHY ER   + ++  +++  
Sbjct: 65  NL-DHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYS 115
Query: 213 VEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGS 265
           ++ C       S+  +HRD+   N L+ + +    +K  DFGLS + +    +   V   
Sbjct: 116 LQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 266 PY-YVAPEVL-LKHYGPEADVWTAGVILYILLS--GVPPFWAETQQGI 309
           P  +++PE +  + +   +DVW   V ++ +LS    P FW E +  I
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + ++ E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 35/262 (13%)
Query: 83  DNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACK 130
           D    Y    KT +I DL        TL R LG G FG  Y           + ++ A K
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
           ++ +  + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   
Sbjct: 68  TLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 124
Query: 191 IIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNK 236
           + +        S     +L  +   +   C  L     +HRD+   N LL       V K
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 184
Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             DF +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + 
Sbjct: 185 IGDFGMAQDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 296 S-GVPPFWAETQQGIFDAVLKG 316
           S G  P+ +++ Q + + V  G
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG 262

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+  K    + ++ E    E  IM 
Sbjct: 23  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 80
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGV 212
           +L  H +IV + G  E+     I+MEL   GEL       GHY ER   + ++  +++  
Sbjct: 81  NL-DHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYS 131
Query: 213 VEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGS 265
           ++ C       S+  +HRD+   N L+ + +    +K  DFGLS + +    +   V   
Sbjct: 132 LQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 266 PY-YVAPEVL-LKHYGPEADVWTAGVILYILLS--GVPPFWAETQQGI 309
           P  +++PE +  + +   +DVW   V ++ +LS    P FW E +  I
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 35/262 (13%)
Query: 83  DNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACK 130
           D    Y    KT +I DL        TL R LG G FG  Y           + ++ A K
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
           ++ +  + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   
Sbjct: 68  TLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 124
Query: 191 IIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNK 236
           + +        S     +L  +   +   C  L     +HRD+   N LL       V K
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 184
Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             DF +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + 
Sbjct: 185 IGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 296 S-GVPPFWAETQQGIFDAVLKG 316
           S G  P+ +++ Q + + V  G
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG 262

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 38/277 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 2   KLSKLRTSTIM---TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 58
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 59  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 115
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 116 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 175
Query: 229 ENFLL-------VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGP 280
            N LL       V K  DF +    +  S + K G     V     ++ PE  ++  +  
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTS 231
Query: 281 EADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           + D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 232 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 268

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 320
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 321 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 379 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 434
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 491
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 492 SLHDLMCQCWRKEPEERPT 510

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G G+FG          G    C +I   K   + +   D   E  IM     H NI+ +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 95
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMH 223
           +G       V I+ E    G L D  +++  G ++  +   + R I   ++    +  +H
Sbjct: 96  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVH 154
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAPEVL-LKHY 278
           RDL   N L+   + +   K  DFG+S   +  P   +T   G     + APE +  + +
Sbjct: 155 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 279 GPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
              +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 212 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 251

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+  K    + ++ E    E  IM 
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 68
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGV 212
           +L  H +IV + G  E+     I+MEL   GEL       GHY ER   + ++  +++  
Sbjct: 69  NL-DHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYS 119
Query: 213 VEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGS 265
           ++ C       S+  +HRD+   N L+ + +    +K  DFGLS + +    +   V   
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 266 PY-YVAPEVL-LKHYGPEADVWTAGVILYILLS--GVPPFWAETQQGI 309
           P  +++PE +  + +   +DVW   V ++ +LS    P FW E +  I
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 70
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 71  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 128
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 189 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 63
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSL- 219
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 120
Query: 220 --GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 121 EASVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G G+FG          G    C +I   K   + +   D   E  IM     H NI+ +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 80
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMH 223
           +G       V I+ E    G L D  +++  G ++  +   + R I   ++    +  +H
Sbjct: 81  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAPEVL-LKHY 278
           RDL   N L+   + +   K  DFG+S   +  P   +T   G     + APE +  + +
Sbjct: 140 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 279 GPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
              +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 236

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI-SKRKLISREDVEDVRREIQIMHHLA 157
           D Y +   +G+G FG      +       A K I +K+  +++  +E    E+   H   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 158 GHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGV 212
               IV +K    + + LC+   M      +L      RG   + + + A ++   ++ +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
             A   L ++H DLKPEN LL N     ++K +DFG S   + GQ     + S +Y +PE
Sbjct: 174 --ATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSC--QLGQRIYQXIQSRFYRSPE 228
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           VLL   Y    D+W+ G IL  + +G P F
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI-SKRKLISREDVEDVRREIQIMHHLA 157
           D Y +   +G+G FG      +       A K I +K+  +++  +E    E+   H   
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 158 GHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGV 212
               IV +K    + + LC+   M      +L      RG   + + + A ++   ++ +
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
             A   L ++H DLKPEN LL N     ++K +DFG S   + GQ     + S +Y +PE
Sbjct: 155 --ATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSC--QLGQRIYQXIQSRFYRSPE 209
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           VLL   Y    D+W+ G IL  + +G P F
Sbjct: 210 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 36/276 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 13  KLSKLRTSTIM---TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 69
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 70  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 126
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 127 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 186
Query: 229 ENFLLVNKDDDFSLKAIDFGLSV------FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
            N LL         K  DFG++       +++ G      V    ++ PE  ++  +  +
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSK 243
Query: 282 ADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
            D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 244 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 279

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 4   YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 62
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 63  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 120
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 121 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 181 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 236
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 237 PYPSKSNQEVLEFVTSG 253

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 86  -VYSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 204 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G G+FG          G    C +I   K   + +   D   E  IM     H NI+ +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 74
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMH 223
           +G       V I+ E    G L D  +++  G ++  +   + R I   ++    +  +H
Sbjct: 75  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAPEVL-LKHY 278
           RDL   N L+   + +   K  DFG+S   +  P   +T   G     + APE +  + +
Sbjct: 134 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 279 GPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
              +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 230

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 36/276 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 36  KLSKLRTSTIM---TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 93  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 149
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209
Query: 229 ENFLLVNKDDDFSLKAIDFGLSV------FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
            N LL         K  DFG++       +++ G      V    ++ PE  ++  +  +
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSK 266
Query: 282 ADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
            D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 267 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 238 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 408
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 48/294 (16%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +  Y  GH        Y   +KLG+G F    L   +  G  +A K I   +   ++D E
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDRE 71
Query: 145 DVRREIQIMHHLAGHKNIVTI-------KGAYEDSLCVHIVMELCAGGELF---DRIIQR 194
           + +RE   MH L  H NI+ +       +GA  ++    +++     G L+   +R+  +
Sbjct: 72  EAQREAD-MHRLFNHPNILRLVAYCLRERGAKHEAW---LLLPFFKRGTLWNEIERLKDK 127
Query: 195 GHY-SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
           G++ +E +   L   I   +EA H+ G  HRDLKP N LL    D+     +D G     
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLG----- 179
Query: 254 KPGQIFTDVVGSPY------YVAPEVLLKHYGPE-------------ADVWTAGVILYIL 294
              Q    V GS        + A    + +  PE              DVW+ G +LY +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPW-PLISDSAKDLIRKMLCSQPSER 347
           + G  P+    Q+G  D+V     +  S P  P  S +   L+  M+   P +R
Sbjct: 240 MFGEGPYDMVFQKG--DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI-SKRKLISREDVEDVRREIQIMHHLA 157
           D Y +   +G+G FG      +       A K I +K+  +++  +E    E+   H   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 158 GHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGV 212
               IV +K    + + LC+   M      +L      RG   + + + A ++   ++ +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
             A   L ++H DLKPEN LL N     ++K +DFG S   + GQ     + S +Y +PE
Sbjct: 174 --ATPELSIIHCDLKPENILLCNPKRX-AIKIVDFGSSC--QLGQRIYQXIQSRFYRSPE 228
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           VLL   Y    D+W+ G IL  + +G P F
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 238 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 408
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 52/300 (17%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 12  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 63
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 257 QI-----FTDVVGSPYYVAPEVL--------LKHYGPEADVWTAGVILYILLS-GVPPFW 302
           Q        +  G+  + APE+L         +      D+++ G + Y +LS G  PF 
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVLCHP 357
            +  +     +++G   F  D    + D      A DLI +M+   P +R TA +VL HP
Sbjct: 242 DKYSRE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HR+L   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 202
Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 203 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 259
Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            PL   D   DL+R+    +P ER +  ++L
Sbjct: 260 -PLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-------EIQIM 153
           + LGRK+G G FG  YL T I T  E A K            +E+V+        E +I 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYESKIY 56
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVG 211
             L G   I  ++    +     +VM+L      +LF+   ++   S +    L   ++ 
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--------PGQIFTDVV 263
            VE  HS   +HRD+KP+NFL+        +  IDFGL+  ++        P +   ++ 
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 264 GSPYYVAPEVLLKHYGPEA----DVWTAGVILYILLSGVPPFWAETQQG 308
           G+  Y +   +  H G E     D+ + G +L   L G  P W   + G
Sbjct: 175 GTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAG 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 63
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 120
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 121 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 66
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 123
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 124 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 179
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 102/254 (40%), Gaps = 13/254 (5%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG G +G  +       G  +A K  S       +D      E+     +  H   V +
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHR 224
           + A+E+   +++  ELC G  L       G    E +     R  +  +   HS G++H 
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADV 284
           D+KP N  L  +      K  DFGL V            G P Y+APE+L   YG  ADV
Sbjct: 182 DVKPANIFLGPRG---RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADV 238
Query: 285 WTAGV-ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
           ++ G+ IL +  +   P   E  Q +    L    +F +     +S   + ++  ML   
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFTAG----LSSELRSVLVMMLEPD 292
Query: 344 PSERLTAHEVLCHP 357
           P  R TA  +L  P
Sbjct: 293 PKLRATAEALLALP 306

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLS-HPK 61
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 118
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 174
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG                ++++ + L    +  +   +  E++I+ 
Sbjct: 28  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 87
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGV 212
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K  +L +  + +
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 213 -------------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ 257
                        +E   S   +HRDL   N LL  K+    +K  DFGL+  +   P  
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDX 204
Query: 258 IFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 52/300 (17%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 12  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 63
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 257 QI-----FTDVVGSPYYVAPEVL--------LKHYGPEADVWTAGVILYILLS-GVPPFW 302
           Q        +  G+  + APE+L         +      D+++ G + Y +LS G  PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVLCHP 357
            +  +     +++G   F  D    + D      A DLI +M+   P +R TA +VL HP
Sbjct: 242 DKYSRE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLS-HPK 64
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 121
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 122 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 177
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 238 -HEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 408
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 106 KLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH L  +  IV
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYIV 73
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVM 222
            + G  +    + +VME+  GG L   ++ +R        AEL   +   ++       +
Sbjct: 74  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY---YVAPEVL-LKH 277
           HRDL   N LLVN+      K  DFGLS         +T      +   + APE +  + 
Sbjct: 133 HRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           +   +DVW+ GV ++  LS G  P+
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LGRK+G G FG  YL   IA+G E A K    +    +  +E      +    + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIES-----KFYKMMQGGV 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            I +IK    +     +VMEL      +LF+   ++  +S +    L   ++  +E  HS
Sbjct: 66  GIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              +HRD+KP+NFL+        +  IDFGL+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 184 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGNM----SPEAFLQEAQVMKKLR 238
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 239 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL    +  + +T   G+ +   + APE
Sbjct: 297 VERMNYVHRDLRAANILV---GENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPE 352
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 409
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 410 SLHDLMCQCWRKDPEERPT 428

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IVME  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +   ED  D   E ++M  L+ H  
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIKEGSM--SED--DFIEEAEVMMKLS-HPK 83
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 140
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 141 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 196
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 197 SFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 14  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E    G L D +  + G Y    +  +++  I   +  
Sbjct: 69  -HEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 127 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 182
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 239
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN-IV 163
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L  H + IV
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--HSDFIV 87
Query: 164 TIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             +G         + +VME    G L D  +QR H +   A+ L      + +    LG 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYLGS 145
Query: 221 --VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-Y 267
              +HRDL   N L+   + +  +K  DFGL+          V  +PGQ       SP +
Sbjct: 146 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------SPIF 195
Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLS 296
           + APE L  + +  ++DVW+ GV+LY L +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 10  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 64
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 65  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 123 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 178
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 235
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 236 SLHDLMCQCWRKEPEERPT 254

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+L  LG+ LG+G+FG+     L  E  T ++ A K++ K    S+ ++E+   E   M 
Sbjct: 33  RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMK 91
Query: 155 HLAGHKNIVTIKGAYEDSLCVH----------IVMELCAGGELFDRIIQRGHYSERKAAE 204
             + H N++ + G     +C+           +++     G+L   ++     +  K   
Sbjct: 92  DFS-HPNVIRLLG-----VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 205 LTRIIVGVVEACHSL------GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV------F 252
           L  ++  +V+    +        +HRDL   N +L    DD ++   DFGLS       +
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDY 202
Query: 253 FKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIF 310
           ++ G+I    V    ++A E L  + Y  ++DVW  GV ++ I   G+ P+       ++
Sbjct: 203 YRQGRIAKMPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 311 DAVLKGH 317
           D +L GH
Sbjct: 260 DYLLHGH 266

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN-IV 163
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L  H + IV
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--HSDFIV 74
Query: 164 TIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             +G         + +VME    G L D  +QR H +   A+ L      + +    LG 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYLGS 132
Query: 221 --VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-Y 267
              +HRDL   N L+   + +  +K  DFGL+          V  +PGQ       SP +
Sbjct: 133 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------SPIF 182
Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLS 296
           + APE L  + +  ++DVW+ GV+LY L +
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV+E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN-IV 163
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L  H + IV
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--HSDFIV 75
Query: 164 TIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             +G         + +VME    G L D  +QR H +   A+ L      + +    LG 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYLGS 133
Query: 221 --VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-Y 267
              +HRDL   N L+   + +  +K  DFGL+          V  +PGQ       SP +
Sbjct: 134 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------SPIF 183
Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLS 296
           + APE L  + +  ++DVW+ GV+LY L +
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 59/284 (20%)
Query: 85  QTYYVLGHKTDNIR--DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           +  Y  G    N++  D Y +   +G+G +G  YL  +       A K ++ R      D
Sbjct: 12  ENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFEDLID 70
Query: 143 VEDVRREIQIMHHLAG------HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH 196
            + + REI I++ L        H  I+       D L  +IV+E+ A  +L         
Sbjct: 71  CKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDEL--YIVLEI-ADSDLKKLFKTPIF 127
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------ 250
            +E+    +   ++   +  H  G++HRDLKP N LL   + D S+K  DFGL+      
Sbjct: 128 LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSD 184
Query: 251 -------------VFFKPG-------QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAG 288
                           +PG       +  T  V + +Y APE++L  ++Y    D+W+ G
Sbjct: 185 KDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTG 244
Query: 289 VILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
            I   LL+                ++K HI+  ++ +PL   S+
Sbjct: 245 CIFAELLN----------------MMKSHINNPTNRFPLFPGSS 272

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +GR++G+G FG  +  T +    + A K   +R      D   +R E +    LAG  
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
            I  +    ++ L   +V++L  G  L D +   G  +S +  A   + ++  V++ H  
Sbjct: 66  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 124
Query: 220 GVMHRDLKPENFLL--VNKDDDFSLKAIDFGLSVFFK 254
            +++RD+KP+NFL+   N  +   +  +DFG+  F++
Sbjct: 125 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 161

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 25/239 (10%)
Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           G  LG+G FG     T   TG     K + +      E      +E+++M  L  H N++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVL 70
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVM 222
              G       ++ + E   GG L   I      Y   +     + I   +   HS+ ++
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 223 HRDLKPENFLLVNKDD----DFSL-------KAIDFGLSVFFKPGQI--FTDVVGSPYYV 269
           HRDL   N L+    +    DF L       K    GL    KP +   +T VVG+PY++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGNPYWM 189
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGV---PPFWAETQQGIFDAVLKGHIDFESDP 324
           APE++  + Y  + DV++ G++L  ++  V   P +   T    F   ++G +D    P
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--FGLNVRGFLDRYCPP 246

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +GR++G+G FG  +  T +    + A K   +R      D   +R E +    LAG  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
            I  +    ++ L   +V++L  G  L D +   G  +S +  A   + ++  V++ H  
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 220 GVMHRDLKPENFLL--VNKDDDFSLKAIDFGLSVFFK 254
            +++RD+KP+NFL+   N  +   +  +DFG+  F++
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 14  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E    G L D +  + G Y    +  +++  I   +  
Sbjct: 69  -HEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 127 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPE 182
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 239
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 80/348 (22%), Positives = 135/348 (38%), Gaps = 94/348 (27%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQI 152
           D +++ Y +   LG+G FG    C + A G     KS    K+I    +  E  R EI +
Sbjct: 47  DWLQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINV 101
Query: 153 MHHLAGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDR----IIQRGHYSERKA 202
           +         +  K      LCV      +    +C   EL  +     ++  ++   + 
Sbjct: 102 L-------KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF---QP 151
Query: 203 AELTRIIVGVVEACHSLGVMHR------DLKPENFLLVNKD----------------DDF 240
             L  +     + CH+L  +H       DLKPEN L VN +                 + 
Sbjct: 152 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 211
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP 299
           S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    G  
Sbjct: 212 SIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 269
Query: 300 PFWAETQQG---IFDAVL------------------KGHIDFESDPW----------PL- 327
            F     +    + + +L                  KG + ++ +            PL 
Sbjct: 270 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 329
Query: 328 ---ISDSAK-----DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
              + DS +     DL+R+ML   P++R+T  E L HP+    G+ P+
Sbjct: 330 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA--GLTPE 375

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 80/348 (22%), Positives = 135/348 (38%), Gaps = 94/348 (27%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQI 152
           D +++ Y +   LG+G FG    C + A G     KS    K+I    +  E  R EI +
Sbjct: 24  DWLQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINV 78
Query: 153 MHHLAGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDR----IIQRGHYSERKA 202
           +         +  K      LCV      +    +C   EL  +     ++  ++   + 
Sbjct: 79  L-------KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF---QP 128
Query: 203 AELTRIIVGVVEACHSLGVMHR------DLKPENFLLVNKD----------------DDF 240
             L  +     + CH+L  +H       DLKPEN L VN +                 + 
Sbjct: 129 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 188
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP 299
           S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    G  
Sbjct: 189 SIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 246
Query: 300 PFWAETQQG---IFDAVL------------------KGHIDFESDP----------WPL- 327
            F     +    + + +L                  KG + ++ +            PL 
Sbjct: 247 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 306
Query: 328 ---ISDSAK-----DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
              + DS +     DL+R+ML   P++R+T  E L HP+    G+ P+
Sbjct: 307 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA--GLTPE 352

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 8   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 63  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 121 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 176
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 233
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 234 SLHDLMCQCWRKDPEERPT 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 6   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 60
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 61  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 119 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 174
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 231
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 232 SLHDLMCQCWRKDPEERPT 250

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHL-----AGH 159
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L       +
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           + +    G  E    + +VME    G L D  +QR H +   A+ L      + +    L
Sbjct: 74  RGVSYGPGRPE----LRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYL 127
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---KPGQIFTDVVGSP-YYVAPE 272
           G    +HRDL   N L+   + +  +K  DFGL+      K   +  +   SP ++ APE
Sbjct: 128 GSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 273 VLLKH-YGPEADVWTAGVILYILLS 296
            L  + +  ++DVW+ GV+LY L +
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 7/176 (3%)
Query: 175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV 234
           +++   L  G +L   + ++G  +  +A  + R I   ++A H+ G  HRD+KPEN L+ 
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV- 167
Query: 235 NKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL 291
              DDF+   +DFG++      ++    + VG+ YY APE   + H    AD++    +L
Sbjct: 168 -SADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVL 225
Query: 292 YILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER 347
           Y  L+G PP+  + Q  +  A +   I   S   P I  +   +I +     P +R
Sbjct: 226 YECLTGSPPYQGD-QLSVXGAHINQAIPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG                ++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGV 212
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K  +L +  + +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--DLYKDFLTL 143
Query: 213 VE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ 257
               C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P  
Sbjct: 144 EHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDY 200
Query: 258 IFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 106 KLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH L  +  IV
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYIV 399
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVM 222
            + G  + +  + +VME+  GG L   ++ +R        AEL   +   ++       +
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY---YVAPEVL-LKH 277
           HR+L   N LLVN+      K  DFGLS         +T      +   + APE +  + 
Sbjct: 459 HRNLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           +   +DVW+ GV ++  LS G  P+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 80/345 (23%), Positives = 133/345 (38%), Gaps = 88/345 (25%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQI 152
           D +++ Y +   LG+G FG    C + A G     KS    K+I    +  E  R EI +
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDR-IIQRGHYSERKAAEL 205
           +         +  K      LCV      +    +C   EL  +   +    +  +   L
Sbjct: 70  L-------KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 206 TRIIVGVVEACHSLGVMHR------DLKPENFLLVNKD----------------DDFSLK 243
             +     + CH+L  +H       DLKPEN L VN +                 + S++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW 302
             DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    G   F 
Sbjct: 183 VADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 303 AETQQG---IFDAVL------------------KGHIDFESDP----------WPL---- 327
               +    + + +L                  KG + ++ +            PL    
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300
Query: 328 ISDSAK-----DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
           + DS +     DL+R+ML   P++R+T  E L HP+    G+ P+
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA--GLTPE 343

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 24/225 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG                ++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI------------IQRGHYSERK 201
           H+  H N+V + GA  +    + +++E C  G L   +            + +   +   
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIF 259
               +  +   +E   S   +HRDL   N LL  K+    +K  DFGL+  ++  P  + 
Sbjct: 146 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKIXDFGLARDIYKDPDYVR 202
Query: 260 TDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
                 P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC--- 216
           KN V         + ++I M+LC    L D + +R    +R+      I + + EA    
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDV---------V 263
           HS G+MHRDLKP N      D    +K  DFGL       +    + T +         V
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV 237
Query: 264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILL 295
           G+  Y++PE +   +Y  + D+++ G+IL+ LL
Sbjct: 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 15  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 72
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 73  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++        + K 
Sbjct: 132 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 188
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 189 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 245 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  + 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKIR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 47/286 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          D+
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMT---------RDI 180
Query: 263 VGSPYY------------VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
             + YY            +APE L    +   +D+W+ GV+L+ + S    P+   + + 
Sbjct: 181 YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   V+ G    + D  P   +   DL+R      P  R T  E++
Sbjct: 241 VLKFVMDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV+E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  +  T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL   N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLAAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 47/286 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          D+
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMT---------RDI 180
Query: 263 VGSPYY------------VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
             + YY            +APE L    +   +D+W+ GV+L+ + S    P+   + + 
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   V+ G    + D  P   +   DL+R      P  R T  E++
Sbjct: 241 VLKFVMDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           +IVME   G  L     Q+   +E  A  L   I+  +   HS+G+++ DLKPEN +L  
Sbjct: 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE--ILPALSYLHSIGLVYNDLKPENIMLTE 217
Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILL 295
           +     LK ID G          F  + G+P + APE++        D++T G  L  L 
Sbjct: 218 E----QLKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALT 270
Query: 296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE 352
             +P     T+ G +   L      E DP     DS   L+R+ +   P +R T  E
Sbjct: 271 LDLP-----TRNGRYVDGLP-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAE 317

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 7   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   + IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 62  -HEKLVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  +  T   G+ +   + APE
Sbjct: 120 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 175
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 232
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 233 SLHDLMCQCWRKEPEERPT 251

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 33/283 (11%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++  +  LGR    G +G       + +G   A K I  R  ++ ++ + +  ++ I
Sbjct: 32  KADDLEPIXELGR----GAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDI 85
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMEL--CAGGELFDRIIQRGH-YSERKAAELTRII 209
                     VT  GA      V I  EL   +  + + ++I +G    E    ++   I
Sbjct: 86  SXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 210 VGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----- 263
           V  +E  HS L V+HRD+KP N L+   +    +K  DFG+S     G +  DV      
Sbjct: 146 VKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKXCDFGIS-----GYLVDDVAKDIDA 197
Query: 264 -----GSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPF--WAETQQGIFDAVLKG 316
                 +P  + PE+  K Y  ++D+W+ G+    L     P+  W    Q +   V + 
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEP 257
Query: 317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                +D +   S    D   + L     ER T  E+  HP+ 
Sbjct: 258 SPQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 47/245 (19%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRRE 149
           H    I D Y +   +G G +G  ++C E    +E    +I K  R      D + + RE
Sbjct: 46  HSDWQIPDRYEIRHLIGTGSYG--HVC-EAYDKLEKRVVAIKKILRVFEDLIDCKRILRE 102
Query: 150 IQIMHHLAGHKNIV-----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAA 203
           I I++ L  H ++V      I    E    +++V+E+      F ++ +   Y +E    
Sbjct: 103 IAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIK 159
Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------------V 251
            L   ++  V+  HS G++HRDLKP N L+   + D S+K  DFGL+            +
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 252 FFKPGQIFTDVVGSP----------------YYVAPEVLL--KHYGPEADVWTAGVILYI 293
              P +   ++V  P                +Y APE++L  ++Y    DVW+ G I   
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 294 LLSGV 298
           LL+ +
Sbjct: 277 LLNMI 281

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 23/235 (9%)
Query: 74  KDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS 133
           K  +M   +  Q  +       N+++L  L + +G+G+FG   L       +   C    
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC---- 223
Query: 134 KRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRII 192
              + +    +    E  +M  L  H N+V + G   E+   ++IV E  A G L D + 
Sbjct: 224 ---IKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 193 QRGHYSERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            RG  S      L +  + V EA   L     +HRDL   N L+    +D   K  DFGL
Sbjct: 280 SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGL 335
Query: 250 SVFFKPGQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   K      D    P  + APE L  K +  ++DVW+ G++L+ + S G  P+
Sbjct: 336 T---KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 17  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 74
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 75  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HR+L   N ++ +   DF++K  DFG++        + K 
Sbjct: 134 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 190
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 191 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 246
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P+ R T  E++
Sbjct: 247 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P+ R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HR+L   N ++ +   DF++K  DFG++        + K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P+ R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L       +   C       + +    +    E  +M  
Sbjct: 19  NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 70
Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 71  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 128
Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 182
Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           PE L  K +  ++DVW+ G++L+ + S G  P+
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 41/269 (15%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L ++LG GQFG  ++ T      + A K++    +      E    E QIM  L 
Sbjct: 8   RESLQLIKRLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTM----SPESFLEEAQIMKKLK 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E    G L D  ++ G     K   L  +   V     
Sbjct: 63  -HDKLVQLYAVVSEE-PIYIVTEYMNKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
               +  +HRDL+  N L+ N       K  DFGL+   +  +  T   G+ +   + AP
Sbjct: 120 YIERMNYIHRDLRSANILVGN---GLICKIADFGLARLIEDNEX-TARQGAKFPIKWTAP 175
Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E  L   +  ++DVW+ G++L  L++ G  P+     + + + V +G+            
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------ 223
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                   +M C Q    ++ HE++ H W
Sbjct: 224 --------RMPCPQDCP-ISLHELMIHCW 243

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 13  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 70
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 71  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          K 
Sbjct: 130 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKG 186
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 187 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 243 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L       +   C       + +    +    E  +M  
Sbjct: 4   NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 55
Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 56  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 113
Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 114 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 167
Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           PE L  K +  ++DVW+ G++L+ + S G  P+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 101 YTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISK-----RKLISRED---VEDVRREIQ 151
           YT+ R +  G +G   +C  + + GI  A K +       R +    D    + V REI+
Sbjct: 24  YTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 152 IMHHLAGHKNIVTIKGAY----EDSLC-VHIVMELCAGGELFDRII--QRGHYSERKAAE 204
           +++H   H NI+ ++  +    E ++  +++V EL        ++I  QR   S +    
Sbjct: 82  LLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQY 138
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
               I+  +   H  GV+HRDL P N LL + +D   +   DF L+         T  V 
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYVT 195
Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDF 320
             +Y APE+++  K +    D+W+AG ++  + +    F   T     + +++  G    
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 321 E-----SDP-----------------W----PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           E     S P                 W    P     A DLI KML   P  R++  + L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 355 CHPWI 359
            HP+ 
Sbjct: 316 RHPYF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 101 YTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISK-----RKLISRED---VEDVRREIQ 151
           YT+ R +  G +G   +C  + + GI  A K +       R +    D    + V REI+
Sbjct: 24  YTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 152 IMHHLAGHKNIVTIKGAY----EDSLC-VHIVMELCAGGELFDRII--QRGHYSERKAAE 204
           +++H   H NI+ ++  +    E ++  +++V EL        ++I  QR   S +    
Sbjct: 82  LLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQY 138
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
               I+  +   H  GV+HRDL P N LL + +D   +   DF L+         T  V 
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYVT 195
Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDF 320
             +Y APE+++  K +    D+W+AG ++  + +    F   T     + +++  G    
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 321 E-----SDP-----------------W----PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           E     S P                 W    P     A DLI KML   P  R++  + L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 355 CHPWI 359
            HP+ 
Sbjct: 316 RHPYF 320

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++        + A K++    +     V+    E  +M  L 
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ 65
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEA 215
            H  +V +         ++I+ E  A G L D +   + G     K  + +  I   +  
Sbjct: 66  -HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    +    K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 125 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 180
Query: 273 VL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            +    +  +++VW+ G++LY I+  G  P+   T   +  A+ +G+
Sbjct: 181 AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY 227

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 105 RKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           R +G+G FG  Y      +    I+ A KS+S+  +   + VE   RE  +M  L  H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGL-NHPN 83
Query: 162 IVTIKGAYEDSLCV-HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++ + G       + H+++     G+L   I  R         +L    + V      L 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY--------- 268
               +HRDL   N +L   D+ F++K  DFGL+          D++   YY         
Sbjct: 142 EQKFVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSVQQHRHAR 189
Query: 269 -----VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
                 A E L  + +  ++DVW+ GV+L+ LL+ G PP+
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 96
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 213
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 214 LARHIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           +LG+ +FG  Y             ++++ + L  + +    E+ R E  +   L  H N+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNV 91
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----------RKAAE------LT 206
           V + G       + ++   C+ G+L + ++ R  +S+          + A E      L 
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             I   +E   S  V+H+DL   N L+ +K    ++K  D GL         F +V  + 
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGL---------FREVYAAD 199
Query: 267 YY------------VAPE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           YY            +APE ++   +  ++D+W+ GV+L+ + S G+ P+   + Q + + 
Sbjct: 200 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259
Query: 313 V 313
           +
Sbjct: 260 I 260

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L ++LG GQFG  ++        + A K++    +     V+    E  +M  L 
Sbjct: 12  RESIKLVKRLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ 66
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEA 215
            H  +V +         ++I+ E  A G L D +   + G     K  + +  I   +  
Sbjct: 67  -HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 125
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    +    K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 126 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 181
Query: 273 VL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            +    +  ++DVW+ G++LY I+  G  P+   T   +  A+ +G+
Sbjct: 182 AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGY 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 73
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 190
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 191 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 32  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 89
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 149
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 150 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 206
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 207 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 264

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           +LG+ +FG  Y             ++++ + L  + +    E+ R E  +   L  H N+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNV 74
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----------RKAAE------LT 206
           V + G       + ++   C+ G+L + ++ R  +S+          + A E      L 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             I   +E   S  V+H+DL   N L+ +K    ++K  D GL         F +V  + 
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGL---------FREVYAAD 182
Query: 267 YY------------VAPE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           YY            +APE ++   +  ++D+W+ GV+L+ + S G+ P+   + Q + + 
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 313 V 313
           +
Sbjct: 243 I 243

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 96
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 213
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 214 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 116/267 (43%), Gaps = 28/267 (10%)
Query: 101 YTLGRKLGQGQFGTT---YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +TLGR LG+G+FG+     L  E  + ++ A K + K  +I+  D+E+  RE   M    
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF- 82
Query: 158 GHKNI-----VTIKGAYEDSLCV-HIVMELCAGGELFDRIIQR---GHYSERKAAELTRI 208
            H ++     V+++   +  L +  +++     G+L   ++      +        L R 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 209 IVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           +V +   +E   S   +HRDL   N +L    +D ++   DFGLS     G  +     S
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 266 PY---YVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDF 320
                ++A E L  + Y   +DVW  GV ++ I+  G  P+       I++ ++ G+   
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN--- 256
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSER 347
                P   +   DL+ +   + P +R
Sbjct: 257 RLKQPPECMEEVYDLMYQCWSADPKQR 283

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 57/292 (19%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           RD+  L R+LG+G FG  +L  C  ++     +  A K++    L +R+D +   RE ++
Sbjct: 15  RDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ---REAEL 70
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELF--------DRIIQRGHYSERKAAE 204
           + +L  H++IV   G   D   + +V E    G+L         D +I       +   E
Sbjct: 71  LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 205 L---------TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
           L         ++I  G+V    S   +HRDL   N L+     +  +K  DFG+S     
Sbjct: 130 LGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLV---GANLLVKIGDFGMS----- 180
Query: 256 GQIFTDVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPF 301
                DV  + YY            + PE ++ + +  E+DVW+ GVIL+ I   G  P+
Sbjct: 181 ----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 302 WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           +  +   + + + +G +       P       D++      +P +RL   E+
Sbjct: 237 FQLSNTEVIECITQGRVLERPRVCP---KEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 34  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 91
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 151
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 152 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 208
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 209 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 187 RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 241
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 242 -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 299 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 354
Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           E +    +  ++DVW+ G++L  I+  G  P+   +   +  A+ +G+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L       +   C       + +    +    E  +M  
Sbjct: 10  NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 61
Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 62  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 119
Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 120 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 173
Query: 271 PEVLLKH-YGPEADVWTAGVILYILLS 296
           PE L +  +  ++DVW+ G++L+ + S
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 14  RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 69  -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 126 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 181
Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           E +    +  ++DVW+ G++L  I+  G  P+   +   +  A+ +G+
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 102 TLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            L R+LG+G FG  +L  C  +    +    ++   K  S    +D  RE +++ +L  H
Sbjct: 16  VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-H 74
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA-----AELTR------- 207
           ++IV   G   +   + +V E    G+L   +   G  +   A      ELT+       
Sbjct: 75  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 208 --IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
             I  G+V    S   +HRDL   N L+    ++  +K  DFG+S          DV  +
Sbjct: 135 QQIAAGMVYLA-SQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYST 181
Query: 266 PYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
            YY            + PE ++ + +  E+DVW+ GV+L+ I   G  P++  +   + +
Sbjct: 182 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241
Query: 312 AVLKGHI 318
            + +G +
Sbjct: 242 CITQGRV 248

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 24  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 79
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAA--ELT 206
            +M     H ++V + G         ++MEL   G+L  + R ++    +    A   L+
Sbjct: 80  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 186
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 247 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 14  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 69
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAA--ELT 206
            +M     H ++V + G         ++MEL   G+L  + R ++    +    A   L+
Sbjct: 70  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 129 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 185
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 186 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 242 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 46  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 101
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 102 SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 161 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 208
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 268
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 269 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 17  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 72
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 73  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 179
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 239
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 240 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 15  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 70
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 71  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 130 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 177
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 237
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 238 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 17  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 72
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 73  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 179
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 239
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 240 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 11  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 66
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 67  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 182
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 183 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 239 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 18  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 73
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 74  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 180
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 181 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 240
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 241 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 24  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 79
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 80  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 186
Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 247 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 181 RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 235
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 236 -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+            VG+ +   + AP
Sbjct: 293 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLA-----------RVGAKFPIKWTAP 338
Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           E +    +  ++DVW+ G++L  I+  G  P+   +   +  A+ +G+
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 386

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 36/281 (12%)
Query: 64  NSAPRISPSKKDNIMRRG--IDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYL--CT 119
            S   +SP++      +G  I+N  Y+         R    L  +LG+G FG  +L  C 
Sbjct: 4   GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63
Query: 120 EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM 179
            +    +    ++   K  S    +D +RE +++  L  H++IV   G   +   + +V 
Sbjct: 64  NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVF 122
Query: 180 ELCAGGELFDRIIQRGHYSERKA------------------AELTRIIVGVVEACHSLGV 221
           E    G+L +R + R H  + K                   A  +++  G+V     L  
Sbjct: 123 EYMRHGDL-NRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHF 179
Query: 222 MHRDLKPENFL----LVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE-VLLK 276
           +HRDL   N L    LV K  DF +    +    +   G+    +   P    PE +L +
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP----PESILYR 235
Query: 277 HYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKG 316
            +  E+DVW+ GV+L+ I   G  P++  +     D + +G
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           RD+  L  +LG+G FG  +L  C  +    +    ++   K  S    +D +RE +++  
Sbjct: 12  RDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 70
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA------------- 202
           L  H++IV   G   +   + +V E    G+L +R + R H  + K              
Sbjct: 71  LQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHGPDAKLLAGGEDVAPGPLG 127
Query: 203 -----AELTRIIVGVVEACHSLGVMHRDLKPENFL----LVNKDDDFSLKAIDFGLSVFF 253
                A  +++  G+V     L  +HRDL   N L    LV K  DF +    +    + 
Sbjct: 128 LGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 186
Query: 254 KPGQIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
             G+    +   P    PE +L + +  E+DVW+ GV+L+ I   G  P++  +     D
Sbjct: 187 VGGRTMLPIRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 242
Query: 312 AVLKG 316
            + +G
Sbjct: 243 CITQG 247

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 11  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 66
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 67  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N  +    +DF++K  DFG++        + 
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETDYYR 182
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 183 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 239 FVMEGGLLDKPDNCP---DMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 9   REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 64
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 65  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 124 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 180
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 181 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 237 FVMEGGLLDKPDNCP---DMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           RD+  L  +LG+G FG  +L  C  +    +    ++   K  S    +D +RE +++  
Sbjct: 18  RDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 76
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA------------- 202
           L  H++IV   G   +   + +V E    G+L +R + R H  + K              
Sbjct: 77  LQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHGPDAKLLAGGEDVAPGPLG 133
Query: 203 -----AELTRIIVGVVEACHSLGVMHRDLKPENFL----LVNKDDDFSLKAIDFGLSVFF 253
                A  +++  G+V     L  +HRDL   N L    LV K  DF +    +    + 
Sbjct: 134 LGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 192
Query: 254 KPGQIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
             G+    +   P    PE +L + +  E+DVW+ GV+L+ I   G  P++  +     D
Sbjct: 193 VGGRTMLPIRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 248
Query: 312 AVLKG 316
            + +G
Sbjct: 249 CITQG 253

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 18  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 73
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 74  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 189
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 190 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 246 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  Y    +A G   A K + + +    E     + E++++  +A H+N++ ++
Sbjct: 46  LGRGGFGKVY-KGRLADGTLVAVKRLKEERXQGGE--LQFQTEVEMIS-MAVHRNLLRLR 101
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELTRIIVGVVEACHS 218
           G         +V    A G +   + +R            +R A    R +  + + C  
Sbjct: 102 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 161
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF--FKPGQIFTDVVGSPYYVAPEVLLK 276
             ++HRD+K  N LL   D++F     DFGL+    +K   +   V G+  ++APE L  
Sbjct: 162 -KIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLST 217
Query: 277 HYGPE-ADVWTAGVILYILLSGVPPF 301
               E  DV+  GV+L  L++G   F
Sbjct: 218 GKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 12/89 (13%)
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV---VGSPYYVAPEV 273
           H   + HRD K +N LL     D +    DFGL+V F+PG+   D    VG+  Y+APEV
Sbjct: 140 HKPSIAHRDFKSKNVLL---KSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 274 L--LKHYGPEA----DVWTAGVILYILLS 296
           L    ++  +A    D++  G++L+ L+S
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 95
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 96  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 148
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 149 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 155
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 156 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 208
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 114
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 115 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 167
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 168 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 18  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 72
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 73  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 131 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 186
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 187 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 242
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 243 -EELYQLMRLCWKERPEDRPT 262

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 101
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 102 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 154
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 155 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 115
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 116 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 168
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 169 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  Y    +A G   A K + + +    E     + E++++  +A H+N++ ++
Sbjct: 38  LGRGGFGKVY-KGRLADGXLVAVKRLKEERTQGGE--LQFQTEVEMIS-MAVHRNLLRLR 93
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGH------YSERKAAELTRIIVGVVEACHSL- 219
           G         +V    A G +   + +R        + +R+     RI +G       L 
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ-----RIALGSARGLAYLH 148
Query: 220 -----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF--FKPGQIFTDVVGSPYYVAPE 272
                 ++HRD+K  N LL   D++F     DFGL+    +K   +   V G   ++APE
Sbjct: 149 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 273 VLLKHYGPE-ADVWTAGVILYILLSGVPPF 301
            L      E  DV+  GV+L  L++G   F
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 97
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 98  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 150
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 151 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 94
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 95  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 147
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 148 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 88
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 89  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 141
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 142 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 230

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 22  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 76
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 77  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 135 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 190
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 191 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 246
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 247 -EELYQLMRLCWKERPEDRPT 266

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 94
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 95  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 147
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 148 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 91
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 92  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 144
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 145 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 17  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 72  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 185
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 186 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 241
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 242 -EELYQLMRLCWKERPEDRPT 261

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 95
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 96  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 148
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 149 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 93
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 94  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 146
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 147 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 7   RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 62  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 120 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 175
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 176 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 231
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 232 -EELYQLMRLCWKERPEDRPT 251

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 426
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 427 L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 484
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 485 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 541
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 368 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 427
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 428 L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 485
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 486 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 542
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 23  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 82
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 83  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 140
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 141 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 197
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 67  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 236
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 237 -EELYQLMRLCWKERPEDRPT 256

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 85  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 143 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 85  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 143 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 3   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 62
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 63  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 120
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 121 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 177
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 178 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	398
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	0.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	0.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	0.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	0.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	0.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	0.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	0.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	0.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	0.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	0.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	0.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	0.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	0.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-179
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-179
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-178
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-178
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-178
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-176
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-176
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-175
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-172
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-172
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-172
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-169
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-169
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-168
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-167
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-158
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-154
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-153
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-104
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-103
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-93
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-89
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-88
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-87
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-87
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-87
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-85
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-84
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-84
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-83
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-82
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-82
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-82
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-82
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-82
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-82
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-81
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-81
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-81
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-81
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-81
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-80
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-80
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-80
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-79
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-75
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-74
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-74
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-71
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-67
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-66
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-65
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-62
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-62
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-62
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-62
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-59
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-58
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-57
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-55
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-54
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-54
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-54
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-53
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-51
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-49
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-49
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-49
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-49
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-48
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-48
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-48
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-47
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-47
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-47
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-47
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-47
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-47
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-47
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-46
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-46
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-45
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-44
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-43
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-43
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-42
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-42
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-42
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-41
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-41
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-41
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-40
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-40
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-40
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-39
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-39
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-39
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-38
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-38
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-38
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-38
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-37
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-37
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-36
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-35
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-35
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-35
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-35
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-34
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-33
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-32
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-31
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-31
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-31
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-31
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-31
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-31
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-31
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-30
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-28
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-28
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-27
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-27
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-26
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-26
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-26
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-19
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	1e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-18
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	6e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	4e-08
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	5e-06
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	1e-04
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	2e-04
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	4e-04
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	5e-04

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  547 bits (1412), Expect = 0.0
 Identities = 116/333 (34%), Positives = 171/333 (51%), Gaps = 8/333 (2%)

Query: 66  APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI 125
            P ++       M RG +      + + +    D Y +  +LG+G F     C    TG+
Sbjct: 1   GPHMASMTGGQQMGRGSE-----FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGL 55

Query: 126 EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG 185
           EFA K I+ +KL S  D + + RE +I   L  H NIV +  + ++    ++V +L  GG
Sbjct: 56  EFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGG 113

Query: 186 ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI 245
           ELF+ I+ R  YSE  A+   + I+  +  CHS G++HR+LKPEN LL +K    ++K  
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAE 304
           DFGL++     + +    G+P Y++PEVL K  Y    D+W  GVILYILL G PPFW E
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233

Query: 305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV 364
            Q  ++  +  G  D+ S  W  ++  AK LI  ML   P +R+TA + L  PWIC    
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293

Query: 365 APDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
                     +  LK+F+A  KLK   L    +
Sbjct: 294 VASAIHRQDTVDCLKKFNARRKLKGAILTTMIA 326

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  540 bits (1393), Expect = 0.0
 Identities = 117/309 (37%), Positives = 166/309 (53%), Gaps = 4/309 (1%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
                   + Y L  +LG+G F     C ++  G E+A   I+ +KL S  D + + RE 
Sbjct: 3   TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREA 61

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +I   L  H NIV +  +  +    +++ +L  GGELF+ I+ R +YSE  A+   + I+
Sbjct: 62  RICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYV 269
             V  CH +GV+HR+LKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y+
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           +PEVL K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  +
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
           +  AKDLI KML   PS+R+TA E L HPWI               +  LK+F+A  KLK
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 300

Query: 389 KMALRVSAS 397
              L V  +
Sbjct: 301 GAILTVMLA 309

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  539 bits (1391), Expect = 0.0
 Identities = 126/310 (40%), Positives = 171/310 (55%), Gaps = 6/310 (1%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +      + Y +   LG+G FG    C +  T  E+A K I+K      +D   + RE++
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVE 73

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +  
Sbjct: 74  LLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD 
Sbjct: 193 EVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWI----CENGVAPDRSLDPAVLSRLKQFSAMNKL 387
           AKDLIRKML   PS R+TA + L HPWI     E     D     + ++ ++QF A  KL
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKL 312

Query: 388 KKMALRVSAS 397
            + AL   AS
Sbjct: 313 AQAALLYMAS 322

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  538 bits (1387), Expect = 0.0
 Identities = 128/312 (41%), Positives = 175/312 (56%), Gaps = 4/312 (1%)

Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            + H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + R
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+Q++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R 
Sbjct: 76  EVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           ++  +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194

Query: 269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           +APEVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +
Sbjct: 195 IAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI---CENGVAPDRSLDPAVLSRLKQFSAMN 385
           S+SAKDLIRKML   PS R++A + L H WI    +  ++ D       +  ++QF    
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQ 314

Query: 386 KLKKMALRVSAS 397
           KL + AL    S
Sbjct: 315 KLAQAALLYMGS 326

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  536 bits (1382), Expect = 0.0
 Identities = 121/344 (35%), Positives = 172/344 (50%), Gaps = 14/344 (4%)

Query: 67  PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIE 126
                S ++N+  +GI       +  K   I + Y   RKLG G +G   LC E     E
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 127 FACKSISKRKLIS----------REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
            A K I K +              +  E++  EI ++  L  H NI+ +   +ED    +
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFY 122

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           +V E   GGELF++II R  + E  AA + + I+  +   H   ++HRD+KPEN LL NK
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           +   ++K +DFGLS FF       D +G+ YY+APEVL K Y  + DVW+ GVI+YILL 
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLC 242

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
           G PPF  +  Q I   V KG   F+ + W  ISD AK+LI+ ML    ++R TA E L  
Sbjct: 243 GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302

Query: 357 PWI---CENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
            WI     N    D+      LS +++F    KL + A+    S
Sbjct: 303 RWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGS 346

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  529 bits (1365), Expect = 0.0
 Identities = 112/327 (34%), Positives = 171/327 (52%), Gaps = 12/327 (3%)

Query: 81  GIDNQTYYVLGHKTD--NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI 138
           GI      +L    D     D+Y L   +G+G F     C    TG +FA K +   K  
Sbjct: 4   GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63

Query: 139 SRE--DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH 196
           S      ED++RE  I H L  H +IV +   Y     +++V E   G +L   I++R  
Sbjct: 64  SSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 197 ----YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV- 251
               YSE  A+   R I+  +  CH   ++HRD+KP   LL +K++   +K   FG+++ 
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
             + G +    VG+P+++APEV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLF 241

Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
           + ++KG        W  IS+SAKDL+R+ML   P+ER+T +E L HPW+ E      +  
Sbjct: 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIH 301

Query: 371 DPAVLSRLKQFSAMNKLKKMALRVSAS 397
            P  + +L++F+A  KLK   L   +S
Sbjct: 302 LPETVEQLRKFNARRKLKGAVLAAVSS 328

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  530 bits (1367), Expect = 0.0
 Identities = 116/335 (34%), Positives = 177/335 (52%), Gaps = 6/335 (1%)

Query: 67  PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIE 126
              S  +++   +  +       +  K  ++ ++Y   +KLG G +G   LC +  T +E
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 127 FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE 186
            A K I K  + S      +  E+ ++  L  H NI+ +   +ED    ++VME   GGE
Sbjct: 65  RAIKIIRKTSV-STSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID 246
           LFD II R  ++E  AA + + ++  V   H   ++HRDLKPEN LL +K+ D  +K +D
Sbjct: 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVD 182

Query: 247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
           FGLS  F+  +   + +G+ YY+APEVL K Y  + DVW+ GVIL+ILL+G PPF  +T 
Sbjct: 183 FGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP 366
           Q I   V KG   F+S  W  +S+ AKDLI++ML      R++A + L HPWI E     
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

Query: 367 DRS----LDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           +           +  +++F    KL + AL   AS
Sbjct: 303 ESGIELPSLANAIENMRKFQNSQKLAQAALLYMAS 337

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  524 bits (1351), Expect = 0.0
 Identities = 120/344 (34%), Positives = 176/344 (51%), Gaps = 10/344 (2%)

Query: 56  SKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
             +   ++     +S                Y++ G   D + D + +  +LG+G     
Sbjct: 10  GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
           Y C +  T   +A K + K       D + VR EI ++  L+ H NI+ +K  +E    +
Sbjct: 70  YRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEI 123

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
            +V+EL  GGELFDRI+++G+YSER AA+  + I+  V   H  G++HRDLKPEN L   
Sbjct: 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYIL 294
              D  LK  DFGLS   +   +   V G+P Y APE+L    YGPE D+W+ G+I YIL
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243

Query: 295 LSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           L G  PF+ E   Q +F  +L     F S  W  +S +AKDL+RK++   P +RLT  + 
Sbjct: 244 LCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

Query: 354 LCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           L HPW+   G A +         +L++F+A  KLK     V AS
Sbjct: 304 LQHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVAS 345

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  520 bits (1342), Expect = 0.0
 Identities = 114/310 (36%), Positives = 171/310 (55%), Gaps = 13/310 (4%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRRE 149
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+  S       ED+ RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           + I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  + I
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + +  
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKL 387
            S  AKD IR++L   P +R+T  + L HPWI               LSR      M K 
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD-------TQQALSRKASAVNMEKF 296

Query: 388 KKMALRVSAS 397
           KK A R  ++
Sbjct: 297 KKFAARKKSN 306

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  515 bits (1329), Expect = 0.0
 Identities = 81/316 (25%), Positives = 149/316 (47%), Gaps = 6/316 (1%)

Query: 81  GIDNQTYYVLGHKTDNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS 139
           G+D  T  +     +N  + Y L  ++LG+G+F     C   +TG E+A K + KR+   
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-G 68

Query: 140 REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHY 197
           ++   ++  EI ++        ++ +   YE++  + +++E  AGGE+F   +       
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           SE     L + I+  V   H   ++H DLKP+N LL +      +K +DFG+S       
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG 316
              +++G+P Y+APE+L         D+W  G+I Y+LL+   PF  E  Q  +  + + 
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248

Query: 317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP-DRSLDPAVL 375
           ++D+  + +  +S  A D I+ +L   P +R TA   L H W+ +          + +  
Sbjct: 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSS 308

Query: 376 SRLKQFSAMNKLKKMA 391
           S+ +  S  +   K +
Sbjct: 309 SQTQDHSVRSSEDKTS 324

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  511 bits (1318), Expect = 0.0
 Identities = 106/322 (32%), Positives = 158/322 (49%), Gaps = 19/322 (5%)

Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            L   +    D Y +   +G G +     C   AT +EFA K I K K        D   
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTE 64

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           EI+I+     H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKP-GQIFTDVVGSP 266
           I   VE  H+ GV+HRDLKP N L V++  +   ++  DFG +   +    +      + 
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184

Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFES 322
            +VAPEVL +  Y    D+W+ GV+LY +L+G  PF     +T + I   +  G      
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ-- 380
             W  +SD+AKDL+ KML   P +RLTA  VL HPWI      P   L+      L +  
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGA 304

Query: 381 ----FSAMNKLKKMALRVSASA 398
               +SA+N+ +   L     +
Sbjct: 305 MAATYSALNRNQSPVLEPVGRS 326

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  510 bits (1315), Expect = 0.0
 Identities = 106/326 (32%), Positives = 157/326 (48%), Gaps = 28/326 (8%)

Query: 93  KTDNIRDLYTLG---RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           K       Y L    + LG+G F     C    +   FA K ISKR         + ++E
Sbjct: 2   KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKE 55

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           I  +    GH NIV +   + D L   +VMEL  GGELF+RI ++ H+SE +A+ + R +
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGSPYY 268
           V  V   H +GV+HRDLKPEN L  +++D+  +K IDFG +    P  Q       + +Y
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175

Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ-------GIFDAVLKGHIDF 320
            APE+L ++ Y    D+W+ GVILY +LSG  PF +  +         I   + KG   F
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL---------D 371
           E + W  +S  AKDLI+ +L   P++RL    +  + W+ +        L          
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSG 295

Query: 372 PAVLSRLK-QFSAMNKLKKMALRVSA 396
            AV + +K  F A NK K+    +  
Sbjct: 296 AAVHTCVKATFHAFNKYKREGFCLQN 321

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  506 bits (1306), Expect = 0.0
 Identities = 109/314 (34%), Positives = 170/314 (54%), Gaps = 9/314 (2%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRR 148
            K   + D Y +G +LG GQF     C E +TG+E+A K I KR+  +       E++ R
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    + 
Sbjct: 65  EVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPY 267
           I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+P 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC--ENGVAPDRSLDPAVLSRLKQFSAM 384
             S+ AKD IRK+L  +  +RLT  E L HPWI   +N  A  R      L   ++    
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVR 303

Query: 385 NKLKKMALRVSASA 398
            + K  +  + +  
Sbjct: 304 RRWKL-SFSIVSLC 316

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  504 bits (1300), Expect = 0.0
 Identities = 112/280 (40%), Positives = 164/280 (58%), Gaps = 4/280 (1%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
           G    +I   YTL   +G+G +G   +  +  T I  A K I K  +   EDV+  ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +IM  L  H NI+ +   +ED+  +++VMELC GGELF+R++ +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             V  CH L V HRDLKPENFL +    D  LK IDFGL+  FKPG++    VG+PYYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 271 PEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           P+VL   YGPE D W+AGV++Y+LL G PPF A T   +   + +G   F    W  +S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
            A+ LIR++L   P +R+T+ + L H W  +   +  R+L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  501 bits (1292), Expect = e-179
 Identities = 83/305 (27%), Positives = 149/305 (48%), Gaps = 12/305 (3%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            + + Y +   LG+G+FG  + C E ++   +  K +  +      D   V++EI I++ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNI 57

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVE 214
              H+NI+ +  ++E    + ++ E  +G ++F+RI       +ER+       +   ++
Sbjct: 58  A-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  + H D++PEN +   +    ++K I+FG +   KPG  F  +  +P Y APEV 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 275 L-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
                    D+W+ G ++Y+LLSG+ PF AET Q I + ++     F+ + +  IS  A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALR 393
           D + ++L  +   R+TA E L HPW+ +        +   V+  LK     + L K  L 
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ----KIERVSTKVIRTLKHRRYYHTLIKKDLN 291

Query: 394 VSASA 398
           +  SA
Sbjct: 292 MVVSA 296

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  501 bits (1291), Expect = e-179
 Identities = 112/313 (35%), Positives = 167/313 (53%), Gaps = 8/313 (2%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRR 148
            K   + D Y +G +LG GQF     C E +TG+E+A K I KR+  +       E++ R
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+ I+  +  H NI+T+   YE+   V +++EL +GGELFD + Q+   SE +A    + 
Sbjct: 65  EVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPY 267
           I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+P 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV--APDRSLDPAVLSRLKQFSAM 384
             S+ AKD IRK+L  +  +RLT  E L HPWI       A  R      L   K+    
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVR 303

Query: 385 NKLKKMALRVSAS 397
            + K     VS  
Sbjct: 304 RRWKLSFSIVSLC 316

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  497 bits (1282), Expect = e-178
 Identities = 115/271 (42%), Positives = 156/271 (57%), Gaps = 2/271 (0%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +      + Y +   LG+G FG    C +  T  E+A K I+K    + +D   + RE++
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVE 73

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +  
Sbjct: 74  LLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD 
Sbjct: 193 EVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
           AKDLIRKML   PS R+TA + L HPWI + 
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  496 bits (1280), Expect = e-178
 Identities = 104/275 (37%), Positives = 150/275 (54%), Gaps = 3/275 (1%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +    D Y +  +LG+G F     C    TG+EFA K I+ +KL S  D + + RE +I 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARIC 59

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             L  H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +
Sbjct: 60  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 118

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
             CHS G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEV
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L K  Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  A
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238

Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD 367
           K LI  ML   P +R+TA + L  PWIC       
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  500 bits (1290), Expect = e-178
 Identities = 106/374 (28%), Positives = 167/374 (44%), Gaps = 27/374 (7%)

Query: 36  TNSDYSTPS--LNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHK 93
           +NS   +P     +     Q  +   P      P   P +      +        +   K
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSG------LQIKK 56

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
              I D     + LG G  G         T  +FA K +              RRE+++ 
Sbjct: 57  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELH 108

Query: 154 HHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTR 207
              +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 168

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            I   ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PY
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228

Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFES 322
           YVAPEVL    Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
             W  +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L  + + +  +  
Sbjct: 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 348

Query: 383 AMNKLKKMALRVSA 396
             +  ++M   ++ 
Sbjct: 349 WEDVKEEMTSALAT 362

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  495 bits (1276), Expect = e-176
 Identities = 104/366 (28%), Positives = 161/366 (43%), Gaps = 21/366 (5%)

Query: 6   RGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNS 65
             S     +    +          N N +   +   +   +  Q      S     +   
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQ------SANLLAEAKK 60

Query: 66  APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI 125
                P   +N+  + +  +               Y     +G+G       C   ATG 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 126 EFACKSISKRKLIS-----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           EFA K +             E  E  RRE  I+  +AGH +I+T+  +YE S  + +V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           L   GELFD + ++   SE++   + R ++  V   H+  ++HRDLKPEN LL   DD+ 
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNM 237

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL-------LKHYGPEADVWTAGVILYI 293
            ++  DFG S   +PG+   ++ G+P Y+APE+L          YG E D+W  GVIL+ 
Sbjct: 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297

Query: 294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           LL+G PPFW   Q  +   +++G   F S  W   S + KDLI ++L   P  RLTA + 
Sbjct: 298 LLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357

Query: 354 LCHPWI 359
           L HP+ 
Sbjct: 358 LQHPFF 363

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  491 bits (1267), Expect = e-176
 Identities = 102/283 (36%), Positives = 159/283 (56%), Gaps = 6/283 (2%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRREIQI 152
            + D Y +G +LG GQF     C +  TG E+A K I KR+L S       E++ RE+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  + I+  
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 213 VEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+P +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           E++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + +   S+
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA 373
            AKD IR++L   P  R+T  + L H WI        R  D  
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  489 bits (1261), Expect = e-175
 Identities = 104/291 (35%), Positives = 155/291 (53%), Gaps = 16/291 (5%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK--LISREDVEDVR- 147
            H T    + Y     LG+G       C    T  E+A K I        S E+V+++R 
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 148 ---REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
              +E+ I+  ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + R ++ V+ A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185

Query: 265 SPYYVAPEVL-------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
           +P Y+APE++          YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR 368
             F S  W   SD+ KDL+ + L  QP +R TA E L HP+  +  V   R
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  482 bits (1242), Expect = e-172
 Identities = 93/274 (33%), Positives = 148/274 (54%), Gaps = 8/274 (2%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +    I DL+   RKLG G FG  +L  E ++G+E   K+I+K +   +  +E +  EI+
Sbjct: 15  YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIE 72

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTR 207
           ++  L  H NI+ I   +ED   ++IVME C GGEL +RI+         SE   AEL +
Sbjct: 73  VLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            ++  +   HS  V+H+DLKPEN L  +      +K IDFGL+  FK  +  T+  G+  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191

Query: 268 YVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           Y+APEV  +    + D+W+AGV++Y LL+G  PF   + + +         ++  +  P 
Sbjct: 192 YMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP- 250

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           ++  A DL+++ML   P  R +A +VL H W  +
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  485 bits (1250), Expect = e-172
 Identities = 98/369 (26%), Positives = 158/369 (42%), Gaps = 28/369 (7%)

Query: 52  SQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQ 111
           S        K          +  D              +  K  ++ D Y +  +LG G 
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63

Query: 112 FGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED 171
           FG  + C E ATG  F  K I+        D   V+ EI IM+ L  H  ++ +  A+ED
Sbjct: 64  FGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFED 119

Query: 172 SLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPEN 230
              + +++E  +GGELFDRI    +  SE +     R     ++  H   ++H D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179

Query: 231 FLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGV 289
            +   K    S+K IDFGL+    P +I      +  + APE++  +  G   D+W  GV
Sbjct: 180 IMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 290 ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT 349
           + Y+LLSG+ PF  E        V +   +F+ D +  +S  AKD I+ +L  +P +RLT
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298

Query: 350 AHEVLCHPWICENGVAPDRSLDPAVLS---------------------RLKQFSAMNKLK 388
            H+ L HPW+  +       +  +  +                     R+  FS++ K +
Sbjct: 299 VHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 358

Query: 389 KMALRVSAS 397
               ++  S
Sbjct: 359 PQEYQIYDS 367

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  481 bits (1240), Expect = e-172
 Identities = 98/316 (31%), Positives = 153/316 (48%), Gaps = 36/316 (11%)

Query: 93  KTDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
            +    D+Y L    LG+G       C  + T  E+A K I K+          V RE++
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVE 62

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +++   GH+N++ +   +E+    ++V E   GG +   I +R H++E +A+ + + +  
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--------V 263
            ++  H+ G+ HRDLKPEN L  + +    +K  DF L    K     + +         
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 264 GSPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPFWAE------------- 304
           GS  Y+APEV+         Y    D+W+ GVILYILLSG PPF                
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242

Query: 305 --TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
              Q  +F+++ +G  +F    W  IS +AKDLI K+L     +RL+A +VL HPW+   
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV--Q 300

Query: 363 GVAPDRSLD-PAVLSR 377
           G AP+ +L  P VL R
Sbjct: 301 GCAPENTLPTPMVLQR 316

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  475 bits (1225), Expect = e-169
 Identities = 112/322 (34%), Positives = 160/322 (49%), Gaps = 24/322 (7%)

Query: 89  VLGHKTDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
               K   + D Y L ++ LG G  G    C    TG + A K +              R
Sbjct: 18  GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KAR 69

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERK 201
           +E+      +G  +IV I   YE+      C+ I+ME   GGELF RI +RG   ++ER+
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129

Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD 261
           AAE+ R I   ++  HS  + HRD+KPEN L  +K+ D  LK  DFG +       + T 
Sbjct: 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 188

Query: 262 VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAVLKG 316
              +PYYVAPEVL    Y    D+W+ GVI+YILL G PPF++ T Q    G+   +  G
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248

Query: 317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD-PAVL 375
              F +  W  +S+ AK LIR +L + P+ERLT  + + HPWI ++ V P   L    VL
Sbjct: 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVL 308

Query: 376 SRLKQFSAMNKLKKMALRVSAS 397
              K     +++K+      A+
Sbjct: 309 QEDKDH--WDEVKEEMTSALAT 328

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  484 bits (1247), Expect = e-169
 Identities = 109/370 (29%), Positives = 159/370 (42%), Gaps = 11/370 (2%)

Query: 32  NSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLG 91
            S              ++   + +  +   K         S  DN +           + 
Sbjct: 90  QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
            K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQ 206

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIV 210
            M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R + 
Sbjct: 207 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + A
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PEV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICE-NGVAPDRSLDPAVLSRLKQFSAMNKLK 388
           +  KD IRK+L + P+ R+T H+ L HPW+   N    D  +     SR  +     K K
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP---SSRYTKIRDSIKTK 441

Query: 389 KMALRVSASA 398
             A       
Sbjct: 442 YDAWPEPLPP 451

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  473 bits (1220), Expect = e-168
 Identities = 103/312 (33%), Positives = 151/312 (48%), Gaps = 18/312 (5%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREI 150
            +RD Y + + LG G  G   L  E  T  + A K ISKRK             +V  EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +I+  L  H  I+ IK  ++     +IV+EL  GGELFD+++      E         ++
Sbjct: 67  EILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 271 PEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPW 325
           PEVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMN 385
             +S+ A DL++K+L   P  R T  E L HPW+       D  +       L + +   
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENEST 298

Query: 386 KLKKMALRVSAS 397
            L ++  + S S
Sbjct: 299 ALPQVLAQPSTS 310

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  471 bits (1214), Expect = e-167
 Identities = 105/372 (28%), Positives = 173/372 (46%), Gaps = 15/372 (4%)

Query: 24  SNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGID 83
            +    N       +     S +      + +S  +  +         S     +     
Sbjct: 12  VDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPA 71

Query: 84  NQTYYVLGHKTDNIRDLYTLGRK--LGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
              + ++  K   +   YT+ +   LG G+FG  + C E ATG++ A K I  R +   +
Sbjct: 72  PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---K 128

Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSER 200
           D E+V+ EI +M+ L  H N++ +  A+E    + +VME   GGELFDRII   +  +E 
Sbjct: 129 DKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
                 + I   +   H + ++H DLKPEN L VN+D    +K IDFGL+  +KP +   
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLK 246

Query: 261 DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID 319
              G+P ++APEV+         D+W+ GVI Y+LLSG+ PF  +      + +L    D
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD 306

Query: 320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLK 379
            E + +  IS+ AK+ I K+L  + S R++A E L HPW+       D  L   + ++ K
Sbjct: 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS------DHKLHSRLSAQKK 360

Query: 380 QFSAMNKLKKMA 391
           +    +    + 
Sbjct: 361 KNRGSDAQDFVT 372

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  446 bits (1150), Expect = e-158
 Identities = 92/315 (29%), Positives = 143/315 (45%), Gaps = 39/315 (12%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K   I D     + LG G  G         T  +FA K +              RRE+++
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVEL 63

Query: 153 MHHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELT 206
               +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + I   ++  HS+ + HRD+KPEN L  +K  +  LK  DFG                  
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166

Query: 267 YYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFES 322
              A E   + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +
Sbjct: 167 ---AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFS 382
             W  +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L  + + +  +  
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE- 282

Query: 383 AMNKLKKMALRVSAS 397
               +K+      A+
Sbjct: 283 RWEDVKEEMTSALAT 297

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  441 bits (1136), Expect = e-154
 Identities = 97/282 (34%), Positives = 142/282 (50%), Gaps = 12/282 (4%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVR 147
               +RD Y + + LG G  G   L  E  T  + A + ISKRK             +V 
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
            EI+I+  L  H  I+ IK  ++     +IV+EL  GGELFD+++      E        
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            ++  V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306

Query: 268 YVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFES 322
           Y+APEVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV 364
           + W  +S+ A DL++K+L   P  R T  E L HPW+ +  +
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  435 bits (1121), Expect = e-153
 Identities = 99/334 (29%), Positives = 148/334 (44%), Gaps = 52/334 (15%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISRED 142
           +  Y  G     ++  Y L   +GQG +G   +  E  T    A K ++K K+  I+ +D
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71

Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH------ 196
           VE ++ E+++M  L  H NI  +   YED   + +VMELC GG L D++           
Sbjct: 72  VERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130

Query: 197 ----------------------------------YSERKAAELTRIIVGVVEACHSLGVM 222
                                               E+  + + R I   +   H+ G+ 
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPYYVAPEVL--- 274
           HRD+KPENFL    +  F +K +DFGLS  F           T   G+PY+VAPEVL   
Sbjct: 191 HRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
            + YGP+ D W+AGV+L++LL G  PF           VL   + FE+  + ++S  A+D
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD 309

Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR 368
           L+  +L     ER  A   L HPWI +      +
Sbjct: 310 LLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  314 bits (805), Expect = e-104
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 23/301 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +     LG G  GT      +    + A K I        E      RE+Q++     H 
Sbjct: 26  FCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
           N++      +D    +I +ELC    L + + Q+   +   +   L +     +   HSL
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFKPGQ----IFTDVVGSPYYVAPEV 273
            ++HRDLKP N L+   +    +KA+  DFGL      G+      + V G+  ++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 274 LL----KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           L     ++     D+++AG + Y ++S G  PF    Q+     +    +D    P    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PEKHE 256

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK 388
              A++LI KM+   P +R +A  VL HP+               V  R+++ S    + 
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL--EKQLQFFQDVSDRIEKESLDGPIV 314

Query: 389 K 389
           K
Sbjct: 315 K 315

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  310 bits (797), Expect = e-103
 Identities = 72/343 (20%), Positives = 125/343 (36%), Gaps = 48/343 (13%)

Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           + +   ++++L    + LG G  GT         G   A K +           +    E
Sbjct: 6   IPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALME 58

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS-------ERKA 202
           I+++     H N++    +      ++I +ELC    L D +  +           E   
Sbjct: 59  IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVF 252
             L R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL   
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 253 FKPGQ-----IFTDVVGSPYYVAPEVLL--------KHYGPEADVWTAGVILYILLS-GV 298
              GQ        +  G+  + APE+L         +      D+++ G + Y +LS G 
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 299 PPFWAETQQGIFDAVLKGHIDF---ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            PF  +  +     +++G       +      +   A DLI +M+   P +R TA +VL 
Sbjct: 238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

Query: 356 HPWICENGVAP----DRSLDPAVLSRLKQFSAMNKLKKMALRV 394
           HP               S    + +R    + + K    +  V
Sbjct: 296 HPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFV 338

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  282 bits (724), Expect = 2e-93
 Identities = 101/360 (28%), Positives = 154/360 (42%), Gaps = 42/360 (11%)

Query: 42  TPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLY 101
            P+   +  V    +   P     A  I     D                    + R  Y
Sbjct: 3   APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------------------PRSRRR-Y 43

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
             GR LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H++
Sbjct: 44  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQH 102

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           +V   G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +HRDLK  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL  K + 
Sbjct: 163 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            E DVW+ G I+Y LL G PPF     +  +  + K   ++       I+  A  LI+KM
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKM 275

Query: 340 LCSQPSERLTAHEVLCHPWICEN-----------GVAPDRSLDPAVLSR--LKQFSAMNK 386
           L + P+ R T +E+L   +                + P  S+ P+ L     K  + +NK
Sbjct: 276 LQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK 335

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  280 bits (719), Expect = 8e-93
 Identities = 63/304 (20%), Positives = 113/304 (37%), Gaps = 43/304 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
               L+ L   LGQG     +      TG  FA K  +         V+   RE +++  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKK 63

Query: 156 LAGHKNIVTIKGAYEDSLCVHI--VMELCAGGELFDRIIQRGH---YSERKAAELTRIIV 210
           L  HKNIV +    E++   H   +ME C  G L+  + +  +     E +   + R +V
Sbjct: 64  LN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 211 GVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           G +      G++HR++KP N +  + +D     K  DFG +   +  + F  + G+  Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 270 APEVL---------LKHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKG 316
            P++           K YG   D+W+ GV  Y   +G  PF         + +   ++ G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 317 ---------------HIDFESD--PWPLISDSAKD----LIRKMLCSQPSERLTAHEVLC 355
                           ID+  D      +S   +     ++  +L +   +     +   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 356 HPWI 359
               
Sbjct: 303 ETSD 306

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  279 bits (715), Expect = 1e-92
 Identities = 88/273 (32%), Positives = 133/273 (48%), Gaps = 11/273 (4%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
               + R  Y  GR LG+G F   +  ++  T   FA K + K  L+     E +  EI 
Sbjct: 9   VDPRSRRR-YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I   LA H+++V   G +ED+  V +V+ELC    L +   +R   +E +A    R IV 
Sbjct: 68  IHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVA 270
             +  H   V+HRDLK  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+A
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PEVL  K +  E DVW+ G I+Y LL G PPF     +  +  + K   ++       I+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--IN 239

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
             A  LI+KML + P+ R T +E+L   +    
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  270 bits (694), Expect = 1e-89
 Identities = 89/265 (33%), Positives = 143/265 (53%), Gaps = 11/265 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +G  LG+G F   Y    I TG+E A K I K+ +     V+ V+ E++I   L  H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HP 71

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSL 219
           +I+ +   +EDS  V++V+E+C  GE+   +  R   +SE +A      I+  +   HS 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL-KH 277
           G++HRDL   N LL     + ++K  DFGL+   K P +    + G+P Y++PE+     
Sbjct: 132 GILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +G E+DVW+ G + Y LL G PPF  +T +   + V+    D+E   +  +S  AKDLI 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLIH 244

Query: 338 KMLCSQPSERLTAHEVLCHPWICEN 362
           ++L   P++RL+   VL HP++  N
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRN 269

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  267 bits (684), Expect = 5e-88
 Identities = 85/270 (31%), Positives = 137/270 (50%), Gaps = 10/270 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL        LK  DFG SV     +    + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 185

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F    +  +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DF--VTEGARDLISRL 241

Query: 340 LCSQPSERLTAHEVLCHPWICENGVAPDRS 369
           L   PS+R    EVL HPWI  N   P   
Sbjct: 242 LKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  266 bits (682), Expect = 1e-87
 Identities = 85/263 (32%), Positives = 136/263 (51%), Gaps = 10/263 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E       A K + K +L        +RREI+I  HL  H 
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +   + D   +++++E    GEL+  + + G + E+++A     +   +  CH   
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN L+        LK  DFG SV     +  T + G+  Y+ PE++  K + 
Sbjct: 135 VIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEMIEGKTHD 190

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W AGV+ Y  L G+PPF + +       ++    D +  P+  +SD +KDLI K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLISKL 246

Query: 340 LCSQPSERLTAHEVLCHPWICEN 362
           L   P +RL    V+ HPW+  N
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKAN 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  266 bits (682), Expect = 2e-87
 Identities = 69/294 (23%), Positives = 114/294 (38%), Gaps = 41/294 (13%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
               +     LGQG FG             +A K I   +    E +  +  E+ ++  L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59

Query: 157 AGHKNIVTIKGAYED-------------SLCVHIVMELCAGGELFDRIIQRGHYSER-KA 202
             H+ +V    A+ +                + I ME C  G L+D I       +R + 
Sbjct: 60  N-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------- 254
             L R I+  +   HS G++HRDLKP N  +   D+  ++K  DFGL+            
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 255 -------PGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET 305
                       T  +G+  YVA EVL    HY  + D+++ G+I + ++   P      
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +  I   +    I+F  D         K +IR ++   P++R  A  +L   W+
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  267 bits (685), Expect = 8e-87
 Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 43/303 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
               L+ L   LGQG     +      TG  FA K  +    +   DV    RE +++  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKK 63

Query: 156 LAGHKNIVTIKGAYEDSLCVHI--VMELCAGGELFDRIIQRGH---YSERKAAELTRIIV 210
           L  HKNIV +    E++   H   +ME C  G L+  + +  +     E +   + R +V
Sbjct: 64  LN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 211 GVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           G +      G++HR++KP N +  + +D     K  DFG +   +  + F  + G+  Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 270 APEVL---------LKHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKG 316
            P++           K YG   D+W+ GV  Y   +G  PF         + +   ++ G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 317 ---------------HIDFESD--PWPLISDSAKD----LIRKMLCSQPSERLTAHEVLC 355
                           ID+  D      +S   +     ++  +L +   +     +   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 356 HPW 358
              
Sbjct: 303 ETS 305

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  259 bits (664), Expect = 4e-85
 Identities = 95/261 (36%), Positives = 132/261 (50%), Gaps = 10/261 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  ++REIQ +     H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HP 71

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +           +VME  +GGELFD I + G   E +A  L + I+  V+ CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+  + Y 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ GVILY LL G  PF  E    +F  +  G   F    +  ++ S   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMH 244

Query: 339 MLCSQPSERLTAHEVLCHPWI 359
           ML   P +R T  ++  H W 
Sbjct: 245 MLQVDPLKRATIKDIREHEWF 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  261 bits (667), Expect = 2e-84
 Identities = 50/361 (13%), Positives = 90/361 (24%), Gaps = 48/361 (13%)

Query: 49  QLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLG 108
           +   +       +       +  +    +  +  +     +L            L   L 
Sbjct: 16  KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERK----LKLVEPLR 71

Query: 109 QGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL------------ 156
            G     +L  ++    +FA K  +     SR ++E +         L            
Sbjct: 72  VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131

Query: 157 -----------AGHKNIVTIKGAYED--SLCVHIVMELCAG------GELFDRIIQRGHY 197
                              +    +D       ++M   +         L    + RG  
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
                  LT  ++ +     S G++H    P+N  +     D  L   D       K G 
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALW--KVGT 246

Query: 258 IFTDVVGSPYYVAPEVLLKH---YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
                     Y   E L      +    + W  G+ +Y +     PF   T         
Sbjct: 247 RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306

Query: 315 KGHIDFESDPWPL-----ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS 369
                  +D         + D  K LI + L      RL   E +  P   +       S
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSS 366

Query: 370 L 370
           L
Sbjct: 367 L 367

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  259 bits (663), Expect = 3e-84
 Identities = 94/292 (32%), Positives = 147/292 (50%), Gaps = 11/292 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K + ++   ++ + RE++IM  L  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN-HP 74

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    ++++ME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+   K Y 
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G   +    +  +S   ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLKR 247

Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKM 390
            L   P +R T  +++   WI       +          +     ++ +  M
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  255 bits (653), Expect = 2e-82
 Identities = 69/325 (21%), Positives = 134/325 (41%), Gaps = 33/325 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
             R  Y++ +++G G     +          +A K ++  +    + ++  R EI  ++ 
Sbjct: 7   KGRI-YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNK 63

Query: 156 LAGH-KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H   I+ +         +++VME C   +L   + ++      +     + ++  V 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAP 271
             H  G++H DLKP NFL+V+      LK IDFG++   +P     +    VG+  Y+ P
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 272 EVLL------------KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHI 318
           E +                 P++DVW+ G ILY +  G  PF     Q     A++  + 
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238

Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPA----- 373
           + E     +     +D+++  L   P +R++  E+L HP++       ++          
Sbjct: 239 EIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK 296

Query: 374 -VLSRLKQFSAMNKLKKMALRVSAS 397
            VL +L   ++ N + K A  +   
Sbjct: 297 YVLGQLVGLNSPNSILKAAKTLYEH 321

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  254 bits (650), Expect = 2e-82
 Identities = 62/290 (21%), Positives = 120/290 (41%), Gaps = 24/290 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH- 159
           Y++ +++G G     +          +A K ++  +    + ++  R EI  ++ L  H 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
             I+ +         +++VME C   +L   + ++      +     + ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL- 275
           G++H DLKP NFL+V+      LK IDFG++   +P     +    VG+  Y+ PE +  
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 276 -----------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
                          P++DVW+ G ILY +  G  PF     Q I         + E + 
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEF 261

Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV 374
             +     +D+++  L   P +R++  E+L HP++       ++      
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  256 bits (654), Expect = 2e-82
 Identities = 43/325 (13%), Positives = 87/325 (26%), Gaps = 66/325 (20%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--- 157
              G  LGQ         T+  TG  F        +      ++ ++ E+  +  L    
Sbjct: 75  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134

Query: 158 ---------------------GHKNIVTIKGAYED--SLCVHIVMELCA------GGELF 188
                                  K ++ ++    D   L    +           G  L 
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194

Query: 189 DRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                          +LT  ++ ++ + H  G++H  L+P + +L   D    +    F 
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFE 251

Query: 249 LSVFFKPGQIFTDVVGSPYYVAPEVLL------------KHYGPEADVWTAGVILYILLS 296
             V             S  +  PE+                     D W  G+++Y +  
Sbjct: 252 HLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
              P   +   G  + + +   +        I    + L+   L     +RL   + +  
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMET 360

Query: 357 PWICENGVAPDRSLDPAVLSRLKQF 381
           P            L   + + L  +
Sbjct: 361 PEY--------EQLRTELSAALPLY 377

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  258 bits (660), Expect = 5e-82
 Identities = 96/274 (35%), Positives = 141/274 (51%), Gaps = 10/274 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  +RREIQ +     H 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +         + +VME  +GGELFD I + G   E+++  L + I+  V+ CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+  + Y 
Sbjct: 137 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W++GVILY LL G  PF  +    +F  +  G   F +  +  ++ S   L++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249

Query: 339 MLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           ML   P +R T  ++  H W  ++        DP
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  253 bits (649), Expect = 5e-82
 Identities = 66/354 (18%), Positives = 133/354 (37%), Gaps = 50/354 (14%)

Query: 71  PSKKDNIMRRGIDNQTYYVLGHKTDNIR-DLYTLGRKLGQGQFGTTYLCTEIATGIEFAC 129
           P      +     N  Y     K  +   + Y + R L QG+F    LC +      +A 
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYAL 59

Query: 130 KSISKRKLI--------------SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
           K   K  L                +   +D + E+QI+  +  ++  +T +G   +   V
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEV 118

Query: 176 HIVMELCAGGELFDRIIQRGH--------YSERKAAELTRIIVGVVEACHS-LGVMHRDL 226
           +I+ E      +                    +    + + ++      H+   + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL---LKHYGPEAD 283
           KP N L+   D +  +K  DFG S +    +I     G+  ++ PE       + G + D
Sbjct: 179 KPSNILM---DKNGRVKLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVD 234

Query: 284 VWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDF---------------ESDPWPL 327
           +W+ G+ LY++   V PF  + +   +F+ +   +I++                +     
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQF 381
           +S+   D ++  L   P+ER+T+ + L H W+ +  +   R     +  + K+ 
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  253 bits (648), Expect = 7e-82
 Identities = 93/261 (35%), Positives = 136/261 (52%), Gaps = 11/261 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG   L T   T  + A K IS++ L   +    V REI  +  L  H 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HP 69

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +         + +V+E  AGGELFD I+++   +E +     + I+  +E CH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           ++HRDLKPEN LL   DD+ ++K  DFGLS     G       GSP Y APEV+  K Y 
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ G++LY++L G  PF  E    +F  V      +    +  +S  A+ LIR+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRR 241

Query: 339 MLCSQPSERLTAHEVLCHPWI 359
           M+ + P +R+T  E+   PW 
Sbjct: 242 MIVADPMQRITIQEIRRDPWF 262

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  252 bits (645), Expect = 2e-81
 Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 22/280 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHH 155
           Y+    LG G FG  +   +     E   K I K K++    +ED     V  EI I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           +  H NI+ +   +E+     +VME   +G +LF  I +     E  A+ + R +V  V 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
                 ++HRD+K EN ++    +DF++K IDFG + + + G++F    G+  Y APEVL
Sbjct: 145 YLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201

Query: 275 L-KHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +   Y GPE ++W+ GV LY L+    PF         +  ++            +S   
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEA--AIHPPYL--VSKEL 251

Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
             L+  +L   P  R T  +++  PW+ +     D + + 
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  253 bits (647), Expect = 4e-81
 Identities = 77/398 (19%), Positives = 151/398 (37%), Gaps = 53/398 (13%)

Query: 22  DHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRG 81
            H ++S           + +      Q + S +   ++  K +S      S  + I  +G
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASS------SANECISVKG 55

Query: 82  IDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
                              Y++ +++G G     +          +A K ++  +    +
Sbjct: 56  RI-----------------YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQ 96

Query: 142 DVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER 200
            ++  R EI  ++ L  H   I+ +         +++VME C   +L   + ++      
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--- 257
           +     + ++  V   H  G++H DLKP NFL+V+      LK IDFG++   +P     
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSV 211

Query: 258 IFTDVVGSPYYVAPEVLL------------KHYGPEADVWTAGVILYILLSGVPPFWAET 305
           +    VG+  Y+ PE +                 P++DVW+ G ILY +  G  PF    
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

Query: 306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA 365
            Q I         + E +   +     +D+++  L   P +R++  E+L HP++      
Sbjct: 272 NQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

Query: 366 PDRSLDPA------VLSRLKQFSAMNKLKKMALRVSAS 397
            ++           VL +L   ++ N + K A  +   
Sbjct: 331 VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEH 368

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  261 bits (667), Expect = 5e-81
 Identities = 66/292 (22%), Positives = 111/292 (38%), Gaps = 33/292 (11%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
               + +  +LG G FG         TG + A K   +    S ++ E    EIQIM  L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL 69

Query: 157 AGHKNIVTIKGAYEDSLCVH------IVMELCAGGELFDRIIQRGH---YSERKAAELTR 207
             H N+V+ +   +    +       + ME C GG+L   + Q  +     E     L  
Sbjct: 70  N-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            I   +   H   ++HRDLKPEN +L         K ID G +     G++ T+ VG+  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW- 325
           Y+APE+L  K Y    D W+ G + +  ++G  PF    Q   +   ++   +     + 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 326 -------------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                               +++   +  ++ ML     +R T  +      
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  248 bits (636), Expect = 6e-81
 Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 14/265 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I   L  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-K 276
           + HRD+KPEN LL   D+  +LK  DFGL+  F+      +   + G+  YVAPE+L  +
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 277 HY-GPEADVWTAGVILYILLSGVPPF-WAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
            +     DVW+ G++L  +L+G  P+         +    +       +PW  I  +   
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240

Query: 335 LIRKMLCSQPSERLTAHEVLCHPWI 359
           L+ K+L   PS R+T  ++    W 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWY 265

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  249 bits (639), Expect = 7e-81
 Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 24/296 (8%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VR 147
           G   +     Y LG  LG+G FGT +    +   ++ A K I + +++    + D     
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 148 REIQIM---HHLAGHKNIVTIKGAYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAA 203
            E+ ++       GH  ++ +   +E      +V+E      +LFD I ++G   E  + 
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142

Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
                +V  ++ CHS GV+HRD+K EN +L++       K IDFG          +TD  
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDEN-ILIDL-RRGCAKLIDFGSGALLHDEP-YTDFD 199

Query: 264 GSPYYVAPEVLL-KHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           G+  Y  PE +    Y    A VW+ G++LY ++ G  PF  E  Q I +A      +  
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEA------ELH 251

Query: 322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSR 377
                 +S     LIR+ L  +PS R +  E+L  PW+     A D  L+P+    
Sbjct: 252 FPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM--QTPAEDVPLNPSKGGP 303

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  247 bits (634), Expect = 2e-80
 Identities = 86/291 (29%), Positives = 128/291 (43%), Gaps = 41/291 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---------------------- 138
           YTL  ++G+G +G   L         +A K +SK+KLI                      
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 139 -SREDVEDVRREIQIMHHLAGHKNIVT----IKGAYEDSLCVHIVMELCAGGELFDRIIQ 193
             R  +E V +EI I+  L  H N+V     +    ED L  ++V EL   G + + +  
Sbjct: 75  QPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHL--YMVFELVNQGPVME-VPT 130

Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
               SE +A    + ++  +E  H   ++HRD+KP N L+    +D  +K  DFG+S  F
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEF 187

Query: 254 KPGQIFTD-VVGSPYYVAPEVL---LKHY-GPEADVWTAGVILYILLSGVPPFWAETQQG 308
           K         VG+P ++APE L    K + G   DVW  GV LY  + G  PF  E    
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247

Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +   +       E    P I++  KDLI +ML   P  R+   E+  HPW+
Sbjct: 248 LHSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  248 bits (636), Expect = 2e-80
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 20/286 (6%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VR 147
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +   V 
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94

Query: 148 REIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
              ++  V  CH+ GV+HRD+K EN +L++  +   LK IDFG     K    +TD  G+
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDEN-ILIDL-NRGELKLIDFGSGALLKDTV-YTDFDGT 211

Query: 266 PYYVAPEVLL-KHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
             Y  PE +    Y G  A VW+ G++LY ++ G  PF  E  + I              
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG------QVFFR 263

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS 369
               +S   + LIR  L  +PS+R T  E+  HPW+ +  +  + +
Sbjct: 264 QR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 307

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  248 bits (636), Expect = 3e-80
 Identities = 79/269 (29%), Positives = 130/269 (48%), Gaps = 16/269 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I   L  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD---VVGSPYYVAPEVLL-K 276
           + HRD+KPEN LL   D+  +LK  DFGL+  F+          + G+  YVAPE+L  +
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 277 HY-GPEADVWTAGVILYILLSGVPPF--WAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            +     DVW+ G++L  +L+G  P+   +++ Q   D   K       +PW  I  +  
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYLNPWKKIDSAPL 239

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWICEN 362
            L+ K+L   PS R+T  ++    W  + 
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  247 bits (633), Expect = 2e-79
 Identities = 89/268 (33%), Positives = 126/268 (47%), Gaps = 14/268 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   + +G G FG   L  +  T    A K I +   I     E+V+REI     L  H 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLR-HP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV  K        + I+ME  +GGEL++RI   G +SE +A    + ++  V  CHS+ 
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           + HRDLK EN  L++      LK  DFG S            VG+P Y+APEVLL + Y 
Sbjct: 137 ICHRDLKLEN-TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIF----DAVLKGHIDFESDPWPLISDSAKD 334
           G  ADVW+ GV LY++L G  PF    +   +      +L        D    IS     
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCH 253

Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICEN 362
           LI ++  + P+ R++  E+  H W  +N
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKN 281

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  233 bits (596), Expect = 6e-75
 Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 21/277 (7%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           + Y +   +G G +G        + G     K +    + +  + + +  E+ ++  L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK- 63

Query: 159 HKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGV 212
           H NIV       D  +  ++IVME C GG+L   I +    R +  E     +   +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 213 VEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSP 266
           ++ CH        V+HRDLKP N  L   D   ++K  DFGL+        F    VG+P
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 267 YYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           YY++PE +    Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +G        +
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
              SD   ++I +ML  +   R +  E+L +P I E+
Sbjct: 241 ---SDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  232 bits (595), Expect = 2e-74
 Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 20/270 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y +G  LG+G +G      +  T    A K + K+KL    + E  V++EIQ++  L  H
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65

Query: 160 KNIVTIKG--AYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           KN++ +      E+   +++VME C  G  E+ D + +   +   +A      ++  +E 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPE 272
            HS G++H+D+KP N LL       +LK    G++     F          GSP +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 273 VL--LKHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           +   L  + G + D+W+AGV LY + +G+ PF  +    +F+ + KG   +         
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CG 237

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               DL++ ML  +P++R +  ++  H W 
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  231 bits (592), Expect = 6e-74
 Identities = 69/321 (21%), Positives = 119/321 (37%), Gaps = 23/321 (7%)

Query: 41  STPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL 100
           S   L ++ L  Q   +  P++ +     S + + +        ++++         +  
Sbjct: 9   SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQ-SPGYDPSRPESFF---------QQS 58

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +    +LG G +G  +       G  +A K  S       +D      E+     +  H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVEACHSL 219
             V ++ A+E+   +++  ELC G  L       G    E +     R  +  +   HS 
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYG 279
           G++H D+KP N  L         K  DFGL V            G P Y+APE+L   YG
Sbjct: 177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233

Query: 280 PEADVWTAGVILYILLSGVP-PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             ADV++ G+ +  +   +  P   E  Q +    L             +S   + ++  
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLVM 287

Query: 339 MLCSQPSERLTAHEVLCHPWI 359
           ML   P  R TA  +L  P +
Sbjct: 288 MLEPDPKLRATAEALLALPVL 308

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  227 bits (581), Expect = 1e-71
 Identities = 67/269 (24%), Positives = 133/269 (49%), Gaps = 14/269 (5%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           + Y   +K+G+G FG   L      G ++  K I+  ++ S ++ E+ RRE+ ++ ++  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK- 81

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEAC 216
           H NIV  + ++E++  ++IVM+ C GG+LF RI  +    + E +  +    I   ++  
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           H   ++HRD+K +N  L     D +++  DFG++             +G+PYY++PE+  
Sbjct: 142 HDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAK 333
            K Y  ++D+W  G +LY L +    F A + + +   ++ G       P     S   +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLR 254

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWICEN 362
            L+ ++    P +R + + +L   +I + 
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  214 bits (547), Expect = 4e-67
 Identities = 63/284 (22%), Positives = 104/284 (36%), Gaps = 30/284 (10%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   +KLG+G F    L   +  G  +A K I       ++D E+ +RE  +      H 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHP 86

Query: 161 NIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGV 212
           NI+ +               +++     G L++ I +        +E +   L   I   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG----------QIFTDV 262
           +EA H+ G  HRDLKP N LL    D+     +D G                  Q +   
Sbjct: 147 LEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 263 VGSPYYVAPEVL-LKHY---GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
             +  Y APE+  ++ +       DVW+ G +LY ++ G  P+    Q+G     L    
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQN 262

Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
                  P  S +   L+  M+   P +R     +L      + 
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  212 bits (541), Expect = 1e-66
 Identities = 73/293 (24%), Positives = 110/293 (37%), Gaps = 40/293 (13%)

Query: 91  GHKTDNIRDL--YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           G  T + R    +     +G G FG  +       G  +  K +           E   R
Sbjct: 1   GAHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAER 53

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSL----------------CVHIVMELCAGGELFDRII 192
           E++ +  L  H NIV   G ++                   C+ I ME C  G L   I 
Sbjct: 54  EVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112

Query: 193 QR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
           +R      +  A EL   I   V+  HS  +++RDLKP N  L    D   +K  DFGL 
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLV 169

Query: 251 VFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
              K     T   G+  Y++PE +  + YG E D++  G+IL  LL              
Sbjct: 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKF 227

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
           F  +  G I        +     K L++K+L  +P +R    E+L    + + 
Sbjct: 228 FTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  213 bits (543), Expect = 2e-65
 Identities = 41/299 (13%), Positives = 81/299 (27%), Gaps = 51/299 (17%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-- 157
               G  LGQ         T+  TG  F        +      ++ ++ E+  +  L   
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 158 ----------------------GHKNIVTIKGAYED--SLCVHIVMELCAG------GEL 187
                                   K ++ ++    D   L    +              L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
                           +LT  ++ ++ + H  G++H  L+P + +L   D    +    F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGF 255

Query: 248 GLSVFFKPGQIF--TDVVGSPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVP 299
              V      +         P   A  +L              D WT G+ +Y +     
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 300 PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           P   +   G  + + +   +        I    + L+   L     +RL   + +  P 
Sbjct: 316 PNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  202 bits (517), Expect = 1e-62
 Identities = 87/272 (31%), Positives = 133/272 (48%), Gaps = 26/272 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
             V +   ++D   ++  +     GEL   I + G + E       AE    IV  +E  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----IVSALEYL 146

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTD-VVGSPYYVAPEV 273
           H  G++HRDLKPEN LL   ++D  ++  DFG +  +  +  Q   +  VG+  YV+PE+
Sbjct: 147 HGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L  K     +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF   P       A
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKA 259

Query: 333 KDLIRKMLCSQPSERLT------AHEVLCHPW 358
           +DL+ K+L    ++RL          +  HP+
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  202 bits (516), Expect = 3e-62
 Identities = 70/304 (23%), Positives = 111/304 (36%), Gaps = 50/304 (16%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           QT  +   +         + R L +G F   Y   ++ +G E+A K +        E   
Sbjct: 21  QTVELGELR-------LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNR 70

Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLC--------VHIVMELCAGGELFDRIIQR-- 194
            + +E+  M  L+GH NIV    A                ++ ELC  G+L + + +   
Sbjct: 71  AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMES 129

Query: 195 -GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
            G  S     ++       V+  H     ++HRDLK EN LL    +  ++K  DFG + 
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSAT 186

Query: 252 FFKPGQIFTD-------------VVGSPYYVAPEVLL----KHYGPEADVWTAGVILYIL 294
                  ++                 +P Y  PE++        G + D+W  G ILY+L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                PF    +      ++ G       P          LIR ML   P ERL+  EV+
Sbjct: 247 CFRQHPFEDGAKL----RIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

Query: 355 CHPW 358
               
Sbjct: 301 HQLQ 304

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  201 bits (513), Expect = 4e-62
 Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 14/267 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y    +  G+  A K +    L+  +   D  +EI ++  L  H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 92

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEAC 216
           N++    ++ +   ++IV+EL   G+L   I           ER   +    +   +E  
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGSPYYVAPEVL- 274
           HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE + 
Sbjct: 153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPWPLISDSA 332
              Y  ++D+W+ G +LY + +   PF+ +      +   + +   D+   P    S+  
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEEL 267

Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWI 359
           + L+   +   P +R     V      
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYDVAKR 294

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  201 bits (512), Expect = 5e-62
 Identities = 69/299 (23%), Positives = 112/299 (37%), Gaps = 41/299 (13%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG+G FG  +          +A K I           E V RE++ +  L  H 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HP 63

Query: 161 NIVTIKGAYED------------SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            IV    A+ +             + ++I M+LC    L D +  R    ER+ +    I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 209 IVGVVEA---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-------------VF 252
            + + EA    HS G+MHRDLKP N        D  +K  DFGL                
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 253 FKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
                  T  VG+  Y++PE +    Y  + D+++ G+IL+ LL   P      +     
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLT 238

Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
            V           +         +++ ML   P ER  A  ++ +    E+   P +++
Sbjct: 239 DVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF-EDLDFPGKTV 293

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  195 bits (498), Expect = 3e-59
 Identities = 55/298 (18%), Positives = 101/298 (33%), Gaps = 39/298 (13%)

Query: 99  DLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
            L  +   LG+G F   Y  T     +     +F  K           +     + ++ +
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----- 208
                    +    A+       +V EL + G L + I    +  E+   +   I     
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNK--------DDDFSLKAIDFGLSV---FFKPGQ 257
           ++ ++E  H   ++H D+KP+NF+L N         D    L  ID G S+    F  G 
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLK 315
           IFT    +  +   E+L  K +  + D +     +Y +L G       E  +   + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300

Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHP---WICENGVAPDRSL 370
                  D W        +    ML       L + ++L         ++     R+L
Sbjct: 301 RL--PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  194 bits (494), Expect = 3e-58
 Identities = 92/328 (28%), Positives = 144/328 (43%), Gaps = 35/328 (10%)

Query: 45  LNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG 104
           L+    +  +      +K+ +        KD I +          +        D Y + 
Sbjct: 26  LDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINK----------IRDLRMKAED-YEVV 74

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + +G+G FG   L    +T   +A K +SK ++I R D      E  IM   A    +V 
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSPWVVQ 133

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  A++D   +++VME   GG+L   ++      E+ A    AE    +V  ++A HS+G
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAE----VVLALDAIHSMG 188

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVLLK-- 276
            +HRD+KP+N LL   D    LK  DFG  +     G +  D  VG+P Y++PEVL    
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245

Query: 277 ---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
              +YG E D W+ GV LY +L G  PF+A++  G +  ++             IS  AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305

Query: 334 DLIRKMLCSQPSERLT---AHEVLCHPW 358
           +LI   L      RL      E+  H +
Sbjct: 306 NLICAFLTD-REVRLGRNGVEEIKRHLF 332

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  188 bits (480), Expect = 9e-57
 Identities = 80/269 (29%), Positives = 139/269 (51%), Gaps = 26/269 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
            +V ++ +++D+  +++VME  AGGE+F  + + G +SE  A    A+    IV   E  
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----IVLTFEYL 157

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           HSL +++RDLKPEN L+   D    ++  DFG +   K  +  T  + G+P  +APE++L
Sbjct: 158 HSLDLIYRDLKPENLLI---DQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIIL 211

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
            K Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKD 267

Query: 335 LIRKMLCSQPSERL-----TAHEVLCHPW 358
           L+R +L    ++R        +++  H W
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  183 bits (466), Expect = 5e-55
 Identities = 76/269 (28%), Positives = 130/269 (48%), Gaps = 26/269 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + R LG G FG  +L      G  +A K + K  ++  + VE    E  ++  +  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
            I+ + G ++D+  + ++M+   GGELF  + +   +    A    AE    +   +E  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----VCLALEYL 122

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           HS  +++RDLKPEN LL   D +  +K  DFG +   K     T  + G+P Y+APEV+ 
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVS 176

Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
              Y    D W+ G+++Y +L+G  PF+       ++ +L   + F   P P  ++  KD
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKD 232

Query: 335 LIRKMLCSQPSERL-----TAHEVLCHPW 358
           L+ +++    S+RL        +V  HPW
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  184 bits (469), Expect = 1e-54
 Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 24/266 (9%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G FG   +  +  T   +A K ++K+K + R +V +V +E+QIM  L  H  +V 
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVN 79

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  +++D   + +V++L  GG+L   + Q  H+ E        E    +V  ++   +  
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE----LVMALDYLQNQR 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--- 277
           ++HRD+KP+N LL   D+   +   DF ++         T + G+  Y+APE+       
Sbjct: 136 IIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192

Query: 278 -YGPEADVWTAGVILYILLSGVPPFW---AETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            Y    D W+ GV  Y LL G  P+    + + + I        + +   P    S    
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWSQEMV 248

Query: 334 DLIRKMLCSQPSERL-TAHEVLCHPW 358
            L++K+L   P +R     +V   P+
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPY 274

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  180 bits (460), Expect = 2e-54
 Identities = 57/290 (19%), Positives = 109/290 (37%), Gaps = 32/290 (11%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
                +    K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAV 66

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVG 211
           L  H ++V    A+ +   + I  E C GG L D I +      ++ E +  +L   +  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI----------------DFGLSVFFKP 255
            +   HS+ ++H D+KP N  +       +                    D G       
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 256 GQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV 313
            Q+     G   ++A EVL ++  + P+AD++   + +       P      Q   +  +
Sbjct: 187 PQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240

Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG 363
            +G +          S    +L++ M+   P  R +A  ++ H  +    
Sbjct: 241 RQGRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  183 bits (467), Expect = 4e-54
 Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 34/274 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G F    +     TG  +A K ++K  ++ R +V   R E  ++ +    + I  + 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRRWITQLH 127

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKA----AELTRIIVGVVEACHSLGV 221
            A++D   +++VME   GG+L   + + G       A    AE    IV  +++ H LG 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE----IVMAIDSVHRLGY 183

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVLLK--- 276
           +HRD+KP+N LL   D    ++  DFG  +  +  G + + V VG+P Y++PE+L     
Sbjct: 184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240

Query: 277 -----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---- 327
                 YGPE D W  GV  Y +  G  PF+A++    +  ++           PL    
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL---SLPLVDEG 297

Query: 328 ISDSAKDLIRKMLCSQPSERLT---AHEVLCHPW 358
           + + A+D I+++LC  P  RL    A +   HP+
Sbjct: 298 VPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPF 330

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  182 bits (463), Expect = 2e-53
 Identities = 77/269 (28%), Positives = 134/269 (49%), Gaps = 26/269 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +         FA K ++K +++ R +    R E  ++ +    K I T+ 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLH 140

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKA----AELTRIIVGVVEACHSLGV 221
            A++D   +++VM+   GG+L   + +      E  A    AE    +V  +++ H L  
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE----MVIAIDSVHQLHY 196

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDV-VGSPYYVAPEVLL---- 275
           +HRD+KP+N L+   D +  ++  DFG      + G + + V VG+P Y++PE+L     
Sbjct: 197 VHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253

Query: 276 --KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW-PLISDSA 332
               YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+       +S++A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313

Query: 333 KDLIRKMLCSQPSERLT---AHEVLCHPW 358
           KDLIR+++CS    RL      +   HP+
Sbjct: 314 KDLIRRLICS-REHRLGQNGIEDFKKHPF 341

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  185 bits (471), Expect = 1e-52
 Identities = 83/369 (22%), Positives = 147/369 (39%), Gaps = 33/369 (8%)

Query: 6   RGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNS 65
           R   + +++  Y   E  + +   + ++   +             + Q + +E  +    
Sbjct: 101 RLVCSREIFDTYIMKELLACSHPFSKSA-IEHVQGHLVKKQVPPDLFQPYIEEICQNLRG 159

Query: 66  APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI 125
                  + D   R     Q   V  +    + D     R +G+G FG  Y C +  TG 
Sbjct: 160 DVFQKFIESDKFTRFC---QWKNVELNIHLTMNDFSVH-RIIGRGGFGEVYGCRKADTGK 215

Query: 126 EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVTIKGAYEDSLCVHIVMELCA 183
            +A K + K+++  ++       E  ++  ++      IV +  A+     +  +++L  
Sbjct: 216 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 275

Query: 184 GGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD 239
           GG+L   + Q G +SE       AE    I+  +E  H+  V++RDLKP N LL   D+ 
Sbjct: 276 GGDLHYHLSQHGVFSEADMRFYAAE----IILGLEHMHNRFVVYRDLKPANILL---DEH 328

Query: 240 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSG 297
             ++  D GL+  F   +     VG+  Y+APEVL K   Y   AD ++ G +L+ LL G
Sbjct: 329 GHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

Query: 298 VPPFWAET---QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL-----T 349
             PF       +  I    L   ++         S   + L+  +L    + RL      
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRG 443

Query: 350 AHEVLCHPW 358
           A EV   P+
Sbjct: 444 AQEVKESPF 452

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  171 bits (435), Expect = 8e-51
 Identities = 59/266 (22%), Positives = 115/266 (43%), Gaps = 14/266 (5%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
              ++G+G F T Y   +  T +E A   +  RKL ++ + +  + E +++  L  H NI
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87

Query: 163 VTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           V    ++E ++    C+ +V EL   G L   + +      +      R I+  ++  H+
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 219 LG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
               ++HRDLK +N  +       S+K  D GL+   +       V+G+P ++APE+  +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYEE 204

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSAKDL 335
            Y    DV+  G+ +  + +   P+        I+  V  G     +    +     K++
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEI 262

Query: 336 IRKMLCSQPSERLTAHEVLCHPWICE 361
           I   +     ER +  ++L H +  E
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  169 bits (431), Expect = 2e-49
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 24/262 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H  +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVM 222
             ++    +  VME   GG+L   I     +   +A    AE   II+G ++  HS G++
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE---IILG-LQFLHSKGIV 140

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL-KH 277
           +RDLK +N LL   D D  +K  DFG+    K   +         G+P Y+APE+LL + 
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMC---KENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W+ GV+LY +L G  PF  + ++ +F ++   +  +   P   +   AKDL+ 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLV 250

Query: 338 KMLCSQPSERLTAH-EVLCHPW 358
           K+   +P +RL    ++  HP 
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPL 272

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  169 bits (430), Expect = 2e-49
 Identities = 87/266 (32%), Positives = 135/266 (50%), Gaps = 29/266 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVM 222
            A++    +  VME   GGELF  + +   ++E +A    AE    IV  +E  HS  V+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE----IVSALEYLHSRDVV 127

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH- 277
           +RD+K EN +L   D D  +K  DFGL    K G      +    G+P Y+APEVL  + 
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YG   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F   P   +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLA 237

Query: 338 KMLCSQPSERL-----TAHEVLCHPW 358
            +L   P +RL      A EV+ H +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRF 263

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  168 bits (427), Expect = 6e-49
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 32/268 (11%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
             +   D L    VME   GG+L   I Q G + E  A    AE    I   +    S G
Sbjct: 88  SCFQTMDRLY--FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----IAIGLFFLQSKG 141

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLK 276
           +++RDLK +N +L   D +  +K  DFG+    K             G+P Y+APE++  
Sbjct: 142 IIYRDLKLDNVML---DSEGHIKIADFGMC---KENIWDGVTTKTFCGTPDYIAPEIIAY 195

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             YG   D W  GV+LY +L+G  PF  E +  +F ++++ ++ +   P   +S  A  +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAI 251

Query: 336 IRKMLCSQPSERLTAH-----EVLCHPW 358
            + ++   P +RL        ++  H +
Sbjct: 252 CKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  167 bits (426), Expect = 9e-49
 Identities = 81/269 (30%), Positives = 125/269 (46%), Gaps = 33/269 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     TG  +A K + K  ++  +DVE    E +I+     H  +  + 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
             +   D L    VME   GG+L   I +   + E +A    AE    I+  +   H  G
Sbjct: 91  CCFQTPDRLF--FVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----IISALMFLHDKG 144

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLK 276
           +++RDLK +N LL   D +   K  DFG+    K G           G+P Y+APE+L +
Sbjct: 145 IIYRDLKLDNVLL---DHEGHCKLADFGMC---KEGICNGVTTATFCGTPDYIAPEILQE 198

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             YGP  D W  GV+LY +L G  PF AE +  +F+A+L   + +   P   + + A  +
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGI 254

Query: 336 IRKMLCSQPSERL------TAHEVLCHPW 358
           ++  +   P+ RL        H +L HP+
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  172 bits (437), Expect = 2e-48
 Identities = 84/268 (31%), Positives = 128/268 (47%), Gaps = 28/268 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C   ATG  +ACK + K+++  R+       E QI+      + +V++ 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVVSLA 250

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKA----AELTRIIVGVVEACHSLG 220
            AYE    + +V+ L  GG+L   I   G   + E +A    AE   I  G +E  H   
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE---ICCG-LEDLHRER 306

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363

Query: 280 PEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
              D W  G +LY +++G  PF        ++ +   V +   ++        S  A+ L
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER----FSPQARSL 419

Query: 336 IRKMLCSQPSERL-----TAHEVLCHPW 358
             ++LC  P+ERL     +A EV  HP 
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  172 bits (437), Expect = 4e-48
 Identities = 85/367 (23%), Positives = 147/367 (40%), Gaps = 29/367 (7%)

Query: 4   TCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKD 63
           T R  F G L  G S+ +    +      S      ++ P        ++E  ++  +  
Sbjct: 251 TSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAK 310

Query: 64  NSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIAT 123
                 +P +K        DN            + D +     LG+G FG   L     T
Sbjct: 311 IGQGTKAPEEKTANTISKFDNNG----NRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGT 365

Query: 124 GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY--EDSLCVHIVMEL 181
              +A K + K  +I  +DVE    E +++        +  +   +   D L    VME 
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY--FVMEY 423

Query: 182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS 241
             GG+L   I Q G + E  A      I   +    S G+++RDLK +N +L   D +  
Sbjct: 424 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGH 480

Query: 242 LKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS 296
           +K  DFG+    K             G+P Y+APE++  + YG   D W  GV+LY +L+
Sbjct: 481 IKIADFGMC---KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL-----TAH 351
           G  PF  E +  +F ++++ ++ +   P   +S  A  + + ++   P +RL        
Sbjct: 538 GQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRLGCGPEGER 593

Query: 352 EVLCHPW 358
           ++  H +
Sbjct: 594 DIKEHAF 600

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  167 bits (426), Expect = 8e-48
 Identities = 89/326 (27%), Positives = 152/326 (46%), Gaps = 35/326 (10%)

Query: 53  QEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG-----RKL 107
           +E++       +   + + ++ D       DN     +       +   T+      + L
Sbjct: 97  EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156

Query: 108 GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKG 167
           G+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K 
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKY 215

Query: 168 AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHS-LGVM 222
           +++    +  VME   GGELF  + +   +SE +A    AE    IV  ++  HS   V+
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE----IVSALDYLHSEKNVV 271

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH- 277
           +RDLK EN +L   D D  +K  DFGL    K G      +    G+P Y+APEVL  + 
Sbjct: 272 YRDLKLENLML---DKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YG   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F   P   +   AK L+ 
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAKSLLS 381

Query: 338 KMLCSQPSERL-----TAHEVLCHPW 358
            +L   P +RL      A E++ H +
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRF 407

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  165 bits (420), Expect = 1e-47
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 31/267 (11%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A  + +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
            ++   D L    V++   GGELF  + +   + E +A    AE    I   +   HSL 
Sbjct: 106 FSFQTADKLY--FVLDYINGGELFYHLQRERCFLEPRARFYAAE----IASALGYLHSLN 159

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLK 276
           +++RDLKPEN LL   D    +   DFGL    K             G+P Y+APEVL K
Sbjct: 160 IVYRDLKPENILL---DSQGHIVLTDFGLC---KENIEHNSTTSTFCGTPEYLAPEVLHK 213

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             Y    D W  G +LY +L G+PPF++     ++D +L   +       P I++SA+ L
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHL 269

Query: 336 IRKMLCSQPSERL----TAHEVLCHPW 358
           +  +L    ++RL       E+  H +
Sbjct: 270 LEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  162 bits (413), Expect = 2e-47
 Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 26/269 (9%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
              LG+G +G  Y   +++  +  A K I           + +  EI +  HL  HKNIV
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVEACHSL 219
              G++ ++  + I ME   GG L   +++        +E+     T+ I+  ++  H  
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            ++HRD+K +N L+        LK  DFG S              G+  Y+APE++ K  
Sbjct: 142 QIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 278 --YGPEADVWTAGVILYILLSGVPPFW--AETQQGIFDAVLKGHIDFESDPWPL---ISD 330
             YG  AD+W+ G  +  + +G PPF+   E Q  +F       +        +   +S 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF------KVGMFKVHPEIPESMSA 253

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            AK  I K     P +R  A+++L   ++
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFL 282

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  168 bits (428), Expect = 2e-47
 Identities = 82/273 (30%), Positives = 133/273 (48%), Gaps = 35/273 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+      + IV++ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVSLA 251

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGH----YSERKA----AELTRIIVGVVEAC 216
            A+E    LC  +VM +  GG++   I         + E +A    A+   I+ G +E  
Sbjct: 252 YAFETKTDLC--LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ---IVSG-LEHL 305

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+LL
Sbjct: 306 HQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISD 330
            + Y    D +  GV LY +++   PF A       + +   VL+  + +        S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSP 418

Query: 331 SAKDLIRKMLCSQPSERL-----TAHEVLCHPW 358
           ++KD    +L   P +RL     +   +  HP 
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  164 bits (418), Expect = 3e-47
 Identities = 76/332 (22%), Positives = 133/332 (40%), Gaps = 39/332 (11%)

Query: 54  EFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG-----RKLG 108
            +   +   D   P          M  GI+ +   +   ++        L      R +G
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61

Query: 109 QGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA 168
           +G +    L     T   +A + + K  +   ED++ V+ E  +    + H  +V +   
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121

Query: 169 Y--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           +  E  L    V+E   GG+L   + ++    E  A   +  I   +   H  G+++RDL
Sbjct: 122 FQTESRLF--FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH-YGPE 281
           K +N LL   D +  +K  D+G+    K G    D      G+P Y+APE+L    YG  
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233

Query: 282 ADVWTAGVILYILLSGVPPFW---------AETQQGIFDAVLKGHIDFESDPWPLISDSA 332
            D W  GV+++ +++G  PF            T+  +F  +L+  I     P   +S  A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVKA 289

Query: 333 KDLIRKMLCSQPSERLTAH------EVLCHPW 358
             +++  L   P ERL  H      ++  HP+
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  162 bits (413), Expect = 4e-47
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 27/266 (10%)

Query: 107 LGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           LGQG FG  +L  +I+       +A K + K  L  R+ V   + E  I+     H  IV
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVE-VNHPFIV 89

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSL 219
            +  A++    ++++++   GG+LF R+ +   ++E       AE    +   ++  HSL
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE----LALALDHLHSL 145

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
           G+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ +  
Sbjct: 146 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +   AD W+ GV+++ +L+G  PF  + ++     +LK  +     P   +S  A+ L+R
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLR 258

Query: 338 KMLCSQPSERL-----TAHEVLCHPW 358
            +    P+ RL        E+  H +
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSF 284

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  163 bits (414), Expect = 5e-47
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 34/274 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H  +V + 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
             +  E  L    V+E   GG+L   + ++    E  A   +  I   +   H  G+++R
Sbjct: 77  SCFQTESRLF--FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLKH-YG 279
           DLK +N LL   D +  +K  D+G+    K G    D      G+P Y+APE+L    YG
Sbjct: 135 DLKLDNVLL---DSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188

Query: 280 PEADVWTAGVILYILLSGVPPFW---------AETQQGIFDAVLKGHIDFESDPWPLISD 330
              D W  GV+++ +++G  PF            T+  +F  +L+  I     P   +S 
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSV 244

Query: 331 SAKDLIRKMLCSQPSERLTAH------EVLCHPW 358
            A  +++  L   P ERL  H      ++  HP+
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  162 bits (411), Expect = 9e-47
 Identities = 67/345 (19%), Positives = 129/345 (37%), Gaps = 44/345 (12%)

Query: 24  SNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGID 83
           S +S +  +       +S+ S   Q+L  +    E          +    ++ +      
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV------ 57

Query: 84  NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
                             T   ++G+G FG  +   +  TG + A K +          +
Sbjct: 58  ---------------HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---------RL 93

Query: 144 EDVR-REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
           E  R  E+     L+    IV + GA  +   V+I MEL  GG L   I Q G   E +A
Sbjct: 94  EVFRVEELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-- 260
                  +  +E  H+  ++H D+K +N +L++ D        DFG ++  +P  +    
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADN-VLLSSDGS-RAALCDFGHALCLQPDGLGKSL 210

Query: 261 ----DVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVL 314
                + G+  ++APEV++      + D+W++  ++  +L+G  P+    +         
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270

Query: 315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           +     E  P    +      I++ L  +P  R +A E+      
Sbjct: 271 EPPPIREIPPS--CAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  161 bits (409), Expect = 2e-46
 Identities = 78/267 (29%), Positives = 135/267 (50%), Gaps = 27/267 (10%)

Query: 107 LGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHLAGHKNI 162
           LG+G +G  +   ++    TG  FA K + K  ++   +D    + E  I+     H  I
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-VKHPFI 83

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHS 218
           V +  A++    +++++E  +GGELF ++ + G + E  A    AE   I + +    H 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE---ISMAL-GHLHQ 139

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLKH 277
            G+++RDLKPEN +L   +    +K  DFGL       G +     G+  Y+APE+L++ 
Sbjct: 140 KGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196

Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +    D W+ G ++Y +L+G PPF  E ++   D +LK  ++    P P ++  A+DL+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLL 252

Query: 337 RKMLCSQPSERL-----TAHEVLCHPW 358
           +K+L    + RL      A EV  HP+
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  161 bits (409), Expect = 3e-46
 Identities = 84/336 (25%), Positives = 151/336 (44%), Gaps = 34/336 (10%)

Query: 45  LNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG 104
           +       +E    +     ++       +  +  +            +   I + + L 
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-FELL 59

Query: 105 RKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHLAGHK 160
           + LG G +G  +L  +I+   TG  +A K + K  ++ + +  E  R E Q++ H+    
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
            +VT+  A++    +H++++   GGELF  + QR  ++E +      E    IV  +E  
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----IVLALEHL 175

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS        +   D  G+  Y+AP+++
Sbjct: 176 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232

Query: 275 LKH---YGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV++Y LL+G  PF  +    +Q  I   +LK    +   P   
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QE 288

Query: 328 ISDSAKDLIRKMLCSQPSERL-----TAHEVLCHPW 358
           +S  AKDLI+++L   P +RL      A E+  H +
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  159 bits (405), Expect = 3e-45
 Identities = 85/344 (24%), Positives = 144/344 (41%), Gaps = 62/344 (18%)

Query: 56  SKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
           S        +  +++P    N + +          G   +     YT  + +G G FG  
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIK-----VLASDGKTGEQREIAYTNCKVIGNGSFGVV 56

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK------GAY 169
           +    + +  E A K +        +D     RE+QIM  +  H N+V +K      G  
Sbjct: 57  FQAKLVESD-EVAIKKV-------LQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDK 107

Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--------VEACHSLGV 221
           +D + +++V+E     E   R  +  HY++ K   +  +++ +        +   HS+G+
Sbjct: 108 KDEVFLNLVLEYV--PETVYRASR--HYAKLKQ-TMPMLLIKLYMYQLLRSLAYIHSIGI 162

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
            HRD+KP+N LL++      LK IDFG +     G+     + S YY APE++    +Y 
Sbjct: 163 CHRDIKPQN-LLLDPPSG-VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220

Query: 280 PEADVWTAGVILYILLSGVPPFWAET--QQ--GIFD-----------AVLKGHIDF---- 320
              D+W+ G ++  L+ G P F  E+   Q   I              +   +++     
Sbjct: 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ 280

Query: 321 -ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
               P+     P     A DLI ++L   PS RLTA E LCHP+
Sbjct: 281 IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  156 bits (395), Expect = 2e-44
 Identities = 62/331 (18%), Positives = 109/331 (32%), Gaps = 81/331 (24%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRK----------------- 136
           +   + +G+G FG  +               I    + +++ K                 
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 137 -------------------------------LISREDVEDVRREIQIMHHLAGHKNIVTI 165
                                          L S   ++    +I+ M   +  KN V  
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQ 126

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA---CHSLGVM 222
                  + ++I M+LC    L D + +R    +R+      I + + EA    HS G+M
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-------------VFFKPGQIFTDVVGSPYYV 269
           HRDLKP N        D  +K  DFGL                       T  VG+  Y+
Sbjct: 187 HRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           +PE +   +Y  + D+++ G+IL+ LL          +  I   V           +   
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKF---PLLFTQK 298

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                 +++ ML   P+ER  A +++ +   
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  153 bits (388), Expect = 1e-43
 Identities = 80/313 (25%), Positives = 138/313 (44%), Gaps = 27/313 (8%)

Query: 58  ENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGH--KTDNIRDLYTLGRKLGQGQFGTT 115
            +    +S   +               Q    L       + R L     K+G+G  G  
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
            L  E  +G + A K +    L  ++  E +  E+ IM     H N+V +  +Y     +
Sbjct: 62  CLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEEL 117

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
            ++ME   GG L D I+ +   +E + A +   ++  +   H+ GV+HRD+K ++ LL  
Sbjct: 118 WVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL-- 174

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTD------VVGSPYYVAPEVLL-KHYGPEADVWTAG 288
              D  +K  DFG        QI  D      +VG+PY++APEV+    Y  E D+W+ G
Sbjct: 175 -TLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG 228

Query: 289 VILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE-SDPWPLISDSAKDLIRKMLCSQPSE 346
           +++  ++ G PP+++++  Q +           + S      S   +D + +ML   P E
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV---SPVLRDFLERMLVRDPQE 285

Query: 347 RLTAHEVLCHPWI 359
           R TA E+L HP++
Sbjct: 286 RATAQELLDHPFL 298

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  152 bits (385), Expect = 2e-43
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 31/278 (11%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
             + +  YT   K+GQG  GT Y   ++ATG E A + +    L  +   E +  EI +M
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM 71

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                + NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD------VVGSPY 267
           E  HS  V+HRD+K +N LL     D S+K  DFG        QI  +      +VG+PY
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPY 181

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP- 324
           ++APEV+  K YGP+ D+W+ G++   ++ G PP+  E   + ++       I     P 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPE 235

Query: 325 ---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                 +S   +D + + L     +R +A E+L H ++
Sbjct: 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  151 bits (383), Expect = 2e-42
 Identities = 73/359 (20%), Positives = 134/359 (37%), Gaps = 30/359 (8%)

Query: 38  SDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI 97
           S Y     +   + + E        D            +     +  +         D+ 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFK---------DDP 52

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
             L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ +  L 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H N +  +G Y       +VME C G       + +    E + A +T   +  +   H
Sbjct: 113 -HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TDVVGSPYYVAPEVLL 275
           S  ++HRD+K  N LL    +   +K  DFG +       +      VG+PY++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILL---SEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVIL 223

Query: 276 ----KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISD 330
                 Y  + DVW+ G+    L    PP +       ++          +S  W   S+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SE 280

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK 389
             ++ +   L   P +R T+  +L H ++      P   +   +         ++ L+ 
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQY 337

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  151 bits (384), Expect = 5e-42
 Identities = 89/354 (25%), Positives = 139/354 (39%), Gaps = 72/354 (20%)

Query: 57  KENPKKDNSAPRISPSKKDNIMRRGIDNQTYYV-----LGHKTDNIRDL-YTLGRKLGQG 110
           +     ++  P   PS   ++      + +         G   D  +++ YT  + +G G
Sbjct: 6   RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65

Query: 111 QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK---- 166
            FG  Y      +G   A K +        +D     RE+QIM  L  H NIV ++    
Sbjct: 66  SFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 117

Query: 167 --GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--------VEAC 216
             G  +D + +++V++     E   R+ +  HYS  K   L  I V +        +   
Sbjct: 118 SSGEKKDEVYLNLVLDYV--PETVYRVAR--HYSRAKQ-TLPVIYVKLYMYQLFRSLAYI 172

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL- 275
           HS G+ HRD+KP+N LL++ D    LK  DFG +     G+     + S YY APE++  
Sbjct: 173 HSFGICHRDIKPQN-LLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQG---------IFD-----------AVL 314
              Y    DVW+AG +L  LL G P F      G         I              + 
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIF-----PGDSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 315 KGHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             + +F     ++ PW     P     A  L  ++L   P+ RLT  E   H +
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  147 bits (372), Expect = 2e-41
 Identities = 73/276 (26%), Positives = 128/276 (46%), Gaps = 22/276 (7%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
             +  +L+T   K+G+G FG  +   +  T    A K I   +  + +++ED+++EI ++
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVL 74

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                   +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  +
Sbjct: 75  SQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF------TDVVGSPY 267
           +  HS   +HRD+K  N LL    +   +K  DFG++     GQ+          VG+P+
Sbjct: 133 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPF 184

Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           ++APEV+ +  Y  +AD+W+ G+    L  G PP        +   + K +       + 
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY- 243

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
             S   K+ +   L  +PS R TA E+L H +I  N
Sbjct: 244 --SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  146 bits (371), Expect = 4e-41
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 36/282 (12%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            ++ L   +G G +G  Y    + TG   A K +     ++ ++ E++++EI ++   + 
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 159 HKNIVTIKGAYEDSLCVH------IVMELCAGGELFD--RIIQRGHYSERKAAELTRIIV 210
           H+NI T  GA+             +VME C  G + D  +  +     E   A + R I+
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI------FTDVVG 264
             +   H   V+HRD+K +N LL    ++  +K +DFG+S      Q+          +G
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVS-----AQLDRTVGRRNTFIG 191

Query: 265 SPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGH 317
           +PY++APEV+         Y  ++D+W+ G+    +  G PP       + +F       
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              +S  W   S   +  I   L    S+R    +++ HP+I
Sbjct: 252 PRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  147 bits (372), Expect = 5e-41
 Identities = 75/305 (24%), Positives = 135/305 (44%), Gaps = 57/305 (18%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
             +D Y L RKLG+G++   +    I    +     +   K++     + ++REI+I+ +
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV---V---KILKPVKKKKIKREIKILEN 86

Query: 156 LAGHKNIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           L G  NI+T+        +   +L    V         F ++ Q    ++         I
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNT-----DFKQLYQT--LTDYDIRFYMYEI 139

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  ++ CHS+G+MHRD+KP N ++++ +    L+ ID+GL+ F+ PGQ +   V S Y+ 
Sbjct: 140 LKALDYCHSMGIMHRDVKPHN-VMIDHEH-RKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA---ETQQ-----------GIFDAV 313
            PE+L+  + Y    D+W+ G +L  ++    PF+       Q            ++D +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257

Query: 314 LKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAHEV 353
            K +I+ +              W          L+S  A D + K+L      RLTA E 
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317

Query: 354 LCHPW 358
           + HP+
Sbjct: 318 MEHPY 322

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  146 bits (370), Expect = 5e-41
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 43/286 (15%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            I DL  LG  +G G  G  +      TG   A K +  R+  ++E+ + +  ++ ++  
Sbjct: 23  EINDLENLGE-MGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLK 79

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
                 IV   G +  +  V I MEL        +   +G   ER   ++T  IV  +  
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139

Query: 216 CHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----TDVVGSPYYV 269
                GV+HRD+KP N LL   D+   +K  DFG+S     G++          G   Y+
Sbjct: 140 LKEKHGVIHRDVKPSNILL---DERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYM 191

Query: 270 APEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDA----------V 313
           APE +         Y   ADVW+ G+ L  L +G  P+  +  +  F+           +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPL 249

Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           L GH+ F        S   +  ++  L     +R   +++L H +I
Sbjct: 250 LPGHMGF--------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  144 bits (366), Expect = 1e-40
 Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 38/268 (14%)

Query: 102 TLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            +   +G+G FG        A     + A K     ++ S  + +    E++ +  +  H
Sbjct: 11  EVEEVVGRGAFGVVCK----AKWRAKDVAIK-----QIESESERKAFIVELRQLSRVN-H 60

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC--- 216
            NIV + GA  + +C  +VME   GG L++ +          AA      +   +     
Sbjct: 61  PNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 217 HSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           HS+    ++HRDLKP N LLV       LK  DFG +   +     T+  GS  ++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEV 174

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFW--AETQQGIFDAVLKGHIDFESDPWPLISD 330
               +Y  + DV++ G+IL+ +++   PF         I  AV  G         P +  
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-------RPPLIK 227

Query: 331 SA----KDLIRKMLCSQPSERLTAHEVL 354
           +     + L+ +     PS+R +  E++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  144 bits (364), Expect = 3e-40
 Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 44/292 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD Y L   +G G               + A K I+  K   +  ++++ +EIQ M    
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCH 71

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV--EA 215
            H NIV+   ++     + +VM+L +GG + D I       E K+  L    +  +  E 
Sbjct: 72  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 216 C------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-------- 261
                  H  G +HRD+K  N LL    +D S++  DFG+S       + T         
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVS-----AFLATGGDITRNKV 182

Query: 262 ---VVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAE---------TQQ 307
               VG+P ++APEV+  ++ Y  +AD+W+ G+    L +G  P+             Q 
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242

Query: 308 GIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                 L+  +  +         S + +I   L   P +R TA E+L H + 
Sbjct: 243 DP--PSLETGVQDKEMLKKY-GKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  143 bits (363), Expect = 4e-40
 Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 46/286 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            +++ +  +LG G FG  Y      TG   A K I      S E++ED   EI+I+    
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCD 74

Query: 158 GHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVE 214
            H  IV + GAY  +  L   I++E C GG +   +++     +E +   + R ++  + 
Sbjct: 75  -HPYIVKLLGAYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF------TDVVGSPYY 268
             HS  ++HRDLK  N L+     +  ++  DFG+S      +           +G+PY+
Sbjct: 132 FLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYW 183

Query: 269 VAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE 321
           +APEV++        Y  +AD+W+ G+ L  +    PP       + +        I   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKS 237

Query: 322 SDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
             P       W   S   +D ++  L   P  R +A ++L HP++ 
Sbjct: 238 DPPTLLTPSKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  141 bits (357), Expect = 4e-39
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 27/276 (9%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T    +++ +  KLG+G +G+ Y      TG   A K +         D++++ +EI IM
Sbjct: 24  TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIM 78

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGV 212
                  ++V   G+Y  +  + IVME C  G + D I  R    +E + A + +  +  
Sbjct: 79  QQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF------TDVVGSP 266
           +E  H +  +HRD+K  N LL   + +   K  DFG++     GQ+         V+G+P
Sbjct: 138 LEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTP 189

Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE-SD 323
           +++APEV+ +  Y   AD+W+ G+    +  G PP+      + IF         F   +
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE 249

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            W   SD+  D +++ L   P +R TA ++L HP++
Sbjct: 250 LW---SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (354), Expect = 5e-39
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR----EDVEDVRREIQIMHHLA 157
              +++G+G FG  +    +      A KS+            E  ++ +RE+ IM +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +     
Sbjct: 82  -HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIE 136

Query: 217 --HSLG--VMHRDLKPENFLLVNKD--DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
              +    ++HRDL+  N  L + D       K  DFGLS         + ++G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMA 194

Query: 271 PEVLL---KHYGPEADVWTAGVILYILLSGVPPF 301
           PE +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  140 bits (355), Expect = 7e-39
 Identities = 78/294 (26%), Positives = 120/294 (40%), Gaps = 43/294 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHL 156
           + Y    K+G+G +G  + C    TG   A K          + V      REI+++  L
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQL 59

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVE 214
             H N+V +   +     +H+V E C        DR   +    E     +T   +  V 
Sbjct: 60  K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVN 116

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEV 273
            CH    +HRD+KPEN +L+ K     +K  DFG + +   P   + D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPEN-ILITKHSV--IKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 274 LL--KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQ--GIF-------DAVLKGHIDF 320
           L+    YGP  DVW  G +   LLSGVP +    +  Q   I            +     
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 321 E----------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           +                   +P IS  A  L++  L   P+ERLT  ++L HP+
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  140 bits (356), Expect = 9e-39
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 40/284 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL  LG ++G+G +G+        +G   A K I  R  +  ++ + +  ++ ++   + 
Sbjct: 23  DLKDLG-EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA---AELTRIIVGVVEA 215
              IV   GA        I MEL +    FD+  +  +           L +I +  V+A
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 216 CHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----TDVVGSP 266
            + L     ++HRD+KP N +L+++  +   K  DFG+S     GQ+      T   G  
Sbjct: 138 LNHLKENLKIIHRDIKPSN-ILLDRSGNI--KLCDFGIS-----GQLVDSIAKTRDAGCR 189

Query: 267 YYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--- 318
            Y+APE +      + Y   +DVW+ G+ LY L +G  P+       +FD +    +   
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLT--QVVKG 245

Query: 319 ---DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                 +      S S  + +   L    S+R    E+L HP+I
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  138 bits (351), Expect = 2e-38
 Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 42/287 (14%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
               DL  +   LG+G +G       + +G   A K I  R  ++ ++ + +  ++ I  
Sbjct: 4   VKADDLEPIME-LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISM 60

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE--LTRIIVGV 212
                   VT  GA      V I MEL       D+  ++     +   E  L +I V +
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 213 VEACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----TDVV 263
           V+A   L     V+HRD+KP N +L+N       K  DFG+S     G +          
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSN-VLINALGQV--KMCDFGIS-----GYLVDDVAKDIDA 170

Query: 264 GSPYYVAPEVLL-----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
           G   Y+APE +      K Y  ++D+W+ G+ +  L     P+  ++    F  +    +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLK--QV 226

Query: 319 ------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                    +D +   S    D   + L     ER T  E++ HP+ 
Sbjct: 227 VEEPSPQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  139 bits (352), Expect = 4e-38
 Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 43/294 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIM 153
             Y     LG+GQF T Y   +  T    A K I   KL  R + +D       REI+++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVG 211
             L+ H NI+ +  A+     + +V +        +          S  KA     + + 
Sbjct: 67  QELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQ 123

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
            +E  H   ++HRDLKP N LL   D++  LK  DFGL+  F  P + +T  V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180

Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET--QQ--GIFDAV----------- 313
           PE+L   + YG   D+W  G IL  LL  VP    ++   Q   IF+ +           
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240

Query: 314 --LKGHIDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             L  ++ F+S P       +    D   DLI+ +    P  R+TA + L   +
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  139 bits (352), Expect = 5e-38
 Identities = 69/307 (22%), Positives = 116/307 (37%), Gaps = 57/307 (18%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +    +LG G  G  +  +   +G+  A K I     I       + RE+Q++H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECN- 89

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              IV   GA+     + I ME   GG L   + + G   E+   +++  ++  +     
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 219 -LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEV 273
              +MHRD+KP N +LVN   +   K  DFG+S     GQ+   +    VG+  Y++PE 
Sbjct: 150 KHKIMHRDVKPSN-ILVNSRGEI--KLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 201

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL------------------ 314
           L   HY  ++D+W+ G+ L  +  G  P      + +                       
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 315 --KGHIDFESDPWPLI--------------------SDSAKDLIRKMLCSQPSERLTAHE 352
                   +S P   I                    S   +D + K L   P+ER    +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 353 VLCHPWI 359
           ++ H +I
Sbjct: 322 LMVHAFI 328

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  137 bits (348), Expect = 1e-37
 Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 47/310 (15%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           + Y     +G+G +G    C    TG   A K     K +  +D + V+    REI+++ 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGV 212
            L  H+N+V +    +     ++V E       +  +          +   +    I+  
Sbjct: 80  QLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIING 136

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAP 271
           +  CHS  ++HRD+KPEN +LV++     +K  DFG +     PG+++ D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPEN-ILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQ--GIFDAV------------ 313
           E+L+    YG   DVW  G ++  +  G P F    +  Q   I   +            
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 314 -LKGHIDFESDPW----------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
                                  P +S+   DL +K L   P +R    E+L H +   +
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

Query: 363 GVAPDRSLDP 372
           G A   S + 
Sbjct: 314 GFAERFSQEL 323

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  136 bits (344), Expect = 4e-37
 Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 48/298 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           D Y    KLG+G +G  Y   +  T    A K I       R + E+        RE+ +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-------RLEHEEEGVPGTAIREVSL 86

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  L  H+NI+ +K     +  +H++ E     +L   + +    S R        ++  
Sbjct: 87  LKELQ-HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFS---LKAIDFGLSVFF-KPGQIFTDVVGSPYY 268
           V  CHS   +HRDLKP+N LL++  D      LK  DFGL+  F  P + FT  + + +Y
Sbjct: 145 VNFCHSRRCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 269 VAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVLK 315
             PE+LL  +HY    D+W+   I   +L   P F  +++      IF       D    
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263

Query: 316 GH---------------IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           G                   +     L+ D   DL+  ML   P +R++A   L HP+
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  133 bits (336), Expect = 3e-36
 Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 50/297 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
             Y    K+G+G +GT +      T    A K +       R D +D        REI +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICL 54

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIV 210
           +  L  HKNIV +         + +V E C     + FD           K+      ++
Sbjct: 55  LKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLL 111

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYV 269
             +  CHS  V+HRDLKP+N LL+N++ +  LK  +FGL+  F  P + ++  V + +Y 
Sbjct: 112 KGLGFCHSRNVLHRDLKPQN-LLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA---ETQQ--GIF-------DAVLK 315
            P+VL   K Y    D+W+AG I   L +   P +       Q   IF       +    
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 316 GHI---DFESDP-----------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                 D++  P            P ++ + +DL++ +L   P +R++A E L HP+
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  133 bits (336), Expect = 4e-36
 Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 28/259 (10%)

Query: 102 TLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            +  K+G G FGT +     A   G + A K + ++     E V +  RE+ IM  L  H
Sbjct: 40  NIKEKIGAGSFGTVHR----AEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-H 93

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC--- 216
            NIV   GA      + IV E  + G L+  + + G   +        +   V +     
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 217 HSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEV 273
           H+    ++HR+LK  N L+   D  +++K  DFGLS +            G+P ++APEV
Sbjct: 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L  +    ++DV++ GVIL+ L +   P+       +  AV              I  + 
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------LEIPRNL 264

Query: 333 ----KDLIRKMLCSQPSER 347
                 +I     ++P +R
Sbjct: 265 NPQVAAIIEGCWTNEPWKR 283

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  133 bits (338), Expect = 5e-36
 Identities = 87/321 (27%), Positives = 133/321 (41%), Gaps = 75/321 (23%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           ++    D + + R  GQG FGT  L  E +TG+  A K +        +D     RE+QI
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQI 69

Query: 153 MHHLA--GHKNIVTIKGAY-------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA 203
           M  LA   H NIV ++  +          + +++VME     +   R  +  +Y  R+  
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCR--NYYRRQV- 124

Query: 204 ELTRIIVGV--------VEACH--SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
               I++ V        +   H  S+ V HRD+KP N +LVN+ D  +LK  DFG +   
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEAD-GTLKLCDFGSAKKL 182

Query: 254 KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG--- 308
            P +     + S YY APE++   +HY    D+W+ G I   ++ G P F     +G   
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-----RGDNS 237

Query: 309 ------IFDAVL----------------------KGHIDFE---SDPWPLISDSAKDLIR 337
                 I   VL                         I +    SD     +  A DL+ 
Sbjct: 238 AGQLHEIVR-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296

Query: 338 KMLCSQPSERLTAHEVLCHPW 358
            +L   P ER+  +E LCHP+
Sbjct: 297 ALLQYLPEERMKPYEALCHPY 317

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  133 bits (336), Expect = 6e-36
 Identities = 73/296 (24%), Positives = 118/296 (39%), Gaps = 49/296 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIM 153
           + Y    KLG+G + T Y      T    A K I       R + E+       RE+ ++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVG 211
             L  H NIVT+         + +V E       +  D      +    K       ++ 
Sbjct: 55  KDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL--FLFQLLR 111

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
            +  CH   V+HRDLKP+N LL+N+  +  LK  DFGL+     P + + + V + +Y  
Sbjct: 112 GLAYCHRQKVLHRDLKPQN-LLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVLKGH 317
           P++LL    Y  + D+W  G I Y + +G P F   T +     IF       +    G 
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228

Query: 318 IDFE---------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           +  E                   P +     DL+ K+L  +   R++A + + HP+
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  132 bits (334), Expect = 1e-35
 Identities = 73/317 (23%), Positives = 115/317 (36%), Gaps = 54/317 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIM 153
             +    KLG G + T Y      TG+  A K +       + D E+       REI +M
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLM 57

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG-----ELFDRIIQRGHYSERKAAELTRI 208
             L  H+NIV +         + +V E          +                      
Sbjct: 58  KELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY 267
           ++  +  CH   ++HRDLKP+N LL+NK     LK  DFGL+  F  P   F+  V + +
Sbjct: 117 LLQGLAFCHENKILHRDLKPQN-LLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLW 173

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVL 314
           Y AP+VL+  + Y    D+W+ G IL  +++G P F     +     IF       +++ 
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233

Query: 315 KGHID-------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                                    +      +  +  D +  +L   P  RL+A + L 
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293

Query: 356 HPWICENGVAPDRSLDP 372
           HPW  E           
Sbjct: 294 HPWFAEYYHHASMGGSR 310

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  130 bits (329), Expect = 3e-35
 Identities = 80/296 (27%), Positives = 125/296 (42%), Gaps = 50/296 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           + Y    K+G+G +G  Y       G  FA K I       R + ED        REI I
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI-------RLEKEDEGIPSTTIREISI 53

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIV 210
           +  L  H NIV +         + +V E       +L D           K+      ++
Sbjct: 54  LKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS--FLLQLL 110

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYV 269
             +  CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  + + +Y 
Sbjct: 111 NGIAYCHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV---------- 313
           AP+VL+  K Y    D+W+ G I   +++G P F   ++      IF  +          
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 314 ---LKG-HIDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
              L     +F              + +S  DL+ KML   P++R+TA + L H +
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  130 bits (329), Expect = 4e-35
 Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 45/306 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-----REIQIM 153
             Y    ++G G +GT Y   +  +G   A KS+   ++ +             RE+ ++
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALL 65

Query: 154 HHL--AGHKNIVTIK-----GAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAE 204
             L    H N+V +         +  + V +V E          D+    G        +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           L R  +  ++  H+  ++HRDLKPEN +LV       +K  DFGL+  +      T VV 
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPEN-ILVTSGGT--VKLADFGLARIYSYQMALTPVVV 181

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DA 312
           + +Y APEVLL   Y    D+W+ G I   +    P F   ++      IF       + 
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 313 VLKGHI---DFESDPW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC 360
                +        P          P + +S   L+ +ML   P +R++A   L H ++ 
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

Query: 361 ENGVAP 366
           ++   P
Sbjct: 302 KDEGNP 307

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  131 bits (332), Expect = 5e-35
 Identities = 53/323 (16%), Positives = 101/323 (31%), Gaps = 72/323 (22%)

Query: 99  DLYTLGRKLGQGQ--FGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
             Y L   +G+G     T  L     TG     + I+     S E V  ++ E+ +    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLF 83

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVE 214
             H NIV  +  +     + +V    A G   D          +E   A + + ++  ++
Sbjct: 84  N-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-------------TD 261
             H +G +HR +K  + L+     D  +       +       +                
Sbjct: 143 YIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSN-----LSMISHGQRQRVVHDFPKY 194

Query: 262 VVGSPYYVAPEVL---LKHYGPEADVWTAGVILYILLSGVPPF----------------- 301
            V    +++PEVL   L+ Y  ++D+++ G+    L +G  PF                 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 302 -------------------WAETQQGIFDAVLKGHIDFESDPWPLI------SDSAKDLI 336
                               +    G+ D++        +   P        S      +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
            + L   P  R +A  +L H + 
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFF 337

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  129 bits (326), Expect = 8e-35
 Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 35/264 (13%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           T+G+++G G FGT Y       G    + A K +      + + ++  + E+ ++     
Sbjct: 27  TVGQRIGSGSFGTVYK------GKWHGDVAVKML-NVTAPTPQQLQAFKNEVGVLRKTR- 78

Query: 159 HKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
           H NI+   G      L   IV + C G  L+  +    H SE K      I +    A  
Sbjct: 79  HVNILLFMGYSTAPQLA--IVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARG 132

Query: 217 ----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS---VFFKPGQIFTDVVGSPYYV 269
               H+  ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 270 APEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP 324
           APEV+       Y  ++DV+  G++LY L++G  P+     +  I + V +G +  +   
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 325 WPLISDSA-KDLIRKMLCSQPSER 347
                    K L+ + L  +  ER
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDER 273

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  129 bits (327), Expect = 2e-34
 Identities = 79/358 (22%), Positives = 133/358 (37%), Gaps = 85/358 (23%)

Query: 87  YY--VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           Y+    G    + R  Y L RKLG G F T +L  ++      A K I +   +  E  E
Sbjct: 7   YHPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAE 63

Query: 145 DVRREIQIMHHL----------AGHKNIV------TIKGAYEDSLCVHIVMELCAGGELF 188
           D   EI+++  +           G  +I+        KG     +   +V E+  G  L 
Sbjct: 64  D---EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV--MVFEVL-GENLL 117

Query: 189 DRIIQRGH--YSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDD---DFSL 242
             I +  H         ++++ ++  ++  H   G++H D+KPEN L+   D       +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177

Query: 243 KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           K  D G + +    + +T+ + +  Y +PEVLL   +G  AD+W+   +++ L++G   F
Sbjct: 178 KIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

Query: 302 WAETQQGIFDAV--------LKGHID-------------FESD----------PWPLISD 330
             +                 L G +              F S            WPL   
Sbjct: 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 295

Query: 331 SAK-------------DLIRKMLCSQPSERLTAHEVLCHPWI-----CENGVAPDRSL 370
             +             D +  ML   P +R  A  ++ HPW+      E    PDR L
Sbjct: 296 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 353

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  128 bits (324), Expect = 3e-34
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 48/280 (17%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            +G  +G+G+FG  Y       G    E A + I   +  + + ++  +RE+        
Sbjct: 36  EIGELIGKGRFGQVYH------GRWHGEVAIRLI-DIERDNEDQLKAFKREVMAYRQTR- 87

Query: 159 HKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEA 215
           H+N+V   GA      L   I+  LC G  L+  +   +      K  ++ + IV  +  
Sbjct: 88  HENVVLFMGACMSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI------FTDVVGSPYYV 269
            H+ G++H+DLK +N       D+  +   DFGL       Q            G   ++
Sbjct: 146 LHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201

Query: 270 APEVL----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID 319
           APE++             +   +DV+  G I Y L +   PF  +  + I   +  G   
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK- 260

Query: 320 FESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVL 354
                 P +S         D++      +  ER T  +++
Sbjct: 261 ------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  127 bits (322), Expect = 4e-34
 Identities = 80/297 (26%), Positives = 123/297 (41%), Gaps = 51/297 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           + Y    K+G+G +G  Y   + + G   A K I       R D ED        REI +
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-------RLDAEDEGIPSTAIREISL 72

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIV 210
           +  L  H NIV++        C+ +V E       ++ D        S+ K       ++
Sbjct: 73  LKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI--YLYQLL 129

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYV 269
             V  CH   ++HRDLKP+N LL+N D    LK  DFGL+  F  P + +T  V + +Y 
Sbjct: 130 RGVAHCHQHRILHRDLKPQN-LLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVLKG 316
           AP+VL+  K Y    D+W+ G I   +++G P F   T       IF             
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246

Query: 317 HI---DFESDP------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                 ++                P       DL+  MLC  P++R++A + + HP+
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  126 bits (320), Expect = 4e-34
 Identities = 39/219 (17%), Positives = 83/219 (37%), Gaps = 28/219 (12%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIM 153
           + + L     KL +   G  +         G +   K +  R   +R+   D   E   +
Sbjct: 8   DFKQL-NFLTKLNENHSGELWK----GRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRL 61

Query: 154 HHLAGHKNIVTIKGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
              + H N++ + GA +     H  ++      G L++ ++  G       ++  +  + 
Sbjct: 62  RIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALD 119

Query: 212 VVEAC---HSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           +       H+L   +    L   + ++   D+D + +     +   F+        + +P
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQ----SPGRMYAP 172

Query: 267 YYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPF 301
            +VAPE L K         AD+W+  V+L+ L++   PF
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  127 bits (322), Expect = 1e-33
 Identities = 77/341 (22%), Positives = 130/341 (38%), Gaps = 96/341 (28%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQ 151
           +     Y+LG+ LG G FG      +I +G  FA K +    + K           RE+ 
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------RELD 52

Query: 152 IMHHLAGHKNIVTIK--------------------------------------GAYEDSL 173
           IM  L  H NI+ +                                            + 
Sbjct: 53  IMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--------VEACHSLGVMHRD 225
            ++++ME     +   ++++   +       +   ++ +        V   HSLG+ HRD
Sbjct: 112 YLNVIMEYV--PDTLHKVLK--SFIRSGR-SIPMNLISIYIYQLFRAVGFIHSLGICHRD 166

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEAD 283
           +KP+N LLVN  D+ +LK  DFG +    P +     + S +Y APE++L    Y P  D
Sbjct: 167 IKPQN-LLVNSKDN-TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSID 224

Query: 284 VWTAGVILYILLSGVPPFWAET--QQ--GIFDAVL----KGHIDF-------------ES 322
           +W+ G +   L+ G P F  ET   Q   I   ++    K  +               ++
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKA 283

Query: 323 DPWPLI-----SDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
             W  I        A DL+ ++L  +P  R+  +E + HP+
Sbjct: 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  128 bits (324), Expect = 2e-33
 Identities = 89/374 (23%), Positives = 149/374 (39%), Gaps = 79/374 (21%)

Query: 41  STPSLNSQQLVSQEFSKE-NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRD 99
           S P+L+ +    Q F K+ +         +S SK DN         + + +  +      
Sbjct: 10  SEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKR------ 63

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KRKLISREDVEDVRREI 150
            Y   + +G G  G      +       A K +S         KR            RE+
Sbjct: 64  -YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----------REL 112

Query: 151 QIMHHLAGHKNIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
            +M  +  HKNI+++          E+   V++VMEL     L  ++IQ     ER +  
Sbjct: 113 VLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANL-CQVIQMELDHERMSYL 169

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           L +++ G+ +  HS G++HRDLKP N ++V  D    LK +DFGL+       + T  V 
Sbjct: 170 LYQMLCGI-KHLHSAGIIHRDLKPSN-IVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 225

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF-------------------WAE 304
           + YY APEV+L   Y    D+W+ G I+  ++     F                     E
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285

Query: 305 TQQGI------------------FDAVLKGHIDF-ESDPWPLISDSAKDLIRKMLCSQPS 345
             + +                  F  +    +   +S+   L +  A+DL+ KML   P+
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345

Query: 346 ERLTAHEVLCHPWI 359
           +R++  + L HP+I
Sbjct: 346 KRISVDDALQHPYI 359

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  125 bits (315), Expect = 4e-33
 Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 28/219 (12%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
             G  LG+G FG     T   TG     K + +      E      +E+++M  L  H N
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC---HS 218
           ++   G       ++ + E   GG L   I  +   S+   ++       +       HS
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS---------------VFFKPGQIFTDVV 263
           + ++HRDL   N  LV   ++ ++   DFGL+               +     +    VV
Sbjct: 127 MNIIHRDLNSHN-CLV--RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF 301
           G+PY++APE++  + Y  + DV++ G++L  ++  V   
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  125 bits (315), Expect = 1e-32
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 59/307 (19%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   + +G G  G      +       A K +S R   ++   +   RE+ +M  +  HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NHK 84

Query: 161 NIVTIK---------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           NI+ +            ++D   V+IVMEL     L  ++IQ     ER +  L +++ G
Sbjct: 85  NIIGLLNVFTPQKSLEEFQD---VYIVMEL-MDANL-CQVIQMELDHERMSYLLYQMLCG 139

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           + +  HS G++HRDLKP N ++V  D    LK +DFGL+       + T  V + YY AP
Sbjct: 140 I-KHLHSAGIIHRDLKPSN-IVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQGI-- 309
           EV+L   Y    D+W+ G I+  ++ G   F                     E  + +  
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 310 ----------------FDAVLKGHIDFESDP-WPLISDSAKDLIRKMLCSQPSERLTAHE 352
                           F+ +    +         L +  A+DL+ KML    S+R++  E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 353 VLCHPWI 359
            L HP+I
Sbjct: 316 ALQHPYI 322

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (320), Expect = 4e-32
 Identities = 62/267 (23%), Positives = 95/267 (35%), Gaps = 41/267 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLISREDVEDV---RREIQIMHHL 156
           Y +   +  G  G  YL       G     K      L+   D E       E Q +  +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136

Query: 157 AGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
             H +IV I               +IVME   G  L             +A      I+ 
Sbjct: 137 V-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD---VVGSPYY 268
            +   HS+G+++ DLKPEN +++ ++    LK ID G                + G+P +
Sbjct: 194 ALSYLHSIGLVYNDLKPEN-IMLTEE---QLKLIDLGAV------SRINSFGYLYGTPGF 243

Query: 269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            APE++        D++T G  L  L   +P        G+           E DP    
Sbjct: 244 QAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKT 293

Query: 329 SDSAKDLIRKMLCSQPSER-LTAHEVL 354
            DS   L+R+ +   P +R  TA E+ 
Sbjct: 294 YDSYGRLLRRAIDPDPRQRFTTAEEMS 320

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (305), Expect = 8e-32
 Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 19/264 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHLAGH 159
           Y +  KLG G   T YL  +    I+ A K         +E+ ++   RE+     L+ H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS-H 70

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +NIV++    E+  C ++VME   G  L + I   G  S   A   T  I+  ++  H +
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD--VVGSPYYVAPE-VLLK 276
            ++HRD+KP+N L+   D + +LK  DFG++       +     V+G+  Y +PE    +
Sbjct: 131 RIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-----SDPWPLISDS 331
                 D+++ G++LY +L G PPF  ET   I    +K HI        +D    I  S
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI---AIK-HIQDSVPNVTTDVRKDIPQS 243

Query: 332 AKDLIRKMLCSQPSER-LTAHEVL 354
             ++I +      + R  T  E+ 
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMK 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  120 bits (303), Expect = 8e-32
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 102 TLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAG 158
           TL   +G G FG  Y     A   G E A K+          + +E+VR+E ++   L  
Sbjct: 10  TLEEIIGIGGFGKVYR----AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK- 64

Query: 159 HKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           H NI+ ++G    E +LC  +VME   GG L   +             L    V +    
Sbjct: 65  HPNIIALRGVCLKEPNLC--LVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGM 118

Query: 217 ---HSLG---VMHRDLKPENFLLVNKD------DDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              H      ++HRDLK  N +L+ +        +  LK  DFGL+  +          G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSN-ILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAG 176

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF 301
           +  ++APEV+    +   +DVW+ GV+L+ LL+G  PF
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  123 bits (310), Expect = 1e-31
 Identities = 82/386 (21%), Positives = 142/386 (36%), Gaps = 84/386 (21%)

Query: 55  FSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGT 114
           F   N KK     +      +N    G D+     +    D++   Y + + +G+G FG 
Sbjct: 60  FLGLNAKK----RQGMTGGPNN---GGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQ 112

Query: 115 TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-----KNIVTIKGA- 168
                +       A K +   K   R+       EI+I+ HL         N++ +    
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQDKDNTMNVIHMLENF 168

Query: 169 -YEDSLCVHIVMELCAGGELFDRIIQRGHY---SERKAAELTRIIVGVVEACHSLGVMHR 224
            + + +C  +  EL     L++ +I++  +   S     +    I+  ++A H   ++H 
Sbjct: 169 TFRNHIC--MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEAD 283
           DLKPEN LL  +     +K IDFG S  ++  +++T +  S +Y APEV+L   YG   D
Sbjct: 225 DLKPENILLKQQ-GRSGIKVIDFG-SSCYEHQRVYTYIQ-SRFYRAPEVILGARYGMPID 281

Query: 284 VWTAGVILYILLSGVPPFWAETQQ----------GIFDAVL-------KGHIDFESDPWP 326
           +W+ G IL  LL+G P    E +           G+    L       K  +  +  P  
Sbjct: 282 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341

Query: 327 LISDSAKD--------------------------------------LIRKMLCSQPSERL 348
               +  D                                       +++ L   P+ R+
Sbjct: 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401

Query: 349 TAHEVLCHPWICENGVAPDRSLDPAV 374
           T  + L HPW+      P      +V
Sbjct: 402 TPGQALRHPWLRRRLPKPPTGEKTSV 427

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  121 bits (306), Expect = 2e-31
 Identities = 68/331 (20%), Positives = 125/331 (37%), Gaps = 61/331 (18%)

Query: 78  MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           M+   +     ++      ++  YT+ R +  G +G      + + GI  A K +     
Sbjct: 2   MQAKGEAAMRDLIAE-LHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVS 59

Query: 138 ISR-----EDVEDVR---REIQIMHHLAGHKNIVTIK--------GAYEDSLCVHIVMEL 181
             R      D    +   REI++++H   H NI+ ++         A      +++V EL
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHK---LYLVTEL 115

Query: 182 CAGGELFDRIIQRGHYS---ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
               +L  ++I         +     +  I++G+    H  GV+HRDL P N +L+  ++
Sbjct: 116 -MRTDL-AQVIHDQRIVISPQHIQYFMYHILLGL-HVLHEAGVVHRDLHPGN-ILLADNN 171

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLS 296
           D  +   DF L+         T  V   +Y APE+++  K +    D+W+AG ++  + +
Sbjct: 172 D--ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 297 GVPPF-------------------WAETQQGIFDAVLKGHID-----FESDPW----PLI 328
               F                     E          + ++        +  W    P  
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA 289

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              A DLI KML   P  R++  + L HP+ 
Sbjct: 290 DPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  121 bits (305), Expect = 2e-31
 Identities = 75/311 (24%), Positives = 124/311 (39%), Gaps = 64/311 (20%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
             Y    K+GQG FG  +      TG + A K     K++   + E       REI+I+ 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71

Query: 155 HLAGHKNIVTIKG--------AYEDSLCVHIVMELC----AGGELFDRIIQRGHYSERKA 202
            L  H+N+V +                 +++V + C    AG  L   ++ +   SE K 
Sbjct: 72  LLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKR 128

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-----KPGQ 257
             + ++++  +   H   ++HRD+K  N L+     D  LK  DFGL+  F         
Sbjct: 129 --VMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF- 310
            +T+ V + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     I  
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243

Query: 311 ------DAVLKGHI---DFESD--------------PWPLISDSAKDLIRKMLCSQPSER 347
                   V         +E                   +    A DLI K+L   P++R
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303

Query: 348 LTAHEVLCHPW 358
           + + + L H +
Sbjct: 304 IDSDDALNHDF 314

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  121 bits (305), Expect = 2e-31
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 45/294 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y     +G G +G+     +  +G + A K +S R   S    +   RE+ ++ H+  H+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQ-HE 83

Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           N++ +        +  +    ++VM      +L  +I+      E+    + +++ G+ +
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDL-QKIMGLKFSEEKIQYLVYQMLKGL-K 140

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS GV+HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APEV+
Sbjct: 141 YIHSAGVVHRDLKPGN-LAVNEDCE--LKILDFGLARHADAE--MTGYVVTRWYRAPEVI 195

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAV 313
           L   HY    D+W+ G I+  +L+G   F                     E  Q + D  
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 314 LKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            K +I          +    P  S  A DL+ KML     +RLTA + L HP+ 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  119 bits (301), Expect = 4e-31
 Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 42/304 (13%)

Query: 60  PKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCT 119
               +         + + M    +++     G         Y L R +G+G  G  Y   
Sbjct: 3   SSHHHHHHSSGLVPRGSHMDGTAESREGTQFGP--------YRLRRLVGRGGMGDVYEAE 54

Query: 120 EIATGIEFACKSISKRKLISREDVEDV------RREIQIMHHLAGHKNIVTI--KGAYED 171
           +       A K      L+S     D       +RE +    L    ++V I   G  + 
Sbjct: 55  DTVRERIVALK------LMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDG 107

Query: 172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF 231
            L  ++ M L  G +L   + ++G  +  +A  + R I   ++A H+ G  HRD+KPEN 
Sbjct: 108 QL--YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165

Query: 232 LLVNKDDDFSLKAIDFGLSVFFKPGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTA 287
           L+     D     +DFG++      ++ T   + VG+ YY+APE     H    AD++  
Sbjct: 166 LV---SADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYAL 221

Query: 288 GVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWPLISDSAKDLIRKMLCSQ 343
             +LY  L+G PP+  +       +V+  HI+      S   P I  +   +I + +   
Sbjct: 222 TCVLYECLTGSPPYQGDQL-----SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKN 276

Query: 344 PSER 347
           P +R
Sbjct: 277 PEDR 280

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  120 bits (304), Expect = 4e-31
 Identities = 76/299 (25%), Positives = 131/299 (43%), Gaps = 44/299 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            + + Y     +G G +G+     +  TG+  A K +S R   S    +   RE++++ H
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84

Query: 156 LAGHKNIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           +  H+N++ +        + E+   V++V  L  G +L + I++    ++     L   I
Sbjct: 85  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQI 141

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  ++  HS  ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSN-LAVNEDCE--LKILDFGLARHTAD--EMTGYVATRWYR 196

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQG 308
           APE++L   HY    D+W+ G I+  LL+G   F                    AE  + 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 309 IFDAVLKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
           I     + +I          +       +  A DL+ KML     +R+TA + L H + 
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  120 bits (302), Expect = 4e-31
 Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 51/300 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISKRKLISREDVED------VRREIQ 151
             Y    ++G+G +G  +   ++   G   A K +       R    +        RE+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVA 63

Query: 152 IMHHL--AGHKNIVTIK-----GAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKA 202
           ++ HL    H N+V +         +    + +V E          D++           
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETI 122

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
            ++   ++  ++  HS  V+HRDLKP+N +LV       +K  DFGL+  +      T V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQN-ILVTSSGQ--IKLADFGLARIYSFQMALTSV 179

Query: 263 VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQ--GIF------- 310
           V + +Y APEVLL   Y    D+W+ G I   +    P F    +  Q   I        
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239

Query: 311 DAVLKGHI---DFESDPW---------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
           +      +                     I +  KDL+ K L   P++R++A+  L HP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  121 bits (304), Expect = 6e-31
 Identities = 73/332 (21%), Positives = 123/332 (37%), Gaps = 83/332 (25%)

Query: 97  IRDLYT-LGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVED-VRREIQI 152
           + DL+   G K+G+G +G  Y     +     ++A K I          +     REI +
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG------TGISMSACREIAL 71

Query: 153 MHHLAGHKNIVTIKGAYEDSL--CVHIVMELCAGGELFD--RII--QRGHYSERKAAELT 206
           +  L  H N+++++  +       V ++ +        D   II   R   + +K  +L 
Sbjct: 72  LRELK-HPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLP 126

Query: 207 RIIV---------GVVEACHSLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLS-VFFK 254
           R +V         G+    H+  V+HRDLKP N +LV  +      +K  D G + +F  
Sbjct: 127 RGMVKSLLYQILDGI-HYLHANWVLHRDLKPAN-ILVMGEGPERGRVKIADMGFARLFNS 184

Query: 255 PGQIFTD---VVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
           P +   D   VV + +Y APE+LL  +HY    D+W  G I   LL+  P F    +   
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 310 FDAVLKG----HI-------------DFESDPW--------------------------P 326
                       I             D +  P                            
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                A  L++K+L   P +R+T+ + +  P+
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  120 bits (302), Expect = 8e-31
 Identities = 75/302 (24%), Positives = 130/302 (43%), Gaps = 50/302 (16%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            +R +Y   + +G G +G      +  TG + A K +  R   S    +   RE++++ H
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80

Query: 156 LAGHKNIVTIK---------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           +  H+N++ +            + D    ++VM    G +L  ++++     E +   L 
Sbjct: 81  MR-HENVIGLLDVFTPDETLDDFTD---FYLVMPF-MGTDL-GKLMKHEKLGEDRIQFLV 134

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             ++  +   H+ G++HRDLKP N L VN+D +  LK +DFGL+         T  V + 
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGN-LAVNEDCE--LKILDFGLARQADSE--MTGYVVTR 189

Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF-------------------WAET 305
           +Y APEV+L    Y    D+W+ G I+  +++G   F                    AE 
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 306 QQGIFDAVLKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLCHP 357
            Q +     K ++      E   +       S  A +L+ KML     +R+TA E L HP
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309

Query: 358 WI 359
           + 
Sbjct: 310 YF 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  117 bits (296), Expect = 2e-30
 Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 54/310 (17%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++   Y   + LG G  G  +   +       A K I          V+   REI+I+  
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRR 64

Query: 156 LAGHKNIVTIK--------------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK 201
           L  H NIV +               G+  +   V+IV E     +L   ++++G   E  
Sbjct: 65  L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQGPLLEEH 121

Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP----GQ 257
           A      ++  ++  HS  V+HRDLKP N L +N  +D  LK  DFGL+    P      
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPHYSHKG 179

Query: 258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF-------------- 301
             ++ + + +Y +P +LL   +Y    D+W AG I   +L+G   F              
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

Query: 302 -----WAETQQGIFDAV---LKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLT 349
                  E +Q +   +   ++  +     P     P IS  A D + ++L   P +RLT
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299

Query: 350 AHEVLCHPWI 359
           A E L HP++
Sbjct: 300 AEEALSHPYM 309

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  116 bits (294), Expect = 1e-29
 Identities = 86/333 (25%), Positives = 130/333 (39%), Gaps = 63/333 (18%)

Query: 73  KKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI 132
              + M          V G    ++   YT    +G+G +G      +    +  A K I
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQ-VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60

Query: 133 S--------KRKLISREDVEDVRREIQIMHHLAGHKNIVTIK-----GAYEDSLCVHIVM 179
           S        +R L          REI+I+     H+NI+ I         E    V+IV 
Sbjct: 61  SPFEHQTYCQRTL----------REIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQ 109

Query: 180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD 239
           +L    +L  ++++  H S          I+  ++  HS  V+HRDLKP N LL+N   D
Sbjct: 110 DL-METDL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN-LLLNTTCD 166

Query: 240 FSLKAIDFGLSVFFKP----GQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYI 293
             LK  DFGL+    P        T+ V + +Y APE++L  K Y    D+W+ G IL  
Sbjct: 167 --LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224

Query: 294 LLSGVPPF-------------------WAETQQGIFDAVLKGHID----FESDPW----P 326
           +LS  P F                     E    I +   + ++         PW    P
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                A DL+ KML   P +R+   + L HP++
Sbjct: 285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (285), Expect = 6e-29
 Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 24/269 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHLAGH 159
           Y LG  LG G     +L  ++    + A K + +  L          RRE Q    L  H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71

Query: 160 KNIVTI--KGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
             IV +   G  E        IVME   G  L D +   G  + ++A E+       +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTD---VVGSPYYVAP 271
            H  G++HRD+KP N ++       ++K +DFG++      G   T    V+G+  Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 272 E-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWP 326
           E          +DV++ G +LY +L+G PPF  ++   +     + H+  +    S    
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AYQ-HVREDPIPPSARHE 244

Query: 327 LISDSAKDLIRKMLCSQPSER-LTAHEVL 354
            +S     ++ K L   P  R  TA E+ 
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMR 273

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (281), Expect = 2e-28
 Identities = 33/251 (13%), Positives = 67/251 (26%), Gaps = 36/251 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L    G       +   + A   + A   +  + ++  + +++       +  +    
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +           +V E   GG L +        S   A    + +    +A H  G
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           V      P   + V+ D                  G +   V+  P  +          P
Sbjct: 150 VALSIDHPSR-VRVSID------------------GDV---VLAYPATMPDA------NP 181

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWPLISDSAKDLI 336
           + D+   G  LY LL    P      +       +     +    +D    I      + 
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-DTAGQPIEPADIDRDIPFQISAVA 240

Query: 337 RKMLCSQPSER 347
            + +      R
Sbjct: 241 ARSVQGDGGIR 251

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  112 bits (283), Expect = 3e-28
 Identities = 89/323 (27%), Positives = 127/323 (39%), Gaps = 80/323 (24%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS--------KRKLISREDVEDVR 147
           NI   + L   LG+G +G     T   TG   A K I          R L          
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------- 57

Query: 148 REIQIMHHLAGHKNIVTIK--------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
           REI+I+ H   H+NI+TI           + +   V+I+ EL    +L  R+I     S+
Sbjct: 58  REIKILKHFK-HENIITIFNIQRPDSFENFNE---VYIIQEL-MQTDL-HRVISTQMLSD 111

Query: 200 RKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--------- 250
                     +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+         
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAAD 168

Query: 251 --VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET- 305
                       + V + +Y APEV+L    Y    DVW+ G IL  L    P F     
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 306 --Q-QGIFDAVLKGHIDFESDPWPLISDSAK--------------------------DLI 336
             Q   IF  +  G    ++D   + S  A+                          DL+
Sbjct: 229 RHQLLLIFGII--GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL 286

Query: 337 RKMLCSQPSERLTAHEVLCHPWI 359
           ++ML   P++R+TA E L HP++
Sbjct: 287 QRMLVFDPAKRITAKEALEHPYL 309

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  110 bits (278), Expect = 1e-27
 Identities = 68/364 (18%), Positives = 117/364 (32%), Gaps = 84/364 (23%)

Query: 70  SPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFAC 129
             S     +    D++  +    K   + + + + RK+G G FG   LC  I     +A 
Sbjct: 6   HHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAV 65

Query: 130 KSI-SKRKLISREDVEDVRREIQIMHHLAGH----KNIVTIKGA--YEDSLCVHIVMELC 182
           K + + +K          + E  I+  +        NIV   G   Y D +C  ++ E  
Sbjct: 66  KVVRNIKKY-----TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC--LIFEPL 118

Query: 183 AGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--- 237
            G  L++ I +  +  +           I+  +     + + H DLKPEN LL +     
Sbjct: 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177

Query: 238 -------------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
                                  +K IDFG + F         ++ +  Y APEV+L   
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG 235

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQ----------GIFDAVL-------KGHIDF 320
           +   +D+W+ G +L  L +G   F                      +        G    
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295

Query: 321 ESDPWPL------------------------ISDSA-KDLIRKMLCSQPSERLTAHEVLC 355
             D   L                        I      D +  +L   P+ R +  E+L 
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355

Query: 356 HPWI 359
           H ++
Sbjct: 356 HKFL 359

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  110 bits (278), Expect = 2e-27
 Identities = 84/354 (23%), Positives = 131/354 (37%), Gaps = 117/354 (33%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KRKLISREDVEDV 146
           ++   Y L +KLG+G +G  +   +  TG   A K I          +R           
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--------- 56

Query: 147 RREIQIMHHLAGHKNIVTIK-----GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK 201
            REI I+  L+GH+NIV +          D   V++V +     +L   +I        +
Sbjct: 57  -REIMILTELSGHENIVNLLNVLRADNDRD---VYLVFDY-METDL-HAVI--------R 102

Query: 202 AAELTR---------IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-- 250
           A  L           +I  + +  HS G++HRD+KP N +L+N +    +K  DFGLS  
Sbjct: 103 ANILEPVHKQYVVYQLIKVI-KYLHSGGLLHRDMKPSN-ILLNAECH--VKVADFGLSRS 158

Query: 251 --------------------VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAG 288
                                F     I TD V + +Y APE+LL    Y    D+W+ G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

Query: 289 VILYILLSGVPPF------------------------------------------WAETQ 306
            IL  +L G P F                                              Q
Sbjct: 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278

Query: 307 QGIFDAVLKGHIDFES-DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
               D   K        +P    ++ A DL+ K+L   P++R++A++ L HP++
Sbjct: 279 SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  107 bits (269), Expect = 3e-26
 Identities = 72/343 (20%), Positives = 118/343 (34%), Gaps = 75/343 (21%)

Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D + + V     D +++ Y +   LG+G FG    C + A G       I +     RE 
Sbjct: 4   DKEGHLVC-RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62

Query: 143 VEDVRREIQIMHHLA-----GHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRG 195
               R EI ++  +           V +     +   +C  I  EL  G   F+ + +  
Sbjct: 63  A---RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFLKENN 116

Query: 196 H--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD---------------- 237
              Y       +   +   +   H   + H DLKPEN L VN +                
Sbjct: 117 FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 238 DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS 296
            + S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 297 GVPPFWAETQQ----------GIFD------AVLKGHIDFESDPWPLISDSAK------- 333
           G   F     +          G            + +       W   S   +       
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294

Query: 334 -----------------DLIRKMLCSQPSERLTAHEVLCHPWI 359
                            DL+R+ML   P++R+T  E L HP+ 
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  107 bits (269), Expect = 4e-26
 Identities = 69/373 (18%), Positives = 118/373 (31%), Gaps = 118/373 (31%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D     Y + RKLG G F T +L  +I      A K + K    +    E    EI+++ 
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS---AEHYTETALDEIRLLK 88

Query: 155 HLA-------GHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY---S 198
            +          + +V       I G     +C  +V E+  G  L    I + +Y    
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVFEV-LGHHLLK-WIIKSNYQGLP 144

Query: 199 ERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD-------------------- 237
                ++ + ++  ++  H+   ++H D+KPEN LL   +                    
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 238 --------------------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
                                     +   +K  D G + +    + FT+ + +  Y + 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSL 262

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD---------AVL------- 314
           EVL+   Y   AD+W+   + + L +G   F   + +              +L       
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 315 -----KGHIDFESD----------PWPLIS-------------DSAKDLIRKMLCSQPSE 346
                     F             PW L                   D +  ML   P +
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 347 RLTAHEVLCHPWI 359
           R TA E L HPW+
Sbjct: 383 RATAAECLRHPWL 395

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  106 bits (266), Expect = 6e-26
 Identities = 77/341 (22%), Positives = 122/341 (35%), Gaps = 79/341 (23%)

Query: 87  YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEF-ACKSI-SKRKLISREDVE 144
           + +     D +   Y +   LG+G FG    C +   G    A K + +  +       E
Sbjct: 3   HLIC-QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-----CE 56

Query: 145 DVRREIQIMHHLA-----GHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGH- 196
             R EIQ++ HL           V +     +   +C  IV EL  G   +D I + G  
Sbjct: 57  AARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC--IVFELL-GLSTYDFIKENGFL 113

Query: 197 -YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------------DD 239
            +      ++   I   V   HS  + H DLKPEN L V  D                 +
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173

Query: 240 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGV 298
             +K +DFG + +    +  + +V + +Y APEV+L   +    DVW+ G IL     G 
Sbjct: 174 PDIKVVDFGSATY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

Query: 299 PPFWAETQQ----------GIFDAVL------KGHIDFESDPWPLISDSAK--------- 333
             F     +          G     +      + +   +   W   S + +         
Sbjct: 232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPL 291

Query: 334 ---------------DLIRKMLCSQPSERLTAHEVLCHPWI 359
                          DLI+KML   P++R+T  E L HP+ 
Sbjct: 292 KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  106 bits (266), Expect = 1e-25
 Identities = 78/381 (20%), Positives = 133/381 (34%), Gaps = 133/381 (34%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KR 135
           +  Y  G K  ++ D Y +   +G+G +G  YL  +  T    A K ++         KR
Sbjct: 12  ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR 71

Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIK--------GAYEDSLCVHIVMELCAGGEL 187
            L          REI I++ L     I+ +           +++   ++IV+E+ A  +L
Sbjct: 72  IL----------REITILNRL-KSDYIIRLYDLIIPDDLLKFDE---LYIVLEI-ADSDL 116

Query: 188 FDRIIQRGHYSERKAAELTR---------IIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
             ++        +    LT          +++G     H  G++HRDLKP N  L+N+D 
Sbjct: 117 -KKLF-------KTPIFLTEEHIKTILYNLLLGE-NFIHESGIIHRDLKPAN-CLLNQDC 166

Query: 239 DFSLKAIDFGLS-----------------------VFFKPGQIFTDVVGSPYYVAPEVLL 275
              +K  DFGL+                             +  T  V + +Y APE++L
Sbjct: 167 S--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224

Query: 276 --KHYGPEADVWTAGVILYILLS-----------------GVPPFWAETQQGIFDAVLKG 316
             ++Y    D+W+ G I   LL+                 G   F     +       K 
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284

Query: 317 HID----------------------------------FESDPW----PLISDSAKDLIRK 338
           + D                                   +        P ISD   +L+  
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344

Query: 339 MLCSQPSERLTAHEVLCHPWI 359
           ML   P++R+T  + L HP++
Sbjct: 345 MLKFNPNKRITIDQALDHPYL 365

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  104 bits (261), Expect = 1e-25
 Identities = 63/300 (21%), Positives = 102/300 (34%), Gaps = 56/300 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHL 156
           RD+ TL   +G+G++G  +  +    G   A K        SR++    R  E+     L
Sbjct: 8   RDI-TLLECVGKGRYGEVWRGS--WQGENVAVK-----IFSSRDEKSWFRETELYNTVML 59

Query: 157 AGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIV-- 210
             H+NI+    +   S        ++      G L+D  +Q           +   I   
Sbjct: 60  R-HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASG 117

Query: 211 ------GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-- 262
                  +        + HRDLK +N L+     +      D GL+V         DV  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 263 ---VGSPYYVAPEVL-------LKHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFD 311
              VG+  Y+APEVL               D+W  G++L+ +   +      E  +  F 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 312 AVLKGHIDFESDPW--------PLISDSA---------KDLIRKMLCSQPSERLTAHEVL 354
            V+     FE            P I +             L+++     PS RLTA  + 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  102 bits (257), Expect = 8e-25
 Identities = 62/300 (20%), Positives = 101/300 (33%), Gaps = 56/300 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHL 156
           R +  L   +G+G+FG  +       G E A K        SRE+    R  EI     L
Sbjct: 42  RTI-VLQESIGKGRFGEVWRGK--WRGEEVAVK-----IFSSREERSWFREAEIYQTVML 93

Query: 157 AGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIV-- 210
             H+NI+    A            +V +    G LFD  + R   +     +L       
Sbjct: 94  R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASG 151

Query: 211 ------GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-- 262
                  +V       + HRDLK +N L+     + +    D GL+V         D+  
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 263 ---VGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFD 311
              VG+  Y+APEVL              AD++  G++ + +          E  Q  + 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 312 AVLKGHIDFESDPW--------PLISDSA---------KDLIRKMLCSQPSERLTAHEVL 354
            ++      E            P I +             ++R+   +  + RLTA  + 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  101 bits (253), Expect = 3e-24
 Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 63/300 (21%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
            L     +G+FG  +           A K    +     +       E+  +  +  H+N
Sbjct: 27  QLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HEN 79

Query: 162 IVTIKGA------YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--- 212
           I+   GA       +  L   ++      G L D  ++    S     EL  I   +   
Sbjct: 80  ILQFIGAEKRGTSVDVDLW--LITAFHEKGSLSD-FLKANVVSWN---ELCHIAETMARG 133

Query: 213 ----------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD- 261
                     ++  H   + HRD+K +N LL    ++ +    DFGL++ F+ G+   D 
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDT 190

Query: 262 --VVGSPYYVAPEVLLKHYGPE------ADVWTAGVILYILLSGVPPFW--AETQQGIFD 311
              VG+  Y+APEVL      +       D++  G++L+ L S         +     F+
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 312 AVLKGHIDFES---------------DPWPLISDSAK--DLIRKMLCSQPSERLTAHEVL 354
             +  H   E                D W   +  A   + I +        RL+A  V 
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  102 bits (255), Expect = 3e-24
 Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 22/251 (8%)

Query: 67  PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIE 126
              S  K+  +   G D+  Y  +    +   D Y +   +G+G FG      +      
Sbjct: 22  SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEW 81

Query: 127 FACKSISKRKLISREDVEDVRREIQIMHHLAGH-----KNIVTIKGA--YEDSLCVHIVM 179
            A K I  +K    +     + E++++  +  H       IV +K    + + LC  +V 
Sbjct: 82  VAIKIIKNKKAFLNQ----AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC--LVF 135

Query: 180 ELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHS--LGVMHRDLKPENFLLVN 235
           E+     L+D +        S     +  + +   +    +  L ++H DLKPEN LL N
Sbjct: 136 EML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYIL 294
                ++K +DFG S     GQ     + S +Y +PEVLL   Y    D+W+ G IL  +
Sbjct: 195 -PKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251

Query: 295 LSGVPPFWAET 305
            +G P F    
Sbjct: 252 HTGEPLFSGAN 262

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 10/29 (34%), Positives = 15/29 (51%)

Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWICE 361
           KDLI +ML   P  R+  +  L H +  +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  102 bits (255), Expect = 5e-24
 Identities = 82/417 (19%), Positives = 144/417 (34%), Gaps = 124/417 (29%)

Query: 46  NSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGR 105
           + +   +Q+ +       + + +    +K +   +           H    I D Y +  
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKP---TASMPRPHSDWQIPDRYEIRH 59

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAGHKNIV 163
            +G G +G      +       A K I +   +  + ++  R  REI I++ L  H ++V
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRL-NHDHVV 115

Query: 164 TIK-----GAYEDSLCVHIVMELC---------AGGELFDRIIQRGHYSERKAAELTRII 209
            +         E    +++V+E+              L +  I+   Y          ++
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY---------NLL 166

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------------------- 250
           VGV +  HS G++HRDLKP N  LVN+D    +K  DFGL+                   
Sbjct: 167 VGV-KYVHSAGILHRDLKPAN-CLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 251 ---------VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVP 299
                          +  T  V + +Y APE++L  ++Y    DVW+ G I   LL+ + 
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 300 PFWAETQQG--IF------------------DAVLKGHID------------FESDPWPL 327
              A       +F                      +G+ D             E D   L
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342

Query: 328 ISDSAKD--------------------------LIRKMLCSQPSERLTAHEVLCHPW 358
             + AK                           L+++ML   P++R+T +E L HP+
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  100 bits (251), Expect = 5e-24
 Identities = 55/302 (18%), Positives = 104/302 (34%), Gaps = 60/302 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVR-REIQIMH 154
           + +  + +++G+G++G  ++        G + A K        + E+    R  EI    
Sbjct: 37  KQI-QMVKQIGKGRYGEVWM----GKWRGEKVAVK-----VFFTTEEASWFRETEIYQTV 86

Query: 155 HLAGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            +  H+NI+    A            ++ +    G L+D  ++      +   +L    V
Sbjct: 87  LMR-HENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSV 144

Query: 211 --------GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
                    +        + HRDLK +N L+     + +    D GL+V F       D+
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201

Query: 263 -----VGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGV----------PP 300
                VG+  Y+ PEVL              AD+++ G+IL+ +               P
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261

Query: 301 FWAETQQGIFDAVLKGHIDFESD----PWPLISDSA----KDLIRKMLCSQPSERLTAHE 352
           +            ++  +  +      P    SD        L+ +     P+ RLTA  
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 353 VL 354
           V 
Sbjct: 322 VK 323

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 34/237 (14%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            +   LG ++G+G FG  +     A     A KS   R+ +  +      +E +I+    
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQY- 169

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G       ++IVMEL  GG+    +  R   +  +   L +++        
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGME 227

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N L+    +   LK  DFG+S          +     Y       
Sbjct: 228 YLESKCCIHRDLAARNCLV---TEKNVLKISDFGMS---------REEADGVYAASGGLR 275

Query: 270 -------APEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
                  APE L    Y  E+DVW+ G++L+     G  P+   + Q   + V KG 
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG 332

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 63/319 (19%), Positives = 116/319 (36%), Gaps = 41/319 (12%)

Query: 23  HSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGI 82
           H +  +R + +        +P L+    + +  +    K  +       +   +I    +
Sbjct: 12  HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 83  DNQTYYVLGHKTDNIRDLY-TLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLI 138
           + +    + H       L       +G+G FG  Y  T +      I  A KS+   ++ 
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRIT 129

Query: 139 SREDVEDVRREIQIMHHLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHY 197
              +V     E  IM   + H N++++ G          +V+     G+L + I  R   
Sbjct: 130 DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNET 186

Query: 198 SERKAAELTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                 +L    + V +    L      HRDL   N +L   D+ F++K  DFGL+    
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLA---- 239

Query: 255 PGQIFTDVVGSPYYV--------------APEVLLKH-YGPEADVWTAGVILYILLS-GV 298
                 D+    +                A E L    +  ++DVW+ GV+L+ L++ G 
Sbjct: 240 -----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294

Query: 299 PPFWAETQQGIFDAVLKGH 317
           PP+       I   +L+G 
Sbjct: 295 PPYPDVNTFDITVYLLQGR 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 94.9 bits (236), Expect = 5e-22
 Identities = 59/325 (18%), Positives = 95/325 (29%), Gaps = 90/325 (27%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRRE 149
            DN+     L   +G+G++G  Y  +     +A             K+ S  + ++   E
Sbjct: 12  LDNL----KLLELIGRGRYGAVYKGSLDERPVAV------------KVFSFANRQNFINE 55

Query: 150 IQIMHHLAG--HKNIVTIKGA-------YEDSLCVHIVMELCAGGELFDRIIQRGHYSER 200
             I   +    H NI                     +VME    G L   +         
Sbjct: 56  KNIYR-VPLMEHDNIARFIVGDERVTADGRMEYL--LVMEYYPNGSLXKYL----SLHTS 108

Query: 201 KAAELTRIIVGVV------------EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                 R+   V                +   + HRDL   N L+    +D +    DFG
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFG 165

Query: 249 LSVFFKPGQIF---------TDVVGSPYYVAPEVL--------LKHYGPEADVWTAGVIL 291
           LS+     ++             VG+  Y+APEVL         +    + D++  G+I 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 292 YILLSG----VPPFWAETQQGIFDAVLKGHIDFES---------------DPWPLISDSA 332
           + +        P       Q  F   +  H  FE                + W   S + 
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 333 ---KDLIRKMLCSQPSERLTAHEVL 354
              K+ I          RLTA    
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAE 310

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 54/249 (21%), Positives = 95/249 (38%), Gaps = 43/249 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
              +TLGR LG+G+FG+        E  + ++ A K + K  +I+  D+E+  RE   M 
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMK 80

Query: 155 HLAGHKNIVTIKGA------YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA---AEL 205
               H ++  + G               +++     G+L   ++               L
Sbjct: 81  EF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 206 TRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
            R +V +      L      HRDL   N +L    +D ++   DFGLS           +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLS---------RKI 187

Query: 263 VGSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
               YY             A E L  + Y   +DVW  GV ++ +++ G  P+       
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

Query: 309 IFDAVLKGH 317
           I++ ++ G+
Sbjct: 248 IYNYLIGGN 256

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 45/244 (18%), Positives = 76/244 (31%), Gaps = 39/244 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYL-------CTEIATGIEFACKSISKRKLISREDVEDVRREI 150
            +       LGQG F   +                E   K +       R   E      
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAA 63

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            +M  L+ HK++V   G         +V E    G L   +  + + +         +  
Sbjct: 64  SMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAK 120

Query: 211 GVVEACH---SLGVMHRDLKPENFLLVNKDDDFSL-----KAIDFGLSVFFKPGQIFTDV 262
            +  A H      ++H ++  +N LL+ ++D  +      K  D G+S+          V
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI---------TV 171

Query: 263 VGSPYY------VAPEVLL--KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           +           V PE +   K+     D W+ G  L+ + S G  P  A   Q      
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 314 LKGH 317
              H
Sbjct: 232 EDRH 235

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.1 bits (234), Expect = 4e-21
 Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 18/228 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R   T+  KLG GQ+G  Y        +  A K++ +       +VE+  +E  +M  + 
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 274

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H N+V + G        +I+ E    G L D + +     E  A  L  +   +  A  
Sbjct: 275 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAME 332

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---AP 271
                  +HR+L   N L+    ++  +K  DFGLS     G  +T   G+ + +   AP
Sbjct: 333 YLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388

Query: 272 EVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E L    +  ++DVW  GV+L+ + + G+ P+       +++ + K +
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 42/248 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R   TL R LG G FG  Y      +G+         A K++   ++ S +D  D   E 
Sbjct: 70  RKNITLIRGLGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEA 125

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            I+     H+NIV   G    SL   I++EL AGG+L   + +      + ++    +L 
Sbjct: 126 LIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 207 RIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
            +   +   C  L      HRD+   N LL         K  DFG++          D+ 
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIY 235

Query: 264 GSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
            + YY              PE  ++  +  + D W+ GV+L+ + S G  P+ +++ Q +
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295

Query: 310 FDAVLKGH 317
            + V  G 
Sbjct: 296 LEFVTSGG 303

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 7/159 (4%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + + Y LGRK+G G FG  YL T+IA G E A K    +    +     +  E +I   +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMM 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEA 215
            G   I TI+    +     +VMEL  G  L D        +S +    L   ++  +E 
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            HS   +HRD+KP+NFL+        +  IDFGL+  ++
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 42/248 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+L  LG+ LG+G+FG+        E  T ++ A K++ K    S+ ++E+   E   M 
Sbjct: 33  RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMK 91

Query: 155 HLAGHKNIVTIKGA--YEDSLCVH---IVMELCAGGELFDRIIQRGHYSERKA---AELT 206
               H N++ + G      S  +    +++     G+L   ++     +  K      L 
Sbjct: 92  DF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 207 RIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
           + +V +      L      HRDL   N +L    DD ++   DFGLS           + 
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLS---------KKIY 198

Query: 264 GSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
              YY             A E L    Y  ++DVW  GV ++ + + G+ P+       +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

Query: 310 FDAVLKGH 317
           +D +L GH
Sbjct: 259 YDYLLHGH 266

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 42/248 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R   TL R LG G FG  Y      +G+         A K++   ++ S +D  D   E 
Sbjct: 29  RKNITLIRGLGHGAFGEVYEGQ--VSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEA 84

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            I+     H+NIV   G    SL   I+MEL AGG+L   + +      + ++    +L 
Sbjct: 85  LIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 207 RIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
            +   +   C  L      HRD+   N LL         K  DFG++          D+ 
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIY 194

Query: 264 GSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
            + YY              PE  ++  +  + D W+ GV+L+ + S G  P+ +++ Q +
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254

Query: 310 FDAVLKGH 317
            + V  G 
Sbjct: 255 LEFVTSGG 262

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 57/243 (23%), Positives = 92/243 (37%), Gaps = 40/243 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
             +      +G+G FG  Y   L       I  A KS+   ++    +V     E  IM 
Sbjct: 24  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81

Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
               H N++++ G          +V+     G+L + I  R         +L    + V 
Sbjct: 82  DF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVA 138

Query: 214 EACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +    L      HRDL   N +L   D+ F++K  DFGL+          D+    YY  
Sbjct: 139 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLA---------RDMYDKEYYSV 186

Query: 270 -------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
                        A E L    +  ++DVW+ GV+L+ L++ G PP+       I   +L
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246

Query: 315 KGH 317
           +G 
Sbjct: 247 QGR 249

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 21/232 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIM 153
              +   + LG G FGT Y    I  G    I  A K +  R+  S +  +++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             +  + ++  + G    S  V ++ +L   G L D +  R H     +  L    V + 
Sbjct: 72  ASVD-NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIA 127

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +  +      ++HRDL   N L+        +K  DFGL+      +      G    + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184

Query: 270 --APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             A E +L + Y  ++DVW+ GV ++ L++ G  P+       I   + KG 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 36/236 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T  ++LG GQFG            + A K I +         ++   E ++M +L+
Sbjct: 23  PKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLS 77

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+ +V + G       + I+ E  A G L + +  R      +  +L  +   V EA  
Sbjct: 78  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAME 134

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N  LVN  D   +K  DFGLS           V+   Y       
Sbjct: 135 YLESKQFLHRDLAARN-CLVN--DQGVVKVSDFGLS---------RYVLDDEYTSSVGSK 182

Query: 270 ------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                  PEVL+   +  ++D+W  GV+++ + S G  P+   T     + + +G 
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 36/236 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T  +++G GQFG  +L   +    + A K+I +         ED   E ++M  L+
Sbjct: 7   PSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIRE----GAMSEEDFIEEAEVMMKLS 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V + G   +   + +V E    G L D +  R       A  L  + + V E   
Sbjct: 62  -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMA 118

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
                 V+HRDL   N  LV   ++  +K  DFG++           V+   Y       
Sbjct: 119 YLEEACVIHRDLAARN-CLVG--ENQVIKVSDFGMT---------RFVLDDQYTSSTGTK 166

Query: 270 ------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                 +PEV     Y  ++DVW+ GV+++ + S G  P+   +   + + +  G 
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 18/228 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R   T+  KLG GQ+G  Y        +  A K++ +       +VE+  +E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 67

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H N+V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A  
Sbjct: 68  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---AP 271
                  +HRDL   N  LV   ++  +K  DFGLS     G  +T   G+ + +   AP
Sbjct: 126 YLEKKNFIHRDLAARN-CLVG--ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181

Query: 272 EVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E L    +  ++DVW  GV+L+ + + G+ P+       +++ + K +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.0 bits (219), Expect = 5e-20
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 36/236 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+  TL ++LG GQFG   L        + A K I +         ++  +E Q M  L+
Sbjct: 7   REEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKE----GSMSEDEFFQEAQTMMKLS 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V   G       ++IV E  + G L + +  R H    + ++L  +   V E   
Sbjct: 62  -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N  LV+   D  +K  DFG++           V+   Y       
Sbjct: 119 FLESHQFIHRDLAARN-CLVD--RDLCVKVSDFGMT---------RYVLDDQYVSSVGTK 166

Query: 270 ------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                 APEV     Y  ++DVW  G++++ + S G  P+   T   +   V +GH
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 7/155 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + LGRK+G G FG  YL T I T  E A K  + +    +     +  E +I   L G  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQGGT 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            I  ++    +     +VM+L  G  L D         S +    L   ++  VE  HS 
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
             +HRD+KP+NFL+        +  IDFGL+  ++
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 87.6 bits (218), Expect = 7e-20
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 30/231 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHH 155
                L + +G+G+FG   L      G + A K I       + D   +    E  +M  
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-------KNDATAQAFLAEASVMTQ 70

Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 71  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 128

Query: 215 ACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
           A         +HRDL   N +LV+  +D   K  DFGL+      +  +        V  
Sbjct: 129 AMEYLEGNNFVHRDLAARN-VLVS--EDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 180

Query: 270 -APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            APE L  K +  ++DVW+ G++L+ + S G  P+     + +   V KG+
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 48/251 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y     A G+         A K++   +  S  +  +   E 
Sbjct: 24  REKITMSRELGQGSFGMVYEGV--AKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEA 79

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA------- 203
            +M       ++V + G         ++MEL   G+L   +                   
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 204 ELTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++ ++   + +    L      HRDL   N ++    +DF++K  DFG++          
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMT---------R 186

Query: 261 DVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY             +PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246

Query: 307 QGIFDAVLKGH 317
           + +   V++G 
Sbjct: 247 EQVLRFVMEGG 257

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 21/232 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIM 153
                  + LG G FGT +    I  G    I    K I       R+  + V   +  +
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAI 69

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             L  H +IV + G    S  + +V +    G L D +  R H        L    V + 
Sbjct: 70  GSLD-HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIA 125

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +  +     G++HR+L   N LL        ++  DFG++    P         +   + 
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182

Query: 270 --APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             A E +    Y  ++DVW+ GV ++ L++ G  P+       + D + KG 
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 59/245 (24%), Positives = 95/245 (38%), Gaps = 49/245 (20%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+   +K  + ++ E    E  IM 
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMK 68

Query: 155 HLAGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +L  H +IV + G     +       I+MEL   GEL   +    + +  K   L    +
Sbjct: 69  NLD-HPHIVKLIG-----IIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSL 120

Query: 211 GVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            + +A     S+  +HRD+   N L+        +K  DFGLS           +    Y
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLS---------RYIEDEDY 168

Query: 268 YV-----------APEVLLKHYG---PEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           Y            +PE +  ++      +DVW   V ++ +LS G  PF+    + +   
Sbjct: 169 YKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226

Query: 313 VLKGH 317
           + KG 
Sbjct: 227 LEKGD 231

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 63/242 (26%), Positives = 88/242 (36%), Gaps = 43/242 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
                L  KLG G FG              +  A K +    L   E ++D  RE+  MH
Sbjct: 17  EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76

Query: 155 HLAGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            L  H+N++ + G     +     + +V EL   G L DR+  R H        L+R  V
Sbjct: 77  SLD-HRNLIRLYG-----VVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAV 128

Query: 211 GVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            V E    L      HRDL   N LL  +D    +K  DFGL                 +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQ--------NDDH 177

Query: 268 YV------------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           YV            APE L  + +   +D W  GV L+ + + G  P+       I   +
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

Query: 314 LK 315
            K
Sbjct: 238 DK 239

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 30/231 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHH 155
                L + +G+G+FG   L      G + A K I       + D   +    E  +M  
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-------KNDATAQAFLAEASVMTQ 242

Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 243 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 300

Query: 215 ACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS--PY-Y 268
           A   L      HRDL   N L+    +D   K  DFGL+      +  +       P  +
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 352

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            APE L  K +  ++DVW+ G++L+ + S G  P+     + +   V KG+
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 50/229 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+    G+ LG G FG     T  A G+         A K +  +     ++ E +  E+
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEAT--AFGLGKEDAVLKVAVKML--KSTAHADEKEALMSEL 100

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD------RIIQRGHYSERKAAE 204
           +IM HL  H+NIV + GA      V ++ E C  G+L +      R+++         + 
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 205 LT-----RIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
            +          V +      S   +HRD+   N LL    +    K  DFGL+      
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLA------ 211

Query: 257 QIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY 292
               D++    Y+            APE +    Y  ++DVW+ G++L+
Sbjct: 212 ---RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 60/243 (24%), Positives = 90/243 (37%), Gaps = 45/243 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   LGR +G+GQFG  +     +     +  A K+   +   S    E   +E   M 
Sbjct: 14  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 71

Query: 155 HLAGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
               H +IV + G     +     V I+MELC  GEL   +  +        A L     
Sbjct: 72  QFD-HPHIVKLIG-----VITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAY 123

Query: 211 GVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            +  A   L      HRD+   N L+     +  +K  DFGLS           +  S Y
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS---------RYMEDSTY 171

Query: 268 YV-----------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
           Y            APE +  + +   +DVW  GV ++ +L  GV PF       +   + 
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

Query: 315 KGH 317
            G 
Sbjct: 232 NGE 234

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score = 84.9 bits (211), Expect = 1e-19
 Identities = 16/48 (33%), Positives = 20/48 (41%), Gaps = 1/48 (2%)

Query: 351 HEVLCHPWICEN-GVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           H    H    EN        L   +L  LK F   N+LKK+AL + A 
Sbjct: 2   HHHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAK 49

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 60/234 (25%), Positives = 88/234 (37%), Gaps = 44/234 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
                   +LG+G FG+  LC        TG   A K +   +    +   D +REIQI+
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQIL 78

Query: 154 HHLAGHKNIVTIKG----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L     IV  +G        SL   +VME    G L D +  + H +   A+ L    
Sbjct: 79  KAL-HSDFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL--QRHRARLDASRLLLYS 133

Query: 210 VGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             + +    LG     HRDL   N L+   + +  +K  DFGL+            +   
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLP--------LDKD 182

Query: 267 YYVAPE---VLLKHYGPEA----------DVWTAGVILYILLS-GVPPFWAETQ 306
           YYV  E     +  Y PE+          DVW+ GV+LY L +          +
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 51/239 (21%), Positives = 96/239 (40%), Gaps = 33/239 (13%)

Query: 98  RDLYTLGRKLGQGQFGT----TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
               T  + +G G+FG         +     +  A K++  +   + +   D   E  IM
Sbjct: 43  PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIM 100

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
              + H NI+ ++G       + I+ E    G L   +  R    E    +L  ++ G+ 
Sbjct: 101 GQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIA 157

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
                  ++  +HRDL   N +LVN   +   K  DFGLS      ++  D   + Y   
Sbjct: 158 AGMKYLANMNYVHRDLAARN-ILVN--SNLVCKVSDFGLS------RVLEDDPEATYTTS 208

Query: 270 ---------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                    APE +  + +   +DVW+ G++++ +++ G  P+W  +   +  A+  G 
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 73/309 (23%), Positives = 115/309 (37%), Gaps = 38/309 (12%)

Query: 29  RNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYY 88
           R  N    +          + L S      N K+   +  +S S+ D+      +  TY 
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378

Query: 89  VLGHKTDNI-RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVE 144
           +   +   I R+   LGR +G+GQFG  +     +     +  A K+   +   S    E
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVRE 436

Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
              +E   M     H +IV + G   ++  V I+MELC  GEL   +  +        A 
Sbjct: 437 KFLQEALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLAS 492

Query: 205 LTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD 261
           L      +  A   L      HRD+   N +LV+   +  +K  DFGLS           
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARN-VLVS--SNDCVKLGDFGLS---------RY 540

Query: 262 VVGSPYYV-----------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
           +  S YY            APE +  + +   +DVW  GV ++ +L  GV PF       
Sbjct: 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

Query: 309 IFDAVLKGH 317
           +   +  G 
Sbjct: 601 VIGRIENGE 609

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 54/233 (23%), Positives = 82/233 (35%), Gaps = 54/233 (23%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+  + G+ LG G FG     T  A G+         A K +  +      + E +  E+
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEAT--AYGLIKSDAAMTVAVKML--KPSAHLTEREALMSEL 77

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD---------------RIIQRG 195
           +++ +L  H NIV + GA        ++ E C  G+L +                 I   
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 196 HYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
                   +L      V +      S   +HRDL   N LL         K  DFGL+  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLA-- 192

Query: 253 FKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY 292
                   D+     YV            APE +    Y  E+DVW+ G+ L+
Sbjct: 193 -------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 21/232 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIM 153
              +   + LG G FGT Y    I  G    I  A K +  R+  S +  +++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             +  + ++  + G    S  V ++ +L   G L D +  R H     +  L    V + 
Sbjct: 72  ASVD-NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIA 127

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +  +      ++HRDL   N L+        +K  DFGL+      +      G    + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184

Query: 270 --APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             A E +L + Y  ++DVW+ GV ++ L++ G  P+       I   + KG 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +      R LG+G FG   LC        TG + A KS+  +       + D+++EI+I+
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEIL 77

Query: 154 HHLAGHKNIVTIKGAYEDSLC--VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
            +L  H+NIV  KG   +     + ++ME    G L + +    + ++    +  +  V 
Sbjct: 78  RNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQ 134

Query: 212 VVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           + +    LG     HRDL   N L+   + +  +K  DFGL+   +            YY
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE--------TDKEYY 183

Query: 269 V------------APEVLLKH-YGPEADVWTAGVILYILLS 296
                        APE L++  +   +DVW+ GV L+ LL+
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 38/161 (23%), Positives = 77/161 (47%), Gaps = 9/161 (5%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           +   Y +GR++G+G FG  +  T +    + A K   +R    +     +R E +    L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLL 62

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEA 215
           AG   I  +    ++ L   +V++L  G  L D   +    +S +  A   + ++  V++
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFK 254
            H   +++RD+KP+NFL+   +   +  +  +DFG+  F++
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 34/239 (14%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
                + + +G G  G      L       +  A K++  +   +     D   E  IM 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMG 105

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
               H NI+ ++G         IV E    G L   +  R H  +    +L  ++ GV  
Sbjct: 106 QFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGA 162

Query: 215 ACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
                  LG +HRDL   N L+   D +   K  DFGLS   +             Y   
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP-------DAAYTTT 212

Query: 270 ---------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                    APE +  + +   +DVW+ GV+++ +L+ G  P+W  T + +  +V +G+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 9e-19
 Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 28/232 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +         +    E  +M  L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66

Query: 158 GHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
            H+ +V +             ++I+ E    G L D +       +    +L  +   + 
Sbjct: 67  -HQRLVRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIA 119

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS--PY- 267
           E          +HRDL+  N +LV+  D  S K  DFGL+   +    +T   G+  P  
Sbjct: 120 EGMAFIEERNYIHRDLRAAN-ILVS--DTLSCKIADFGLARLIE-DNEYTAREGAKFPIK 175

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           + APE +    +  ++DVW+ G++L  +++ G  P+   T   +   + +G+
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 56/260 (21%), Positives = 95/260 (36%), Gaps = 59/260 (22%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
                  ++LG+G FG+  +C     +  TG   A K +   +  + E + D  REI+I+
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 65

Query: 154 HHLAGHKNIVTIKG----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H NIV  KG    A   +L   ++ME    G L D +  + H       +L +  
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL--QKHKERIDHIKLLQYT 120

Query: 210 VGVVEAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             + +      +   +HRDL   N L+   +++  +K  DFGL+                
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLP--------QDKE 169

Query: 267 YYV------------APEVLL-KHYGPEADVWTAGVILYILLS----------------G 297
           ++             APE L    +   +DVW+ GV+LY L +                G
Sbjct: 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

Query: 298 VPPFWAETQQGIFDAVLKGH 317
                      + + +    
Sbjct: 230 NDKQGQMIVFHLIELLKNNG 249

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 18/227 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T        A K++           E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLR 237

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+ +V +     +   ++IV E  + G L D +         +  +L  +   +     
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMA 294

Query: 218 SLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPE 272
            +  M   HRDL+  N L+    ++   K  DFGL+   +  +         P  + APE
Sbjct: 295 YVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 398

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 60/243 (24%), Positives = 97/243 (39%), Gaps = 40/243 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           R +    R +G+G FG  Y    I      I+ A KS+   ++   + VE   RE  +M 
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMR 77

Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
            L  H N++ + G         H+++     G+L   I  R         +L    + V 
Sbjct: 78  GLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVA 134

Query: 214 EACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
                L      HRDL   N +L   D+ F++K  DFGL+          D++   YY  
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSV 182

Query: 270 -------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
                        A E L  + +  ++DVW+ GV+L+ LL+ G PP+       +   + 
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

Query: 315 KGH 317
           +G 
Sbjct: 243 QGR 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 55/259 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF---------ACKSISKRKLISREDVEDVRR 148
           RD  TLG+ LG+G FG   +    A GI+          A K +  +   + +D+ D+  
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAE--AVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVS 89

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRG 195
           E+++M  +  HKNI+ + GA      +++++E  + G L             +   I R 
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 196 HYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
              +    +L      +        S   +HRDL   N L+    ++  +K  DFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLA-- 204

Query: 253 FKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGV 298
                   D+    YY             APE L    Y  ++DVW+ GV+++ I   G 
Sbjct: 205 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257

Query: 299 PPFWAETQQGIFDAVLKGH 317
            P+     + +F  + +GH
Sbjct: 258 SPYPGIPVEELFKLLKEGH 276

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 36/157 (22%), Positives = 62/157 (39%), Gaps = 9/157 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +G+K+G G FG   L   + T    A K +   K         +  E +    L    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQLGSGD 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            I  +           +V+EL  G  L D   +    +S +    +   ++  +E  HS 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 220 GVMHRDLKPENFLL--VNKDDDFSLKAIDFGLSVFFK 254
            +++RD+KPENFL+          +  IDF L+  + 
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 37/240 (15%)

Query: 98  RDLYTLGR-KLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           RD   +   +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH
Sbjct: 8   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMH 65

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  +  IV + G  +    + +VME+  GG L   +   G   E   + +  ++  V  
Sbjct: 66  QLD-NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSM 121

Query: 215 ACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
               L      HRDL   N LLVN+      K  DFGLS                YY   
Sbjct: 122 GMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALG--------ADDSYYTAR 170

Query: 270 ----------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                     APE +  + +   +DVW+ GV ++  LS G  P+       +   + +G 
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 61/259 (23%), Positives = 106/259 (40%), Gaps = 55/259 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF---------ACKSISKRKLISREDVEDVRR 148
           RD  TLG+ LG+G FG   +    A GI+          A K +  +   + +D+ D+  
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAE--AVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVS 135

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-----RIIQRGHYSERKAA 203
           E+++M  +  HKNI+ + GA      +++++E  + G L +     R     +  +    
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 204 --------ELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
                   +L      +        S   +HRDL   N L+    ++  +K  DFGL+  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLA-- 250

Query: 253 FKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGV 298
                   D+    YY             APE L    Y  ++DVW+ GV+++ I   G 
Sbjct: 251 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303

Query: 299 PPFWAETQQGIFDAVLKGH 317
            P+     + +F  + +GH
Sbjct: 304 SPYPGIPVEELFKLLKEGH 322

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 43/223 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
                  ++LG+G FG+  +C     +  TG   A K +   +  + E + D  REI+I+
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 96

Query: 154 HHLAGHKNIVTIKG----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H NIV  KG    A   +L   ++ME    G L D +  + H       +L +  
Sbjct: 97  KSLQ-HDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL--QKHKERIDHIKLLQYT 151

Query: 210 VGVVEAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             + +      +   +HRDL   N L+   +++  +K  DFGL+                
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLP--------QDKE 200

Query: 267 YYV------------APEVLLKH-YGPEADVWTAGVILYILLS 296
           YY             APE L +  +   +DVW+ GV+LY L +
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 32/238 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
               ++ + +G G+FG      L       I  A K++  +   + +   D   E  IM 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 101

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
               H NI+ ++G    S  V IV E    G L   +  R H ++    +L  ++ G+  
Sbjct: 102 QFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIAS 158

Query: 215 ACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
                  +G +HRDL   N +L+N   +   K  DFGL       ++  D   + Y    
Sbjct: 159 GMKYLSDMGYVHRDLAARN-ILIN--SNLVCKVSDFGLG------RVLEDDPEAAYTTRG 209

Query: 270 --------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                   +PE +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 60/261 (22%), Positives = 98/261 (37%), Gaps = 59/261 (22%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG        A GI+        A K +  ++  +  +   +  E+
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKML--KEGATHSEHRALMSEL 81

Query: 151 QIMHHLAGHKNIVTIKGA---YEDSLCVHIVMELCAGGEL-------------FDRIIQR 194
           +I+ H+  H N+V + GA       L   +++E C  G L             +    + 
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 195 GHYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
            +        L      V +      S   +HRDL   N LL    +   +K  DFGL+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLA- 195

Query: 252 FFKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSG 297
                    D+   P YV            APE +    Y  ++DVW+ GV+L+ I   G
Sbjct: 196 --------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247

Query: 298 VPPFWA-ETQQGIFDAVLKGH 317
             P+   +  +     + +G 
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGT 268

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 18/227 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T        A K++           E   +E Q+M  L 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLR 320

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+ +V +     +   ++IV E  + G L D +         +  +L  +   +     
Sbjct: 321 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMA 377

Query: 218 SLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPE 272
            +  M   HRDL+  N L+    ++   K  DFGL+   +  +         P  + APE
Sbjct: 378 YVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G+
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 63/221 (28%), Positives = 87/221 (39%), Gaps = 40/221 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLC----TEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +      R LG+G FG   L     T   TG   A K++  +     +     ++EI I+
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDIL 87

Query: 154 HHLAGHKNIVTIKGAYEDSLC--VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
             L  H++I+  KG  ED+    + +VME    G L D +    H      A+L      
Sbjct: 88  RTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRH--SIGLAQLLLFAQQ 142

Query: 212 VVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           + E    L      HRDL   N LL   D+D  +K  DFGL+             G  YY
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVP--------EGHEYY 191

Query: 269 VAPE---VLLKHYGPEA----------DVWTAGVILYILLS 296
              E     +  Y PE           DVW+ GV LY LL+
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 22/229 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++          VE    E  +M  L 
Sbjct: 187 RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKP----GSMSVEAFLAEANVMKTLQ 241

Query: 158 GHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            H  +V +     ++ +   I+ E  A G L D +      S++   +L      + E  
Sbjct: 242 -HDKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGM 297

Query: 217 HSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---A 270
             +      HRDL+  N L+         K  DFGL+   +    +T   G+ + +   A
Sbjct: 298 AFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTA 353

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           PE +    +  ++DVW+ G++L  +++ G  P+   +   +  A+ +G+
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 55/242 (22%), Positives = 86/242 (35%), Gaps = 44/242 (18%)

Query: 99  DLYTLGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
            L    ++LG G FGT               A K + K +       +++  E  +M  L
Sbjct: 17  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL 75

Query: 157 AGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
             +  IV + G     +C      +VME+   G L   + Q  H        +  ++  V
Sbjct: 76  D-NPYIVRMIG-----ICEAESWMLVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQV 126

Query: 213 VEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
                 L      HRDL   N LLV +      K  DFGLS   +  +         YY 
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADE--------NYYK 175

Query: 270 ------------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK 315
                       APE +    +  ++DVW+ GV+++   S G  P+       +   + K
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

Query: 316 GH 317
           G 
Sbjct: 236 GE 237

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score = 80.4 bits (199), Expect = 6e-18
 Identities = 9/44 (20%), Positives = 17/44 (38%)

Query: 354 LCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           + H     +G          VL   K +  + K +K+A+ + A 
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQ 44

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 51/257 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR---KLI----SREDVEDVRREI 150
           RD   LG+ LG+G FG   L    A G++    +   +   K++    + +D+ D+  E+
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRGHY 197
           ++M  +  HKNI+ + GA      +++++E  + G L             +         
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 198 SERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            +  + +L      V        S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLA---- 238

Query: 255 PGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGVPP 300
                 D+    YY             APE L    Y  ++DVW+ GV+L+ I   G  P
Sbjct: 239 -----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

Query: 301 FWAETQQGIFDAVLKGH 317
           +     + +F  + +GH
Sbjct: 294 YPGVPVEELFKLLKEGH 310

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 24/182 (13%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
            D   + + LG+K+G G FG  YL        + A   +     +  ++   +  E++  
Sbjct: 32  DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFY 87

Query: 154 HHLAGHKNIVTIK----------------GAYEDSLCVH--IVMELCAGGELFDRIIQRG 195
             +A    I                    G  E     +  +VME   G +L     Q G
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG 146

Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            + +    +L   ++ V+E  H    +H D+K  N LL  K+ D  +   D+GLS  + P
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSYRYCP 205

Query: 256 GQ 257
             
Sbjct: 206 NG 207

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 36/238 (15%)

Query: 99  DLYTLGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           +L     +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH L
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL 393

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             +  IV + G  +    + +VME+  GG L   +   G   E   + +  ++  V    
Sbjct: 394 -DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGM 449

Query: 217 HSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---- 269
             L      HR+L   N LLVN+      K  DFGLS                YY     
Sbjct: 450 KYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALG--------ADDSYYTARSA 498

Query: 270 --------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                   APE +  + +   +DVW+ GV ++  LS G  P+       +   + +G 
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 49/252 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT--EIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            +       +G+G FG        +    ++ A K +  ++  S++D  D   E++++  
Sbjct: 24  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCK 81

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-------------RIIQRGHYSERKA 202
           L  H NI+ + GA E    +++ +E    G L D               I     S   +
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 203 AELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF 259
            +L      V            +HRDL   N L+    +++  K  DFGLS         
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS--------- 189

Query: 260 TDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAET 305
               G   YV            A E L    Y   +DVW+ GV+L+ I+  G  P+   T
Sbjct: 190 ---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246

Query: 306 QQGIFDAVLKGH 317
              +++ + +G+
Sbjct: 247 CAELYEKLPQGY 258

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 59/260 (22%), Positives = 100/260 (38%), Gaps = 59/260 (22%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R    L R+LG+G FG  +L       +         A K++   K  +    +D +RE 
Sbjct: 14  RRDIVLKRELGEGAFGKVFLAE--CYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREA 68

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRGHY 197
           +++ +L  H++IV   G   D   + +V E    G+L                   R   
Sbjct: 69  ELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 198 SERKAAELTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            E   +++  I   +      L      HRDL   N  LV    +  +K  DFG+S    
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN-CLVG--ANLLVKIGDFGMS---- 180

Query: 255 PGQIFTDVVGSPYYV------------APEVLLKHYG---PEADVWTAGVILYILLS-GV 298
                 DV  + YY              PE ++  Y     E+DVW+ GVIL+ + + G 
Sbjct: 181 -----RDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGK 233

Query: 299 PPFWAETQQGIFDAVLKGHI 318
            P++  +   + + + +G +
Sbjct: 234 QPWFQLSNTEVIECITQGRV 253

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 54/256 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R    L  +LG+G FG  +L       +         A K++   K  S    +D +RE 
Sbjct: 40  RRDIVLKWELGEGAFGKVFLA--ECHNLLPEQDKMLVAVKAL---KEASESARQDFQREA 94

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA------- 203
           +++  L  H++IV   G   +   + +V E    G+L   +   G  ++  A        
Sbjct: 95  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 204 -----ELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
                +L  +   V         L  +HRDL   N  LV       +K  DFG+S     
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN-CLVG--QGLVVKIGDFGMS----- 205

Query: 256 GQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
                D+  + YY              PE +L   +  E+DVW+ GV+L+ + + G  P+
Sbjct: 206 ----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

Query: 302 WAETQQGIFDAVLKGH 317
           +  +     D + +G 
Sbjct: 262 YQLSNTEAIDCITQGR 277

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 61/239 (25%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+    G+ LG G FG     T  A GI         A K +  ++     + E +  E+
Sbjct: 44  RENLEFGKVLGSGAFGKVMNAT--AYGISKTGVSIQVAVKML--KEKADSSEREALMSEL 99

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAAELTRI 208
           ++M  L  H+NIV + GA   S  ++++ E C  G+L  + R  +R  +SE +     + 
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR-SKREKFSEDEIEYENQK 158

Query: 209 IVGVVEACHSL----------------------GVMHRDLKPENFLLVNKDDDFSLKAID 246
            +   E  + L                        +HRDL   N L+        +K  D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICD 215

Query: 247 FGLSVFFKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY 292
           FGL+          D++    YV            APE L +  Y  ++DVW+ G++L+
Sbjct: 216 FGLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 63/308 (20%), Positives = 112/308 (36%), Gaps = 69/308 (22%)

Query: 63  DNSAPRISPSKKDNIMRRGIDNQTY----YVLGHKTDNI---RDLYTLGRKLGQGQFGTT 115
           +++A  ++    + ++ R   N  Y     +L  K  ++   R+     R +G+G FG  
Sbjct: 4   ESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV 63

Query: 116 YLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA 168
           +     A G+         A K +  ++  S +   D +RE  +M     + NIV + G 
Sbjct: 64  FQA--RAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF-DNPNIVKLLGV 118

Query: 169 YEDSLCVHIVMELCAGGEL---------------------FDRIIQRGHYSERKAAELTR 207
                 + ++ E  A G+L                         +          AE   
Sbjct: 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178

Query: 208 IIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           I   V            +HRDL   N L+    ++  +K  DFGLS          ++  
Sbjct: 179 IARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS---------RNIYS 226

Query: 265 SPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIF 310
           + YY              PE +  + Y  E+DVW  GV+L+ + S G+ P++    + + 
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286

Query: 311 DAVLKGHI 318
             V  G+I
Sbjct: 287 YYVRDGNI 294

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 56/267 (20%), Positives = 99/267 (37%), Gaps = 66/267 (24%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R    LG+ LG+G+FG     T  A  ++        A K +  ++  S  ++ D+  E 
Sbjct: 22  RKNLVLGKTLGEGEFGKVVKAT--AFHLKGRAGYTTVAVKML--KENASPSELRDLLSEF 77

Query: 151 QIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGEL--------------------- 187
            ++  +  H +++ + GA   +  L   +++E    G L                     
Sbjct: 78  NVLKQV-NHPHVIKLYGACSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKA 244
               +           +L      + +       + ++HRDL   N L+    +   +K 
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKI 191

Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVIL 291
            DFGLS          DV     YV            A E L  H Y  ++DVW+ GV+L
Sbjct: 192 SDFGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 292 Y-ILLSGVPPFWAETQQGIFDAVLKGH 317
           + I+  G  P+     + +F+ +  GH
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGH 269

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 49/257 (19%), Positives = 92/257 (35%), Gaps = 54/257 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
                   +LG+ +FG  Y       G          A K++  +        E+ R E 
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGH--LFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEA 63

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRGHY 197
            +   L  H N+V + G       + ++   C+ G+L                   R   
Sbjct: 64  MLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 198 SERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
           S  +  +   ++  +        S  V+H+DL   N +LV   D  ++K  D GL     
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN-VLVY--DKLNVKISDLGLF---- 175

Query: 255 PGQIFTDVVGSPYYV------------APEVLL-KHYGPEADVWTAGVILYILLS-GVPP 300
                 +V  + YY             APE ++   +  ++D+W+ GV+L+ + S G+ P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 301 FWAETQQGIFDAVLKGH 317
           +   + Q + + +    
Sbjct: 231 YCGYSNQDVVEMIRNRQ 247

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 35/190 (18%), Positives = 71/190 (37%), Gaps = 37/190 (19%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLC-----TEIATGIEFACKSISKRKLISREDVEDVRR 148
           TD     + +G  +GQG FG  YL        + +      K       +   D   +  
Sbjct: 30  TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK-------VEPSDNGPLFT 82

Query: 149 EIQIMHHLAGHKNIVTIK----------------GAYEDSLCVH--IVMELCAG---GEL 187
           E++     A  + I                    G ++ +   +  ++M+   G    ++
Sbjct: 83  ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKI 141

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
           ++       +S +   +L+  I+ ++E  H    +H D+K  N LL  K+ D  +  +D+
Sbjct: 142 YEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDY 198

Query: 248 GLSVFFKPGQ 257
           GL+  + P  
Sbjct: 199 GLAYRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 30/181 (16%), Positives = 60/181 (33%), Gaps = 21/181 (11%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI--------EFACKSISKRKLISREDVED 145
           TD     + L     +   G  Y     +T          +F+ K  +K   +  E    
Sbjct: 37  TDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFF 96

Query: 146 VRR----EIQIMHHLAG--HKNIVTIK--GAYEDSLCVHIVMELCAGGELFD--RIIQRG 195
            R     ++     L       I T    G ++D     +V+    G  L     +  + 
Sbjct: 97  QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKH 154

Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             SER   ++   ++  +E  H    +H ++  EN  + + +D   +    +G +  + P
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV-DPEDQSQVTLAGYGFAFRYCP 213

Query: 256 G 256
            
Sbjct: 214 S 214

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 69/252 (27%)

Query: 86  TYYVLGHKTDNIRD--LYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISR 140
           ++Y L + T+N  +  +   G K+G+G FG  Y   +          A K     KL + 
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVK-----KLAAM 65

Query: 141 EDVEDV------RREIQIMHHLAGHKNIVTIKG----------AYE----DSLCVHIVME 180
            D+          +EI++M     H+N+V + G           Y      SL       
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDR---- 120

Query: 181 LCAGGELFDRIIQRGHYSERKAAEL---TR--IIVGV---VEACHSLGVMHRDLKPENFL 232
                 L                 L    R  I  G    +   H    +HRD+K  N L
Sbjct: 121 ------LSCL---------DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165

Query: 233 LVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGV 289
           L   D+ F+ K  DFGL+   +      + + +VG+  Y+APE L     P++D+++ GV
Sbjct: 166 L---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGV 222

Query: 290 ILYILLSGVPPF 301
           +L  +++G+P  
Sbjct: 223 VLLEIITGLPAV 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 12/100 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG        A GI+        A K +  ++  +  +   +  E+
Sbjct: 21  RDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKML--KEGATHSEHRALMSEL 76

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLC-VHIVMELCAGGELFD 189
           +I+ H+  H N+V + GA       + +++E C  G L  
Sbjct: 77  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 30/97 (30%), Positives = 41/97 (42%), Gaps = 26/97 (26%)

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-------- 269
           S   +HRDL   N LL    +   +K  DFGL+          D+   P YV        
Sbjct: 211 SRKCIHRDLAARNILL---SEKNVVKICDFGLA---------RDIYKDPDYVRKGDARLP 258

Query: 270 ----APEVLLKH-YGPEADVWTAGVILY-ILLSGVPP 300
               APE +    Y  ++DVW+ GV+L+ I   G  P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
            LG+G FG  Y    +A G   A K + K +     +++  + E++++     H+N++ +
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRL 92

Query: 166 KGAYEDSLCVH-----IVMELCAGGELFDRIIQRGHYSERKAAELT-----RIIVGVV-- 213
           +G      C+      +V    A G +   +             L      RI +G    
Sbjct: 93  RG-----FCMTPTERLLVYPYMANGSVASCL----RERPESQPPLDWPKRQRIALGSARG 143

Query: 214 -----EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--IFTDVVGSP 266
                + C    ++HRD+K  N LL   D++F     DFGL+         + T V G+ 
Sbjct: 144 LAYLHDHCD-PKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 267 YYVAPEVLLKHYGPE-ADVWTAGVILYILLSGVPPF 301
            ++APE L      E  DV+  GV+L  L++G   F
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 61/268 (22%), Positives = 105/268 (39%), Gaps = 47/268 (17%)

Query: 86  TYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED 145
               L   T+N          +G G FG  Y    +  G + A K   +R   S + +E+
Sbjct: 30  PLVDLEEATNNFDH----KFLIGHGVFGKVYKGV-LRDGAKVALK---RRTPESSQGIEE 81

Query: 146 VRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
              EI+ +     H ++V++ G  ++   + ++ +    G L   +    + S+     +
Sbjct: 82  FETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL----YGSDLPTMSM 136

Query: 206 T-----RIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           +      I +G    +   H+  ++HRD+K  N LL   D++F  K  DFG+S       
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELD 193

Query: 258 ---IFTDVVGSPYYVAPEVLLKHYGPE-ADVWTAGVILYILLSGVPPF------------ 301
              + T V G+  Y+ PE  +K    E +DV++ GV+L+ +L                  
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

Query: 302 -WAETQQ------GIFDAVLKGHIDFES 322
            WA           I D  L   I  ES
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPES 281

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.7 bits (133), Expect = 1e-08
 Identities = 43/249 (17%), Positives = 76/249 (30%), Gaps = 68/249 (27%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREIQI 152
            +      K+G+G FG  +    IA     A K I+               E++  EI I
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 153 MHHLAGH--------------KNIVTIKGAYEDSLC------------------------ 174
              L+                 ++  ++G+Y   L                         
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV 234
           + IV+E   GG   +++  +        + L ++   +  A  SL   HRDL   N LL 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 235 N---------------KDDDFSLKA--IDFGLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK 276
                                 L+   ID+ LS   + G  +F D       +  ++   
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD-----VSMDEDLFTG 251

Query: 277 HYGPEADVW 285
               + D++
Sbjct: 252 DGDYQFDIY 260

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 51.9 bits (125), Expect = 4e-08
 Identities = 5/28 (17%), Positives = 15/28 (53%)

Query: 370 LDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           + P VL+ +K +   + ++ + + + A 
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINIMAH 29

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 51.5 bits (124), Expect = 6e-08
 Identities = 7/30 (23%), Positives = 13/30 (43%)

Query: 368 RSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           +      L  +K+F +  KL + A+    S
Sbjct: 2   KHALTGALGNMKKFQSSQKLAQAAMLFMGS 31

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 2e-06
 Identities = 55/380 (14%), Positives = 103/380 (27%), Gaps = 137/380 (36%)

Query: 38  SDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI 97
           ++   PS+ ++  + Q   ++    DN         K N+ R                 +
Sbjct: 100 TEQRQPSMMTRMYIEQ---RDRLYNDNQ-----VFAKYNVSRL-----------QPYLKL 140

Query: 98  RD-LYTL--GRKL---GQGQFGTTYLCTEIATGIEFACKSISKRKLISRE----DVEDVR 147
           R  L  L   + +   G    G T++  +        C S   +  +  +    ++++  
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALD-------VCLSYKVQCKMDFKIFWLNLKNCN 193

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
               ++  L                L   I     +  +    I  R H  +   AEL R
Sbjct: 194 SPETVLEMLQ--------------KLLYQIDPNWTSRSDHSSNIKLRIHSIQ---AELRR 236

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++              +  +  N LLV          +                      
Sbjct: 237 LL------------KSKPYE--NCLLV----------LL--------------------- 251

Query: 268 YVAPEVLLKHYGPEADVWTAGVILY------ILLSGVPPFWAETQ-QGIFDAV---LKGH 317
                          +V  A           ILL+        T+ + + D +      H
Sbjct: 252 ---------------NVQNAKAWNAFNLSCKILLT--------TRFKQVTDFLSAATTTH 288

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL-CHPWICENGVAPDRSLDPAVLS 376
           I  +     L  D  K L+ K L     + L   EVL  +P    + +A       A   
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYL-DCRPQDL-PREVLTTNPRRL-SIIAESIRDGLATWD 345

Query: 377 RLKQ--FSAMNKLKKMALRV 394
             K      +  + + +L V
Sbjct: 346 NWKHVNCDKLTTIIESSLNV 365

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score = 45.8 bits (109), Expect = 5e-06
 Identities = 9/36 (25%), Positives = 14/36 (38%), Gaps = 3/36 (8%)

Query: 362 NGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS 397
           +G+ P   L   +       + M KL+   L   AS
Sbjct: 2   SGLVPRGPLGSHMD---AVDATMEKLRAQCLSRGAS 34

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 13/99 (13%), Positives = 27/99 (27%), Gaps = 8/99 (8%)

Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR------KMLCSQPSERLTAHEVLCH 356
            E  Q   D     H +        I+   ++         + + ++   R  A      
Sbjct: 21  LEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREA 80

Query: 357 PWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVS 395
                +  A  + L   +       S  N+L+     +S
Sbjct: 81  AR--GDAAAEKQRLASLLKDLEDDASGYNRLRPSKPMLS 117

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 1/43 (2%), Positives = 11/43 (25%)

Query: 356 HPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSASA 398
            P +    +   + +  + +     +     ++        + 
Sbjct: 2   QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNT 44

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166

 Score = 39.8 bits (94), Expect = 4e-04
 Identities = 16/19 (84%), Positives = 16/19 (84%)

Query: 379 KQFSAMNKLKKMALRVSAS 397
           KQFSAMNK KKMALRV A 
Sbjct: 1   KQFSAMNKFKKMALRVIAE 19

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256

 Score = 40.4 bits (94), Expect = 5e-04
 Identities = 11/90 (12%), Positives = 20/90 (22%), Gaps = 10/90 (11%)

Query: 302 WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
             E  +        G++  +    PL    +    R     Q   R          WI  
Sbjct: 4   TKEAVKAS-----DGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCL-----IKWILS 53

Query: 362 NGVAPDRSLDPAVLSRLKQFSAMNKLKKMA 391
           +          + L           L ++ 
Sbjct: 54  SAAPQGSDSSDSELELSTVRHQPEGLDQLQ 83

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	398
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.0
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.79
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.21
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.11
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.1
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.75
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.67
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.57
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.57
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.53
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.42
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.19
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.17
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.01
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.64
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.16
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.34

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.4e-67  Score=493.61  Aligned_cols=264  Identities=32%  Similarity=0.538  Sum_probs=239.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|+++++||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|++|. |||||+++++|++.+.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence            35999999999999999999999999999999998665444555778999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC--
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG--  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~--  256 (398)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999   88899999999999876533  


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       ......+||+.|||||++.+ .|+.++|||||||++|||++|..||.+.+..+++..+.++...++.    .+++++++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d  263 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD  263 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence             23457899999999999985 5999999999999999999999999999999999999998876654    48999999


Q ss_pred             HHHHhcccCCCCCCCHHH------HhcCCCccCCCCCCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHE------VLCHPWICENGVAPDRSL  370 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~e------iL~hp~~~~~~~~~~~~~  370 (398)
                      ||.+||+.||++|||++|      +++||||++..+......
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence            999999999999999988      589999999776654433

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-65  Score=476.42  Aligned_cols=255  Identities=36%  Similarity=0.648  Sum_probs=216.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|+.|+ ||||+++++++++.+.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999998766555566778999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||| +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 68999999999999999999999999999999999999999999999999   8889999999999988776666


Q ss_pred             ccccccCCcccCccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ....+||+.|||||++.+. | +.++|||||||++|+|++|..||.+.+...++..+.++...++.    .+++++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            6778999999999999853 4 68999999999999999999999999999999999888766543    5899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          337 RKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .+||+.||++|||++|+|+||||+..
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHHccCChhHCcCHHHHHcCcccccC
Confidence            99999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-65  Score=484.52  Aligned_cols=259  Identities=28%  Similarity=0.488  Sum_probs=231.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.++||+|+||+||+|.++.+|+.||||++......   ..+.+.+|+.+|+.|. |||||+++++|++.+.+|
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            345699999999999999999999999999999999765432   2356789999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCC
Confidence            99999999999998865 569999999999999999999999999999999999999   88899999999999876543


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       ......+||+.|||||++.+ .|+.++|||||||++|||++|..||.+.+..+.+..+..... .....+..+++++++
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence             44567899999999999985 599999999999999999999999999998888888876532 233344568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ||.+||+.||++|||+.|+|+||||++...
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            999999999999999999999999987653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.7e-65  Score=486.66  Aligned_cols=257  Identities=25%  Similarity=0.497  Sum_probs=226.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+... .....+.+.+|+.+|++|+ |||||+++++|++.+.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            569999999999999999999999999999999976544 5566788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+||+|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            9999999999999754  347999999999999999999999999999999999999   88899999999999876543


Q ss_pred             C-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      . .....+||+.|||||++.+ .|+.++|||||||+||||++|..||.+.+..+++..+..+.....   ...+++++.+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHHH
Confidence            2 3456789999999999986 599999999999999999999999999999999999988765432   3468999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ||.+||+.||++|||+.|+|+||||++..
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999998643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-63  Score=466.65  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=220.7

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec----CCeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SLCVH  176 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~----~~~~~  176 (398)
                      |++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|++|+ |||||+++++|+.    ...+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEE
Confidence            4788899999999999999999999999999976543 5566788999999999998 9999999999865    45689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecC-CCccEEEeecCCceec
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFF  253 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~-~~~~~kL~DFG~a~~~  253 (398)
                      ||||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|  ||||||||+|||+   + .++.+||+|||+|+..
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl---~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI---TGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE---SSTTSCEEECCTTGGGGC
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE---ECCCCCEEEEeCcCCEeC
Confidence            99999999999999999899999999999999999999999999  9999999999999   5 4689999999999864


Q ss_pred             CCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .. ......+||+.|||||++.+.|+.++|||||||++|||+||..||.+... ..++..+..+...  ......+++++
T Consensus       183 ~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~  259 (290)
T 3fpq_A          183 RA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEV  259 (290)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHH
T ss_pred             CC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCccCCHHH
Confidence            43 44567899999999999988899999999999999999999999976544 4455555544322  12223578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .+||.+||+.||++|||+.|+|+||||++
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-63  Score=485.58  Aligned_cols=259  Identities=28%  Similarity=0.493  Sum_probs=231.6

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.++||+|+||+||+|.++.+|+.||||++.....   ...+.+.+|+.+|+.|. |||||+++++|.+.+.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEE
Confidence            45679999999999999999999999999999999976543   23456889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||||+||+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+||||   +.+|.+||+|||+|......
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCC
Confidence            99999999999998864 569999999999999999999999999999999999999   88899999999999876543


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       ......+||+.|||||++.+ .|+.++|||||||++|||++|..||.+.+..+.+..+..... .....+..+++++++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             44567899999999999985 599999999999999999999999999999888888876532 233345578999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ||.+||+.||++|||+.|+|+||||++...
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            999999999999999999999999988653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.3e-64  Score=473.04  Aligned_cols=256  Identities=28%  Similarity=0.478  Sum_probs=223.2

Q ss_pred             ccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|++.+.||+|+||+||+|++.   .+++.||||++.+.... .....++.+|+.+|++|+ |||||+++++|++.+.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            46999999999999999999874   46789999999765432 223346788999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            9999999999999999999999999999999999999999999999999999999999   8889999999999986543


Q ss_pred             -CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 -GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                       .......+||+.|||||++.+ .|+.++|||||||++|||++|..||.+.+..+++..+.+....++.    .+|+++.
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHH
Confidence             334567899999999999985 5999999999999999999999999999999999999888766543    5899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          334 DLIRKMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      +||.+||+.||++|||     ++|+++||||++..
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            9999999999999998     47999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3e-62  Score=465.21  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=223.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +.|++.++||+|+||+||+|.++.+|+.||||++......        .+|+.+++.|+ |||||+++++|.+.+.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            4588999999999999999999999999999999764322        36999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-cEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+|||+   +.++ .+||+|||+|+......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999998999999999999999999999999999999999999999   7776 69999999998765432


Q ss_pred             c------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          258 I------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       258 ~------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .      ....+||+.|||||++.+ .|+.++|||||||++|||++|..||.+.+...++..+......+. ..++.+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence            1      234689999999999985 599999999999999999999999998887777888777654432 23456899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHH-------------hcCCCccCCCCCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEV-------------LCHPWICENGVAP  366 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~ei-------------L~hp~~~~~~~~~  366 (398)
                      ++.+||.+||+.||++|||+.|+             |+|||+.+...+.
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            99999999999999999999997             6799998876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-61  Score=469.30  Aligned_cols=263  Identities=25%  Similarity=0.393  Sum_probs=227.4

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec----
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----  171 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~----  171 (398)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+++.+|+.+|+.|+ |||||++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            35578999999999999999999999999999999996543 34556678999999999997 9999999998753    


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                        .+.+|||||||+ |+|.+++...+.+++..++.+++||+.||.|||++|||||||||+|||+   +.++.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecce
Confidence              467999999995 6899999988899999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCC-----CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          250 SVFFKPG-----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       250 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      |+.+...     ......+||+.|||||++.+  .|+.++||||+||++|||++|.+||.+.+..+.+..+......+..
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9865332     23456899999999999875  4799999999999999999999999999988888887653322211


Q ss_pred             C---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          323 D---------------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       323 ~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      .                           .++.++++++|||.+||++||++|||+.|+|+||||++...
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            1                           12357899999999999999999999999999999998643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-59  Score=452.90  Aligned_cols=257  Identities=27%  Similarity=0.461  Sum_probs=211.7

Q ss_pred             ccccccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..+.++|++.++||+|+||+||+|+++   .+++.||||.+....     ...++.+|+.+|+.+.+||||++++++|++
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            356788999999999999999999875   467899999986432     345688999999999779999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC-ccEEEeecCCc
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLS  250 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~-~~~kL~DFG~a  250 (398)
                      .+.+|+||||++|++|.+++   +.+++.+++.+++||+.||+|||++|||||||||+|||+   +.+ +.+||+|||+|
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl---~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLY---NRRLKKYALVDFGLA  165 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---ETTTTEEEECCCTTC
T ss_pred             CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEE---eCCCCeEEECcCCCC
Confidence            99999999999999999988   359999999999999999999999999999999999999   444 78999999999


Q ss_pred             eecCCCC-----------------------------cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCC
Q 015898          251 VFFKPGQ-----------------------------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVP  299 (398)
Q Consensus       251 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~  299 (398)
                      +......                             .....+||+.|+|||++.+  .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            7654321                             2345689999999999875  48999999999999999999999


Q ss_pred             CCCCc-ChHHHHHHHHcC--------------------------------------C------------CcCCCCCCCCC
Q 015898          300 PFWAE-TQQGIFDAVLKG--------------------------------------H------------IDFESDPWPLI  328 (398)
Q Consensus       300 pf~~~-~~~~~~~~~~~~--------------------------------------~------------~~~~~~~~~~~  328 (398)
                      ||... +..+.+..+..-                                      .            .......+..+
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            99644 333333333210                                      0            00111234568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +++++|||.+||++||++|||++|+|+||||++.
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.2e-59  Score=474.86  Aligned_cols=268  Identities=35%  Similarity=0.588  Sum_probs=244.0

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +.+-++|++.+.||+|+||+||+|.++.+|+.||+|++...   .....+.+.+|+.+|+.|+ |||||+++++|++.+.
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            34557899999999999999999999999999999999654   3455678899999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      +|||||||+||+|++++.. .+.+++..+..+++||+.||.|||++||+||||||+|||+.. +..+.+||+|||+|+..
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEEC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEc
Confidence            9999999999999999864 467999999999999999999999999999999999999932 13478999999999998


Q ss_pred             CCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .........+||+.|||||++.+ .|+.++|||||||+||||++|..||.+.+..+.+..+......++...+..+++++
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            87777778899999999999985 59999999999999999999999999999999999999988888777778899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ++||.+||+.||++|||+.|+|+||||++......
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence            99999999999999999999999999998665443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-59  Score=441.48  Aligned_cols=254  Identities=26%  Similarity=0.371  Sum_probs=201.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-----
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-----  173 (398)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++....  .....+.+.+|+.+|++|+ |||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            35999999999999999999999999999999996543  4555678999999999997 999999999986543     


Q ss_pred             -------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEE
Q 015898          174 -------CVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (398)
Q Consensus       174 -------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~k  243 (398)
                             .+|+|||||++|+|.+++.....   ..+..++.++.||+.||+|||++|||||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   47999999999999999987654   4556789999999999999999999999999999999   8889999


Q ss_pred             EeecCCceecCCCC-------------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH-H
Q 015898          244 AIDFGLSVFFKPGQ-------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ-G  308 (398)
Q Consensus       244 L~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~  308 (398)
                      |+|||+|+......             ..+..+||+.|||||++.+ .|+.++|||||||++|||++   ||...... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            99999998765432             1234689999999999985 59999999999999999996   88654322 2


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      .+..+.....+   ..+...++.+.+||.+||+.||++|||+.|+|+||||++..+
T Consensus       236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            33333333221   112234677899999999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-58  Score=435.73  Aligned_cols=251  Identities=21%  Similarity=0.368  Sum_probs=217.6

Q ss_pred             ccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ++|.+.+.||+|+||+||+|.+.     .++..||||++...   +....+++.+|+.+|++|+ |||||++++++.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            46999999999999999999865     36789999999643   5566788999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          174 CVHIVMELCAGGELFDRIIQR-------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      .+|||||||++|+|.++|...             ..+++.++..++.||+.||.|||+++||||||||+|||+   ++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCC
Confidence            999999999999999999764             359999999999999999999999999999999999999   8889


Q ss_pred             cEEEeecCCceecCCCCc---ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHc
Q 015898          241 SLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~  315 (398)
                      .+||+|||+|+.......   .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986544332   23356899999999998 469999999999999999999 8999999999999999888


Q ss_pred             CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      +.....   ...+++++.+|+.+||+.||++|||+.||  |+|+++
T Consensus       246 ~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          246 GRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            764322   23589999999999999999999999998  445543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.4e-58  Score=437.47  Aligned_cols=248  Identities=21%  Similarity=0.351  Sum_probs=210.6

Q ss_pred             ccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ++|.+.++||+|+||+||+|...     .+++.||||++...   +....+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            45888999999999999999864     46889999999643   5566788999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRIIQR---------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      .+|||||||++|+|.+++...               +++++.++..++.||+.||.|||+++||||||||+|||+   ++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence            999999999999999998753               358999999999999999999999999999999999999   88


Q ss_pred             CccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHH
Q 015898          239 DFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~  313 (398)
                      ++.+||+|||+|+......   .....+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8999999999998764432   2345689999999999985 69999999999999999999 89999999998988888


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .++...   .....+++++.+|+.+||+.||++|||+.||+++
T Consensus       274 ~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            776432   2223689999999999999999999999999764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-58  Score=469.83  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=221.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHH---HHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE---IQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---i~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|+++++||+|+||+||+|.++.+|+.||||++.+...........+.+|   +.+++.+. |||||+++++|++.+.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECCEE
Confidence            569999999999999999999999999999999976543222333334444   55556665 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.+|++||+|||+|.....
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCC
Confidence            9999999999999999999999999999999999999999999999999999999999   8899999999999988765


Q ss_pred             CCcccccccCCcccCccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---hHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          256 GQIFTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .. ....+||+.|||||++. + .|+.++|||||||++|||++|.+||.+..   ...+...+......++    ..+++
T Consensus       345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~  419 (689)
T 3v5w_A          345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSP  419 (689)
T ss_dssp             CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCH
Confidence            43 45679999999999996 3 59999999999999999999999997643   3345556666555444    35899


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          331 SAKDLIRKMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      ++++||.+||+.||++|++     ++||++||||++..
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            9999999999999999998     79999999999854

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-58  Score=431.27  Aligned_cols=248  Identities=22%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      +++++.++||+|+||+||+|....   .||||+++... .+.+..+.+.+|+.+|++|+ |||||++++++.+ +.+|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence            458889999999999999998532   69999986433 35667789999999999998 9999999998765 568999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      ||||++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||+   ++++.+||+|||+|+..... 
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence            9999999999999764 579999999999999999999999999999999999999   88899999999999865432 


Q ss_pred             --CcccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC--CCCCCCC
Q 015898          257 --QIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--SDPWPLI  328 (398)
Q Consensus       257 --~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  328 (398)
                        ......+||+.|||||++.+    .|+.++|||||||+||||+||+.||.+.+....+..+.......+  ......+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence              23456789999999999852    489999999999999999999999988766555444443332221  2334568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++++.+|+.+||+.||++|||+.||++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-57  Score=431.06  Aligned_cols=249  Identities=20%  Similarity=0.338  Sum_probs=216.3

Q ss_pred             ccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..+++.++||+|+||+||+|...     .+++.||||++....  .....+.+.+|+.++++|+ |||||+++|++.+.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            34788899999999999999853     467899999996443  3445678999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC
Q 015898          174 CVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~  237 (398)
                      .++||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+|||+   +
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---Y  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---C
Confidence            999999999999999999653                358999999999999999999999999999999999999   8


Q ss_pred             CCccEEEeecCCceecCCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHH
Q 015898          238 DDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~  312 (398)
                      +++.+||+|||+|+......   .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            88999999999998654332   234568999999999987 469999999999999999999 8999999999999998


Q ss_pred             HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +..+.....   ...+++++.+|+.+||+.||++|||+.||+++
T Consensus       260 i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            887654322   33689999999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.6e-57  Score=449.15  Aligned_cols=299  Identities=39%  Similarity=0.679  Sum_probs=267.3

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH   84 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence            3466789999999999999999999999999999999976543 4455678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .|+||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+....+++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999999999998999999999999999999999999999999999999999554467889999999997765


Q ss_pred             CCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+....+..+..+...++...++.+++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            432 3456789999999999985 59999999999999999999999999999999999999999888888888899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVS  395 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (398)
                      .+||.+||+.||++|||+.|+|+||||.+.............+.++++|.+++++|..++.+-
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~  307 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM  307 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999876554555556788999999999999999877653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.4e-57  Score=437.12  Aligned_cols=299  Identities=37%  Similarity=0.690  Sum_probs=267.4

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.|. ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            34566789999999999999999999999999999999976543 5566778999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ..|+||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999999999988888999999999999999999999999999999999999955445567999999999887


Q ss_pred             CCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+..+...++...+..+++++
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            76665667889999999999985 59999999999999999999999999999999999999988888777777899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhh
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRV  394 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (398)
                      .+||.+||+.||++|||+.|+|+||||+.................++.|.++++++..++.+
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  323 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTT  323 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999987543334444567889999999999999887654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-56  Score=449.50  Aligned_cols=302  Identities=42%  Similarity=0.677  Sum_probs=271.9

Q ss_pred             cccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        92 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      .....+.++|++.++||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.+++++. ||||+++++++..
T Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~   97 (484)
T 3nyv_A           19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED   97 (484)
T ss_dssp             CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            344567788999999999999999999999999999999997665544556788999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      .+.+|+||||+.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999999999999988899999999999999999999999999999999999999655567899999999998


Q ss_pred             ecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+.+..+..+...+....+..++++
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             EcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            87766666778899999999999888999999999999999999999999999999999999999888777777789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHhhh
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA---PDRSLDPAVLSRLKQFSAMNKLKKMALRV  394 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (398)
                      +.+||.+||+.||.+|||+.|+|+||||+.....   .......+.+.++++|+..+++++.++.+
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~  323 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLY  323 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHH
Confidence            9999999999999999999999999999876532   23334467888999999999999988765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-56  Score=434.56  Aligned_cols=298  Identities=37%  Similarity=0.605  Sum_probs=248.2

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---hhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ...+.+.|++.+.||+|+||.||+|.+..+|+.||+|++.+......   ...+.+.+|+.+++.+. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~   85 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE   85 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence            34567889999999999999999999999999999999976543221   23578899999999998 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc----cEEEee
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAID  246 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~----~~kL~D  246 (398)
                      +...+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   ++++    .+||+|
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll---~~~~~~~~~vkl~D  162 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKLID  162 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---eCCCCCccCEEEEe
Confidence            999999999999999999999888889999999999999999999999999999999999999   4444    799999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      ||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...+
T Consensus       163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (361)
T 2yab_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF  242 (361)
T ss_dssp             CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence            999998776666677889999999999985 6999999999999999999999999999999999999988877776666


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHhhhc
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD--RSLDPAVLSRLKQFSAMNKLKKMALRVS  395 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (398)
                      ..+++++.+||.+||..||++|||+.|+|+||||+.......  .......+.+++.|.+++++++...-|+
T Consensus       243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (361)
T 2yab_A          243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVS  314 (361)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHHHHHTCBCCHHHHHHHTC------------
T ss_pred             cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhhhcccchhhHHHHHHHHHHhHHHHHHHHHH
Confidence            678999999999999999999999999999999986432110  0000112466777777777776554443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.4e-56  Score=428.98  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=212.8

Q ss_pred             cccceecceecccCceEEEEEEEccC-----CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-  171 (398)
                      .++|++++.||+|+||+||+|.+...     ++.||||.+....  .....+.+.+|+.+|.++.+|||||+++++|.. 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            46799999999999999999997654     3679999986543  455667899999999999856999999999865 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN  235 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~  235 (398)
                      ++.+|||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+|||+  
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--  218 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  218 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence            56789999999999999999753                348999999999999999999999999999999999999  


Q ss_pred             cCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChH-HH
Q 015898          236 KDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQ-GI  309 (398)
Q Consensus       236 ~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~-~~  309 (398)
                       ++++.+||+|||+|+......   .....+||+.|||||++.+ .|+.++|||||||+||||+| |..||.+.... .+
T Consensus       219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             888999999999998765433   2345678999999999984 69999999999999999998 99999886543 44


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ...+..+...   .....+++++.+|+.+||+.||++|||+.||++|
T Consensus       298 ~~~i~~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4555444322   1223588999999999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.2e-56  Score=447.46  Aligned_cols=302  Identities=37%  Similarity=0.637  Sum_probs=263.1

Q ss_pred             cccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        92 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      .....+.++|++.+.||+|+||+||+|.+..++..||+|++.+... .......+.+|+.+++.+. ||||+++++++..
T Consensus        30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  107 (494)
T 3lij_A           30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFED  107 (494)
T ss_dssp             CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence            3445677789999999999999999999999999999999976433 2334567899999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      ...+|+||||+++|+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999999999999999888899999999999999999999999999999999999999654556779999999998


Q ss_pred             ecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+.+..+..+...+....+..++++
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            87776666778899999999999888999999999999999999999999999999999999999888887778889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHhhhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGV----APDRSLDPAVLSRLKQFSAMNKLKKMALRVS  395 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (398)
                      +.+||.+||+.||.+|||+.|+|+||||++...    ..........+.++++|++.+++++.++.+-
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~i  335 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYM  335 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHH
Confidence            999999999999999999999999999987421    1222233467889999999999999987653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.2e-56  Score=446.59  Aligned_cols=299  Identities=41%  Similarity=0.681  Sum_probs=263.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.++||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++++. ||||+++++++.....
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCE
Confidence            3567789999999999999999999999999999999865432 2234578899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +|+||||+.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999999999888899999999999999999999999999999999999999655566789999999998777


Q ss_pred             CCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+.+..+..+...+....+..+++++.+
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            66666678899999999999988999999999999999999999999999999999999998888877777789999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC----CHHHHHHHHHHHHHHHHHHHHhhhc
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL----DPAVLSRLKQFSAMNKLKKMALRVS  395 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  395 (398)
                      ||.+||+.||.+|||+.|+|+||||++.........    ......++++|.+.+++++.++.+-
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i  320 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYM  320 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999998765443221    1345678999999999999887643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.6e-55  Score=416.05  Aligned_cols=257  Identities=36%  Similarity=0.628  Sum_probs=235.7

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++..... +....+.+.+|+.+++.++ ||||+++++++...+.+|+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence            3569999999999999999999999999999999976443 5666788999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....+.
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSC
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCC
Confidence            99999999999999988899999999999999999999999999999999999999   888999999999998877666


Q ss_pred             cccccccCCcccCcccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+..+....+.    .+++++.+|
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  244 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENL  244 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence            6778899999999999975 34 47999999999999999999999999999999999888766553    478999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |.+||+.||.+|||+.|+|+||||....
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998744

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.9e-56  Score=446.49  Aligned_cols=303  Identities=38%  Similarity=0.617  Sum_probs=262.8

Q ss_pred             cccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH----------hhHHHHHHHHHHHHHhcCCCC
Q 015898           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR----------EDVEDVRREIQIMHHLAGHKN  161 (398)
Q Consensus        92 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~~h~n  161 (398)
                      .....+.++|++.++||+|+||+||+|.+..+++.||||++.+......          ...+.+.+|+.+++.+. |||
T Consensus        29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  107 (504)
T 3q5i_A           29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN  107 (504)
T ss_dssp             EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred             ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence            3455677889999999999999999999999999999999976543211          34577899999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc
Q 015898          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       162 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                      |+++++++.+...+|+||||+++++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||+...+....
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999999999998889999999999999999999999999999999999999954333347


Q ss_pred             EEEeecCCceecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                      +||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+.+..+..+...+.
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999998877666677889999999999988899999999999999999999999999999999999999887777


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC---CCHHHHHHHHHHHHHHHHHHHHhhhc
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS---LDPAVLSRLKQFSAMNKLKKMALRVS  395 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (398)
                      ...+..+++++.+||.+||++||.+|||+.|+|+||||++........   .....+.++++|...+++++.++.+-
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i  344 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFI  344 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence            666678999999999999999999999999999999999876543321   12356788999999999998877553

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.7e-56  Score=427.23  Aligned_cols=300  Identities=35%  Similarity=0.614  Sum_probs=247.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC--CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++......  .....+.+.+|+.+++.+. ||||+++++++...
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSD   98 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence            34667899999999999999999999999999999998653221  1123577899999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          173 LCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      +.+|+||||+++++|.+.+...    ..+++..+..++.||+.||.|||++||+||||||+|||+..++..+.+||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998877543    248999999999999999999999999999999999999544445569999999


Q ss_pred             CceecCCCCc-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          249 LSVFFKPGQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       249 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      ++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ....+..+..+...+....+.
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            9987655432 446789999999999975 5899999999999999999999999875 456667777776655544456


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhcc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSA  396 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (398)
                      .+++++.+||.+||+.||++|||+.|+|+||||++..........+....+++.|.+++++++.++.+.+
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  327 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVS  327 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----------
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999998755434444557889999999999999988776543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-56  Score=421.93  Aligned_cols=287  Identities=28%  Similarity=0.526  Sum_probs=252.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|.+...    ......+.+|+.+++.+. ||||+++++++.+.+.++
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   77 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEEE
Confidence            567899999999999999999999999999999998642    344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++.....
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCC
Confidence            9999999999999997653 6999999999999999999999999999999999999932 1268999999999998877


Q ss_pred             CCcccccccCCcccCccccccc-CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      +.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......+....++.++.++.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            7666778899999999999854 899999999999999999999999999999999999988877776666778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhh
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALR  393 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (398)
                      ||.+||+.||.+|||+.|+|+||||++......    +..+.+++.+...+++.+..+.
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  291 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVS----TKVIRTLKHRRYYHTLIKKDLN  291 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSC----CCCCCCHHHHHHHHHHHCCCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccCccccc----HHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999988654332    2345677777777777765543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=417.45  Aligned_cols=295  Identities=39%  Similarity=0.663  Sum_probs=241.6

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++....     ..+.+.+|+.+++++. ||||+++++++.....
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTE  122 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecCCe
Confidence            446678999999999999999999999999999999986432     3456889999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .++||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+...++++.+||+|||++....
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999999999999888889999999999999999999999999999999999999544458899999999998776


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+....+..++.++
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            5555566789999999999885 58999999999999999999999997665544 667777776666666667889999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhhhccc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRVSAS  397 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (398)
                      .+||.+||+.||++|||+.|+|+||||.+......  .......+++.|..++++++....+.+.
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV--HMDTAQKKLQEFNARRKLKAAVKAVVAS  345 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS--CCHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCccchh--hhcchHHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999988765544  3457788999999999999988777654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.6e-55  Score=420.87  Aligned_cols=258  Identities=30%  Similarity=0.531  Sum_probs=229.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||+||+|.++.+++.||||++.+.........+.+.+|+.++..+.+||||+++++++.+.+.+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999997654444556678899999999986799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|.... ...
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCCc
Confidence            9999999999999988899999999999999999999999999999999999999   888999999999998643 233


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+.+..+..+...++.    .+++++.+||
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  255 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGIL  255 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            4456789999999999985 5999999999999999999999999999999999999988776654    4789999999


Q ss_pred             HHhcccCCCCCCCH------HHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLTA------HEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps~------~eiL~hp~~~~~~  363 (398)
                      .+||+.||++||++      .|+++||||++..
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            99999999999999      8999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-54  Score=412.85  Aligned_cols=265  Identities=40%  Similarity=0.688  Sum_probs=236.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---hhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.+++.+. ||||+++++++..
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            3466789999999999999999999999999999999976543221   23578899999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc----cEEEeec
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDF  247 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~----~~kL~DF  247 (398)
                      ...+++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++    .+||+||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll---~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML---LDRNVPKPRIKIIDF  162 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---SCSSSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE---ecCCCCCCCEEEEEC
Confidence            99999999999999999999888889999999999999999999999999999999999999   5544    7999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      |++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+....+.
T Consensus       163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (326)
T 2y0a_A          163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  242 (326)
T ss_dssp             TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence            99988766555667789999999999874 69999999999999999999999999998888888887776665554455


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            7899999999999999999999999999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3e-54  Score=411.79  Aligned_cols=294  Identities=35%  Similarity=0.618  Sum_probs=227.2

Q ss_pred             ccccceec---ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           97 IRDLYTLG---RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        97 ~~~~y~~~---~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +-++|.+.   +.||+|+||.||+|.+..+++.||||++...      ....+.+|+.+++.+.+||||+++++++.+..
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            33456664   7899999999999999999999999998542      34677889999999988999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ..|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+....+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999999999889999999999999999999999999999999999999965444558999999999865


Q ss_pred             CCC-CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-------hHHHHHHHHcCCCcCCCCC
Q 015898          254 KPG-QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-------QQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       254 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~  324 (398)
                      ... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||....       ..+.+..+..+...+....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence            443 33456778999999999975 58999999999999999999999997643       3567777777777666655


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHH---------HHHHH-HHHHHHHHHHHHhhh
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAV---------LSRLK-QFSAMNKLKKMALRV  394 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~---------~~~~~-~~~~~~~~~~~~~~~  394 (398)
                      +..+++++.+||.+||+.||++|||+.|+++||||++....+.....++.         ...++ .|.+.+.++++.|+.
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGFCL  319 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHC---
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCCCCcccccchHHHHHHHHHHHHHHHhhhccceee
Confidence            56789999999999999999999999999999999987655554444332         22233 789999999999886


Q ss_pred             cc
Q 015898          395 SA  396 (398)
Q Consensus       395 ~~  396 (398)
                      ..
T Consensus       320 ~~  321 (325)
T 3kn6_A          320 QN  321 (325)
T ss_dssp             --
T ss_pred             ee
Confidence            53

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.2e-55  Score=418.49  Aligned_cols=276  Identities=28%  Similarity=0.445  Sum_probs=235.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+.+||||+++++++.+...+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999997654323345667889999999885599999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~  257 (398)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCC
Confidence            9999999999999988889999999999999999999999999999999999999   8889999999999976432 23


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+......++.    .+++++.+||
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  249 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL  249 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHHHH
Confidence            4456789999999999985 5999999999999999999999999999999999888887655443    4789999999


Q ss_pred             HHhcccCCCCCCCHH-HHhcCCCccCCCCCCC--CCCCHHHHHHHHHH
Q 015898          337 RKMLCSQPSERLTAH-EVLCHPWICENGVAPD--RSLDPAVLSRLKQF  381 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~-eiL~hp~~~~~~~~~~--~~~~~~~~~~~~~~  381 (398)
                      .+||+.||++||++. |+++||||++..+...  ....|++.|.++..
T Consensus       250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~  297 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSP  297 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC---------
T ss_pred             HHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCc
Confidence            999999999999998 9999999998654322  34556677766543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.3e-54  Score=412.63  Aligned_cols=257  Identities=32%  Similarity=0.533  Sum_probs=232.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++.+...........+.+|+.+++.+. ||||+++++++...+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999997654333445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   888999999999997643 334


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+.......+......++.    .+++++.+||
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            4567789999999999975 5999999999999999999999999999988888888887666553    4789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      .+||+.||++||     ++.|+++||||.+..
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            999999999999     999999999998743

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.2e-54  Score=411.99  Aligned_cols=289  Identities=36%  Similarity=0.617  Sum_probs=243.6

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ...+.++|++.+.||+|+||.||+|.++.+++.||||++.+...       ...+|+.++.++.+||||+++++++.+..
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            34567789999999999999999999999999999999975432       23468888988866999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~DFG~a~~  252 (398)
                      .+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999999999888899999999999999999999999999999999999984332 224699999999987


Q ss_pred             cCCC-CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC---cChHHHHHHHHcCCCcCCCCCCCC
Q 015898          253 FKPG-QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       253 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..   ....+++..+..+...+....+..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 34456789999999999985 489999999999999999999999975   456778888888888877777788


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHH-----HHH-HHHHHHHHHH
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLS-----RLK-QFSAMNKLKK  389 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~  389 (398)
                      +++++.+||.+||+.||++|||+.|+|+||||.++...+...+.++..+     .+. .|.+++..++
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  317 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQS  317 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGSCCSCCCCCCCHHHHHHHHHHHHHHHTTTC-
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccccccccCCCccchhhhhhHHHHHHhhhcccCC
Confidence            9999999999999999999999999999999988766655555433332     222 5555555444

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-53  Score=417.59  Aligned_cols=258  Identities=26%  Similarity=0.476  Sum_probs=226.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||+||+|.++.+++.||||++.+.........+.+.+|..++.++.+||||++++++|.+...+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            45999999999999999999999999999999998766655666677889999999886699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee-cCCCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~-~~~~~  257 (398)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.. .....
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   8889999999999986 33444


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---------ChHHHHHHHHcCCCcCCCCCCCC
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---------TQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||...         ........+......++.    .
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~  284 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S  284 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----T
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----c
Confidence            5567899999999999985 5999999999999999999999999632         233456666666655543    4


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTA------HEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~------~eiL~hp~~~~~~  363 (398)
                      ++.++.+||.+||+.||++||++      .||++||||++..
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            88999999999999999999995      7999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.6e-53  Score=394.82  Aligned_cols=268  Identities=39%  Similarity=0.737  Sum_probs=244.2

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++...+..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence            467789999999999999999999999999999999976543 5666788999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||||+++++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||++..++..+.+||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999999999998888899999999999999999999999999999999999995544455699999999988776


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            666667889999999999885 5899999999999999999999999999999999999888888877777789999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      ||.+||+.||++|||+.|+|+||||++....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            9999999999999999999999999886543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.9e-53  Score=406.68  Aligned_cols=258  Identities=26%  Similarity=0.465  Sum_probs=229.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.+.........+.+.+|+.++.++.+||||+++++++.+...+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999998776666777888999999999985699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCCC
Confidence            9999999999999888889999999999999999999999999999999999999   888999999999998632 334


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC---------cChHHHHHHHHcCCCcCCCCCCCC
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA---------ETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~---------~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||..         .........+......++.    .
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~  241 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S  241 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT----T
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC----C
Confidence            4566789999999999985 589999999999999999999999965         2334455666666555443    4


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTA------HEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~------~eiL~hp~~~~~~  363 (398)
                      ++.++.+||.+||+.||.+||++      .|+++||||++..
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            78999999999999999999996      8999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-53  Score=403.69  Aligned_cols=255  Identities=28%  Similarity=0.546  Sum_probs=231.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence            45999999999999999999999999999999997653323345677889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  .
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--V  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--C
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC--c
Confidence            9999999999999988889999999999999999999999999999999999999   8889999999999987543  2


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+......++.    .+++++.+||.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  235 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS  235 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Confidence            346789999999999875 5899999999999999999999999999988899888887765543    47899999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      +||+.||++||     +++|+++||||++..
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            99999999999     999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-53  Score=411.78  Aligned_cols=272  Identities=32%  Similarity=0.575  Sum_probs=241.2

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.+. ||||+++++++.+..
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY  121 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence            344567899999999999999999999999999999998653   3445567899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .+++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++..
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence            9999999999999999887654 6999999999999999999999999999999999999932 1356899999999998


Q ss_pred             cCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          253 FKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+....+..++++
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            776666666789999999999985 5899999999999999999999999999988888888888777777777789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL  370 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~  370 (398)
                      +.+||.+||+.||++|||+.|+|+||||++.........
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  319 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI  319 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccCCcccccccC
Confidence            999999999999999999999999999998655444333

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-54  Score=425.95  Aligned_cols=276  Identities=30%  Similarity=0.449  Sum_probs=235.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.++||+|+||+||+|.++.+++.||+|++.+.........+.+.+|+.+++.+. ||||++++++|.+...+|+
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence            356999999999999999999999999999999997533222223345788999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.......
T Consensus       147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTS
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccCC
Confidence            9999999999998865 468999999999999999999999999999999999999   889999999999998765543


Q ss_pred             --cccccccCCcccCcccccc-c----CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          258 --IFTDVVGSPYYVAPEVLLK-H----YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~-~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                        .....+||+.|+|||++.+ .    |+.++|||||||++|||++|..||.+.+..+.+..+......+.......+++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence              2346789999999999873 2    78999999999999999999999999999999998887654333334456899


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCC--CCCCCCCCHHHHHHH
Q 015898          331 SAKDLIRKMLCSQPSE--RLTAHEVLCHPWICENG--VAPDRSLDPAVLSRL  378 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~--~~~~~~~~~~~~~~~  378 (398)
                      ++++||.+||+.+|.+  ||+++||++||||++..  +.......|++.|.+
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~  354 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL  354 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCC
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcC
Confidence            9999999999999988  99999999999999843  333444445554443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-53  Score=396.53  Aligned_cols=265  Identities=41%  Similarity=0.776  Sum_probs=241.1

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.+.||+|+||.||+|.+..++..||+|.+.....   ...+.+.+|+.+++.+. ||||+++++++.....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD   80 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence            4567789999999999999999999999999999999975432   33567899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+..++.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999888889999999999999999999999999999999999999766677899999999998877


Q ss_pred             CCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+...++...+..+++++.+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            66666778899999999999888999999999999999999999999999998888888888777666555568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ||.+||+.||++|||+.++|+||||++..
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999998744

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-53  Score=410.50  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=232.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|..++..+.+||+|+++++++...+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            45999999999999999999999999999999997654333445677889999999886699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCCc
Confidence            9999999999999988889999999999999999999999999999999999999   888999999999998643 233


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+......++.    .+++++.+||
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  252 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC  252 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence            4556789999999999975 5999999999999999999999999999999999999887766553    4889999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      .+||+.||++||+     +.|+++||||++..
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            9999999999995     69999999998744

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-53  Score=394.77  Aligned_cols=264  Identities=35%  Similarity=0.619  Sum_probs=225.5

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.+.||+|+||.||+|.+..++..||+|++....  .....+.+.+|+.+++.+. ||||+++++++.....
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCe
Confidence            346678999999999999999999999999999999997654  3344678899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          175 VHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      .++||||+++++|.+.+..    ...+++..+..++.||+.||.|||+.||+||||||+|||+...+.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999998854    367999999999999999999999999999999999999965556688999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .............||+.|+|||++.+.++.++|||||||++|+|++|..||.+................+.... ..+++
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  253 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTP  253 (285)
T ss_dssp             CC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCH
T ss_pred             eecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCH
Confidence            87766665667789999999999988899999999999999999999999999888877777666554443332 24789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      ++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.2e-54  Score=425.24  Aligned_cols=274  Identities=27%  Similarity=0.486  Sum_probs=234.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.++||+|+||+||+|.+..+++.||||++.+...........+.+|+.++..+. ||||++++++|.+.+.+|+
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEE
Confidence            467999999999999999999999999999999997543222223345888999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||++||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence            9999999999999987 5679999999999999999999999999999999999999   88899999999999776544


Q ss_pred             Cc--ccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC--CcCCCCCCC
Q 015898          257 QI--FTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH--IDFESDPWP  326 (398)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~  326 (398)
                      ..  ....+||+.|+|||++.      +.|+.++|||||||++|||++|..||.+.+..+.+..+....  ..++. ...
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~  307 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-QVT  307 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-ccc
Confidence            32  23468999999999986      258999999999999999999999999999988888887643  22222 234


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCCCCCCCCCCCHHHHH
Q 015898          327 LISDSAKDLIRKMLCSQPSE--RLTAHEVLCHPWICENGVAPDRSLDPAVLS  376 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~--Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~  376 (398)
                      .+++++++||.+||+.+|++  |++++|+++||||++..+.......|++.|
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P  359 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIP  359 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCC
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCC
Confidence            58999999999999998888  999999999999998766554444444444

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.3e-53  Score=407.19  Aligned_cols=256  Identities=30%  Similarity=0.560  Sum_probs=232.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEE
Confidence            356999999999999999999999999999999997654333345678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC-
Confidence            99999999999999988889999999999999999999999999999999999999   88899999999999876543 


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                       ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+..+...++.    .+++++.+||
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  269 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLL  269 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence             345789999999999875 5899999999999999999999999999999999999888766553    4789999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          337 RKMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       337 ~~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      .+||+.||.+||+     +.||++||||.+..
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            9999999999998     99999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-53  Score=419.80  Aligned_cols=277  Identities=27%  Similarity=0.467  Sum_probs=236.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.++||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.++..+. ||||++++++|.+.+.+|+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEE
Confidence            466999999999999999999999999999999997543333334456889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+   +.++++||+|||++......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccCC
Confidence            999999999999998754 79999999999999999999999999999999999999   88899999999999876544


Q ss_pred             Cc--ccccccCCcccCccccc--------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC-CC
Q 015898          257 QI--FTDVVGSPYYVAPEVLL--------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD-PW  325 (398)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  325 (398)
                      ..  ....+||+.|+|||++.        ..|+.++|||||||++|||++|..||.+.+..+.+..+.......... ..
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            32  23468999999999986        248999999999999999999999999999888888887643221111 12


Q ss_pred             CCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCCCCCCCCCCCHHHHHHHH
Q 015898          326 PLISDSAKDLIRKMLCSQPSER---LTAHEVLCHPWICENGVAPDRSLDPAVLSRLK  379 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~R---ps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~  379 (398)
                      ..+++++++||.+||+ +|.+|   ++++|+++||||++..+...+...|++.|.++
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~  351 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE  351 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC--
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCC
Confidence            3589999999999999 99998   59999999999999877776666777766654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=409.05  Aligned_cols=258  Identities=26%  Similarity=0.473  Sum_probs=229.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+. ||||++++++|.+...+|+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEE
Confidence            456999999999999999999999999999999997654444455678999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCCC
Confidence            99999999999999988889999999999999999999999999999999999999   888999999999999877666


Q ss_pred             cccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCc---ChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          258 IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      .....+||+.|+|||++..    .|+.++|||||||++|+|++|..||...   ........+......++.    .++.
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~~s~  245 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQ  245 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----cCCH
Confidence            6778899999999999862    4899999999999999999999999743   344555555555544443    4789


Q ss_pred             HHHHHHHHhcccCCCCCCC-HHHHhcCCCccCCC
Q 015898          331 SAKDLIRKMLCSQPSERLT-AHEVLCHPWICENG  363 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps-~~eiL~hp~~~~~~  363 (398)
                      ++.+||.+||+.||++||+ +.++++||||.+..
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            9999999999999999998 89999999998754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-53  Score=400.62  Aligned_cols=247  Identities=22%  Similarity=0.258  Sum_probs=190.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~----  173 (398)
                      .++|.+.++||+|+||+||+|.+  +|+.||||++....    ........|+..+.+++ |||||++++++.+.+    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            45689999999999999999985  68999999986432    11122334566666787 999999999997653    


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEeecCCCccEEEe
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--------GVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~--------~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      .+|||||||++|+|.+++... .+++..+..++.|++.||.|||++        +||||||||+|||+   +.++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence            689999999999999999764 589999999999999999999987        99999999999999   889999999


Q ss_pred             ecCCceecCCCCc-----ccccccCCcccCcccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCc---------
Q 015898          246 DFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAE---------  304 (398)
Q Consensus       246 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlG~il~elltg~~pf~~~---------  304 (398)
                      |||+|+.......     ....+||+.|||||++.+       .|+.++|||||||+||||+||..||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654322     234689999999999864       3677999999999999999997765321         


Q ss_pred             ------ChHHHHHHHHcCCCcCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          305 ------TQQGIFDAVLKGHIDFESDP-W--PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       305 ------~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                            ........+........... +  ..+++.+.+|+.+||+.||++|||+.||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                  12233333333332211110 0  112357889999999999999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.8e-54  Score=410.56  Aligned_cols=257  Identities=36%  Similarity=0.621  Sum_probs=224.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++......+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence            3456999999999999999999999999999999996543322333467889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+ +|+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   ++++.+||+|||++.....+
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence            999999 78999999888899999999999999999999999999999999999999   88899999999999887776


Q ss_pred             CcccccccCCcccCccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+......+    ...+++++.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~  237 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM----PDFLSPGAQS  237 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC----CTTSCHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----cccCCHHHHH
Confidence            666778999999999999853 3 789999999999999999999998765544433333322222    2347899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      ||.+||+.||.+|||+.|+++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.1e-53  Score=401.69  Aligned_cols=277  Identities=27%  Similarity=0.499  Sum_probs=239.1

Q ss_pred             cccccccccceec-ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           92 HKTDNIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        92 ~~~~~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ...+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+.+||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            3456678889997 899999999999999999999999999975432 34446788999999999987899999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      ....+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+.....++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999999988543  569999999999999999999999999999999999999433337899999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......+....+..
T Consensus       180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            9988766555566789999999999874 589999999999999999999999999999888888888887777777778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~  369 (398)
                      +++.+.+||.+||+.||++|||+.|+|+||||++..+.....
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC--
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccC
Confidence            999999999999999999999999999999999887665543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-52  Score=392.72  Aligned_cols=259  Identities=30%  Similarity=0.459  Sum_probs=224.9

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.+++.+. ||||+++++++...+.+
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence            345679999999999999999999999999999999875532   23467889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence            9999999999999988764 58999999999999999999999999999999999999   8888999999999987654


Q ss_pred             CC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+....... ......++..+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHHH
Confidence            32 3455789999999999875 59999999999999999999999998887776665554433221 112235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +||.+||+.||++|||+.|+|+||||+...
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            999999999999999999999999998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-52  Score=396.84  Aligned_cols=267  Identities=34%  Similarity=0.582  Sum_probs=220.1

Q ss_pred             ccccccceec-ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           95 DNIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        95 ~~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..+.++|++. +.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++.++.+||||+++++++.+.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3466779985 78999999999999999999999999996542   3345678999999999766999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+..++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998888999999999999999999999999999999999999943333345999999998765


Q ss_pred             CCCC--------cccccccCCcccCcccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcC--------------
Q 015898          254 KPGQ--------IFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAET--------------  305 (398)
Q Consensus       254 ~~~~--------~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~--------------  305 (398)
                      ....        .....+||+.|+|||++.+      .++.++|||||||++|+|++|..||.+..              
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3221        1234569999999999863      48999999999999999999999997654              


Q ss_pred             -hHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          306 -QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       306 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                       .......+..+...++...+..+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence             23456666666665554444568899999999999999999999999999999987643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-52  Score=405.74  Aligned_cols=260  Identities=37%  Similarity=0.654  Sum_probs=227.2

Q ss_pred             ccccee--cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           98 RDLYTL--GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        98 ~~~y~~--~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.|.+  .+.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.++++|. ||||+++++++...+.+
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  161 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDI  161 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            344555  67899999999999999999999999999754   3355678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+.. ++++.+||+|||++....
T Consensus       162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecC
Confidence            9999999999999988654 46999999999999999999999999999999999999954 345789999999999877


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .........||+.|+|||++.. .++.++|||||||++|||++|..||.+....+.+..+......+....+..+++++.
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  320 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK  320 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred             CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence            6666667789999999999874 589999999999999999999999999999888888888777766666677899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +||.+||+.||.+|||+.|+|+||||.+.
T Consensus       321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          321 EFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.2e-52  Score=396.70  Aligned_cols=265  Identities=39%  Similarity=0.681  Sum_probs=236.0

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---hhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++.+. ||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            3466789999999999999999999999999999999976543221   23577899999999998 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc----cEEEeec
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDF  247 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~----~~kL~DF  247 (398)
                      ...+++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+   +.++    .+||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~---~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKLIDF  163 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE---ecCCCCcCCEEEccC
Confidence            99999999999999999999888889999999999999999999999999999999999999   5555    7999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      |++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++...+.
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            99988776655667789999999999874 58999999999999999999999999998888888888776655544445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .++.++.+||.+||+.||++|||+.|+|+||||....
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            6889999999999999999999999999999997654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.5e-52  Score=407.83  Aligned_cols=264  Identities=37%  Similarity=0.640  Sum_probs=218.5

Q ss_pred             cccccceec-ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec---
Q 015898           96 NIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (398)
Q Consensus        96 ~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~---  171 (398)
                      .+.+.|.+. ++||+|+||+||+|.+..+++.||||++...        ..+.+|+.++.++.+||||++++++|..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            344557776 7899999999999999999999999998532        3567899988777679999999999875   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 -SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                       ...+|+||||++||+|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             667999999999999999997653  59999999999999999999999999999999999999443337899999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHHcCCCcCCCC
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAVLKGHIDFESD  323 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~  323 (398)
                      ++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....    .....+..+...++..
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            9988766555667889999999999974 6999999999999999999999999765432    3556666777777766


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      .+..++.++.+||.+||+.||++|||+.|+|+||||.+....+.
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  333 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  333 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCC
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCC
Confidence            67789999999999999999999999999999999987654443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.4e-52  Score=389.67  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=217.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            469999999999999999999999999999999975543 4445678889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+++ ++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999975 56565544 5779999999999999999999999999999999999999   88899999999999876533 


Q ss_pred             CcccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCC-CCCcChHHHHHHHHcCCCcCCC-----------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFES-----------  322 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~-----------  322 (398)
                      .......||+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+....+.+..+.........           
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            33456688999999999874 3 89999999999999999998877 4555666666655432111111           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          323 --------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       323 --------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                    ...+.++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                          11234789999999999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-52  Score=405.86  Aligned_cols=257  Identities=27%  Similarity=0.502  Sum_probs=221.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHH-HHhcCCCCeeEEeEEEecCCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM-HHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l-~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.+...........+.+|..++ +.+. ||||+++++++.+.+.+|+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEEEE
Confidence            4599999999999999999999999999999999877665555666778888874 5565 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec-CCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~-~~~  256 (398)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++... ...
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccCC
Confidence            99999999999999988889999999999999999999999999999999999999   88899999999999763 333


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+.+..+......++.    .++.++.+|
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~l  269 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHL  269 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHHH
Confidence            44567889999999999985 5999999999999999999999999999999999998887665543    588999999


Q ss_pred             HHHhcccCCCCCCCH----HHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTA----HEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~----~eiL~hp~~~~~~  363 (398)
                      |.+||+.||.+||++    .++++||||++..
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            999999999999987    6999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-52  Score=392.01  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=217.1

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC--CHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEec
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLA--GHKNIVTIKGAYED  171 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~~  171 (398)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++......  .......+.+|+.+++.+.  +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567899999999999999999999999999999998654321  1112245667777777664  39999999999976


Q ss_pred             CC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEE
Q 015898          172 SL-----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       172 ~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                      ..     .+++||||+. ++|.+++.....  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence            55     5899999996 599999887654  9999999999999999999999999999999999999   88889999


Q ss_pred             eecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC
Q 015898          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (398)
                      +|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.......+..
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999987766666677889999999999874 69999999999999999999999999988888777765532211111


Q ss_pred             C-----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          324 P-----------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       324 ~-----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      .                       .+.+++++.+||.+||++||++|||+.|+|+||||++....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~~  307 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP  307 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-------
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCCC
Confidence            1                       135788999999999999999999999999999998865443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-51  Score=387.38  Aligned_cols=269  Identities=37%  Similarity=0.666  Sum_probs=238.0

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC--C----HhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--S----REDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~----~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++......  .    ....+.+.+|+.+++++.+||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            4566799999999999999999999999999999999654311  1    233567889999999997799999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      ......++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~  170 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF  170 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence            9999999999999999999999888889999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCCcccccccCCcccCccccc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      +.............|++.|+|||++.       ..++.++||||||+++|+|++|..||...........+..+...+..
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            98877666666778999999999884       24788999999999999999999999998888888888888777766


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ..+..++.++.+||.+||+.||++|||+.|+|+||||++......
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence            666678999999999999999999999999999999998765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-52  Score=417.38  Aligned_cols=259  Identities=36%  Similarity=0.598  Sum_probs=233.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.+. ||||+++++++...+.+|
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            3456999999999999999999999999999999997654323344678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....+
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccc
Confidence            999999999999999888889999999999999999999999999999999999999   88899999999999987766


Q ss_pred             CcccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ......+||+.|+|||++.+.  ++.++|||||||++|+|++|..||.+......+..+..+....+    ..+++++.+
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  245 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVIS  245 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHH
Confidence            666778999999999999853  46899999999999999999999999888888888888765443    247899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ||.+||+.||++|||+.|+++||||++..
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            99999999999999999999999998753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-52  Score=416.60  Aligned_cols=258  Identities=31%  Similarity=0.521  Sum_probs=221.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.+. ||||+++++++...+.+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEE
Confidence            456999999999999999999999999999999997655445556677889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecC-C
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-P  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~  255 (398)
                      ||||+++++|.+++...+.+++..+..++.||+.||+|||+ .||+||||||+|||+   +.++.+||+|||+|.... .
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccCC
Confidence            99999999999999988899999999999999999999998 999999999999999   888899999999997633 2


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.........+......++.    .+++++.+
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~  378 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKS  378 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHH
Confidence            334566889999999999874 6999999999999999999999999999998898888887766553    47899999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ||.+||+.||++||     |+.|+|+||||.+..
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            99999999999999     999999999999854

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-52  Score=407.87  Aligned_cols=263  Identities=30%  Similarity=0.459  Sum_probs=213.1

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-  173 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+.+|+.+++.+.+||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            34567899999999999999999999999999999998643 3356677889999999999988999999999997544 


Q ss_pred             -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 -CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                       .+|+||||++ ++|..++.. +.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence             7999999996 589887765 579999999999999999999999999999999999999   8889999999999986


Q ss_pred             cCC----------------------CCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH
Q 015898          253 FKP----------------------GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (398)
Q Consensus       253 ~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  308 (398)
                      ...                      .......+||+.|+|||++.+  .|+.++|||||||++|||++|.+||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            532                      122345689999999999874  58999999999999999999999999988877


Q ss_pred             HHHHHHcCCCcCC-------------------------------------------CCCCCCCCHHHHHHHHHhcccCCC
Q 015898          309 IFDAVLKGHIDFE-------------------------------------------SDPWPLISDSAKDLIRKMLCSQPS  345 (398)
Q Consensus       309 ~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~L~~dP~  345 (398)
                      .+..+........                                           ......+++++.+||.+||++||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            7766653110000                                           001125789999999999999999


Q ss_pred             CCCCHHHHhcCCCccCCC
Q 015898          346 ERLTAHEVLCHPWICENG  363 (398)
Q Consensus       346 ~Rps~~eiL~hp~~~~~~  363 (398)
                      +|||+.|+|+||||....
T Consensus       319 ~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTC
T ss_pred             cCCCHHHHhCCHHHHHhc
Confidence            999999999999997654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9e-52  Score=392.15  Aligned_cols=263  Identities=26%  Similarity=0.450  Sum_probs=217.3

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .+.+.++|++.+.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.+++.+. ||||+++++++....
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCC
Confidence            3456678999999999999999999984 589999999965432 3344577889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .+++||||+++ +|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARA  168 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCcee
Confidence            99999999975 788877664 459999999999999999999999999999999999999   8888999999999987


Q ss_pred             cCCC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC------
Q 015898          253 FKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD------  323 (398)
Q Consensus       253 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------  323 (398)
                      .... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+..........      
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            6533 33455688999999999874  48999999999999999999999998877766665554311111100      


Q ss_pred             --------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          324 --------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       324 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                          ..+.+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                0124678999999999999999999999999999998754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-52  Score=436.98  Aligned_cols=274  Identities=25%  Similarity=0.419  Sum_probs=241.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||.||+|.+..+++.||||++.+.........+.+..|..++..+.+||+|+.+++++++.+.+|||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            56999999999999999999999999999999997654334445677889999999887799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC-CCC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~-~~~  257 (398)
                      |||+++|+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|.... ...
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTC
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCCc
Confidence            9999999999999988899999999999999999999999999999999999999   888999999999998643 334


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....+||+.|+|||++.+ .|+.++|||||||+||||++|..||.+.+..+++..+......++.    .+++++.+||
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  573 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC  573 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHH
Confidence            4567899999999999984 6999999999999999999999999999999999999998777664    4899999999


Q ss_pred             HHhcccCCCCCCCH-----HHHhcCCCccCCCCC--CCCCCCHHHHHHHH
Q 015898          337 RKMLCSQPSERLTA-----HEVLCHPWICENGVA--PDRSLDPAVLSRLK  379 (398)
Q Consensus       337 ~~~L~~dP~~Rps~-----~eiL~hp~~~~~~~~--~~~~~~~~~~~~~~  379 (398)
                      .+||+.||++||++     +||++||||++..+.  ....+.|++.|+++
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~  623 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS  623 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence            99999999999998     999999999975432  22234445555443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-52  Score=386.92  Aligned_cols=264  Identities=33%  Similarity=0.592  Sum_probs=229.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEE
Confidence            56999999999999999999999999999999986543323334567899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... .
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc-c
Confidence            9999999999999888889999999999999999999999999999999999999   88899999999998654433 3


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+......++.    .+++++.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~  239 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS  239 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence            355689999999999875 5889999999999999999999999999888888888776655443    47899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD  371 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~  371 (398)
                      +||+.||++|||+.|+|+||||.+....+..+..
T Consensus       240 ~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~  273 (279)
T 3fdn_A          240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN  273 (279)
T ss_dssp             HHCCSSGGGSCCHHHHHHCHHHHHHCSSCCCC--
T ss_pred             HHhccChhhCCCHHHHhhCccccCCccCcccccc
Confidence            9999999999999999999999998777665543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8e-52  Score=401.25  Aligned_cols=263  Identities=37%  Similarity=0.670  Sum_probs=234.6

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC-C----HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-S----REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .    ....+.+.+|+.+++++.+||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4557799999999999999999999989999999998654311 1    1224578899999999956999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      .....++||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS  247 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence            999999999999999999999888889999999999999999999999999999999999999   88899999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (398)
                      .............||+.|+|||++.+       .++.++|||||||++|+|++|..||...........+..+...+...
T Consensus       248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  327 (365)
T 2y7j_A          248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP  327 (365)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            88776666677889999999998852       47889999999999999999999999988888888888877666554


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .+..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            45568899999999999999999999999999999963

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-51  Score=393.44  Aligned_cols=258  Identities=29%  Similarity=0.526  Sum_probs=218.2

Q ss_pred             cccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .++|++.+.||+|+||.||+|.+.   .+++.||+|++.+.... .......+.+|+.+++.+. ||||+++++++...+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            356999999999999999999975   68999999999765332 2234566889999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC---
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccccc
Confidence            999999999999999999988889999999999999999999999999999999999999   88899999999999754


Q ss_pred             CC-CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          254 KP-GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       254 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      .. .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++.    .++.+
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~  247 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQE  247 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence            32 233456789999999999875 5899999999999999999999999999988888888887665443    47899


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||+.||++||     ++.|+++||||++..
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            99999999999999999     889999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.1e-52  Score=413.42  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=202.9

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-----
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-----  170 (398)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++... .......+++.+|+.+|+.+. ||||+++++++.     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence            3457799999999999999999999999999999998643 335666788999999999997 999999999984     


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      ....+|+||||+ +++|.+++.....+++..++.++.||+.||.|||+.|||||||||+|||+   +.++.+||+|||+|
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla  203 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA  203 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence            336799999998 57999999888889999999999999999999999999999999999999   88899999999999


Q ss_pred             eecCCC----------------------------CcccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHh----
Q 015898          251 VFFKPG----------------------------QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLS----  296 (398)
Q Consensus       251 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ellt----  296 (398)
                      +.....                            ......+||+.|+|||++.  ..|+.++|||||||+||||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            875422                            1234568899999999864  359999999999999999999    


Q ss_pred             -------CCCCCCCcCh--------------------HHHHHHHHcC---------------------------CCcCCC
Q 015898          297 -------GVPPFWAETQ--------------------QGIFDAVLKG---------------------------HIDFES  322 (398)
Q Consensus       297 -------g~~pf~~~~~--------------------~~~~~~~~~~---------------------------~~~~~~  322 (398)
                             |.++|.+...                    .+.+..+.+.                           ......
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   6667755431                    1122211110                           000011


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ..++.+++++.+||.+||++||++|||+.|+|+||||++...
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            123457899999999999999999999999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.6e-52  Score=401.78  Aligned_cols=257  Identities=35%  Similarity=0.521  Sum_probs=208.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....    ..+.+.+|+.+++.++ ||||+++++++.....++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEE
Confidence            34679999999999999999999999999999999975432    2356789999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc--cEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF--SLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~--~~kL~DFG~a~~~~  254 (398)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++  .+||+|||++....
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill---~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE---CSSSSCCEEECCCCCC----
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCceEEEeecCcccccc
Confidence            999999999999999888889999999999999999999999999999999999999   5444  49999999998655


Q ss_pred             CCCcccccccCCcccCcccccc-cCCC-cccHHHHHHHHHHHHhCCCCCCCcCh----HHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGP-EADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwSlG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .........||+.|+|||++.+ .++. ++|||||||++|+|++|..||.+...    ......+......++.  ...+
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  247 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRI  247 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCC
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCC
Confidence            4445566789999999999875 4544 48999999999999999999976443    3445555554444332  2357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++++.+||.+||+.||++|||+.|+++||||....
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            89999999999999999999999999999997654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-51  Score=391.66  Aligned_cols=263  Identities=25%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.+. ||||+++++++...+.+++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence            46999999999999999999999999999999996543  2333467889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          179 MELCAGGELFDRIIQR------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      |||++ ++|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCcccee
Confidence            99997 5999888654      358999999999999999999999999999999999999   8889999999999987


Q ss_pred             cCCC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-------
Q 015898          253 FKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-------  322 (398)
Q Consensus       253 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------  322 (398)
                      .... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.+.......       
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6533 33456688999999999874  4899999999999999999999999988887777666442111000       


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 015898          323 -----------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR  368 (398)
Q Consensus       323 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~  368 (398)
                                             .....++.++.+||.+||+.||++|||+.|+|+||||++.......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence                                   0112468899999999999999999999999999999987765443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.3e-52  Score=394.55  Aligned_cols=259  Identities=29%  Similarity=0.520  Sum_probs=218.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc--ccchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            4567999999999999999999999999999999986543  2233467889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence            999999999999999887789999999999999999999999999999999999999   88889999999999765422


Q ss_pred             ---CcccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCCCcCCCCCCCCCCH
Q 015898          257 ---QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                         .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||...... ...........  ....+..+++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  236 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCH
Confidence               22346789999999999875 3 477899999999999999999999765543 22333332222  2223456889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++.+||.+||+.||++|||+.|+++||||.+..
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            999999999999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-51  Score=402.63  Aligned_cols=265  Identities=20%  Similarity=0.257  Sum_probs=219.7

Q ss_pred             cccceecceeccc--CceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           98 RDLYTLGRKLGQG--QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        98 ~~~y~~~~~iG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .++|++.++||+|  +||.||+|.+..+++.||||++..... .....+.+.+|+.+++.+. ||||+++++++...+.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEE
Confidence            3569999999999  999999999999999999999976543 5566788999999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          176 HIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence            9999999999999999775  679999999999999999999999999999999999999   88889999999988654


Q ss_pred             CCC--------CcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC--
Q 015898          254 KPG--------QIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF--  320 (398)
Q Consensus       254 ~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--  320 (398)
                      ...        ......+||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.........+..+....  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            221        11233578999999999875   48999999999999999999999998766555544433322110  


Q ss_pred             ----------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          321 ----------------------------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       321 ----------------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                                                              .......+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                    0012234788999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 015898          361 ENGVAPD  367 (398)
Q Consensus       361 ~~~~~~~  367 (398)
                      +......
T Consensus       339 ~~~~~~~  345 (389)
T 3gni_B          339 QIKRRAS  345 (389)
T ss_dssp             GC---CC
T ss_pred             HHhhcch
Confidence            8765443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.9e-52  Score=415.61  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=214.7

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-  172 (398)
                      ...+.++|++.+.||+|+||+||+|.+..+++.||||++... .......+++.+|+.+++.+. ||||+++++++... 
T Consensus        57 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           57 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK  134 (464)
T ss_dssp             EEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred             ceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCC
Confidence            334567899999999999999999999999999999999754 335566788999999999997 99999999999654 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          173 -----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       173 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                           ..+|+||||+++ +|.+.+.  ..+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+||
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DF  208 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDF  208 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEE
Confidence                 468999999965 5766664  348999999999999999999999999999999999999   88899999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC------
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF------  320 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------  320 (398)
                      |+|............+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.+.....      
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             EeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99988776666677899999999999985 69999999999999999999999999988777766665421110      


Q ss_pred             ----------------CCCCC----CC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          321 ----------------ESDPW----PL------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       321 ----------------~~~~~----~~------------~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                      ....+    +.            .++++++||.+||++||++|||+.|+|+||||..+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                            00000    00            146799999999999999999999999999998754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-51  Score=386.42  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=213.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            4699999999999999999998 6789999999865432 2333467889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+++ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999965 898888764 669999999999999999999999999999999999999   88899999999999765432 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------------  322 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------  322 (398)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.........            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            23345678999999999874  4899999999999999999999999988877766665431110000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          323 -------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       323 -------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                                   .....+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                         0123478999999999999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.3e-52  Score=387.78  Aligned_cols=267  Identities=43%  Similarity=0.736  Sum_probs=239.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++++. ||||+++++++...+.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence            4466789999999999999999999999999999999965433 3345678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .++||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||++...+.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999554445689999999998766


Q ss_pred             CCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .........+|+.|+|||.+.+.++.++||||||+++|+|++|..||.+....+....+..+...+....+..+++++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55555566789999999999888999999999999999999999999999988888888888776665555678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ||.+||+.||++|||+.|+|+||||++..
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            99999999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=400.68  Aligned_cols=283  Identities=24%  Similarity=0.376  Sum_probs=228.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            46999999999999999999999999999999986432  1112224557999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||++ ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            99996 58988887654 59999999999999999999999999999999999999   88889999999999765432 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC----------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP----------  324 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  324 (398)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.+.........          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            23345678999999999874  489999999999999999999999999888877776655222111111          


Q ss_pred             ----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 015898          325 ----------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLK  388 (398)
Q Consensus       325 ----------------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (398)
                                      .+.+++++.+||.+||++||++|||+.|+|+||||.+..........+....++++.+.+++-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~q~~~~  314 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEAS  314 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCCCC---
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHhhhhhh
Confidence                            1246889999999999999999999999999999999988877777777677777666555443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-51  Score=394.46  Aligned_cols=267  Identities=28%  Similarity=0.449  Sum_probs=215.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+.+|+.+++.+. ||||+++++++.....++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence            34569999999999999999999999999999999965432 3344567789999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec--CCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~--~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+..+  ++.+.+||+|||++....
T Consensus       110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9999997 5999999988889999999999999999999999999999999999999532  235569999999997654


Q ss_pred             CC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC------
Q 015898          255 PG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW------  325 (398)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  325 (398)
                      .. .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+...........+      
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            32 33455678999999999875  4899999999999999999999999988887777666543211111111      


Q ss_pred             --------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          326 --------------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       326 --------------------~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                                          ..+++++.+||.+||+.||++|||+.|+|+||||++..+.|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P  329 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP  329 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence                                01678999999999999999999999999999999887654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-51  Score=386.27  Aligned_cols=255  Identities=33%  Similarity=0.558  Sum_probs=216.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC-----------------------HhhHHHHHHHHHHHHH
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----------------------REDVEDVRREIQIMHH  155 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~Ei~~l~~  155 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.......                       ....+.+.+|+.+++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            56999999999999999999999999999999997653221                       1224578899999999


Q ss_pred             hcCCCCeeEEeEEEec--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          156 LAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       156 l~~h~niv~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      +. ||||+++++++.+  ...+++||||+++++|.+++ ....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        93 l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           93 LD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             CC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            97 9999999999986  67899999999999997754 34579999999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCC-cccccccCCcccCccccccc----CCCcccHHHHHHHHHHHHhCCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQ-IFTDVVGSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~  308 (398)
                         +.++.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|..||.......
T Consensus       171 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          171 ---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             ---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence               888899999999998765432 34567899999999999743    3778999999999999999999999888877


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      ....+......++.  .+.+++++.+||.+||+.||++|||+.|+|+||||.
T Consensus       248 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          248 LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            77777766554433  346889999999999999999999999999999995

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-51  Score=387.54  Aligned_cols=257  Identities=23%  Similarity=0.310  Sum_probs=214.0

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.++||+|+||+||+|.+..+++.||||++..... ..........|+..+..+.+||||+++++++.+.+.
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            3456779999999999999999999999999999999864332 444555667777777777569999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      +++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeec
Confidence            99999999 678988886644 59999999999999999999999999999999999999   88889999999999887


Q ss_pred             CCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      ..........||+.|+|||++.+.++.++|||||||++|||++|..|+.....   ...+..+...  ......+++++.
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~l~  282 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLP--PEFTAGLSSELR  282 (311)
T ss_dssp             C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCC--HHHHTTSCHHHH
T ss_pred             ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCC--cccccCCCHHHH
Confidence            66555566789999999999988899999999999999999999777655432   3333332221  112235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      +||.+||++||++|||+.|+|+||||++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999976

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-52  Score=411.25  Aligned_cols=266  Identities=36%  Similarity=0.632  Sum_probs=218.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC-----CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.+....     .......+.+|+.+|+++. ||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            34567899999999999999999999999999999999765432     1222335889999999997 99999999998


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      .. ...|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            65 45799999999999999998888899999999999999999999999999999999999996555566799999999


Q ss_pred             ceecCCCCcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHcCCCcCCCCC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~  324 (398)
                      +............+||+.|+|||++.    ..|+.++|||||||++|+|++|..||..... ......+..+...+....
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            98876666666788999999999985    3478899999999999999999999976433 345556666665555444


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            55689999999999999999999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-51  Score=386.89  Aligned_cols=264  Identities=28%  Similarity=0.475  Sum_probs=218.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++++. ||||+++++++...+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEE
Confidence            56999999999999999999999999999999986543 24455677889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++...... .
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCccc
Confidence            9999999998888878889999999999999999999999999999999999999   88889999999999876533 3


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc----------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------------  319 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------------  319 (398)
                      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.+....                
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            3456688999999999874  5899999999999999999999999888777665554331100                


Q ss_pred             ---CCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          320 ---FESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       320 ---~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                         .+..        ..+.++.++.+||.+||+.||++|||+.|+|+||||++......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence               0000        12457889999999999999999999999999999998765443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-50  Score=380.45  Aligned_cols=264  Identities=33%  Similarity=0.485  Sum_probs=236.0

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence            4567999999999999999999999999999999998766556677788999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecccC
Confidence            999999999999999888889999999999999999999999999999999999999   88889999999999876532


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.......+.    .+++++.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  244 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS  244 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHHH
Confidence             33445679999999999875 5899999999999999999999999998888887777776554433    47899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDR  368 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~  368 (398)
                      ||.+||+.||++|||+.|+++||||.....+...
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~  278 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  278 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             HHHHHcccChhhCcCHHHHhhChheecCCcCCCC
Confidence            9999999999999999999999999887655443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.9e-52  Score=420.10  Aligned_cols=258  Identities=32%  Similarity=0.522  Sum_probs=227.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.++||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence            3466999999999999999999999999999999997654333344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||++||+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence            99999999999999876543  9999999999999999999999999999999999999   888999999999999877


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .+......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+..    ...+...+......++    ..++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s  413 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS  413 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence            6666667899999999999985 59999999999999999999999998753    3445555555444333    3589


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 015898          330 DSAKDLIRKMLCSQPSERL-----TAHEVLCHPWICEN  362 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~  362 (398)
                      +++.+||.+||+.||.+||     ++.||++||||++.
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9999999999999999999     88999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-51  Score=383.16  Aligned_cols=263  Identities=38%  Similarity=0.666  Sum_probs=228.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---hhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.+++++. ||||+++++++....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence            45679999999999999999999999999999999976543221   23678899999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc----cEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDFGL  249 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~----~~kL~DFG~  249 (398)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||++   +.++    .+||+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIML---LDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---SCSSSSSCCEEECCCTT
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEE---ecCCCCCCceEEEeccc
Confidence            999999999999999999888889999999999999999999999999999999999999   4444    799999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      +.............|++.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......+....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence            988766555566789999999999874 5899999999999999999999999998888888888776655544444568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +..+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            89999999999999999999999999999998744

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.8e-51  Score=380.49  Aligned_cols=261  Identities=32%  Similarity=0.581  Sum_probs=230.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++...+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999986543222233567899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... .
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS-C
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc-c
Confidence            9999999999999988889999999999999999999999999999999999999   78889999999999765433 2


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++    +.++.++.+||.
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  244 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLIS  244 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHH
Confidence            345679999999999885 589999999999999999999999998888888888777655444    347899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENGVAPDR  368 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~  368 (398)
                      +||+.||.+|||+.|+++||||+........
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p  275 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLP  275 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence            9999999999999999999999886544433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.9e-50  Score=386.90  Aligned_cols=261  Identities=33%  Similarity=0.493  Sum_probs=234.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            3457999999999999999999999999999999998766656677788999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecccC
Confidence            999999999999999888889999999999999999999999999999999999999   88889999999999876532


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......++.    .++.++.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  270 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS  270 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHH
Confidence             33455679999999999875 5899999999999999999999999988888887777776554433    47899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      ||.+||+.||++|||+.|+|+||||......
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence            9999999999999999999999999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.9e-51  Score=403.87  Aligned_cols=267  Identities=26%  Similarity=0.411  Sum_probs=214.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++... .......+++.+|+.+|+.+. ||||+++++++...  
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence            34667899999999999999999999999999999999643 335566788999999999998 99999999999766  


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGl  175 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGL  175 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCC
Confidence               57999999995 6999999888889999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCC-----------------------cccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCC------
Q 015898          250 SVFFKPGQ-----------------------IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGV------  298 (398)
Q Consensus       250 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~------  298 (398)
                      |.......                       .....+||+.|+|||++.  ..|+.++|||||||++|||++|.      
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            98764332                       236678999999999864  35999999999999999999853      


Q ss_pred             -----CCCCCcC-----------------hHHHHHHHHc------------------------CCCcCCC---CCCCCCC
Q 015898          299 -----PPFWAET-----------------QQGIFDAVLK------------------------GHIDFES---DPWPLIS  329 (398)
Q Consensus       299 -----~pf~~~~-----------------~~~~~~~~~~------------------------~~~~~~~---~~~~~~~  329 (398)
                           ++|.+..                 ..+.+..+..                        .......   ..++.++
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence                 3343322                 1111111111                        0000000   0124578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      +++.+||.+||++||++|||+.|+|+||||++......
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            99999999999999999999999999999998654433

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-51  Score=395.71  Aligned_cols=267  Identities=36%  Similarity=0.614  Sum_probs=228.1

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEeccccc--CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+.+|+.+++.+. ||||+++++++.+.
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  100 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccC
Confidence            3466789999999999999999999999999999999865432  13455678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 015898          173 LCVHIVMELCAGGELFDRIIQ----------------------------------------RGHYSERKAAELTRIIVGV  212 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~~i~~a  212 (398)
                      +..++||||+++++|.+++..                                        ...+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999988742                                        1113678899999999999


Q ss_pred             HHHHHhCCceeccCCCCcEEEeecCCCc--cEEEeecCCceecCCCC-----cccccccCCcccCccccc---ccCCCcc
Q 015898          213 VEACHSLGVMHRDLKPENFLLVNKDDDF--SLKAIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLL---KHYGPEA  282 (398)
Q Consensus       213 l~~lH~~~iiHrDikp~NIll~~~~~~~--~~kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~  282 (398)
                      |.|||+.||+||||||+|||+   +.++  .+||+|||++.......     ......||+.|+|||++.   ..++.++
T Consensus       181 l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            999999999999999999999   5444  89999999998653211     234567999999999986   3589999


Q ss_pred             cHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       283 DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      |||||||++|+|++|..||.+....+....+......+....+..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            99999999999999999999999988888888887777666666689999999999999999999999999999999886


Q ss_pred             CCC
Q 015898          363 GVA  365 (398)
Q Consensus       363 ~~~  365 (398)
                      ...
T Consensus       338 ~~~  340 (345)
T 3hko_A          338 SDK  340 (345)
T ss_dssp             SSC
T ss_pred             hHh
Confidence            543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-50  Score=395.93  Aligned_cols=288  Identities=23%  Similarity=0.406  Sum_probs=216.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcC-CCCeeEEeEEEecCCeEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-h~niv~l~~~~~~~~~~~  176 (398)
                      .++|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.|.. ||||+++++++...+.+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3459999999999999999999754 89999999975443 55667889999999999974 699999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||| +.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   + ++.+||+|||++......
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE---S-SSCEEECCCSSSCCC---
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---E-CCeEEEEecCccccccCC
Confidence            9999 5588999999988889999999999999999999999999999999999999   4 368999999999876543


Q ss_pred             C---cccccccCCcccCcccccc------------cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcC
Q 015898          257 Q---IFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDF  320 (398)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~  320 (398)
                      .   .....+||+.|+|||++.+            .++.++|||||||++|||++|..||.... ....+..+.......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            2   2345689999999999863            58889999999999999999999997653 334555565554433


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCC------CCHHHHHHHHHHHHHHHHHHHHhhh
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRS------LDPAVLSRLKQFSAMNKLKKMALRV  394 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  394 (398)
                      ...  ...+.++.+||.+||+.||++|||+.|+|+||||+....+....      .....+.++..+...+++++.+..+
T Consensus       288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (390)
T 2zmd_A          288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTL  365 (390)
T ss_dssp             CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-------------------------------------
T ss_pred             CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCccchhcccccHHHHHHHHHHhhcCCCCchHHHHHHHH
Confidence            322  23578999999999999999999999999999998755332211      1123445566666666666655443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-50  Score=393.18  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=217.6

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-  172 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+++.+|+.+++.+. ||||+++++++... 
T Consensus        20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   97 (367)
T ss_dssp             EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence            344567899999999999999999999999999999998643 235566778999999999998 99999999999765 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          173 -----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       173 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                           ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Df  172 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  172 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEee
Confidence                 3469999999 8899888765 569999999999999999999999999999999999999   88899999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-----
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-----  320 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-----  320 (398)
                      |++.....  .....++|+.|+|||++.+  .++.++|||||||++|||++|..||.+.+..+.+..+.+.....     
T Consensus       173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99987543  3456789999999999875  59999999999999999999999999888777666654311110     


Q ss_pred             ------------------C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          321 ------------------E----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       321 ------------------~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                        .    ...++.+++++.+||.+||+.||++|||+.|+|+||||.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                              0    1123457899999999999999999999999999999988653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.5e-51  Score=379.18  Aligned_cols=259  Identities=36%  Similarity=0.604  Sum_probs=220.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.+. ||||+++++++...+..+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence            4467999999999999999999999999999999996543323344668899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCCC
Confidence            999999999999999888889999999999999999999999999999999999999   88889999999999877665


Q ss_pred             CcccccccCCcccCccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      .......+|+.|+|||.+.+. + +.++||||||+++|+|++|..||...........+..+....+    ..++.++.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  240 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVAT  240 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHH
Confidence            555667899999999999854 3 6799999999999999999999998888888888777654433    247899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +|.+||+.||++|||+.|+++||||++..
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            99999999999999999999999998653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-51  Score=390.22  Aligned_cols=266  Identities=36%  Similarity=0.641  Sum_probs=221.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC-----CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.+. ||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence            34567899999999999999999999999999999999754321     1223446889999999997 99999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      .... .|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+..++.++.+||+|||+
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            7765 899999999999999998888899999999999999999999999999999999999995444455699999999


Q ss_pred             ceecCCCCcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCCCcCCCCC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDP  324 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~  324 (398)
                      +.............||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+....
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            98876655555678999999999974    35889999999999999999999999765432 34455555554443333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +..++.++.+||.+||+.||++|||+.++|+||||.+.
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            45688999999999999999999999999999999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-50  Score=390.25  Aligned_cols=263  Identities=25%  Similarity=0.419  Sum_probs=221.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------  171 (398)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            4579999999999999999999999999999999865432 2333456789999999998 9999999999876      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                        .+.+++||||+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg  169 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG  169 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCT
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccch
Confidence              4578999999975 777777553 569999999999999999999999999999999999999   888899999999


Q ss_pred             CceecCC-----CCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          249 LSVFFKP-----GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       249 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                      ++.....     ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+......++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987642     223355678999999998874  489999999999999999999999999888877777765433333


Q ss_pred             CCCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          322 SDPWPL----------------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       322 ~~~~~~----------------------------~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      ...++.                            .++++.+||.+||+.||++|||+.|+|+||||.....+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            333222                            267899999999999999999999999999998765544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=392.41  Aligned_cols=257  Identities=29%  Similarity=0.520  Sum_probs=222.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH-----hhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----EDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++........     .....+.+|+.+++.+. ||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            4466789999999999999999999999999999999976543221     13446778999999997 99999999999


Q ss_pred             ecCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          170 EDSLCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      ...+.+++||||+.+| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg  175 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG  175 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence            9999999999998766 999999888889999999999999999999999999999999999999   888999999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      ++.............||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.....      ....    ......
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~----~~~~~~  245 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA----AIHPPY  245 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT----CCCCSS
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh----ccCCCc
Confidence            9998777666667889999999999875 34 7899999999999999999999975322      1111    112223


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      .+++++.+||.+||+.||++|||+.|+++||||++....
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  284 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL  284 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCCG
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCccc
Confidence            478999999999999999999999999999999875543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-50  Score=391.74  Aligned_cols=261  Identities=23%  Similarity=0.392  Sum_probs=219.8

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc----CCCCeeEEeEE
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----GHKNIVTIKGA  168 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~h~niv~l~~~  168 (398)
                      ....+.++|++.++||+|+||.||+|.+..+++.||||++..    .......+..|+.+++.+.    +||||++++++
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            444567889999999999999999999999999999999863    3445667888999999986    59999999999


Q ss_pred             EecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec----------
Q 015898          169 YEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK----------  236 (398)
Q Consensus       169 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~----------  236 (398)
                      +...+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+...          
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence            99999999999999 899999997754  49999999999999999999999999999999999999321          


Q ss_pred             ------------CCCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC
Q 015898          237 ------------DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA  303 (398)
Q Consensus       237 ------------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~  303 (398)
                                  ..++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        1267899999999987543  2346789999999999885 699999999999999999999999988


Q ss_pred             cChHHHHHHHHcCCCcCCCC---------------------CC---------------------CCCCHHHHHHHHHhcc
Q 015898          304 ETQQGIFDAVLKGHIDFESD---------------------PW---------------------PLISDSAKDLIRKMLC  341 (398)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~---------------------~~---------------------~~~~~~~~~li~~~L~  341 (398)
                      ....+.+..+.......+..                     .+                     ...++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            88777666654432211100                     00                     0123678899999999


Q ss_pred             cCCCCCCCHHHHhcCCCcc
Q 015898          342 SQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       342 ~dP~~Rps~~eiL~hp~~~  360 (398)
                      +||++|||+.|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999995

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-50  Score=375.01  Aligned_cols=257  Identities=23%  Similarity=0.383  Sum_probs=220.0

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec----CC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~----~~  173 (398)
                      ...|++.+.||+|+||.||+|.+..++..||+|++..... +....+.+.+|+.+++.+. ||||+++++++..    ..
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence            3458999999999999999999999999999999975443 5666788999999999997 9999999999864    46


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecC-CCccEEEeecCCc
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKD-DDFSLKAIDFGLS  250 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~-~~~~~kL~DFG~a  250 (398)
                      .+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.|  |+||||||+|||+   + +++.+||+|||++
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI---TGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE---SSTTSCEEECCTTGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE---ECCCCCEEEeeCCCc
Confidence            79999999999999999988888999999999999999999999999  9999999999999   5 6789999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHcCCCcCCCCCCCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ...... ......||+.|+|||++.+.++.++|||||||++|+|++|..||..... ......+..+....  ......+
T Consensus       180 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  256 (290)
T 1t4h_A          180 TLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAI  256 (290)
T ss_dssp             GGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCC
T ss_pred             cccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--ccCCCCC
Confidence            764433 3456789999999999988899999999999999999999999987444 44444444332221  1123467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            899999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.6e-50  Score=382.14  Aligned_cols=255  Identities=29%  Similarity=0.490  Sum_probs=222.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.+. ||||+++++++...+..++||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            4777889999999999999999999999999986543   334567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-c
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~  258 (398)
                      ||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++....... .
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc
Confidence            99999999987754 569999999999999999999999999999999999999   888899999999998765432 3


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+........ .....+++++.+||.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  276 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLE  276 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHH
Confidence            356789999999999875 589999999999999999999999998888777777665533221 122357899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +||+.||++|||+.|+|+||||.+..
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHccCChhhCcCHHHHhcChhhccCC
Confidence            99999999999999999999998765

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.1e-51  Score=378.26  Aligned_cols=257  Identities=33%  Similarity=0.588  Sum_probs=198.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEE
Confidence            45999999999999999999999999999999996543222334578899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++...... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCCC
Confidence            9999999999998765 569999999999999999999999999999999999999   88889999999999876532 


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                      .......||+.|+|||.+.+ .++.++|||||||++|+|++|..||...........+......    ....++.++.+|
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l  242 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIEAKDL  242 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHHHHHH
Confidence            22345678999999999875 5889999999999999999999999876655554444333222    223578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          336 IRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |.+||+.||++|||+.++|+||||.+..
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-50  Score=408.53  Aligned_cols=258  Identities=31%  Similarity=0.509  Sum_probs=226.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++.++||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.....+|+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEE
Confidence            366999999999999999999999999999999997654333345678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          178 VMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeeec
Confidence            99999999999998763    369999999999999999999999999999999999999   88899999999999876


Q ss_pred             CCCCc-ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc----ChHHHHHHHHcCCCcCCCCCCCC
Q 015898          254 KPGQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       254 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.    ....+...+......++    ..
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~  415 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK  415 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence            65433 345689999999999985 5999999999999999999999999765    34566666666655544    35


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLT-----AHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps-----~~eiL~hp~~~~~~  363 (398)
                      +++++.+||.+||+.||++||+     +.++++||||++..
T Consensus       416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence            8999999999999999999996     58999999999743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-51  Score=389.27  Aligned_cols=265  Identities=23%  Similarity=0.342  Sum_probs=224.7

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-  173 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.+. ||||+++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence            446778999999999999999999999999999999998765556666788999999999997 999999999987543 


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          174 ---CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       174 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                         ..|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  163 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCc
Confidence               459999999999999999988899999999999999999999999999999999999999   77789999999999


Q ss_pred             eecCCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      .......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......................
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  243 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence            7654332    2234678999999999875 5899999999999999999999999988887777776665544443334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ..++.++.+||.+||+.||++||++.++|.|+|++...
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            56899999999999999999999999999999997643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.9e-51  Score=394.38  Aligned_cols=262  Identities=28%  Similarity=0.410  Sum_probs=210.4

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++....
T Consensus        20 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           20 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK   97 (371)
T ss_dssp             EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred             ccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence            3345678999999999999999999999999999999996532 35566778999999999997 999999999997654


Q ss_pred             ------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          174 ------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       174 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                            .+|+||||++ ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Df  171 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDF  171 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEe
Confidence                  7899999996 47888775  458999999999999999999999999999999999999   88889999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC----
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES----  322 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----  322 (398)
                      |++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........    
T Consensus       172 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          172 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             CC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99987665555566789999999999985 5899999999999999999999999998887777776553211100    


Q ss_pred             -------------CC--------------CC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          323 -------------DP--------------WP-------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       323 -------------~~--------------~~-------~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                   ..              .+       ..+.++.+||.+||+.||++|||+.|+|+||||..+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                         00              00       0146799999999999999999999999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-49  Score=375.44  Aligned_cols=278  Identities=27%  Similarity=0.419  Sum_probs=239.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++......+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence            4456999999999999999999999999999999997543  2345678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTT
T ss_pred             EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCcc
Confidence            99999999999988754 569999999999999999999999999999999999999   88889999999999876543


Q ss_pred             C-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      . ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......   .....++.++.+
T Consensus       173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~  249 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKE  249 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHHH
T ss_pred             ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHHH
Confidence            3 2345678999999999875 5899999999999999999999999888777776666554332   222357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNK  386 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (398)
                      ||.+||+.||++|||+.|+++||||.......+.  -.++..+.+.|.+.++
T Consensus       250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  299 (303)
T 3a7i_A          250 FVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY--LTELIDRYKRWKAEQS  299 (303)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGG--GHHHHHHHHHHHHHCC
T ss_pred             HHHHHcCCChhhCcCHHHHhhChhhhcCCCccHH--HHHHHHHHHHhhhhcc
Confidence            9999999999999999999999999887655443  3577788888776654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.3e-50  Score=385.00  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=223.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..+.|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++ ||||+++++++...+..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeEE
Confidence            3456999999999999999999999999999999997655445556678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC
Confidence            9999996 588887754 5679999999999999999999999999999999999999   7788999999999976543


Q ss_pred             CCcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                         .....||+.|+|||++.    +.++.++|||||||++|||++|..||...........+........  ....+++.
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  281 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY  281 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHH
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHH
Confidence               24568999999999984    3589999999999999999999999988887776666655443221  22357899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||+.||++|||+.++|+||||....
T Consensus       282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            99999999999999999999999999997654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-49  Score=380.04  Aligned_cols=255  Identities=29%  Similarity=0.511  Sum_probs=213.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCe
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLC  174 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~  174 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...      ..+.+.+|+.+++.+.+||||+++++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            346799999999999999999999999999999998532      246788999999999889999999999987  678


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-cEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-~~kL~DFG~a~~~  253 (398)
                      .++||||+.+++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||+   +.++ .+||+|||++...
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTTEEEECCCTTCEEC
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---cCCCCEEEEEeCCCceEc
Confidence            999999999999988774   38999999999999999999999999999999999999   5444 8999999999887


Q ss_pred             CCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHH-------------HcCC
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAV-------------LKGH  317 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~~-------------~~~~  317 (398)
                      ..........||+.|+|||++.+  .++.++|||||||++|+|++|..||... ...+.+..+             ....
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            76666677789999999999874  5899999999999999999999999543 222222221             1111


Q ss_pred             CcC--------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          318 IDF--------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       318 ~~~--------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ...                    .......+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            111                    0111123789999999999999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.8e-50  Score=395.39  Aligned_cols=265  Identities=25%  Similarity=0.371  Sum_probs=219.5

Q ss_pred             ccccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc-----CCCCeeEE
Q 015898           91 GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-----GHKNIVTI  165 (398)
Q Consensus        91 ~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~niv~l  165 (398)
                      ....+.+.++|++.+.||+|+||.||+|.+..+++.||||++..    .......+.+|+.+++.++     +|+||+++
T Consensus        89 ~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             CCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             ccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            34456677889999999999999999999999999999999964    3445567888999998885     37799999


Q ss_pred             eEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc--
Q 015898          166 KGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS--  241 (398)
Q Consensus       166 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~--  241 (398)
                      ++++...+.+++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.  
T Consensus       165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~  240 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSG  240 (429)
T ss_dssp             EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCC
T ss_pred             EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcc
Confidence            999999999999999995 68999887754  49999999999999999999999999999999999999   66665  


Q ss_pred             EEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC
Q 015898          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      +||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+.......
T Consensus       241 vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p  318 (429)
T 3kvw_A          241 IKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP  318 (429)
T ss_dssp             EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999999976543  3346789999999999885 59999999999999999999999999888777666554310000


Q ss_pred             C---------------CC----------------------------------------CCCCCCHHHHHHHHHhcccCCC
Q 015898          321 E---------------SD----------------------------------------PWPLISDSAKDLIRKMLCSQPS  345 (398)
Q Consensus       321 ~---------------~~----------------------------------------~~~~~~~~~~~li~~~L~~dP~  345 (398)
                      +               ..                                        .....++++.+||.+||++||+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence            0               00                                        0012368899999999999999


Q ss_pred             CCCCHHHHhcCCCccCCCCC
Q 015898          346 ERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       346 ~Rps~~eiL~hp~~~~~~~~  365 (398)
                      +|||+.|+|+||||++....
T Consensus       399 ~Rpta~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRRLPK  418 (429)
T ss_dssp             TSCCHHHHHTSTTTC-----
T ss_pred             hCCCHHHHhCChhhccCCCC
Confidence            99999999999999886533

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=381.23  Aligned_cols=259  Identities=24%  Similarity=0.421  Sum_probs=213.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CCeeEEeEEEecCCeE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCV  175 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~niv~l~~~~~~~~~~  175 (398)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.++..+.+| |||+++++++.....+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            456799999999999999999997 568899999997543 3556678899999999999832 9999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   + ++.+||+|||++.....
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll---~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---E-TTEEEECCCSSSCCC--
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---E-CCcEEEeecccccccCc
Confidence            999995 588999999998899999999999999999999999999999999999999   4 46799999999987654


Q ss_pred             CC---cccccccCCcccCccccc------------ccCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCc
Q 015898          256 GQ---IFTDVVGSPYYVAPEVLL------------KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHID  319 (398)
Q Consensus       256 ~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~  319 (398)
                      ..   .....+||+.|+|||++.            ..++.++|||||||++|+|++|..||.... ....+..+......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  239 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence            32   234568999999999985            347889999999999999999999997643 33444444443332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ..  .....+.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       240 ~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          240 IE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             cC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            22  12346789999999999999999999999999999986543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-50  Score=391.55  Aligned_cols=265  Identities=25%  Similarity=0.428  Sum_probs=206.7

Q ss_pred             cccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        92 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      .....+.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+.+|+.+++.+. ||||+++++++..
T Consensus        22 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~   99 (367)
T 2fst_X           22 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTP   99 (367)
T ss_dssp             TEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred             CcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEec
Confidence            33445667899999999999999999999999999999998643 235566778999999999998 9999999999865


Q ss_pred             C------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          172 S------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       172 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      .      ..+|+|||++ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+
T Consensus       100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~  174 (367)
T 2fst_X          100 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL  174 (367)
T ss_dssp             CSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred             CCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEe
Confidence            4      5689999999 7899887765 579999999999999999999999999999999999999   888999999


Q ss_pred             ecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc----
Q 015898          246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----  319 (398)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  319 (398)
                      |||++.....  .....+||+.|+|||++.+  .++.++|||||||++|||++|..||.+.+..+.+..+.+....    
T Consensus       175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  252 (367)
T 2fst_X          175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE  252 (367)
T ss_dssp             C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999986543  2456789999999999875  5899999999999999999999999988877766665431100    


Q ss_pred             -------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          320 -------------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       320 -------------------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                         .+.    ..++.+++++.+||.+||+.||++|||+.|+|+||||.+...+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                               000    0123468899999999999999999999999999999986543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.9e-50  Score=375.39  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=222.5

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++. ||||+++++++...+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence            3456788999999999999999999999999999999997665556677789999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcccc
Confidence            999999999999999999988899999999999999999999999999999999999999   88889999999999765


Q ss_pred             CCCC--cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-CCCCCCCCC
Q 015898          254 KPGQ--IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-ESDPWPLIS  329 (398)
Q Consensus       254 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  329 (398)
                      ....  ......||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+................. .....+.++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence            4332  2334679999999999875 58899999999999999999999999888776665555543322 122345688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      +.+.++|.+||+.||++||+..+.+.+.|..
T Consensus       242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          242 QSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            9999999999999999999666666665543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-50  Score=386.07  Aligned_cols=264  Identities=26%  Similarity=0.366  Sum_probs=215.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC--HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.......  ....+.+.+|+.+++.+. ||||+++++++...+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence            3467999999999999999999999999999999986533211  112346789999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence            9999999975 888888664 358999999999999999999999999999999999999   88899999999999876


Q ss_pred             CCC-CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC------
Q 015898          254 KPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP------  324 (398)
Q Consensus       254 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------  324 (398)
                      ... .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+.+..+...........      
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            432 34456789999999999864  488999999999999999999999998888777777655321111111      


Q ss_pred             ------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          325 ------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       325 ------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                        +..++.++.+||.+||+.||++|||+.|+|+||||.+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                              13467899999999999999999999999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-49  Score=369.86  Aligned_cols=258  Identities=21%  Similarity=0.328  Sum_probs=214.5

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+..+..+.+||||+++++++.+.+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            356779999999999999999999999999999999975433 3445678889999999995599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC--------------
Q 015898          176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--------------  237 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~--------------  237 (398)
                      ++||||+++++|.+++...    ..+++..+..++.||+.||.|||++||+||||||+|||+....              
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999764    6699999999999999999999999999999999999994322              


Q ss_pred             --CCccEEEeecCCceecCCCCcccccccCCcccCccccccc--CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Q 015898          238 --DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (398)
Q Consensus       238 --~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~  313 (398)
                        ....+||+|||++.......   ...||+.|+|||++.+.  ++.++|||||||++|+|++|.+|+....   ....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence              45579999999998765432   34689999999999753  5679999999999999999998775443   33444


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ..+....   ....+++++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       241 ~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            4443322   2235889999999999999999999999999999998753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-50  Score=383.91  Aligned_cols=254  Identities=25%  Similarity=0.372  Sum_probs=208.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC---
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL---  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~---  173 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.++++++ ||||++++++|.+..   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            3467999999999999999999999999999999997543  3445678999999999997 999999999985433   


Q ss_pred             ------------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---
Q 015898          174 ------------------------------------------------------CVHIVMELCAGGELFDRIIQRGH---  196 (398)
Q Consensus       174 ------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---  196 (398)
                                                                            ..++||||+++++|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-------------cccccc
Q 015898          197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-------------IFTDVV  263 (398)
Q Consensus       197 ~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-------------~~~~~~  263 (398)
                      .++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......             ......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            5667799999999999999999999999999999999   788899999999998765432             223467


Q ss_pred             cCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..|+..  .......+.......   .....++++.+||.+||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---LFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---ccccCChhHHHHHHHHccC
Confidence            9999999999875 589999999999999999998777522  122233333322111   1123467889999999999


Q ss_pred             CCCCCCCHHHHhcCCCccC
Q 015898          343 QPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       343 dP~~Rps~~eiL~hp~~~~  361 (398)
                      ||++|||+.|+|+||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.3e-50  Score=383.01  Aligned_cols=260  Identities=24%  Similarity=0.396  Sum_probs=217.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEE
Confidence            356999999999999999999999999999999986543 34555677889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCc
Confidence            99999998888877777789999999999999999999999999999999999999   88889999999999765432 


Q ss_pred             CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc---------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------------  319 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------------  319 (398)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+......               
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            33456789999999999875  5899999999999999999999999888776655554321000               


Q ss_pred             ----CCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          320 ----FES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       320 ----~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                          .+.        ...+.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                000        0123578999999999999999999999999999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-49  Score=369.66  Aligned_cols=259  Identities=29%  Similarity=0.520  Sum_probs=221.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            4467999999999999999999999999999999997544  2345678899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999998877789999999999999999999999999999999999999   78889999999999765432


Q ss_pred             ---CcccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCCCcCCCCCCCCCCH
Q 015898          257 ---QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                         .......||+.|+|||.+.+ . ++.++|||||||++|+|++|..||...... ..+.........  ...+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence               22345678999999999975 3 477899999999999999999999765543 233333332221  122346889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++.+||.+||+.||++|||+.|+++||||++..
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-50  Score=389.32  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=212.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-----  171 (398)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.....       ...+|+.+++.+. ||||++++++|..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence            34679999999999999999999999999999999864321       1236999999997 9999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 015898          172 ---------------------------------SLCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVE  214 (398)
Q Consensus       172 ---------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~al~  214 (398)
                                                       ...+++||||++ ++|.+.+.    ....+++..+..++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             345899999997 57766664    3567999999999999999999


Q ss_pred             HHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHH
Q 015898          215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILY  292 (398)
Q Consensus       215 ~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~  292 (398)
                      |||+.||+||||||+|||+.  ..++.+||+|||+|.............+|+.|+|||++.+  .++.++|||||||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            99999999999999999993  2568999999999998776666677889999999998874  4899999999999999


Q ss_pred             HHHhCCCCCCCcChHHHHHHHHcCC-----------------CcCCCC--------CCCCCCHHHHHHHHHhcccCCCCC
Q 015898          293 ILLSGVPPFWAETQQGIFDAVLKGH-----------------IDFESD--------PWPLISDSAKDLIRKMLCSQPSER  347 (398)
Q Consensus       293 elltg~~pf~~~~~~~~~~~~~~~~-----------------~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~R  347 (398)
                      +|++|..||.+....+.+..+.+..                 ..++..        ....+++++.+||.+||+.||++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            9999999999988877776665311                 011100        112478899999999999999999


Q ss_pred             CCHHHHhcCCCccCC
Q 015898          348 LTAHEVLCHPWICEN  362 (398)
Q Consensus       348 ps~~eiL~hp~~~~~  362 (398)
                      ||+.|+|+||||++.
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-49  Score=386.20  Aligned_cols=266  Identities=23%  Similarity=0.348  Sum_probs=219.1

Q ss_pred             eccccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC-----eeE
Q 015898           90 LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-----IVT  164 (398)
Q Consensus        90 ~~~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n-----iv~  164 (398)
                      .......+.++|++.+.||+|+||+||+|.+..+++.||||++..    .......+.+|+.+++.+..|++     |+.
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            334556677889999999999999999999999999999999964    34456778889999998875664     999


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEeecCCCc
Q 015898          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACH--SLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       165 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH--~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +++++...+..++||||+. ++|.+++...  ..+++..+..++.|++.||.|||  +.||+||||||+|||+.. +.++
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~  198 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRS  198 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCC
Confidence            9999999999999999995 5999998765  45899999999999999999999  579999999999999942 2367


Q ss_pred             cEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc
Q 015898          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID  319 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  319 (398)
                      .+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..+......
T Consensus       199 ~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             CEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             cEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            899999999987643  2356789999999999985 5999999999999999999999999988887777666542110


Q ss_pred             CC------------------CCCC-----------------CC-------------------------CCHHHHHHHHHh
Q 015898          320 FE------------------SDPW-----------------PL-------------------------ISDSAKDLIRKM  339 (398)
Q Consensus       320 ~~------------------~~~~-----------------~~-------------------------~~~~~~~li~~~  339 (398)
                      .+                  ...|                 ..                         .++++.+||.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence            00                  0000                 00                         013789999999


Q ss_pred             cccCCCCCCCHHHHhcCCCccCCC
Q 015898          340 LCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       340 L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      |++||++|||+.|+|+||||++..
T Consensus       357 L~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             cCCChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999998764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-49  Score=384.39  Aligned_cols=260  Identities=28%  Similarity=0.442  Sum_probs=219.7

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC---
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~---  172 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++++. ||||+++++++...   
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence            34568999999999999999999999999999999986432  4556678999999999997 99999999999654   


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          173 --LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       173 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                        ...|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  175 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence              46899999996 589888765 469999999999999999999999999999999999999   88889999999999


Q ss_pred             eecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC---
Q 015898          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE---  321 (398)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---  321 (398)
                      .......    .....+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+........   
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            8765332    1345689999999998753  489999999999999999999999988877776666543111000   


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          322 ------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       322 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                              ....+.+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                                    001235789999999999999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-50  Score=389.18  Aligned_cols=258  Identities=31%  Similarity=0.528  Sum_probs=217.8

Q ss_pred             ccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ++|++.+.||+|+||.||+|.+.   .+++.||||++...... .....+.+.+|+.+++++.+||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            56999999999999999999984   58899999998654321 112334567899999999669999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeecc
Confidence            99999999999999999988889999999999999999999999999999999999999   888999999999998654


Q ss_pred             CCC--cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcC----hHHHHHHHHcCCCcCCCCCC
Q 015898          255 PGQ--IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~  325 (398)
                      ...  .....+||+.|+|||++.+   .++.++|||||||++|+|++|..||....    ...+...+......++    
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  286 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----  286 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC----
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC----
Confidence            322  2345689999999999874   37899999999999999999999996432    3344444444433322    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ..++..+.+||.+||..||++||     |++|+++||||.+..
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            35789999999999999999999     999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=377.69  Aligned_cols=260  Identities=23%  Similarity=0.383  Sum_probs=215.7

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC--
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~--  173 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.++++++ ||||+++++++....  
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence            356779999999999999999999999999999999975432  334567889999999998 999999999998655  


Q ss_pred             eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-cCCCccEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN-KDDDFSLKAIDFGL  249 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~-~~~~~~~kL~DFG~  249 (398)
                      ..++||||+++++|.+++.....   +++..+..++.||+.||.|||+.||+||||||+|||+.. .+.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999976443   899999999999999999999999999999999999833 35567899999999


Q ss_pred             ceecCCCCcccccccCCcccCccccc---------ccCCCcccHHHHHHHHHHHHhCCCCCCCc----ChHHHHHHHHcC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLL---------KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKG  316 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlG~il~elltg~~pf~~~----~~~~~~~~~~~~  316 (398)
                      +.............||+.|+|||++.         ..++.++|||||||++|||++|..||...    .....+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            99877766666788999999999885         45889999999999999999999999632    234444444443


Q ss_pred             CCc---------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          317 HID---------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       317 ~~~---------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      ...                     ........++..+.+||.+||+.||++|||++|+|+||=
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            221                     000111224568899999999999999999999999973

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.1e-50  Score=392.38  Aligned_cols=267  Identities=24%  Similarity=0.439  Sum_probs=200.3

Q ss_pred             ccccccccee-cceecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           94 TDNIRDLYTL-GRKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        94 ~~~~~~~y~~-~~~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ...+.+.|++ +++||+|+||.||+|.+.  .+++.||||++.....     ...+.+|+.+|+.|. ||||+++++++.
T Consensus        15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~   88 (405)
T 3rgf_A           15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFL   88 (405)
T ss_dssp             CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred             hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEe
Confidence            3445667887 568999999999999965  5788999999864322     246778999999998 999999999994


Q ss_pred             --cCCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec-CC
Q 015898          171 --DSLCVHIVMELCAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DD  238 (398)
Q Consensus       171 --~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~-~~  238 (398)
                        ....+|+||||+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+... +.
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           89 SHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             ETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred             cCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence              5778999999996 5888877532         248999999999999999999999999999999999999543 45


Q ss_pred             CccEEEeecCCceecCCC----CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCh------
Q 015898          239 DFSLKAIDFGLSVFFKPG----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ------  306 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~------  306 (398)
                      ++.+||+|||+|......    ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...      
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            689999999999876432    23345789999999999875  489999999999999999999999976543      


Q ss_pred             ---HHHHHHHHcCCCcCCCCCC----------------------------------CCCCHHHHHHHHHhcccCCCCCCC
Q 015898          307 ---QGIFDAVLKGHIDFESDPW----------------------------------PLISDSAKDLIRKMLCSQPSERLT  349 (398)
Q Consensus       307 ---~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~li~~~L~~dP~~Rps  349 (398)
                         .+.+..+...........|                                  ...++++.+||.+||++||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               2333333221111111111                                  112678999999999999999999


Q ss_pred             HHHHhcCCCccCCCCCCC
Q 015898          350 AHEVLCHPWICENGVAPD  367 (398)
Q Consensus       350 ~~eiL~hp~~~~~~~~~~  367 (398)
                      +.|+|+||||.+...+..
T Consensus       328 a~e~L~hp~f~~~~~~~~  345 (405)
T 3rgf_A          328 SEQAMQDPYFLEDPLPTS  345 (405)
T ss_dssp             HHHHHTSGGGTSSSCCCS
T ss_pred             HHHHhcChhhccCCCCcc
Confidence            999999999998665443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.6e-51  Score=396.43  Aligned_cols=252  Identities=15%  Similarity=0.165  Sum_probs=206.6

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEe------
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIK------  166 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~------  166 (398)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.  +||||++++      
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            334567999999999999999999998999999999998655555667788999996555543  499999998      


Q ss_pred             -EEEecCCe-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCc
Q 015898          167 -GAYEDSLC-----------------VHIVMELCAGGELFDRIIQRGHYSE-------RKAAELTRIIVGVVEACHSLGV  221 (398)
Q Consensus       167 -~~~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~~i~~al~~lH~~~i  221 (398)
                       ++++..+.                 .|+||||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence             77765542                 89999999 6799999987655555       8888899999999999999999


Q ss_pred             eeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccc------------cCCCcccHHHHHH
Q 015898          222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGV  289 (398)
Q Consensus       222 iHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~  289 (398)
                      +||||||+|||+   +.++.+||+|||+|....  ......+| +.|+|||++.+            .++.++|||||||
T Consensus       228 vHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999   788899999999998643  34456678 99999999874            5999999999999


Q ss_pred             HHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          290 ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       290 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      ++|||++|..||.+.........+.        ..+..+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999999997655433322222        223468899999999999999999999999999999965

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-49  Score=386.85  Aligned_cols=257  Identities=29%  Similarity=0.455  Sum_probs=210.8

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-  173 (398)
                      .....+|++.++||+|+||+||+|.+..+++ ||+|.+......       ..+|+.+++.+. ||||+++++++...+ 
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEESS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEecCC
Confidence            3345679999999999999999999877665 888877543221       236999999997 999999999985433 


Q ss_pred             -----eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEE
Q 015898          174 -----CVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLK  243 (398)
Q Consensus       174 -----~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~k  243 (398)
                           .+++||||++++ +...+.    ....+++..++.++.||+.||.|||++||+||||||+|||+   + .++.+|
T Consensus       107 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~~k  182 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLK  182 (394)
T ss_dssp             SSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---ETTTTEEE
T ss_pred             CCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE---cCCCCcEE
Confidence                 488999999764 444433    25679999999999999999999999999999999999999   5 678999


Q ss_pred             EeecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC----
Q 015898          244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH----  317 (398)
Q Consensus       244 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----  317 (398)
                      |+|||+|.....+.......||+.|+|||++.+  .|+.++|||||||++|||++|..||.+.+..+.+..+.+..    
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999988766666667889999999999864  48999999999999999999999999888777666654410    


Q ss_pred             -------------CcCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          318 -------------IDFES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       318 -------------~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                   ..++.        ...+.+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                         00000        011237889999999999999999999999999999997544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.2e-49  Score=377.85  Aligned_cols=267  Identities=39%  Similarity=0.669  Sum_probs=194.0

Q ss_pred             cccccceecc-eecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec---
Q 015898           96 NIRDLYTLGR-KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (398)
Q Consensus        96 ~~~~~y~~~~-~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~---  171 (398)
                      .+.++|++.+ +||+|+||.||+|.+..+++.||||++...    .    ...+|+..+.++.+||||+++++++..   
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            4566799954 699999999999999999999999998542    2    223344443334459999999999875   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 -SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                       ...+++||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             556899999999999999998754  59999999999999999999999999999999999999655556779999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHHcCCCcCCCC
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGI----FDAVLKGHIDFESD  323 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~  323 (398)
                      ++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........    ...+......++..
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            99875533 3345678999999999874 588999999999999999999999976654433    23333344445555


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCC
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLD  371 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~  371 (398)
                      .+..+++++.+||.+||+.||++|||+.|+|+||||.+....+.....
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  303 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLH  303 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBCS
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCccc
Confidence            556789999999999999999999999999999999987666654443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.9e-49  Score=383.45  Aligned_cols=264  Identities=23%  Similarity=0.353  Sum_probs=222.6

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.+. ||||+++++++...+.
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCE
Confidence            344567999999999999999999999999999999997542  5566788999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      +++||||+++++|.+++...+.+++..+..++.+++.||.|||+. ||+||||||+|||+   +.++.+||+|||++...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence            999999999999999999888899999999999999999999996 99999999999999   88889999999998654


Q ss_pred             CCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHH--------------------
Q 015898          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDA--------------------  312 (398)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~--------------------  312 (398)
                      ... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........                    
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            322 2345689999999999885 589999999999999999999999977655443222                    


Q ss_pred             ----------------------HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          313 ----------------------VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       313 ----------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                                            +.....  +......++.++.+||.+||+.||++|||+.|+|+||||++......
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence                                  111111  11112346889999999999999999999999999999988664443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=372.27  Aligned_cols=262  Identities=26%  Similarity=0.468  Sum_probs=221.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE--ecCC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAY--EDSL  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~--~~~~  173 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++.+. ||||+++++++  .+..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            346799999999999999999999999999999999654321 1234578999999999997 99999999998  4556


Q ss_pred             eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          174 CVHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      ..++||||++++ |.+.+..  ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            899999999775 7777765  4569999999999999999999999999999999999999   788899999999998


Q ss_pred             ecCC---CCcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          252 FFKP---GQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       252 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      ....   ........||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.........+.++...++.   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---  234 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG---  234 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS---
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC---
Confidence            7643   223345678999999999874   2477999999999999999999999998888888888777654433   


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                       .+++++.+||.+||+.||++|||+.|+++||||++......
T Consensus       235 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~  275 (305)
T 2wtk_C          235 -DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE  275 (305)
T ss_dssp             -SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred             -ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence             47899999999999999999999999999999988654443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9e-49  Score=386.79  Aligned_cols=255  Identities=28%  Similarity=0.412  Sum_probs=210.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------  171 (398)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++.....       ...+|+.+++.|. ||||++++++|..      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCCc
Confidence            3469999999999999999999999999999999864321       2346999999997 9999999998843      


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEEEee
Q 015898          172 SLCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAID  246 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~D  246 (398)
                      ...+++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||+   + +.+.+||+|
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl---~~~~~~~kl~D  200 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCD  200 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---ETTTTEEEECC
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE---eCCCCeEEecc
Confidence            2347799999975 66665542    4679999999999999999999999999999999999999   5 346789999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC--------
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--------  316 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--------  316 (398)
                      ||++............+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+....+.+..+.+.        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999988766655667889999999999864  5899999999999999999999999988876666555431        


Q ss_pred             ---------CCcCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          317 ---------HIDFESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       317 ---------~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                               ...++..        ..+.+++++.+||.+||+.||++|||+.|+|+||||.+...
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                     0111100        11246889999999999999999999999999999987543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.7e-49  Score=368.53  Aligned_cols=259  Identities=25%  Similarity=0.260  Sum_probs=199.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+..+...++.+. ||||+++++++...+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCEE
Confidence            3467999999999999999999999999999999986542 12233333444444566665 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          177 IVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      +||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+||++   +.++.+||+|||++.
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC----
T ss_pred             EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence            9999996 588776653    46799999999999999999999998 99999999999999   788899999999998


Q ss_pred             ecCCCCcccccccCCcccCcccc----c-ccCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCC
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVL----L-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~----~-~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      ............||+.|+|||++    . ..++.++|||||||++|+|++|..||.. ................  ....
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  236 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLPA  236 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCCT
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Cccc
Confidence            77665555556899999999996    2 3588999999999999999999999975 3333334443333222  1122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ..+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            35789999999999999999999999999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.3e-49  Score=377.46  Aligned_cols=264  Identities=29%  Similarity=0.415  Sum_probs=219.0

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++...  ........+.+|+.+++.+. ||||+++++++...  
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCS
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccccc
Confidence            34667899999999999999999999999999999999543  24556678889999999997 99999999987654  


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ...++||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGL  158 (353)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccc
Confidence               67999999996 589888765 569999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCC-----------cccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC
Q 015898          250 SVFFKPGQ-----------IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG  316 (398)
Q Consensus       250 a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~  316 (398)
                      +.......           ......||+.|+|||++.  ..++.++|||||||++|+|++|..||.+....+.+..+...
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            98764321           122357899999999875  35899999999999999999999999888766655444321


Q ss_pred             CCc------------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          317 HID------------------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       317 ~~~------------------------~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                      ...                        ...    ..++.+++++.+||.+||+.||++|||+.|+|+||||+......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            000                        000    01235789999999999999999999999999999999866443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.3e-49  Score=382.22  Aligned_cols=262  Identities=28%  Similarity=0.430  Sum_probs=217.7

Q ss_pred             cccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        92 ~~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      .....+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++..
T Consensus        35 ~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  112 (371)
T 4exu_A           35 KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTP  112 (371)
T ss_dssp             TEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECS
T ss_pred             cceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheec
Confidence            344456778999999999999999999999999999999996533 35556788999999999998 9999999999987


Q ss_pred             CCeE------EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          172 SLCV------HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       172 ~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      .+..      ++||||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+
T Consensus       113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~  186 (371)
T 4exu_A          113 ASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL  186 (371)
T ss_dssp             CSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred             cCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEE
Confidence            7654      99999996 68877663  459999999999999999999999999999999999999   888999999


Q ss_pred             ecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC---
Q 015898          246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF---  320 (398)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---  320 (398)
                      |||++.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.......   
T Consensus       187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  264 (371)
T 4exu_A          187 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE  264 (371)
T ss_dssp             STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence            9999986543  3356788999999999875  58999999999999999999999999888777666654311000   


Q ss_pred             --------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          321 --------------------ES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       321 --------------------~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                          ..    ..++.+++++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                                00    01235689999999999999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=370.44  Aligned_cols=258  Identities=25%  Similarity=0.440  Sum_probs=215.0

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-----  171 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....    ...+.+.+|+.+++++.+||||+++++++..     
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            4567999999999999999999999999999999986432    2346788999999999669999999999976     


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 -SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                       .+.+++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCc
Confidence             56899999999999999998764  569999999999999999999999999999999999999   788899999999


Q ss_pred             CceecCCC-CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC
Q 015898          249 LSVFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (398)
Q Consensus       249 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  321 (398)
                      ++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||...........+......  
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  252 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--  252 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred             CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--
Confidence            99765432 2234567899999999985      34889999999999999999999999888776666655544322  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ......++.++.+||.+||..||.+|||+.++++||||.+..
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            112345789999999999999999999999999999998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=373.77  Aligned_cols=267  Identities=28%  Similarity=0.414  Sum_probs=214.7

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe---
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE---  170 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~---  170 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++...   +....+.+.+|+.+++.+. ||||+++++++.   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG   81 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence            345678899999999999999999999999999999998643   4566788999999999997 999999999873   


Q ss_pred             -----------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC
Q 015898          171 -----------DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (398)
Q Consensus       171 -----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~  239 (398)
                                 .....++||||++ ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+.  .++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~  157 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TED  157 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTT
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCC
Confidence                       4478999999997 699888754 5689999999999999999999999999999999999993  245


Q ss_pred             ccEEEeecCCceecCCC----CcccccccCCcccCccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Q 015898          240 FSLKAIDFGLSVFFKPG----QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (398)
Q Consensus       240 ~~~kL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~  313 (398)
                      +.+||+|||++......    .......+|+.|+|||.+.  ..++.++|||||||++|+|++|..||.+....+....+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            78999999999865432    1234456799999999886  35899999999999999999999999988877666655


Q ss_pred             HcCCCcC----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          314 LKGHIDF----------------------ES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       314 ~~~~~~~----------------------~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      .......                      +.    ...+.++.++.+||.+||+.||++|||+.|+|+||||.....+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            4432110                      00    012357899999999999999999999999999999998776654


Q ss_pred             C
Q 015898          368 R  368 (398)
Q Consensus       368 ~  368 (398)
                      +
T Consensus       318 ~  318 (320)
T 2i6l_A          318 E  318 (320)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-49  Score=386.58  Aligned_cols=258  Identities=17%  Similarity=0.144  Sum_probs=198.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc-CCCCeeEEe-------EEEe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-GHKNIVTIK-------GAYE  170 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~h~niv~l~-------~~~~  170 (398)
                      ..|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++..|. +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            44999999999999999999999999999999998765545566778888866666554 499988755       4444


Q ss_pred             cC-----------------CeEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceeccC
Q 015898          171 DS-----------------LCVHIVMELCAGGELFDRIIQR-GHYSERKA------AELTRIIVGVVEACHSLGVMHRDL  226 (398)
Q Consensus       171 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~~i~~al~~lH~~~iiHrDi  226 (398)
                      ..                 ..+|+||||++ ++|.+++... ..+.+..+      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            32                 34899999998 8999999764 33455555      677899999999999999999999


Q ss_pred             CCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCC
Q 015898          227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWA  303 (398)
Q Consensus       227 kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~  303 (398)
                      ||+|||+   +.++.+||+|||+|......  .....+|+.|+|||++.+   .++.++|||||||++|||++|..||.+
T Consensus       221 kp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999999   88899999999999876432  225567799999999974   589999999999999999999999976


Q ss_pred             cChHHH--HHH---HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          304 ETQQGI--FDA---VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       304 ~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      ......  +..   .......+....++.+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            643211  000   01111122223335789999999999999999999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-48  Score=369.87  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=211.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||+||+|.+  ++..||||++..... .....+.+.+|+.++++++ ||||+++++++.....++
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceE
Confidence            446799999999999999999985  688999999875433 5666788999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          177 IVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      +||||+++++|.+++...+.   +++..+..++.||+.||.|||+.|  |+||||||+|||+   +.++.+||+|||++.
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCc
Confidence            99999999999999976553   899999999999999999999999  9999999999999   888999999999997


Q ss_pred             ecCCCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          252 FFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       252 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.......  .....++
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~  265 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRNLN  265 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTTSC
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCC
Confidence            654332 2345689999999999985 58999999999999999999999999888877777664333222  2223588


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc--CCCccCCCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLC--HPWICENGVA  365 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~--hp~~~~~~~~  365 (398)
                      +++.+||.+||+.||++|||+.++++  .++++....+
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998  6777665433

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-48  Score=368.54  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=218.4

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.+. ||||+++++++...+..
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeE
Confidence            4567799999999999999999999999999999998654   3445678899999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcccc
Confidence            999999999999988865 4569999999999999999999999999999999999999   788899999999875322


Q ss_pred             CC-CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          255 PG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .. .......||+.|+|||++.      ..++.++|||||||++|+|++|..||...........+........ .....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  247 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSK  247 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGG
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccc
Confidence            11 1223467899999999983      3588999999999999999999999998887777766665543221 11235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ++.++.+||.+||+.||++|||+.++++||||.+..
T Consensus       248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            789999999999999999999999999999998755

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-48  Score=371.15  Aligned_cols=264  Identities=24%  Similarity=0.367  Sum_probs=219.7

Q ss_pred             ccccceecceecccCceEEEEEEEc-cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEe---
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYE---  170 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~---  170 (398)
                      ..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.+.  +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4467999999999999999999985 6789999999875432 2222235667888887773  4999999999987   


Q ss_pred             --cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          171 --DSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       171 --~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                        .....++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEec
Confidence              5677999999997 59999987753  48999999999999999999999999999999999999   8888999999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-----C
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----F  320 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~  320 (398)
                      ||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......     +
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999987665545566789999999999874 5899999999999999999999999988877777666532100     0


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          321 ------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       321 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                                        .......++.++.+||.+||+.||++|||+.|+|+||||.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                              011124578999999999999999999999999999999886543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.9e-49  Score=364.83  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=223.1

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe--cCCeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCV  175 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~--~~~~~  175 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++.  ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence            3569999999999999999999999999999999975433 4566788999999999997 999999999874  46789


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEeecCCCccEEEee
Q 015898          176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~al~~lH~~~-----iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.|     |+||||||+||++   +.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence            9999999999999998653    34999999999999999999999999     9999999999999   8888999999


Q ss_pred             cCCceecCCCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC
Q 015898          247 FGLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       247 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (398)
                      ||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---  236 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---  236 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence            99997655432 2334678999999999875 589999999999999999999999998888888887777654322   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ...++.++.+||.+||+.||++|||+.|+|+|+|+.+...
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            2357899999999999999999999999999999987653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.8e-50  Score=383.91  Aligned_cols=261  Identities=23%  Similarity=0.441  Sum_probs=224.6

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHh--------------hHHHHHHHHHHHHHhcCCCC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE--------------DVEDVRREIQIMHHLAGHKN  161 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~Ei~~l~~l~~h~n  161 (398)
                      .+.++|++.+.||+|+||.||+|.+  +++.||||++.........              ..+.+.+|+.+++.+. |||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~  104 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY  104 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence            3456799999999999999999997  8999999998754332211              1278999999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEE
Q 015898          162 IVTIKGAYEDSLCVHIVMELCAGGELFDR------IIQ--RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFL  232 (398)
Q Consensus       162 iv~l~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIl  232 (398)
                      |+++++++.+.+..++||||+++++|.++      +..  ...+++..+..++.||+.||.|||+ .||+||||||+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999987      655  5679999999999999999999999 99999999999999


Q ss_pred             EeecCCCccEEEeecCCceecCCCCcccccccCCcccCccccccc--CCC-cccHHHHHHHHHHHHhCCCCCCCcCh-HH
Q 015898          233 LVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--YGP-EADVWTAGVILYILLSGVPPFWAETQ-QG  308 (398)
Q Consensus       233 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwSlG~il~elltg~~pf~~~~~-~~  308 (398)
                      +   +.++.+||+|||++...... ......||+.|+|||++.+.  ++. ++|||||||++|+|++|..||..... .+
T Consensus       185 ~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 M---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             E---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             E---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9   88889999999999876544 44567899999999999753  555 99999999999999999999987776 77


Q ss_pred             HHHHHHcCCCcCCCCC---------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          309 IFDAVLKGHIDFESDP---------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ....+..+...++...               ...++.++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            7777777665554321               145789999999999999999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.3e-48  Score=371.29  Aligned_cols=262  Identities=29%  Similarity=0.410  Sum_probs=216.4

Q ss_pred             ccccccccceecceecccCceEEEEEEE-ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC------CeeEE
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTE-IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK------NIVTI  165 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~------niv~l  165 (398)
                      ..+.+.++|++.+.||+|+||.||+|.+ ..+++.||||++..    .....+.+.+|+.+++.+. |+      +++++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~   82 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLN-TTDPNSTFRCVQM   82 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhh-hcCCCCceeeEee
Confidence            3445677899999999999999999998 56889999999863    3445678889999999887 54      59999


Q ss_pred             eEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-----
Q 015898          166 KGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-----  238 (398)
Q Consensus       166 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-----  238 (398)
                      ++++...+..++||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||+...+.     
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 889999998765  6899999999999999999999999999999999999943211     


Q ss_pred             -----------CccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh
Q 015898          239 -----------DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ  306 (398)
Q Consensus       239 -----------~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~  306 (398)
                                 ++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       56799999999987543  2345789999999999875 589999999999999999999999988777


Q ss_pred             HHHHHHHHcCCCcCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCCCC
Q 015898          307 QGIFDAVLKGHIDFES----------------------------------------DPWPLISDSAKDLIRKMLCSQPSE  346 (398)
Q Consensus       307 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~L~~dP~~  346 (398)
                      .+....+.......+.                                        ......++++.+||.+||+.||++
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            6655444321111000                                        001123467899999999999999


Q ss_pred             CCCHHHHhcCCCccCC
Q 015898          347 RLTAHEVLCHPWICEN  362 (398)
Q Consensus       347 Rps~~eiL~hp~~~~~  362 (398)
                      |||+.|+|+||||+..
T Consensus       320 Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          320 RITLREALKHPFFDLL  335 (339)
T ss_dssp             SCCHHHHTTSGGGGGG
T ss_pred             ccCHHHHhcCHHHHHH
Confidence            9999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-48  Score=377.41  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=217.5

Q ss_pred             ccccceecceecccCceEEEEEEEc-------cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-------ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..++|++.+.||+|+||.||+|.+.       .++..||||++....  .....+.+.+|+.+++.+.+||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3467999999999999999999875       345679999996542  4556778999999999995599999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      ...+.+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999997653                47899999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~  308 (398)
                         +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|||++ |..||.+....+
T Consensus       237 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          237 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             ---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence               888999999999998765432   2234567789999999875 59999999999999999999 999999988888


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ....+..+...   .....++.++.+||.+||+.||++|||+.|++++
T Consensus       314 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            88777766432   2223578999999999999999999999999863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.9e-49  Score=371.23  Aligned_cols=262  Identities=28%  Similarity=0.416  Sum_probs=199.1

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcE
Confidence            3456999999999999999999998899999999986443  2344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          177 IVMELCAGGELFDRIIQ--------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      +||||+++++|.+++..        ...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEecc
Confidence            99999999999998864        3558999999999999999999999999999999999999   888899999999


Q ss_pred             CceecCCCC------cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC
Q 015898          249 LSVFFKPGQ------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       249 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                      ++.......      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||...................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            987654321      2234678999999999874  58999999999999999999999998877666655554443221


Q ss_pred             C------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          321 E------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       321 ~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      .      ......++.++.+||.+||+.||++|||+.|+++||||.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            1      1223457899999999999999999999999999999987553

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.6e-49  Score=379.18  Aligned_cols=260  Identities=28%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~----  173 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....    ......+|+..+..+. ||||+++++++....    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccc
Confidence            3569999999999999999999999999999999865322    2235567788888887 999999999986433    


Q ss_pred             ---eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCcEEEeecCC-CccEE
Q 015898          174 ---CVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACH--SLGVMHRDLKPENFLLVNKDD-DFSLK  243 (398)
Q Consensus       174 ---~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~al~~lH--~~~iiHrDikp~NIll~~~~~-~~~~k  243 (398)
                         .+++||||+++ +|...+.    ....+++..+..++.|++.||.|||  +.||+||||||+|||+   +. ++.+|
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~~k  172 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---NEADGTLK  172 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE---ETTTTEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE---eCCCCcEE
Confidence               38899999976 5544443    4567899999999999999999999  9999999999999999   54 78999


Q ss_pred             EeecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-
Q 015898          244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-  320 (398)
Q Consensus       244 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-  320 (398)
                      |+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+..+.+..... 
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            999999988776666667789999999999864  38999999999999999999999999888877776665421000 


Q ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          321 ---------------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       321 ---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                                                 ........++++.+||.+||+.||++|||+.|+|+||||++.....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                       0011112567899999999999999999999999999999865443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=367.15  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....     ..+.+.+|+.+++.+. ||||+++++++...+..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            35567999999999999999999999999999999986432     3467889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++. ....+++..+..++.+|+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence            99999999999999886 45679999999999999999999999999999999999999   788899999999997765


Q ss_pred             CCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ... ......||+.|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .......++.++
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  255 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNF  255 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHH
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHH
Confidence            432 2345678999999999875 5899999999999999999999999887766555544443221 111223468999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      .+||.+||+.||.+|||+.++|+||||.+..
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            9999999999999999999999999998765

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.3e-49  Score=382.48  Aligned_cols=259  Identities=24%  Similarity=0.383  Sum_probs=209.6

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc-------CCCCeeEE
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-------GHKNIVTI  165 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-------~h~niv~l  165 (398)
                      ..+.+.++|++.+.||+|+||+||+|.+..+++.||||++..    .....+.+.+|+.+++.+.       +|+||+++
T Consensus        31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            344567889999999999999999999999999999999863    3455678899999999996       27889999


Q ss_pred             eEEEe----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCC
Q 015898          166 KGAYE----DSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       166 ~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~  238 (398)
                      ++++.    ....+++||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||+   +.
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll---~~  182 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL---SV  182 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE---CC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE---ec
Confidence            99987    567899999999 66777777654  4699999999999999999999998 99999999999999   54


Q ss_pred             Cc-------------------------------------------------cEEEeecCCceecCCCCcccccccCCccc
Q 015898          239 DF-------------------------------------------------SLKAIDFGLSVFFKPGQIFTDVVGSPYYV  269 (398)
Q Consensus       239 ~~-------------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~gt~~y~  269 (398)
                      ++                                                 .+||+|||++......  .....||+.|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~  260 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYR  260 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGC
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCccc
Confidence            43                                                 7999999999876532  45668999999


Q ss_pred             Ccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh------HHHHHHHHcC--C----------Cc---CC------
Q 015898          270 APEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ------QGIFDAVLKG--H----------ID---FE------  321 (398)
Q Consensus       270 aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~------~~~~~~~~~~--~----------~~---~~------  321 (398)
                      |||++.+ .++.++|||||||++|+|++|..||.....      ...+..+...  .          ..   +.      
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999985 599999999999999999999999975442      2222222110  0          00   00      


Q ss_pred             --C---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          322 --S---------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       322 --~---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                        .               ......+.++.+||.+||+.||++|||+.|||+||||.+
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence              0               000123457889999999999999999999999999963

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-48  Score=363.97  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=212.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-----
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-----  171 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++..    .....+.+.+|+.+++.+. ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            45679999999999999999999999999999999854    3455678999999999997 9999999998854     


Q ss_pred             --------CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccE
Q 015898          172 --------SLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       172 --------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~  242 (398)
                              ....|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    457899999999999999997644 57889999999999999999999999999999999999   888899


Q ss_pred             EEeecCCceecCCC---------------CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCC-c
Q 015898          243 KAIDFGLSVFFKPG---------------QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWA-E  304 (398)
Q Consensus       243 kL~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~-~  304 (398)
                      ||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||.. .
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765421               22345678999999999874  58999999999999999998   5543 3


Q ss_pred             ChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      ........+......++.......+..+.+||.+||+.||++|||+.++++||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            3445566666666666655556678889999999999999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-48  Score=373.82  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=216.6

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCC-cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC------eeEE
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN------IVTI  165 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n------iv~l  165 (398)
                      ..+.+.++|++.+.||+|+||.||+|.+..++ +.||+|++..    .....+.+.+|+.+++.+. |++      ++.+
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~   87 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIK-EKDKENKFLCVLM   87 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHh-hcCCCCceeEEEe
Confidence            44557788999999999999999999998777 6899999864    3445677889999999997 555      9999


Q ss_pred             eEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec-------
Q 015898          166 KGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-------  236 (398)
Q Consensus       166 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~-------  236 (398)
                      ++++...+..++||||+ +++|.+.+....  .+++..+..++.||+.||.|||++||+||||||+|||+...       
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            99999999999999999 667778776653  69999999999999999999999999999999999999432       


Q ss_pred             ---------CCCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh
Q 015898          237 ---------DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ  306 (398)
Q Consensus       237 ---------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~  306 (398)
                               +.++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.....
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     2467899999999987543  2355789999999999875 689999999999999999999999988777


Q ss_pred             HHHHHHHHcCCCcCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCCCC
Q 015898          307 QGIFDAVLKGHIDFES----------------------------------------DPWPLISDSAKDLIRKMLCSQPSE  346 (398)
Q Consensus       307 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~L~~dP~~  346 (398)
                      .+....+.+.....+.                                        ......+.++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            6655544332111100                                        000112457899999999999999


Q ss_pred             CCCHHHHhcCCCccCCC
Q 015898          347 RLTAHEVLCHPWICENG  363 (398)
Q Consensus       347 Rps~~eiL~hp~~~~~~  363 (398)
                      |||+.|+|+||||.+..
T Consensus       325 Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLT  341 (355)
T ss_dssp             SCCHHHHTTSGGGGGCC
T ss_pred             CcCHHHHhcChhhcCCC
Confidence            99999999999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=372.84  Aligned_cols=259  Identities=28%  Similarity=0.437  Sum_probs=215.4

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe-
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC-  174 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~-  174 (398)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++..... 
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence            45678999999999999999999999999999999996532 35556778999999999997 9999999999987654 


Q ss_pred             -----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          175 -----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       175 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                           +|+||||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence                 599999996 58877663  358999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC---------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI---------  318 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~---------  318 (398)
                      +......  .....+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.+...         
T Consensus       173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9765432  345688999999999874  589999999999999999999999998877666655543100         


Q ss_pred             ------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          319 ------------------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       319 ------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                        .......+.+++++.+||.+||+.||++|||+.|+|+||||.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                              0011123457899999999999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.9e-48  Score=367.74  Aligned_cols=250  Identities=22%  Similarity=0.324  Sum_probs=215.2

Q ss_pred             ccccceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..++|++.+.||+|+||.||+|.+..++.   .||||++....  .....+.+.+|+.+++.+. ||||+++++++...+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            34679999999999999999999886555   49999996432  5566778999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ..++||||+++++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence            999999999999999998654 579999999999999999999999999999999999999   8889999999999987


Q ss_pred             cCCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          253 FKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       253 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      .....    ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||......+....+..+....   ...
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  277 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APM  277 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCC
Confidence            65432    1223455778999999974 68999999999999999999 999999999888888887763322   223


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+++++.+||.+||+.||++|||+.++++
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            58899999999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=377.53  Aligned_cols=260  Identities=23%  Similarity=0.282  Sum_probs=220.7

Q ss_pred             cccccceecceecccCceEEEEEE-----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ...++|++.+.||+|+||.||+|.     +..+++.||||++...  ........+.+|+.+++.+. ||||+++++++.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            345679999999999999999999     4557789999998533  25566678999999999997 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEE
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRG-------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~k  243 (398)
                      .....++||||+++|+|.+++....       .+++..+..++.||+.||.|||++||+||||||+|||+..++.+..+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999997653       489999999999999999999999999999999999994333555699


Q ss_pred             EeecCCceecCC---CCcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCC
Q 015898          244 AIDFGLSVFFKP---GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (398)
Q Consensus       244 L~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  318 (398)
                      |+|||++.....   ........||+.|+|||++. ..++.++|||||||++|||++ |..||......+....+..+..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999975421   12233466789999999987 469999999999999999998 9999999998888888877653


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      ...   ...++.++.+||.+||+.||++|||+.+|++|.++..
T Consensus       305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            322   2357899999999999999999999999999987754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.5e-48  Score=375.76  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=208.7

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEeccccc--------CCHhhHHHHHHHHHHHHHhcCCCCeeEEeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--------ISREDVEDVRREIQIMHHLAGHKNIVTIKG  167 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~  167 (398)
                      .+.++|++.+.||+|+||.||+|.+. +++.||||++.....        ......+.+.+|+.+++++. ||||+++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~   96 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRD   96 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceee
Confidence            45678999999999999999999975 499999999865322        12334578999999999997 999999999


Q ss_pred             EEe-----cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc
Q 015898          168 AYE-----DSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       168 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                      ++.     ....+|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCC
Confidence            984     3457899999997 5888877654 369999999999999999999999999999999999999   88889


Q ss_pred             EEEeecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCC-
Q 015898          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-  318 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-  318 (398)
                      +||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+..... 
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999987665555566789999999998874  589999999999999999999999998887776666543110 


Q ss_pred             -----------------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          319 -----------------------DFESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       319 -----------------------~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                             ..+..    ..+.+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                                   00000    1134678999999999999999999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.6e-48  Score=367.91  Aligned_cols=265  Identities=22%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..++|++.+.||+|+||.||+|.+..++.   .||||++..... .....+.+.+|+.+++.+. ||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence            44579999999999999999999877765   899999865433 3455788999999999997 999999999998776


Q ss_pred             eE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc
Q 015898          174 CV------HIVMELCAGGELFDRIIQRG------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       174 ~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                      ..      ++||||+++++|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||+   ++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence            55      99999999999999886543      58999999999999999999999999999999999999   88899


Q ss_pred             EEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcC
Q 015898          242 LKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG  316 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~  316 (398)
                      +||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+.........+..+
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999987644332   223456778999999875 58999999999999999999 99999988888888887766


Q ss_pred             CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCccCCCCCCCCC
Q 015898          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLT-------AHEVLCHPWICENGVAPDRS  369 (398)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~eiL~hp~~~~~~~~~~~~  369 (398)
                      .....   .+.+++++.+||.+||+.||++|||       +++++.|||+......|...
T Consensus       256 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~  312 (323)
T 3qup_A          256 NRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYI  312 (323)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------------
T ss_pred             CCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCC
Confidence            53222   2357899999999999999999999       78889999998877665543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3e-48  Score=369.35  Aligned_cols=256  Identities=29%  Similarity=0.548  Sum_probs=217.2

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---hhHHHHHHHHHHHHHhc-CCCCeeEEeEEE
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLA-GHKNIVTIKGAY  169 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~-~h~niv~l~~~~  169 (398)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++........   ...+.+.+|+.+++++. +|+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34466789999999999999999999999999999999976543221   12245678999999997 379999999999


Q ss_pred             ecCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEEEeec
Q 015898          170 EDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDF  247 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~DF  247 (398)
                      ...+..++|||++.+ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   + +++.+||+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~~kL~Df  194 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDF  194 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTTEEEECCC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE---eCCCCCEEEeeC
Confidence            999999999999976 8999999988889999999999999999999999999999999999999   5 6689999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      |++...... ......||+.|+|||++.+ . ++.++|||||||++|||++|..||....      .+......+.    
T Consensus       195 g~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----  263 (320)
T 3a99_A          195 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----  263 (320)
T ss_dssp             TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----
T ss_pred             ccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----
Confidence            999876543 3455779999999999874 3 4688999999999999999999996542      2223332222    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ..+++++.+||.+||+.||++|||+.|+++||||.+..
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            35789999999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-48  Score=373.20  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=211.1

Q ss_pred             ccccceecceecccCceEEEEEE-----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.     +..+++.||||++....  .....+.+.+|+.++.++.+||||+++++++..
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            45679999999999999999998     55677899999996432  455667899999999999769999999999887


Q ss_pred             CC-eEEEEEeccCCCChHHHHHhcCC------------------------------------------------------
Q 015898          172 SL-CVHIVMELCAGGELFDRIIQRGH------------------------------------------------------  196 (398)
Q Consensus       172 ~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  196 (398)
                      .+ .+++||||+++|+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 48999999999999999976543                                                      


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC---cccc
Q 015898          197 ------------YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTD  261 (398)
Q Consensus       197 ------------~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~---~~~~  261 (398)
                                  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......   ....
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhccc
Confidence                        8999999999999999999999999999999999999   788899999999998654332   2345


Q ss_pred             cccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHh
Q 015898          262 VVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (398)
Q Consensus       262 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  339 (398)
                      ..||+.|+|||++.+ .++.++|||||||++|||++ |..||.+..................  ....+++++.++|.+|
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHH
Confidence            678889999999874 68999999999999999998 9999987664444333333222211  2235789999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 015898          340 LCSQPSERLTAHEVLCH  356 (398)
Q Consensus       340 L~~dP~~Rps~~eiL~h  356 (398)
                      |+.||++|||+.|+++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999876

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=359.36  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=207.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      |....+||+|+||.||+|.+..+++.||||.+...   .....+.+.+|+.+++.+. ||||+++++++...+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            44456899999999999999999999999998654   3344577899999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC-CccEEEeecCCceecCCC
Q 015898          181 LCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~-~~~~kL~DFG~a~~~~~~  256 (398)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.||+||||||+||++   +. ++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI---NTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE---ECCCCCEEEeecccccccCCC
Confidence            999999999987652   46789999999999999999999999999999999999   54 678999999999876542


Q ss_pred             C-cccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHHcCCCcCCCCCCCCCCHH
Q 015898          257 Q-IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      . ......||+.|+|||++.+   .++.++||||||+++|+|++|..||....... ........  .........++++
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  254 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAE  254 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHH
Confidence            2 2345678999999999874   38899999999999999999999997643322 11111111  1112223457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||+.||++|||+.|+|+||||+...
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            99999999999999999999999999998654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=371.45  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=218.8

Q ss_pred             ccccceecceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..++|++.+.||+|+||.||+|.+..       ++..||||++...  ........+.+|+.+++.+.+||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            45679999999999999999999754       3357999999654  25666788999999999995599999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      ...+..++||||+++++|.+++....                .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999998754                48999999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~  308 (398)
                         +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus       225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               888899999999998665432   2334567889999999875 58999999999999999999 999999988888


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ....+..+.....   ...+++++.+||.+||+.||++|||+.|++++
T Consensus       302 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 LFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8888776643322   23588999999999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.1e-47  Score=359.94  Aligned_cols=262  Identities=23%  Similarity=0.422  Sum_probs=211.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcC-CCCeeEEeEEEecCCeE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-h~niv~l~~~~~~~~~~  175 (398)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.++.++.. ||||+++++++...+..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3456999999999999999999974 588999999965432 55667889999999999974 69999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   ++ +.+||+|||++.....
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---VD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ET-TEEEECCCSSSCC---
T ss_pred             EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---EC-CeEEEeeccccccccC
Confidence            99999 4588999999988889999999999999999999999999999999999999   43 6899999999987644


Q ss_pred             CC---cccccccCCcccCcccccc------------cCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCc
Q 015898          256 GQ---IFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHID  319 (398)
Q Consensus       256 ~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~  319 (398)
                      ..   ......||+.|+|||++.+            .++.++|||||||++|+|++|..||.... ....+..+......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            32   1234578999999999863            57889999999999999999999997653 33344444443332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ..  .....+.++.+||.+||+.||++|||+.|+|+||||+....+..
T Consensus       259 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          259 IE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             CC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             cC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence            22  12345789999999999999999999999999999987654443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.2e-47  Score=358.72  Aligned_cols=244  Identities=23%  Similarity=0.328  Sum_probs=207.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEE
Confidence            5699999999999999999999999999999988542   5667788999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccc
Confidence            999999999999987 5679999999999999999999999999999999999999   888999999999998764332


Q ss_pred             cc---------------cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHH-----HHHHHHcC
Q 015898          258 IF---------------TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG-----IFDAVLKG  316 (398)
Q Consensus       258 ~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-----~~~~~~~~  316 (398)
                      ..               ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......     ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            11               15679999999999985 58999999999999999999999985432110     01111111


Q ss_pred             CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .      ..+.+++++.+||.+||+.||++|||+.++++
T Consensus       243 ~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 Y------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             T------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1      12357889999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.9e-47  Score=351.83  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=215.1

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++. ||||+++++++......+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceE
Confidence            3467999999999999999999864 577899999965432    2356889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+++++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecch
Confidence            9999999999999997754 49999999999999999999999999999999999999   8889999999999987654


Q ss_pred             CCc--ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...  .....+|+.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+..+......   ..++++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHH
Confidence            432  223455678999999875 58999999999999999999 99999988888888777776544333   246899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +.++|.+||+.||++|||+.|++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.7e-48  Score=368.28  Aligned_cols=249  Identities=18%  Similarity=0.212  Sum_probs=207.7

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....     .+.+.+|+.+++.|.+||||+++++++......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            45679999999999999999999999999999999865432     2357889999999955999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc-----EEEeecCCc
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-----LKAIDFGLS  250 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~-----~kL~DFG~a  250 (398)
                      +||||+ +++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.     +||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCCTTC
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEcccc
Confidence            999999 9999999976 4679999999999999999999999999999999999999   66666     999999999


Q ss_pred             eecCCCCc--------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---hHHHHHHHHcCCC
Q 015898          251 VFFKPGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHI  318 (398)
Q Consensus       251 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~  318 (398)
                      ........        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..   ....+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            87644322        246789999999999985 58999999999999999999999998743   3344444433322


Q ss_pred             cCCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          319 DFESDP-WPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       319 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+... ...++ ++.+||.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            222111 11244 9999999999999999999988876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-47  Score=366.62  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=217.4

Q ss_pred             ccccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++..
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence            4467999999999999999999987     345899999986543  4556778999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR------------------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDik  227 (398)
                      .+..++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999763                        568999999999999999999999999999999


Q ss_pred             CCcEEEeecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCC
Q 015898          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFW  302 (398)
Q Consensus       228 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~  302 (398)
                      |+|||+   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.
T Consensus       202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          202 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999   788899999999997654322   2234567889999999874 69999999999999999999 999999


Q ss_pred             CcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +....+....+..+.....   ...++.++.+||.+||+.||++|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9988888888877654322   23578999999999999999999999999763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-47  Score=361.49  Aligned_cols=251  Identities=21%  Similarity=0.321  Sum_probs=217.2

Q ss_pred             ccccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+.     .++..||||++....  .....+.+.+|+.+++.+. ||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence            3466999999999999999999873     455899999986432  5666788999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGH------------------------YSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~~i~~al~~lH~~~iiHrDik  227 (398)
                      .+..++||||+++++|.+++.....                        +++..+..++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999986543                        8999999999999999999999999999999


Q ss_pred             CCcEEEeecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCC
Q 015898          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFW  302 (398)
Q Consensus       228 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~  302 (398)
                      |+|||+   +.++.+||+|||++........   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.
T Consensus       178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             GGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999   7788999999999987654332   234456788999999875 58999999999999999999 999999


Q ss_pred             CcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +.........+..+...   .....+++++.+||.+||+.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            88888887777665432   2224688999999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.5e-47  Score=359.36  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=209.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.+. ||||+++++++...+..|+|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEEE
Confidence            56999999999999999999999999999999997665545566788999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC---------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccccccc
Confidence            9999999999999988889999999999999999999999999999999999999   788899999999997654432 


Q ss_pred             -cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+ ...........+.++.++.+|
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l  268 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAV  268 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHHHH
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHHHH
Confidence             2345678999999999875 5899999999999999999999999877665444333 333333333445688999999


Q ss_pred             HHHhcccCCCCCC-CHHHHhc
Q 015898          336 IRKMLCSQPSERL-TAHEVLC  355 (398)
Q Consensus       336 i~~~L~~dP~~Rp-s~~eiL~  355 (398)
                      |.+||+.||++|| |++++++
T Consensus       269 i~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          269 IARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999 7887765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-47  Score=353.30  Aligned_cols=246  Identities=23%  Similarity=0.369  Sum_probs=213.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEE
Confidence            56999999999999999999975 577899999975432    2357889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccccc
Confidence            9999999999998654 458999999999999999999999999999999999999   778899999999998654432


Q ss_pred             --cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 --IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                        ......+|+.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+........   ...+++++.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  237 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY  237 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHH
Confidence              223445677899999987 469999999999999999999 9999999988888888877643322   235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +||.+||+.||++|||+.++++|
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-47  Score=372.98  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=215.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...  ......+.+.+|+.+++++. ||||+++++++...+.+++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEE
Confidence            45799999999999999999999989999999998643  24555667899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCC
Confidence            999999999999997654 59999999999999999999999999999999999999   88889999999999875443


Q ss_pred             Cccc---ccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          257 QIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       257 ~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ....   ...+++.|+|||++. +.++.++|||||||++|||++ |..||.+.........+..+....   ....++++
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  343 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPELCPDA  343 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCTTCCHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHH
Confidence            2211   123466799999987 468999999999999999998 999999888888777776654322   22357899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.+||.+||+.||++|||+.++++
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=360.06  Aligned_cols=258  Identities=24%  Similarity=0.314  Sum_probs=196.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHH-HHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~-~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....  ......+ +..+..+++.+. ||||+++++++...+..++
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEE
Confidence            56999999999999999999999999999999996543  2333333 444445566665 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+ ++.+..+... ...+++..+..++.||+.||.|||+. ||+||||||+||++   +.++.+||+|||++.....
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-----
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccC
Confidence            99999 5555554443 46799999999999999999999995 99999999999999   8888999999999987665


Q ss_pred             CCcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          256 GQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ........||+.|+|||++.      ..++.++|||||||++|+|++|..||.. ......+..+......... ....+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  256 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHMGF  256 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SSSCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-ccCCC
Confidence            55555678999999999984      3488999999999999999999999976 3455556666554433221 22357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      ++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            899999999999999999999999999999987543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-47  Score=366.14  Aligned_cols=263  Identities=24%  Similarity=0.291  Sum_probs=194.0

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHH-HHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ-IMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ......++..|+. +++.+. ||||+++++++...+..+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~-h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSD-CPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCC-CTTBCCEEEEEECSSEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCC-CCcEeeeeeEEEeCCceE
Confidence            356999999999999999999999999999999996542  3445556667777 555554 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          177 IVMELCAGGELFDRIIQ-----RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      +||||+++ +|.+++..     ...+++..+..++.+++.||.|||+. ||+||||||+|||+   +.++.+||+|||++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCc
Confidence            99999975 78777753     56799999999999999999999999 99999999999999   77889999999999


Q ss_pred             eecCCCCcccccccCCcccCccccc-----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCC-CcCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLL-----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGH-IDFESD  323 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~-~~~~~~  323 (398)
                      .............||+.|+|||++.     ..++.++|||||||++|+|++|..||...... +.+..+..+. ..+...
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            8766554445568999999999983     34899999999999999999999999764321 2222221211 112222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                      ....+++++.+||.+||+.||++|||+.|+++||||.+......
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~  297 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV  297 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHH
Confidence            23458899999999999999999999999999999987654444

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.1e-47  Score=370.17  Aligned_cols=263  Identities=22%  Similarity=0.394  Sum_probs=209.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc----------CCCCeeEEeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----------GHKNIVTIKG  167 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----------~h~niv~l~~  167 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..    .....+.+.+|+.+++++.          +||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            4579999999999999999999999999999999864    3345567889999999876          2789999999


Q ss_pred             EEecCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCcEEEeec---C
Q 015898          168 AYEDSL----CVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNK---D  237 (398)
Q Consensus       168 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~-~iiHrDikp~NIll~~~---~  237 (398)
                      ++...+    .+++|||++ +++|.+++...  ..+++..+..++.||+.||.|||++ ||+||||||+|||+...   +
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987654    799999999 88999998763  4599999999999999999999998 99999999999999542   3


Q ss_pred             CCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh------HHHH
Q 015898          238 DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ------QGIF  310 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~------~~~~  310 (398)
                      ..+.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.....      .+.+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            445899999999987653  2345689999999999985 589999999999999999999999975431      2222


Q ss_pred             HHHHcCCCcCC--------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 015898          311 DAVLKGHIDFE--------------------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHE  352 (398)
Q Consensus       311 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  352 (398)
                      ..+.......+                                      ......++.++.+||.+||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            22221000000                                      0001124568899999999999999999999


Q ss_pred             HhcCCCccCCCCCCC
Q 015898          353 VLCHPWICENGVAPD  367 (398)
Q Consensus       353 iL~hp~~~~~~~~~~  367 (398)
                      +|+||||++......
T Consensus       331 ll~hp~f~~~~~~~~  345 (373)
T 1q8y_A          331 LVNHPWLKDTLGMEE  345 (373)
T ss_dssp             HHTCGGGTTCTTCTT
T ss_pred             HhhChhhhcccCccc
Confidence            999999998654433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-47  Score=357.80  Aligned_cols=252  Identities=20%  Similarity=0.303  Sum_probs=210.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++....     ..+.+.+|+.+++.+.+|+|++++++++.....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            446678999999999999999999999999999999986432     224577899999999779999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc-----EEEeecC
Q 015898          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-----LKAIDFG  248 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~-----~kL~DFG  248 (398)
                      .++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.     +||+|||
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI---GRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CCSSSTTTTCEEECCCT
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---ccCCCCCCCeEEEEECc
Confidence            99999999 999999998754 59999999999999999999999999999999999999   44444     9999999


Q ss_pred             CceecCCCC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---ChHHHHHHHHcC
Q 015898          249 LSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKG  316 (398)
Q Consensus       249 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~~~~~  316 (398)
                      ++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.   .....+..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            998765432        1345679999999999875 5899999999999999999999999774   333444443332


Q ss_pred             CCcCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          317 HIDFE-SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       317 ~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ....+ ....+.+++++.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            21111 1112357899999999999999999999999865

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=362.77  Aligned_cols=256  Identities=29%  Similarity=0.552  Sum_probs=206.0

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---hhHHHHHHHHHHHHHhc---CCCCeeEEeEE
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLA---GHKNIVTIKGA  168 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~---~h~niv~l~~~  168 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++........   .....+.+|+.++.++.   +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4456779999999999999999999999999999999965433221   22344667999999983   39999999999


Q ss_pred             EecCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEEEee
Q 015898          169 YEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAID  246 (398)
Q Consensus       169 ~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~D  246 (398)
                      +...+..++|||+ +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   + .++.+||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~kl~d  183 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI---DLRRGCAKLID  183 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE---ETTTTEEEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE---eCCCCeEEEEE
Confidence            9999999999999 7899999999988889999999999999999999999999999999999999   5 678999999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCC
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  324 (398)
                      ||++...... ......||+.|+|||++.+ .+ +.++|||||||++|+|++|..||....      .+......++   
T Consensus       184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~---  253 (312)
T 2iwi_A          184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP---  253 (312)
T ss_dssp             CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC---
T ss_pred             cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc---
Confidence            9999876543 3456779999999999874 34 458999999999999999999996532      2223333322   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                       ..++.++.+||.+||+.||++|||+.|+++||||+....
T Consensus       254 -~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence             357899999999999999999999999999999987553

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.1e-47  Score=353.31  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=211.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+. ||||+++++++...+..++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEE
Confidence            356999999999999999999864 677899999975432    2356889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccc
Confidence            9999999999999976 4569999999999999999999999999999999999999   88889999999999865443


Q ss_pred             Cc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          257 QI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ..  .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+......   ..+++.+
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  250 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV  250 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHH
Confidence            21  22345677899999987 468999999999999999998 99999998888888888776433332   3578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .+||.+||+.||++|||+.++++|
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          251 YTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.2e-47  Score=362.98  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=211.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEE--EEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEF--ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ++|++.+.||+|+||.||+|.+..++..+  |+|.+...  ......+.+.+|+.+++++.+||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            45999999999999999999999898865  99988643  244456778999999999955999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          177 IVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||+   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            9999999999999997654                69999999999999999999999999999999999999   7788


Q ss_pred             cEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCC
Q 015898          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  318 (398)
                      .+||+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            999999999975433333344567889999999875 58999999999999999998 9999999888887777665532


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .   .....+++++.+||.+||+.||++|||+.|++++
T Consensus       260 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2   2223578999999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=364.57  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=211.5

Q ss_pred             ccccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+.     .++..||||++....  .....+.+.+|+.+++++.+||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            4467999999999999999999973     466789999996432  334557899999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRG-----------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp  228 (398)
                      .+..++||||+++++|.+++....                       .+++..+..++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            999999999999999999997643                       278999999999999999999999999999999


Q ss_pred             CcEEEeecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 015898          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWA  303 (398)
Q Consensus       229 ~NIll~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~  303 (398)
                      +|||+   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+
T Consensus       201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          201 RNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             GGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999   778899999999997654332   2234567889999999874 68999999999999999998 9999988


Q ss_pred             cChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      ......+...........  ....+++++.+||.+||+.||.+|||+.++++|..
T Consensus       278 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            765555555444433222  22357899999999999999999999999998654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.3e-47  Score=353.68  Aligned_cols=250  Identities=25%  Similarity=0.330  Sum_probs=203.0

Q ss_pred             cccccceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++.+. ||||+++++++. .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-c
Confidence            3456799999999999999999998653   4579999986432  4556778999999999997 999999999985 4


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      +..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccc
Confidence            56889999999999999997654 69999999999999999999999999999999999999   667899999999998


Q ss_pred             ecCCCCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          252 FFKPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       252 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .......  .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..+....   ..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~  241 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN  241 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCC
Confidence            7654332  23345678899999987 468999999999999999997 999999888888888777654322   2346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++++.++|.+||+.||++|||+.|+++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          242 CPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8899999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-46  Score=359.95  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=216.2

Q ss_pred             ccccceecceecccCceEEEEEEEc-------cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEI-------ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..++|++.+.||+|+||.||+|.+.       .++..||||++....  .....+.+.+|+.+++.+.+||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            3467999999999999999999975       467789999986442  5566788999999999995599999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      ...+.+++||||+++++|.+++....                .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            99999999999999999999997653                38999999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~  308 (398)
                         +.++.+||+|||++........   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus       191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence               8888999999999987654332   233456788999999874 58999999999999999999 999999888888


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ....+..+....   ....++.++.+||.+||+.||++|||+.|++++
T Consensus       268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            877776654322   223578999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.9e-47  Score=357.70  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=213.5

Q ss_pred             ccccceecceecccCceEEEEEEE-----ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||++....  .....+.+.+|+.+++++.+||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            446799999999999999999985     4577899999996543  445567899999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRG------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      .+..++||||+++++|.+++....                  .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            999999999999999999997654                  48999999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~  308 (398)
                         +.++.+||+|||++........   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.....
T Consensus       179 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence               7788999999999987654432   234556788999998874 68999999999999999999 999998766554


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .............  ....++.++.+||.+||+.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          256 KFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4444443332222  223578999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8e-47  Score=359.04  Aligned_cols=258  Identities=22%  Similarity=0.307  Sum_probs=221.4

Q ss_pred             cccccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||||++....  .......+.+|+.+++.+. ||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   98 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   98 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc
Confidence            44567999999999999999999876     467889999986432  4555677999999999997 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQR----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      ..+..++||||+++++|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCC
Confidence            999999999999999999988653          357999999999999999999999999999999999999   8888


Q ss_pred             cEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHc
Q 015898          241 SLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~  315 (398)
                      .+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999997654332   1233466889999999874 58999999999999999999 8999998888888888777


Q ss_pred             CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC------CCccCC
Q 015898          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH------PWICEN  362 (398)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h------p~~~~~  362 (398)
                      +.....   ...++.++.+||.+||+.||++|||+.|+++|      ++|.+.
T Consensus       256 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~  305 (322)
T 1p4o_A          256 GGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  305 (322)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence            654322   23578999999999999999999999999986      777653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2e-46  Score=350.47  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=206.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhh----HHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED----VEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..........    .+.+.+|+.+++++. ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            3467999999999999999999999999999999986544322222    267899999999997 99999999999776


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCcc-----EEE
Q 015898          173 LCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFS-----LKA  244 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~-----~kL  244 (398)
                      .  ++||||+++++|.+.+... ..+++..+..++.|++.||.|||++|  |+||||||+|||+   +.++.     +||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~---~~~~~~~~~~~kl  170 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL---QSLDENAPVCAKV  170 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE---SCCCTTCSCCEEE
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE---eccCCCCceeEEe
Confidence            6  6999999999998888654 46999999999999999999999999  9999999999999   44444     999


Q ss_pred             eecCCceecCCCCcccccccCCcccCccccc---ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHHcCCCc
Q 015898          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI--FDAVLKGHID  319 (398)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~  319 (398)
                      +|||++.....  ......||+.|+|||++.   ..++.++|||||||++|+|++|..||........  ...+......
T Consensus       171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  248 (287)
T 4f0f_A          171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR  248 (287)
T ss_dssp             CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred             CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence            99999975433  345678999999999984   2478999999999999999999999976554333  3333333222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                        ......+++++.+||.+||+.||++|||+.|+++
T Consensus       249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 --PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              2233468899999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.2e-47  Score=354.73  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             cccccceecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ...++|++.+.||+|+||.||+|.    +..+++.||||++...   .....+.+.+|+.++++++ ||||+++++++..
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   82 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS   82 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence            345679999999999999999998    5678999999998643   5566778999999999998 9999999999854


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                        ...+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg  159 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFG  159 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCc
Confidence              456899999999999999997754 49999999999999999999999999999999999999   677899999999


Q ss_pred             CceecCCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH----------------
Q 015898          249 LSVFFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ----------------  307 (398)
Q Consensus       249 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~----------------  307 (398)
                      ++.......    ......++..|+|||.+.+ .++.++|||||||++|+|++|..||......                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            998765432    2233456778999999874 6899999999999999999999998543221                


Q ss_pred             HHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          308 GIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .....+.....   ......+++++.+||.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          240 HLIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCc---CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            12222222221   1223468899999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-46  Score=348.21  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=201.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC-HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ++|++.+.||+|+||.||+|.+  ++..||||++....... ....+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceEE
Confidence            4699999999999999999996  48899999986543222 334578899999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCcEEEeecC-----CCccEEEeecCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLLVNKD-----DDFSLKAIDFGL  249 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iiHrDikp~NIll~~~~-----~~~~~kL~DFG~  249 (398)
                      ||||+++++|.+++. .+.+++..+..++.|++.||.|||++|   |+||||||+|||+....     .++.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999988774 457999999999999999999999999   89999999999994311     267899999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      +....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.........+.........  ...+
T Consensus       163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  239 (271)
T 3dtc_A          163 AREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PSTC  239 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Cccc
Confidence            98655433 235678999999999875 5899999999999999999999999988877777776665443332  2457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++++.+||.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            8999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.6e-47  Score=366.94  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=203.7

Q ss_pred             cccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .++|++.+.||+|+||.||+|.+.   .++..||||++....  .....+.+.+|+.+++++. ||||+++++++...+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence            356999999999999999999876   467789999986432  4556778999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence            999999999999999997654 69999999999999999999999999999999999999   88899999999999876


Q ss_pred             CCCCc----ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          254 KPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       254 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .....    .....+++.|+|||++. ..++.++|||||||++|||++ |..||......+....+..+....   ....
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP---PPMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---CCTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            44321    12234567899999987 469999999999999999998 999999988888887776653221   2235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.++.+||.+||+.||++||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            7899999999999999999999998876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.5e-47  Score=360.75  Aligned_cols=249  Identities=21%  Similarity=0.285  Sum_probs=204.6

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEE----EEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEF----ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .++|++.+.||+|+||+||+|.+..+++.+    |+|.+....  .....+.+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            356999999999999999999988887754    777664322  3445678999999999997 999999999998765


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                       .++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence             7789999999999999977 4569999999999999999999999999999999999999   6778999999999987


Q ss_pred             cCCCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          253 FKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       253 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ......   .....+|+.|+|||.+.+ .++.++|||||||++|||++ |..||.+.........+..+....   ....
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence            654332   233456789999999875 58999999999999999999 999999888877777776654322   2235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++.++.+|+.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            78999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.5e-47  Score=360.86  Aligned_cols=259  Identities=24%  Similarity=0.305  Sum_probs=216.4

Q ss_pred             ccccceecceecccCceEEEEEE-----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.     +..++..||||++...  ........+.+|+.+++++. ||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence            45679999999999999999999     5567889999998633  25566678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEE
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRG-------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                      ....|+||||+++++|.+++....       .+++..+..++.||+.||.|||+.||+||||||+|||+...+++..+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998753       4899999999999999999999999999999999999954335667999


Q ss_pred             eecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCc
Q 015898          245 IDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHID  319 (398)
Q Consensus       245 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  319 (398)
                      +|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||...........+..+...
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999987543222   2234567889999999874 68999999999999999998 99999988888888777766433


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .   ....++..+.+||.+||+.||.+|||+.++++|.|+..
T Consensus       265 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          265 D---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            2   22357899999999999999999999999999988754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.1e-47  Score=354.75  Aligned_cols=245  Identities=19%  Similarity=0.247  Sum_probs=204.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCC-------cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      ..++|++.+.||+|+||.||+|.+..++       ..||+|++...   .....+.+.+|+.+++++. ||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence            3467999999999999999999988877       47999998643   3455678999999999998 99999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc-------
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-------  241 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~-------  241 (398)
                      ...+..++||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+.   .++.       
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~  158 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPP  158 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccc
Confidence            999999999999999999999987654 99999999999999999999999999999999999994   3443       


Q ss_pred             -EEEeecCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCC-CCCCcChHHHHHHHHcCC
Q 015898          242 -LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVP-PFWAETQQGIFDAVLKGH  317 (398)
Q Consensus       242 -~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~-pf~~~~~~~~~~~~~~~~  317 (398)
                       +||+|||++......   ....+|+.|+|||++.+  .++.++|||||||++|+|++|.. ||........... ....
T Consensus       159 ~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~  234 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YEDR  234 (289)
T ss_dssp             EEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTT
T ss_pred             eeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhcc
Confidence             999999998754332   34567899999999874  48999999999999999999654 4544444443333 3332


Q ss_pred             CcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ...+    ...++++.+||.+||+.||++|||+.|+++|
T Consensus       235 ~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 HQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2222    2357889999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.4e-46  Score=353.00  Aligned_cols=252  Identities=25%  Similarity=0.450  Sum_probs=203.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.+. ||||+++++++...+..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEEE
Confidence            346999999999999999999999999999999997655556677788999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ||||+++++|.+++..    ...+++..+..++.+|+.||.|||+.||+||||||+||++   +.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeee
Confidence            9999999999998864    4568999999999999999999999999999999999999   78889999999999765


Q ss_pred             CCCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          254 KPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       254 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+..  .......+......  ......++
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  264 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYS  264 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTSC
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCcccccC
Confidence            4332 2345678999999999875 58999999999999999999999997543  33444455444322  22234678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .++.+||.+||+.||++|||+.++++
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-47  Score=372.19  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=211.8

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC--
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~--  173 (398)
                      .+.++|++.++||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.++++++ ||||+++++++....  
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence            356779999999999999999999999999999999975432  334567889999999998 999999999998655  


Q ss_pred             eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee-cCCCccEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN-KDDDFSLKAIDFGL  249 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~-~~~~~~~kL~DFG~  249 (398)
                      ..++||||+++++|.+++.....   +++..++.++.||+.||.|||+.||+||||||+|||+.. .+.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            78999999999999999875433   999999999999999999999999999999999999843 34567899999999


Q ss_pred             ceecCCCCcccccccCCcccCccccc---------ccCCCcccHHHHHHHHHHHHhCCCCCCC----cChHHHHHHHHcC
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLL---------KHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKG  316 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlG~il~elltg~~pf~~----~~~~~~~~~~~~~  316 (398)
                      +.............||+.|+|||++.         ..++.++|||||||++|||++|..||..    ....+.+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            99877666666788999999999885         3478899999999999999999999964    2334555555544


Q ss_pred             CCcC---------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          317 HIDF---------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       317 ~~~~---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ....                     .......++..+.++|.+||++||++|||++|+++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            3210                     00011124567889999999999999999999854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-46  Score=350.28  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=216.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++..    .....+.+.+|+.+++.++ ||||+++++++......+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS----CSTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc----CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEE
Confidence            44569999999999999999999999999999999864    3345678899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+++++|.+++...  ..+++..+..++.+|+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceecc
Confidence            999999999999999764  348999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCC--cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ...  ......+|+.|+|||.+. ..++.++||||||+++|+|++ |..||...........+......   .....+++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  239 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPE  239 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCCCCH
Confidence            433  223455678899999987 468999999999999999999 99999888887777777665322   22346889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+||.+||+.||.+|||+.++++
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.4e-47  Score=362.73  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=208.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcE----EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIE----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ++|++.+.||+|+||.||+|.+..+++.    ||+|.+....  .......+.+|+.+++.+. ||||+++++++. ...
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BSS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CCc
Confidence            5699999999999999999999888876    7777664322  2233456778999999997 999999999886 456


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||+.+++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence            88999999999999998764 569999999999999999999999999999999999999   88889999999999876


Q ss_pred             CCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          254 KPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       254 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....   ......+|..|+|||++. +.++.++|||||||++|+|++ |..||.+.........+..+......   ..+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  242 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QIC  242 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TTB
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---CcC
Confidence            4432   234566788999999998 469999999999999999999 99999988877777777765433222   246


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +.++.+||.+||+.||.+|||+.++++|
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999999885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.3e-46  Score=349.76  Aligned_cols=249  Identities=35%  Similarity=0.614  Sum_probs=199.6

Q ss_pred             cccccceec-ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec---
Q 015898           96 NIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (398)
Q Consensus        96 ~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~---  171 (398)
                      .+.++|.+. +.||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            345567776 7899999999999999999999999998532        3567899988666669999999999876   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          172 -SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       172 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                       ...+++||||+++++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+|||+...+.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998754  69999999999999999999999999999999999999543337899999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcC----CCcCCCCC
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG----HIDFESDP  324 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~----~~~~~~~~  324 (398)
                      ++.....                    ..++.++|||||||++|+|++|..||...............    ...++...
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9975432                    23678999999999999999999999765543322111111    11111111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCH
Q 015898          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP  372 (398)
Q Consensus       325 ~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~  372 (398)
                      +..+++++.+||.+||+.||++|||+.|+|+||||.+....+.....+
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~~  273 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHT  273 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCSH
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCcc
Confidence            135789999999999999999999999999999999877666655443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5e-46  Score=348.85  Aligned_cols=249  Identities=23%  Similarity=0.263  Sum_probs=210.1

Q ss_pred             cccceecc-eecccCceEEEEEEE--ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           98 RDLYTLGR-KLGQGQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        98 ~~~y~~~~-~iG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .++|++.+ .||+|+||.||+|.+  ..+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence            35688888 999999999999954  5667899999996543 23445678999999999997 99999999999 5567


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      .++||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeec
Confidence            89999999999999999988889999999999999999999999999999999999999   667899999999998765


Q ss_pred             CCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....    .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+..+....   ....+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  245 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGC  245 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Confidence            4432    123446788999999874 58899999999999999999 999999988888877776654322   22358


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++++.++|.+||+.||++|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-46  Score=350.38  Aligned_cols=251  Identities=28%  Similarity=0.435  Sum_probs=213.5

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec---
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~---  171 (398)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++....       +.+.+|+.+++.+. ||||+++++++..   
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc
Confidence            346677999999999999999999999899999999986432       34668999999997 9999999998854   


Q ss_pred             -------------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec
Q 015898          172 -------------SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK  236 (398)
Q Consensus       172 -------------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~  236 (398)
                                   ...+++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---  155 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---  155 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---
Confidence                         45689999999999999999754  579999999999999999999999999999999999999   


Q ss_pred             CCCccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHc
Q 015898          237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK  315 (398)
Q Consensus       237 ~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~  315 (398)
                      ++++.+||+|||++.............||+.|+|||.+.+ .++.++|||||||++|+|++|..||...  ......+..
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~  233 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD  233 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred             cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence            6678999999999988776655566789999999999875 5899999999999999999999987532  233333433


Q ss_pred             CCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                      +..      ...++.++.+||.+||+.||.+|||+.|+++|.+......
T Consensus       234 ~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          234 GII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             TCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            322      1347899999999999999999999999999988766543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-46  Score=355.03  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=210.6

Q ss_pred             ccccceecceecccCceEEEEEEE-----ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||++....  .....+.+.+|+.++.++.+||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            346799999999999999999985     3567899999996542  455667899999999999669999999999876


Q ss_pred             C-CeEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          172 S-LCVHIVMELCAGGELFDRIIQRGH----------------YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       172 ~-~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                      . ..+++||||+++++|.+++.....                +++..+..++.||+.||.|||+.||+||||||+||++ 
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-  181 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-  181 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence            5 459999999999999999987543                8999999999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH-
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG-  308 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~-  308 (398)
                        +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+..... 
T Consensus       182 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          182 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             --CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence              778899999999998654332   2234567889999999874 58999999999999999998 999998765433 


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ....+..+...   .....+++++.++|.+||+.||.+|||+.|+++|
T Consensus       260 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33333333221   1123578999999999999999999999999976

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-46  Score=343.63  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=213.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEE
Confidence            56999999999999999999975 678899999975432    2367889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccccc
Confidence            9999999999999765 468999999999999999999999999999999999999   778899999999998654322


Q ss_pred             --cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 --IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                        ......+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+.....   ...++.++.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~  235 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY  235 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHHH
Confidence              123445678899999987 468999999999999999999 8999998888888888776643322   235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +||.+||+.||++|||+.+++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          236 QIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.9e-46  Score=345.99  Aligned_cols=250  Identities=25%  Similarity=0.345  Sum_probs=208.8

Q ss_pred             ccccceecceecccCceEEEEEEEcc---CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|++....  .....+.+.+|+.+++.+. ||||+++++++.+. 
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-
Confidence            34679999999999999999998654   34469999986542  4556788999999999997 99999999998755 


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCcc
Confidence            468999999999999999765 459999999999999999999999999999999999999   6678999999999986


Q ss_pred             cCCCC--cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          253 FKPGQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       253 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .....  ......+++.|+|||++. ..++.++|||||||++|+|++ |..||......+....+..+.....   ...+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  239 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLC  239 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCC
Confidence            65432  223455678899999987 468999999999999999998 9999988777777776666543222   2357


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++.+.+||.+||+.||++|||+.|++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            8999999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.1e-46  Score=369.33  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ..+.+.|.+.++||+|+||+||.+. ..+|+.||||++...      ..+.+.+|+.+++++.+||||+++++++.....
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            3455668888999999999998754 568999999998542      235678899999988569999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec----------C
Q 015898          175 VHIVMELCAGGELFDRIIQRGHY-------SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK----------D  237 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~----------~  237 (398)
                      +|+||||+. |+|.+++......       ++..+..++.||+.||.|||++||+||||||+|||+...          +
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            999999995 6999999765432       233457899999999999999999999999999999532          2


Q ss_pred             CCccEEEeecCCceecCCCCc-----ccccccCCcccCcccccc--------cCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 015898          238 DDFSLKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLS-GVPPFWA  303 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ellt-g~~pf~~  303 (398)
                      .++.+||+|||++........     .....||+.|+|||++.+        .++.++|||||||++|||++ |..||..
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            456899999999987654321     234689999999999853        48899999999999999999 9999976


Q ss_pred             cChHHHHHHHHcCCCcCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          304 ETQQGIFDAVLKGHIDFESDP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .....  ..+..+........   ...+++++.+||.+||+.||++|||+.|+++||||..
T Consensus       243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            54433  23334333322211   1124578999999999999999999999999999965

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5e-46  Score=349.02  Aligned_cols=254  Identities=22%  Similarity=0.291  Sum_probs=205.9

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....     .+.+.+|+.+++.+.+|+++..+..++......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            356789999999999999999999999999999999865432     235789999999998344455555555788889


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...++++.+||+|||++....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            9999999 8999999874 4569999999999999999999999999999999999999544467889999999998765


Q ss_pred             CCCc--------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---hHHHHHHHHcCCCcCCC
Q 015898          255 PGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFES  322 (398)
Q Consensus       255 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~---~~~~~~~~~~~~~~~~~  322 (398)
                      ....        .....||+.|+|||.+.+ .++.++|||||||++|+|++|..||....   ....+..+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            4322        245689999999999885 58999999999999999999999997632   22333333332222221


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          323 -DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       323 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                       .....+++++.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence             112357899999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-46  Score=356.08  Aligned_cols=252  Identities=23%  Similarity=0.393  Sum_probs=211.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCCc-----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGI-----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||.||+|.+..++.     .||+|.+....  .....+.+.+|+.+++.+.+||||+++++++..
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            34669999999999999999999877664     79999986433  455677899999999999459999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR--------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~  237 (398)
                      .+..++||||+++++|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||+   +
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---T  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---E
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---C
Confidence            99999999999999999998653              357999999999999999999999999999999999999   7


Q ss_pred             CCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHH
Q 015898          238 DDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~  312 (398)
                      .++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            77899999999998654332   1234556788999999874 68999999999999999999 9999987665555544


Q ss_pred             HHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +........  ....+++++.+||.+||+.||.+|||+.|+++
T Consensus       279 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          279 LVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            444333222  22357899999999999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-46  Score=357.10  Aligned_cols=246  Identities=20%  Similarity=0.245  Sum_probs=197.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC----Ce
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----LC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~----~~  174 (398)
                      ++|++.++||+|+||.||+|.+.  ++.||||++...    ........+|+.++++++ ||||+++++++...    ..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCce
Confidence            46999999999999999999864  789999998643    233445667999999997 99999999999764    34


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCcEEEeecCCCccEEE
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL----------GVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~----------~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                      +++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.          ||+||||||+|||+   +.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEE
Confidence            7999999999999998866 4599999999999999999999999          99999999999999   88899999


Q ss_pred             eecCCceecCCCCc---ccccccCCcccCcccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcC----------
Q 015898          245 IDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAET----------  305 (398)
Q Consensus       245 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~----------  305 (398)
                      +|||++........   .....||+.|+|||++.+      .++.++|||||||++|||++|..||.+..          
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332   334679999999999874      35678899999999999999999996532          


Q ss_pred             ------hHHHHHHHHcCCCcCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          306 ------QQGIFDAVLKGHIDFESDP-W--PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       306 ------~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                            .......+........... +  ...++++.+||.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  1222222222222111110 0  012345999999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.6e-46  Score=374.81  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=215.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++.+.||+|+||.||+|.+..++..||||++....    ...+.+.+|+.+|+++. ||||+++++++.....+++
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEE
Confidence            456999999999999999999999899999999986532    23578999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccC
Confidence            99999999999999764  458999999999999999999999999999999999999   7888999999999987654


Q ss_pred             CCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ...  .....++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+..+...   .....++++
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  447 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPEK  447 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHH
Confidence            332  22344567899999987 469999999999999999999 99999988888877777654322   223468899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +.+||.+||+.||++|||+.++++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.7e-46  Score=348.56  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=203.7

Q ss_pred             cccceecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC-
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~-  172 (398)
                      .++|++.+.||+|+||.||+|.    +..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            3559999999999999999998    56789999999997543  3445678999999999997 99999999999876 


Q ss_pred             -CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          173 -LCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       173 -~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                       ..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT  173 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccc
Confidence             678999999999999999954 4569999999999999999999999999999999999999   66789999999999


Q ss_pred             eecCCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc--------------C-hHHHH
Q 015898          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE--------------T-QQGIF  310 (398)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~--------------~-~~~~~  310 (398)
                      .......    ......||..|+|||++.+ .++.++|||||||++|+|++|..|+...              . .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            8765543    2234567888999999874 5889999999999999999999875321              1 11222


Q ss_pred             HHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+..+.   .......+++++.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222222   11223468899999999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=352.98  Aligned_cols=251  Identities=20%  Similarity=0.334  Sum_probs=208.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCC----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ...+|++.+.||+|+||.||+|.+..++    ..||||++....  .......+.+|+.+++.+. ||||+++++++...
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence            3456999999999999999999976553    459999986432  4556678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 LCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      +..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence            9999999999999999998764 569999999999999999999999999999999999999   888899999999998


Q ss_pred             ecCCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          252 FFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       252 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      ......    ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||......+....+..+....   ..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~---~~  272 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---TP  272 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC---Cc
Confidence            764332    1123345778999999874 68999999999999999999 999999888888888777653221   22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ..++.++.+||.+||+.||++||++.+++++
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3578999999999999999999999998764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-47  Score=359.46  Aligned_cols=253  Identities=21%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++...   .....+.+.+|+.+++.+. ||||+++++++...+..+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTCCE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEE
Confidence            445699999999999999999995 57899999988654   3345678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          177 IVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      +||||+++++|.+++....    .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccccc
Confidence            9999999999999886543    48999999999999999999999999999999999999   8889999999999986


Q ss_pred             cCCC---CcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHH-------HHHHcCCCcC-
Q 015898          253 FKPG---QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIF-------DAVLKGHIDF-  320 (398)
Q Consensus       253 ~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-------~~~~~~~~~~-  320 (398)
                      ....   .......||+.|+|||++. ..++.++|||||||++|+|++|..||......+..       .....+.... 
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            4422   2234456899999999987 46999999999999999999999999765432211       1111111110 


Q ss_pred             -----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015898          321 -----ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHP  357 (398)
Q Consensus       321 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp  357 (398)
                           .....+.++..+.+++.+||+.||++|||+.|+++|.
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                 0111122456789999999999999999999999764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.5e-46  Score=342.27  Aligned_cols=245  Identities=18%  Similarity=0.256  Sum_probs=210.9

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--CeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--~~~  175 (398)
                      .++|++.+.||+|+||.||+|.+  ++..||||++.... .+....+.+.+|+.++++++ ||||+++++++...  ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCe
Confidence            35699999999999999999996  48899999997543 25566778999999999997 99999999999877  789


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          176 HIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      ++||||+++++|.+++....  .+++..+..++.||+.||.|||+.|  |+||||||+||++   +.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKF  161 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCC
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecccee
Confidence            99999999999999998765  4899999999999999999999999  9999999999999   888899999998876


Q ss_pred             ecCCCCcccccccCCcccCccccccc-C---CCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLKH-Y---GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ....    ....||+.|+|||++.+. +   +.++|||||||++|+|++|..||.+.........+........  ....
T Consensus       162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (271)
T 3kmu_A          162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPG  235 (271)
T ss_dssp             TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTT
T ss_pred             eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCC
Confidence            5332    345789999999998742 3   3479999999999999999999998888777766665543322  2346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++++.++|.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8899999999999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-46  Score=346.15  Aligned_cols=249  Identities=24%  Similarity=0.308  Sum_probs=211.7

Q ss_pred             ccceecc-eecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGR-KLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~-~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||++....  .....+.+.+|+.+++.+. ||||+++++++. .+..
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE-SSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEec-CCCc
Confidence            4566666 9999999999999854  467889999996542  5566788999999999997 999999999994 5568


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeec
Confidence            9999999999999988654 459999999999999999999999999999999999999   667899999999998765


Q ss_pred             CCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||......+....+..+....   ..+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~  238 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPEC  238 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTTC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCCCc
Confidence            4322    123456789999999874 58999999999999999998 999999888888877777654322   22468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLCHP  357 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~hp  357 (398)
                      ++++.+||.+||+.||++|||+.++++|.
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            89999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=372.91  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=197.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|.+.++||+|+||+||. ....+++.||||++.....      ..+.+|+.+|+.+.+||||+++++++.+....|+||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            489999999999999764 3357899999999864321      235679999999956999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC--CCccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~--~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||+. ++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||+...+  ....+||+|||+|......
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9995 69999887654 356667789999999999999999999999999999995332  2346889999999876543


Q ss_pred             C----cccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          257 Q----IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       257 ~----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .    .....+||+.|+|||++.+    .++.++|||||||++|||++ |..||...........+...... .......
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~  255 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD-CLHPEKH  255 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT-TSCTTCH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc-ccCcccc
Confidence            2    2345789999999999862    47889999999999999999 88998665544333222221111 1111122


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .+..+.+||.+||+.||++|||+.|||+||||...
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            35668999999999999999999999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-45  Score=367.52  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=208.1

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-eEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CVH  176 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-~~~  176 (398)
                      .++|++.+.||+|+||.||+|.+  +++.||||++....     ..+.+.+|+.++++++ ||||+++++++.... .+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceE
Confidence            35699999999999999999986  47799999996432     3567899999999997 999999999986654 799


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccc
Confidence            99999999999999987654  7999999999999999999999999999999999999   888999999999998654


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ..  .....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+....+....+.++...   .....+++++
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l  415 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAV  415 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTTCCHHH
T ss_pred             cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHH
Confidence            32  233467889999999874 69999999999999999998 99999988888888877765322   2234688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+||.+||+.||++|||+.++++
T Consensus       416 ~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          416 YDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.5e-46  Score=351.09  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=204.2

Q ss_pred             cccceecceecccCceEEEEEEEcc---CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC-
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~-  173 (398)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++.... ......+.+.+|+.+++++. ||||+++++++.... 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence            4569999999999999999998765   45689999986543 25566778999999999998 999999999997655 


Q ss_pred             ----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEE
Q 015898          174 ----CVHIVMELCAGGELFDRIIQ------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (398)
Q Consensus       174 ----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~k  243 (398)
                          ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEE
Confidence                35999999999999998843      3569999999999999999999999999999999999999   8888999


Q ss_pred             EeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCC
Q 015898          244 AIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (398)
Q Consensus       244 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~  318 (398)
                      |+|||++.......   ......+++.|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..+..
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            99999997654432   1233456788999999875 58999999999999999999 8999998888888877776643


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ..   ....+++++.+||.+||..||++|||+.+++++
T Consensus       268 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 LK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22   223578999999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.2e-46  Score=347.17  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=199.5

Q ss_pred             cccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .+...++|++.+.||+|+||.||+|.+.   ..||+|++.... ......+.+.+|+.+++.+. ||||++++++. ...
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP   92 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence            3445677999999999999999999853   359999986543 35666788999999999998 99999999955 556


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceeccc
Confidence            68999999999999998854 3569999999999999999999999999999999999999   7778999999999976


Q ss_pred             cCC---CCcccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHHcCCCcCC-CC
Q 015898          253 FKP---GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFE-SD  323 (398)
Q Consensus       253 ~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~-~~  323 (398)
                      ...   ........||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+..... ..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            542   22334567999999999985    34788999999999999999999999875544 44444444433322 22


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ....+++++.+||.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23467899999999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.2e-46  Score=352.92  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=208.5

Q ss_pred             cccceecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe--c
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--D  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~--~  171 (398)
                      .++|++.+.||+|+||.||+|.    +..+++.||||++...   .....+.+.+|+.+++++. ||||+++++++.  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence            3579999999999999999998    5678999999998653   4566678999999999997 999999999886  5


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          172 SLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      ...+++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence            6679999999999999999976 4569999999999999999999999999999999999999   67789999999999


Q ss_pred             eecCCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---------------HHH
Q 015898          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GIF  310 (398)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------------~~~  310 (398)
                      .......    ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            8765433    2234567888999999875 5899999999999999999999998654322               222


Q ss_pred             HHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh---cCCCccCC
Q 015898          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL---CHPWICEN  362 (398)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL---~hp~~~~~  362 (398)
                      ..+..+..   ......+++++.+||.+||+.||++|||+.|++   +..|....
T Consensus       255 ~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          255 ELLEEGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHhhcccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            22222221   122346889999999999999999999999995   44554443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=352.62  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=205.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe----cCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----DSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~----~~~  173 (398)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.+++.+. ||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCc
Confidence            35699999999999999999999999999999998643   4566788999999999997 999999999986    345


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      ..++||||+++++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCc
Confidence            78999999999999998876    4669999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCC----------cccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHH
Q 015898          250 SVFFKPGQ----------IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAV  313 (398)
Q Consensus       250 a~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~  313 (398)
                      +.......          ......||+.|+|||++.+    .++.++|||||||++|+|++|..||....  .......+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            87643211          1123467999999999863    27899999999999999999999995321  11122222


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHP  357 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp  357 (398)
                      .. ....  ...+.++.++.+||.+||+.||++|||+.+++++-
T Consensus       261 ~~-~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          261 QN-QLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HC-C--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hc-cCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            22 2222  22346789999999999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=352.58  Aligned_cols=248  Identities=28%  Similarity=0.424  Sum_probs=189.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-------
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-------  170 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-------  170 (398)
                      ..+|++.++||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.++.++.+||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34699999999999999999999999999999998543   45666789999999999977999999999983       


Q ss_pred             -cCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEE
Q 015898          171 -DSLCVHIVMELCAGGELFDRIIQ---RGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       171 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                       ....+++||||+. |+|.+++..   .+.+++..+..++.||+.||.|||+.|  |+||||||+|||+   +.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEE
Confidence             4456899999995 689888865   456999999999999999999999999  9999999999999   88889999


Q ss_pred             eecCCceecCCCCcc-------------cccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChH
Q 015898          245 IDFGLSVFFKPGQIF-------------TDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ  307 (398)
Q Consensus       245 ~DFG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  307 (398)
                      +|||++.........             ....||+.|+|||++.    ..++.++|||||||++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221             1456899999999983    34888999999999999999999999765443


Q ss_pred             HHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015898          308 GIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW  358 (398)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~  358 (398)
                      .....    ....  ......+..+.+||.+||+.||++|||+.|+++|-+
T Consensus       260 ~~~~~----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 RIVNG----KYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhhcC----cccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            33222    2221  222356788999999999999999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5e-46  Score=348.83  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=201.1

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....     ....+.+|+.+++.+.+|+++..+..++......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            45678999999999999999999999999999999875432     2235778999999998444455555556788899


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...++++.+||+|||++....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 8999999875 4569999999999999999999999999999999999999554567889999999998765


Q ss_pred             CCCc--------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---HHHHHHHHcCCCcCCC
Q 015898          255 PGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFES  322 (398)
Q Consensus       255 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~~  322 (398)
                      ....        .....||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+...   ...+..+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            4322        235689999999999885 589999999999999999999999976432   1223332222222111


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          323 -DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       323 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                       .....+++++.+||.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             111347899999999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.1e-46  Score=361.67  Aligned_cols=256  Identities=15%  Similarity=0.152  Sum_probs=194.9

Q ss_pred             ccccceecceecccCceEEEEEEEccC-----CcEEEEEEecccccCCHh--------hHHHHHHHHHHHHHhcCCCCee
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISRE--------DVEDVRREIQIMHHLAGHKNIV  163 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~--------~~~~~~~Ei~~l~~l~~h~niv  163 (398)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||++.........        ....+..|+..+..+. ||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence            445799999999999999999998764     588999998643210000        0012233444555565 99999


Q ss_pred             EEeEEEecC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          164 TIKGAYEDS----LCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       164 ~l~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      ++++++...    ...|+||||+ +++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+.. +.
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence            999998754    5689999999 99999999775 57999999999999999999999999999999999999932 16


Q ss_pred             CccEEEeecCCceecCCCCc--------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHH
Q 015898          239 DFSLKAIDFGLSVFFKPGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGI  309 (398)
Q Consensus       239 ~~~~kL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~  309 (398)
                      ++.+||+|||++........        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            78999999999977643221        134569999999999985 599999999999999999999999985432222


Q ss_pred             HHHHHcC----CCc-CC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          310 FDAVLKG----HID-FE--SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       310 ~~~~~~~----~~~-~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .......    ... ..  .-....+++++.+|+..||+.||++||++.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1111110    000 00  0001357899999999999999999999998875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=352.58  Aligned_cols=248  Identities=21%  Similarity=0.294  Sum_probs=204.8

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEE----EEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEF----ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~  173 (398)
                      .++|++.+.||+|+||.||+|.+..+++.|    |+|.+....  .....+.+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            356999999999999999999998888765    666554322  3445678999999999997 999999999998765


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                       .++|+||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence             78899999999999999764 569999999999999999999999999999999999999   6678999999999987


Q ss_pred             cCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          253 FKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       253 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .....   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+.....   ...
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            64332   2233456778999999875 58999999999999999999 9999998888887777766543222   235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.++.+||.+||+.||.+|||+.|+++
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7899999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.3e-45  Score=340.84  Aligned_cols=247  Identities=21%  Similarity=0.311  Sum_probs=210.9

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...++|++.+.||+|+||.||+|.+. ++..||||.+....    ...+.+.+|+.+++.+. ||||+++++++.. +..
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~   82 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPI   82 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CCc
Confidence            34567999999999999999999964 57789999986432    23467889999999997 9999999998874 458


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          176 HIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++...
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccc
Confidence            89999999999999886543  69999999999999999999999999999999999999   88889999999999876


Q ss_pred             CCCCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          254 KPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       254 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .....  .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+..+....   ....++
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  236 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCP  236 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Cccccc
Confidence            54432  23345678899999987 458999999999999999999 999999888888887776653322   223578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++.+||.+||+.||++|||+.++++
T Consensus       237 ~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          237 EELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99999999999999999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-45  Score=367.95  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=211.9

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...++|++.+.||+|+||.||+|.+. ++..||||++....    ...+.+.+|+.+++.|. ||||+++++++. ....
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCcc
Confidence            34567999999999999999999974 57789999996532    34678999999999997 999999999986 5678


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          176 HIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGB
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEc
Confidence            9999999999999999753  368999999999999999999999999999999999999   88899999999999876


Q ss_pred             CCCCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          254 KPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       254 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .....  .....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+...   .....++
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  411 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCP  411 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTSC
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            54321  12344577899999997 569999999999999999999 99999998888888887765322   2234688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++.+||.+||+.||++|||+.+|++
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHH
Confidence            99999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.4e-46  Score=348.69  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHH--hcCCCCeeEEeEEEec-
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH--LAGHKNIVTIKGAYED-  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~h~niv~l~~~~~~-  171 (398)
                      ..+.++|++.+.||+|+||.||+|.+  +++.||||++...      ....+.+|.+++..  +. ||||+++++++.. 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeeccc
Confidence            34567899999999999999999986  7899999998532      34556677777776  55 9999999998643 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEeecCCCc
Q 015898          172 ---SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH--------SLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       172 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH--------~~~iiHrDikp~NIll~~~~~~~  240 (398)
                         ...+++||||+++++|.+++. ...+++..+..++.||+.||.|||        +.||+||||||+|||+   +.++
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~  150 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNG  150 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTS
T ss_pred             cCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCC
Confidence               456899999999999999885 456999999999999999999999        9999999999999999   8888


Q ss_pred             cEEEeecCCceecCCCCc-----ccccccCCcccCccccccc-------CCCcccHHHHHHHHHHHHhC----------C
Q 015898          241 SLKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLKH-------YGPEADVWTAGVILYILLSG----------V  298 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~elltg----------~  298 (398)
                      .+||+|||++........     .....||+.|+|||++.+.       ++.++|||||||++|||++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            999999999976544322     2335899999999998742       44689999999999999999          8


Q ss_pred             CCCCCcCh----HHHHHHHHcCCCcCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          299 PPFWAETQ----QGIFDAVLKGHIDFESDP----WPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       299 ~pf~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .||.....    ..............+..+    ...+++++.+||.+||+.||++|||+.|+++
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            88854321    222222222111111110    0113467999999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-45  Score=344.60  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             cccceecceecccCceEEEEEEEccCC---cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE-ecCC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY-EDSL  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~-~~~~  173 (398)
                      ..+|++.+.||+|+||.||+|.+..++   ..||+|.+...  ......+.+.+|+.+++++. ||||+++++++ ...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence            345999999999999999999965433   46899988643  25566788999999999997 99999999985 5567


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++..
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD  177 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence            889999999999999999753 458999999999999999999999999999999999999   8888999999999986


Q ss_pred             cCCCC-----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          253 FKPGQ-----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       253 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      .....     ......+|+.|+|||.+.+ .++.++|||||||++|+|++ |.+||......+....+..+......   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence            54332     2234567788999999874 68999999999999999999 66777777777777777666544332   


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..+++++.++|.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            357899999999999999999999999886

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-45  Score=345.32  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=203.7

Q ss_pred             cccceecceecccCceEEEEEEEcc-CCc--EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA-TGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .++|++.+.||+|+||.||+|.+.. ++.  .||||++...........+.+.+|+.+++.+. ||||+++++++.... 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence            3569999999999999999998643 333  69999987654445566788999999999997 999999999998765 


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence            88999999999999998764 569999999999999999999999999999999999999   66789999999999876


Q ss_pred             CCCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          254 KPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       254 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .....    .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.......+.  ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  249 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED  249 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence            54321    223467788999999874 58899999999999999999 99999998888888887765443332  346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.++.++|.+||..||++|||+.++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            8899999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-45  Score=342.71  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=207.3

Q ss_pred             cceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE-
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV-  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~-  175 (398)
                      .|.+.++||+|+||.||+|.+..++.   .||+|++...  ......+.+.+|+.+++.+. ||||+++++++...+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCc
Confidence            47778999999999999999765554   7999998643  25566788999999999997 99999999999766554 


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccccc
Confidence            999999999999999976 4568999999999999999999999999999999999999   888899999999997654


Q ss_pred             CCC-----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCC-CCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          255 PGQ-----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       255 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ...     ......+++.|+|||.+.+ .++.++|||||||++|+|++|. +||...........+........   ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  252 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PEY  252 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Ccc
Confidence            322     2234567889999999985 5899999999999999999955 55666666666666665543222   235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7899999999999999999999999876

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.3e-46  Score=349.34  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=204.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEeccccc-CCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      |..++.||+|+||.||+|.+  +++.||||++..... ......+.+.+|+.+++.+. ||||+++++++...+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence            66679999999999999984  688999999865432 23445678999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          180 ELCAGGELFDRIIQ---RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       180 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence            99999999998864   3459999999999999999999999999999999999999   88889999999999875432


Q ss_pred             C---cccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHHcCCCcC-------CC
Q 015898          257 Q---IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAVLKGHIDF-------ES  322 (398)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~-------~~  322 (398)
                      .   ......||+.|+|||++.+.++.++|||||||++|+|++|..||.......    ....+......+       ..
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            2   223467899999999998889999999999999999999999997654322    222222211100       01


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112234678999999999999999999999863

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.4e-45  Score=347.88  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             ccccc-eecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLY-TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y-~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      +.++| ++.+.||+|+||.||+|.    +..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++.+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence            45556 999999999999998775    34578999999997542  5566778999999999998 9999999999987


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                        ...+++||||+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL  180 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred             CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence              46899999999999999988654 48999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH---------------HH
Q 015898          250 SVFFKPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GI  309 (398)
Q Consensus       250 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~---------------~~  309 (398)
                      +........    .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||......               ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            987755432    234567888999999975 5889999999999999999999998653221               11


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ...+..+..   ......++.++.+||.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            222222221   1223458899999999999999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=359.20  Aligned_cols=254  Identities=18%  Similarity=0.155  Sum_probs=196.3

Q ss_pred             ccccceecceecccCceEEEEEEEcc---CCcEEEEEEecccccCCH--------hhHHHHHHHHHHHHHhcCCCCeeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR--------EDVEDVRREIQIMHHLAGHKNIVTI  165 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~~~~--------~~~~~~~~Ei~~l~~l~~h~niv~l  165 (398)
                      ..++|++.+.||+|+||.||+|.+..   ++..||||++........        .....+.+|+.+++.+. ||||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence            34679999999999999999999887   788999999875421100        01123567888888887 9999999


Q ss_pred             eEEEec----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc-
Q 015898          166 KGAYED----SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-  240 (398)
Q Consensus       166 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~-  240 (398)
                      ++++..    ....|+||||+ +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~  189 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL---GYKNP  189 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---ESSST
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE---ccCCC
Confidence            999987    78899999999 99999999877789999999999999999999999999999999999999   4444 


Q ss_pred             -cEEEeecCCceecCCCC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc--ChHH
Q 015898          241 -SLKAIDFGLSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE--TQQG  308 (398)
Q Consensus       241 -~~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~--~~~~  308 (398)
                       .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|||++|..||...  ....
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             89999999998764321        1245689999999999885 5899999999999999999999999653  2222


Q ss_pred             HHHHHHcCCCcCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          309 IFDAVLKGHIDFES-----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       309 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ............+.     .....+++++.+||.+||..||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            21111110000000     001157899999999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-45  Score=351.53  Aligned_cols=258  Identities=23%  Similarity=0.272  Sum_probs=205.5

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++.....  ......+.+|+.+++.+. ||||+++++++......
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCC
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEEecCCce
Confidence            3456799999999999999999984 5689999999865432  222336889999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          176 HIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~al~~lH~~---~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                      ++||||+++++|.+++....    .+++..+..++.|++.||.|||+.   ||+||||||+|||+   ++++.+||+|||
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg  179 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFG  179 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCS
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCc
Confidence            99999999999999997643    389999999999999999999999   99999999999999   888899999999


Q ss_pred             CceecCCC--CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-----ChHHHHHHHHcCCCcC
Q 015898          249 LSVFFKPG--QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDF  320 (398)
Q Consensus       249 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~-----~~~~~~~~~~~~~~~~  320 (398)
                      ++......  .......||+.|+|||++.+ .++.++|||||||++|+|++|..||...     ........+ ......
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~  258 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV-KGLLKE  258 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH-TTTTSS
T ss_pred             cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH-HHHhhc
Confidence            99876433  23345669999999999874 5899999999999999999999999521     111111111 111000


Q ss_pred             -----------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          321 -----------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       321 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                                 ........+.++.+++.+||+.||.+|||+.|+++|-.-..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                       00001112367999999999999999999999999876443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-46  Score=384.32  Aligned_cols=260  Identities=26%  Similarity=0.386  Sum_probs=212.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------C
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------S  172 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------~  172 (398)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...  ......+.+.+|+.+++++. ||||+++++++..      .
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence            5699999999999999999999999999999998643  25666788999999999997 9999999998765      6


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      +..++||||+++++|.+++....   .+++..++.++.+++.||.|||+.||+||||||+||++..++....+||+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            77899999999999999997644   589999999999999999999999999999999999996544555699999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHH--------------HH
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDA--------------VL  314 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~--------------~~  314 (398)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||...........              ..
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            998776666677889999999999974 699999999999999999999999976433211100              00


Q ss_pred             cCCCcC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          315 KGHIDF------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       315 ~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                      .+...+      +......+++++.+||.+||.+||++|||+.|+|+||||..
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            111111      11112235688999999999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3e-45  Score=341.10  Aligned_cols=242  Identities=23%  Similarity=0.313  Sum_probs=200.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-CCeEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVH  176 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~~~~~  176 (398)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++...     ...+.+.+|+.+++++. ||||+++++++.. .+..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceE
Confidence            35699999999999999999985  5889999998643     24567899999999997 9999999998754 45789


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+++++|.+++...+.  +++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccc
Confidence            99999999999999976543  8999999999999999999999999999999999999   788899999999997654


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      ..  .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+..   ......+++++
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  243 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAV  243 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHH
T ss_pred             cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHH
Confidence            32  234467889999999874 58999999999999999998 9999988887777777765532   22234688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .++|.+||+.||++|||+.|+++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=357.58  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=200.1

Q ss_pred             cceecceecccCceEEEEEEEccCC---cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-cCCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-DSLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-~~~~~  175 (398)
                      .|++.+.||+|+||.||+|.+..++   ..||+|.+...  ......+.+.+|+.+++++. ||||+++++++. ..+..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCCe
Confidence            4888999999999999999976443   46899988643  24566788999999999997 999999999864 45688


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccc
Confidence            9999999999999999764 458999999999999999999999999999999999999   888999999999997654


Q ss_pred             CCC-----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          255 PGQ-----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       255 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ...     ......+|+.|+|||++.+ .++.++|||||||++|||++ |.+||......+....+..+.....   ...
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~~  320 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEY  320 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CTT
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence            322     1234566788999999874 68999999999999999999 7788877777667666666543322   235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ++.++.++|.+||+.||++|||+.|++++
T Consensus       321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          321 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78999999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-45  Score=363.04  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=209.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.++++++ ||||+++++++.. ...+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceE
Confidence            44679999999999999999999754 5679999987543    22467899999999997 9999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||++....
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecC
Confidence            99999999999999964  3569999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ....  .....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+...   .....+++
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  408 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPE  408 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            4321  22345678899999987 469999999999999999999 99999998888888887765322   22236889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLC--HPWICE  361 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~--hp~~~~  361 (398)
                      ++.+||.+||+.||++|||+.++++  ..++..
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999999999999999987  355544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9e-45  Score=375.20  Aligned_cols=243  Identities=23%  Similarity=0.257  Sum_probs=206.6

Q ss_pred             cceecccCceEEEEEEE--ccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEec
Q 015898          104 GRKLGQGQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      .+.||+|+||.||+|.+  ..+++.||||++.... ......+.+.+|+.++++|+ ||||+++++++... ..++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~-~~~lv~E~  450 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEM  450 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-CEEEEEEc
Confidence            34799999999999954  4567899999996543 34556788999999999998 99999999999754 58899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc---
Q 015898          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---  258 (398)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---  258 (398)
                      +++|+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||++........   
T Consensus       451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC------
T ss_pred             cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccccc
Confidence            9999999999988889999999999999999999999999999999999999   6778999999999987654321   


Q ss_pred             -ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHH
Q 015898          259 -FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (398)
Q Consensus       259 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  335 (398)
                       .....+|+.|+|||++.+ .++.++|||||||++|||++ |..||.+....+....+..+.....   ...+++++.+|
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~l  604 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDL  604 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHH
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence             233456788999999985 69999999999999999998 9999999998888888877653322   23588999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 015898          336 IRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       336 i~~~L~~dP~~Rps~~eiL~  355 (398)
                      |.+||+.||++|||+.+|++
T Consensus       605 i~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.7e-45  Score=366.14  Aligned_cols=254  Identities=22%  Similarity=0.278  Sum_probs=209.4

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.++||+|+||.||+|.+..+++.||||++.....     ...+.+|+.+++.|.+|+++..+..++......
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            356789999999999999999999999999999998865432     234778999999998668888888888899999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +|||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||...+.++.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8999999975 5679999999999999999999999999999999999999654567899999999998765


Q ss_pred             CCCc--------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---HHHHHHHHcCCCcCC-
Q 015898          255 PGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFE-  321 (398)
Q Consensus       255 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~~-  321 (398)
                      ....        .....||+.|+|||++.+ .++.++|||||||+||||++|..||.+...   ...+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4322        225789999999999885 589999999999999999999999976433   333333332221111 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       322 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ......++.++.+||.+||+.||++||++.+|++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1111357899999999999999999999988765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=354.37  Aligned_cols=245  Identities=14%  Similarity=0.154  Sum_probs=200.1

Q ss_pred             cccceecceecccCceEEEEEEEcc--------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeE-----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA--------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT-----  164 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~-----  164 (398)
                      .++|++.+.||+|+||.||+|.+..        +++.||||++...        +.+.+|+.+++++. ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            4679999999999999999999887        4889999998643        35778999999997 998887     


Q ss_pred             ----------EeEEEec-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcE
Q 015898          165 ----------IKGAYED-SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (398)
Q Consensus       165 ----------l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NI  231 (398)
                                +++++.. ....++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777765 78899999999 99999999875  6799999999999999999999999999999999999


Q ss_pred             EEeecCCCc--cEEEeecCCceecCCCC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCC
Q 015898          232 LLVNKDDDF--SLKAIDFGLSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPP  300 (398)
Q Consensus       232 ll~~~~~~~--~~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~p  300 (398)
                      |+   +.++  .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus       191 l~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99   6666  89999999997654321        1234589999999999985 689999999999999999999999


Q ss_pred             CCCcC--hHHHHHHHH---cCCCcCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          301 FWAET--QQGIFDAVL---KGHIDFE--SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       301 f~~~~--~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      |....  .........   .....+.  ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            98753  222222221   1111111  1112356899999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=341.66  Aligned_cols=239  Identities=27%  Similarity=0.381  Sum_probs=193.7

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||.||+|.+  .++.||||++..     ....+.+.+|+.+++++. ||||+++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEE
Confidence            4699999999999999999985  478999999853     334578899999999997 9999999998874  47899


Q ss_pred             EeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCcEEEeecCCCcc-EEEeecCCce
Q 015898          179 MELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHS---LGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSV  251 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~al~~lH~---~~iiHrDikp~NIll~~~~~~~~-~kL~DFG~a~  251 (398)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+   +||+||||||+|||+   +.++. +||+|||++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE---ETTTTEEEECCCCC--
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE---eCCCCEEEEccccccc
Confidence            99999999999997654   37899999999999999999999   899999999999999   55554 8999999997


Q ss_pred             ecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--hHHHHHHHHcCCCcCCCCCCCCC
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....  .......+..+..   ......+
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  229 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTC
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCccccc
Confidence            65432  344578999999999885 58999999999999999999999997543  2233333333322   2223468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.+.+||.+||+.||++|||+.++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            899999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=353.07  Aligned_cols=245  Identities=20%  Similarity=0.232  Sum_probs=195.3

Q ss_pred             cccceecceecccCceEEEEE-----EEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcC--CCCeeEEeEEEe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLC-----TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIVTIKGAYE  170 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~--h~niv~l~~~~~  170 (398)
                      .++|++.+.||+|+||.||+|     .+..+++.||||++...      ....+..|+.++..+..  |+||+.+++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            466999999999999999999     46788999999998643      23456777777777753  899999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee--------cC
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQ-----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN--------KD  237 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~--------~~  237 (398)
                      ..+..|+||||+++|+|.+++..     ...+++..+..++.||+.||+|||++|||||||||+|||+..        .+
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999999974     456999999999999999999999999999999999999932        11


Q ss_pred             CCccEEEeecCCceecC---CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Q 015898          238 DDFSLKAIDFGLSVFFK---PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (398)
Q Consensus       238 ~~~~~kL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~  313 (398)
                      .++.+||+|||+|....   ........+||+.|+|||++.+ .|+.++|||||||++|||++|..||........    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence            17899999999996543   3345567789999999999985 589999999999999999999999965432110    


Q ss_pred             HcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                         ......... ..++.+.+++.+||+.+|.+|++..+.|.+
T Consensus       294 ---~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          294 ---KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ---EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ---eechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence               000011111 246789999999999999999765554443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=368.61  Aligned_cols=246  Identities=24%  Similarity=0.329  Sum_probs=205.0

Q ss_pred             ccceecc-eecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGR-KLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~-~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +.+.+.+ .||+|+||.||+|.+.  .++..||||++....  .....+.+.+|+.+|++++ ||||+++++++.. +.+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCe
Confidence            3455555 8999999999999875  356679999996542  3445678999999999997 9999999999986 558


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccccc
Confidence            9999999999999998654 459999999999999999999999999999999999999   677899999999998754


Q ss_pred             CCCc----ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....    .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+...   .....+
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~  564 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPEC  564 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTTC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence            3321    12234568899999997 469999999999999999998 99999998888888888776432   222358


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHh
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVL  354 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL  354 (398)
                      ++++.+||.+||+.||++|||+.+++
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            89999999999999999999999974

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=342.28  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=193.8

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc-CCCCeeEEeEEEecC-
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-GHKNIVTIKGAYEDS-  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~h~niv~l~~~~~~~-  172 (398)
                      ..+.++|++.+.||+|+||.||+|.+  +++.||||++...      ......+|.+++..+. +||||+++++++... 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            34567799999999999999999986  4889999998532      2334555666665541 499999999999877 


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCcEEEeecCCCcc
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--------GVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~--------~iiHrDikp~NIll~~~~~~~~  241 (398)
                         ..+++||||+++++|.+++... .+++..+..++.|++.||.|||+.        ||+||||||+|||+   +.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCC
Confidence               7899999999999999998654 689999999999999999999999        99999999999999   88889


Q ss_pred             EEEeecCCceecCCCCc-----ccccccCCcccCccccccc-CCC------cccHHHHHHHHHHHHhC----------CC
Q 015898          242 LKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLKH-YGP------EADVWTAGVILYILLSG----------VP  299 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~------~~DiwSlG~il~elltg----------~~  299 (398)
                      +||+|||++........     .....||+.|+|||++.+. +..      ++|||||||++|||++|          ..
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            99999999976544322     1245799999999998753 333      38999999999999999          67


Q ss_pred             CCCCcC-----hHHHHHHHHcCCCcCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          300 PFWAET-----QQGIFDAVLKGHIDFESDP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       300 pf~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ||....     .......+...........   ...+++++.+||.+||+.||++|||+.|+++|
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            775432     1222222222211111110   01345679999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-44  Score=366.12  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=213.6

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.+|++|+ ||||+++++++.+ ..+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccce
Confidence            34679999999999999999999754 5679999997543    22467899999999998 9999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||||+++|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecC
Confidence            99999999999999964  3569999999999999999999999999999999999999   778899999999998654


Q ss_pred             CCCc--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCH
Q 015898          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (398)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (398)
                      ....  .....++..|+|||++. +.++.++|||||||+||||++ |..||.+....+.+..+..+...   .....++.
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  491 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPE  491 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            3221  12345677899999887 469999999999999999999 99999998888888887765322   22236889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC--CCccC
Q 015898          331 SAKDLIRKMLCSQPSERLTAHEVLCH--PWICE  361 (398)
Q Consensus       331 ~~~~li~~~L~~dP~~Rps~~eiL~h--p~~~~  361 (398)
                      ++.+||.+||+.||++|||+.+|++.  .+|..
T Consensus       492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            99999999999999999999999873  55543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=341.39  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             ccccceecceecccCceEEEEEE----EccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ..++|++.+.||+|+||.||+|.    +..+++.||||++...   .....+.+.+|+.+++.+. ||||+++++++...
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA  114 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence            34569999999999999999998    4678999999998653   4556678999999999997 99999999998654


Q ss_pred             C--eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 L--CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                      +  .+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL  191 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcc
Confidence            4  789999999999999999875 459999999999999999999999999999999999999   6678999999999


Q ss_pred             ceecCCCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH----------------H
Q 015898          250 SVFFKPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ----------------G  308 (398)
Q Consensus       250 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~----------------~  308 (398)
                      +........    .....++..|+|||.+.+ .++.++|||||||++|+|++|..||......                .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            987654432    223456778999999874 5889999999999999999999988542110                1


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ....+.... .  ......++.++.+||.+||+.||++|||+.|+++
T Consensus       272 ~~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNG-R--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTC-C--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCC-C--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            112222221 1  1123458899999999999999999999999984

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.7e-44  Score=344.27  Aligned_cols=248  Identities=22%  Similarity=0.287  Sum_probs=201.6

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHH--hcCCCCeeEEeEEEecCC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH--LAGHKNIVTIKGAYEDSL  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~h~niv~l~~~~~~~~  173 (398)
                      .+.++|++.+.||+|+||.||+|.+  +++.||||++..      .....+.+|++++..  +. ||||+++++++....
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS------REERSWFREAEIYQTVMLR-HENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG------GGHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc------hhHHHHHHHHHHHHHhhcC-CCcEEEEEeeecccC
Confidence            4567799999999999999999986  589999999853      234667889999987  55 999999999998776


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCcEEEeecCCCcc
Q 015898          174 ----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH--------SLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       174 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH--------~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                          .+++||||+++++|.+++.. ..+++..+..++.|++.||.|||        +.||+||||||+|||+   +.++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~  185 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT  185 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSC
T ss_pred             CccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCC
Confidence                89999999999999999875 46899999999999999999999        8999999999999999   88889


Q ss_pred             EEEeecCCceecCCCC-----cccccccCCcccCccccccc-------CCCcccHHHHHHHHHHHHhC----------CC
Q 015898          242 LKAIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLLKH-------YGPEADVWTAGVILYILLSG----------VP  299 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~elltg----------~~  299 (398)
                      +||+|||++.......     ......||+.|+|||++.+.       ++.++|||||||++|||++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999998765443     22456799999999998753       33689999999999999999          78


Q ss_pred             CCCCcC-----hHHHHHHHHcCCCcCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          300 PFWAET-----QQGIFDAVLKGHIDFESDP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       300 pf~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      ||....     .......+...........   ...+++.+.+||.+||+.||++|||+.+|++|
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            886542     2333444333322211110   01234579999999999999999999999865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=347.81  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=190.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHH--HHhcCCCCeeEEeEEEe-----c
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM--HHLAGHKNIVTIKGAYE-----D  171 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l--~~l~~h~niv~l~~~~~-----~  171 (398)
                      ++|++.+.||+|+||.||+|.+  +++.||||++...      ....+..|.+++  ..+. ||||+++++.+.     .
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLME-HDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTS
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhcc-CcchhhheecccccccCC
Confidence            4699999999999999999974  7899999998643      223344444444  4465 999999998653     3


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCcEEEeecCCCccE
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---------GVMHRDLKPENFLLVNKDDDFSL  242 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~---------~iiHrDikp~NIll~~~~~~~~~  242 (398)
                      ...+++||||+++|+|.+++.... +++..+..++.||+.||.|||+.         ||+||||||+|||+   +.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcE
Confidence            346899999999999999886654 58999999999999999999999         99999999999999   888899


Q ss_pred             EEeecCCceecCCCC---------cccccccCCcccCcccccc--------cCCCcccHHHHHHHHHHHHhCCCCCCCcC
Q 015898          243 KAIDFGLSVFFKPGQ---------IFTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLSGVPPFWAET  305 (398)
Q Consensus       243 kL~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~elltg~~pf~~~~  305 (398)
                      ||+|||++.......         ......||+.|+|||++.+        .++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998764321         2234579999999999874        36678999999999999999977763321


Q ss_pred             h-----------------HHHHHHHHcCCCcCC--CCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHH------hcCC
Q 015898          306 Q-----------------QGIFDAVLKGHIDFE--SDPW---PLISDSAKDLIRKMLCSQPSERLTAHEV------LCHP  357 (398)
Q Consensus       306 ~-----------------~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ei------L~hp  357 (398)
                      .                 ..............+  ...+   ..+++++.+||.+||+.||++|||+.|+      +-++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1                 111111111111101  1111   1134579999999999999999999999      5588


Q ss_pred             CccCCCCCCC
Q 015898          358 WICENGVAPD  367 (398)
Q Consensus       358 ~~~~~~~~~~  367 (398)
                      |-++....+.
T Consensus       320 ~~~~~~~~~~  329 (336)
T 3g2f_A          320 WERNKSVSPT  329 (336)
T ss_dssp             CCC-------
T ss_pred             HHhcccCCCc
Confidence            8887665443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-45  Score=359.84  Aligned_cols=248  Identities=17%  Similarity=0.168  Sum_probs=194.9

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CCe---------------
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNI---------------  162 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~ni---------------  162 (398)
                      ..|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. | +|.               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhh
Confidence            34888999999999999999999999999999987554444455678999999999887 5 321               


Q ss_pred             ------eEEeEEEec-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 015898          163 ------VTIKGAYED-----SLCVHIVMELCAGGELFDRIIQ-------RGHYSERKAAELTRIIVGVVEACHSLGVMHR  224 (398)
Q Consensus       163 ------v~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~~i~~al~~lH~~~iiHr  224 (398)
                            ..+..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111111111     22467888876 6799888742       2337788999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccc----------cc-cCCCcccHHHHHHHHHH
Q 015898          225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL----------LK-HYGPEADVWTAGVILYI  293 (398)
Q Consensus       225 Dikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DiwSlG~il~e  293 (398)
                      ||||+|||+   +.++.+||+|||++.....  .....+| +.|+|||++          .+ .++.++|||||||++||
T Consensus       236 DiKp~NILl---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVL---DQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEE---ecCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999   8888999999999986543  2456678 999999998          32 37889999999999999


Q ss_pred             HHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       294 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      |++|+.||...........+.        .....+++++.+||.+||+.||++|||+.++++||||++.
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            999999998765543333222        2233578999999999999999999999999999999753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-45  Score=351.32  Aligned_cols=251  Identities=19%  Similarity=0.190  Sum_probs=197.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccC-----CHhhHHHHHHHHHHHHHhc--------CCCCeeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLA--------GHKNIVT  164 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~--------~h~niv~  164 (398)
                      .++|++.+.||+|+||+||+|.+  +|+.||||++......     .....+.+.+|+.+++.|+        +||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35699999999999999999996  7899999999765321     2334578899999999886        5888888


Q ss_pred             EeEEEe------------------------------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 015898          165 IKGAYE------------------------------DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE  214 (398)
Q Consensus       165 l~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~  214 (398)
                      +.+++.                              ....+|+||||+++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            887643                              26789999999999987776644 56899999999999999999


Q ss_pred             HHH-hCCceeccCCCCcEEEeecC-----------------CCccEEEeecCCceecCCCCcccccccCCcccCcccccc
Q 015898          215 ACH-SLGVMHRDLKPENFLLVNKD-----------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK  276 (398)
Q Consensus       215 ~lH-~~~iiHrDikp~NIll~~~~-----------------~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  276 (398)
                      ||| ++||+||||||+|||+..++                 ....+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999995432                 1238999999999876543    4589999999999987


Q ss_pred             cCCCcccHHHHHHH-HHHHHhCCCCCCCcCh-HHHHHHHHcCCCcC---CCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 015898          277 HYGPEADVWTAGVI-LYILLSGVPPFWAETQ-QGIFDAVLKGHIDF---ESDPWPLISDSAKDLIRKMLCSQPSERLTAH  351 (398)
Q Consensus       277 ~~~~~~DiwSlG~i-l~elltg~~pf~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  351 (398)
                      ..+.++||||||++ .+++++|..||..... ......+.......   ....++.+++++.+||.+||++|     |+.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            77889999998877 6788889999854321 12223333211111   11112246789999999999977     999


Q ss_pred             HHh-cCCCcc
Q 015898          352 EVL-CHPWIC  360 (398)
Q Consensus       352 eiL-~hp~~~  360 (398)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=343.53  Aligned_cols=247  Identities=22%  Similarity=0.319  Sum_probs=206.2

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||.||+|.+..   .||+|++..... .....+.+.+|+.+++.+. ||||+++++++.....+++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEE
Confidence            3569999999999999999998753   499999865432 3333456778999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-  255 (398)
                      ||||+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+   + ++.+||+|||++..... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccccccc
Confidence            999999999999987654 69999999999999999999999999999999999999   5 56899999999865431 


Q ss_pred             -----CCcccccccCCcccCcccccc----------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC
Q 015898          256 -----GQIFTDVVGSPYYVAPEVLLK----------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (398)
Q Consensus       256 -----~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  320 (398)
                           ........||+.|+|||++..          .++.++|||||||++|+|++|..||...........+..+....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 122334568999999999863          37889999999999999999999999988888877776654332


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ..  ...++.++.+||.+||+.||++|||+.++++
T Consensus       263 ~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 LS--QIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22  2357889999999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.4e-43  Score=364.68  Aligned_cols=250  Identities=25%  Similarity=0.324  Sum_probs=210.2

Q ss_pred             cccccceecceecccCceEEEEEEEccC---CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ...++|++.+.||+|+||.||+|.+..+   +..||||.+...  ......+.+.+|+.+++++. ||||+++++++.+ 
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVITE-  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec-
Confidence            3456799999999999999999997643   457999988543  24556678999999999997 9999999999854 


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      +..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCe
Confidence            56899999999999999997654 68999999999999999999999999999999999999   667899999999998


Q ss_pred             ecCCCCc--ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          252 FFKPGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       252 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      .......  .....+|+.|+|||++.+ .++.++|||||||++|||++ |..||.+....+....+..+....   ..+.
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~  616 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN  616 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTT
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            7654332  223456789999999874 68999999999999999997 999999988888888877654322   2236


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +++++.+||.+||+.||++|||+.++++
T Consensus       617 ~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          617 CPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8899999999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-43  Score=331.12  Aligned_cols=229  Identities=14%  Similarity=0.064  Sum_probs=190.6

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++..+. ||||+++++++...+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence            45678999999999999999999999999999999998766555667788999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |+||||++|++|.+++.. + ....++..++.||+.||.|||++||+||||||+|||+   ++++.+||+++|       
T Consensus       107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC-------
T ss_pred             EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc-------
Confidence            999999999999998854 3 4667889999999999999999999999999999999   778889997543       


Q ss_pred             CCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHH---HHHcCCCcCCCCCCCCCCHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD---AVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  332 (398)
                                  |++|      ++.++|||||||++|+|++|..||.+......+.   ....+.........+.+++++
T Consensus       175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                        3333      6889999999999999999999998765432110   001111111111224588999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .+||.+||+.||++| |+.|+++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-43  Score=370.45  Aligned_cols=245  Identities=26%  Similarity=0.315  Sum_probs=203.6

Q ss_pred             cccccccceecceecccCceEEEEEEEcc-CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        94 ~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ...+.++|++.+.||+|+||.||+|.+.. +++.||||++...  ........+.+|+.++.++. ||||+++++++...
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT  151 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence            34566789999999999999999999976 7899999998643  24566678899999999998 99999999999866


Q ss_pred             Ce-----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          173 LC-----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       173 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                      +.     .||||||++|++|.+++..  .+++..+..++.||+.||.|||++|||||||||+|||+   +.+ .+||+||
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll---~~~-~~kl~DF  225 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML---TEE-QLKLIDL  225 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSS-CEEECCC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE---eCC-cEEEEec
Confidence            55     7999999999999887754  79999999999999999999999999999999999999   543 7999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      |++......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+......         . .......
T Consensus       226 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~-~~~~~~~  292 (681)
T 2pzi_A          226 GAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------P-EDDPVLK  292 (681)
T ss_dssp             TTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------C-TTCHHHH
T ss_pred             ccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc---------c-ccccccc
Confidence            999876543   45679999999999987779999999999999999999988865321100         0 0000112


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      .++.+.+||.+||+.||++||+..+++.|+|+.
T Consensus       293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            357899999999999999999999999888874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=4e-36  Score=306.44  Aligned_cols=190  Identities=17%  Similarity=0.151  Sum_probs=140.6

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccC-------CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-------SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ...+.|++|.+..+.....|+.||+|++.+....       .....+++.+|+++|+++..|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3578889998888888889999999999765322       133456799999999999879999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-  256 (398)
                      ||||++|++|.+.|...+++++.   .|+.||+.||+|||++|||||||||+|||+   ++++.+||+|||+|+..... 
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence            99999999999999998888765   478999999999999999999999999999   88899999999999876543 


Q ss_pred             CcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCC
Q 015898          257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP  300 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~p  300 (398)
                      ......+||+.|+|||++.+.+..++|+||+|++++++.++..+
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            34556789999999999998888999999999998877665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.2e-29  Score=257.34  Aligned_cols=183  Identities=19%  Similarity=0.160  Sum_probs=145.1

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEecccccCCHh-----hHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      ..++||+|+||.||+|.  ..+..+|+|...........     ..+++.+|+.++++++ ||||+++..++......|+
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccEE
Confidence            35689999999999994  56789999987654332222     2456899999999997 9999955555556667799


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      ||||+++++|.+++..        +..++.|++.||.|||++||+||||||+|||+   ++  .+||+|||+|+......
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEECCCHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEECCCcc
Confidence            9999999999998865        67899999999999999999999999999999   65  89999999999876543


Q ss_pred             c--------ccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCC
Q 015898          258 I--------FTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPF  301 (398)
Q Consensus       258 ~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf  301 (398)
                      .        ....+||+.|+|||++..   .|+..+|+|+..+-..+-+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2        236789999999999974   4888899999998888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.4e-26  Score=214.37  Aligned_cols=159  Identities=22%  Similarity=0.274  Sum_probs=123.7

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCH---------------hhHHHHHHHHHHHHHhcCCCCeeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---------------EDVEDVRREIQIMHHLAGHKNIVT  164 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~Ei~~l~~l~~h~niv~  164 (398)
                      .|.+.+.||+|+||.||+|.+ .+|+.||||++........               .....+.+|+.+++++. |++++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~  168 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK  168 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe
Confidence            466779999999999999998 8899999999864321110               23567899999999997 555444


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEE
Q 015898          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (398)
Q Consensus       165 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL  244 (398)
                         ++.. +..|+||||++|++|.+ +      .......++.|++.||.|||+.||+||||||+|||+   + ++.+||
T Consensus       169 ---~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vkl  233 (282)
T 1zar_A          169 ---VYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIWI  233 (282)
T ss_dssp             ---EEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEEE
T ss_pred             ---EEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEEE
Confidence               4433 45699999999999987 4      123456799999999999999999999999999999   6 789999


Q ss_pred             eecCCceecCCCCcccccccCCcccCccccc-----------ccCCCcccHHHH
Q 015898          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-----------KHYGPEADVWTA  287 (398)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----------~~~~~~~DiwSl  287 (398)
                      +|||+|..            +..|+|||.+.           ..|...+|+|.+
T Consensus       234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            99999974            34578999874           235666677654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.8e-22  Score=185.61  Aligned_cols=141  Identities=15%  Similarity=0.150  Sum_probs=108.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcE--EEEEEecccccCC---------------------HhhHHHHHHHHHHHHHh
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLIS---------------------REDVEDVRREIQIMHHL  156 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~Ei~~l~~l  156 (398)
                      .|++.+.||+|+||.||+|.+..+|+.  ||||++.......                     ......+.+|+.+|..|
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378889999999999999998788999  9999975431110                     01123678999999999


Q ss_pred             cCCCCe--eEEeEEEecCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCC
Q 015898          157 AGHKNI--VTIKGAYEDSLCVHIVMELCAG-G----ELFDRIIQRGHYSERKAAELTRIIVGVVEACH-SLGVMHRDLKP  228 (398)
Q Consensus       157 ~~h~ni--v~l~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH-~~~iiHrDikp  228 (398)
                      . |+++  +.+++.    ...+|||||+.+ |    +|.+....   .++..+..++.|++.||.||| +.||+||||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            7 7653  444442    246899999932 3    66554322   235678899999999999999 99999999999


Q ss_pred             CcEEEeecCCCccEEEeecCCceec
Q 015898          229 ENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       229 ~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      +|||+   ++  .++|+|||+|...
T Consensus       200 ~NILl---~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMY---ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEE---SS--SEEECCCTTCEET
T ss_pred             HHEEE---cC--cEEEEECcccccC
Confidence            99999   55  7999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=5.4e-19  Score=169.84  Aligned_cols=143  Identities=18%  Similarity=0.235  Sum_probs=101.4

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccC--------------CHhh-----HHHHHHHHHHHHHhcCCC
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--------------SRED-----VEDVRREIQIMHHLAGHK  160 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~-----~~~~~~Ei~~l~~l~~h~  160 (398)
                      .|+++..||+|+||.||+|.+ .+|+.||||+++.....              ....     .....+|...|.+|. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            399999999999999999997 57999999997542110              0000     011346778888875 44


Q ss_pred             Cee--EEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCC
Q 015898          161 NIV--TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (398)
Q Consensus       161 niv--~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~  238 (398)
                      ++.  ..++.  ..  .+|||||++|++|..+.      .......++.||+.+|.+||+.|||||||||.|||+..+.+
T Consensus       174 gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          174 GFPVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             TCSCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            432  22322  22  26999999998885432      22345678999999999999999999999999999943221


Q ss_pred             -------CccEEEeecCCceecC
Q 015898          239 -------DFSLKAIDFGLSVFFK  254 (398)
Q Consensus       239 -------~~~~kL~DFG~a~~~~  254 (398)
                             ...+.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                   1148999999886543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=1.3e-13  Score=126.28  Aligned_cols=140  Identities=19%  Similarity=0.152  Sum_probs=112.3

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++...+|.|+++.||++..  .+..+++|+......   .....+.+|+.+++.|.++..++++++++...+..|+||
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            488888899999999999873  467999999864211   112358899999999976788899999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-----------------------------------------  218 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-----------------------------------------  218 (398)
                      ||++|.+|.+.+     .+......++.++..+|..||+                                         
T Consensus        90 e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           90 SEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            999999887652     1223345788899999999998                                         


Q ss_pred             ------------------CCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          219 ------------------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       219 ------------------~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                                        ..++|+|++|.||++   +++..+.|+||+.+..
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhccc
Confidence                              458999999999999   5555667999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.34  E-value=3.5e-12  Score=116.06  Aligned_cols=134  Identities=15%  Similarity=0.147  Sum_probs=98.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC-eeEEeEEEecCCeEEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~  179 (398)
                      |.+..+.+.|..+.||++. ..+|..+++|+....      ....+.+|+.+++.|..+.- +++++++....+..++||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            5554444466679999986 456788999987532      12457789999999975522 567889888888899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG---------------------------------------  220 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~---------------------------------------  220 (398)
                      ||++|.+|.  .   ....   ...++.+++.+|..||+..                                       
T Consensus        95 e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998883  2   1112   2356677777777777643                                       


Q ss_pred             -------------------ceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          221 -------------------VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       221 -------------------iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                                         ++|+|++|.||++   ++++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhccc
Confidence                               9999999999999   5556677999999865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.23  E-value=2.2e-11  Score=114.08  Aligned_cols=183  Identities=16%  Similarity=0.207  Sum_probs=124.1

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCC--eeEEeEEEecCC---eEEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVTIKGAYEDSL---CVHIV  178 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~n--iv~l~~~~~~~~---~~~lv  178 (398)
                      .+.++.|....||++.     ..+++|+..     .......+.+|..+|+.+..+..  +..++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~-----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPK-----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEES-----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecC-----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            3568999999999863     468899753     23456788999999998853433  445555443333   35899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS----------------------------------------  218 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~----------------------------------------  218 (398)
                      ||+++|.+|.+...  ..++..+...++.+++..|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988865433  246778888888888888888885                                        


Q ss_pred             ------------------CCceeccCCCCcEEEeecCC--CccEEEeecCCceecCCCCcccccccCCcccCccccc---
Q 015898          219 ------------------LGVMHRDLKPENFLLVNKDD--DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL---  275 (398)
Q Consensus       219 ------------------~~iiHrDikp~NIll~~~~~--~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---  275 (398)
                                        ..++|+|++|.||++   ++  ...+.|+||+.+.................-..|+...   
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~---~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILF---DTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEE---ETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEE---eCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                              237999999999999   44  5668899999987654321111111000002333221   


Q ss_pred             ccCC------------CcccHHHHHHHHHHHHhCCCCC
Q 015898          276 KHYG------------PEADVWTAGVILYILLSGVPPF  301 (398)
Q Consensus       276 ~~~~------------~~~DiwSlG~il~elltg~~pf  301 (398)
                      ..|.            ...+.|++|.++|.+.+|..+|
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1121            2258999999999999998876

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=5.1e-11  Score=114.17  Aligned_cols=141  Identities=22%  Similarity=0.335  Sum_probs=104.4

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEec--ccccCCHhhHHHHHHHHHHHHHhcC-CCCeeEEeEEEecC---CeEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSIS--KRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDS---LCVHI  177 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~Ei~~l~~l~~-h~niv~l~~~~~~~---~~~~l  177 (398)
                      .+.|+.|.++.||++..  .+..+++|+..  ....  ......+.+|..+++.|.. +..+++++.++.+.   +..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            46789999999999874  34688888764  2211  1223467889999999974 34578888888766   45899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS---------------------------------------  218 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~---------------------------------------  218 (398)
                      ||||++|..+.+..  ...++......++.+++.+|..||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999988774321  1236788889999999999999997                                       


Q ss_pred             -------------------CCceeccCCCCcEEEeecCCCc--cEEEeecCCceec
Q 015898          219 -------------------LGVMHRDLKPENFLLVNKDDDF--SLKAIDFGLSVFF  253 (398)
Q Consensus       219 -------------------~~iiHrDikp~NIll~~~~~~~--~~kL~DFG~a~~~  253 (398)
                                         ..++|+|++|.|||+   ++++  .+.|+||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~---~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF---HPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE---CSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEE---eCCCCcEEEEECccccccC
Confidence                               368999999999999   5443  4689999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.86  E-value=3.6e-08  Score=90.18  Aligned_cols=133  Identities=20%  Similarity=0.208  Sum_probs=97.7

Q ss_pred             ecccCce-EEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCC
Q 015898          107 LGQGQFG-TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG  185 (398)
Q Consensus       107 iG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~  185 (398)
                      +..|..| .||+......+..+++|+-..      .....+.+|...|+.|..+--+.+++.++.+.+..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445444 699988766778899998642      235578899999999986656788999999999999999999998


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 015898          186 ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL----------------------------------------------  219 (398)
Q Consensus       186 ~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~----------------------------------------------  219 (398)
                      ++.+.....    ......+..++...|..||..                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            876654321    122334555555555555531                                              


Q ss_pred             ------------CceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          220 ------------GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       220 ------------~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                                  .++|+|+.+.|||+   ++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECccccc
Confidence                        27999999999999   6666677999999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.79  E-value=1.4e-07  Score=88.20  Aligned_cols=139  Identities=18%  Similarity=0.223  Sum_probs=94.4

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC--CeeEEeEEEe-cCCeEEEEEe
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK--NIVTIKGAYE-DSLCVHIVME  180 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~--niv~l~~~~~-~~~~~~lv~e  180 (398)
                      .+.++.|....||+.     +..+++|+-.     .......+.+|..+|+.|..+-  .+.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            356888999999987     5678888742     3345678999999999997432  3566666664 4566889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-----------------------------------------  219 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~-----------------------------------------  219 (398)
                      +++|..+.+...  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988765321  1234444445555555554444432                                         


Q ss_pred             -------------------CceeccCCCCcEEEeecCCCcc-EEEeecCCceecC
Q 015898          220 -------------------GVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFK  254 (398)
Q Consensus       220 -------------------~iiHrDikp~NIll~~~~~~~~-~kL~DFG~a~~~~  254 (398)
                                         .++|+|++|.||++...+.++. +.|+||+.+....
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               4599999999999932111344 5899999887644

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.49  E-value=5.1e-07  Score=87.39  Aligned_cols=80  Identities=11%  Similarity=0.070  Sum_probs=50.6

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEeccccc-CC---HhhHHHHHHHHHHHHHhcCC-C-CeeEEeEEEecCCeEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-IS---REDVEDVRREIQIMHHLAGH-K-NIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~Ei~~l~~l~~h-~-niv~l~~~~~~~~~~~l  177 (398)
                      .+.||.|.++.||++....++..|+||....... ..   .....++..|..+++.+..+ + .+++++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            4579999999999997655678999998653211 00   11234567899999888633 3 344565442  334579


Q ss_pred             EEeccCCC
Q 015898          178 VMELCAGG  185 (398)
Q Consensus       178 v~e~~~~~  185 (398)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.35  E-value=4.4e-07  Score=86.41  Aligned_cols=84  Identities=6%  Similarity=0.032  Sum_probs=55.6

Q ss_pred             ccee-cccCceEEEEEEEc--c----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEecC--
Q 015898          104 GRKL-GQGQFGTTYLCTEI--A----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDS--  172 (398)
Q Consensus       104 ~~~i-G~G~fg~Vy~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~~--  172 (398)
                      .+.| +.|....+|+....  .    ++..+++|+..............+.+|..+++.|..+  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88999999987643  1    2668899976432200000013567888888888754  3577788877655  


Q ss_pred             -CeEEEEEeccCCCCh
Q 015898          173 -LCVHIVMELCAGGEL  187 (398)
Q Consensus       173 -~~~~lv~e~~~~~~L  187 (398)
                       +..|+|||+++|..+
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             457899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.21  E-value=3.9e-05  Score=72.02  Aligned_cols=136  Identities=15%  Similarity=0.112  Sum_probs=77.4

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC-CCeeEEeE------EEecCCeEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKG------AYEDSLCVHI  177 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-~niv~l~~------~~~~~~~~~l  177 (398)
                      +.|+.|..+.||++.. . +..+++|+...    ..   ..+..|..+++.|..+ -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~----~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHT-D-SGAVCLKRIHR----PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEE-T-TEEEEEEEECS----CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEe-C-CCCEEEEecCC----CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            4566678899999874 3 34589998853    22   3344566666655421 12344443      1234667899


Q ss_pred             EEeccCCCChH--------------HHHHh-cCCC-------------CHHH----------------------------
Q 015898          178 VMELCAGGELF--------------DRIIQ-RGHY-------------SERK----------------------------  201 (398)
Q Consensus       178 v~e~~~~~~L~--------------~~l~~-~~~~-------------~~~~----------------------------  201 (398)
                      +|+|++|..+.              ..++. ...+             .+..                            
T Consensus       109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  188 (346)
T 2q83_A          109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY  188 (346)
T ss_dssp             EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred             EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            99999986431              11111 1101             1110                            


Q ss_pred             ---HHHHHHHHHHHHHHHH-------------hCCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          202 ---AAELTRIIVGVVEACH-------------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       202 ---~~~i~~~i~~al~~lH-------------~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                         +..+...+..++.+|+             ...++|+|+++.|||+   +.++.+.|+||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhccc
Confidence               1111122334555554             3579999999999999   6567899999998864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.11  E-value=2.2e-05  Score=76.45  Aligned_cols=77  Identities=14%  Similarity=0.125  Sum_probs=46.0

Q ss_pred             HhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccccc--CCcccCccccccc----CCCcccHHHHHHH
Q 015898          217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG--SPYYVAPEVLLKH----YGPEADVWTAGVI  290 (398)
Q Consensus       217 H~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~----~~~~~DiwSlG~i  290 (398)
                      +...++|+|++|.|||+   ++++ +.|+||+.+..............  ...|++|+.....    -....++.+....
T Consensus       230 ~~~~liHGDl~~~Nil~---~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMV---TQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ  305 (420)
T ss_dssp             BCCEEECSCCSGGGEEE---CSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEE---eCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence            45679999999999999   5554 99999999876442211111111  1235555544310    1123445567777


Q ss_pred             HHHHHhC
Q 015898          291 LYILLSG  297 (398)
Q Consensus       291 l~elltg  297 (398)
                      +|+.+.+
T Consensus       306 ~~~~y~~  312 (420)
T 2pyw_A          306 TWNLFNK  312 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            7777653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.10  E-value=2.6e-05  Score=72.85  Aligned_cols=76  Identities=16%  Similarity=0.110  Sum_probs=60.6

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEecCCeEEEEEec
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHIVMEL  181 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~~~~~~lv~e~  181 (398)
                      .+.|+.|....+|+...  ++..+++|+....      ....+..|...|+.|..+  ..+++++.+....+..++||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            46789999999999873  5678899986432      356788999999988643  5688899888888899999999


Q ss_pred             cCCCCh
Q 015898          182 CAGGEL  187 (398)
Q Consensus       182 ~~~~~L  187 (398)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.75  E-value=0.00011  Score=68.12  Aligned_cols=72  Identities=7%  Similarity=-0.066  Sum_probs=45.8

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc-
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC-  182 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~-  182 (398)
                      .+.|+.|....+|++      ..+++|+.....   . ..-...+|..+++.+..+.-..+++++..+  .-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---E-EYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCc---c-ceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecC
Confidence            567888999999998      468999875421   1 111224588888877644333566654433  346899999 


Q ss_pred             CCCCh
Q 015898          183 AGGEL  187 (398)
Q Consensus       183 ~~~~L  187 (398)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.67  E-value=0.00042  Score=60.44  Aligned_cols=122  Identities=16%  Similarity=0.076  Sum_probs=80.1

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCccccc
Q 015898          185 GELFDRIIQ-RGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV  262 (398)
Q Consensus       185 ~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~l-H~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~  262 (398)
                      .+|.++|.. ..+++++++|.++.|.+.+|.-+ +...-..+=+.|..|++   ..+|.|-+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            478888865 46799999999999999998776 22222234455788888   7777776653 1111           


Q ss_pred             ccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhccc
Q 015898          263 VGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (398)
Q Consensus       263 ~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  342 (398)
                      .....+.|||......+.+.=|||||+++|.-+--..|                     .+.-..+|+.+-.||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence            11235678888754456778899999999998873333                     122235899999999999865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.67  E-value=7.5e-05  Score=69.69  Aligned_cols=139  Identities=19%  Similarity=0.129  Sum_probs=78.1

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEE------EecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA------YEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~------~~~~~~~~  176 (398)
                      .+.|+.|....||++.. .+| .+++|+....     .....+..|+.++..|..+. .+++++..      ....+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEe-CCc-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            45678888899999874 334 6889988542     11234567888888776331 13333321      12346679


Q ss_pred             EEEeccCCCChH----H----------HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHh
Q 015898          177 IVMELCAGGELF----D----------RIIQR-GHY--------SERKAAEL---------------TRIIVGVVEACHS  218 (398)
Q Consensus       177 lv~e~~~~~~L~----~----------~l~~~-~~~--------~~~~~~~i---------------~~~i~~al~~lH~  218 (398)
                      ++|+|++|..+.    .          .++.. ..+        ........               ...+...+..++.
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999885431    0          11111 011        11110100               0113334455542


Q ss_pred             -------CCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          219 -------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       219 -------~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                             .+++|+|+.+.|||+   +++..+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEE---eCCceEEEecchhccC
Confidence                   469999999999999   5555567999998865

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.65  E-value=0.00032  Score=64.40  Aligned_cols=79  Identities=14%  Similarity=0.063  Sum_probs=54.6

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEecCCeEEEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~~~~~~lv  178 (398)
                      ..-.+.+|.|..+.||+.. ..+|+.|++|+.....   ......+..|...|+.|...  --+++++.+.    .-++|
T Consensus        17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3446789999999999987 5789999999864332   11223577899999988633  2345555542    23689


Q ss_pred             EeccCCCCh
Q 015898          179 MELCAGGEL  187 (398)
Q Consensus       179 ~e~~~~~~L  187 (398)
                      |||+.++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999976543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.57  E-value=0.00026  Score=66.42  Aligned_cols=139  Identities=13%  Similarity=0.077  Sum_probs=73.2

Q ss_pred             ceecccCceE-EEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEEEecCCeEEEEEecc
Q 015898          105 RKLGQGQFGT-TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       105 ~~iG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      +.|+.|+... +|+.. ..++..+++|......      ...+..|+.+++.|..+. .+++++.+....+  +++||++
T Consensus        24 ~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEE-CTTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eECCCCCCCceEEEEE-cCCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            4565555444 66665 2236677787653221      023456777777776432 3556666543444  6899999


Q ss_pred             CCCChHHHHHhc--------------------------CCCCHHHHHH--------HH------------HHHHHHHHHH
Q 015898          183 AGGELFDRIIQR--------------------------GHYSERKAAE--------LT------------RIIVGVVEAC  216 (398)
Q Consensus       183 ~~~~L~~~l~~~--------------------------~~~~~~~~~~--------i~------------~~i~~al~~l  216 (398)
                      .+..+.+.+...                          ..+.......        +.            ..+..++..+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            776665433211                          0122211100        00            0111122222


Q ss_pred             ------HhCCceeccCCCCcEEEeecCCC----ccEEEeecCCceecCC
Q 015898          217 ------HSLGVMHRDLKPENFLLVNKDDD----FSLKAIDFGLSVFFKP  255 (398)
Q Consensus       217 ------H~~~iiHrDikp~NIll~~~~~~----~~~kL~DFG~a~~~~~  255 (398)
                            +...++|+|+.+.||++   +.+    +.+.|+||+.+.....
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~---~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLW---LPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEE---CTTSCGGGGEEECCCTTCEEECT
T ss_pred             HHhcccCCCeeEeCCcCcccEEe---ccCcCCCCCeEEEeCCCcCcCCC
Confidence                  23479999999999999   442    6789999999876543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.57  E-value=0.00017  Score=69.07  Aligned_cols=140  Identities=15%  Similarity=0.150  Sum_probs=82.8

Q ss_pred             ceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898          105 RKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      +.|..|....+|++....       ++..+++++....    ........+|..+++.|..+.-..++++.+.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            457678888899987532       3578999986321    11234556899999988765555777777654    28


Q ss_pred             EEeccCCCChHH--------------HH---Hhc-----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 015898          178 VMELCAGGELFD--------------RI---IQR-----GHYS--ERKAAELTRIIVG-------------------VVE  214 (398)
Q Consensus       178 v~e~~~~~~L~~--------------~l---~~~-----~~~~--~~~~~~i~~~i~~-------------------al~  214 (398)
                      ||||++|..|..              .|   +..     +...  +.++..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998754421              11   111     1112  3455555544322                   122


Q ss_pred             HH----Hh----CCceeccCCCCcEEEeec-CCCccEEEeecCCcee
Q 015898          215 AC----HS----LGVMHRDLKPENFLLVNK-DDDFSLKAIDFGLSVF  252 (398)
Q Consensus       215 ~l----H~----~~iiHrDikp~NIll~~~-~~~~~~kL~DFG~a~~  252 (398)
                      .|    ..    ..++|+|+.+.||++..+ +..+.+.|+||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32    22    258999999999999432 1136799999998875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.53  E-value=0.00036  Score=65.13  Aligned_cols=76  Identities=12%  Similarity=0.082  Sum_probs=48.8

Q ss_pred             ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEE-----EecCCeEEEE
Q 015898          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA-----YEDSLCVHIV  178 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~-----~~~~~~~~lv  178 (398)
                      ..|+ |....||++. ..+|+.+++|+.....    .....+..|..++..|..+. .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEE-cCCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3566 8888999876 3456789999885321    12345667888888886331 23444432     2234567899


Q ss_pred             EeccCCCC
Q 015898          179 MELCAGGE  186 (398)
Q Consensus       179 ~e~~~~~~  186 (398)
                      |++++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.53  E-value=0.00021  Score=69.82  Aligned_cols=74  Identities=11%  Similarity=0.084  Sum_probs=51.1

Q ss_pred             cceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      .+.|+.|....||++....       ++..+++|+.....  .   ...+.+|..+++.|..+.-.+++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4568888889999987542       35789999874211  1   13455799999988755445677776643    2


Q ss_pred             EEEeccCCCC
Q 015898          177 IVMELCAGGE  186 (398)
Q Consensus       177 lv~e~~~~~~  186 (398)
                      +|+||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.42  E-value=0.00042  Score=66.00  Aligned_cols=75  Identities=8%  Similarity=0.068  Sum_probs=45.3

Q ss_pred             cceecccCceEEEEEEEcc--------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898          104 GRKLGQGQFGTTYLCTEIA--------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.|+.|....+|++....        .+..+++|+.....    ........|..+++.|..+.-.+++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            3567888888999987543        13689999874321    11112357888888887443355677654  22  


Q ss_pred             EEEEeccCCCC
Q 015898          176 HIVMELCAGGE  186 (398)
Q Consensus       176 ~lv~e~~~~~~  186 (398)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.19  E-value=0.0035  Score=58.94  Aligned_cols=69  Identities=12%  Similarity=0.024  Sum_probs=44.1

Q ss_pred             cccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCC--CCeeEEeEE------EecCCeEEEEE
Q 015898          108 GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGA------YEDSLCVHIVM  179 (398)
Q Consensus       108 G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~------~~~~~~~~lv~  179 (398)
                      |.|....||++.. .+| .+++|+......         ..|+.++..|..+  |.+++++..      ....+..+++|
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            4444689999873 445 899998754321         3566677666522  324554432      23457789999


Q ss_pred             eccCCCCh
Q 015898          180 ELCAGGEL  187 (398)
Q Consensus       180 e~~~~~~L  187 (398)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998655

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.17  E-value=0.0021  Score=63.10  Aligned_cols=76  Identities=13%  Similarity=0.093  Sum_probs=49.2

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccC
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  183 (398)
                      .+.|+.|-...+|++.....+..+++|+.....   ...+ .-.+|..++..|..+.-.+++++.+.  +  .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            456888888999998854435789999874321   1111 11479999999985554567887773  2  25999998


Q ss_pred             CCCh
Q 015898          184 GGEL  187 (398)
Q Consensus       184 ~~~L  187 (398)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.01  E-value=0.013  Score=56.80  Aligned_cols=76  Identities=12%  Similarity=0.149  Sum_probs=49.4

Q ss_pred             cceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      .+.|..|....+|++....       .+..+++++.....   .. .-...+|..+++.|..+.-..++++.+.  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            3567778888999988542       15789999864321   11 1123468888888875555566776443  2  6


Q ss_pred             EEEeccCCCCh
Q 015898          177 IVMELCAGGEL  187 (398)
Q Consensus       177 lv~e~~~~~~L  187 (398)
                      +||||++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.64  E-value=0.12  Score=49.45  Aligned_cols=33  Identities=30%  Similarity=0.465  Sum_probs=26.6

Q ss_pred             ceeccCCCCcEEEee---cCCCccEEEeecCCceec
Q 015898          221 VMHRDLKPENFLLVN---KDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       221 iiHrDikp~NIll~~---~~~~~~~kL~DFG~a~~~  253 (398)
                      ++|+|+.+.|||+..   ++++..+.++||-.|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            689999999999953   234567999999988753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.16  E-value=0.042  Score=53.89  Aligned_cols=63  Identities=10%  Similarity=0.050  Sum_probs=18.0

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEE------EEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFAC------KSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      +.+.||   ||.||+|....+..+||+      |..... ..+.+....+.+|..+++.+. |||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~-~~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQD-GVSEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccc-ccccccccccccccccccccc-ccccCCCcceEE
Confidence            456776   999999997665678898      665432 224455567888999998887 999999888653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.34  E-value=2.5  Score=36.46  Aligned_cols=122  Identities=13%  Similarity=0.111  Sum_probs=81.8

Q ss_pred             HHHHHHHhcCCCCeeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 015898          149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (398)
Q Consensus       149 Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp  228 (398)
                      |+.+|..  .||+++.. .+-+..+.+.+.++.-+.+-=+..+   ..++....++++..|+....++  ..=+|--|.|
T Consensus        36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P  107 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAP  107 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSG
T ss_pred             HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEec
Confidence            5666654  38988876 5667777888878775433222223   3478899999999998877443  3457788999


Q ss_pred             CcEEEeecCCCccEEEeecCCceecCCCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCC
Q 015898          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPF  301 (398)
Q Consensus       229 ~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf  301 (398)
                      +||++   +.++.+++.-.|+-..+.+..           +.+|-+         .-.+=|++..+++++..|
T Consensus       108 ~NL~f---~~~~~p~i~~RGik~~l~P~~-----------~~ee~f---------L~qyKAliiall~~K~~F  157 (215)
T 4ann_A          108 DELFF---TRDGLPIAKTRGLQNVVDPLP-----------VSEAEF---------LTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGEEE---CTTSCEEESCCEETTTBSCCC-----------CCHHHH---------HHHHHHHHHHHHCTTCCH
T ss_pred             ceEEE---cCCCCEEEEEccCccCCCCCC-----------CCHHHH---------HHHHHHHHHHHHcCCCCH
Confidence            99999   999999998877654322211           011212         234457788888887776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	398
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-96
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-87
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-86
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-86
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-86
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-84
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-83
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-82
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-82
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-80
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-79
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-78
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-78
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-75
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-73
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-72
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-70
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-70
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-70
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-70
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-69
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-67
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-67
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-63
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-63
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-62
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-62
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-61
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-60
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-59
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-59
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-59
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-57
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-56
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-54
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-21
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	2e-04

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  287 bits (735), Expect = 6e-96
 Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 5/298 (1%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K+ L  +E    +  EI +
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAV 60

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 61  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK 389
           AKD IR ++   P +R T  + L HPWI     A D+++  +V  ++K+  A +K K+
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWI-AGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  264 bits (676), Expect = 7e-87
 Identities = 83/304 (27%), Positives = 148/304 (48%), Gaps = 12/304 (3%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + + Y +   LG+G+FG  + C E ++   +  K +  +      D   V++EI I++  
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA 58

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEA 215
             H+NI+ +  ++E    + ++ E  +G ++F+RI       +ER+       +   ++ 
Sbjct: 59  -RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
            HS  + H D++PEN +        ++K I+FG +   KPG  F  +  +P Y APEV  
Sbjct: 118 LHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
                   D+W+ G ++Y+LLSG+ PF AET Q I + ++     F+ + +  IS  A D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 335 LIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKMALRV 394
            + ++L  +   R+TA E L HPW+ +        +   V+  LK     + L K  L +
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKI----ERVSTKVIRTLKHRRYYHTLIKKDLNM 292

Query: 395 SASA 398
             SA
Sbjct: 293 VVSA 296

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  260 bits (666), Expect = 5e-86
 Identities = 99/272 (36%), Positives = 145/272 (53%), Gaps = 16/272 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS------REDVEDVRREIQIMH 154
           Y     LG+G       C    T  E+A K I      S      +E  E   +E+ I+ 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++ R ++ V+ 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G+P Y+APE++
Sbjct: 125 ALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 275 L-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
                     YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+  F S  W  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            SD+ KDL+ + L  QP +R TA E L HP+ 
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  263 bits (673), Expect = 5e-86
 Identities = 104/303 (34%), Positives = 147/303 (48%), Gaps = 9/303 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ 
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQT 76

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVG 211
           M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R +  
Sbjct: 77  MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + AP
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS+
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKKM 390
             KD IRK+L + P+ R+T H+ L HPW+         S  P+  SR  +     K K  
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS--SRYTKIRDSIKTKYD 312

Query: 391 ALR 393
           A  
Sbjct: 313 AWP 315

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  263 bits (672), Expect = 6e-86
 Identities = 89/293 (30%), Positives = 146/293 (49%), Gaps = 7/293 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K  ++ D Y +  +LG G FG  + C E ATG  F  K I+    + +  V   + EI I
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISI 79

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVG 211
           M+ L  H  ++ +  A+ED   + +++E  +GGELFDRI    +  SE +     R    
Sbjct: 80  MNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 138

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            ++  H   ++H D+KPEN +        S+K IDFGL+    P +I      +  + AP
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           E++  +  G   D+W  GV+ Y+LLSG+ PF  E        V +   +F+ D +  +S 
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSA 383
            AKD I+ +L  +P +RLT H+ L HPW+  +       +  +  ++++Q   
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 310

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  255 bits (653), Expect = 3e-84
 Identities = 85/263 (32%), Positives = 136/263 (51%), Gaps = 10/263 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHP 66

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL        LK  DFG SV     +  T + G+  Y+ PE++  + + 
Sbjct: 127 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHD 182

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISRL 238

Query: 340 LCSQPSERLTAHEVLCHPWICEN 362
           L   PS+R    EVL HPWI  N
Sbjct: 239 LKHNPSQRPMLREVLEHPWITAN 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (646), Expect = 9e-83
 Identities = 105/272 (38%), Positives = 160/272 (58%), Gaps = 6/272 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRRE 149
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+  S       ED+ RE
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           + I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  + I
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + +  
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            S  AKD IR++L   P +R+T  + L HPWI
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (644), Expect = 3e-82
 Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 22/305 (7%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL    +   +K  DFG +    P       VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVI 183

Query: 275 L----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           L      Y  + DVW+ G+    L    PP +          + +   +  +      S+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ--FSAMNKLK 388
             ++ +   L   P +R T+  +L H ++        R   P V+  L Q    A+ +L 
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFV-------LRERPPTVIMDLIQRTKDAVRELD 294

Query: 389 KMALR 393
            +  R
Sbjct: 295 NLQYR 299

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 8e-82
 Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 16/287 (5%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
            +  N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI 
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEID 61

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIV 210
           I+     H NIV +  A+     + I++E CAGG +   +++     +E +   + +  +
Sbjct: 62  ILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYV 269
             +   H   ++HRDLK  N L      D  +K  DFG+S    +  Q     +G+PY++
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177

Query: 270 APEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
           APEV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + 
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL 370
           P    S + KD ++K L      R T  ++L HP++  +   P R L
Sbjct: 238 P-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (627), Expect = 5e-80
 Identities = 84/265 (31%), Positives = 128/265 (48%), Gaps = 12/265 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF           A+DL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDLV 241

Query: 337 RKMLCSQPSERLTAHEVLCHPWICE 361
            K+L    ++RL   E+  +  +  
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKA 266

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (629), Expect = 1e-79
 Identities = 100/316 (31%), Positives = 156/316 (49%), Gaps = 20/316 (6%)

Query: 93  KTDNIRDLYT-LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           K + I D Y    + LG G  G         T  +FA K +              RRE++
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 56

Query: 152 IMHHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAEL 205
           +    +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
            + I   ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 266 PYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKGHIDF 320
           PYYVAPEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ 380
            +  W  +S+  K LIR +L ++P++R+T  E + HPWI ++   P   L  + + +  +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 296

Query: 381 FSAMNKLKKMALRVSA 396
               +  ++M   ++ 
Sbjct: 297 ERWEDVKEEMTSALAT 312

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (618), Expect = 1e-78
 Identities = 83/288 (28%), Positives = 138/288 (47%), Gaps = 14/288 (4%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
            + +  YT   K+GQG  GT Y   ++ATG E A + ++ ++   +   E +  EI +M 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMR 72

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
               + NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E
Sbjct: 73  EN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEV 273
             HS  V+HRD+K +N LL     D S+K  DFG            + +VG+PY++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +  K YGP+ D+W+ G++   ++ G PP+  E        +       E      +S   
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF 246

Query: 333 KDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQ 380
           +D + + L     +R +A E+L H ++      P  SL P +++  K+
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFL--KIAKPLSSLTP-LIAAAKE 291

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 2e-78
 Identities = 77/267 (28%), Positives = 130/267 (48%), Gaps = 12/267 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++  + +  E++++EI I   L  H+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKML-NHE 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLL-- 275
           + HRD+KPEN LL   D+  +LK  DFGL+  F+     ++   + G+  YVAPE+L   
Sbjct: 124 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           + +    DVW+ G++L  +L+G  P+   +      +  K    +  +PW  I  +   L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPLAL 239

Query: 336 IRKMLCSQPSERLTAHEVLCHPWICEN 362
           + K+L   PS R+T  ++    W  + 
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKP 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 7e-75
 Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 14/266 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
                ++G+G F T Y   +  T +E A   +  RKL ++ + +  + E +++  L  H 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HP 68

Query: 161 NIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           NIV    ++E ++    C+ +V EL   G L   + +      +      R I+  ++  
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 217 HSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           H+    ++HRDLK +N  +       S+K  D GL+   K       V+G+P ++APE+ 
Sbjct: 129 HTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY 185

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            + Y    DV+  G+ +  + +   P+   +    I+  V  G      D         K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--AIPEVK 243

Query: 334 DLIRKMLCSQPSERLTAHEVLCHPWI 359
           ++I   +     ER +  ++L H + 
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (586), Expect = 2e-73
 Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 10/262 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N L    D D  +K  DFG+      G        G+P Y+APE+LL + Y
Sbjct: 124 IVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
               D W+ GV+LY +L G  PF  + ++ +F ++   +  +       +   AKDL+ K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVK 236

Query: 339 MLCSQPSERLTAH-EVLCHPWI 359
           +   +P +RL    ++  HP  
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLF 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 2e-72
 Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 21/272 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   +G G +G        + G     K +     ++  + + +  E+ ++  L  H 
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK-HP 63

Query: 161 NIVTIKGAYEDSL--CVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVE 214
           NIV       D     ++IVME C GG+L   I     +R +  E     +   +   ++
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 215 ACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGSPYY 268
            CH        V+HRDLKP N  L   D   ++K  DFGL+        F    VG+PYY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           ++PE +    Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +G           
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 237

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
            SD   ++I +ML  +   R +  E+L +P I
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 1e-70
 Identities = 66/309 (21%), Positives = 115/309 (37%), Gaps = 53/309 (17%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D+    +    +LG G  G  +  +   +G+  A K I     I       + RE+Q+
Sbjct: 4   KDDD----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQV 57

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H       IV   GA+     + I ME   GG L   + + G   E+   +++  ++  
Sbjct: 58  LHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116

Query: 213 VEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           +        +MHRD+KP N L+   +    +K  DFG+S            VG+  Y++P
Sbjct: 117 LTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSP 172

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESD---- 323
           E L   HY  ++D+W+ G+ L  +  G  P         + +F   ++G           
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 324 ---------------------------------PWPLISDSAKDLIRKMLCSQPSERLTA 350
                                            P  + S   +D + K L   P+ER   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 351 HEVLCHPWI 359
            +++ H +I
Sbjct: 293 KQLMVHAFI 301

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  222 bits (567), Expect = 1e-70
 Identities = 72/265 (27%), Positives = 128/265 (48%), Gaps = 16/265 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + R LG G FG  +L      G  +A K + K  ++  + VE    E  ++  +  H 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            I+ + G ++D+  + ++M+   GGELF  + +   +    A      +   +E  HS  
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   D +  +K  DFG + +     +   + G+P Y+APEV+  K Y 
Sbjct: 125 IIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W+ G+++Y +L+G  PF+       ++ +L   + F     P  ++  KDL+ ++
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSRL 235

Query: 340 LCSQPSERL-----TAHEVLCHPWI 359
           +    S+RL        +V  HPW 
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  223 bits (569), Expect = 2e-70
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 14/268 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--G 158
           +++ R +G+G FG  Y C +  TG  +A K + K+++  ++       E  ++  ++   
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--K 276
             V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL    
Sbjct: 126 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGV 181

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y   AD ++ G +L+ LL G  PF     +     + +  +    +     S   + L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLL 240

Query: 337 RKMLCSQPSERLT-----AHEVLCHPWI 359
             +L    + RL      A EV   P+ 
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  219 bits (560), Expect = 4e-70
 Identities = 58/270 (21%), Positives = 102/270 (37%), Gaps = 7/270 (2%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y LG  LG G     +L  ++    + A K +              RRE Q    
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 156 LAGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           L  H  IV +    E         +IVME   G  L D +   G  + ++A E+      
Sbjct: 64  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG-LSVFFKPGQIFTDVVGSPYYVA 270
            +   H  G++HRD+KP N ++   +    +       ++           V+G+  Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PE          +DV++ G +LY +L+G PPF  ++   +    ++      S     +S
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                ++ K L   P  R      +    +
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 2e-69
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 20/270 (7%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VRREIQIM 153
           +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +   V  E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 154 HHL-AGHKNIVTIKGAYEDSLCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVG 211
             + +G   ++ +   +E      +++E      +LFD I +RG   E  A      ++ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V  CH+ GV+HRD+K EN L+    +   LK IDFG     K   ++TD  G+  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E +   +++G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VS 228

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
              + LIR  L  +PS+R T  E+  HPW+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 4e-67
 Identities = 83/266 (31%), Positives = 131/266 (49%), Gaps = 15/266 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHP 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +K A++    +  VME   GGELF  + +   ++E +A      IV  +E  HS  
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL-KHY 278
           V++RD+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           G   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLAG 238

Query: 339 MLCSQPSERL-----TAHEVLCHPWI 359
           +L   P +RL      A EV+ H + 
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 5e-67
 Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 19/269 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T+G+++G G FGT Y         + A K ++     + + ++  + E+ ++    
Sbjct: 7   DGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR 62

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEAC 216
            H NI+   G Y  +  + IV + C G  L+  + I    +   K  ++ R     ++  
Sbjct: 63  -HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEV 273
           H+  ++HRDLK  N  L    +D ++K  DFGL+           F  + GS  ++APEV
Sbjct: 121 HAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 274 LL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--SDPWPL 327
           +       Y  ++DV+  G++LY L++G  P+     +     ++         S     
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
              + K L+ + L  +  ER    ++L  
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-64
 Identities = 76/337 (22%), Positives = 127/337 (37%), Gaps = 46/337 (13%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++   YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62

Query: 156 LAGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
              H+NI+ I                ++    G +L+  +++  H S          I+ 
Sbjct: 63  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILR 120

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPY 267
            ++  HS  V+HRDLKP N LL   +    LK  DFGL+    P        T+ V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 268 YVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           Y APE++L    Y    D+W+ G IL  +LS  P F  +      + +L        +  
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 326 ---------------------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPW 358
                                      P     A DL+ KML   P +R+   + L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 359 ICENGVAPDRSLDPAVLSRLKQFSAMNK--LKKMALR 393
           + +     D  +  A      +   + K  LK++   
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-63
 Identities = 70/284 (24%), Positives = 108/284 (38%), Gaps = 33/284 (11%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIMHHLAGHKNI 162
             LG+GQF T Y   +  T    A K I        +D       REI+++  L  H NI
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           + +  A+     + +V +                 +         + +  +E  H   ++
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP N LL   D++  LK  DFGL+  F  P + +T  V + +Y APE+L   + YG
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP------------- 326
              D+W  G IL  LL  VP    ++       + +       + WP             
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 327 -----------LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                         D   DLI+ +    P  R+TA + L   + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (517), Expect = 7e-63
 Identities = 83/310 (26%), Positives = 153/310 (49%), Gaps = 24/310 (7%)

Query: 56  SKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
           +K+  ++++    ++ +K+D + +    +Q    L        D +   + LG G FG  
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--------DQFDRIKTLGTGSFGRV 57

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
            L     +G  +A K + K+K++  + +E    E +I+  +     +V ++ +++D+  +
Sbjct: 58  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNL 116

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           ++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++RDLKPEN L+  
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-- 174

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYIL 294
            D    ++  DFG +   K       + G+P  +APE++L K Y    D W  GV++Y +
Sbjct: 175 -DQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

Query: 295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL-----T 349
            +G PPF+A+    I++ ++ G + F        S   KDL+R +L    ++R       
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287

Query: 350 AHEVLCHPWI 359
            +++  H W 
Sbjct: 288 VNDIKNHKWF 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 74/301 (24%), Positives = 131/301 (43%), Gaps = 49/301 (16%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
             +D Y L RKLG+G++   +    I    +   K +           + ++REI+I+ +
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 85

Query: 156 LAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           L G  NI+T+    +D  S    +V E     +           ++         I+  +
Sbjct: 86  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 142

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           + CHS+G+MHRD+KP N ++ +  +   L+ ID+GL+ F+ PGQ +   V S Y+  PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 274 LL--KHYGPEADVWTAGVILYILLSGVPPFWAET--------------QQGIFDAVLKGH 317
           L+  + Y    D+W+ G +L  ++    PF+                  + ++D + K +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 318 ID--------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHP 357
           I+                      S+   L+S  A D + K+L      RLTA E + HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320

Query: 358 W 358
           +
Sbjct: 321 Y 321

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-62
 Identities = 78/273 (28%), Positives = 136/273 (49%), Gaps = 17/273 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISRED-VEDVRREIQIMHHL 156
           + L + LG G +G  +L  +I+   TG  +A K + K  ++ +    E  R E Q++ H+
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR  ++E +       IV  +E  
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F     +   D  G+  Y+AP+++
Sbjct: 146 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 275 L---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
                 +    D W+ GV++Y LL+G  PF  + ++     + +  +  E      +S  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 332 AKDLIRKMLCSQPSERL-----TAHEVLCHPWI 359
           AKDLI+++L   P +RL      A E+  H + 
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-61
 Identities = 67/310 (21%), Positives = 119/310 (38%), Gaps = 48/310 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y    K+GQG FG  +      TG + A K +               REI+I+  L  H+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HE 69

Query: 161 NIVTIKGAYEDSL--------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           N+V +                 +++V + C              ++  +   + ++++  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-----IFTDVVGSPY 267
           +   H   ++HRD+K  N L+     D  LK  DFGL+  F   +      +T+ V + +
Sbjct: 130 LYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +       + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 326 PLI----------------------------SDSAKDLIRKMLCSQPSERLTAHEVLCHP 357
           P +                               A DLI K+L   P++R+ + + L H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 358 WICENGVAPD 367
           +   + +  D
Sbjct: 307 FFWSDPMPSD 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-61
 Identities = 67/309 (21%), Positives = 125/309 (40%), Gaps = 44/309 (14%)

Query: 86  TYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED 145
               +      +R +Y   + +G G +G      +  TG + A K +  R   S    + 
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKR 63

Query: 146 VRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
             RE++++ H+  H+N++ +   +      +D    ++VM     G    ++++     E
Sbjct: 64  AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120

Query: 200 RKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF 259
            +   L   ++  +   H+ G++HRDLKP N  +   ++D  LK +DFGL+         
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEM 175

Query: 260 TDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
           T  V + +Y APEV+L    Y    D+W+ G I+  +++G   F           ++K  
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 318 IDFESDPWPLI---------------------------SDSAKDLIRKMLCSQPSERLTA 350
               ++    +                           S  A +L+ KML     +R+TA
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

Query: 351 HEVLCHPWI 359
            E L HP+ 
Sbjct: 296 GEALAHPYF 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 9e-60
 Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 35/293 (11%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-- 158
           Y    ++G+G +G  +   ++  G  F      + +           RE+ ++ HL    
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 159 HKNIVTIKGAYEDS-----LCVHIVMELCAGGEL-FDRIIQRGHYSERKAAELTRIIVGV 212
           H N+V +      S       + +V E        +   +           ++   ++  
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           ++  HS  V+HRDLKP+N L+        +K  DFGL+  +      T VV + +Y APE
Sbjct: 129 LDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---- 327
           VLL   Y    D+W+ G I   +    P F   +       +L        + WP     
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 328 -------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
                              I +  KDL+ K L   P++R++A+  L HP+  +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-59
 Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 34/290 (11%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y    K+G+G +GT +      T    A K +               REI ++  L  HK
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HK 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +         + +V E C            G             ++  +  CHS  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--KH 277
           V+HRDLKP+N L+   + +  LK  +FGL+  F  P + ++  V + +Y  P+VL   K 
Sbjct: 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 278 YGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPW----------- 325
           Y    D+W+AG I   L +   P F           + +       + W           
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 326 --------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE 361
                         P ++ + +DL++ +L   P +R++A E L HP+  +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  192 bits (487), Expect = 4e-59
 Identities = 74/287 (25%), Positives = 115/287 (40%), Gaps = 34/287 (11%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y    K+G+G +G  Y       G  FA K I   K           REI I+  L  H 
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HS 60

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +         + +V E           +  G      A      ++  +  CH   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--KH 277
           V+HRDLKP+N L+   + +  LK  DFGL+  F  P + +T  + + +Y AP+VL+  K 
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI--------- 328
           Y    D+W+ G I   +++G P F   ++      + +      S  WP +         
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 329 ----------------SDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                            +S  DL+ KML   P++R+TA + L H + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (488), Expect = 4e-59
 Identities = 59/291 (20%), Positives = 102/291 (35%), Gaps = 22/291 (7%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + + Y LGRK+G G FG  YL T+IA G E A K    +          +  E +I   +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM 59

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            G   I TI+    +     +VMEL               +S +    L   ++  +E  
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--------TDVVGSPYY 268
           HS   +HRD+KP+NFL+        +  IDFGL+  ++  +           ++ G+  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--- 324
            +    L        D+ + G +L     G  P+             +      S P   
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTA---HEVLCHPWICENGVAPDRSLD 371
                       +      +  ++       ++  + +    G + D   D
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH-RQGFSYDYVFD 289

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 6e-59
 Identities = 59/267 (22%), Positives = 95/267 (35%), Gaps = 17/267 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMH 154
                L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVV 213
            L  H+N++ + G       + +V EL   G L DR+ +  GH+     +     +   +
Sbjct: 67  SL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYV 269
               S   +HRDL   N LL        +K  DFGL            +         + 
Sbjct: 125 GYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           APE L  + +   +D W  GV L+ + + G  P+       I   + K            
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED-- 239

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                 +++ +    +P +R T   + 
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-58
 Identities = 72/306 (23%), Positives = 113/306 (36%), Gaps = 47/306 (15%)

Query: 91  GHKTDNIRDL-YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           G   D  +++ YT  + +G G FG  Y      +G   A K + +       D     RE
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRE 63

Query: 150 IQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGG---ELFDRIIQRGHYSER 200
           +QIM  L  H NIV ++  +      +D + +++V++                +      
Sbjct: 64  LQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
                   +   +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+   
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNV 180

Query: 261 DVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG-- 316
             + S YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K   
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 317 -----------------------HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                                     +     P     A  L  ++L   P+ RLT  E 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

Query: 354 LCHPWI 359
             H + 
Sbjct: 301 CAHSFF 306

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 4e-58
 Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 24/274 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
                 +G+G FG          G+         ++  S++D  D   E++++  L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAE 204
           NI+ + GA E    +++ +E    G L D + +                    S ++   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
               +   ++       +HRDL   N L+    +++  K  DFGLS   +     T    
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES 322
              ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G   +  
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRL 245

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
           +      D   DL+R+    +P ER +  ++L  
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-58
 Identities = 54/292 (18%), Positives = 108/292 (36%), Gaps = 40/292 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+    G+ LG G FG     T     +    I+ A K + ++      + E +  E+++
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKM 93

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---------------- 196
           M  L  H+NIV + GA   S  ++++ E C  G+L + +  +                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 197 -------YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
                   +          +   +E       +HRDL   N L+        +K  DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGL 210

Query: 250 SVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAE 304
           +          +  +      ++APE L    Y  ++DVW+ G++L+ + S GV P+   
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
                F  +++     +   +   ++    +++        +R +   +   
Sbjct: 271 PVDANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 8e-58
 Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 21/264 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
                L + +G+G+FG   L      G + A K I           +    E  +M  L 
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR 58

Query: 158 GHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVE 214
            H N+V + G   E+   ++IV E  A G L D +  RG          + +  +   +E
Sbjct: 59  -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
                  +HRDL   N L+    +D   K  DFGL+      Q          + APE L
Sbjct: 118 YLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEAL 172

Query: 275 L-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             K +  ++DVW+ G++L+ + S G  P+     + +   V KG   ++ D       + 
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAV 229

Query: 333 KDLIRKMLCSQPSERLTAHEVLCH 356
            ++++       + R +  ++   
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 5e-57
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 34/288 (11%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +    K+G+G +G  Y      TG   A K I      +        REI ++  L  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKEL-NHP 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCA-GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           NIV +         +++V E      + F                    ++  +  CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--K 276
            V+HRDLKP+N L+   + + ++K  DFGL+  F  P + +T  V + +Y APE+LL  K
Sbjct: 122 RVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL--------- 327
           +Y    D+W+ G I   +++    F  +++      + +     +   WP          
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 328 ----------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI 359
                           + +  + L+ +ML   P++R++A   L HP+ 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-56
 Identities = 69/329 (20%), Positives = 133/329 (40%), Gaps = 41/329 (12%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            + + Y     +G G +G+     +  TG+  A K +S+    S    +   RE++++ H
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73

Query: 156 LAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +  H+N++ +   +  +  +     + +     G   + I++    ++     L   I+ 
Sbjct: 74  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            ++  HS  ++HRDLKP N      ++D  LK +DFGL+         T  V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-------- 321
           E++L   HY    D+W+ G I+  LL+G   F           +L+              
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 322 -------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN 362
                              ++ +   +  A DL+ KML     +R+TA + L H +  + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

Query: 363 GVAPDRSL-DPAVLSRLKQFSAMNKLKKM 390
               D  + DP   S   +   +++ K +
Sbjct: 308 HDPDDEPVADPYDQSFESRDLLIDEWKSL 336

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 61/273 (22%), Positives = 98/273 (35%), Gaps = 21/273 (7%)

Query: 98  RDLYTLG-RKLGQGQFGTTYLCT--EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R L TL  ++LG G FGT               A K + K +       +++  E  +M 
Sbjct: 5   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQ 63

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  +  IV + G  E      +VME+   G L   + Q  H  ++   EL   +   ++
Sbjct: 64  QL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVA 270
                  +HRDL   N LL         K  DFGLS   +  + +    T       + A
Sbjct: 122 YLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           PE +    +  ++DVW+ GV+++   S G  P+       +   + KG            
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGC 235

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEV---LCHPW 358
                DL+          R     V   L + +
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 5e-56
 Identities = 58/261 (22%), Positives = 107/261 (40%), Gaps = 17/261 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
            T  ++LG GQFG            + A K I +  +   E       E ++M +L+ H+
Sbjct: 6   LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLS-HE 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSL 219
            +V + G       + I+ E  A G L + +   R  +  ++  E+ + +   +E   S 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLL-K 276
             +HRDL   N L+   +D   +K  DFGLS +    +            +  PEVL+  
Sbjct: 120 QFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
            +  ++D+W  GV+++ + S G  P+   T     + + +G          L S+    +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTI 233

Query: 336 IRKMLCSQPSERLTAHEVLCH 356
           +      +  ER T   +L +
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 7e-56
 Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 18/267 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   LGR +G+GQFG  +    ++     +  A K+   +   S    E   +E   M 
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 63

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVV 213
               H +IV + G   ++  V I+MELC  GEL   +  R               +   +
Sbjct: 64  QF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TDVVGSPYYVAP 271
               S   +HRD+   N L+     +  +K  DFGLS + +    +  +       ++AP
Sbjct: 122 AYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 272 EVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E +  + +   +DVW  GV ++ IL+ GV PF       +   +  G         P   
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCP 235

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCH 356
            +   L+ K     PS R    E+   
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 75/335 (22%), Positives = 133/335 (39%), Gaps = 54/335 (16%)

Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S+    ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTH 59

Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M  +  HKNI+++   +      E+   V++VMEL            +  
Sbjct: 60  AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QME 115

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
               + + L   ++  ++  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 172

Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            + T  V + YY APEV+L   Y    D+W+ G I+  ++     F        ++ V++
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Query: 316 G--------------------------------------HIDFESDPWPLISDSAKDLIR 337
                                                      +S+   L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292

Query: 338 KMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDP 372
           KML   P++R++  + L HP+I       +    P
Sbjct: 293 KMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 327

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-55
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 18/272 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T  +++G GQFG  +L   +    + A K+I +         ED   E ++M  L 
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE----GAMSEEDFIEEAEVMMKL- 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H  +V + G   +   + +V E    G L D +  +   ++      +   +   +   
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--IFTDVVGSPYYVAPEVL 274
               V+HRDL   N L+    ++  +K  DFG++ F    Q    T       + +PEV 
Sbjct: 118 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 275 L-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
               Y  ++DVW+ GV+++ + S G  P+   +   + + +  G   F      L S   
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHV 231

Query: 333 KDLIRKMLCSQPSERLTAHEVLCH-PWICENG 363
             ++      +P +R     +L     I E+G
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (463), Expect = 2e-55
 Identities = 57/288 (19%), Positives = 108/288 (37%), Gaps = 22/288 (7%)

Query: 82  IDNQTYYVLGHKTDNI-----RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK-R 135
           ID  T+                    + + +G G+FG          G      +I   +
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
              + +   D   E  IM     H N++ ++G    S  V I+ E    G L   + Q  
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122

Query: 195 GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
           G ++  +   + R I   ++    +  +HRDL   N L+   + +   K  DFGLS F +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 179

Query: 255 PGQIFTDV------VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
                              + APE +  + +   +DVW+ G++++ ++S G  P+W  T 
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           Q + +A+ +   D+   P      +   L+        + R    +++
Sbjct: 240 QDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-55
 Identities = 61/270 (22%), Positives = 109/270 (40%), Gaps = 21/270 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++           E   +E Q+M  L 
Sbjct: 16  RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKL- 69

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +      +    +  ++   I   +  
Sbjct: 70  RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--IFTDVVGSPYYVAPEV 273
              +  +HRDL+  N L+    ++   K  DFGL+   +  +            + APE 
Sbjct: 129 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
            L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +S
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242

Query: 332 AKDLIRKMLCSQPSERLTAHEVL--CHPWI 359
             DL+ +    +P ER T   +      + 
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-55
 Identities = 62/275 (22%), Positives = 105/275 (38%), Gaps = 23/275 (8%)

Query: 98  RDLYTLG-RKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMH 154
           RD   +   +LG G FG+            I+ A K + +     + D E++ RE QIMH
Sbjct: 7   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMH 64

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVV 213
            L  +  IV + G  +    + +VME+  GG L   ++ +R        AEL   +   +
Sbjct: 65  QL-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYV 269
           +       +HRDL   N LL    +    K  DFGLS        +    +       + 
Sbjct: 123 KYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           APE +  + +   +DVW+ GV ++  LS G  P+       +   + +G      +  P 
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPE 236

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEV---LCHPWI 359
                  L+      +  +R     V   +   + 
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 4e-55
 Identities = 59/263 (22%), Positives = 105/263 (39%), Gaps = 17/263 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R   T+  KLG GQ+G  Y        +  A K++ +       +VE+  +E  +M  + 
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 71

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY--SERKAAELTRIIVGVVEA 215
            H N+V + G        +I+ E    G L D + +      S      +   I   +E 
Sbjct: 72  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEV 273
                 +HRDL   N L+    ++  +K  DFGLS                   + APE 
Sbjct: 131 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           L    +  ++DVW  GV+L+ + + G+ P+       +++ + K   D+  +      + 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEK 244

Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
             +L+R      PS+R +  E+ 
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIH 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 9e-54
 Identities = 53/263 (20%), Positives = 100/263 (38%), Gaps = 19/263 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +         +    E  +M  L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 67  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TDVVGSPYYVAPEV 273
                 +HRDL+  N L+    D  S K  DFGL+   +  +            + APE 
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           +    +  ++DVW+ G++L  +++ G  P+   T   +   + +G   +         + 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238

Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
              L+R     +P +R T   + 
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLR 261

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 46/262 (17%), Positives = 97/262 (37%), Gaps = 20/262 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +GR++G+G FG  +  T +    + A K   +R      D   +R E +    LAG  
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            I  +    ++ L   +V++L          +    +S +  A   + ++  V++ H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 221 VMHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPG--------QIFTDVVGSPYYVA 270
           +++RD+KP+NFL+   +   +  +  +DFG+  F++          +   ++ G+  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP----W 325
               L +      D+   G +    L G  P+             +     +S P     
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 326 PLISDSAKDLIRKMLCSQPSER 347
               +     +           
Sbjct: 242 AGFPEEFYKYMHYARNLAFDAT 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 4e-52
 Identities = 58/285 (20%), Positives = 104/285 (36%), Gaps = 35/285 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+  + G+ LG G FG     T     +    +  A K +         + E +  E+++
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKV 79

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---------------- 196
           + +L  H NIV + GA        ++ E C  G+L + + ++                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 197 --YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                      +  +   +    S   +HRDL   N LL         K  DFGL+   K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIK 196

Query: 255 PGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
                 +  +      ++APE +    Y  E+DVW+ G+ L+ L S G  P+        
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           F  ++K      S           D+++    + P +R T  +++
Sbjct: 257 FYKMIKEGFRMLSPEH--APAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 4e-52
 Identities = 50/263 (19%), Positives = 94/263 (35%), Gaps = 14/263 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIMHHLAG 158
           +   + LG G FGT Y    I  G +       K  R+  S +  +++  E  +M  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           + ++  + G    S    I   +  G  L      + +   +        I   +     
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL 275
             ++HRDL   N L+        +K  DFGL+      +             ++A E +L
Sbjct: 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 276 -KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            + Y  ++DVW+ GV ++ L++ G  P+       I   + KG         P+ +    
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVY 243

Query: 334 DLIRKMLCSQPSERLTAHEVLCH 356
            ++ K        R    E++  
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 7e-52
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 69

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--------------- 195
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R                
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 196 -HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
              S +        +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 186

Query: 255 PGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
               +    +      ++APE L  + Y  ++DVW+ GV+L+ + + G  P+     + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           F  + +GH     D     ++    ++R    + PS+R T  +++
Sbjct: 247 FKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (433), Expect = 5e-51
 Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 43/291 (14%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+     R +G+G FG  +                A K + +    S +   D +RE  +
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAAL 69

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY--------------- 197
           M     + NIV + G       + ++ E  A G+L + +     +               
Sbjct: 70  MAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 198 ---------SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                    S  +   + R +   +        +HRDL   N L+    ++  +K  DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFG 185

Query: 249 LSVFFKPGQIF---TDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWA 303
           LS        +    +      ++ PE +  + Y  E+DVW  GV+L+ + S G+ P++ 
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245

Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              + +   V  G+I               +L+R      P++R +   + 
Sbjct: 246 MAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-48
 Identities = 53/273 (19%), Positives = 108/273 (39%), Gaps = 21/273 (7%)

Query: 94  TDNI-RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRR 148
           T  I     T  + +G G+FG  Y      +     +  A K++      + +   D   
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLG 58

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTR 207
           E  IM     H NI+ ++G       + I+ E    G L   + ++ G +S  +   + R
Sbjct: 59  EAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVV 263
            I   ++   ++  +HRDL   N L+   + +   K  DFGLS   +         +   
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

Query: 264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE 321
               + APE +  + +   +DVW+ G++++ +++ G  P+W  +   +  A+  G   F 
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FR 231

Query: 322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                    +   L+ +    + + R    +++
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 8e-48
 Identities = 57/290 (19%), Positives = 111/290 (38%), Gaps = 35/290 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+  T+ R+LGQG FG  Y        +       A K++++    S  +  +   E  +
Sbjct: 19  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASV 76

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----------YSERKA 202
           M       ++V + G         ++MEL   G+L   +                S  K 
Sbjct: 77  MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IF 259
            ++   I   +   ++   +HRDL   N ++    +DF++K  DFG++            
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGH 317
              +    +++PE L    +   +DVW+ GV+L+ + +    P+   + + +   V++G 
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL------CHPWICE 361
           +    D      D   +L+R      P  R +  E++        P   E
Sbjct: 253 LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 7e-46
 Identities = 57/266 (21%), Positives = 106/266 (39%), Gaps = 21/266 (7%)

Query: 103 LGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
               +G+G FG  Y  T +      I  A KS+++       +V     E  IM   + H
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-H 87

Query: 160 KNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACH 217
            N++++ G          +V+     G+L + I    H  + +        +   ++   
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPE 272
           S   +HRDL   N +L   D+ F++K  DFGL+      +       T       ++A E
Sbjct: 148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
            L  + +  ++DVW+ GV+L+ L++ G PP+       I   +L+G             D
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCPD 261

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCH 356
              +++ K    +   R +  E++  
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 7e-46
 Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 34/286 (11%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           RD   LG+ LG+G FG           + AT    A K + +    +  +   +  E++I
Sbjct: 12  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKI 69

Query: 153 MHHLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHY-------------- 197
           + H+  H N+V + GA  +    + +++E C  G L   +  + +               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 198 --SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             +       +  +   +E   S   +HRDL   N LL    +   +K  DFGL+     
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYK 186

Query: 256 GQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGV-PPFWAETQQGIF 310
              +    D      ++APE +  + Y  ++DVW+ GV+L+ + S    P+        F
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH 356
              LK      +  +   +      +      +PS+R T  E++ H
Sbjct: 247 CRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 9e-46
 Identities = 57/295 (19%), Positives = 98/295 (33%), Gaps = 51/295 (17%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
             L   +G+G+FG  +       G E A K  S R+    E       EI     L  H+
Sbjct: 5   IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHE 57

Query: 161 NIVTIKGAYEDS----LCVHIVMELCAGGELFDRIIQRGHYSERK-------AAELTRII 209
           NI+    A          + +V +    G LFD + +     E         A+ L  + 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-----VVG 264
           + +V       + HRDLK +N L+     + +    D GL+V         D      VG
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 265 SPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAE------------- 304
           +  Y+APEVL              AD++  G++ + +                       
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234

Query: 305 --TQQGIFDAVLKGHIDFESDPWPL---ISDSAKDLIRKMLCSQPSERLTAHEVL 354
             + + +   V +  +                   ++R+   +  + RLTA  + 
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 72/357 (20%), Positives = 128/357 (35%), Gaps = 79/357 (22%)

Query: 87  YY--VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           Y+    G    + R  Y L RKLG G F T +L  ++      A K +   K+ +    E
Sbjct: 1   YHPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----E 54

Query: 145 DVRREIQIMHHL----------AGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII 192
               EI+++  +           G  +I+ +   +       VH+VM     GE    +I
Sbjct: 55  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114

Query: 193 QRGHYSERKAAELTRIIVGVVEACHSL----GVMHRDLKPENFLLVNKD---DDFSLKAI 245
           ++  +       + +I   ++     +    G++H D+KPEN L+   D   +   +K  
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174

Query: 246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAE 304
           D G + ++      +    +  Y +PEVLL   +G  AD+W+   +++ L++G   F  +
Sbjct: 175 DLGNACWYDEHYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232

Query: 305 TQQG-------------------------------IFDAVLKGHIDFESDPWPL------ 327
                                               F++        +   WPL      
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292

Query: 328 -------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI-----CENGVAPDRSLDP 372
                   +    D +  ML   P +R  A  ++ HPW+      E    PDR L  
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYG 349

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 7e-21
 Identities = 37/211 (17%), Positives = 70/211 (33%), Gaps = 37/211 (17%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACK-----SISKRKLISREDVEDVR-REIQIM 153
           +  +G+ +G+G+    + C       E   K       S +K+  + D  D+    + I 
Sbjct: 1   VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 154 HHLAGHKNIVTIKGAYE----DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
                 + +  ++G             ++MEL           +          E+  +I
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMI 112

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  V   +  G++H DL   N L+     +  +  IDF  SV            G    +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSV-------EVGEEGWREIL 161

Query: 270 APEV------LLKHYGPEADVWTAGVILYIL 294
             +V        + Y  E D+ +   I  IL
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINS--AIDRIL 190

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 15/139 (10%), Positives = 39/139 (28%), Gaps = 4/139 (2%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE----DVEDVRREIQIMHHLAGHK 160
           +++G G     +   +         K       +  E     ++  R E   +     H 
Sbjct: 32  QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +  +  Y D+     VME  +  ++  + +  G      +  +   +   +       
Sbjct: 92  PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151

Query: 221 VMHRDLKPENFLLVNKDDD 239
           +  +  K       N +  
Sbjct: 152 LEPKVKKQLVKQFTNPELC 170

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	398
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.83
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.45

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-65  Score=482.54  Aligned_cols=291  Identities=39%  Similarity=0.718  Sum_probs=238.4

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +++.++|++.+.||+|+||+||+|.++.+++.||||++.+...  ......+.+|+.+|+++. ||||+++++++.+.+.
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGH   81 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh--hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            4577889999999999999999999999999999999976543  223456889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +|||||||+||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+|||+...++++.+||+|||+|....
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999999999988899999999999999999999999999999999999999765678899999999998877


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .+......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+....+....+.+....++...++.+|+++.
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            6666677899999999999985 599999999999999999999999999999999999999888887777778999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSLDPAVLSRLKQFSAMNKLKK  389 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (398)
                      +||.+||+.||++|||+.|+|+||||++..... ......+.+++++...++++++
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  296 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD-KNIHQSVSEQIKKNFAKSKWKQ  296 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCC-CCCHHHHHHHHHHHSCCCTTTS
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCCCccc-cccchhHHHHHHHHHHHhhhhh
Confidence            999999999999999999999999998754332 3444555666776655555443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-64  Score=460.78  Aligned_cols=255  Identities=33%  Similarity=0.601  Sum_probs=232.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            45999999999999999999999999999999997654434445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      ||||++|+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|....... 
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc-
Confidence            9999999999999988899999999999999999999999999999999999999   888899999999998765433 


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+.+..+.+....++.    .+++++.+||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence            456789999999999986 5899999999999999999999999999999999998887766543    48999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCCccCC
Q 015898          338 KMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       338 ~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      +||++||++|||+.|+|+||||...
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-63  Score=459.61  Aligned_cols=260  Identities=30%  Similarity=0.506  Sum_probs=220.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.++|++.+.||+|+||+||+|.++.+|+.||||++....  ..+..+.+.+|+.+|++++ ||||+++++++.+.+.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            3467999999999999999999999999999999997653  2334567899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|......
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999888889999999999999999999999999999999999999   88889999999999876433


Q ss_pred             ---CcccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          257 ---QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                         ......+||+.|+|||++.+ . ++.++|||||||++|||++|..||.................. ....+..++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~  235 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSA  235 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHH
Confidence               23456789999999999975 3 467899999999999999999999776544333222222222 22334568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +.+||.+||+.||++|||++|+|+||||++..
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            99999999999999999999999999998643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-63  Score=463.62  Aligned_cols=262  Identities=32%  Similarity=0.545  Sum_probs=233.4

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+++++. ||||++++++|.+.+.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            56999999999999999999999999999999997654434455678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC--
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG--  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~--  256 (398)
                      |||++||+|.+++...+.+++..++.++.|++.||+|||++|||||||||+|||+   ++++.+||+|||+|+.....  
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   88899999999999876533  


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+++..+.+....++.    .+++++++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHH
Confidence             23345789999999999985 5999999999999999999999999999999999999888766553    48999999


Q ss_pred             HHHHhcccCCCCCCCHHH------HhcCCCccCCCCCCCC
Q 015898          335 LIRKMLCSQPSERLTAHE------VLCHPWICENGVAPDR  368 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~e------iL~hp~~~~~~~~~~~  368 (398)
                      ||.+||+.||++|||++|      +++||||++..+....
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence            999999999999999988      5889999987654433

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-62  Score=459.52  Aligned_cols=268  Identities=39%  Similarity=0.689  Sum_probs=240.1

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC---HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---REDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      .++.++|++++.||+|+||+||+|.++.+|+.||||++.+.....   ....+.+.+|+.+|++|+ |||||+++++|.+
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~   84 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   84 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            456788999999999999999999999999999999997654322   224678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecC-CCccEEEeecCCc
Q 015898          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLS  250 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~-~~~~~kL~DFG~a  250 (398)
                      .+.+|||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+...+ ....+||+|||+|
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999999999888999999999999999999999999999999999999993322 1236999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .....+.......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+......++...++.++
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            98877766777899999999999985 59999999999999999999999999999999999998887776665556789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +++++||.+||+.||++|||+.|+|+||||++..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999998744

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-62  Score=468.01  Aligned_cols=270  Identities=33%  Similarity=0.579  Sum_probs=243.0

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+-+.|++.+.||+|+||+||+|.+..+|+.||||++...   .....+.+.+|+.+|++|. ||||++++++|.+.+.+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            3456799999999999999999999999999999998754   3345567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||||||+||+|.+.+...+ .+++.+++.++.||+.||.|||++|||||||||+|||+.. ..++.+||+|||+|....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecC
Confidence            99999999999998876544 6999999999999999999999999999999999999932 156789999999999988


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .........||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+......++...++.+++++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            7777778899999999999985 599999999999999999999999999999999999999888888877788999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL  370 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~  370 (398)
                      +||.+||++||++|||+.|+|+||||++.........
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~~~  297 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI  297 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCCCB
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCcchhcccC
Confidence            9999999999999999999999999988654443333

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-62  Score=455.42  Aligned_cols=258  Identities=30%  Similarity=0.462  Sum_probs=226.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ..++|++.+.||+|+||+||+|.++.+|+.||||++.....   ...+.+.+|+.+++++. ||||++++++|.+.+.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence            34579999999999999999999999999999999976543   23467899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      +|||||+||+|.+++.+ +.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence            99999999999987655 569999999999999999999999999999999999999   78899999999999876543


Q ss_pred             -CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                       ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+...... .......+++++++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence             34566789999999999985 5999999999999999999999999988877776666554322 12223468999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ||.+||++||++|||+.|+|+||||+...
T Consensus       249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999999997543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.9e-62  Score=466.78  Aligned_cols=265  Identities=35%  Similarity=0.591  Sum_probs=240.3

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+-++|++.+.||+|+||.||+|.++.+|+.||||++...   .....+.+.+|+.+|++|+ ||||+++++++.+.+.+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            3456799999999999999999999999999999999654   3455678999999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |||||||+||+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||+.. +.++.+||+|||+|....
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecc
Confidence            999999999999998854 457999999999999999999999999999999999999943 235789999999999887


Q ss_pred             CCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .........||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+......++...++.++++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            7777778899999999999985 589999999999999999999999999999999999998887777766677999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENGVA  365 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~  365 (398)
                      +||.+||+.||++|||+.|+|+||||.+....
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            99999999999999999999999999876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-61  Score=447.86  Aligned_cols=263  Identities=38%  Similarity=0.682  Sum_probs=240.5

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCC------HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS------REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~  170 (398)
                      |.++|++.+.||+|+||+||+|.+..+|+.||||++.+.....      ....+.+.+|+.++++|..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            3567999999999999999999999999999999997654322      2234568899999999987999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       171 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                      +++.+||||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence            999999999999999999999999999999999999999999999999999999999999999   88899999999999


Q ss_pred             eecCCCCcccccccCCcccCcccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC
Q 015898          251 VFFKPGQIFTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (398)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  323 (398)
                      .....+......+||+.|+|||++.+       .++.++||||+||++|+|++|..||.+.+.......+..+...++..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98877666677899999999999852       37889999999999999999999999999999999999888877777


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       324 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      .++.+|+++++||.+||+.||++|||++|||+||||++.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            777899999999999999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-61  Score=460.04  Aligned_cols=256  Identities=32%  Similarity=0.534  Sum_probs=235.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+++. ||||++++++|++.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            45999999999999999999999999999999997655444556788999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC-CC
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~-~~  257 (398)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+   +.+|.+||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   8889999999999987543 34


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+++..+..+...++.    .+++++++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Confidence            5567899999999999985 5999999999999999999999999999999999999988776654    4899999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCCccCC
Q 015898          337 RKMLCSQPSERLT-----AHEVLCHPWICEN  362 (398)
Q Consensus       337 ~~~L~~dP~~Rps-----~~eiL~hp~~~~~  362 (398)
                      .+||++||++|++     +.|+++||||.+.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999994     8999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-62  Score=453.03  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=227.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++.+.||+|+||+||+|.++.+++.||||++...   .....+.+.+|+++|++|+ ||||+++++++.+.+.+|+
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence            45699999999999999999999999999999999754   3445678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||||++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCC
Confidence            9999999999998765 4569999999999999999999999999999999999999   88899999999999765432


Q ss_pred             -CcccccccCCcccCccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          257 -QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                       ......+||+.|+|||++.      ..|+.++|||||||++|||++|..||.+.+..+.+..+.++..... .....++
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s  242 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWS  242 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSC
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCC
Confidence             2334678999999999984      2488999999999999999999999999888888888887654322 2234689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +++.+||.+||++||++|||+.|+|+||||+...
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999997543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-61  Score=443.96  Aligned_cols=253  Identities=23%  Similarity=0.381  Sum_probs=219.8

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec----CCeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SLCVH  176 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~----~~~~~  176 (398)
                      |++.++||+|+||+||+|.+..+++.||+|.+..... .....+.+.+|+++|++++ ||||++++++|+.    ...+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence            4778899999999999999999999999999976543 5566778999999999998 9999999999864    45689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~--iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      +||||+++|+|.+++.+...+++..+..++.||+.||+|||+++  |+||||||+|||+.  ++++.+||+|||+|....
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc
Confidence            99999999999999998889999999999999999999999999  99999999999992  246889999999998644


Q ss_pred             CCCcccccccCCcccCcccccccCCCcccHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      . ......+||+.|+|||++.+.|+.++|||||||++|||++|..||.+.. ...+...+..+....  .....+++++.
T Consensus       167 ~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~  243 (270)
T d1t4ha_         167 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVK  243 (270)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCHHHH
T ss_pred             C-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCccCCHHHH
Confidence            3 3445788999999999998889999999999999999999999997654 445555555443221  12235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWIC  360 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~  360 (398)
                      +||.+||++||++|||+.|+|+||||+
T Consensus       244 ~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         244 EIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-61  Score=454.32  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=230.1

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .+.|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+|++|+ |||||++++++.+.+.+|+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEE
Confidence            456999999999999999999999999999999998766555667788999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||||.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|.....  
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS--
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC--
Confidence            99999999998777778889999999999999999999999999999999999999   7888999999999986543  


Q ss_pred             cccccccCCcccCccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                       ....+||+.|+|||++.    +.|+.++|||||||++|||++|..||.+....+.+..+..+......  ...+++++.
T Consensus       168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~~  244 (309)
T d1u5ra_         168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFR  244 (309)
T ss_dssp             -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHHH
T ss_pred             -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHHH
Confidence             34578999999999985    24899999999999999999999999988888887777766543322  235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +||.+||+.||++|||+.|+|+||||....
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            999999999999999999999999997643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-61  Score=444.90  Aligned_cols=253  Identities=28%  Similarity=0.483  Sum_probs=214.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCVH  176 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~~  176 (398)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++..... +....+.+.+|+.+++++. ||||+++++++.+  .+.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            569999999999999999999999999999999976543 5666788999999999997 9999999999864  56689


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCcEEEeecCCCccEEEeec
Q 015898          177 IVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~al~~lH~~~-----iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                      +|||||++|+|.+++.+    ...+++..++.++.||+.||.|||+.|     ||||||||+|||+   ++++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence            99999999999998854    457999999999999999999999976     9999999999999   88899999999


Q ss_pred             CCceecCCCC-cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCC
Q 015898          248 GLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (398)
Q Consensus       248 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  325 (398)
                      |+|....... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..++...+..+.....   .
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            9998765433 3456789999999999975 599999999999999999999999999999998888887765432   2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       326 ~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      ..+++++.+||.+||+.||++|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            3589999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-60  Score=451.46  Aligned_cols=254  Identities=28%  Similarity=0.538  Sum_probs=232.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      +|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeEe
Confidence            4999999999999999999999999999999997654434445678999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCcc
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~  259 (398)
                      |||+||+|..++.....+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|......  .
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--~  158 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--T  158 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--B
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--c
Confidence            999999999999999999999999999999999999999999999999999999   88899999999999886543  3


Q ss_pred             cccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHH
Q 015898          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  338 (398)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+.++...++.    .+++++.++|.+
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~  234 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSR  234 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHH
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence            56789999999999986 5999999999999999999999999999999999999888765543    588999999999


Q ss_pred             hcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          339 MLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       339 ~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      ||++||.+|+     |++|+|+||||++..
T Consensus       235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            9999999996     999999999998853

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-61  Score=453.20  Aligned_cols=275  Identities=28%  Similarity=0.463  Sum_probs=234.1

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+..|+.++.+..+||||+++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46999999999999999999999999999999997654333445667778888776433499999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-C
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~  257 (398)
                      |||+++|+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|...... .
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccccc
Confidence            9999999999999999999999999999999999999999999999999999999   88899999999999865433 3


Q ss_pred             cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      ......||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+...++..+..+...++.    .+++++.+||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHH
Confidence            4456789999999999985 6999999999999999999999999999999999998887665443    5899999999


Q ss_pred             HHhcccCCCCCCCHH-HHhcCCCccCCCCC--CCCCCCHHHHHHHHH
Q 015898          337 RKMLCSQPSERLTAH-EVLCHPWICENGVA--PDRSLDPAVLSRLKQ  380 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~-eiL~hp~~~~~~~~--~~~~~~~~~~~~~~~  380 (398)
                      .+||+.||++|||+. |+++||||++..+.  .....+|++.|+++.
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~  281 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKS  281 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC--------
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCC
Confidence            999999999999995 89999999885432  233455666666654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-61  Score=453.80  Aligned_cols=261  Identities=29%  Similarity=0.558  Sum_probs=237.4

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +-++|++.+.||+|+||+||+|.++.+++.||||++...    ......+.+|+.+|+.++ ||||++++++|++.+.+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC----cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            557799999999999999999999999999999999654    233456889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||+.. ++...+||+|||++.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhcccc
Confidence            9999999999999997665 6999999999999999999999999999999999999943 2446899999999998877


Q ss_pred             CCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (398)
                      ........+|+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+.+....++...++.+++++++
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            766677889999999999875 5899999999999999999999999999999999999998888777666779999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          335 LIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       335 li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      ||.+||+.||++|||++|+|+||||++..
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-61  Score=457.49  Aligned_cols=260  Identities=24%  Similarity=0.362  Sum_probs=219.4

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++....  .....+++.+|+.+|++++ |||||+++++|.+.+.+|+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            467999999999999999999999999999999997543  4455678999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||+   ++++.+||+|||+|......
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC
Confidence            99999999999999988899999999999999999999997 599999999999999   88899999999999865432


Q ss_pred             CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHH------------------------
Q 015898          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD------------------------  311 (398)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~------------------------  311 (398)
                       .....+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+.+......                        
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence             2356799999999999985 69999999999999999999999997654322110                        


Q ss_pred             ------------------HHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          312 ------------------AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       312 ------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                                        .+....  .+......++.+++|||.+||+.||++|||++|+|+||||++.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             cccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence                              000000  01111123678999999999999999999999999999998755433

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-60  Score=454.22  Aligned_cols=255  Identities=31%  Similarity=0.565  Sum_probs=233.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|+.+. ||||+++++++.+...+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            56999999999999999999999999999999997654434455678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~  258 (398)
                      |||+.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999998999999999999999999999999999999999999999   88899999999999886543  


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (398)
                      .....||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+....+..+..+...++.    .+++++.+||.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Confidence            346789999999999985 5999999999999999999999999999999999999888765543    58999999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          338 KMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       338 ~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      +||++||.+|+     |++|+++||||++..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            99999999995     999999999998754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-60  Score=450.62  Aligned_cols=268  Identities=36%  Similarity=0.622  Sum_probs=225.1

Q ss_pred             ccccccceec-ceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--
Q 015898           95 DNIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--  171 (398)
Q Consensus        95 ~~~~~~y~~~-~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--  171 (398)
                      ..+-++|++. ++||+|+||+||+|.+..+++.||||++...        ..+.+|+.++.++.+||||++++++|++  
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            3455679886 4699999999999999999999999998632        3567899998777669999999999875  


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeec
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DF  247 (398)
                        ...+|+|||||+||+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||+...++.+.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46799999999999999999764  36999999999999999999999999999999999999965556788999999


Q ss_pred             CCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHH----HcCCCcCCC
Q 015898          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV----LKGHIDFES  322 (398)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~----~~~~~~~~~  322 (398)
                      |+|+...........+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.........+    ......++.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            99998877777778899999999999985 5999999999999999999999999876654444333    333444444


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCCC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPDRSL  370 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~  370 (398)
                      ..+..+++++.+||.+||+.||++|||+.|+|+||||.+....+....
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  286 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  286 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence            444568999999999999999999999999999999987665554433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-59  Score=449.35  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=218.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHH---HHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE---IQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---i~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|++.++||+|+||.||+|.++.+|+.||||++.+...........+.+|   +.+++.+. ||||++++++|.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence            459999999999999999999999999999999975443222233334444   56666665 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      |+|||||+||+|.+++.....+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999998999999999999999999999999999999999999999   8889999999999987765


Q ss_pred             CCcccccccCCcccCccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .. ....+||+.|+|||++. + .|+.++|||||||++|||++|..||.+......... ..............+++++.
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSSCCCCCCSSSCHHHH
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccCCCCCCCCCCHHHH
Confidence            43 35678999999999986 3 489999999999999999999999987654433322 22222233333446899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 015898          334 DLIRKMLCSQPSERLT-----AHEVLCHPWICEN  362 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps-----~~eiL~hp~~~~~  362 (398)
                      +||.+||+.||++|||     ++|+++||||++.
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-59  Score=435.98  Aligned_cols=257  Identities=26%  Similarity=0.350  Sum_probs=215.3

Q ss_pred             ecceecccCceEEEEEEEccCCcEEEEEEecccccCC--HhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEe
Q 015898          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (398)
Q Consensus       103 ~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  180 (398)
                      .+++||+|+||+||+|.++.+|+.||||++.......  ....+.+.+|+.+|++++ ||||+++++++...+.+|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            3578999999999999999999999999986543221  112356889999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC-Ccc
Q 015898          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIF  259 (398)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~-~~~  259 (398)
                      |+.++.+..+......+++..+..+++||+.||+|||++||+||||||+|||+   +.++.+||+|||+|...... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99888777666666779999999999999999999999999999999999999   88899999999999776543 334


Q ss_pred             cccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC--------------
Q 015898          260 TDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD--------------  323 (398)
Q Consensus       260 ~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  323 (398)
                      ...+||+.|+|||++..  .|+.++|||||||++|||++|..||.+.+..+.+..+.+........              
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            56789999999999863  48999999999999999999999999998888877776421111100              


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          324 ----------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       324 ----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                ..+.+++++++||.+||+.||++|||+.|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                      0134688999999999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=426.99  Aligned_cols=254  Identities=29%  Similarity=0.536  Sum_probs=217.3

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHh---hHHHHHHHHHHHHHhc-CCCCeeEEeEEEecC
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRREIQIMHHLA-GHKNIVTIKGAYEDS  172 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~Ei~~l~~l~-~h~niv~l~~~~~~~  172 (398)
                      +.++|++.++||+|+||+||+|.+..+|+.||||++.+.......   ...++.+|+.+|+++. +||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            456799999999999999999999999999999999765433221   2234678999999986 489999999999999


Q ss_pred             CeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          173 LCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       173 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                      +..|+||||+.+ +++.+++.....+++..++.++.||+.||+|||++||+||||||+|||+.  .+++.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccce
Confidence            999999999976 57888888888999999999999999999999999999999999999993  245789999999998


Q ss_pred             ecCCCCcccccccCCcccCcccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          252 FFKPGQIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .... ...+...||+.|+|||++.+ . ++.++|||||||++|||++|..||....      .+.++...++    +.+|
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence            7544 34567889999999999874 3 4678999999999999999999997532      3444444443    3589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                      +++.+||.+||++||++|||++|+|+||||++..
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999999998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=424.62  Aligned_cols=260  Identities=24%  Similarity=0.382  Sum_probs=216.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      |+|++++.||+|+||+||+|.+..+|+.||||++.... ......+++.+|+.+|+++. ||||++++++|.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            46999999999999999999999999999999996543 23344678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+.+ .+.+.+..  ...+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence            999965 45455533  3569999999999999999999999999999999999999   88889999999999876543


Q ss_pred             -CcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCC----------
Q 015898          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD----------  323 (398)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------  323 (398)
                       .......||+.|+|||.+..  .++.++|||||||++|+|++|+.||.+.+..+.+..+.+........          
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             34456789999999998763  36899999999999999999999999888777766654321111110          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 015898          324 ---------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGV  364 (398)
Q Consensus       324 ---------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~  364 (398)
                                     ..+.+++++++||.+||++||++|||++|+|+||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                           01246789999999999999999999999999999987543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.1e-57  Score=421.82  Aligned_cols=260  Identities=24%  Similarity=0.350  Sum_probs=222.3

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC--
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~--  173 (398)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++.+....+....+.+.+|+.+++.++ ||||+++++++...+  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            35678999999999999999999999999999999998766666777788999999999997 999999999987543  


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCce
Q 015898          174 --CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (398)
Q Consensus       174 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~  251 (398)
                        .+|+||||++|++|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||+   +.++.++|+|||.+.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR  159 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence              489999999999999999998999999999999999999999999999999999999999   778899999999987


Q ss_pred             ecCCC----CcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          252 FFKPG----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       252 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      .....    ......+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+.+..+.+..+......++....+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            65332    23456789999999999985 59999999999999999999999999999888888888777666666667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCHPWI  359 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~  359 (398)
                      .+|+++.+||.+||++||++||+..+.|.|+|+
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            899999999999999999999954444556654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=423.70  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=217.0

Q ss_pred             cccceecceecccCceEEEEEEEccC-CcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc--CCCCeeEEeEEEe----
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYE----  170 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~h~niv~l~~~~~----  170 (398)
                      .++|+++++||+|+||+||+|.+..+ ++.||||++..... .......+.+|+.+|+.|.  +||||++++++|.    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36799999999999999999999765 67799999975432 2223345667888887763  4999999999985    


Q ss_pred             -cCCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecC
Q 015898          171 -DSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (398)
Q Consensus       171 -~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG  248 (398)
                       ....++++|||+.++.+..... ....+++..++.++.|++.||+|||++|||||||||+|||+   ++++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence             3457899999998876644333 34568999999999999999999999999999999999999   888999999999


Q ss_pred             CceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC-------
Q 015898          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------  320 (398)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------  320 (398)
                      ++.............||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+.+..+.......       
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            9987766666678899999999999875 69999999999999999999999999998888777765421100       


Q ss_pred             ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          321 ----------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       321 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                      .......+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                            0011235789999999999999999999999999999998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-56  Score=418.59  Aligned_cols=257  Identities=27%  Similarity=0.400  Sum_probs=216.2

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||+||+|.++ +|+.||||++..... .....+++.+|+.+|++++ ||||+++++++...+..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            57999999999999999999985 789999999966532 3444678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      ||++.++.+..+....+.+++..+..++.||+.||+|||+.|||||||||+|||+   +.++.+||+|||.|....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999877776666667789999999999999999999999999999999999999   888999999999998765432 


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCC--------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--------------  321 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------  321 (398)
                      ......+++.|+|||.+.+  .++.++|||||||++|||++|+.||.+.+..+.+..+........              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2345678999999999874  479999999999999999999999998887777666543111110              


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 015898          322 -----------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICE  361 (398)
Q Consensus       322 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~  361 (398)
                                 ....+.+++++.|||.+||++||++|||+.|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                       0112346889999999999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-56  Score=414.87  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=205.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCc---EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +.|++.++||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+.+|++|+ |||||++++++...+.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEE
Confidence            569999999999999999999877664   58888875432  5666778999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++|||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEcc
Confidence            9999999999999988764 469999999999999999999999999999999999999   889999999999998765


Q ss_pred             CCCc------ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCC
Q 015898          255 PGQI------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (398)
Q Consensus       255 ~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  326 (398)
                      ....      .....||+.|+|||.+.+ .|+.++|||||||++|||+| |..||.+....++...+..+....   ...
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~  256 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---PPM  256 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCT
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCc
Confidence            4322      123467899999999874 69999999999999999998 899999999988888887764322   234


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       327 ~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .+++++.+||.+||+.||++|||+.||+++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            689999999999999999999999998764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=417.56  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=215.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------  171 (398)
                      .++|+++++||+|+||+||+|++..+|+.||||++..... ......++.+|+.+|++++ ||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            4679999999999999999999999999999999876543 3344567889999999997 9999999999854      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       172 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                        .+.+|+||||+.++.+.........+++..++.+++||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence              45689999999877665555556679999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCC-----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC
Q 015898          250 SVFFKPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (398)
Q Consensus       250 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  322 (398)
                      +.......     .....+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+.+.......+.+....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97664322     2344679999999999874  5899999999999999999999999988887777766553332222


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 015898          323 DPWPL----------------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICEN  362 (398)
Q Consensus       323 ~~~~~----------------------------~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~  362 (398)
                      ..+..                            .+++++|||.+||++||++|||++|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            21111                            36788999999999999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-56  Score=419.70  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=212.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCc-----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGI-----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|++.++||+|+||+||+|.+...++     .||+|.+....  .......+.+|+.++.++.+|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3679999999999999999999876553     69999986543  3444567899999999996699999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG-----------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPE  229 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~  229 (398)
                      +.+|+|||||++|+|.+++....                       .+++..++.++.||+.||+|||++|||||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            99999999999999999997542                       4889999999999999999999999999999999


Q ss_pred             cEEEeecCCCccEEEeecCCceecCCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCc
Q 015898          230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAE  304 (398)
Q Consensus       230 NIll~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~  304 (398)
                      |||+   +.++.+||+|||+|+......   ......||+.|+|||++. +.|+.++|||||||++|||+| |..||.+.
T Consensus       194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999   788999999999998654433   223567899999999987 469999999999999999998 89999887


Q ss_pred             ChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      .....+..+......+  +....+++++.+||.+||+.||++|||++||++|
T Consensus       271 ~~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7666666655554332  2234689999999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=421.69  Aligned_cols=262  Identities=26%  Similarity=0.419  Sum_probs=216.3

Q ss_pred             ccccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        93 ~~~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      ....+.++|+++++||+|+||+||+|.++.+|+.||||++.+.. .+....+.+.+|+.+|+++. |||||+++++|...
T Consensus        12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~   89 (346)
T d1cm8a_          12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD   89 (346)
T ss_dssp             SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred             ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccC
Confidence            33457789999999999999999999999999999999997543 36666788999999999997 99999999999765


Q ss_pred             C------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEee
Q 015898          173 L------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (398)
Q Consensus       173 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~D  246 (398)
                      +      .+|+||||+ +.+|...+ +.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~D  164 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILD  164 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred             ccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccc
Confidence            4      579999999 55666554 55679999999999999999999999999999999999999   8889999999


Q ss_pred             cCCceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc-----
Q 015898          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----  319 (398)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----  319 (398)
                      ||+|.....  ..+...||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+..+.+..+......     
T Consensus       165 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         165 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            999987653  3466789999999999874  4789999999999999999999999888776665554331111     


Q ss_pred             ------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          320 ------------------FE----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       320 ------------------~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                        ..    ......+++++++||.+||++||++|||+.|||+||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                              01    112245789999999999999999999999999999998744

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=412.25  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||+||+|+..   ..||||++..... +....+.+.+|+.+|++++ ||||+++++++.+ +.+++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEEEE
Confidence            356999999999999999999743   3699999865433 4566788999999999997 9999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeecccc
Confidence            99999999999999754 569999999999999999999999999999999999999   78899999999999775432


Q ss_pred             ---CcccccccCCcccCcccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHH-cCCCcC-CCCCCCC
Q 015898          257 ---QIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL-KGHIDF-ESDPWPL  327 (398)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~~-~~~~~~~  327 (398)
                         .......||+.|+|||++..    .|+.++|||||||++|||+||+.||.+.+....+.... ++.... .......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence               23456789999999999862    48899999999999999999999998876554444443 333221 1223446


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +++++.+||.+||+.||++|||+.||+++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            88999999999999999999999999976

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-55  Score=411.79  Aligned_cols=246  Identities=22%  Similarity=0.299  Sum_probs=212.0

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....    ...+++.+|+.+|++++ |||||++++++.+.+.+++|
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEE
Confidence            46999999999999999999999999999999986532    34567899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCC
Confidence            9999999999998764  468999999999999999999999999999999999999   88899999999999876544


Q ss_pred             C--cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCC-CCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          257 Q--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF-WAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .  ......|++.|+|||++. +.|+.++|||||||++|||++|..|| .+.+...+.+.+..+..   ......+++++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l  245 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEKV  245 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC---CCCCccchHHH
Confidence            3  223456889999999987 46999999999999999999976655 45555666555555422   22334689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+||.+||+.||++|||+.||++
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999976

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-56  Score=410.12  Aligned_cols=246  Identities=23%  Similarity=0.264  Sum_probs=208.6

Q ss_pred             ceecccCceEEEEEEEc--cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEEecc
Q 015898          105 RKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (398)
Q Consensus       105 ~~iG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  182 (398)
                      ++||+|+||+||+|.+.  .+++.||||++.... .+....+++.+|+.+|++++ ||||+++++++..+ ..+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            57999999999999864  345789999996543 24555678999999999997 99999999999765 578999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCCc----
Q 015898          183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI----  258 (398)
Q Consensus       183 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~----  258 (398)
                      ++|+|.+++.....+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.......    
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence            999999999988899999999999999999999999999999999999999   7788999999999987654322    


Q ss_pred             ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHH
Q 015898          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (398)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  336 (398)
                      .....||+.|+|||++.+ .++.++|||||||++|||+| |..||.+.+..++...+.++....   ....+++++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHH
Confidence            234578999999999874 68999999999999999998 899999988888888887764322   2245899999999


Q ss_pred             HHhcccCCCCCCCHHHH---hcCCCc
Q 015898          337 RKMLCSQPSERLTAHEV---LCHPWI  359 (398)
Q Consensus       337 ~~~L~~dP~~Rps~~ei---L~hp~~  359 (398)
                      .+||+.||++|||+.+|   |+|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            99999999999999998   566665

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-55  Score=419.37  Aligned_cols=253  Identities=28%  Similarity=0.397  Sum_probs=211.6

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec------CC
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------SL  173 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~------~~  173 (398)
                      +|+..++||+|+||+||+|++..+|+.||||++.....       ...+|+.+|++|+ ||||++++++|..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            48999999999999999999999999999999975432       2236999999997 9999999999853      34


Q ss_pred             eEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCC-ccEEEeecCC
Q 015898          174 CVHIVMELCAGGELFDRI---IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFGL  249 (398)
Q Consensus       174 ~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~-~~~kL~DFG~  249 (398)
                      ++||||||++++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||+   +.+ ..+||+|||+
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl---~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTTCCEEECCCTT
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE---ecCCCceeEecccc
Confidence            589999999765332222   335569999999999999999999999999999999999999   655 4899999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCC----------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH----------  317 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----------  317 (398)
                      +............+||+.|+|||.+.+  .|+.++|||||||++|||++|..||......+.+..+.+..          
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            998877777777899999999998763  58999999999999999999999999888777766654310          


Q ss_pred             -------CcCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          318 -------IDFE--------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       318 -------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                             ..++        ....+.+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                   0000        111235789999999999999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=408.55  Aligned_cols=252  Identities=24%  Similarity=0.322  Sum_probs=215.4

Q ss_pred             ccceecce-ecccCceEEEEEEEcc--CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRK-LGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~-iG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +.|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+++.+|+.+|++++ |||||++++++..+ .+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-eE
Confidence            45777774 9999999999998654  45579999996442  5666788999999999997 99999999998754 57


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      |+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccc
Confidence            899999999999998765 4569999999999999999999999999999999999999   677899999999998765


Q ss_pred             CCCc----ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....    .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+....++...+.++....   ..+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~  237 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPEC  237 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTTC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcC
Confidence            4432    23456889999999987 469999999999999999998 999999888888888887765332   23468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHH---hcCCCcc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEV---LCHPWIC  360 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~ei---L~hp~~~  360 (398)
                      ++++.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999888   6677764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=405.42  Aligned_cols=246  Identities=23%  Similarity=0.359  Sum_probs=203.8

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.+. ++..||||++....    ...+++.+|+.++++++ ||||+++++++...+.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            35999999999999999999975 57789999986532    23467899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+   ++++.+||+|||+|+......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence            9999999999988654 558999999999999999999999999999999999999   888999999999998765433


Q ss_pred             c--ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 I--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .  .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||......++...+..+.....   ...+++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHH
Confidence            2  234678999999999984 69999999999999999999 5677777777778888777643322   235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +||.+||+.||++|||++||++|
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=407.01  Aligned_cols=250  Identities=21%  Similarity=0.303  Sum_probs=213.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~l  177 (398)
                      .++|++.+.||+|+||+||+|.+. ++..||||++....    ...+.+.+|+.++++++ |||||++++++.+ +.+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence            457999999999999999999964 67889999996532    23467899999999997 9999999998765 45789


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+|+....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccC
Confidence            99999999999877443  359999999999999999999999999999999999999   8889999999999988765


Q ss_pred             CC--cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHH
Q 015898          256 GQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (398)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (398)
                      ..  ......||+.|+|||++. +.++.++|||||||++|||+|| .+||......+.+..+..+.....   ...++++
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~  238 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPEE  238 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccChHH
Confidence            43  234567899999999987 4699999999999999999995 556667777778888776643322   2368899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc--CCCcc
Q 015898          332 AKDLIRKMLCSQPSERLTAHEVLC--HPWIC  360 (398)
Q Consensus       332 ~~~li~~~L~~dP~~Rps~~eiL~--hp~~~  360 (398)
                      +.+||.+||+.||++|||++||++  |+||.
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999999999998  78874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.7e-55  Score=415.07  Aligned_cols=255  Identities=29%  Similarity=0.504  Sum_probs=212.5

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec--CCeE
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~--~~~~  175 (398)
                      .++|+++++||+|+||+||+|+++.+|+.||||++...      ..+++.+|+.+|+.+.+||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            36799999999999999999999999999999998643      246788999999999779999999999974  4569


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ++||||+.+++|....   +.+++..++.+++||+.||.|||++||+||||||+|||+.  .+++.+||+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccC
Confidence            9999999999987653   4699999999999999999999999999999999999993  2345699999999998877


Q ss_pred             CCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCh-HHHHHHHHc-------------CCCc
Q 015898          256 GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLK-------------GHID  319 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~~~~-------------~~~~  319 (398)
                      .......++|+.|+|||.+.+  .++.++||||+||++|+|++|..||..... .+....+..             ....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            777778899999999999874  489999999999999999999999975432 222222111             0000


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          320 --------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       320 --------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                          ........++++++|||.+||++||++|||++|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                01111234788999999999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=400.22  Aligned_cols=246  Identities=23%  Similarity=0.367  Sum_probs=216.6

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.++||+|+||+||+|++ .+++.||||++.+...    ..+.+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            3589999999999999999997 4788999999975432    3457899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC
Q 015898          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~  257 (398)
                      |||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   ++++.+||+|||++.......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            999999999888654 4568999999999999999999999999999999999999   888999999999998765443


Q ss_pred             c--ccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          258 I--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .  .....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.+..++...+.++.....   ...+++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHH
Confidence            2  23467899999999987 469999999999999999998 8999999999988888887643332   236789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +||.+||+.||++|||+.+|++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=404.00  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=221.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|+++++||+|+||+||+|++..+++.||||++.... .......++.+|+.+|+.++ ||||+++++++......++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            47999999999999999999999999999999996554 24556788999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCCC-
Q 015898          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-  257 (398)
                      +|++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||.|....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999998888888889999999999999999999999999999999999999   778899999999998765433 


Q ss_pred             cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCC-CcChHHHHHHHHcCCCc---------------
Q 015898          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHID---------------  319 (398)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~-~~~~~~~~~~~~~~~~~---------------  319 (398)
                      ......+++.|+|||++..  .++.++|||||||++|||++|+.||. +.+..+.+..+......               
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            3345567888999998874  37999999999999999999998864 45555555554331111               


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          320 ----------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       320 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                ......+.+++++.+||.+||++||.+|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                      01112235688999999999999999999999999999998643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-55  Score=416.98  Aligned_cols=264  Identities=28%  Similarity=0.435  Sum_probs=215.7

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCC--
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~--  173 (398)
                      ++.++|+++++||+|+||+||+|.+..+|+.||||++.+..  .....+++.+|+.+|++|+ ||||+++++++....  
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence            35578999999999999999999999999999999996533  4566778999999999997 999999999986543  


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCc
Q 015898          174 ---CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (398)
Q Consensus       174 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a  250 (398)
                         .+|+++ ++.+++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+   ++++.+||+|||+|
T Consensus        82 ~~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a  156 (345)
T d1pmea_          82 QMKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  156 (345)
T ss_dssp             TCCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCce
Confidence               355555 5568999998865 469999999999999999999999999999999999999   88899999999999


Q ss_pred             eecCCCC----cccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcC----
Q 015898          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF----  320 (398)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----  320 (398)
                      .......    .....+||+.|+|||++..  .++.++||||+||++|+|++|..||.+....+............    
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            8754332    2355789999999999863  47899999999999999999999998877665554443211000    


Q ss_pred             ----------------CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 015898          321 ----------------ES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAPD  367 (398)
Q Consensus       321 ----------------~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~~  367 (398)
                                      +.       ..++.+++++++||.+||+.||++|||+.|+|+||||+......+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~  306 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD  306 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence                            00       113457889999999999999999999999999999997655433

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=416.13  Aligned_cols=262  Identities=30%  Similarity=0.495  Sum_probs=222.0

Q ss_pred             ccceecceecccCceEEEEEEEc---cCCcEEEEEEecccccC-CHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      ++|++++.||+|+||+||+|.+.   .+|+.||||++.+.... .....+.+.+|+.+++++++||||+++++++++...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999874   47899999998754332 223346688999999999855899999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++++|||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999   888999999999998764


Q ss_pred             CC--CcccccccCCcccCcccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          255 PG--QIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       255 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ..  .......|++.|+|||.+.+   .++.++|||||||+||+|++|..||.+....+....+.+............++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            33  23345789999999999863   37889999999999999999999998766555544444443333333334689


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSERL-----TAHEVLCHPWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rp-----s~~eiL~hp~~~~~~  363 (398)
                      +++.+||.+||++||++||     |++|+|+||||++..
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            9999999999999999999     589999999998744

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=416.59  Aligned_cols=264  Identities=24%  Similarity=0.400  Sum_probs=218.2

Q ss_pred             ccccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC--
Q 015898           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (398)
Q Consensus        95 ~~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~--  172 (398)
                      .++.++|++.++||+|+||+||+|.+..+|+.||||++.+.. .+....+++.+|+.+|++|. ||||+++++++...  
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccc
Confidence            345688999999999999999999999999999999997543 35566778999999999997 99999999998633  


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       173 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                         ...+++|+++.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||+
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~  167 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGL  167 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC--
T ss_pred             cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccch
Confidence               334556667779999987754 569999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCcCCC-----
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-----  322 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  322 (398)
                      |....  .......||+.|+|||.+.+  .++.++|||||||++|+|++|..||.+.+.......+.........     
T Consensus       168 a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         168 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             --CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            97643  34456789999999998764  3789999999999999999999999988877776666543221110     


Q ss_pred             ------------------C----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 015898          323 ------------------D----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENGVAP  366 (398)
Q Consensus       323 ------------------~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~~~~  366 (398)
                                        .    .+..++++++|||.+||+.||++|||+.|+|+||||++.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence                              0    1235789999999999999999999999999999999865433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=396.01  Aligned_cols=248  Identities=20%  Similarity=0.333  Sum_probs=204.3

Q ss_pred             ccceecceecccCceEEEEEEEccCC----cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      +.|++.++||+|+||+||+|.+..++    ..||||++....  .......+.+|+.++++|+ |||||+++|++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            35889999999999999999977654    469999986433  4555678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      .++||||+.++++.+.+... +.+++..+..++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+|+..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence            99999999999998877654 569999999999999999999999999999999999999   88899999999999876


Q ss_pred             CCCC----cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCC-CCCCCcChHHHHHHHHcCCCcCCCCCCCC
Q 015898          254 KPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (398)
Q Consensus       254 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (398)
                      ....    ......||+.|+|||++.+ .++.++|||||||++|||++|. +|+......+++..+..+...   .....
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCchh
Confidence            4432    2234568999999999874 6999999999999999999954 556666777777777665432   22235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       328 ~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++.++.+||.+||+.||++|||+.||++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            8899999999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=416.32  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=206.2

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEe-----
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----  170 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~-----  170 (398)
                      .+.++|+++++||+|+||+||+|.++.+|+.||||++.+.. .+.....++.+|+.+++++. ||||++++++|.     
T Consensus        14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence            34578999999999999999999999999999999997543 35667788999999999997 999999999995     


Q ss_pred             -cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCC
Q 015898          171 -DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (398)
Q Consensus       171 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~  249 (398)
                       ....+|+||||+.+ ++.+.+  ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||+
T Consensus        92 ~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~  165 (355)
T d2b1pa1          92 EEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred             ccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhh
Confidence             34789999999965 455555  3568999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHHcCCCc---------
Q 015898          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------  319 (398)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------  319 (398)
                      +............++|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+......         
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            988777667778899999999999985 5999999999999999999999999888776665554321110         


Q ss_pred             -------------CCCCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 015898          320 -------------FESDP----------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCHPWICENG  363 (398)
Q Consensus       320 -------------~~~~~----------------~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~hp~~~~~~  363 (398)
                                   .....                ....++++.+||.+||++||++|||++|||+||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                         00000                001356789999999999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-54  Score=396.50  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             cccceecceecccCceEEEEEEEccCC---cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCe
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~  174 (398)
                      .++|++.+.||+|+||.||+|.+..++   ..||||.+...  ......+.+.+|+.++++++ ||||+++++++. .+.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence            467999999999999999999976543   46888887543  25566778999999999997 999999999986 467


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceec
Q 015898          175 VHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (398)
Q Consensus       175 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~  253 (398)
                      +|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+||++   ++++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence            8999999999999987765 4469999999999999999999999999999999999999   77789999999999876


Q ss_pred             CCCC--cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          254 KPGQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       254 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ....  ......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+....+++..+..+...   ..++.++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            5432  234567899999999997 469999999999999999998 89999999998998888776533   2334689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +++.+||.+||+.||++|||+.||++|
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=402.40  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=211.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcE--EEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ++|++.++||+|+||+||+|.++.+|..  ||||.+...  ......+.+.+|+.+|.++.+||||+++++++.+.+.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            4599999999999999999999888875  666766432  244556789999999999955999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCc
Q 015898          177 IVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~  240 (398)
                      +||||+++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999998654                468999999999999999999999999999999999999   8888


Q ss_pred             cEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCC-CCCCCcChHHHHHHHHcCCC
Q 015898          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHI  318 (398)
Q Consensus       241 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~  318 (398)
                      .+||+|||+|.............||+.|+|||.+.+ .|+.++|||||||++|||++|. +||.+.+..++...+.++..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            999999999987654444455678999999999974 6999999999999999999965 67888888888888776532


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                         ......+++++.+||.+||+.||++|||+.||++|
T Consensus       245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence               22334688999999999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=394.04  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=207.3

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv  178 (398)
                      ++|++.+.||+|+||+||+|.+.. +..||||++....    ...+.+.+|+.++++++ |||||++++++.+ +..++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEEE
Confidence            569999999999999999999754 4679999986432    23467899999999998 9999999999865 457899


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||+++|+|...+..  .+.+++.++..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+|+.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCC
Confidence            999999999888754  3569999999999999999999999999999999999999   88899999999999876443


Q ss_pred             C--cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCC-CCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHH
Q 015898          257 Q--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (398)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (398)
                      .  ......||+.|+|||++. +.++.++|||||||++|||++|. +|+......+.+..+.++...   .....+++++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l  243 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESL  243 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCCcccCHHH
Confidence            3  234467899999999997 46999999999999999999965 555666677777777665422   2334689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc--CCCccCC
Q 015898          333 KDLIRKMLCSQPSERLTAHEVLC--HPWICEN  362 (398)
Q Consensus       333 ~~li~~~L~~dP~~Rps~~eiL~--hp~~~~~  362 (398)
                      .+||.+||+.||++|||+++|++  ++||...
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999999988  8899664

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=400.89  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=206.1

Q ss_pred             cceecceecccCceEEEEEEEccCCc----EEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      +|+++++||+|+||+||+|.+..+|+    +||+|.+....  +....+++.+|+.++++++ |||||++++++.++. .
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~-~   85 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-V   85 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESSS-E
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC-e
Confidence            49999999999999999999888876    57888775332  4455678999999999997 999999999998764 5


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++++|++.+++|.+.+... ..+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecc
Confidence            6788888899998887664 569999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCc---ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          255 PGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       255 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      ....   .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||.+.+..++...+.++....   ..+.++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~  239 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICT  239 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTBC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccC
Confidence            4332   234568999999999874 69999999999999999998 889998888888888777764322   223588


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +++.+||.+||+.||++|||+.||+.|
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=395.85  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=201.5

Q ss_pred             cccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-  171 (398)
                      .++|++.++||+|+||.||+|.+..     +++.||||++....  .....+.+.+|..++.++.+|+||+.+++++.. 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            4679999999999999999999754     44689999986433  455667888999999998779999999998765 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEee
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN  235 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~  235 (398)
                      +..+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||++|||||||||+|||+  
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--  167 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  167 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence            45689999999999999999653                248899999999999999999999999999999999999  


Q ss_pred             cCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCC-CCCCCcChHHHH
Q 015898          236 KDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGV-PPFWAETQQGIF  310 (398)
Q Consensus       236 ~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~  310 (398)
                       ++++.+||+|||+|+......   ......||+.|+|||++.+ .++.++|||||||++|||++|. +||.+......+
T Consensus       168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             888999999999998654332   2345689999999999985 5999999999999999999964 678766544444


Q ss_pred             -HHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          311 -DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       311 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                       ..+..+...   .....+++++.+||.+||+.||++|||+.||++|
T Consensus       247 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             444443322   2234588999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-53  Score=394.94  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=215.7

Q ss_pred             cccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      +++|++.+.||+|+||+||+|+.+.     +++.||||++....  .....+++.+|+.+|++++ ||||+++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            4569999999999999999999753     56789999986443  4556778999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG------------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp  228 (398)
                      +..++||||+++|+|.+++....                        .+++..+..++.|++.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986532                        388999999999999999999999999999999


Q ss_pred             CcEEEeecCCCccEEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCC-CCCCC
Q 015898          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGV-PPFWA  303 (398)
Q Consensus       229 ~NIll~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~  303 (398)
                      +|||+   +.++.+||+|||+|.......   ......||+.|+|||.+.+ .|+.++|||||||++|||++|. +||.+
T Consensus       169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999   888999999999997654332   2345678999999999985 6999999999999999999985 68989


Q ss_pred             cChHHHHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      .+..+....+.++.....   ...+++++.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999988888764322   3368899999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=389.77  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=203.3

Q ss_pred             ccceecceecccCceEEEEEEEccC-C--cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIAT-G--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      ++|++.+.||+|+||.||+|....+ +  ..||||++.+.........+.+.+|+.+|++++ ||||+++++++.+. ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence            4599999999999999999986433 3  468999997766556666788999999999997 99999999999764 67


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecC
Q 015898          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~  254 (398)
                      ++||||++++++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhcc
Confidence            899999999999987755 4569999999999999999999999999999999999999   667899999999999865


Q ss_pred             CCCc----ccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCC
Q 015898          255 PGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (398)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (398)
                      ....    .....|+..|+|||++.+ .++.++|||||||++|||+| |..||.+.+..+....+.+....++  ....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence            4432    234567889999999985 58999999999999999998 8999999999999888877654432  23468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          329 SDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       329 ~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++++.+||.+||+.||++|||+.||++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=390.67  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=212.9

Q ss_pred             ccccceecceecccCceEEEEEEEccCC-------cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~  169 (398)
                      -.++|++++.||+|+||.||+|.+..++       ..||||++.+..  .......+.+|...+.++.+||||+++++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3467999999999999999999876544       479999986543  5566788999999999996699999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEE
Q 015898          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (398)
Q Consensus       170 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll  233 (398)
                      .+++..++||||+++|+|.+++....                .+++..+..++.||+.||+|||+.|||||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            99999999999999999999997543                48999999999999999999999999999999999999


Q ss_pred             eecCCCccEEEeecCCceecCCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHH
Q 015898          234 VNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (398)
Q Consensus       234 ~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~  308 (398)
                         +.++.+||+|||++.......   ......+|+.|+|||.+. +.|+.++|||||||++|||++ |.+||.+.+...
T Consensus       169 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         169 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence               888999999999998765432   234567899999999987 469999999999999999998 789999888888


Q ss_pred             HHHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ++..+..+...   .....+++++.+||.+||+.||++|||+.||++
T Consensus       246 ~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            88887765432   223468899999999999999999999999976

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=386.36  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-CCeEEE
Q 015898           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVHI  177 (398)
Q Consensus        99 ~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~~~~~l  177 (398)
                      ++|++.+.||+|+||.||+|.+  +|..||||+++..     ...+.+.+|+.++++++ ||||+++++++.+ .+.+|+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            4589999999999999999996  5789999999643     23467899999999997 9999999998854 566899


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      ||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+|+||||||+|||+   +.++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCC
Confidence            999999999999986543  48999999999999999999999999999999999999   8889999999999987543


Q ss_pred             CCcccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHHcCCCcCCCCCCCCCCHHHH
Q 015898          256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (398)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (398)
                      .  .....+|..|+|||++. +.++.++|||||||++|||+| |.+||...+..++...+.++...   .....+++++.
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHH
Confidence            3  34567899999999987 469999999999999999998 78999888888888888765432   22335789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 015898          334 DLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       334 ~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                      +||.+||+.||++|||+.|++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999763

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=389.00  Aligned_cols=256  Identities=22%  Similarity=0.310  Sum_probs=221.2

Q ss_pred             ccccceecceecccCceEEEEEEEcc-----CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~  171 (398)
                      ..++|++.+.||+|+||+||+|.+..     ++..||||++....  .......+.+|+.+++++. ||||+++++++..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEec
Confidence            34679999999999999999998753     45789999986432  5566678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCcc
Q 015898          172 SLCVHIVMELCAGGELFDRIIQR----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (398)
Q Consensus       172 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~  241 (398)
                      ....++||||+++|+|.+++...          ..+++..+..++.+++.||.|||+++|+||||||+|||+   ++++.
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCce
Confidence            99999999999999999988643          247899999999999999999999999999999999999   88999


Q ss_pred             EEEeecCCceecCCCC---cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhC-CCCCCCcChHHHHHHHHcC
Q 015898          242 LKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKG  316 (398)
Q Consensus       242 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~  316 (398)
                      +||+|||+|.......   ......||+.|+|||.+.+ .++.++|||||||++|||+|| .+||.+.+..+.+..+.++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999998654332   2344578999999999874 589999999999999999998 5888888999999888876


Q ss_pred             CCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCccC
Q 015898          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC------HPWICE  361 (398)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~------hp~~~~  361 (398)
                      .....   .+.+++.+.+||.+||+.||++|||+.+|++      +|+|++
T Consensus       252 ~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         252 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            54322   2468899999999999999999999999998      777754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=386.17  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=212.8

Q ss_pred             cccceecceecccCceEEEEEEEc-----cCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecC
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~  172 (398)
                      .++|+++++||+|+||.||+|++.     .+++.||||++....  .......+.+|+.+++++.+||||+++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            467999999999999999999853     466789999996543  4566678999999999997799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEe
Q 015898          173 LCVHIVMELCAGGELFDRIIQRG------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (398)
Q Consensus       173 ~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~  234 (398)
                      ..+++|||||++|+|.+++....                  .+++..+..++.||+.||+|||++|||||||||+|||+ 
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~-  178 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-  178 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence            99999999999999999987643                  58999999999999999999999999999999999999 


Q ss_pred             ecCCCccEEEeecCCceecCCCC---cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcChHHH
Q 015898          235 NKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (398)
Q Consensus       235 ~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~  309 (398)
                        +.++.+||+|||.++......   ......||+.|+|||++. +.++.++|||||||++|||+| |.+||......+.
T Consensus       179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence              778899999999998765432   224568899999999998 468999999999999999999 5666666666555


Q ss_pred             HHHHHcCCCcCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      +..+........  ....+++++.+||.+||+.||++|||+.+|++
T Consensus       257 ~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            555444333222  22357899999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-51  Score=386.33  Aligned_cols=260  Identities=22%  Similarity=0.272  Sum_probs=206.8

Q ss_pred             ccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus        97 ~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      +.++|++.+.||+|+||+||+|.+..+|+.||||++.....     .+++..|+++++.+.+|++|+.+.+++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            45679999999999999999999999999999999865432     2357789999999985666777777788999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCC
Q 015898          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (398)
Q Consensus       177 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~  255 (398)
                      +||||+ +++|.+.+.. .+.+++..+..++.|++.||+|||++|||||||||+|||+...+.+..+||+|||+|.....
T Consensus        80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999999 5566665544 56799999999999999999999999999999999999996555667899999999987654


Q ss_pred             CC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChHHHHHHHH---cCCCcCC-C
Q 015898          256 GQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL---KGHIDFE-S  322 (398)
Q Consensus       256 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~---~~~~~~~-~  322 (398)
                      ..        ......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+.   ......+ .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            32        2345689999999999986 59999999999999999999999997655443322221   1111111 1


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCccCC
Q 015898          323 DPWPLISDSAKDLIRKMLCSQPSERLTAH---EVLCHPWICEN  362 (398)
Q Consensus       323 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~---eiL~hp~~~~~  362 (398)
                      .....+|+++.+||.+||+.||++||++.   ++|+|+|.+..
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            12335889999999999999999999986   55788876543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=379.09  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=207.6

Q ss_pred             eecceecccCceEEEEEEEccCC---cEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEec-CCeEEE
Q 015898          102 TLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVHI  177 (398)
Q Consensus       102 ~~~~~iG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~-~~~~~l  177 (398)
                      .+.++||+|+||+||+|.+..++   ..||||.+..  ..+....+++.+|+++|++|+ ||||+++++++.. ++..++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence            34678999999999999976543   3689999864  236677789999999999998 9999999999764 678999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEeecCCceecCCC
Q 015898          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (398)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~~~~~  256 (398)
                      |||||++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+   ++++.+||+|||+++.....
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence            999999999999887543 47788999999999999999999999999999999999   88899999999999876443


Q ss_pred             C-----cccccccCCcccCccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCC-cChHHHHHHHHcCCCcCCCCCCCCCC
Q 015898          257 Q-----IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLIS  329 (398)
Q Consensus       257 ~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~elltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (398)
                      .     ......||+.|+|||.+. +.++.++||||||+++|||++|..||.. ....+....+..+.....   ...++
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~  260 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCP  260 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTCC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCc
Confidence            2     223457899999999987 5699999999999999999997777654 344455666666543322   23578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC------CCccCCC
Q 015898          330 DSAKDLIRKMLCSQPSERLTAHEVLCH------PWICENG  363 (398)
Q Consensus       330 ~~~~~li~~~L~~dP~~Rps~~eiL~h------p~~~~~~  363 (398)
                      +++.+||.+||+.||++|||+.||++|      .|..+..
T Consensus       261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~  300 (311)
T d1r0pa_         261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  300 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence            999999999999999999999999988      6666544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-49  Score=371.82  Aligned_cols=254  Identities=19%  Similarity=0.283  Sum_probs=207.3

Q ss_pred             cccccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeE
Q 015898           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (398)
Q Consensus        96 ~~~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~  175 (398)
                      .+.++|++++.||+|+||+||+|.+..+|+.||||++....     ....+.+|+++++.|.+|+|++.+++++..+...
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            35678999999999999999999999999999999986432     1235678999999998679999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeec--CCCccEEEeecCCcee
Q 015898          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVF  252 (398)
Q Consensus       176 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~--~~~~~~kL~DFG~a~~  252 (398)
                      ++||||+ +++|.+++...+ .+++..+..++.|++.||+|||++|||||||||+|||+...  ...+.+||+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 789988887654 69999999999999999999999999999999999999532  1357899999999987


Q ss_pred             cCCCC--------cccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCh---HHHHHHHHcCCCc-
Q 015898          253 FKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHID-  319 (398)
Q Consensus       253 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~-  319 (398)
                      .....        .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+...   ......+...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            64321        2345689999999999986 599999999999999999999999975433   2333333222111 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015898          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (398)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eiL~  355 (398)
                      ......+.+++++.+++..|+..+|++||+++.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111122457899999999999999999998776643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=370.21  Aligned_cols=246  Identities=22%  Similarity=0.278  Sum_probs=189.3

Q ss_pred             cccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHH--HHHHHHHhcCCCCeeEEeEEEecCC--
Q 015898           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR--EIQIMHHLAGHKNIVTIKGAYEDSL--  173 (398)
Q Consensus        98 ~~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--Ei~~l~~l~~h~niv~l~~~~~~~~--  173 (398)
                      ..+|.+.+.||+|+||.||+|+.  +|+.||||++...      ......+  |+..+..++ ||||+++++++...+  
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence            45689999999999999999984  6899999998543      2233444  444555676 999999999987543  


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCcEEEeecCCCccEE
Q 015898          174 --CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS--------LGVMHRDLKPENFLLVNKDDDFSLK  243 (398)
Q Consensus       174 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~--------~~iiHrDikp~NIll~~~~~~~~~k  243 (398)
                        .+|+||||+++|+|.+++.+. .+++..+..++.+++.||.|||+        +|||||||||+||||   ++++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence              689999999999999999764 58999999999999999999996        599999999999999   8889999


Q ss_pred             EeecCCceecCCCC-----cccccccCCcccCccccccc-------CCCcccHHHHHHHHHHHHhCCCCCCCc-------
Q 015898          244 AIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLLKH-------YGPEADVWTAGVILYILLSGVPPFWAE-------  304 (398)
Q Consensus       244 L~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~elltg~~pf~~~-------  304 (398)
                      |+|||++.......     .....+||+.|+|||++.+.       ++.++|||||||+||||+||..||...       
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998764432     23457899999999998642       567899999999999999998876321       


Q ss_pred             --------ChHHHHHHHHcCCCcCCC-CCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015898          305 --------TQQGIFDAVLKGHIDFES-DPW--PLISDSAKDLIRKMLCSQPSERLTAHEVLCH  356 (398)
Q Consensus       305 --------~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~li~~~L~~dP~~Rps~~eiL~h  356 (398)
                              .................. ..+  ......+.+|+.+||+.||++|||+.||+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                    112222222222221111 000  0122458999999999999999999998763

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-47  Score=366.57  Aligned_cols=263  Identities=23%  Similarity=0.424  Sum_probs=197.8

Q ss_pred             cccc-ccceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhc----------CCCCee
Q 015898           95 DNIR-DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----------GHKNIV  163 (398)
Q Consensus        95 ~~~~-~~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----------~h~niv  163 (398)
                      +.+. ++|+++++||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.+.          +|+||+
T Consensus         8 ~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv   83 (362)
T d1q8ya_           8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   83 (362)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence            3444 4699999999999999999999999999999999653    334567788999988875          268899


Q ss_pred             EEeEEEec--CCeEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCcEEEeecC
Q 015898          164 TIKGAYED--SLCVHIVMELCAGGELFDRI---IQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD  237 (398)
Q Consensus       164 ~l~~~~~~--~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~~i~~al~~lH~-~~iiHrDikp~NIll~~~~  237 (398)
                      ++++++..  ....+++|+++..+......   .....+++..+..++.||+.||.|||+ .||+||||||+|||+...+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence            99998854  45666777766554433322   223568999999999999999999998 8999999999999994322


Q ss_pred             CC---ccEEEeecCCceecCCCCcccccccCCcccCcccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcChH------
Q 015898          238 DD---FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ------  307 (398)
Q Consensus       238 ~~---~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~------  307 (398)
                      ..   ..++|+|||.|.....  .....+||+.|+|||++.. .|+.++||||+||++++|++|+.||......      
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence            21   2499999999986543  3356789999999998874 6999999999999999999999999643321      


Q ss_pred             HHHHHHHc--CC------------------C----cC--------------CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 015898          308 GIFDAVLK--GH------------------I----DF--------------ESDPWPLISDSAKDLIRKMLCSQPSERLT  349 (398)
Q Consensus       308 ~~~~~~~~--~~------------------~----~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps  349 (398)
                      +.+.....  +.                  .    ..              ........+++++|||.+||++||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            11111100  00                  0    00              00011123578999999999999999999


Q ss_pred             HHHHhcCCCccCCC
Q 015898          350 AHEVLCHPWICENG  363 (398)
Q Consensus       350 ~~eiL~hp~~~~~~  363 (398)
                      ++|||+||||++..
T Consensus       322 a~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         322 AGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.4e-27  Score=207.84  Aligned_cols=167  Identities=20%  Similarity=0.230  Sum_probs=124.0

Q ss_pred             ceecceecccCceEEEEEEEccCCcEEEEEEecccccC---------------CHhhHHHHHHHHHHHHHhcCCCCeeEE
Q 015898          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---------------SREDVEDVRREIQIMHHLAGHKNIVTI  165 (398)
Q Consensus       101 y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~Ei~~l~~l~~h~niv~l  165 (398)
                      +.++++||+|+||+||+|.+ .+|+.||||++......               .........+|...+.++. |.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            56789999999999999997 47899999987532110               0112234567889999997 9999988


Q ss_pred             eEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCcEEEeecCCCccEEEe
Q 015898          166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (398)
Q Consensus       166 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~~~iiHrDikp~NIll~~~~~~~~~kL~  245 (398)
                      +++..    .+++|||+++..+..       ++...+..++.|++.+|.|||++||+||||||+|||+   +++ .++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv---~~~-~~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---SEE-GIWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---ETT-EEEEC
T ss_pred             EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee---eCC-CEEEE
Confidence            87532    269999998865532       5566778899999999999999999999999999999   444 48999


Q ss_pred             ecCCceecCCCCcccccccCCcccC------cccccccCCCcccHHHHHHHH
Q 015898          246 DFGLSVFFKPGQIFTDVVGSPYYVA------PEVLLKHYGPEADVWTAGVIL  291 (398)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwSlG~il  291 (398)
                      |||+|.....+...       .|..      .+.+.+.|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999775433211       1222      123345689999999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.83  E-value=1e-08  Score=91.09  Aligned_cols=140  Identities=19%  Similarity=0.156  Sum_probs=94.8

Q ss_pred             cceecceecccCceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEEEEE
Q 015898          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (398)
Q Consensus       100 ~y~~~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~lv~  179 (398)
                      .|++.+..+-++.+.||+..  .++..++||+......   .....+.+|...+..|.++--+.+++.+....+..++||
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            46666665555567899876  5666788898754422   123356789999988876656788888888889999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015898          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-----------------------------------------  218 (398)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~al~~lH~-----------------------------------------  218 (398)
                      ++++|.++.+....     ......++.++...+..||+                                         
T Consensus        90 ~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          90 SEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             Eecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            99998777543321     11112223333333333332                                         


Q ss_pred             ------------------CCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          219 ------------------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       219 ------------------~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                                        ..++|+|+.|.|||+   ++++.+-|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhccc
Confidence                              137999999999999   6656567999998875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.31  E-value=1.1e-06  Score=82.60  Aligned_cols=82  Identities=11%  Similarity=0.074  Sum_probs=51.7

Q ss_pred             cceecccCceEEEEEEEccCCcEEEEEEecccccC----CHhhHHHHHHHHHHHHHhcCC--CCeeEEeEEEecCCeEEE
Q 015898          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHI  177 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~Ei~~l~~l~~h--~niv~l~~~~~~~~~~~l  177 (398)
                      .+.||.|....||++.+...++.|+||.-......    ......+...|...|+.+..+  ..+++++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            35689999999999987777889999975431111    112334566788888877543  3456666543  334578


Q ss_pred             EEeccCCCCh
Q 015898          178 VMELCAGGEL  187 (398)
Q Consensus       178 v~e~~~~~~L  187 (398)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.31  E-value=7.5e-07  Score=78.26  Aligned_cols=74  Identities=9%  Similarity=0.055  Sum_probs=52.1

Q ss_pred             ecccC-ceEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeEEEecCCeEEEEEeccCC
Q 015898          107 LGQGQ-FGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVMELCAG  184 (398)
Q Consensus       107 iG~G~-fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~~~  184 (398)
                      +..|. .+.||+.. ...+..+++|......      ...+..|...++.|..+. .+.+++.+..+.+..++||++++|
T Consensus        18 ~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEE-CTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEE-eCCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            44454 36899987 3556678899764332      234677888888776432 367788888888899999999987


Q ss_pred             CCh
Q 015898          185 GEL  187 (398)
Q Consensus       185 ~~L  187 (398)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00032  Score=63.51  Aligned_cols=68  Identities=13%  Similarity=0.106  Sum_probs=44.2

Q ss_pred             eEEEEEEEccCCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCC-CeeEEeE-----EEecCCeEEEEEeccCCC
Q 015898          113 GTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKG-----AYEDSLCVHIVMELCAGG  185 (398)
Q Consensus       113 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~-niv~l~~-----~~~~~~~~~lv~e~~~~~  185 (398)
                      -.||++. ..+|..|++|+....    ....+++..|+..+..|..+. -++..+.     .+...+..+.++++++|.
T Consensus        36 N~vy~v~-~~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQ-DEDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEEC-CTTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEE-cCCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            5799987 468889999997542    123456778999888886321 1111111     234566788999999763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.32  E-value=0.00046  Score=64.18  Aligned_cols=75  Identities=12%  Similarity=0.090  Sum_probs=52.2

Q ss_pred             cceecccCceEEEEEEEcc-------CCcEEEEEEecccccCCHhhHHHHHHHHHHHHHhcCCCCeeEEeEEEecCCeEE
Q 015898          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (398)
Q Consensus       104 ~~~iG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h~niv~l~~~~~~~~~~~  176 (398)
                      ++.|+-|-.-.+|++....       .++.|.+++....    .. .-...+|..+++.+..+.-.+++++++.+    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            3568888888999987542       3466888876521    11 22455799999998866656788887754    5


Q ss_pred             EEEeccCCCCh
Q 015898          177 IVMELCAGGEL  187 (398)
Q Consensus       177 lv~e~~~~~~L  187 (398)
                      +|+||++|..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.45  E-value=0.0035  Score=55.87  Aligned_cols=31  Identities=32%  Similarity=0.373  Sum_probs=26.7

Q ss_pred             CCceeccCCCCcEEEeecCCCccEEEeecCCcee
Q 015898          219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (398)
Q Consensus       219 ~~iiHrDikp~NIll~~~~~~~~~kL~DFG~a~~  252 (398)
                      .|+||+|+.+.||++   +++...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFF---LGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhc---ccccceeEeccccccc
Confidence            479999999999999   6666678999998864